
TTD - Therapeutic Targets Database Full Data Download File
Title - TTD targets information in raw format
Version 8.1.01 (2021.11.08)
Provided by IDRB   Lab of Innovative Drug Reasearch and Bioinformatics
                   College of Pharmaceutical Sciences
                   Zhejiang University
                   https://idrblab.org/
Provided by BIDD   BioInformatic and Drug Design Group
                   Department of Pharmacy
                   National Unviersity of Singapore
                   http://bidd.nus.edu.sg/
Any question about data provided here, please contact with:
Dr. Zhou (zhou_ying@zju.edu.cn) and Dr. Zhang (zhangyintao@zju.edu.cn)

--------------------------------------------------------------------------------------------------------
Abbreviations:
TARGETID	TTD Target ID
FORMERID	TTD Former Target ID
UNIPROID	Uniprot ID
TARGNAME	Target Name
GENENAME	Target Gene Name
TARGTYPE	Target Type
SYNONYMS	Synonyms
FUNCTION	Function
PDBSTRUC	PDB Structure
BIOCLASS	BioChemical Class
ECNUMBER	EC Number
SEQUENCE	Sequence
DRUGINFO	TTD Drug ID	Drug Name	Highest Clinical Status
KEGGPATH	KEGG Pathway
WIKIPATH	WiKipathway
WHIZPATH	PathWhiz Pathway
REACPATH	Reactome Pathway
NET_PATH	NetPathway
INTEPATH	Pathway Interact
PANTPATH	PANTHER Pathway
BIOCPATH	BioCyc
--------------------------------------------------------------------------------------------------------

T47101	TARGETID	T47101		
T47101	FORMERID	TTDC00024		
T47101	UNIPROID	FGFR1_HUMAN		
T47101	TARGNAME	Fibroblast growth factor receptor 1 (FGFR1)		
T47101	GENENAME	FGFR1		
T47101	TARGTYPE	Successful target		
T47101	SYNONYMS	c-fgr; bFGF-R-1; bFGF-R; N-sam; HBGFR; Fms-like tyrosine kinase 2; FLT2; FLT-2; FLG; FGFR-1; FGFBR; CEK; CD331 antigen; CD331; Basic fibroblast growth factor receptor 1; BFGFR		
T47101	FUNCTION	Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Promotes phosphorylation of SHC1, STAT1 and PTPN11/SHP2. In the nucleus, enhances RPS6KA1 and CREB1 activity and contributes to the regulation of transcription. FGFR1 signaling is down-regulated by IL17RD/SEF, and by FGFR1 ubiquitination, internalization and degradation. Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration.		
T47101	PDBSTRUC	6MZW; 6MZQ; 6C1O; 6C1C; 6C1B		
T47101	BIOCLASS	Kinase		
T47101	ECNUMBER	EC 2.7.10.1		
T47101	SEQUENCE	MWSWKCLLFWAVLVTATLCTARPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWLRDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETDNTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIMDSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKHIEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPAVMTSPLYLEIIIYCTGAFLISCMVGSVIVYKMKSGTKKSDFHSQMAVHKLAKSIPLRRQVTVSADSSASMNSGVLLVRPSRLSSSGTPMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGCFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEYLDLSMPLDQYSPSFPDTRSSTCSSGEDSVFSHEPLPEEPCLPRHPAQLANGGLKRR		
T47101	DRUGINFO	D09HNV	Intedanib	Approved
T47101	DRUGINFO	D0O6UY	Pemigatinib	Approved
T47101	DRUGINFO	D01PZD	Romiplostim	Approved
T47101	DRUGINFO	D07PQJ	ARQ-087	Phase 3
T47101	DRUGINFO	D03LWG	BGJ398	Phase 3
T47101	DRUGINFO	D02WVT	E-3810	Phase 3
T47101	DRUGINFO	D0A1AQ	Rosiglitazone + metformin	Phase 3
T47101	DRUGINFO	D05PWX	Sulfatinib	Phase 3
T47101	DRUGINFO	D0NU0U	AZD4547	Phase 2/3
T47101	DRUGINFO	D08DFF	AM-001	Phase 2
T47101	DRUGINFO	D0XT0W	Debio 1347	Phase 2
T47101	DRUGINFO	D08ZHL	FGF-1	Phase 2
T47101	DRUGINFO	D0U2DO	FP-1039	Phase 2
T47101	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T47101	DRUGINFO	D00ABO	KW-2449	Phase 1
T47101	DRUGINFO	D0DJ0S	NGM313	Phase 1
T47101	DRUGINFO	D0LF0O	BMS-695735	Preclinical
T47101	DRUGINFO	D0Z0KD	PD-0183812	Terminated
T47101	DRUGINFO	D0XC6G	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	Investigative
T47101	DRUGINFO	D06QUJ	3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine	Investigative
T47101	DRUGINFO	D07QMC	3-Benzimidazol-2-ylhydroquinolin-2-one	Investigative
T47101	DRUGINFO	D0EE6A	AAL-993	Investigative
T47101	DRUGINFO	D0R6OM	ACTB-1003	Investigative
T47101	DRUGINFO	D00JZS	Anti-FGFR1 mab program	Investigative
T47101	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T47101	DRUGINFO	D04FNY	NP-506	Investigative
T47101	DRUGINFO	D0P3JW	PD-0166326	Investigative
T47101	DRUGINFO	D0S1KJ	PD-0173952	Investigative
T47101	DRUGINFO	D03NPX	PD-0173955	Investigative
T47101	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T47101	DRUGINFO	D0Z7GH	PD-0173958	Investigative
T47101	DRUGINFO	D0OH3J	PD-0179483	Investigative
T47101	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T47101	DRUGINFO	D0E7VO	PMID24900538C2c	Investigative
T47101	DRUGINFO	D06FFZ	PMID26080733C7r	Investigative
T47101	DRUGINFO	D09XIL	Ro-4396686	Investigative
T47101	DRUGINFO	D01AVF	SAR-106881	Investigative
T47101	KEGGPATH	hsa04010:MAPK signaling pathway		
T47101	KEGGPATH	hsa04014:Ras signaling pathway		
T47101	KEGGPATH	hsa04015:Rap1 signaling pathway		
T47101	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T47101	KEGGPATH	hsa04520:Adherens junction		
T47101	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T47101	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T47101	KEGGPATH	hsa05200:Pathways in cancer		
T47101	KEGGPATH	hsa05205:Proteoglycans in cancer		
T47101	KEGGPATH	hsa05215:Prostate cancer		
T47101	KEGGPATH	hsa05218:Melanoma		
T47101	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T47101	WIKIPATH	WP1911:Signaling by FGFR		
T47101	WIKIPATH	WP2064:Neural Crest Differentiation		
T47101	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T47101	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T47101	WIKIPATH	WP2804:Hair Follicle Development: Induction (Part 1 of 3)		
T47101	WIKIPATH	WP2857:Mesodermal Commitment Pathway		
T47101	WIKIPATH	WP382:MAPK Signaling Pathway		
T47101	WIKIPATH	WP474:Endochondral Ossification		
T47101	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T47101	NET_PATH	NetPath_11:TCR Signaling Pathway		
T47101	INTEPATH	fgf_pathway:FGF signaling pathway		
T47101	INTEPATH	glypican_1pathway:Glypican 1 network		
T47101	INTEPATH	ncadherinpathway:N-cadherin signaling events		
T47101	INTEPATH	syndecan_4_pathway:Syndecan-4-mediated signaling events		
T47101	PANTPATH	P00005:Angiogenesis		
T47101	PANTPATH	P00021:FGF signaling pathway		
				
T59328	TARGETID	T59328		
T59328	FORMERID	TTDS00355		
T59328	UNIPROID	EGFR_HUMAN		
T59328	TARGNAME	Epidermal growth factor receptor (EGFR)		
T59328	GENENAME	EGFR		
T59328	TARGTYPE	Successful target		
T59328	SYNONYMS	Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB		
T59328	FUNCTION	Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, AREG, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Plays a role in enhancing learning and memory performance (By similarity).		
T59328	PDBSTRUC	6D8E; 6B3S; 6ARU; 5ZWJ; 5YU9		
T59328	BIOCLASS	Kinase		
T59328	ECNUMBER	EC 2.7.10.1		
T59328	SEQUENCE	MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA		
T59328	DRUGINFO	D05UFG	BIBW 2992	Approved
T59328	DRUGINFO	D0N5OV	Cetuximab	Approved
T59328	DRUGINFO	D06XXH	Dacomitinib	Approved
T59328	DRUGINFO	D08TPS	Epidermal growth factor	Approved
T59328	DRUGINFO	D07POC	Erlotinib	Approved
T59328	DRUGINFO	D09XZB	Gefitinib	Approved
T59328	DRUGINFO	D05GGP	HEGF	Approved
T59328	DRUGINFO	D08CDI	Lapatinib	Approved
T59328	DRUGINFO	D0F0ZE	Merimepodib	Approved
T59328	DRUGINFO	D03WPP	Necitumumab	Approved
T59328	DRUGINFO	D0U1ZV	NERATINIB MALEATE	Approved
T59328	DRUGINFO	D07YDE	Nitroglycerin	Approved
T59328	DRUGINFO	D0O8GK	Osimertinib	Approved
T59328	DRUGINFO	D0HU9H	Panitumumab	Approved
T59328	DRUGINFO	D03MNN	SKI-758	Approved
T59328	DRUGINFO	D0W5HK	Sorafenib	Approved
T59328	DRUGINFO	D0G6QF	Vandetanib	Approved
T59328	DRUGINFO	D06WRJ	Icotinib hydrochloride	Registered
T59328	DRUGINFO	DDH8L6	Almonertinib	Phase 3
T59328	DRUGINFO	DQ5X1Z	Amivantamab	Phase 3
T59328	DRUGINFO	DWK96T	ASP1929	Phase 3
T59328	DRUGINFO	D09BKY	Bevacizumab + Erlotinib	Phase 3
T59328	DRUGINFO	D0M4AV	CO-1686	Phase 3
T59328	DRUGINFO	D0FJ1W	DE-766	Phase 3
T59328	DRUGINFO	D0K7FY	EGF816	Phase 3
T59328	DRUGINFO	D0Q9CY	HKI-272	Phase 3
T59328	DRUGINFO	D05FRP	Rindopepimut	Phase 3
T59328	DRUGINFO	D0CR8H	SYM-004	Phase 3
T59328	DRUGINFO	D0R4PW	Zalutumumab	Phase 3
T59328	DRUGINFO	D0F3KC	Indium-111	Phase 2/3
T59328	DRUGINFO	D00NYJ	Varlitinib	Phase 2/3
T59328	DRUGINFO	D06XIT	ABT-414	Phase 2
T59328	DRUGINFO	D0P9RG	ABX-EGF	Phase 2
T59328	DRUGINFO	D02BYZ	ASP8273	Phase 2
T59328	DRUGINFO	D0U4FF	BMS-599626	Phase 2
T59328	DRUGINFO	D0R6UV	BMS-690514	Phase 2
T59328	DRUGINFO	D0K9MC	CetuGEX	Phase 2
T59328	DRUGINFO	D0YB3W	CI-1033	Phase 2
T59328	DRUGINFO	D0A6CC	Depatuxizumab	Phase 2
T59328	DRUGINFO	D0C3LL	HER1-VSSP vaccine	Phase 2
T59328	DRUGINFO	D00YER	HM-78136B	Phase 2
T59328	DRUGINFO	D0BZ7V	Matuzumab	Phase 2
T59328	DRUGINFO	D09BZJ	MEHD-7945A	Phase 2
T59328	DRUGINFO	D03UKJ	Pazopanib + Tyverb/Tykerb	Phase 2
T59328	DRUGINFO	D0S3PO	Pelitinib	Phase 2
T59328	DRUGINFO	D0FN4T	RM-1929	Phase 2
T59328	DRUGINFO	DUW81M	Tarloxotinib	Phase 2
T59328	DRUGINFO	D0T5JS	TT-100	Phase 2
T59328	DRUGINFO	D0P6DJ	VATALANIB	Phase 2
T59328	DRUGINFO	DK8QG3	AFM24	Phase 1/2
T59328	DRUGINFO	D9FJ5V	BDTX-189	Phase 1/2
T59328	DRUGINFO	D04DHZ	CART-EGFR	Phase 1/2
T59328	DRUGINFO	D0G1ZU	EGFR CART	Phase 1/2
T59328	DRUGINFO	DWQ6J1	EMB-01	Phase 1/2
T59328	DRUGINFO	D0S8BG	EMD 55900	Phase 1/2
T59328	DRUGINFO	D05ETC	SN-32793	Phase 1/2
T59328	DRUGINFO	D0FF2G	Sym013	Phase 1/2
T59328	DRUGINFO	D0B4OK	Sym015	Phase 1/2
T59328	DRUGINFO	DF0PR6	ZN-e4	Phase 1/2
T59328	DRUGINFO	D0V4XY	S-222611	Phase 1b
T59328	DRUGINFO	D05LMC	AMG 595	Phase 1
T59328	DRUGINFO	D0T0SE	Anti-EGFR CAR T	Phase 1
T59328	DRUGINFO	D0JW2O	Anti-HER3/EGFR DAF	Phase 1
T59328	DRUGINFO	D0X7BN	AP32788	Phase 1
T59328	DRUGINFO	D04OLK	AST-1306	Phase 1
T59328	DRUGINFO	D0U7XJ	BCA101	Phase 1
T59328	DRUGINFO	D00RMC	BIBX-1382	Phase 1
T59328	DRUGINFO	D08JAN	Cipatinib	Phase 1
T59328	DRUGINFO	D68RMI	CLN-081	Phase 1
T59328	DRUGINFO	D0Z4RC	CUDC-101	Phase 1
T59328	DRUGINFO	DR4ND6	D2C7	Phase 1
T59328	DRUGINFO	D0I7ZH	EGFR806-specific CAR T cell	Phase 1
T59328	DRUGINFO	D0E7RC	HER-2/HER-1 vaccine	Phase 1
T59328	DRUGINFO	D04HSH	IMGN289	Phase 1
T59328	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T59328	DRUGINFO	D01IJM	LY3164530	Phase 1
T59328	DRUGINFO	DV8I4Q	MCLA-158	Phase 1
T59328	DRUGINFO	D01NAP	MM-151	Phase 1
T59328	DRUGINFO	D0N3PC	MR1-1	Phase 1
T59328	DRUGINFO	D0JS0W	PF-05230907	Phase 1
T59328	DRUGINFO	D6JM8Z	SI-B001	Phase 1
T59328	DRUGINFO	D00KML	SYN004	Phase 1
T59328	DRUGINFO	D0Z2PC	Pyrrolo[2,3-d]pyrimidine derivative 24	Patented
T59328	DRUGINFO	D07GFF	PKI166	Discontinued in Phase 2
T59328	DRUGINFO	D0E2CQ	RG7160	Discontinued in Phase 2
T59328	DRUGINFO	D02RZL	AZD4769	Discontinued in Phase 1
T59328	DRUGINFO	D0Q7HO	PD-153035	Discontinued in Phase 1
T59328	DRUGINFO	D0A9OV	TAK165	Discontinued in Phase 1
T59328	DRUGINFO	D0V2FZ	111In-hEGF	Preclinical
T59328	DRUGINFO	D0TI4U	EGFR/IGFR tandem adnectin	Preclinical
T59328	DRUGINFO	D0Y1YX	AZD-9935	Terminated
T59328	DRUGINFO	D03QTP	CGP-52411	Terminated
T59328	DRUGINFO	D0HO1S	CGP-53353	Terminated
T59328	DRUGINFO	D02GFZ	Heparin-EGF-like factor	Terminated
T59328	DRUGINFO	D0Y2AM	(3-Bromo-phenyl)-(5-nitro-quinazolin-4-yl)-amine	Investigative
T59328	DRUGINFO	D02ZRO	(3-Bromo-phenyl)-quinazolin-4-yl-amine	Investigative
T59328	DRUGINFO	D06UEK	(E)-5-(4-Hydroxybenzylidene)-1-phenethylhydantoin	Investigative
T59328	DRUGINFO	D0KN1L	(S)-benzyl 4-chloro-3-oxobutan-2-ylcarbamate	Investigative
T59328	DRUGINFO	D0W6CE	10-hydroxy-18-methoxybetaenone	Investigative
T59328	DRUGINFO	D02RIG	2-(4,5-Dihydroxy-indan-1-ylidene)-malononitrile	Investigative
T59328	DRUGINFO	D07IHD	2-(5,6-Dihydroxy-indan-1-ylidene)-malononitrile	Investigative
T59328	DRUGINFO	D00VZA	2-benzoyl-3-(3,4-dihydroxyphenyl)acrylonitrile	Investigative
T59328	DRUGINFO	D01NTW	2-cyano-3-(3,4-dihydroxyphenyl)acrylamide	Investigative
T59328	DRUGINFO	D0O9UR	2-methoxy-4-(2-nitrovinyl)phenol	Investigative
T59328	DRUGINFO	D0C9KC	3-(3-Chloro-phenyl)-5,7-dihydroxy-chromen-4-one	Investigative
T59328	DRUGINFO	D0EK0G	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D06AOY	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D00NYT	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D0C3WY	3,4-diphenyl-1H-pyrrole-2,5-dione	Investigative
T59328	DRUGINFO	D0B8DE	3-Pyridin-4-yl-quinoline-6,7-diol	Investigative
T59328	DRUGINFO	D0K2YY	4-(2-nitroprop-1-enyl)benzene-1,2-diol	Investigative
T59328	DRUGINFO	D0L3SN	4-(2-nitrovinyl)benzene-1,2-diol	Investigative
T59328	DRUGINFO	D0W1BE	4-(2-nitrovinyl)phenol	Investigative
T59328	DRUGINFO	D03HLH	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	Investigative
T59328	DRUGINFO	D05QMN	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59328	DRUGINFO	D0J9WO	4-(3-Bromo-phenylamino)-quinazoline-6,7-diol	Investigative
T59328	DRUGINFO	D0G4HR	4-(4-(2-nitrovinyl)phenoxysulfonyl)benzoic acid	Investigative
T59328	DRUGINFO	D0I7RA	4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline	Investigative
T59328	DRUGINFO	D0X4OU	4557W	Investigative
T59328	DRUGINFO	D0W2PQ	4-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Investigative
T59328	DRUGINFO	D0S9QP	4-biphenyl-2-ylethynyl-6,7-dimethoxy-quinazoline	Investigative
T59328	DRUGINFO	D0EH6L	5,6-Bis-p-tolylamino-isoindole-1,3-dione	Investigative
T59328	DRUGINFO	D03WEN	5-acrylamido-N-(3-bromophenyl)-2-hydroxybenzamide	Investigative
T59328	DRUGINFO	D03CVQ	6,7-diethoxy-4-(4-phenylbut-1-enyl)quinazoline	Investigative
T59328	DRUGINFO	D04LXG	6,7-diethoxy-4-(5-phenylpent-1-enyl)quinazoline	Investigative
T59328	DRUGINFO	D01WXV	6,7-diethoxy-4-styrylquinazoline	Investigative
T59328	DRUGINFO	D0P2GE	6,7-dimethoxy-4-(2-phenylethynyl)quinazoline	Investigative
T59328	DRUGINFO	D00WZG	6,7-dimethoxy-4-(3-phenoxyprop-1-ynyl)quinazoline	Investigative
T59328	DRUGINFO	D0K2VO	6,7-dimethoxy-4-(4-phenylbut-1-ynyl)quinazoline	Investigative
T59328	DRUGINFO	D0DF3Z	6,7-dimethoxy-N-m-tolylquinazolin-4-amine	Investigative
T59328	DRUGINFO	D0J5SK	6-chloro-N-(3-chlorophenyl)quinazolin-4-amine	Investigative
T59328	DRUGINFO	D02FGG	AFM-21	Investigative
T59328	DRUGINFO	D02KVB	AG 112	Investigative
T59328	DRUGINFO	D0H3UI	AG 9	Investigative
T59328	DRUGINFO	D0Q3GG	AG-213	Investigative
T59328	DRUGINFO	D0NH7M	AG-538	Investigative
T59328	DRUGINFO	D0C5WE	AGT-2000	Investigative
T59328	DRUGINFO	D0T7OS	AL-6802	Investigative
T59328	DRUGINFO	D0R2RV	Anti-EGFR humanized mabs	Investigative
T59328	DRUGINFO	D09RXX	Anti-EGFR mab	Investigative
T59328	DRUGINFO	D0GB7F	ARX-AHD	Investigative
T59328	DRUGINFO	D0G9KD	Benzo[g]quinazolin-4-yl-(3-bromo-phenyl)-amine	Investigative
T59328	DRUGINFO	D01WDI	Benzyl-quinazolin-4-yl-amine	Investigative
T59328	DRUGINFO	D04GCH	Bmab-200	Investigative
T59328	DRUGINFO	D0U6WB	BPIQ-I	Investigative
T59328	DRUGINFO	D00TZD	CL-387785	Investigative
T59328	DRUGINFO	D0ZT9D	Cochliobolic acid	Investigative
T59328	DRUGINFO	D0K3FG	EDP-13	Investigative
T59328	DRUGINFO	D03BJB	EGFR inhibitor	Investigative
T59328	DRUGINFO	D05MEY	Epitinib	Investigative
T59328	DRUGINFO	D0D0GS	FHT-2107	Investigative
T59328	DRUGINFO	D0D0YK	GI-3000	Investigative
T59328	DRUGINFO	D05FFT	HDS-029	Investigative
T59328	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T59328	DRUGINFO	D01SQP	HM-61713B	Investigative
T59328	DRUGINFO	D04HGN	HTS-00213	Investigative
T59328	DRUGINFO	D07CZM	HTS-02876	Investigative
T59328	DRUGINFO	D0EP1G	HTS-05058	Investigative
T59328	DRUGINFO	D03ZIW	ICR 62	Investigative
T59328	DRUGINFO	D0AC7C	IPS-01003	Investigative
T59328	DRUGINFO	D03MTY	LA22-radioimmunoconjugates	Investigative
T59328	DRUGINFO	D0D9TU	LAVENDUSTIN A	Investigative
T59328	DRUGINFO	D0V0JV	mabionHER2	Investigative
T59328	DRUGINFO	D0WD8R	MDP-01	Investigative
T59328	DRUGINFO	D0P0JW	MG-111	Investigative
T59328	DRUGINFO	D08RXW	MT-062	Investigative
T59328	DRUGINFO	D0N8TQ	N-(4-(phenylamino)quinazolin-6-yl)acrylamide	Investigative
T59328	DRUGINFO	D01WYI	N-(4-m-Tolylamino-quinazolin-6-yl)-acrylamide	Investigative
T59328	DRUGINFO	D0F6FZ	N-(4-m-Tolylamino-quinazolin-7-yl)-acrylamide	Investigative
T59328	DRUGINFO	D0B4PH	N*4*-(3-Bromo-phenyl)-quinazoline-4,6,7-triamine	Investigative
T59328	DRUGINFO	D0HM5W	N*4*-(3-Bromo-phenyl)-quinazoline-4,6-diamine	Investigative
T59328	DRUGINFO	D0K7GD	N*4*-(3-Bromo-phenyl)-quinazoline-4,7-diamine	Investigative
T59328	DRUGINFO	D05ARF	N*4*-Benzyl-pyrido[4,3-d]pyrimidine-4,7-diamine	Investigative
T59328	DRUGINFO	D00TJF	N4-(3-chlorophenyl)quinazoline-4,6-diamine	Investigative
T59328	DRUGINFO	D0X4UE	N4-(3-methylphenyl)-4,6-quinazolinediamine	Investigative
T59328	DRUGINFO	D0Y6MD	NRC-2694	Investigative
T59328	DRUGINFO	D0CY9O	ON-128	Investigative
T59328	DRUGINFO	D06QEQ	OSI-75	Investigative
T59328	DRUGINFO	D0P3JW	PD-0166326	Investigative
T59328	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T59328	DRUGINFO	D03ATU	PD-158780	Investigative
T59328	DRUGINFO	D01VFR	PD-168393	Investigative
T59328	DRUGINFO	D02GCE	PD182905	Investigative
T59328	DRUGINFO	D0J2CP	PF 5208766	Investigative
T59328	DRUGINFO	D06BJG	PMID24915291C38	Investigative
T59328	DRUGINFO	D07UYV	PMID8568816C56	Investigative
T59328	DRUGINFO	D03EHM	PP121	Investigative
T59328	DRUGINFO	D0A0JL	RG-50810	Investigative
T59328	DRUGINFO	D0AH2V	RM-6427	Investigative
T59328	DRUGINFO	D09XIL	Ro-4396686	Investigative
T59328	DRUGINFO	D0Y1LD	RX-1792	Investigative
T59328	DRUGINFO	D0Q8GX	SYM-011	Investigative
T59328	DRUGINFO	D0H3FX	TGF alpha	Investigative
T59328	DRUGINFO	D0J3EA	Theliatinib	Investigative
T59328	DRUGINFO	D0ZH1U	Tyrphostin ag-1478	Investigative
T59328	DRUGINFO	D0E5IP	WHI-P154	Investigative
T59328	DRUGINFO	D0NJ3Q	WZ-3146	Investigative
T59328	KEGGPATH	hsa04010:MAPK signaling pathway		
T59328	KEGGPATH	hsa04012:ErbB signaling pathway		
T59328	KEGGPATH	hsa04014:Ras signaling pathway		
T59328	KEGGPATH	hsa04015:Rap1 signaling pathway		
T59328	KEGGPATH	hsa04020:Calcium signaling pathway		
T59328	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T59328	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T59328	KEGGPATH	hsa04068:FoxO signaling pathway		
T59328	KEGGPATH	hsa04144:Endocytosis		
T59328	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T59328	KEGGPATH	hsa04320:Dorso-ventral axis formation		
T59328	KEGGPATH	hsa04510:Focal adhesion		
T59328	KEGGPATH	hsa04520:Adherens junction		
T59328	KEGGPATH	hsa04540:Gap junction		
T59328	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T59328	KEGGPATH	hsa04912:GnRH signaling pathway		
T59328	KEGGPATH	hsa04915:Estrogen signaling pathway		
T59328	KEGGPATH	hsa04921:Oxytocin signaling pathway		
T59328	KEGGPATH	hsa05120:Epithelial cell signaling in Helicobacter pylori infection		
T59328	KEGGPATH	hsa05160:Hepatitis C		
T59328	KEGGPATH	hsa05200:Pathways in cancer		
T59328	KEGGPATH	hsa05205:Proteoglycans in cancer		
T59328	KEGGPATH	hsa05206:MicroRNAs in cancer		
T59328	KEGGPATH	hsa05212:Pancreatic cancer		
T59328	KEGGPATH	hsa05213:Endometrial cancer		
T59328	KEGGPATH	hsa05214:Glioma		
T59328	KEGGPATH	hsa05215:Prostate cancer		
T59328	KEGGPATH	hsa05218:Melanoma		
T59328	KEGGPATH	hsa05219:Bladder cancer		
T59328	KEGGPATH	hsa05223:Non-small cell lung cancer		
T59328	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T59328	KEGGPATH	hsa05231:Choline metabolism in cancer		
T59328	WIKIPATH	WP1843:L1CAM interactions		
T59328	WIKIPATH	WP1910:Signaling by EGFR		
T59328	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T59328	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T59328	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase		
T59328	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T59328	WIKIPATH	WP2100:Arylhydrocarbon receptor (AhR) signaling pathway		
T59328	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T59328	WIKIPATH	WP2324:AGE/RAGE pathway		
T59328	WIKIPATH	WP2363:Gastric cancer network 2		
T59328	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T59328	WIKIPATH	WP2431:Spinal Cord Injury		
T59328	WIKIPATH	WP2586:Aryl Hydrocarbon Receptor		
T59328	WIKIPATH	WP2643:Nanoparticle-mediated activation of receptor signaling		
T59328	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T59328	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T59328	WIKIPATH	WP2780:Signaling by ERBB2		
T59328	WIKIPATH	WP2781:Signaling by ERBB4		
T59328	WIKIPATH	WP2804:Hair Follicle Development: Induction (Part 1 of 3)		
T59328	WIKIPATH	WP2828:Bladder Cancer		
T59328	WIKIPATH	WP2840:Hair Follicle Development: Cytodifferentiation (Part 3 of 3)		
T59328	WIKIPATH	WP2868:TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer		
T59328	WIKIPATH	WP2870:Extracellular vesicle-mediated signaling in recipient cells		
T59328	WIKIPATH	WP2873:Aryl Hydrocarbon Receptor Pathway		
T59328	WIKIPATH	WP306:Focal Adhesion		
T59328	WIKIPATH	WP382:MAPK Signaling Pathway		
T59328	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T59328	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T59328	WIKIPATH	WP673:ErbB Signaling Pathway		
T59328	REACPATH	R-HSA-1236382:Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants		
T59328	REACPATH	R-HSA-1250196:SHC1 events in ERBB2 signaling		
T59328	REACPATH	R-HSA-1251932:PLCG1 events in ERBB2 signaling		
T59328	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T59328	REACPATH	R-HSA-179812:GRB2 events in EGFR signaling		
T59328	REACPATH	R-HSA-180292:GAB1 signalosome		
T59328	REACPATH	R-HSA-180336:SHC1 events in EGFR signaling		
T59328	REACPATH	R-HSA-182971:EGFR downregulation		
T59328	REACPATH	R-HSA-1963640:GRB2 events in ERBB2 signaling		
T59328	REACPATH	R-HSA-1963642:PI3K events in ERBB2 signaling		
T59328	REACPATH	R-HSA-2179392:EGFR Transactivation by Gastrin		
T59328	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T59328	REACPATH	R-HSA-5637810:Constitutive Signaling by EGFRvIII		
T59328	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T59328	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T59328	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T59328	INTEPATH	a6b1_a6b4_integrin_pathway:a6b1 and a6b4 Integrin signaling		
T59328	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T59328	INTEPATH	arf6_pathway:Arf6 signaling events		
T59328	INTEPATH	ecadherin_keratinocyte_pathway:E-cadherin signaling in keratinocytes		
T59328	INTEPATH	ecadherin_stabilization_pathway:Stabilization and expansion of the E-cadherin adherens junction		
T59328	INTEPATH	erbb_network_pathway:ErbB receptor signaling network		
T59328	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T59328	INTEPATH	erbb1_internalization_pathway:Internalization of ErbB1		
T59328	INTEPATH	erbb1_receptor_proximal_pathway:EGF receptor (ErbB1) signaling pathway		
T59328	INTEPATH	et_egfrpathway:EGFR-dependent Endothelin signaling events		
T59328	INTEPATH	lysophospholipid_pathway:LPA receptor mediated events		
T59328	INTEPATH	p53downstreampathway:Direct p53 effectors		
T59328	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T59328	INTEPATH	shp2_pathway:SHP2 signaling		
T59328	INTEPATH	syndecan_3_pathway:Syndecan-3-mediated signaling events		
T59328	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T59328	INTEPATH	telomerasepathway:Regulation of Telomerase		
T59328	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T59328	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling		
T59328	PANTPATH	P00012:Cadherin signaling pathway		
T59328	PANTPATH	P00018:EGF receptor signaling pathway		
				
T89515	TARGETID	T89515		
T89515	FORMERID	TTDS00208		
T89515	UNIPROID	DEFM_HUMAN		
T89515	TARGNAME	Polypeptide deformylase (PDF)		
T89515	GENENAME	PDF		
T89515	TARGTYPE	Successful target		
T89515	SYNONYMS	PDF		
T89515	FUNCTION	Bifunctional enzyme. Involved in de novo dTMP biosynthesis. Key enzyme in folate metabolism. Catalyzes an essential reaction for de novo glycine and purine synthesis, DNA precursor synthesis, and for the conversion of dUMP to dTMP.		
T89515	PDBSTRUC	3G5P; 3G5K		
T89515	BIOCLASS	CH-NH donor oxidoreductase		
T89515	ECNUMBER	EC 3.5.1.88		
T89515	SEQUENCE	MARLWGALSLWPLWAAVPWGGAAAVGVRACSSTAAPDGVEGPALRRSYWRHLRRLVLGPPEPPFSHVCQVGDPVLRGVAAPVERAQLGGPELQRLTQRLVQVMRRRRCVGLSAPQLGVPRQVLALELPEALCRECPPRQRALRQMEPFPLRVFVNPSLRVLDSRLVTFPEGCESVAGFLACVPRFQAVQISGLDPNGEQVVWQASGWAARIIQHEMDHLQGCLFIDKMDSRTFTNVYWMKVND		
T89515	DRUGINFO	D0Y2DI	Chlorproguanil	Approved
T89515	DRUGINFO	D0E3SF	MCB-3837	Approved
T89515	DRUGINFO	D0Y4AW	Meprobamate	Approved
T89515	DRUGINFO	D02LWU	Pralatrexate	Approved
T89515	DRUGINFO	D0P8RS	Proguanil	Approved
T89515	DRUGINFO	D0Y7TS	Trimetrexate	Approved
T89515	DRUGINFO	D0A2UV	Ustekinumab	Approved
T89515	DRUGINFO	D0W3LI	LY333531	Phase 2
T89515	DRUGINFO	D02AIM	Metoprine	Phase 2
T89515	DRUGINFO	D0D2RN	Aminopterin	Withdrawn from market
T89515	DRUGINFO	D07KZA	2-(N-Morpholino)-Ethanesulfonic Acid	Investigative
T89515	DRUGINFO	D03DRF	2-Allylthio-3-benzyl-6-nitro-quinazolin-4(3H)-one	Investigative
T89515	DRUGINFO	D0S4ZT	2-Allylthio-6-amino-3-benzyl-quinazolin-4(3H)-one	Investigative
T89515	DRUGINFO	D0J2FY	2'-Monophosphoadenosine 5'-Diphosphoribose	Investigative
T89515	DRUGINFO	D0CH7U	2'-Monophosphoadenosine-5'-Diphosphate	Investigative
T89515	DRUGINFO	D0Q5FV	2-Sulfhydryl-Ethanol	Investigative
T89515	DRUGINFO	D01UOO	3-Benzyl-2-ethylthio-6-nitro-quinazolin-4(3H)-one	Investigative
T89515	DRUGINFO	D0UR9D	3-benzyl-2-mercapto-6-nitroquinazolin-4(3H)-one	Investigative
T89515	DRUGINFO	D0AT2Z	3-Phenylsulfanylmethyl-quinoxaline-5,7-diamine	Investigative
T89515	DRUGINFO	D0U7CJ	4-(2,6-diamino-9H-purin-8-yl)-2,6-dimethoxyphenol	Investigative
T89515	DRUGINFO	D02ZPZ	5-((E)-Styryl)-quinazoline-2,4-diamine	Investigative
T89515	DRUGINFO	D0ME8Z	5-(2-fluorobenzyloxy)quinazoline-2,4-diamine	Investigative
T89515	DRUGINFO	D0C1EF	5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine	Investigative
T89515	DRUGINFO	D0KY9B	5-Chloryl-2,4,6-Quinazolinetriamine	Investigative
T89515	DRUGINFO	D0A9WT	5-Formyl-6-Hydrofolic Acid	Investigative
T89515	DRUGINFO	D08GPU	5-Phenethyl-quinazoline-2,4-diamine	Investigative
T89515	DRUGINFO	D02ZCP	5-Phenylsulfanyl-2,4-Quinazolinediamine	Investigative
T89515	DRUGINFO	D0J4KJ	5-p-Tolylsulfanyl-quinazoline-2,4-diamine	Investigative
T89515	DRUGINFO	D0V1UL	6-(2-Phenylsulfanyl-ethyl)-pteridine-2,4-diamine	Investigative
T89515	DRUGINFO	D01ILN	6,7-Diphenyl-pteridine-2,4-diamine	Investigative
T89515	DRUGINFO	D0A8HX	6-m-Tolyl-pteridine-2,4,7-triamine	Investigative
T89515	DRUGINFO	D08CMW	6-Phenylaminomethyl-quinazoline-2,4-diamine	Investigative
T89515	DRUGINFO	D0V9US	6-Phenylsulfanylmethyl-pteridine-2,4-diamine	Investigative
T89515	DRUGINFO	D0Y3TU	7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine	Investigative
T89515	DRUGINFO	D06QEN	7-Methyl-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine	Investigative
T89515	DRUGINFO	D0Y5JB	8-(2,3,4-trimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D05TPU	8-(2,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D05KJX	8-(2,4,6-trimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0SB0W	8-(2,4-dimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0A5GM	8-(2,5-dimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0U0KY	8-(2,6-Dichloro-phenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D07BKE	8-(3,4,5-trimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D04UBQ	8-(3,4-dichlorophenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D03POU	8-(3,4-dimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0S1VJ	8-(3,5-dimethoxyphenyl)-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0H2VY	8-benzyl-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0B9MY	8-Pyridin-4-yl-9H-purine-2,6-diamine	Investigative
T89515	DRUGINFO	D0C9NE	Biopterin	Investigative
T89515	DRUGINFO	D0DT4R	Brodimoprim-4,6-Dicarboxylate	Investigative
T89515	DRUGINFO	D0A6CS	Bromo-WR99210	Investigative
T89515	DRUGINFO	D0O9YG	Cycloguanil	Investigative
T89515	DRUGINFO	D06YIB	DDATHF	Investigative
T89515	DRUGINFO	D09YVN	Dihydrofolic Acid	Investigative
T89515	DRUGINFO	D05WHM	Edatrexate	Investigative
T89515	DRUGINFO	D06DIH	Furo[2,3d]Pyrimidine Antifolate	Investigative
T89515	DRUGINFO	D0LH5P	GNF-PF-173	Investigative
T89515	DRUGINFO	D0H8AW	GNF-PF-607	Investigative
T89515	DRUGINFO	D07XLJ	N*6*-Benzyl-quinazoline-2,4,6-triamine	Investigative
T89515	DRUGINFO	D04MOZ	NB3178	Investigative
T89515	DRUGINFO	D0H4NN	NB3322	Investigative
T89515	DRUGINFO	D0T1XE	Pergularinine	Investigative
T89515	DRUGINFO	D0UZ9U	PREMETREXED	Investigative
T89515	DRUGINFO	D0B1PE	Ro 5-4864	Investigative
T89515	DRUGINFO	D06UPT	Sri-9439	Investigative
T89515	DRUGINFO	D0D1ON	Sri-9662	Investigative
T89515	DRUGINFO	D0C1UM	Tylophorinidine	Investigative
T89515	WHIZPATH	PW000024:Folate Metabolism		
T89515	WHIZPATH	PW000140:Pterine Biosynthesis		
T89515	REACPATH	R-HSA-113510:E2F mediated regulation of DNA replication		
T89515	REACPATH	R-HSA-1474151:Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation		
T89515	REACPATH	R-HSA-196757:Metabolism of folate and pterines		
T89515	REACPATH	R-HSA-69205:G1/S-Specific Transcription		
				
T08391	TARGETID	T08391		
T08391	FORMERID	TTDC00187		
T08391	UNIPROID	JAK2_HUMAN		
T08391	TARGNAME	Janus kinase 2 (JAK-2)		
T08391	GENENAME	JAK2		
T08391	TARGTYPE	Successful target		
T08391	SYNONYMS	Tyrosine-protein kinase JAK2		
T08391	FUNCTION	Mediates essential signaling events in both innate and adaptive immunity. In the cytoplasm, plays a pivotal role in signal transduction via its association with type I receptors such as growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), thrombopoietin (THPO); or type II receptors including IFN-alpha, IFN-beta, IFN-gamma and multiple interleukins. Following ligand-binding to cell surface receptors, phosphorylates specific tyrosine residues on the cytoplasmic tails of the receptor, creating docking sites for STATs proteins. Subsequently, phosphorylates the STATs proteins once they are recruited to the receptor. Phosphorylated STATs then form homodimer or heterodimers and translocate to the nucleus to activate gene transcription. For example, cell stimulation with erythropoietin (EPO) during erythropoiesis leads to JAK2 autophosphorylation, activation, and its association with erythropoietin receptor (EPOR) that becomes phosphorylated in its cytoplasmic domain. Then, STAT5 (STAT5A or STAT5B) is recruited, phosphorylated and activated by JAK2. Once activated, dimerized STAT5 translocates into the nucleus and promotes the transcription of several essential genes involved in the modulation of erythropoiesis. Part of a signaling cascade that is activated by increased cellular retinol and that leads to the activation of STAT5 (STAT5A or STAT5B). In addition, JAK2 mediates angiotensin-2-induced ARHGEF1 phosphorylation. Plays a role in cell cycle by phosphorylating CDKN1B. Cooperates with TEC through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin. Non-receptor tyrosine kinase involved in various processes such as cell growth, development, differentiation or histone modifications.		
T08391	PDBSTRUC	6M9H; 6E2Q; 6E2P; 6DRW; 6BSS		
T08391	BIOCLASS	Kinase		
T08391	ECNUMBER	EC 2.7.10.2		
T08391	SEQUENCE	MGMACLTMTEMEGTSTSSIYQNGDISGNANSMKQIDPVLQVYLYHSLGKSEADYLTFPSGEYVAEEICIAASKACGITPVYHNMFALMSETERIWYPPNHVFHIDESTRHNVLYRIRFYFPRWYCSGSNRAYRHGISRGAEAPLLDDFVMSYLFAQWRHDFVHGWIKVPVTHETQEECLGMAVLDMMRIAKENDQTPLAIYNSISYKTFLPKCIRAKIQDYHILTRKRIRYRFRRFIQQFSQCKATARNLKLKYLINLETLQSAFYTEKFEVKEPGSGPSGEEIFATIIITGNGGIQWSRGKHKESETLTEQDLQLYCDFPNIIDVSIKQANQEGSNESRVVTIHKQDGKNLEIELSSLREALSFVSLIDGYYRLTADAHHYLCKEVAPPAVLENIQSNCHGPISMDFAISKLKKAGNQTGLYVLRCSPKDFNKYFLTFAVERENVIEYKHCLITKNENEEYNLSGTKKNFSSLKDLLNCYQMETVRSDNIIFQFTKCCPPKPKDKSNLLVFRTNGVSDVPTSPTLQRPTHMNQMVFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKWAELANLINNCMDYEPDFRPSFRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG		
T08391	DRUGINFO	D0Y7IC	Baricitinib	Approved
T08391	DRUGINFO	D0G8BM	Fedratinib	Approved
T08391	DRUGINFO	D04LKS	Ruxolitinib	Approved
T08391	DRUGINFO	D0GH3Q	ITF2357	Phase 3
T08391	DRUGINFO	D0D5ZJ	Momelotinib	Phase 3
T08391	DRUGINFO	D0PN8H	Pacritinib	Phase 3
T08391	DRUGINFO	D05AJT	XL019	Phase 3
T08391	DRUGINFO	D0MP0X	AZD1480	Phase 2
T08391	DRUGINFO	D0DK8X	BMS-911543	Phase 2
T08391	DRUGINFO	D0BI3N	Cerdulatinib	Phase 2
T08391	DRUGINFO	D01UAU	CTP-543	Phase 2
T08391	DRUGINFO	DU10JI	CTP-543	Phase 2
T08391	DRUGINFO	D09AFI	INCB039110	Phase 2
T08391	DRUGINFO	D05TSJ	LY2784544	Phase 2
T08391	DRUGINFO	D00MYW	NS-018	Phase 1/2
T08391	DRUGINFO	D08CNP	AC430	Phase 1
T08391	DRUGINFO	D0S0NX	Peginterferon beta	Phase 1
T08391	DRUGINFO	D00RYA	SB-1578	Phase 1
T08391	DRUGINFO	D07XYI	1,2,4-triazolo[1,5a]pyridine derivative 1	Patented
T08391	DRUGINFO	D0NP2W	1,2,4-triazolo[1,5a]pyridine derivative 2	Patented
T08391	DRUGINFO	D0JZ2B	Alkynyl-substituted pyrimidinyl-pyrrole derivative 1	Patented
T08391	DRUGINFO	D05AXE	Aminooxazole carboxamide derivative 1	Patented
T08391	DRUGINFO	D09ALF	Aminotriazolopyridine derivative 1	Patented
T08391	DRUGINFO	D0QD5Y	Aromatic bicyclic compound 1	Patented
T08391	DRUGINFO	D0VI7E	Aromatic bicyclic compound 2	Patented
T08391	DRUGINFO	D0M5AG	Aromatic bicyclic compound 3	Patented
T08391	DRUGINFO	D0M9YZ	Aromatic bicyclic compound 4	Patented
T08391	DRUGINFO	D0Q5JV	Aromatic bicyclic compound 5	Patented
T08391	DRUGINFO	D09RTW	Aromatic bicyclic compound 6	Patented
T08391	DRUGINFO	D01CRX	Benzimidazole derivative 7	Patented
T08391	DRUGINFO	D01FVC	Bis-aminopyrimidine derivative 1	Patented
T08391	DRUGINFO	D0LR6J	Bis-aminopyrimidine derivative 2	Patented
T08391	DRUGINFO	D0S6XT	Bis-aminopyrimidine derivative 3	Patented
T08391	DRUGINFO	D0SJ1Q	Bis-aminopyrimidine derivative 4	Patented
T08391	DRUGINFO	D0M2OK	Bis-aminopyrimidine derivative 5	Patented
T08391	DRUGINFO	D0WD1Z	Curcumin analog 1	Patented
T08391	DRUGINFO	D0IC8O	Curcumin analog 2	Patented
T08391	DRUGINFO	D0K2RW	Cyanomethyl pypazole carboxamide derivative 1	Patented
T08391	DRUGINFO	D05GEL	Cyclic cyanoethypypazole derivative 1	Patented
T08391	DRUGINFO	D0V0KI	Cycloalkyl nitrile pyrazole carboxamide derivative 1	Patented
T08391	DRUGINFO	D0PB5X	Cycloalkyl nitrile pyrazolo pyridone derivative 1	Patented
T08391	DRUGINFO	D0S4TH	Cycloalkyl nitrile pyrazolo pyridone derivative 2	Patented
T08391	DRUGINFO	D08WPB	Five-and-six-membered heterocyclic compound 1	Patented
T08391	DRUGINFO	D0H6XN	Geminally-substituted cyanoethylpypazolo pyridone derivative 1	Patented
T08391	DRUGINFO	D0KI5F	Geminally-substituted cyanoethylpypazolo pyridone derivative 2	Patented
T08391	DRUGINFO	D0VJ1R	Imidazo[4,5-c]pyridine derivative 2	Patented
T08391	DRUGINFO	D0G9MM	Isoxazole derivative 1	Patented
T08391	DRUGINFO	D0TX2G	Isoxazole derivative 2	Patented
T08391	DRUGINFO	D0Y2IM	N-(cyanomethyl)-4-(2-(phenylamino)pyrimidin-4-yl)benzamide derivative 1	Patented
T08391	DRUGINFO	D0A8BV	PMID27774822-Compound-Figure10Compound12	Patented
T08391	DRUGINFO	D0AE0M	PMID27774822-Compound-Figure10Compound4	Patented
T08391	DRUGINFO	D0GH8D	PMID27774822-Compound-Figure10Example1	Patented
T08391	DRUGINFO	D0W8DN	PMID27774822-Compound-Figure10Example19	Patented
T08391	DRUGINFO	D0RJ3W	PMID27774822-Compound-Figure11Example5	Patented
T08391	DRUGINFO	D0M3CB	PMID27774822-Compound-Figure1Example20	Patented
T08391	DRUGINFO	D0E2WK	PMID27774822-Compound-Figure2Example1-1left	Patented
T08391	DRUGINFO	D0IQ6G	PMID27774822-Compound-Figure2Example1-1right	Patented
T08391	DRUGINFO	D0NY6M	PMID27774822-Compound-Figure3CompoundI-165	Patented
T08391	DRUGINFO	D04OCD	PMID27774822-Compound-Figure7Example63	Patented
T08391	DRUGINFO	D0B9TH	PMID27774822-Compound-Figure8Example5	Patented
T08391	DRUGINFO	D0YR8S	PMID27774824-Compound-Figure11Example1up	Patented
T08391	DRUGINFO	D0A6RG	PMID27774824-Compound-Figure2Example4	Patented
T08391	DRUGINFO	D0U1HA	PMID27774824-Compound-Figure3Example18	Patented
T08391	DRUGINFO	D0GB7G	PMID27774824-Compound-Figure6Example12	Patented
T08391	DRUGINFO	D0F3BK	PMID27774824-Compound-Figure6Example6	Patented
T08391	DRUGINFO	D0PM8K	PMID27774824-Compound-Figure7Example10	Patented
T08391	DRUGINFO	D0KF8H	PMID27774824-Compound-Figure8Example22	Patented
T08391	DRUGINFO	D0HS2J	PMID27774824-Compound-Figure8Example99	Patented
T08391	DRUGINFO	D01DBB	PMID27774824-Compound-Figure9Example2down	Patented
T08391	DRUGINFO	D0WZ8N	PMID27774824-Compound-Figure9Example2up	Patented
T08391	DRUGINFO	D09PIS	Pyrazolo[4,3-c]pyridine derivative 2	Patented
T08391	DRUGINFO	D03QAY	Pyrazolopyridine derivative 3	Patented
T08391	DRUGINFO	D09RUN	Pyrazolopyridine derivative 4	Patented
T08391	DRUGINFO	D02VGC	Pyrazolopyridine derivative 6	Patented
T08391	DRUGINFO	D0D1QH	Pyrazolopyridine derivative 7	Patented
T08391	DRUGINFO	D0CD6Y	Pyrimidopyridazinone derivative 1	Patented
T08391	DRUGINFO	D0WA1V	Pyrimidopyridazinone derivative 2	Patented
T08391	DRUGINFO	D0YJ4D	Pyrrole derivative 7	Patented
T08391	DRUGINFO	D09UBE	Pyrrole six-membered heteroaryl ring derivative 1	Patented
T08391	DRUGINFO	D0VQ7P	Pyrrolo[2,3-d]pyrimidine derivative 11	Patented
T08391	DRUGINFO	D0FQ4Z	Pyrrolo[2,3-d]pyrimidine derivative 6	Patented
T08391	DRUGINFO	D0U5FZ	Pyrrolo[2,3-d]pyrimidine derivative 7	Patented
T08391	DRUGINFO	D0KL3B	Pyrrolo[2,3-d]pyrimidine derivative 8	Patented
T08391	DRUGINFO	D0VR6E	Pyrrolo-pyridine derivative 3	Patented
T08391	DRUGINFO	D06MQB	Pyrrolo-pyridone derivative 1	Patented
T08391	DRUGINFO	D03PBI	Pyrrolo-pyridone derivative 2	Patented
T08391	DRUGINFO	D01EYJ	Ruxolitinib derivative 2	Patented
T08391	DRUGINFO	D00JUI	Triazolo-pyridine derivative 1	Patented
T08391	DRUGINFO	D0G0FK	Tricyclic compound 1	Patented
T08391	DRUGINFO	D0LS1O	Tricyclic compound 11	Patented
T08391	DRUGINFO	D0X1FD	Tricyclic heterocycle derivative 1	Patented
T08391	DRUGINFO	D03TEE	Tricyclic heterocycle derivative 2	Patented
T08391	DRUGINFO	D0M2WA	Tricyclic heterocycle derivative 5	Patented
T08391	DRUGINFO	D04BOW	Tricyclic pyrrolopyridine compound 1	Patented
T08391	DRUGINFO	D0GZ7B	AG490	Terminated
T08391	DRUGINFO	DLW69V	1,2,3,4,5,6-hexabromocyclohexane	Investigative
T08391	DRUGINFO	D0I3EY	5-phenyl-1H-indazol-3-amine	Investigative
T08391	DRUGINFO	D00MAM	AMG-JAK2-01	Investigative
T08391	DRUGINFO	D05MHL	Atropisomer 1	Investigative
T08391	DRUGINFO	D0OP3D	AZ960	Investigative
T08391	DRUGINFO	D0N8CN	BVB-808	Investigative
T08391	DRUGINFO	D0IR6U	CMP-6	Investigative
T08391	DRUGINFO	D0I6QN	K-454	Investigative
T08391	DRUGINFO	D02UVS	NSC-1771	Investigative
T08391	DRUGINFO	D0A7XQ	ON-044580	Investigative
T08391	DRUGINFO	D02NNT	PMID21493067C1d	Investigative
T08391	DRUGINFO	D0US9O	PMID24359159C19a	Investigative
T08391	DRUGINFO	D09VZR	SGI-1252	Investigative
T08391	DRUGINFO	D0E5IP	WHI-P154	Investigative
T08391	KEGGPATH	hsa04062:Chemokine signaling pathway		
T08391	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T08391	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T08391	KEGGPATH	hsa04630:Jak-STAT signaling pathway		
T08391	KEGGPATH	hsa04725:Cholinergic synapse		
T08391	KEGGPATH	hsa04917:Prolactin signaling pathway		
T08391	KEGGPATH	hsa04920:Adipocytokine signaling pathway		
T08391	KEGGPATH	hsa05140:Leishmaniasis		
T08391	KEGGPATH	hsa05145:Toxoplasmosis		
T08391	KEGGPATH	hsa05152:Tuberculosis		
T08391	KEGGPATH	hsa05162:Measles		
T08391	KEGGPATH	hsa05164:Influenza A		
T08391	KEGGPATH	hsa05168:Herpes simplex infection		
T08391	WIKIPATH	WP127:IL-5 Signaling Pathway		
T08391	WIKIPATH	WP1815:Factors involved in megakaryocyte development and platelet production		
T08391	WIKIPATH	WP1836:Interferon gamma signaling		
T08391	WIKIPATH	WP1840:Interleukin-3, 5 and GM-CSF signaling		
T08391	WIKIPATH	WP2032:TSH signaling pathway		
T08391	WIKIPATH	WP2034:Leptin signaling pathway		
T08391	WIKIPATH	WP2112:IL17 signaling pathway		
T08391	WIKIPATH	WP2203:TSLP Signaling Pathway		
T08391	WIKIPATH	WP2324:AGE/RAGE pathway		
T08391	WIKIPATH	WP2332:Interleukin-11 Signaling Pathway		
T08391	WIKIPATH	WP2374:Oncostatin M Signaling Pathway		
T08391	WIKIPATH	WP2380:BDNF signaling pathway		
T08391	WIKIPATH	WP2593:JAK/STAT		
T08391	WIKIPATH	WP2657:Growth hormone receptor signaling		
T08391	WIKIPATH	WP2678:Prolactin receptor signaling		
T08391	WIKIPATH	WP2713:Signaling by SCF-KIT		
T08391	WIKIPATH	WP2732:Interleukin-2 signaling		
T08391	WIKIPATH	WP2857:Mesodermal Commitment Pathway		
T08391	WIKIPATH	WP286:IL-3 Signaling Pathway		
T08391	WIKIPATH	WP304:Kit receptor signaling pathway		
T08391	WIKIPATH	WP364:IL-6 signaling pathway		
T08391	WIKIPATH	WP395:IL-4 Signaling Pathway		
T08391	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T08391	WIKIPATH	WP581:EPO Receptor Signaling		
T08391	WIKIPATH	WP61:Notch Signaling Pathway		
T08391	WIKIPATH	WP619:Type II interferon signaling (IFNG)		
T08391	WIKIPATH	WP733:Serotonin Receptor 2 and STAT3 Signaling		
T08391	REACPATH	R-HSA-1059683:Interleukin-6 signaling		
T08391	REACPATH	R-HSA-110056:MAPK3 (ERK1) activation		
T08391	REACPATH	R-HSA-112411:MAPK1 (ERK2) activation		
T08391	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T08391	REACPATH	R-HSA-1170546:Prolactin receptor signaling		
T08391	REACPATH	R-HSA-3214858:RMTs methylate histone arginines		
T08391	REACPATH	R-HSA-392451:G beta:gamma signalling through PI3Kgamma		
T08391	REACPATH	R-HSA-512988:Interleukin-3, 5 and GM-CSF signaling		
T08391	REACPATH	R-HSA-5673000:RAF activation		
T08391	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T08391	REACPATH	R-HSA-877300:Interferon gamma signaling		
T08391	REACPATH	R-HSA-877312:Regulation of IFNG signaling		
T08391	REACPATH	R-HSA-912526:Interleukin receptor SHC signaling		
T08391	REACPATH	R-HSA-982772:Growth hormone receptor signaling		
T08391	REACPATH	R-HSA-983231:Factors involved in megakaryocyte development and platelet production		
T08391	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T08391	INTEPATH	endothelinpathway:Endothelins		
T08391	INTEPATH	epopathway:EPO signaling pathway		
T08391	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T08391	INTEPATH	erbb4_pathway:ErbB4 signaling events		
T08391	INTEPATH	gmcsf_pathway:GMCSF-mediated signaling events		
T08391	INTEPATH	hes_heypathway:Notch-mediated HES/HEY network		
T08391	INTEPATH	ifngpathway:IFN-gamma pathway		
T08391	INTEPATH	il12_2pathway:IL12-mediated signaling events		
T08391	INTEPATH	il23pathway:IL23-mediated signaling events		
T08391	INTEPATH	il27pathway:IL27-mediated signaling events		
T08391	INTEPATH	il3_pathway:IL3-mediated signaling events		
T08391	INTEPATH	il4_2pathway:IL4-mediated signaling events		
T08391	INTEPATH	il5_pathway:IL5-mediated signaling events		
T08391	INTEPATH	il6_7pathway:IL6-mediated signaling events		
T08391	INTEPATH	kitpathway:Signaling events mediated by Stem cell factor receptor (c-Kit)		
T08391	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T08391	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T08391	INTEPATH	s1p_s1p3_pathway:S1P3 pathway		
T08391	INTEPATH	shp2_pathway:SHP2 signaling		
T08391	PANTPATH	P00031:Inflammation mediated by chemokine and cytokine signaling pathway		
T08391	PANTPATH	P00035:Interferon-gamma signaling pathway		
T08391	PANTPATH	P00038:JAK/STAT signaling pathway		
T08391	PANTPATH	P00047:PDGF signaling pathway		
T08391	PANTPATH	P00048:PI3 kinase pathway		
T08391	PANTPATH	P06959:CCKR signaling map ST		
				
T07663	TARGETID	T07663		
T07663	FORMERID	TTDS00296		
T07663	UNIPROID	PDE5A_HUMAN		
T07663	TARGNAME	Phosphodiesterase 5A (PDE5A)		
T07663	GENENAME	PDE5A		
T07663	TARGTYPE	Successful target		
T07663	SYNONYMS	cGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A; CGMP-binding cGMP-specific phosphodiesterase; CGB-PDE		
T07663	FUNCTION	Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP. Specifically regulates nitric-oxide-generated cGMP.		
T07663	PDBSTRUC	6ACB; 5ZZ2; 5JO3; 4OEX; 4OEW		
T07663	BIOCLASS	Phosphoric diester hydrolase		
T07663	ECNUMBER	EC 3.1.4.35		
T07663	SEQUENCE	MERAGPSFGQQRQQQQPQQQKQQQRDQDSVEAWLDDHWDFTFSYFVRKATREMVNAWFAERVHTIPVCKEGIRGHTESCSCPLQQSPRADNSAPGTPTRKISASEFDRPLRPIVVKDSEGTVSFLSDSEKKEQMPLTPPRFDHDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEVSNNCIRLEWNKGIVGHVAALGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTREHDANKINYMYAQYVKNTMEPLNIPDVSKDKRFPWTTENTGNVNQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEENTGKVKPFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKMLINGESGQAKRN		
T07663	DRUGINFO	D0Y5JC	Avanafil	Approved
T07663	DRUGINFO	D0F9GE	Dipyridamole	Approved
T07663	DRUGINFO	D0NJ3V	Papaverine	Approved
T07663	DRUGINFO	D0Z7ZM	Rhucin	Approved
T07663	DRUGINFO	D05MQK	Tadalafil	Approved
T07663	DRUGINFO	D01GUS	Udenafil	Approved
T07663	DRUGINFO	D0C9SY	Vardenafil	Approved
T07663	DRUGINFO	D0M9VE	EXISULIND	Phase 3
T07663	DRUGINFO	D05OQG	ICARIIN	Phase 3
T07663	DRUGINFO	D0M9FQ	PF-489791	Phase 2
T07663	DRUGINFO	D09OCK	UK-371800	Phase 1
T07663	DRUGINFO	D0K2BQ	BRL-61063	Discontinued in Phase 2
T07663	DRUGINFO	D0K2QG	DASANTAFIL	Discontinued in Phase 2
T07663	DRUGINFO	D00SPK	E-4021	Discontinued in Phase 2
T07663	DRUGINFO	D0X1LO	EMR-62203	Discontinued in Phase 2
T07663	DRUGINFO	D0D7XW	SINITRODIL	Discontinued in Phase 2
T07663	DRUGINFO	D04NPP	SLX-2101	Discontinued in Phase 2
T07663	DRUGINFO	D0N5SC	UK-369003	Discontinued in Phase 1/2
T07663	DRUGINFO	D0W8QG	FR-229934	Terminated
T07663	DRUGINFO	D09UMA	IMAZODAN	Terminated
T07663	DRUGINFO	D0W8OH	SKF-96231	Terminated
T07663	DRUGINFO	D01FRF	Trequinsin	Terminated
T07663	DRUGINFO	D00YPW	ZAPRINAST	Terminated
T07663	DRUGINFO	D09WUP	3,7-Bis(2-hydroxyethyl)icaritin	Investigative
T07663	DRUGINFO	D03BWH	7-(2-Hydroxyethyl)-3-O-rhamnosylicariin	Investigative
T07663	DRUGINFO	D0X7SR	8-prenylapigenin	Investigative
T07663	DRUGINFO	D0W2BI	8-prenylquercetin	Investigative
T07663	DRUGINFO	D0V3BI	Aom-0890	Investigative
T07663	DRUGINFO	D0O3QI	Benzo[1,3]dioxol-5-ylmethyl-quinazolin-4-yl-amine	Investigative
T07663	DRUGINFO	D0V1CL	Cartazolate	Investigative
T07663	DRUGINFO	D06URK	CKD-533	Investigative
T07663	DRUGINFO	D08VGM	Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine	Investigative
T07663	DRUGINFO	D04AWP	Guanosine-5'-Monophosphate	Investigative
T07663	DRUGINFO	D06TLQ	Icariside II	Investigative
T07663	DRUGINFO	D0R6MT	isobutylmethylxanthine	Investigative
T07663	DRUGINFO	D06GUJ	KURAIDIN	Investigative
T07663	DRUGINFO	D0W4ZU	KURARINOL	Investigative
T07663	DRUGINFO	D0YZ0L	LORNEIC ACID A	Investigative
T07663	DRUGINFO	D0T5PO	ROLIPRAM	Investigative
T07663	DRUGINFO	D0H6ZC	RWJ-387273	Investigative
T07663	DRUGINFO	D02VHD	SCH51866	Investigative
T07663	DRUGINFO	D0KD6S	SCH-57726	Investigative
T07663	DRUGINFO	D00QCL	SOPHOFLAVESCENOL	Investigative
T07663	DRUGINFO	D0S8AV	SOPHORAFLAVANONE B	Investigative
T07663	DRUGINFO	D0LZ5R	T0156	Investigative
T07663	DRUGINFO	D0XQ8A	TPN-729	Investigative
T07663	KEGGPATH	hsa00230:Purine metabolism		
T07663	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T07663	REACPATH	R-HSA-418457:cGMP effects		
T07663	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
				
T63505	TARGETID	T63505		
T63505	FORMERID	TTDNS00592		
T63505	UNIPROID	ABL1_HUMAN		
T63505	TARGNAME	Tyrosine-protein kinase ABL1 (ABL)		
T63505	GENENAME	ABL1		
T63505	TARGTYPE	Successful target		
T63505	SYNONYMS	p150; Proto-oncogene tyrosine-protein kinase ABL1; Proto-oncogene c-Abl; JTK7; C-ABL; Abl; Abelson tyrosine-protein kinase 1; Abelson murine leukemia viral oncogene homolog 1		
T63505	FUNCTION	Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717'. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-153' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine-phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E. coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H. pylori, or AnkA (ankyrin repeat-containing protein A) of A. phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1. Regulates T-cell differentiation in a TBX21-dependent manner. Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity. Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis.		
T63505	PDBSTRUC	6NPV; 6NPU; 6NPE; 6BL8; 6AMW		
T63505	BIOCLASS	Kinase		
T63505	ECNUMBER	EC 2.7.10.2		
T63505	SEQUENCE	MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR		
T63505	DRUGINFO	D01BYB	Adenosine triphosphate	Approved
T63505	DRUGINFO	D0OB0F	Bosutinib	Approved
T63505	DRUGINFO	D0H0EQ	Ponatinib	Approved
T63505	DRUGINFO	D03MNN	SKI-758	Approved
T63505	DRUGINFO	D06JHV	Flumatinib	Phase 2
T63505	DRUGINFO	D0M0XB	Saracatinib	Phase 2
T63505	DRUGINFO	D0E0NM	DCC-2036	Phase 1/2
T63505	DRUGINFO	D06CIJ	ISIS-CRP	Phase 1
T63505	DRUGINFO	D00ABO	KW-2449	Phase 1
T63505	DRUGINFO	D0O0RB	6,6-fused nitrogenous heterocyclic compound 1	Patented
T63505	DRUGINFO	D0QD6T	6,6-fused nitrogenous heterocyclic compound 2	Patented
T63505	DRUGINFO	D0XL1M	6,6-fused nitrogenous heterocyclic compound 3	Patented
T63505	DRUGINFO	D0X9VH	Azaindole derivative 1	Patented
T63505	DRUGINFO	D05TYI	Azaindole derivative 2	Patented
T63505	DRUGINFO	D0F4AW	Indol-5-ol derivative 1	Patented
T63505	DRUGINFO	D0X0VH	PMID25656651-Compound-28a	Patented
T63505	DRUGINFO	D0RT8M	PMID25656651-Compound-28b	Patented
T63505	DRUGINFO	D0TX1S	PMID25656651-Compound-33a	Patented
T63505	DRUGINFO	D0JD9Z	PMID25656651-Compound-33b	Patented
T63505	DRUGINFO	D06LHV	PMID25656651-Compound-34a	Patented
T63505	DRUGINFO	D0KM7V	PMID25656651-Compound-34b	Patented
T63505	DRUGINFO	D03JXD	PMID25656651-Compound-34c	Patented
T63505	DRUGINFO	D0ZH4I	PMID25656651-Compound-42	Patented
T63505	DRUGINFO	D0Y0PE	PMID25656651-Compound-46	Patented
T63505	DRUGINFO	D01DBB	PMID27774824-Compound-Figure9Example2down	Patented
T63505	DRUGINFO	D0WZ8N	PMID27774824-Compound-Figure9Example2up	Patented
T63505	DRUGINFO	D04GFO	MC-2001	Preclinical
T63505	DRUGINFO	D03PLP	[1,1':2',1'']-terphenyl-4,3'',5''-triol	Investigative
T63505	DRUGINFO	D0A5RM	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol	Investigative
T63505	DRUGINFO	D0D8OY	AP-24226	Investigative
T63505	DRUGINFO	D04QUI	BAS-00387275	Investigative
T63505	DRUGINFO	D01GNF	BAS-00387328	Investigative
T63505	DRUGINFO	D03GQI	BAS-00387347	Investigative
T63505	DRUGINFO	D07LYJ	BAS-00672722	Investigative
T63505	DRUGINFO	D0D8ZN	BAS-01373578	Investigative
T63505	DRUGINFO	D09QKH	BAS-0338872	Investigative
T63505	DRUGINFO	D0H3RD	BAS-0338876	Investigative
T63505	DRUGINFO	D0A5MG	BAS-09534324	Investigative
T63505	DRUGINFO	D0I3XZ	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Investigative
T63505	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T63505	DRUGINFO	D08OBF	MYRISTIC ACID	Investigative
T63505	DRUGINFO	D0P3JW	PD-0166326	Investigative
T63505	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T63505	DRUGINFO	D0H1OK	TG-100435	Investigative
T63505	DRUGINFO	D0O9NE	TRISMETHOXYRESVERATROL	Investigative
T63505	KEGGPATH	hsa04012:ErbB signaling pathway		
T63505	KEGGPATH	hsa04014:Ras signaling pathway		
T63505	KEGGPATH	hsa04110:Cell cycle		
T63505	KEGGPATH	hsa04360:Axon guidance		
T63505	KEGGPATH	hsa04722:Neurotrophin signaling pathway		
T63505	KEGGPATH	hsa05130:Pathogenic Escherichia coli infection		
T63505	KEGGPATH	hsa05131:Shigellosis		
T63505	KEGGPATH	hsa05200:Pathways in cancer		
T63505	KEGGPATH	hsa05206:MicroRNAs in cancer		
T63505	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T63505	KEGGPATH	hsa05416:Viral myocarditis		
T63505	WIKIPATH	WP1815:Factors involved in megakaryocyte development and platelet production		
T63505	WIKIPATH	WP1865:Myogenesis		
T63505	WIKIPATH	WP1918:Signaling by Robo receptor		
T63505	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T63505	WIKIPATH	WP2038:Regulation of Microtubule Cytoskeleton		
T63505	WIKIPATH	WP2272:Pathogenic Escherichia coli infection		
T63505	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T63505	WIKIPATH	WP2446:Retinoblastoma (RB) in Cancer		
T63505	WIKIPATH	WP2516:ATM Signaling Pathway		
T63505	WIKIPATH	WP2719:Fcgamma receptor (FCGR) dependent phagocytosis		
T63505	WIKIPATH	WP2864:Apoptosis-related network due to altered Notch3 in ovarian cancer		
T63505	REACPATH	R-HSA-2029482:Regulation of actin dynamics for phagocytic cup formation		
T63505	REACPATH	R-HSA-375170:CDO in myogenesis		
T63505	REACPATH	R-HSA-5663213:RHO GTPases Activate WASPs and WAVEs		
T63505	REACPATH	R-HSA-5685938:HDR through Single Strand Annealing (SSA)		
T63505	REACPATH	R-HSA-5693565:Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks		
T63505	REACPATH	R-HSA-983231:Factors involved in megakaryocyte development and platelet production		
T63505	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T63505	INTEPATH	atm_pathway:ATM pathway		
T63505	INTEPATH	lis1pathway:Lissencephaly gene (LIS1) in neuronal migration and development		
T63505	INTEPATH	p53regulationpathway:p53 pathway		
T63505	INTEPATH	p73pathway:p73 transcription factor network		
T63505	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T63505	INTEPATH	rb_1pathway:Regulation of retinoblastoma protein		
T63505	INTEPATH	tap63pathway:Validated transcriptional targets of TAp63 isoforms		
T63505	INTEPATH	telomerasepathway:Regulation of Telomerase		
T63505	INTEPATH	trkrpathway:Neurotrophic factor-mediated Trk receptor signaling		
T63505	PANTPATH	P00008:Axon guidance mediated by Slit/Robo		
				
T13201	TARGETID	T13201		
T13201	FORMERID	TTDR01224		
T13201	UNIPROID	CAH1_HUMAN		
T13201	TARGNAME	Carbonic anhydrase I (CA-I)		
T13201	GENENAME	CA1		
T13201	TARGTYPE	Successful target		
T13201	SYNONYMS	Carbonic anhydrase B; Carbonic anhydrase 1; Carbonate dehydratase I; CAB		
T13201	FUNCTION	Can hydrates cyanamide to urea. Reversible hydration of carbon dioxide.		
T13201	PDBSTRUC	6HWZ; 6G3V; 6FAG; 6FAF; 6F3B		
T13201	BIOCLASS	Alpha-carbonic anhydrase		
T13201	ECNUMBER	EC 4.2.1.1		
T13201	SEQUENCE	MASPDWGYDDKNGPEQWSKLYPIANGNNQSPVDIKTSETKHDTSLKPISVSYNPATAKEIINVGHSFHVNFEDNDNRSVLKGGPFSDSYRLFQFHFHWGSTNEHGSEHTVDGVKYSAELHVAHWNSAKYSSLAEAASKADGLAVIGVLMKVGEANPKLQKVLDALQAIKTKGKRAPFTNFDPSTLLPSSLDFWTYPGSLTHPPLYESVTWIICKESISVSSEQLAQFRSLLSNVEGDNAVPMQHNNRPTQPLKGRTVRASF		
T13201	DRUGINFO	D0E1SW	Acetazolamide	Approved
T13201	DRUGINFO	D0J4GO	Dichlorphenamide	Approved
T13201	DRUGINFO	D07INV	Ethoxzolamide	Approved
T13201	DRUGINFO	D0C2II	Methazolamide	Approved
T13201	DRUGINFO	D07HBX	Salicyclic acid	Approved
T13201	DRUGINFO	D0W2CX	CG-100649	Phase 3
T13201	DRUGINFO	D07SDQ	Curcumin	Phase 3
T13201	DRUGINFO	D0A8JP	PARABEN	Phase 3
T13201	DRUGINFO	D0L6HN	PHENOL	Phase 2/3
T13201	DRUGINFO	D0Y6OA	Coumate	Phase 2
T13201	DRUGINFO	D0V0UK	SULFAMIDE	Phase 1
T13201	DRUGINFO	D03SLR	FERULIC ACID	Patented
T13201	DRUGINFO	D04JIN	(2-bromophenyl)difluoromethanesulfonamide	Investigative
T13201	DRUGINFO	D0IU3X	(4-bromophenyl)difluoromethanesulfonamide	Investigative
T13201	DRUGINFO	D0CM3O	[Au(CN)2]-	Investigative
T13201	DRUGINFO	D0L2GD	[Cu(CN)2]-	Investigative
T13201	DRUGINFO	D05RAB	1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D00XIB	1-acetamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D04SNH	1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0G9NE	1-cyclohexylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D0O4KL	1-pentafluorophenylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D0KZ2D	1-valproylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D05BMD	2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide	Investigative
T13201	DRUGINFO	D06NDR	2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide	Investigative
T13201	DRUGINFO	D0G0OP	2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide	Investigative
T13201	DRUGINFO	D0FD8G	2-(biphenyl-4-yl)vinylboronic acid	Investigative
T13201	DRUGINFO	D0RK7J	2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide	Investigative
T13201	DRUGINFO	D0LC0F	2,3-dihydro-1H-indene-5-sulfonamide	Investigative
T13201	DRUGINFO	D0S6CO	2,4-dichloro-5-sulfamoylbenzoic acid	Investigative
T13201	DRUGINFO	D0M3PO	2,4-Disulfamyltrifluoromethylaniline	Investigative
T13201	DRUGINFO	D00FGB	2-acetamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D08TBP	2-Acetylamino-indan-5-sulfonic acid hydrate	Investigative
T13201	DRUGINFO	D0C4QB	2-Amino-indan-5-sulfonic acid	Investigative
T13201	DRUGINFO	D0SF3B	2-butylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D0HN0R	2-cyclohexylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D08AOA	2-ethylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D05WQF	2-Hydroxycinnamic acid	Investigative
T13201	DRUGINFO	D01EEM	2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide	Investigative
T13201	DRUGINFO	D0D0BO	2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide	Investigative
T13201	DRUGINFO	D07PNA	2-nonylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D0H3NS	2-oxo-2H-chromene-3-carboxylic acid	Investigative
T13201	DRUGINFO	D0D6UR	2-oxo-2H-thiochromene-3-carboxylic acid	Investigative
T13201	DRUGINFO	D0J3SP	2-pentafluorophenylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D0O8WV	2-propylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D07LYW	2-valproylamido-5-sulfonamidoindane	Investigative
T13201	DRUGINFO	D06ZMH	3-(3-Phenyl-ureido)-benzenesulfonamide	Investigative
T13201	DRUGINFO	D09CSP	3-(4-sulfamoylphenyl)propanoic acid	Investigative
T13201	DRUGINFO	D01JTI	3-bromophenyl-difluoromethanesulfonamide	Investigative
T13201	DRUGINFO	D01UDU	3-Chloro-4-hydrazino-benzenesulfonamide	Investigative
T13201	DRUGINFO	D01YHK	3-Fluoro-4-hydrazino-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0DY9U	3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide	Investigative
T13201	DRUGINFO	D07OMY	3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide	Investigative
T13201	DRUGINFO	D04RCR	3-phenylprop-1-enylboronic acid	Investigative
T13201	DRUGINFO	D04NSN	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Investigative
T13201	DRUGINFO	D0TY8X	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide	Investigative
T13201	DRUGINFO	D05ETN	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0Z5GE	4-(2-Phenylacetamido)-3-bromobenzenesulfonamide	Investigative
T13201	DRUGINFO	D0A3JR	4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide	Investigative
T13201	DRUGINFO	D0O9VU	4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide	Investigative
T13201	DRUGINFO	D0O0UE	4-(2-Phenylacetamido)benzenesulfonamide	Investigative
T13201	DRUGINFO	D09LWR	4-(2-Phenylacetamidoethyl)benzenesulfonamide	Investigative
T13201	DRUGINFO	D06XNT	4-(2-Phenylacetamidomethyl)benzenesulfonamide	Investigative
T13201	DRUGINFO	D02BMV	4-(2-Propynylthio)pyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D0N7WP	4-(2-Pyridin-2-ylacetamido)benzenesulfonamide	Investigative
T13201	DRUGINFO	D00GVA	4-(2-Pyridin-4-ylacetamido)benzenesulfonamide	Investigative
T13201	DRUGINFO	D05EBZ	4-(4-Cyanophenoxy)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D08JCC	4-(4-Fluorophenoxy)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0R4KQ	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D09TKG	4-(Allylamino)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0V5OW	4-(Carbamolymethylthio)pyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D01OTW	4-(Cyanomethylthio)pyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D05XZM	4-(hydroxymethyl)benzenesulfonamide	Investigative
T13201	DRUGINFO	D0Q5VB	4-(Methylhydrazino)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D02NQK	4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D05JAJ	4-(Quinolinoxy)-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D03KRB	4,4'-thiodipyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D0BR1D	4,6-Dinitro salicylic acid	Investigative
T13201	DRUGINFO	D0W9VC	4-[2-(2-Thienyl)acetamido]benzenesulfonamide	Investigative
T13201	DRUGINFO	D01ISX	4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide	Investigative
T13201	DRUGINFO	D09LUD	4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0P6AM	4-Amino-3-bromo-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0YU8J	4-Amino-3-chloro-benzenesulfonamide	Investigative
T13201	DRUGINFO	D04CVC	4-Amino-3-fluoro-benzenesulfonamide	Investigative
T13201	DRUGINFO	D01STY	4-Amino-3-iodo-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0Z1HY	4-amino-6-chlorobenzene-1,3-disulfonamide	Investigative
T13201	DRUGINFO	D0X6IE	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide	Investigative
T13201	DRUGINFO	D0Z6TM	4-azidobenzenesulfonamide	Investigative
T13201	DRUGINFO	D0YD9F	4-Benzenesulfonylamino-benzenesulfonamide	Investigative
T13201	DRUGINFO	D06IOI	4-Benzythiopyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D0Z1CL	4-bromophenylboronic acid	Investigative
T13201	DRUGINFO	D05NFU	4-butylphenylboronic acid	Investigative
T13201	DRUGINFO	D0A8HW	4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide	Investigative
T13201	DRUGINFO	D04VSP	4-Ethoxy-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0LJ5P	4-ethynyl benzene sulfonamide	Investigative
T13201	DRUGINFO	D0X9LJ	4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide	Investigative
T13201	DRUGINFO	D0UM1I	4-Hydrazino-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0NN3Q	4-Hydrazino-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0Q0EK	4-Hydrazinocarbonyl-benzenesulfonamide	Investigative
T13201	DRUGINFO	D0U1AN	4-isothiocyanatobenzenesulfonamide	Investigative
T13201	DRUGINFO	D00NUK	4-Methanesulfonylamino-benzenesulfonamide	Investigative
T13201	DRUGINFO	D00IKQ	4-Methoxy-3-pyridinesulfonamide	Investigative
T13201	DRUGINFO	D0A4HS	4-methoxyphenylboronic acid	Investigative
T13201	DRUGINFO	D06GPL	4-methylphenyl-difluoromethanesulfonamide	Investigative
T13201	DRUGINFO	D0X0RE	4-methylstyrylboronic acid	Investigative
T13201	DRUGINFO	D0J7GU	4-Methylthiopyridine-3-sulfonamide	Investigative
T13201	DRUGINFO	D0T0YI	4-nitrophenyl phosphate	Investigative
T13201	DRUGINFO	D0I5YQ	4-nitrophenyl-difluoromethanesulfonamide	Investigative
T13201	DRUGINFO	D0D2JA	4-phenoxyphenylboronic acid	Investigative
T13201	DRUGINFO	D0X1MY	5-Amino-[1,3,4]thiadiazole-2-thiol	Investigative
T13201	DRUGINFO	D05FMD	5-Chlorosalicylic Acid	Investigative
T13201	DRUGINFO	D06SME	5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one	Investigative
T13201	DRUGINFO	D0D1HC	5-oxo-1-tosyl-2,5-dihydro-1Hpyrrol-2-yl acetate	Investigative
T13201	DRUGINFO	D0N1AW	6-(aminomethyl)-2H-chromen-2-one	Investigative
T13201	DRUGINFO	D0O1QT	6-Amino-benzothiazole-2-sulfonic acid amide	Investigative
T13201	DRUGINFO	D0Q2LL	6-Hydroxy-benzothiazole-2-sulfonic acid amide	Investigative
T13201	DRUGINFO	D00XJA	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T13201	DRUGINFO	D0G3BI	6-methyl-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T13201	DRUGINFO	D0RB0D	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid	Investigative
T13201	DRUGINFO	D06DYP	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T13201	DRUGINFO	D05QEK	Aminobenzolamide derivative	Investigative
T13201	DRUGINFO	D09JHA	Azide	Investigative
T13201	DRUGINFO	D09QHC	BENZENESULFONAMIDE	Investigative
T13201	DRUGINFO	D0E8CC	BENZOLAMIDE	Investigative
T13201	DRUGINFO	D0XL5K	Benzothiazole-2-sulfonic acid amide	Investigative
T13201	DRUGINFO	D0C8ZY	Beta-naphthylboronic acid	Investigative
T13201	DRUGINFO	D09OSN	Biphenyl-4-ylboronic acid	Investigative
T13201	DRUGINFO	D0Y6EL	Carbamoyl phosphate disodium	Investigative
T13201	DRUGINFO	D09PWX	Carzenide	Investigative
T13201	DRUGINFO	D0V7AA	CATECHIN	Investigative
T13201	DRUGINFO	D0VD7H	CL-5343	Investigative
T13201	DRUGINFO	D03ZMQ	COUMARIN	Investigative
T13201	DRUGINFO	D04FXD	CYANATE	Investigative
T13201	DRUGINFO	D0T6VB	Cynooxide anion	Investigative
T13201	DRUGINFO	D00YEF	Decane-1,10-diyl disulfamate	Investigative
T13201	DRUGINFO	D09WSJ	Decyl sulfamate	Investigative
T13201	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T13201	DRUGINFO	D00ZUQ	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	Investigative
T13201	DRUGINFO	D0Y3TZ	GALLICACID	Investigative
T13201	DRUGINFO	D0U4BB	HERNIARIN	Investigative
T13201	DRUGINFO	D09JPC	Hexane-1,6-diamine	Investigative
T13201	DRUGINFO	D0T6ZX	HYDROSULFIDE	Investigative
T13201	DRUGINFO	D08RKK	IODIDE	Investigative
T13201	DRUGINFO	D05EPY	L-693612	Investigative
T13201	DRUGINFO	D0M4EV	N-(4-cyanophenyl)sulfamide	Investigative
T13201	DRUGINFO	D0KB6T	N-(4-Sulfamoyl-phenyl)-benzamide	Investigative
T13201	DRUGINFO	D0K3LN	N-(4-Sulfamoyl-phenyl)-butyramide	Investigative
T13201	DRUGINFO	D0N8LR	N-(4-Sulfamoyl-phenyl)-propionamide	Investigative
T13201	DRUGINFO	D07YSQ	N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide	Investigative
T13201	DRUGINFO	D0S4NO	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T13201	DRUGINFO	D0J1PZ	N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide	Investigative
T13201	DRUGINFO	D06JVR	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T13201	DRUGINFO	D0T2VH	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T13201	DRUGINFO	D0PA5L	N-(pentafluorophenyl)sulfamide	Investigative
T13201	DRUGINFO	D0K5NQ	N-[4-(trifluoromethyl)phenyl]sulfamide	Investigative
T13201	DRUGINFO	D0E3VJ	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T13201	DRUGINFO	D04PSK	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T13201	DRUGINFO	D0M7QA	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	Investigative
T13201	DRUGINFO	D00BMI	N-1,3,4-thiadiazol-2-ylsulfamide	Investigative
T13201	DRUGINFO	D09CXX	N-hydroxysulfamide	Investigative
T13201	DRUGINFO	D03EAQ	N-hydroxysulfonamides	Investigative
T13201	DRUGINFO	D00RJT	NITRATE	Investigative
T13201	DRUGINFO	D01XFH	N-propynyl amidebenzenesulphonide	Investigative
T13201	DRUGINFO	D0B4IN	NSC-654077	Investigative
T13201	DRUGINFO	D0D4OV	Octane-1,8-diyl disulfamate	Investigative
T13201	DRUGINFO	D05TLB	Octyl sulfamate	Investigative
T13201	DRUGINFO	D08XQI	PARAOXON	Investigative
T13201	DRUGINFO	D0AU0M	P-Coumaric Acid	Investigative
T13201	DRUGINFO	D02QGI	Pentane-1,5-diamine	Investigative
T13201	DRUGINFO	D0Q0XO	Pentanoic acid (4-sulfamoyl-phenyl)-amide	Investigative
T13201	DRUGINFO	D06ORV	Phenethylboronic acid	Investigative
T13201	DRUGINFO	D01GNQ	Phenoxyarsonous acid	Investigative
T13201	DRUGINFO	D0EJ9B	Phenyl Boronic acid	Investigative
T13201	DRUGINFO	D0UN0E	PHENYLDIFLUOROMETHANESULFONAMIDE	Investigative
T13201	DRUGINFO	D07SIA	PHENYLMETHANESULFONAMIDE	Investigative
T13201	DRUGINFO	D0L4FM	PHENYLSULFAMATE	Investigative
T13201	DRUGINFO	D00IAE	Prop-2-ynyl 4-sulfamoylbenzoate	Investigative
T13201	DRUGINFO	D0A0YX	SACCHARIN	Investigative
T13201	DRUGINFO	D0D5XC	Sodium trithiocarbonate	Investigative
T13201	DRUGINFO	D0F7QZ	Styrylboronic acid	Investigative
T13201	DRUGINFO	D03VDJ	SULFAMATE	Investigative
T13201	DRUGINFO	D07ZXR	Sulfamic acid 12-sulfamoyloxy-dodecyl ester	Investigative
T13201	DRUGINFO	D07CBA	Sulfamic acid 16-sulfamoyloxy-hexadecyl ester	Investigative
T13201	DRUGINFO	D07IHP	Sulfamic acid 3-sulfamoyloxy-phenyl ester	Investigative
T13201	DRUGINFO	D04BKU	Sulfamic acid 4-sulfamoyloxy-butyl ester	Investigative
T13201	DRUGINFO	D0X0PO	Sulfamic acid 6-sulfamoyloxy-hexyl ester	Investigative
T13201	DRUGINFO	D05FNN	Sulfamic acid 7-sulfamoyloxy-heptyl ester	Investigative
T13201	DRUGINFO	D03LWY	SULFATE	Investigative
T13201	DRUGINFO	D0Q7DJ	Syringic Acid	Investigative
T13201	DRUGINFO	D0I0RT	Thioureido sulfonamide	Investigative
T13201	DRUGINFO	D0S8RD	Trecadrine	Investigative
T13201	KEGGPATH	hsa00910:Nitrogen metabolism		
T13201	WIKIPATH	WP2681:Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes		
T13201	WIKIPATH	WP2744:Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes		
T13201	WIKIPATH	WP2770:Reversible Hydration of Carbon Dioxide		
T13201	WHIZPATH	PW000565:Gastric Acid Production		
T13201	REACPATH	R-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen		
T13201	REACPATH	R-HSA-1247673:Erythrocytes take up oxygen and release carbon dioxide		
T13201	REACPATH	R-HSA-1475029:Reversible hydration of carbon dioxide		
T13201	INTEPATH	cmyb_pathway:C-MYB transcription factor network		
				
T20401	TARGETID	T20401		
T20401	FORMERID	TTDS00306		
T20401	UNIPROID	CAH2_HUMAN		
T20401	TARGNAME	Carbonic anhydrase II (CA-II)		
T20401	GENENAME	CA2		
T20401	TARGTYPE	Successful target		
T20401	SYNONYMS	Carbonic anhydrase C; Carbonic anhydrase 2; Carbonate dehydratase II; CAC		
T20401	FUNCTION	Reversible hydration of carbon dioxide. Can hydrate cyanamide to urea. Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption. Stimulates the chloride-bicarbonate exchange activity of SLC26A6. Essential for bone resorption and osteoclast differentiation.		
T20401	PDBSTRUC	9CA2; 8CA2; 7CA2; 6QEB; 6MBY		
T20401	BIOCLASS	Alpha-carbonic anhydrase		
T20401	ECNUMBER	EC 4.2.1.1		
T20401	SEQUENCE	MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK		
T20401	DRUGINFO	D0L2MX	Benzthiazide	Approved
T20401	DRUGINFO	D0M9WM	Chlorothiazide	Approved
T20401	DRUGINFO	D03CNS	Cyclothiazide	Approved
T20401	DRUGINFO	D0J4GO	Dichlorphenamide	Approved
T20401	DRUGINFO	D05UYW	Dorzolamide	Approved
T20401	DRUGINFO	D0CK3G	Ethinamate	Approved
T20401	DRUGINFO	D07INV	Ethoxzolamide	Approved
T20401	DRUGINFO	D07HBX	Salicyclic acid	Approved
T20401	DRUGINFO	D0K1QD	Sulfamylon	Approved
T20401	DRUGINFO	D0W2CX	CG-100649	Phase 3
T20401	DRUGINFO	D07SDQ	Curcumin	Phase 3
T20401	DRUGINFO	D02JUW	GUAIACOL	Phase 3
T20401	DRUGINFO	D0A8JP	PARABEN	Phase 3
T20401	DRUGINFO	D06PII	SULTHIAME	Phase 3
T20401	DRUGINFO	D0L6HN	PHENOL	Phase 2/3
T20401	DRUGINFO	D0Y6OA	Coumate	Phase 2
T20401	DRUGINFO	D07ZNI	STX-140	Phase 2
T20401	DRUGINFO	D0W1SL	BUTYLATEDHYDROXYTOLUENE	Phase 1
T20401	DRUGINFO	D0V0UK	SULFAMIDE	Phase 1
T20401	DRUGINFO	D03SLR	FERULIC ACID	Patented
T20401	DRUGINFO	D01KOO	(2,2-dimethyl-1,3-dioxolan-4-yl)methyl sulfamate	Investigative
T20401	DRUGINFO	D04JIN	(2-bromophenyl)difluoromethanesulfonamide	Investigative
T20401	DRUGINFO	D0IU3X	(4-bromophenyl)difluoromethanesulfonamide	Investigative
T20401	DRUGINFO	D09UQM	1-(3,4-dichlorophenyl)-3-hydroxyurea	Investigative
T20401	DRUGINFO	D0OT2H	1,2,4-Triazole	Investigative
T20401	DRUGINFO	D05RAB	1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0C6ED	1,4-phenylene disulfamate	Investigative
T20401	DRUGINFO	D00XIB	1-acetamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D04SNH	1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0G9NE	1-cyclohexylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D0O4KL	1-pentafluorophenylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D06OVA	1-pentenyl-4-(aminosulfonyl)benzoate	Investigative
T20401	DRUGINFO	D0KZ2D	1-valproylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D05BMD	2-(4-chlorobenzyloxyamino)-N-hydroxyacetamide	Investigative
T20401	DRUGINFO	D06NDR	2-(4-chlorobenzyloxyamino)-N-hydroxyhexanamide	Investigative
T20401	DRUGINFO	D0G0OP	2-(4-chlorobenzyloxyamino)-N-hydroxypropanamide	Investigative
T20401	DRUGINFO	D09SFY	2-(4-hydroxybenzylideneamino)ethanesulfonamide	Investigative
T20401	DRUGINFO	D08ORD	2-(4-tert-butylbenzylideneamino)ethanesulfonamide	Investigative
T20401	DRUGINFO	D0U0QW	2-(benzylideneamino)ethanesulfonamide	Investigative
T20401	DRUGINFO	D0Y1XM	2-(benzyloxyamino)-N-hydroxyhexanamide	Investigative
T20401	DRUGINFO	D02KDH	2-(N''-Acetyl-hydrazino)-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0RK7J	2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide	Investigative
T20401	DRUGINFO	D03DAM	2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide	Investigative
T20401	DRUGINFO	D0LC0F	2,3-dihydro-1H-indene-5-sulfonamide	Investigative
T20401	DRUGINFO	D0S6CO	2,4-dichloro-5-sulfamoylbenzoic acid	Investigative
T20401	DRUGINFO	D0M3PO	2,4-Disulfamyltrifluoromethylaniline	Investigative
T20401	DRUGINFO	D05DFJ	2,6-Difluorobenzenesulfonamide	Investigative
T20401	DRUGINFO	D06MZK	2,6-di-t-butylphenol	Investigative
T20401	DRUGINFO	D09ZUN	2,6-di-tert-butyl-4-methoxyphenol	Investigative
T20401	DRUGINFO	D00FGB	2-acetamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D08TBP	2-Acetylamino-indan-5-sulfonic acid hydrate	Investigative
T20401	DRUGINFO	D0OI1H	2-Amino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0C4QB	2-Amino-indan-5-sulfonic acid	Investigative
T20401	DRUGINFO	D0SF3B	2-butylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D0HN0R	2-cyclohexylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D08AOA	2-ethylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D06KTD	2-Hydrazinocarbonyl-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0G0FJ	2-hydrazinylbenzenesulfonamide	Investigative
T20401	DRUGINFO	D05WQF	2-Hydroxycinnamic acid	Investigative
T20401	DRUGINFO	D01EEM	2-Mercapto-N-(4-sulfamoyl-phenyl)-benzamide	Investigative
T20401	DRUGINFO	D04GDW	2-methoxyestradiol-17-O-sulfamate	Investigative
T20401	DRUGINFO	D09PUF	2-methoxyestrrone-3-O-sulfamate	Investigative
T20401	DRUGINFO	D0D0BO	2-Morpholin-4-yl-N-(4-sulfamoyl-phenyl)-acetamide	Investigative
T20401	DRUGINFO	D07PNA	2-nonylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D0D6UR	2-oxo-2H-thiochromene-3-carboxylic acid	Investigative
T20401	DRUGINFO	D0J3SP	2-pentafluorophenylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D0O8WV	2-propylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D07CQI	2-Sulfamoyl-benzoic acid methyl ester	Investigative
T20401	DRUGINFO	D0Q5FV	2-Sulfhydryl-Ethanol	Investigative
T20401	DRUGINFO	D07LYW	2-valproylamido-5-sulfonamidoindane	Investigative
T20401	DRUGINFO	D0H4CF	3-((4-aminophenyl)diazenyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0C7WG	3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D06ZMH	3-(3-Phenyl-ureido)-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0BD0K	3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide	Investigative
T20401	DRUGINFO	D09CSP	3-(4-sulfamoylphenyl)propanoic acid	Investigative
T20401	DRUGINFO	D0S6GK	3,5-Difluorobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0J2AE	3-Amino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D01JTI	3-bromophenyl-difluoromethanesulfonamide	Investigative
T20401	DRUGINFO	D01UDU	3-Chloro-4-hydrazino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D01YHK	3-Fluoro-4-hydrazino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0C9ZY	3-hydroxy-2-methoxybenzaldehyde	Investigative
T20401	DRUGINFO	D0DY9U	3-mercapto-N-(4-sulfamoyl-phenyl)-propionamide	Investigative
T20401	DRUGINFO	D0A2PD	3-Mercuri-4-Aminobenzenesulfonamide	Investigative
T20401	DRUGINFO	D07ZHE	3-Nitro-benzenesulfonamide	Investigative
T20401	DRUGINFO	D07OMY	3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide	Investigative
T20401	DRUGINFO	D04RCR	3-phenylprop-1-enylboronic acid	Investigative
T20401	DRUGINFO	D04HRS	4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0I1XT	4-((benzylideneamino)methyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D04NSN	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Investigative
T20401	DRUGINFO	D0TY8X	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide	Investigative
T20401	DRUGINFO	D04VLI	4-(2-Hydroxy-ethyl)-benzenesulfonamide	Investigative
T20401	DRUGINFO	D05ETN	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0Z5GE	4-(2-Phenylacetamido)-3-bromobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0A3JR	4-(2-Phenylacetamido)-3-chlorobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0O9VU	4-(2-Phenylacetamido)-3-fluorobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0O0UE	4-(2-Phenylacetamido)benzenesulfonamide	Investigative
T20401	DRUGINFO	D09LWR	4-(2-Phenylacetamidoethyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D06XNT	4-(2-Phenylacetamidomethyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D02BMV	4-(2-Propynylthio)pyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D0N7WP	4-(2-Pyridin-2-ylacetamido)benzenesulfonamide	Investigative
T20401	DRUGINFO	D00GVA	4-(2-Pyridin-4-ylacetamido)benzenesulfonamide	Investigative
T20401	DRUGINFO	D05EBZ	4-(4-Cyanophenoxy)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D08JCC	4-(4-Fluorophenoxy)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D03VUQ	4-(4-hydroxy-benzylideneamino)-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0R6JK	4-(4-hydroxybenzylideneamino)benzoic acid	Investigative
T20401	DRUGINFO	D02DCD	4-(4-tert-butylbenzylideneamino)benzoic acid	Investigative
T20401	DRUGINFO	D0R4KQ	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D09TKG	4-(Allylamino)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0S2II	4-(benzylideneamino)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0K4IH	4-(benzylideneamino)benzoic acid	Investigative
T20401	DRUGINFO	D0V5OW	4-(Carbamolymethylthio)pyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D01OTW	4-(Cyanomethylthio)pyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D07QHM	4-(Hydroxymercury)Benzoic Acid	Investigative
T20401	DRUGINFO	D05XZM	4-(hydroxymethyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0Q5VB	4-(Methylhydrazino)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0M7VN	4-(N-Methyl-hydrazino)-benzenesulfonamide	Investigative
T20401	DRUGINFO	D02NQK	4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D05JAJ	4-(Quinolinoxy)-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D03KRB	4,4'-thiodipyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D0BR1D	4,6-Dinitro salicylic acid	Investigative
T20401	DRUGINFO	D0W9VC	4-[2-(2-Thienyl)acetamido]benzenesulfonamide	Investigative
T20401	DRUGINFO	D01ISX	4-[2-(2-Thienyl)acetamidoethyl]benzenesulfonamide	Investigative
T20401	DRUGINFO	D09LUD	4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0P6AM	4-Amino-3-bromo-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0YU8J	4-Amino-3-chloro-benzenesulfonamide	Investigative
T20401	DRUGINFO	D04CVC	4-Amino-3-fluoro-benzenesulfonamide	Investigative
T20401	DRUGINFO	D01STY	4-Amino-3-iodo-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0Z1HY	4-amino-6-chlorobenzene-1,3-disulfonamide	Investigative
T20401	DRUGINFO	D0X6IE	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0Z6TM	4-azidobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0YD9F	4-Benzenesulfonylamino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D06IOI	4-Benzythiopyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D0Z1CL	4-bromophenylboronic acid	Investigative
T20401	DRUGINFO	D05NFU	4-butylphenylboronic acid	Investigative
T20401	DRUGINFO	D0A8HW	4-Chloro-N-(5-sulfamoyl-indan-2-yl)-benzamide	Investigative
T20401	DRUGINFO	D00IUB	4-CYANOPHENOL	Investigative
T20401	DRUGINFO	D04VSP	4-Ethoxy-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0LJ5P	4-ethynyl benzene sulfonamide	Investigative
T20401	DRUGINFO	D00SJT	4-Flourobenzenesulfonamide	Investigative
T20401	DRUGINFO	D0X9LJ	4-fluoro-N-(4-sulfamoylbenzyl)benzenesulfonamide	Investigative
T20401	DRUGINFO	D0UM1I	4-Hydrazino-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0NN3Q	4-Hydrazino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0Q0EK	4-Hydrazinocarbonyl-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0U1AN	4-isothiocyanatobenzenesulfonamide	Investigative
T20401	DRUGINFO	D00NUK	4-Methanesulfonylamino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D00IKQ	4-Methoxy-3-pyridinesulfonamide	Investigative
T20401	DRUGINFO	D0A4HS	4-methoxyphenylboronic acid	Investigative
T20401	DRUGINFO	D0T8SN	4-methoxyphenylsulfamide	Investigative
T20401	DRUGINFO	D07AGM	4-Methylamino-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0KK4F	4-Methylimidazole	Investigative
T20401	DRUGINFO	D06GPL	4-methylphenyl-difluoromethanesulfonamide	Investigative
T20401	DRUGINFO	D0J7GU	4-Methylthiopyridine-3-sulfonamide	Investigative
T20401	DRUGINFO	D06LVE	4-Nitro-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0T0YI	4-nitrophenyl phosphate	Investigative
T20401	DRUGINFO	D0I5YQ	4-nitrophenyl-difluoromethanesulfonamide	Investigative
T20401	DRUGINFO	D0I8DW	4-nitrophenylsulfamide	Investigative
T20401	DRUGINFO	D0D2JA	4-phenoxyphenylboronic acid	Investigative
T20401	DRUGINFO	D0O0HT	4-Sulfonamide-[1-(4-Aminobutane)]Benzamide	Investigative
T20401	DRUGINFO	D05PRS	4-Thiocyanato-benzenesulfonamide	Investigative
T20401	DRUGINFO	D0X1MY	5-Amino-[1,3,4]thiadiazole-2-thiol	Investigative
T20401	DRUGINFO	D05FMD	5-Chlorosalicylic Acid	Investigative
T20401	DRUGINFO	D06SME	5-hydroxy-1-tosyl-1H-pyrrol-2(5H)-one	Investigative
T20401	DRUGINFO	D0N1AW	6-(aminomethyl)-2H-chromen-2-one	Investigative
T20401	DRUGINFO	D0L5TZ	6-(hydroxymethyl)-2H-chromen-2-one	Investigative
T20401	DRUGINFO	D0O1QT	6-Amino-benzothiazole-2-sulfonic acid amide	Investigative
T20401	DRUGINFO	D0A6HS	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	Investigative
T20401	DRUGINFO	D0M8UY	6-hydroxybenzo[d][1,3]oxathiol-2-one	Investigative
T20401	DRUGINFO	D0Q2LL	6-Hydroxy-benzothiazole-2-sulfonic acid amide	Investigative
T20401	DRUGINFO	D00XJA	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T20401	DRUGINFO	D0G3BI	6-methyl-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T20401	DRUGINFO	D07JYF	6-Nitro-benzothiazole-2-sulfonic acid amide	Investigative
T20401	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T20401	DRUGINFO	D04POB	ACETYLSULFANILAMIDE	Investigative
T20401	DRUGINFO	D09HNP	AL4623	Investigative
T20401	DRUGINFO	D08CNG	AL5300	Investigative
T20401	DRUGINFO	D0D6UL	AL5424	Investigative
T20401	DRUGINFO	D0M8HC	AL5927	Investigative
T20401	DRUGINFO	D09LMH	AL6528	Investigative
T20401	DRUGINFO	D04XMZ	Al7089a	Investigative
T20401	DRUGINFO	D0XX9C	AL7099A	Investigative
T20401	DRUGINFO	D0B8CU	AL7182	Investigative
T20401	DRUGINFO	D05NAR	Allyl 4-(aminosulfonyl)benzoate	Investigative
T20401	DRUGINFO	D05QEK	Aminobenzolamide derivative	Investigative
T20401	DRUGINFO	D09JHA	Azide	Investigative
T20401	DRUGINFO	D0E8CC	BENZOLAMIDE	Investigative
T20401	DRUGINFO	D0XL5K	Benzothiazole-2-sulfonic acid amide	Investigative
T20401	DRUGINFO	D0C8ZY	Beta-naphthylboronic acid	Investigative
T20401	DRUGINFO	D09OSN	Biphenyl-4-ylboronic acid	Investigative
T20401	DRUGINFO	D09PWX	Carzenide	Investigative
T20401	DRUGINFO	D0V7AA	CATECHIN	Investigative
T20401	DRUGINFO	D07QJJ	CATECHOL	Investigative
T20401	DRUGINFO	D0VD7H	CL-5343	Investigative
T20401	DRUGINFO	D03ZMQ	COUMARIN	Investigative
T20401	DRUGINFO	D0S7NH	Dansylamide	Investigative
T20401	DRUGINFO	D00YEF	Decane-1,10-diyl disulfamate	Investigative
T20401	DRUGINFO	D09WSJ	Decyl sulfamate	Investigative
T20401	DRUGINFO	D0A0RT	Di(2,6-diisopropylphenol)	Investigative
T20401	DRUGINFO	D04LNI	Di(2,6-dimethylphenol)	Investigative
T20401	DRUGINFO	D0C3SL	Di(2,6-di-t-butylphenol)	Investigative
T20401	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T20401	DRUGINFO	D0R7QY	EMATE	Investigative
T20401	DRUGINFO	D00ZUQ	ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE	Investigative
T20401	DRUGINFO	D06EWG	Formic Acid	Investigative
T20401	DRUGINFO	D0Y3TZ	GALLICACID	Investigative
T20401	DRUGINFO	D0T6ZX	HYDROSULFIDE	Investigative
T20401	DRUGINFO	D08RKK	IODIDE	Investigative
T20401	DRUGINFO	D06CGS	Mercuribenzoic Acid	Investigative
T20401	DRUGINFO	D07AUN	Methyl 4-(4-hydroxybenzylideneamino)benzoate	Investigative
T20401	DRUGINFO	D05DIH	Methyl 4-(4-tert-butylbenzylideneamino)benzoate	Investigative
T20401	DRUGINFO	D09CZV	Methyl Mercury Ion	Investigative
T20401	DRUGINFO	D0A4TC	MMI270	Investigative
T20401	DRUGINFO	D0M7DE	N-(1-benzofuran-3-ylmethyl)sulfamide	Investigative
T20401	DRUGINFO	D0A7ZH	N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE	Investigative
T20401	DRUGINFO	D0S5LS	N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide	Investigative
T20401	DRUGINFO	D0U7GL	N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide	Investigative
T20401	DRUGINFO	D0L4KE	N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide	Investigative
T20401	DRUGINFO	D0M4EV	N-(4-cyanophenyl)sulfamide	Investigative
T20401	DRUGINFO	D0KB6T	N-(4-Sulfamoyl-phenyl)-benzamide	Investigative
T20401	DRUGINFO	D0K3LN	N-(4-Sulfamoyl-phenyl)-butyramide	Investigative
T20401	DRUGINFO	D0T2YZ	N-(4-Sulfamoyl-phenyl)-isobutyramide	Investigative
T20401	DRUGINFO	D0N8LR	N-(4-Sulfamoyl-phenyl)-propionamide	Investigative
T20401	DRUGINFO	D07YSQ	N-(4-sulfamoylphenylethyl)-4-sulfamoylbenzamide	Investigative
T20401	DRUGINFO	D0S4NO	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T20401	DRUGINFO	D0J1PZ	N-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-acetamide	Investigative
T20401	DRUGINFO	D06JVR	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T20401	DRUGINFO	D0T2VH	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T20401	DRUGINFO	D0PA5L	N-(pentafluorophenyl)sulfamide	Investigative
T20401	DRUGINFO	D0L6CN	N-(phosphonacetyl)-L-aspartate	Investigative
T20401	DRUGINFO	D0LM8L	N-[(4-bromo-1-benzothien-3-yl)methyl]sulfamide	Investigative
T20401	DRUGINFO	D0GI2R	N-[(5-chloro-1-benzothien-3-yl)methyl]sulfamide	Investigative
T20401	DRUGINFO	D0N8RD	N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide	Investigative
T20401	DRUGINFO	D0K5NQ	N-[4-(trifluoromethyl)phenyl]sulfamide	Investigative
T20401	DRUGINFO	D0E3VJ	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T20401	DRUGINFO	D04PSK	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T20401	DRUGINFO	D0M7QA	N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE	Investigative
T20401	DRUGINFO	D00BMI	N-1,3,4-thiadiazol-2-ylsulfamide	Investigative
T20401	DRUGINFO	D07RZN	N-Benzyl-4-Sulfamoyl-Benzamide	Investigative
T20401	DRUGINFO	D09CXX	N-hydroxysulfamide	Investigative
T20401	DRUGINFO	D03EAQ	N-hydroxysulfonamides	Investigative
T20401	DRUGINFO	D00RJT	NITRATE	Investigative
T20401	DRUGINFO	D01XFH	N-propynyl amidebenzenesulphonide	Investigative
T20401	DRUGINFO	D0B4IN	NSC-654077	Investigative
T20401	DRUGINFO	D0D4OV	Octane-1,8-diyl disulfamate	Investigative
T20401	DRUGINFO	D05TLB	Octyl sulfamate	Investigative
T20401	DRUGINFO	D08XQI	PARAOXON	Investigative
T20401	DRUGINFO	D0AU0M	P-Coumaric Acid	Investigative
T20401	DRUGINFO	D02QGI	Pentane-1,5-diamine	Investigative
T20401	DRUGINFO	D0Q0XO	Pentanoic acid (4-sulfamoyl-phenyl)-amide	Investigative
T20401	DRUGINFO	D06ORV	Phenethylboronic acid	Investigative
T20401	DRUGINFO	D01GNQ	Phenoxyarsonous acid	Investigative
T20401	DRUGINFO	D0EJ9B	Phenyl Boronic acid	Investigative
T20401	DRUGINFO	D0UN0E	PHENYLDIFLUOROMETHANESULFONAMIDE	Investigative
T20401	DRUGINFO	D07SIA	PHENYLMETHANESULFONAMIDE	Investigative
T20401	DRUGINFO	D00CIW	Phenyl-phosphonic acid	Investigative
T20401	DRUGINFO	D0L4FM	PHENYLSULFAMATE	Investigative
T20401	DRUGINFO	D06IYU	PHENYLSULFAMIDE	Investigative
T20401	DRUGINFO	D0SV6C	PRONTOCIL	Investigative
T20401	DRUGINFO	D00IAE	Prop-2-ynyl 4-sulfamoylbenzoate	Investigative
T20401	DRUGINFO	D0ZC3W	P-toluenesulfonamide	Investigative
T20401	DRUGINFO	D0L8ZG	P-tolylboronic acid	Investigative
T20401	DRUGINFO	D0F7SO	Quinoline-8-sulfonamide	Investigative
T20401	DRUGINFO	D02DBP	RESORCINOL	Investigative
T20401	DRUGINFO	D0A0YX	SACCHARIN	Investigative
T20401	DRUGINFO	D0G6OW	Sodium 2,3,5,6-tetrafluorobenzoate	Investigative
T20401	DRUGINFO	D0F4ZW	SODIUM PERFLUOROHEXANESULFONAMIDE	Investigative
T20401	DRUGINFO	D0D5XC	Sodium trithiocarbonate	Investigative
T20401	DRUGINFO	D03VDJ	SULFAMATE	Investigative
T20401	DRUGINFO	D07ZXR	Sulfamic acid 12-sulfamoyloxy-dodecyl ester	Investigative
T20401	DRUGINFO	D07CBA	Sulfamic acid 16-sulfamoyloxy-hexadecyl ester	Investigative
T20401	DRUGINFO	D07IHP	Sulfamic acid 3-sulfamoyloxy-phenyl ester	Investigative
T20401	DRUGINFO	D04BKU	Sulfamic acid 4-sulfamoyloxy-butyl ester	Investigative
T20401	DRUGINFO	D0N5KX	Sulfamic acid 4-sulfamoyloxymethyl-benzyl ester	Investigative
T20401	DRUGINFO	D0X0PO	Sulfamic acid 6-sulfamoyloxy-hexyl ester	Investigative
T20401	DRUGINFO	D05FNN	Sulfamic acid 7-sulfamoyloxy-heptyl ester	Investigative
T20401	DRUGINFO	D0A5XB	Sulfamic acid benzo[1,3]dioxol-2-ylmethyl ester	Investigative
T20401	DRUGINFO	D04MAM	Sulfamic acid chroman-2-ylmethyl ester	Investigative
T20401	DRUGINFO	D0Q7DJ	Syringic Acid	Investigative
T20401	DRUGINFO	D0I0RT	Thioureido sulfonamide	Investigative
T20401	DRUGINFO	D0S8RD	Trecadrine	Investigative
T20401	KEGGPATH	hsa00910:Nitrogen metabolism		
T20401	KEGGPATH	hsa04964:Proximal tubule bicarbonate reclamation		
T20401	KEGGPATH	hsa04966:Collecting duct acid secretion		
T20401	KEGGPATH	hsa04971:Gastric acid secretion		
T20401	KEGGPATH	hsa04972:Pancreatic secretion		
T20401	KEGGPATH	hsa04976:Bile secretion		
T20401	WIKIPATH	WP2681:Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes		
T20401	WIKIPATH	WP2744:Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes		
T20401	WIKIPATH	WP2770:Reversible Hydration of Carbon Dioxide		
T20401	REACPATH	R-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen		
T20401	REACPATH	R-HSA-1247673:Erythrocytes take up oxygen and release carbon dioxide		
T20401	REACPATH	R-HSA-1475029:Reversible hydration of carbon dioxide		
T20401	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T20401	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
				
T89534	TARGETID	T89534		
T89534	FORMERID	TTDS00242		
T89534	UNIPROID	ESR1_HUMAN		
T89534	TARGNAME	Estrogen receptor (ESR)		
T89534	GENENAME	ESR1		
T89534	TARGTYPE	Successful target		
T89534	SYNONYMS	Nuclear receptor subfamily 3 group A member 1; NR3A1; Estradiol receptor; ESR; ER-alpha; ER		
T89534	FUNCTION	Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.		
T89534	PDBSTRUC	6IAR; 6HMU; 6HKF; 6HKB; 6HHP		
T89534	BIOCLASS	Nuclear hormone receptor		
T89534	SEQUENCE	MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPFLQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV		
T89534	DRUGINFO	D06LOQ	ARZOXIFENE	Approved
T89534	DRUGINFO	D0JY8T	Bazedoxifene	Approved
T89534	DRUGINFO	D0N6YV	Cenestin	Approved
T89534	DRUGINFO	D0CT9Y	Clomifene	Approved
T89534	DRUGINFO	D0I5WB	Clomiphene Citrate	Approved
T89534	DRUGINFO	D0A2RG	Conjugated estrogens a	Approved
T89534	DRUGINFO	D01ICU	Conjugated estrogens b	Approved
T89534	DRUGINFO	D0X1EZ	Cyclofenil	Approved
T89534	DRUGINFO	D09IPV	Danazol	Approved
T89534	DRUGINFO	D09ZQN	Dienestrol	Approved
T89534	DRUGINFO	D0Y2NE	Diethylstilbestrol	Approved
T89534	DRUGINFO	D0R6RE	Esterified estrogens	Approved
T89534	DRUGINFO	D08QMX	Estradiol	Approved
T89534	DRUGINFO	D0T7ZQ	Estradiol Acetate	Approved
T89534	DRUGINFO	D0U0XD	Estradiol Cypionate	Approved
T89534	DRUGINFO	D07VBA	Estradiol Valerate	Approved
T89534	DRUGINFO	D0Z1FX	Estriol	Approved
T89534	DRUGINFO	D0M8PD	Estrogen	Approved
T89534	DRUGINFO	D00ZFP	Estrone	Approved
T89534	DRUGINFO	D03IUY	Estropipate	Approved
T89534	DRUGINFO	D06NXY	Ethinyl Estradiol	Approved
T89534	DRUGINFO	D0JO8Z	Fosfestrol	Approved
T89534	DRUGINFO	D0JO7Y	Fulvestrant	Approved
T89534	DRUGINFO	D0M5RF	Gestrinone	Approved
T89534	DRUGINFO	D09NMD	Lasofoxifene	Approved
T89534	DRUGINFO	D0W9GA	Levormeloxifene	Approved
T89534	DRUGINFO	D0J1ML	Mestranol	Approved
T89534	DRUGINFO	D0Z5OE	Mitotane	Approved
T89534	DRUGINFO	D0V2JK	Nomegestrol acetate	Approved
T89534	DRUGINFO	D02CTS	Ospemifene	Approved
T89534	DRUGINFO	D0S1UW	Premarin/Trimegestone	Approved
T89534	DRUGINFO	D0C4NY	Promestriene	Approved
T89534	DRUGINFO	D04UZT	Quinestrol	Approved
T89534	DRUGINFO	D01XBA	Raloxifene	Approved
T89534	DRUGINFO	D07KSG	Tamoxifen	Approved
T89534	DRUGINFO	D04VFJ	Toremifene	Approved
T89534	DRUGINFO	D0XB0T	Acolbifene	Phase 3
T89534	DRUGINFO	D0VF3C	NPC-01	Phase 3
T89534	DRUGINFO	D0G7IV	Premarin/Pravachol	Phase 3
T89534	DRUGINFO	D07KUN	RAD-1901	Phase 3
T89534	DRUGINFO	D02BAE	Synthetic conjugated estrogen	Phase 3
T89534	DRUGINFO	D0C6XR	Trimegestone/ethinyl estradiol	Phase 3
T89534	DRUGINFO	D0IC7A	TZTX-001	Phase 3
T89534	DRUGINFO	D09NST	Afimoxifene	Phase 2
T89534	DRUGINFO	D00JFE	ARN-810	Phase 2
T89534	DRUGINFO	DATO92	AZD9833	Phase 2
T89534	DRUGINFO	D0W4EB	Endoxifen	Phase 2
T89534	DRUGINFO	D0L3TR	Estetrol	Phase 2
T89534	DRUGINFO	D0E7FM	GTx-758	Phase 2
T89534	DRUGINFO	D0L0BX	ICARITIN	Phase 2
T89534	DRUGINFO	D02PYN	SR 16234	Phase 2
T89534	DRUGINFO	D0Z5VW	H3B-6545	Phase 1/2
T89534	DRUGINFO	DZ91HE	OP-1250	Phase 1/2
T89534	DRUGINFO	DJ1W5R	ZN-c5	Phase 1/2
T89534	DRUGINFO	D09BQO	ATD transdermal gel	Phase 1
T89534	DRUGINFO	D0X1OW	AZD9496	Phase 1
T89534	DRUGINFO	D03YGP	CC-8490	Phase 1
T89534	DRUGINFO	D08OUV	CHF-4227	Phase 1
T89534	DRUGINFO	D09OJI	D-0502	Phase 1
T89534	DRUGINFO	DG38QS	G1T-48	Phase 1
T89534	DRUGINFO	DH4Y3O	LY3484356	Phase 1
T89534	DRUGINFO	DNTW18	SCO-120	Phase 1
T89534	DRUGINFO	D0NZ3C	TTC-352	Phase 1
T89534	DRUGINFO	DT4WU3	TTC-352	Phase 1
T89534	DRUGINFO	D0QQ1J	BITHIONOL	Withdrawn from market
T89534	DRUGINFO	D0X0KJ	Chlorotrianisene	Withdrawn from market
T89534	DRUGINFO	D0C4FT	HEXESTROL	Withdrawn from market
T89534	DRUGINFO	D0MU0S	EM-800	Discontinued in Phase 3
T89534	DRUGINFO	D0GR2J	Idoxifene	Discontinued in Phase 3
T89534	DRUGINFO	D01OML	IoGen	Discontinued in Phase 3
T89534	DRUGINFO	D02VFB	Miproxifene	Discontinued in Phase 3
T89534	DRUGINFO	D0R2JS	Droloxifene	Discontinued in Phase 2
T89534	DRUGINFO	D0R8TB	ERA-923	Discontinued in Phase 2
T89534	DRUGINFO	D01AXT	NP-50301	Discontinued in Phase 2
T89534	DRUGINFO	D04HVB	Panomifene	Discontinued in Phase 2
T89534	DRUGINFO	D04MNL	SERM-3339	Discontinued in Phase 2
T89534	DRUGINFO	D04BIG	SR-90067	Discontinued in Phase 2
T89534	DRUGINFO	D08DZZ	HE2100	Discontinued in Phase 1
T89534	DRUGINFO	D0B6HS	HRT	Discontinued in Phase 1
T89534	DRUGINFO	D05BCA	MX-4509	Discontinued in Phase 1
T89534	DRUGINFO	D0P5NU	BN-AA-003-NY	Preclinical
T89534	DRUGINFO	D01EXY	BN-AO-014	Preclinical
T89534	DRUGINFO	D0QI9N	BN-CB-045	Preclinical
T89534	DRUGINFO	D0N6YN	BN-DF-037	Preclinical
T89534	DRUGINFO	D0QX9U	BN-GU-005-DHP	Preclinical
T89534	DRUGINFO	D06YGP	BN-OD-026	Preclinical
T89534	DRUGINFO	D09AAM	ICI-164384	Terminated
T89534	DRUGINFO	D0SM0J	LY-117018	Terminated
T89534	DRUGINFO	D0J4ZH	Tamoxifen methyl iodide	Terminated
T89534	DRUGINFO	D0TR4Z	Zindoxifene	Terminated
T89534	DRUGINFO	D0H5CV	ZK-119010	Terminated
T89534	DRUGINFO	D00HUB	[1,1':2',1'']Terphenyl-4'-carbaldehyde oxime	Investigative
T89534	DRUGINFO	D0Z0UC	1,2-Bis-(4-hydroxy-phenyl)-3H-inden-5-ol	Investigative
T89534	DRUGINFO	D05FUY	1,8-Dichloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D08JCJ	17-METHYL-17-ALPHA-DIHYDROEQUILENIN	Investigative
T89534	DRUGINFO	D0S6NV	1-Bromo-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D01KJU	1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL	Investigative
T89534	DRUGINFO	D0ZT4U	1-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0V7QZ	2-(2-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0DK9S	2-(3-Butoxy-4-hydroxy-phenyl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D0K1TW	2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D08HCF	2-(3-Chloro-4-hydroxy-phenyl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D09TQE	2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0AD3U	2-(3-Fluoro-4-hydroxy-phenyl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D01SWO	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	Investigative
T89534	DRUGINFO	D03DVM	2-(3-hydroxyphenyl)-1,2'-spirobi[1H-indene]-6-ol	Investigative
T89534	DRUGINFO	D0W3FF	2-(4-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D0X2VK	2-(4-hydroxyphenyl)-1,2'-spirobi[1H-indene]-5-ol	Investigative
T89534	DRUGINFO	D0L6IQ	2-(4-Hydroxy-phenyl)-4-methoxy-quinolin-6-ol	Investigative
T89534	DRUGINFO	D0K7HR	2-(4-Hydroxy-phenyl)-4-vinyl-quinolin-6-ol	Investigative
T89534	DRUGINFO	D02LCC	2-(4-Hydroxy-phenyl)-7-isopropyl-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D03XEU	2-(4-Hydroxy-phenyl)-7-methoxy-benzofuran-5-ol	Investigative
T89534	DRUGINFO	D05JPW	2-(4-Hydroxy-phenyl)-7-methoxy-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0C6AP	2-(4-Hydroxy-phenyl)-7-methyl-benzofuran-5-ol	Investigative
T89534	DRUGINFO	D07VPM	2-(4-Hydroxy-phenyl)-7-phenyl-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D02EJM	2-(4-Hydroxy-phenyl)-7-propenyl-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D04WHH	2-(4-Hydroxy-phenyl)-7-propyl-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0YW4C	2-(4-Hydroxy-phenyl)-7-vinyl-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D01WCA	2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL	Investigative
T89534	DRUGINFO	D0N0OY	2-(4-Hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D09CQC	2-(4-Hydroxy-phenyl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D00CWN	2-(4-Hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D0U2VA	2-(5-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D01QXL	2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0YH4T	2-(6-Hydroxy-naphthalen-1-yl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D02JJU	2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D00HZT	2-(6-Hydroxy-naphthalen-2-yl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D0P7PK	2,3-diphenyl-1H-indole	Investigative
T89534	DRUGINFO	D03BOO	2,4-Dibenzylamino-6-isopentylpyrimidine	Investigative
T89534	DRUGINFO	D02GLM	2,4-diisobutylamino-6-isopentylpyrimidine	Investigative
T89534	DRUGINFO	D00ZAJ	2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE	Investigative
T89534	DRUGINFO	D0H1CO	2-Naphthalen-1-yl-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D0O2KP	2-phenyl-1,2'-spirobi[1H-indene]-5'-ol	Investigative
T89534	DRUGINFO	D04EAY	3-(2-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	Investigative
T89534	DRUGINFO	D0GH1I	3-(4-Hydroxyphenyl)-7-isobutoxychromen-4-one	Investigative
T89534	DRUGINFO	D0O9UY	3-(4-Hydroxyphenyl)-7-isopropoxychromen-4-one	Investigative
T89534	DRUGINFO	D08FLV	3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-5-ol	Investigative
T89534	DRUGINFO	D0B1HP	3-(4-Hydroxy-phenyl)-benzo[d]isoxazol-6-ol	Investigative
T89534	DRUGINFO	D0W2YR	3-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Investigative
T89534	DRUGINFO	D0S2ZJ	3-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Investigative
T89534	DRUGINFO	D0C5FY	3,8-dihydroxy-4-methyl-6H-benzo[c]chromen-6-one	Investigative
T89534	DRUGINFO	D0HM8Y	3,8-dihydroxy-7-methyl-6H-benzo[c]chromen-6-one	Investigative
T89534	DRUGINFO	D00AAU	3-[1-ethyl-2-(3-hydroxyphenyl)butyl]phenol	Investigative
T89534	DRUGINFO	D01ZRX	3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Investigative
T89534	DRUGINFO	D01UAO	3-chloro-4-(4-hydroxyphenyl)salicylaldoxime	Investigative
T89534	DRUGINFO	D0A8CS	3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL	Investigative
T89534	DRUGINFO	D0U0ZE	3-hydroxy-8,10-dimethyl-6H-benzo[c]chromen-6-one	Investigative
T89534	DRUGINFO	D0A1JP	3'-Methoxy-4'Hydroxyclomiphene	Investigative
T89534	DRUGINFO	D0V7OK	4-(1,2-Diphenyl-but-1-enyl)-phenol	Investigative
T89534	DRUGINFO	D09WEK	4-(1-benzyl-7-chloro-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0Q4VG	4-(1-butyl-7-chloro-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0F8LS	4-(1-cyclopentyl-7-fluoro-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0I5HZ	4-(2-phenyl-1H-benzo[d]imidazol-1-yl)phenol	Investigative
T89534	DRUGINFO	D0K0IC	4-(2-phenyl-1H-indol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0U7KV	4-(3-(4-hydroxyphenyl)-1H-indol-2-yl)phenol	Investigative
T89534	DRUGINFO	D00NEK	4-(3-phenyl-1H-indol-2-yl)phenol	Investigative
T89534	DRUGINFO	D0R7AG	4-(5-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	Investigative
T89534	DRUGINFO	D0K5LX	4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL	Investigative
T89534	DRUGINFO	D0C9XK	4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,2-diol	Investigative
T89534	DRUGINFO	D03RYU	4-(6-Hydroxy-benzooxazol-2-yl)-benzene-1,3-diol	Investigative
T89534	DRUGINFO	D0H8ZT	4-(7-chloro-1-cyclohexyl-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0V7ZI	4-(7-chloro-1-cyclopentyl-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0C4VX	4-(7-chloro-1-propyl-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D0J6KN	4-(7-methyl-1-propyl-1H-indazol-3-yl)phenol	Investigative
T89534	DRUGINFO	D00URP	4,10-dimethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0NN0V	4',5,7-trihydroxy-6,8-dimethylisoflavone	Investigative
T89534	DRUGINFO	D0S8EB	4,6,10-trimethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0H5HI	4,6,6,7-tetramethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0O6FX	4,6,7,10-tetramethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0O5KR	4,6,7-trimethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D09PXU	4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0K8QD	4-[1-(4-hydroxyphenyl)-2-phenylbut-1-enyl]phenol	Investigative
T89534	DRUGINFO	D0XC3V	4-[1-(4-hydroxyphenyl)-2-phenylhex-1-enyl]phenol	Investigative
T89534	DRUGINFO	D0OV3S	4-[1-(4-hydroxyphenyl)-2-phenylpent-1-enyl]phenol	Investigative
T89534	DRUGINFO	D0Q6MS	4-[1-(4-hydroxyphenyl)-2-phenylprop-1-enyl]phenol	Investigative
T89534	DRUGINFO	D07TGS	4-[1-(4-hydroxyphenyl)-2-phenylvinyl]phenol	Investigative
T89534	DRUGINFO	D0I1NX	4-[1,2-bis(4-hydroxyphenyl)but-1-enyl]phenol	Investigative
T89534	DRUGINFO	D06DNN	4-[1,2-bis(4-hydroxyphenyl)hex-1-enyl]phenol	Investigative
T89534	DRUGINFO	D02DVT	4-[1,2-bis(4-hydroxyphenyl)pent-1-enyl]phenol	Investigative
T89534	DRUGINFO	D00OLH	4-[1,2-bis(4-hydroxyphenyl)vinyl]phenol	Investigative
T89534	DRUGINFO	D03EOD	4-[2,2-bis(4-hydroxyphenyl)-1-methylvinyl]phenol	Investigative
T89534	DRUGINFO	D08WDN	4-Benzo[d]isoxazol-3-yl-benzene-1,3-diol	Investigative
T89534	DRUGINFO	D04TPC	4-benzyl-2,6-diisobutylamino-pyrimidine	Investigative
T89534	DRUGINFO	D03CBX	4-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D01TUB	4-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D09FWS	4-Ethyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D08SJL	4-Ethynyl-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D0Z9ZY	4-hydroxy-N,N-diphenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D0J3PM	4-hydroxy-N-isopropyl-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D08LVT	4-hydroxy-N-neopentyl-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D0L0RK	4-hydroxy-N-phenyl-N-propylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D0L3AX	4-Naphthalen-2-yl-phenol	Investigative
T89534	DRUGINFO	D0J0AG	5-Bromo-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D01KSR	5-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-6-ol	Investigative
T89534	DRUGINFO	D02HGS	5-Chloro-2-(4-hydroxy-phenyl)-quinolin-6-ol	Investigative
T89534	DRUGINFO	D0X6LK	5-hydroxy-2-phenylisoindoline-1,3-dione	Investigative
T89534	DRUGINFO	D0X7DJ	6-(2,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0V6KJ	6-(2,6-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D02OKF	6-(2-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0CC6R	6-(2-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0MY8V	6-(3,5-Difluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0K6TE	6-(3-Chloro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0X4VN	6-(3-Fluoro-4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0HR8L	6-(3-Hydroxy-phenyl)-naphthalen-1-ol	Investigative
T89534	DRUGINFO	D0P8PK	6-(3-Hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0P6FN	6-(4-Hydroxy-2-methoxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D01GPY	6-(4-Hydroxy-2-methyl-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0M0XL	6-(4-Hydroxy-phenyl)-1-methoxy-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D07XBD	6-(4-Hydroxy-phenyl)-1-methyl-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0H2FI	6-(4-Hydroxy-phenyl)-1-nitro-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0VN2R	6-(4-Hydroxy-phenyl)-1-phenyl-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0H8PI	6-(4-Hydroxy-phenyl)-naphthalen-1-ol	Investigative
T89534	DRUGINFO	D07LUI	6-(4-Hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0C9XW	6-butyl-2,4-dipropylaminopyrimidine	Investigative
T89534	DRUGINFO	D05JKC	6-Chloro-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0H6MZ	6-ethyl-2,4-diisobutylaminopyrimidine	Investigative
T89534	DRUGINFO	D00IXB	6-ethyl-4,7-dimethyl-6H-benzo[c]chromene-3,8-diol	Investigative
T89534	DRUGINFO	D0UV9G	6-Phenyl-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D01IAT	7-(3-Hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D09DEK	7-(4-Hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D00ZBL	7-Allyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0L2MU	7-Bromo-2-(4-hydroxy-phenyl)-benzofuran-5-ol	Investigative
T89534	DRUGINFO	D03GYS	7-Butyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D05YIU	7-Chloro-2-(4-hydroxy-phenyl)-benzofuran-5-ol	Investigative
T89534	DRUGINFO	D05QTG	7-Cyclopentyloxy-3-(4-hydroxyphenyl)chromen-4-one	Investigative
T89534	DRUGINFO	D06OAL	7-Ethyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0S0SZ	7-Ethynyl-2-(4-hydroxy-phenyl)-benzooxazol-5-ol	Investigative
T89534	DRUGINFO	D0SR8Q	7-Phenyl-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D03QHG	8-(2,2-dimethylpropyl)naringenin	Investigative
T89534	DRUGINFO	D0Y2LJ	8-(2-methylpropyl)naringenin	Investigative
T89534	DRUGINFO	D09NOH	8-(3-methylbutyl)naringenin	Investigative
T89534	DRUGINFO	D0D1LB	8-benzylnaringenin	Investigative
T89534	DRUGINFO	D08VDX	8-Chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D0FD6Z	8-Fluoro-6-(4-hydroxy-phenyl)-naphthalen-2-ol	Investigative
T89534	DRUGINFO	D07XUY	8-methylnaringenin	Investigative
T89534	DRUGINFO	D0J2NG	8-n-heptylnaringenin	Investigative
T89534	DRUGINFO	D0W5HT	8-n-nonylnaringenin	Investigative
T89534	DRUGINFO	D0LI0M	8-n-pentylnaringenin	Investigative
T89534	DRUGINFO	D0W0LG	8-n-propylnaringenin	Investigative
T89534	DRUGINFO	D05KXP	8-n-undecylnaringenin	Investigative
T89534	DRUGINFO	D06DDT	BROUSSONIN A	Investigative
T89534	DRUGINFO	D07KXE	Carboron Cluster with phenol	Investigative
T89534	DRUGINFO	D02DML	COUMESTROL	Investigative
T89534	DRUGINFO	D0L5IC	CP-394531	Investigative
T89534	DRUGINFO	D0J7XZ	CP-409069	Investigative
T89534	DRUGINFO	D0SY2M	daidzein	Investigative
T89534	DRUGINFO	D02VIW	DIHYDRORALOXIFENE	Investigative
T89534	DRUGINFO	D0RI6O	Doxorubicin-Formaldehyde Conjugate	Investigative
T89534	DRUGINFO	D0W4WF	EFFUSOL	Investigative
T89534	DRUGINFO	D0V4DH	Estriol E3	Investigative
T89534	DRUGINFO	D0H6OS	Geldanamycin-estradiol hybrid	Investigative
T89534	DRUGINFO	D09NFD	GSK-5182	Investigative
T89534	DRUGINFO	D04SAO	GW7604	Investigative
T89534	DRUGINFO	D00DJX	JNJ-17148066	Investigative
T89534	DRUGINFO	D09UQU	JNJ-19398990	Investigative
T89534	DRUGINFO	D0X0RJ	JNJ-26529126	Investigative
T89534	DRUGINFO	D02TPO	JNJ-26529152	Investigative
T89534	DRUGINFO	D04PEM	LTERHKILHRLLQEGSPSD	Investigative
T89534	DRUGINFO	D0XF9F	methyl-piperidino-pyrazole	Investigative
T89534	DRUGINFO	D07TGW	MPrP	Investigative
T89534	DRUGINFO	D07HBQ	N,N,N-Triisobutyl-pyrimidine-2,4,6-triamine	Investigative
T89534	DRUGINFO	D00FUO	Nafoxidine	Investigative
T89534	DRUGINFO	D0AD8G	N-allyl-4-hydroxy-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D00XLU	N-benzyl-4-hydroxy-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D0M4LQ	N-butyl-4-hydroxy-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D01XCA	N-cyclohexyl-4-hydroxy-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D09ULU	N-ethyl-4-hydroxy-N-phenylbenzenesulfonamide	Investigative
T89534	DRUGINFO	D0I6QZ	Org-37663	Investigative
T89534	DRUGINFO	D0Y8UF	propylpyrazoletriol	Investigative
T89534	DRUGINFO	D04SEX	R,R-THC	Investigative
T89534	DRUGINFO	D0E3UW	RG6046	Investigative
T89534	DRUGINFO	D0GY3R	SERMs	Investigative
T89534	DRUGINFO	D09BDK	SNG-163	Investigative
T89534	DRUGINFO	D01NDN	SNG-8006	Investigative
T89534	DRUGINFO	D03NWC	SNG-8023	Investigative
T89534	DRUGINFO	D03AVA	SNG-8033	Investigative
T89534	DRUGINFO	D0S8AV	SOPHORAFLAVANONE B	Investigative
T89534	DRUGINFO	D0E6AP	STX	Investigative
T89534	DRUGINFO	D0S5RI	Tamoxifen butyl bromide	Investigative
T89534	DRUGINFO	D0C6UR	Tamoxifen ethyl bromide	Investigative
T89534	DRUGINFO	D08GWS	Tamoxifen isopropyl bromide	Investigative
T89534	DRUGINFO	D0B4VV	Trans-hydroxytamoxifen	Investigative
T89534	DRUGINFO	D0W1YZ	TSERaM	Investigative
T89534	DRUGINFO	D0Y9BO	WAY-169916	Investigative
T89534	DRUGINFO	D06SCS	WAY200070	Investigative
T89534	DRUGINFO	D0P0FN	ZK-164015	Investigative
T89534	KEGGPATH	hsa04915:Estrogen signaling pathway		
T89534	KEGGPATH	hsa04917:Prolactin signaling pathway		
T89534	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T89534	KEGGPATH	hsa04961:Endocrine and other factor-regulated calcium reabsorption		
T89534	KEGGPATH	hsa05205:Proteoglycans in cancer		
T89534	WIKIPATH	WP170:Nuclear Receptors		
T89534	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T89534	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T89534	WIKIPATH	WP2034:Leptin signaling pathway		
T89534	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T89534	WIKIPATH	WP2593:JAK/STAT		
T89534	WIKIPATH	WP2781:Signaling by ERBB4		
T89534	WIKIPATH	WP2881:Estrogen Receptor Pathway		
T89534	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T89534	WIKIPATH	WP712:Estrogen signaling pathway		
T89534	REACPATH	R-HSA-1251985:Nuclear signaling by ERBB4		
T89534	REACPATH	R-HSA-383280:Nuclear Receptor transcription pathway		
T89534	NET_PATH	NetPath_21:RANKL Signaling Pathway		
T89534	NET_PATH	NetPath_25:FSH Signaling Pathway		
T89534	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T89534	INTEPATH	ap1_pathway:AP-1 transcription factor network		
T89534	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T89534	INTEPATH	er_nongenomic_pathway:Plasma membrane estrogen receptor signaling		
T89534	INTEPATH	era_genomic_pathway:Validated nuclear estrogen receptor alpha network		
T89534	INTEPATH	foxm1pathway:FOXM1 transcription factor network		
T89534	INTEPATH	hdac_classii_pathway:Signaling events mediated by HDAC Class II		
T89534	INTEPATH	hnf3apathway:FOXA1 transcription factor network		
T89534	INTEPATH	lkb1_pathway:LKB1 signaling events		
T89534	INTEPATH	p38alphabetadownstreampathway:Signaling mediated by p38-alpha and p38-beta		
T89534	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
T89534	INTEPATH	telomerasepathway:Regulation of Telomerase		
				
T52450	TARGETID	T52450		
T52450	FORMERID	TTDC00147		
T52450	UNIPROID	MMP1_HUMAN		
T52450	TARGNAME	Matrix metalloproteinase-1 (MMP-1)		
T52450	GENENAME	MMP1		
T52450	TARGTYPE	Successful target		
T52450	SYNONYMS	Interstitial collagenase; Fibroblast collagenase; CLG		
T52450	FUNCTION	Cleaves collagens of types VII and X. In case of HIV infection, interacts and cleaves the secreted viral Tat protein, leading to a decrease in neuronal Tat's mediated neurotoxicity. Cleaves collagens of types I, II, and III at one site in the helical domain.		
T52450	PDBSTRUC	966C; 4AYK; 4AUO; 3SHI; 3AYK		
T52450	BIOCLASS	Peptidase		
T52450	ECNUMBER	EC 3.4.24.7		
T52450	SEQUENCE	MHSFPPLLLLLFWGVVSHSFPATLETQEQDVDLVQKYLEKYYNLKNDGRQVEKRRNSGPVVEKLKQMQEFFGLKVTGKPDAETLKVMKQPRCGVPDVAQFVLTEGNPRWEQTHLTYRIENYTPDLPRADVDHAIEKAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPFDGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHELGHSLGLSHSTDIGALMYPSYTFSGDVQLAQDDIDGIQAIYGRSQNPVQPIGPQTPKACDSKLTFDAITTIRGEVMFFKDRFYMRTNPFYPEVELNFISVFWPQLPNGLEAAYEFADRDEVRFFKGNKYWAVQGQNVLHGYPKDIYSSFGFPRTVKHIDAALSEENTGKTYFFVANKYWRYDEYKRSMDPGYPKMIAHDFPGIGHKVDAVFMKDGFFYFFHGTRQYKFDPKTKRILTLQKANSWFNCRKN		
T52450	DRUGINFO	D00MDP	Prinomastat	Approved
T52450	DRUGINFO	D0MW3H	CIPEMASTAT	Phase 3
T52450	DRUGINFO	D05VZE	Marimastat	Phase 3
T52450	DRUGINFO	D0HG5M	Apratastat	Phase 2
T52450	DRUGINFO	D05GAP	PMID29130358-Compound-Figure10(2a)	Patented
T52450	DRUGINFO	D0X6GG	PMID29130358-Compound-Figure18(14a)	Patented
T52450	DRUGINFO	D01EUF	BMS 275291	Discontinued in Phase 3
T52450	DRUGINFO	D0T9HG	GM6001	Discontinued in Phase 2
T52450	DRUGINFO	D03BOZ	RS-130830	Discontinued in Phase 2
T52450	DRUGINFO	D0G4OT	XL784	Discontinued in Phase 2
T52450	DRUGINFO	D05VNG	BB-1101	Terminated
T52450	DRUGINFO	D08WBF	BB-3644	Terminated
T52450	DRUGINFO	D08CEE	L-696418	Terminated
T52450	DRUGINFO	D0EF7V	Ro-31-4724	Terminated
T52450	DRUGINFO	D0E5GY	RO-319790	Terminated
T52450	DRUGINFO	D0Y1XT	SC-44463	Terminated
T52450	DRUGINFO	D0N0FX	3-(4-Methoxy-benzenesulfonyl)-cyclohexanethiol	Investigative
T52450	DRUGINFO	D09XUQ	3-(4-Methoxy-benzenesulfonyl)-hexane-1-thiol	Investigative
T52450	DRUGINFO	D01OCR	3-(4-Methoxy-benzenesulfonyl)-pentane-1-thiol	Investigative
T52450	DRUGINFO	D0K3RC	3-(4-Phenoxy-benzenesulfonyl)-cyclohexanethiol	Investigative
T52450	DRUGINFO	D0D7UA	3-(4-Phenoxy-benzenesulfonyl)-propane-1-thiol	Investigative
T52450	DRUGINFO	D02BTV	3-Benzenesulfinyl-heptanoic acid hydroxyamide	Investigative
T52450	DRUGINFO	D08ELY	3-Benzenesulfonyl-heptanoic acid hydroxyamide	Investigative
T52450	DRUGINFO	D0N6CD	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide	Investigative
T52450	DRUGINFO	D0T4AN	4-(4-Butoxy-phenyl)-N-hydroxy-4-oxo-butyramide	Investigative
T52450	DRUGINFO	D0XE4B	4-(4-Methoxy-benzenesulfonyl)-butane-2-thiol	Investigative
T52450	DRUGINFO	D01QOB	4-Butoxy-N-hydroxycarbamoylmethyl-benzamide	Investigative
T52450	DRUGINFO	D0R2BO	METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID	Investigative
T52450	DRUGINFO	D0A4TC	MMI270	Investigative
T52450	DRUGINFO	D0L7AY	N-(Ethylphosphoryl)-L-isoleucyl-L-Trp-NHCH3	Investigative
T52450	DRUGINFO	D08ZDD	N-Hydroxy-4-(4-methoxy-phenyl)-4-oxo-butyramide	Investigative
T52450	DRUGINFO	D06BYR	N-Hydroxy-4-oxo-4-(4-phenoxy-phenyl)-butyramide	Investigative
T52450	DRUGINFO	D0P2OA	N-Hydroxycarbamoylmethyl-4-methoxy-benzamide	Investigative
T52450	DRUGINFO	D09SYW	N-Hydroxycarbamoylmethyl-4-phenoxy-benzamide	Investigative
T52450	DRUGINFO	D0H2PA	PKF-242-484	Investigative
T52450	DRUGINFO	D0XL8K	Ro-37-9790	Investigative
T52450	DRUGINFO	D0BI8T	RS-39066	Investigative
T52450	DRUGINFO	D03AMR	SR-973	Investigative
T52450	KEGGPATH	hsa03320:PPAR signaling pathway		
T52450	KEGGPATH	hsa05200:Pathways in cancer		
T52450	KEGGPATH	hsa05219:Bladder cancer		
T52450	KEGGPATH	hsa05323:Rheumatoid arthritis		
T52450	WIKIPATH	WP129:Matrix Metalloproteinases		
T52450	WIKIPATH	WP1794:Cell surface interactions at the vascular wall		
T52450	WIKIPATH	WP1971:Integrated Cancer pathway		
T52450	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T52450	WIKIPATH	WP2263:Prostate Cancer		
T52450	WIKIPATH	WP2374:Oncostatin M Signaling Pathway		
T52450	WIKIPATH	WP2435:Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis		
T52450	WIKIPATH	WP2708:Degradation of collagen		
T52450	WIKIPATH	WP2769:Activation of Matrix Metalloproteinases		
T52450	WIKIPATH	WP2828:Bladder Cancer		
T52450	WIKIPATH	WP366:TGF beta Signaling Pathway		
T52450	REACPATH	R-HSA-1442490:Collagen degradation		
T52450	REACPATH	R-HSA-1474228:Degradation of the extracellular matrix		
T52450	REACPATH	R-HSA-1592389:Activation of Matrix Metalloproteinases		
T52450	REACPATH	R-HSA-210991:Basigin interactions		
T52450	REACPATH	R-HSA-381426:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T52450	NET_PATH	NetPath_13:IL1 Signaling Pathway		
T52450	NET_PATH	NetPath_26:TWEAK Signaling Pathway		
T52450	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T52450	NET_PATH	NetPath_8:Wnt Signaling Pathway		
T52450	INTEPATH	ap1_pathway:AP-1 transcription factor network		
T52450	INTEPATH	endothelinpathway:Endothelins		
T52450	INTEPATH	fra_pathway:Validated transcriptional targets of AP1 family members Fra1 and Fra2		
T52450	INTEPATH	reg_gr_pathway:Glucocorticoid receptor regulatory network		
T52450	INTEPATH	syndecan_1_pathway:Syndecan-1-mediated signaling events		
T52450	PANTPATH	P00004:Alzheimer disease-presenilin pathway		
T52450	PANTPATH	P00050:Plasminogen activating cascade		
				
T53585	TARGETID	T53585		
T53585	FORMERID	TTDS00195		
T53585	UNIPROID	HMDH_HUMAN		
T53585	TARGNAME	HMG-CoA reductase (HMGCR)		
T53585	GENENAME	HMGCR		
T53585	TARGTYPE	Successful target		
T53585	SYNONYMS	3-hydroxy-3-methylglutaryl-coenzyme A reductase		
T53585	FUNCTION	Transmembrane glycoprotein that is the rate-limiting enzyme in cholesterol biosynthesis as well as in the biosynthesis of nonsterol isoprenoids that are essential for normal cell function including ubiquinone and geranylgeranyl proteins.		
T53585	PDBSTRUC	3CDB; 3CDA; 3CD7; 3CD5; 3CD0		
T53585	BIOCLASS	CH-OH donor oxidoreductase		
T53585	ECNUMBER	EC 1.1.1.34		
T53585	SEQUENCE	MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYECPKFEEDVLSSDIIILTITRCIAILYIYFQFQNLRQLGSKYILGIAGLFTIFSSFVFSTVVIHFLDKELTGLNEALPFFLLLIDLSRASTLAKFALSSNSQDEVRENIARGMAILGPTFTLDALVECLVIGVGTMSGVRQLEIMCCFGCMSVLANYFVFMTFFPACVSLVLELSRESREGRPIWQLSHFARVLEEEENKPNPVTQRVKMIMSLGLVLVHAHSRWIADPSPQNSTADTSKVSLGLDENVSKRIEPSVSLWQFYLSKMISMDIEQVITLSLALLLAVKYIFFEQTETESTLSLKNPITSPVVTQKKVPDNCCRREPMLVRNNQKCDSVEEETGINRERKVEVIKPLVAETDTPNRATFVVGNSSLLDTSSVLVTQEPEIELPREPRPNEECLQILGNAEKGAKFLSDAEIIQLVNAKHIPAYKLETLMETHERGVSIRRQLLSKKLSEPSSLQYLPYRDYNYSLVMGACCENVIGYMPIPVGVAGPLCLDEKEFQVPMATTEGCLVASTNRGCRAIGLGGGASSRVLADGMTRGPVVRLPRACDSAEVKAWLETSEGFAVIKEAFDSTSRFARLQKLHTSIAGRNLYIRFQSRSGDAMGMNMISKGTEKALSKLHEYFPEMQILAVSGNYCTDKKPAAINWIEGRGKSVVCEAVIPAKVVREVLKTTTEAMIEVNINKNLVGSAMAGSIGGYNAHAANIVTAIYIACGQDAAQNVGSSNCITLMEASGPTNEDLYISCTMPSIEIGTVGGGTNLLPQQACLQMLGVQGACKDNPGENARQLARIVCGTVMAGELSLMAALAAGHLVKSHMIHNRSKINLQDLQGACTKKTA		
T53585	DRUGINFO	D0GY5Z	Aspirin	Approved
T53585	DRUGINFO	D01QIN	Atorvastatin	Approved
T53585	DRUGINFO	D03KIA	Cerivastatin	Approved
T53585	DRUGINFO	D04XGU	Crestor/TriLipix	Approved
T53585	DRUGINFO	D08GHB	Fluvastatin	Approved
T53585	DRUGINFO	D06WTZ	Lovastatin	Approved
T53585	DRUGINFO	D0G1WL	PITAVASTATIN CALCIUM	Approved
T53585	DRUGINFO	D02RQU	Pravastatin	Approved
T53585	DRUGINFO	D0JE2E	Rosuvastatin	Approved
T53585	DRUGINFO	D0H0ND	Simvastatin	Approved
T53585	DRUGINFO	D07QFP	Teriflunomide	Approved
T53585	DRUGINFO	D03VFL	TOCOTRIENOL	Approved
T53585	DRUGINFO	D0WL5V	LAROPIPRANT	Phase 4
T53585	DRUGINFO	D0G7IV	Premarin/Pravachol	Phase 3
T53585	DRUGINFO	D0CC8L	CRILVASTATIN	Phase 2
T53585	DRUGINFO	D06BBV	XZK-monascus	Phase 2
T53585	DRUGINFO	D0H0FX	NCX-6560	Phase 1
T53585	DRUGINFO	D0LJ0M	2-cyclopropyl-4-substituted-phenoxy-quinoline derivative 1	Patented
T53585	DRUGINFO	D09ZXW	Atorvastatin lactole derivative 1	Patented
T53585	DRUGINFO	D0L3BE	Hexahydro naphthalene derivative 1	Patented
T53585	DRUGINFO	D0M9ZW	Hexahydro naphthalene derivative 2	Patented
T53585	DRUGINFO	D05SOY	Hexahydro naphthalene derivative 3	Patented
T53585	DRUGINFO	D0AY4N	Lactol derivative 1	Patented
T53585	DRUGINFO	D0CM4R	Lactol derivative 2	Patented
T53585	DRUGINFO	D0G8JX	Pitavastatin derivative 1	Patented
T53585	DRUGINFO	D0YX0O	PMID27537201-Compound-Figure11	Patented
T53585	DRUGINFO	D03HKN	PMID27537201-Compound-Figure13b	Patented
T53585	DRUGINFO	D0EF9J	PMID27537201-Compound-Figure13c	Patented
T53585	DRUGINFO	D00YVL	PMID27537201-Compound-Figure15a	Patented
T53585	DRUGINFO	D0SH0L	PMID27537201-Compound-Figure15b	Patented
T53585	DRUGINFO	D0S3BE	PMID27537201-Compound-Figure17	Patented
T53585	DRUGINFO	D0RW8J	Poly-substituted azoles statin lactone derivative 1	Patented
T53585	DRUGINFO	D0AP6V	Poly-substituted azoles statin lactone derivative 2	Patented
T53585	DRUGINFO	D0CW2F	Poly-substituted miazine derivative 1	Patented
T53585	DRUGINFO	D0KU2T	Pravastatin derivative 1	Patented
T53585	DRUGINFO	D0U2CK	Quinoline derivative 1	Patented
T53585	DRUGINFO	D0QW7F	Quinoline derivative 16	Patented
T53585	DRUGINFO	D04MFJ	Quinoline derivative 17	Patented
T53585	DRUGINFO	D08FMC	Sterol derivative 1	Patented
T53585	DRUGINFO	D0YZ3U	Sterol derivative 2	Patented
T53585	DRUGINFO	D0O0OD	Sterol derivative 3	Patented
T53585	DRUGINFO	D0Y9XD	Dalvastatin	Discontinued in Phase 3
T53585	DRUGINFO	D0L1LJ	Bervastatin	Discontinued in Phase 2
T53585	DRUGINFO	D04NCJ	BMY-21950	Discontinued in Phase 2
T53585	DRUGINFO	D0U5NU	GLENVASTATIN	Discontinued in Phase 2
T53585	DRUGINFO	D02GSA	RBx10558	Discontinued in Phase 2
T53585	DRUGINFO	D0MF7U	PF-3052334	Discontinued in Phase 1
T53585	DRUGINFO	D0E2CO	BMY-22089	Terminated
T53585	DRUGINFO	D07QSA	CP-83101	Terminated
T53585	DRUGINFO	D0YQ9G	GT-16-239	Terminated
T53585	DRUGINFO	D0J9GD	Mevastatin	Terminated
T53585	DRUGINFO	D0Y3OR	SQ-33600	Terminated
T53585	DRUGINFO	D0C7RV	SR12813	Terminated
T53585	DRUGINFO	D0C8HK	(E)-5-octadecen-7,9-diynoic acid	Investigative
T53585	DRUGINFO	D0A6FX	(E)-octadecan-9-ynoic acid	Investigative
T53585	DRUGINFO	D03GRA	(R)-Mevalonate	Investigative
T53585	DRUGINFO	D0NU6K	(Z)-5-octadecen-7,9-diynoic acid	Investigative
T53585	DRUGINFO	D0CU3I	(Z)-7-octedecan-9-ynoic acid	Investigative
T53585	DRUGINFO	D01GMJ	1,4-Dithiothreitol	Investigative
T53585	DRUGINFO	D0J2FY	2'-Monophosphoadenosine 5'-Diphosphoribose	Investigative
T53585	DRUGINFO	D08SKU	3-(1,3 dodecadiynyl)-6-oxiranebutanoic acid	Investigative
T53585	DRUGINFO	D0IJ7H	3-Hydroxy-3-Methyl-Glutaric Acid	Investigative
T53585	DRUGINFO	D0I0IM	5-ketodihydromevinolin	Investigative
T53585	DRUGINFO	D01YQX	6-hydroxy-7,9-octadecadiynoic acid	Investigative
T53585	DRUGINFO	D0C5LO	7,9-octadecadiynoic acid	Investigative
T53585	DRUGINFO	D09EBV	7,9-tetradecadiynoic acid	Investigative
T53585	DRUGINFO	D09QIA	9-octadecynoic acid	Investigative
T53585	DRUGINFO	D02SRB	BPL-001	Investigative
T53585	DRUGINFO	D0Q2EH	Brutieridin	Investigative
T53585	DRUGINFO	D0W3NA	Coenzyme A	Investigative
T53585	DRUGINFO	D09CSQ	DFGYVAE	Investigative
T53585	DRUGINFO	D0X1VL	F(4-Fluoro)VAE	Investigative
T53585	DRUGINFO	D01WQF	FPYVAE peptide	Investigative
T53585	DRUGINFO	D03CYY	GFPDGG	Investigative
T53585	DRUGINFO	D0C1RY	GFPEGG	Investigative
T53585	DRUGINFO	D0S1LA	GFPTGG	Investigative
T53585	DRUGINFO	D0X0GV	GLPDGG peptide	Investigative
T53585	DRUGINFO	D0B2FM	GLPTGG	Investigative
T53585	DRUGINFO	D03ZIK	MT-001	Investigative
T53585	DRUGINFO	D04XQG	NCX-1067	Investigative
T53585	DRUGINFO	D0R6JE	Nicotinamide-Adenine-Dinucleotide	Investigative
T53585	DRUGINFO	D03TKT	o-hydroxyatorvastatin	Investigative
T53585	DRUGINFO	D0W5FM	PMID1527791C29	Investigative
T53585	DRUGINFO	D07QAX	PMID15686906C17	Investigative
T53585	DRUGINFO	D0Q6WP	PMID15686906C29	Investigative
T53585	DRUGINFO	D06FRE	PMID1656041C11dd	Investigative
T53585	DRUGINFO	D0O2FD	PMID1656041C11ff	Investigative
T53585	DRUGINFO	D0T4PL	PMID1656041C11jj	Investigative
T53585	DRUGINFO	D0M9BZ	PMID1656041C11nn	Investigative
T53585	DRUGINFO	D00TIO	PMID1656041C4ff	Investigative
T53585	DRUGINFO	D0X0GG	PMID1656041C4rr	Investigative
T53585	DRUGINFO	D0R8YV	PMID1656041C74	Investigative
T53585	DRUGINFO	D0O8XW	PMID17560788C29f	Investigative
T53585	DRUGINFO	D00RHH	PMID17574411C41	Investigative
T53585	DRUGINFO	D0G6PS	PMID17574411C42	Investigative
T53585	DRUGINFO	D00UOI	PMID17574412C33	Investigative
T53585	DRUGINFO	D0L6HX	PMID18072721C50	Investigative
T53585	DRUGINFO	D0O7AS	PMID18155906C16f	Investigative
T53585	DRUGINFO	D02TIT	PMID18412317C13b	Investigative
T53585	DRUGINFO	D06HNA	PMID1875346C18	Investigative
T53585	DRUGINFO	D01XMY	PMID1895299C1	Investigative
T53585	DRUGINFO	D02OET	PMID1895299C4p	Investigative
T53585	DRUGINFO	D0M4YT	PMID1895299C6v	Investigative
T53585	DRUGINFO	D0N7RK	PMID19502059C25d	Investigative
T53585	DRUGINFO	D0G2QW	PMID1992138C8b	Investigative
T53585	DRUGINFO	D00VMO	PMID1992149C13	Investigative
T53585	DRUGINFO	D02ITS	PMID1992149C9	Investigative
T53585	DRUGINFO	D06BIF	PMID2153213C13b	Investigative
T53585	DRUGINFO	D09TKN	PMID2153213C13g	Investigative
T53585	DRUGINFO	D0R1FP	PMID2153213C1a	Investigative
T53585	DRUGINFO	D03EAN	PMID2153213C1e	Investigative
T53585	DRUGINFO	D0RA8F	PMID2153213C1f	Investigative
T53585	DRUGINFO	D02MEX	PMID2153213C2c	Investigative
T53585	DRUGINFO	D05GWF	PMID2153213C2d	Investigative
T53585	DRUGINFO	D0G4ZG	PMID2153213C2f	Investigative
T53585	DRUGINFO	D0MU7C	PMID2231594C3j	Investigative
T53585	DRUGINFO	D00ZJG	PMID2231594C3k	Investigative
T53585	DRUGINFO	D0UQ6A	PMID2231594C3q	Investigative
T53585	DRUGINFO	D02EQL	PMID2231594C3u	Investigative
T53585	DRUGINFO	D0J9DY	PMID2296027C25	Investigative
T53585	DRUGINFO	D0ZQ3B	PMID2296027C29	Investigative
T53585	DRUGINFO	D0O1OC	PMID2296036C2g	Investigative
T53585	DRUGINFO	D05UQC	PMID2296036C2t	Investigative
T53585	DRUGINFO	D0I9TR	PMID2296036C4d	Investigative
T53585	DRUGINFO	D01ZAL	PMID2296036C4i	Investigative
T53585	DRUGINFO	D0J8BD	PMID2909732C7	Investigative
T53585	DRUGINFO	D0K1MB	PMID7932551C9	Investigative
T53585	DRUGINFO	D0S1ER	PMID8246233C28	Investigative
T53585	DRUGINFO	D0NJ5U	PMID8246233C35	Investigative
T53585	DRUGINFO	D00TBG	PMID8246233C5ab	Investigative
T53585	DRUGINFO	D07VEB	PMID8246234C3h	Investigative
T53585	DRUGINFO	D0FD8Q	PMID8246237C18t	Investigative
T53585	DRUGINFO	D05YUT	PMID8426367C18	Investigative
T53585	DRUGINFO	D0Y6DJ	rawsonol	Investigative
T53585	DRUGINFO	D0W7VX	Statin	Investigative
T53585	KEGGPATH	hsa00900:Terpenoid backbone biosynthesis		
T53585	KEGGPATH	hsa01100:Metabolic pathways		
T53585	KEGGPATH	hsa01130:Biosynthesis of antibiotics		
T53585	KEGGPATH	hsa04152:AMPK signaling pathway		
T53585	KEGGPATH	hsa04976:Bile secretion		
T53585	WIKIPATH	WP197:Cholesterol Biosynthesis		
T53585	WIKIPATH	WP1982:SREBP signalling		
T53585	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T53585	WIKIPATH	WP2011:SREBF and miR33 in cholesterol and lipid homeostasis		
T53585	WIKIPATH	WP2706:Activation of Gene Expression by SREBP (SREBF)		
T53585	WIKIPATH	WP2797:Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)		
T53585	WIKIPATH	WP430:Statin Pathway		
T53585	WHIZPATH	PW000050:Steroid Biosynthesis		
T53585	NET_PATH	NetPath_17:IL5 Signaling Pathway		
T53585	NET_PATH	NetPath_23:TSH Signaling Pathway		
T53585	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T53585	PANTPATH	P00014:Cholesterol biosynthesis		
T53585	BIOCPATH	PWY-5910:Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)		
T53585	BIOCPATH	PWY66-5:Superpathway of cholesterol biosynthesis		
T53585	BIOCPATH	PWY-922:Mevalonate pathway		
				
T14597	TARGETID	T14597		
T14597	FORMERID	TTDS00249		
T14597	UNIPROID	ERBB2_HUMAN		
T14597	TARGNAME	Erbb2 tyrosine kinase receptor (HER2)		
T14597	GENENAME	ERBB2		
T14597	TARGTYPE	Successful target		
T14597	SYNONYMS	p185erbB2; Tyrosine kinase-type cell surface receptor HER2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; NGL; NEU; Metastatic lymph node gene 19 protein; MLN19; MLN 19; HER2; CD340		
T14597	FUNCTION	Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.		
T14597	PDBSTRUC	6OGE; 6J71; 6BGT; 6ATT; 5TQS		
T14597	BIOCLASS	Kinase		
T14597	ECNUMBER	EC 2.7.10.1		
T14597	SEQUENCE	MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV		
T14597	DRUGINFO	D05UFG	BIBW 2992	Approved
T14597	DRUGINFO	D06XXH	Dacomitinib	Approved
T14597	DRUGINFO	D08CDI	Lapatinib	Approved
T14597	DRUGINFO	D01YYP	Margetuximab	Approved
T14597	DRUGINFO	D0U3YB	Masoprocol	Approved
T14597	DRUGINFO	D0F0ZE	Merimepodib	Approved
T14597	DRUGINFO	D0U1ZV	NERATINIB MALEATE	Approved
T14597	DRUGINFO	D0CI4E	Pertuzumab	Approved
T14597	DRUGINFO	D04WFL	Trastuzumab	Approved
T14597	DRUGINFO	D09GRX	Tucatinib	Approved
T14597	DRUGINFO	D04SLF	Bevacizumab + Trastuzumab	Phase 3
T14597	DRUGINFO	D0Q9CY	HKI-272	Phase 3
T14597	DRUGINFO	D0F8UV	Nelipepimut S	Phase 3
T14597	DRUGINFO	D04VRB	NeuVax	Phase 3
T14597	DRUGINFO	D0HR7Z	PF-05280014	Phase 3
T14597	DRUGINFO	D0J6PY	Taxol/Paraplatin/Herceptin	Phase 3
T14597	DRUGINFO	D0P4TH	Trastuzumab-DM1	Phase 3
T14597	DRUGINFO	D00NYJ	Varlitinib	Phase 2/3
T14597	DRUGINFO	D0P7KI	Anti-CD3 and anti-Her2/neu bispecific antibody-armed activated T cells	Phase 2
T14597	DRUGINFO	D0BM7M	AZD8931	Phase 2
T14597	DRUGINFO	D0U4FF	BMS-599626	Phase 2
T14597	DRUGINFO	D0YB3W	CI-1033	Phase 2
T14597	DRUGINFO	D0CN9Q	CP-724714	Phase 2
T14597	DRUGINFO	D06KOM	DN24-02	Phase 2
T14597	DRUGINFO	D0O2JI	Ertumaxomab	Phase 2
T14597	DRUGINFO	D09XHU	HER-2 Protein AutoVac	Phase 2
T14597	DRUGINFO	D0QF7Z	HER2/neu peptide vaccine	Phase 2
T14597	DRUGINFO	D0B1TL	Her2-targeted autologous T-cell therapy	Phase 2
T14597	DRUGINFO	D00YER	HM-78136B	Phase 2
T14597	DRUGINFO	DV2N5P	KN026	Phase 2
T14597	DRUGINFO	D0P1DI	MCLA-128	Phase 2
T14597	DRUGINFO	D0G5GB	MGAH22	Phase 2
T14597	DRUGINFO	D0Q2KM	MM-111	Phase 2
T14597	DRUGINFO	DM7WY2	MRG002	Phase 2
T14597	DRUGINFO	D03UKJ	Pazopanib + Tyverb/Tykerb	Phase 2
T14597	DRUGINFO	DUW81M	Tarloxotinib	Phase 2
T14597	DRUGINFO	DD94ZN	A166	Phase 1/2
T14597	DRUGINFO	D08KCJ	ABY-025	Phase 1/2
T14597	DRUGINFO	D0G4AJ	AGN-208397	Phase 1/2
T14597	DRUGINFO	D08QZH	Anti-HER2 CAR-T	Phase 1/2
T14597	DRUGINFO	D03TQB	AU105	Phase 1/2
T14597	DRUGINFO	D0F3MT	AVX901	Phase 1/2
T14597	DRUGINFO	D9FJ5V	BDTX-189	Phase 1/2
T14597	DRUGINFO	D0NN7P	CART-HER-2	Phase 1/2
T14597	DRUGINFO	D06KQG	HER-2-targeting CAR T Cells	Phase 1/2
T14597	DRUGINFO	DNC79U	ISB 1302	Phase 1/2
T14597	DRUGINFO	D0FF2G	Sym013	Phase 1/2
T14597	DRUGINFO	DY13WU	TAS-0728	Phase 1/2
T14597	DRUGINFO	D6SL3N	Zenocutuzomab	Phase 1/2
T14597	DRUGINFO	D0V4XY	S-222611	Phase 1b
T14597	DRUGINFO	DEI07S	AIP-303	Phase 1
T14597	DRUGINFO	D0M8AI	ARRY-380	Phase 1
T14597	DRUGINFO	D6IOB5	BAY 2701439	Phase 1
T14597	DRUGINFO	D06XWD	CAR-T Cells targeting HER2	Phase 1
T14597	DRUGINFO	D0JI4M	CAR-T cells targeting HER2	Phase 1
T14597	DRUGINFO	D08JAN	Cipatinib	Phase 1
T14597	DRUGINFO	D0Z4RC	CUDC-101	Phase 1
T14597	DRUGINFO	D1C0WB	DZD1516	Phase 1
T14597	DRUGINFO	D0DBS7	GBR1302	Phase 1
T14597	DRUGINFO	DSOE74	GQ1001	Phase 1
T14597	DRUGINFO	D0TN5W	HER2-CAR T Cells	Phase 1
T14597	DRUGINFO	D0U2PS	HER2p63-71 peptide vaccine	Phase 1
T14597	DRUGINFO	D0YF6K	HER2-specific CAR T cell	Phase 1
T14597	DRUGINFO	D06RCE	HER2-specific T cells	Phase 1
T14597	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T14597	DRUGINFO	D3FYE1	M802	Phase 1
T14597	DRUGINFO	DU54BA	MB-103	Phase 1
T14597	DRUGINFO	DQ04FJ	MBS301	Phase 1
T14597	DRUGINFO	D08UDG	MEDI4276	Phase 1
T14597	DRUGINFO	D07USV	MM-302	Phase 1
T14597	DRUGINFO	DS60CK	MT-5111	Phase 1
T14597	DRUGINFO	D05ATQ	MVA HER-2 AutoVac	Phase 1
T14597	DRUGINFO	DEX8D5	NJH395	Phase 1
T14597	DRUGINFO	D0UL7L	Recombinant human Erbb3 fragment therapeutic tumor vaccine	Phase 1
T14597	DRUGINFO	DUA7P2	SBT6050	Phase 1
T14597	DRUGINFO	D02UFQ	TAK-285	Phase 1
T14597	DRUGINFO	D0O9HF	TrasGEX	Phase 1
T14597	DRUGINFO	D0H7ZN	VM-206	Phase 1
T14597	DRUGINFO	D09UGG	Zemab	Phase 1
T14597	DRUGINFO	DH09QZ	ZW49	Phase 1
T14597	DRUGINFO	D05YLO	Her-2-Bi-armed ATC	Discontinued in Phase 2
T14597	DRUGINFO	D0A9OV	TAK165	Discontinued in Phase 1
T14597	DRUGINFO	DO6UE8	227Th-labelled HER2-TTC	Preclinical
T14597	DRUGINFO	D02YAQ	GW-974	Terminated
T14597	DRUGINFO	D0NX2G	(1-Benzyl-1H-indazol-5-yl)-quinazolin-4-yl-amine	Investigative
T14597	DRUGINFO	D02ARA	(1-Benzyl-1H-indol-5-yl)-quinazolin-4-yl-amine	Investigative
T14597	DRUGINFO	D0J2CP	PF 5208766	Investigative
T14597	DRUGINFO	D0B1SW	Redoxal	Investigative
T14597	DRUGINFO	D0O5CR	TA1-RTA	Investigative
T14597	KEGGPATH	hsa04012:ErbB signaling pathway		
T14597	KEGGPATH	hsa04020:Calcium signaling pathway		
T14597	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T14597	KEGGPATH	hsa04510:Focal adhesion		
T14597	KEGGPATH	hsa04520:Adherens junction		
T14597	KEGGPATH	hsa05200:Pathways in cancer		
T14597	KEGGPATH	hsa05205:Proteoglycans in cancer		
T14597	KEGGPATH	hsa05206:MicroRNAs in cancer		
T14597	KEGGPATH	hsa05212:Pancreatic cancer		
T14597	KEGGPATH	hsa05213:Endometrial cancer		
T14597	KEGGPATH	hsa05215:Prostate cancer		
T14597	KEGGPATH	hsa05219:Bladder cancer		
T14597	KEGGPATH	hsa05223:Non-small cell lung cancer		
T14597	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T14597	WIKIPATH	WP1907:Semaphorin interactions		
T14597	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T14597	WIKIPATH	WP2034:Leptin signaling pathway		
T14597	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T14597	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T14597	WIKIPATH	WP2780:Signaling by ERBB2		
T14597	WIKIPATH	WP2828:Bladder Cancer		
T14597	WIKIPATH	WP2870:Extracellular vesicle-mediated signaling in recipient cells		
T14597	WIKIPATH	WP306:Focal Adhesion		
T14597	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T14597	WIKIPATH	WP673:ErbB Signaling Pathway		
T14597	WIKIPATH	WP710:DNA Damage Response (only ATM dependent)		
T14597	WHIZPATH	PW000168:Phosphatidylinositol Phosphate Metabolism		
T14597	REACPATH	R-HSA-1250196:SHC1 events in ERBB2 signaling		
T14597	REACPATH	R-HSA-1251932:PLCG1 events in ERBB2 signaling		
T14597	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T14597	REACPATH	R-HSA-1963640:GRB2 events in ERBB2 signaling		
T14597	REACPATH	R-HSA-1963642:PI3K events in ERBB2 signaling		
T14597	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T14597	REACPATH	R-HSA-416572:Sema4D induced cell migration and growth-cone collapse		
T14597	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T14597	NET_PATH	NetPath_11:TCR Signaling Pathway		
T14597	INTEPATH	a6b1_a6b4_integrin_pathway:a6b1 and a6b4 Integrin signaling		
T14597	INTEPATH	erbb_network_pathway:ErbB receptor signaling network		
T14597	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T14597	INTEPATH	erbb4_pathway:ErbB4 signaling events		
T14597	INTEPATH	myc_represspathway:Validated targets of C-MYC transcriptional repression		
T14597	PANTPATH	P00012:Cadherin signaling pathway		
T14597	PANTPATH	P00018:EGF receptor signaling pathway		
				
T07173	TARGETID	T07173		
T07173	FORMERID	TTDC00318		
T07173	UNIPROID	NTRK1_HUMAN		
T07173	TARGNAME	Tropomyosin-related kinase A (TrkA)		
T07173	GENENAME	NTRK1		
T07173	TARGTYPE	Successful target		
T07173	SYNONYMS	gp140trk; Tyrosine kinase receptor A; Tyrosine kinase receptor; Trk-A; TRKA; TRK1-transforming tyrosine kinase protein; TRK1 transforming tyrosinekinase protein; TRK; P140-TrkA; Neurotrophic tyrosine kinase receptor type 1; NGF-trk receptor type A; MTC; High affinity nerve growth factor receptor		
T07173	FUNCTION	High affinity receptor for NGF which is its primary ligand. Can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors. Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons.		
T07173	PDBSTRUC	6NSS; 6NSP; 6NPT; 6DKW; 6DKI		
T07173	BIOCLASS	Kinase		
T07173	ECNUMBER	EC 2.7.10.1		
T07173	SEQUENCE	MLRGGRRGQLGWHSWAAGPGSLLAWLILASAGAAPCPDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQVPNASVDVGDDVLLRCQVEGRGLEQAGWILTELEQSATVMKSGGLPSLGLTLANVTSDLNRKNVTCWAENDVGRAEVSVQVNVSFPASVQLHTAVEMHHWCIPFSVDGQPAPSLRWLFNGSVLNETSFIFTEFLEPAANETVRHGCLRLNQPTHVNNGNYTLLAANPFGQASASIMAAFMDNPFEFNPEDPIPVSFSPVDTNSTSGDPVEKKDETPFGVSVAVGLAVFACLFLSTLLLVLNKCGRRNKFGINRPAVLAPEDGLAMSLHFMTLGGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPVYLDVLG		
T07173	DRUGINFO	D0O0LS	Entrectinib	Approved
T07173	DRUGINFO	D07TOK	Larotrectinib	Approved
T07173	DRUGINFO	D0C2OR	MIM-D3	Phase 3
T07173	DRUGINFO	D0B7OY	CT 327	Phase 2
T07173	DRUGINFO	D04QYS	SNA-120	Phase 2
T07173	DRUGINFO	D0QP8X	ONO-7579	Phase 1/2
T07173	DRUGINFO	D05NFR	TPX-0005	Phase 1/2
T07173	DRUGINFO	D0FA6S	Altiratinib	Phase 1
T07173	DRUGINFO	D0N0DU	DS-6051	Phase 1
T07173	DRUGINFO	D03UDF	LOXO-195	Phase 1
T07173	DRUGINFO	D07PSL	PLX7486	Phase 1
T07173	DRUGINFO	D1ZD0N	VMD-928	Phase 1
T07173	DRUGINFO	D0AU4G	3-amino-5-benzyl-substituted indazole derivative 1	Patented
T07173	DRUGINFO	D0Y1NH	Azaindazole amide derivative 1	Patented
T07173	DRUGINFO	D0T3TZ	Benzimidazole derivative 6	Patented
T07173	DRUGINFO	D0HF1A	Bicyclic heteroaryl benzamide derivative 1	Patented
T07173	DRUGINFO	D0F8BF	Bicyclic heteroaryl benzamide derivative 2	Patented
T07173	DRUGINFO	D0O0GZ	Bicyclic heteroaryl benzamide derivative 3	Patented
T07173	DRUGINFO	D0I9FU	Bicyclic heteroaryl benzamide derivative 4	Patented
T07173	DRUGINFO	D0KC8X	Bicyclic heteroaryl benzamide derivative 5	Patented
T07173	DRUGINFO	D07CPL	Bicyclic heteroaryl benzamide derivative 6	Patented
T07173	DRUGINFO	D0N6NG	Bicyclic heteroaryl benzamide derivative 7	Patented
T07173	DRUGINFO	D0DY5R	Bicyclic heteroaryl benzamide derivative 8	Patented
T07173	DRUGINFO	D07AJO	Bicyclic heteroaryl benzamide derivative 9	Patented
T07173	DRUGINFO	D0T4CF	Five membered heterocyclic benzamide derivative 1	Patented
T07173	DRUGINFO	D04BRW	Five membered heterocyclic benzamide derivative 2	Patented
T07173	DRUGINFO	D0CY3U	Five membered heterocyclic benzamide derivative 3	Patented
T07173	DRUGINFO	D0WI7N	Imidazo pyridine derivative 1	Patented
T07173	DRUGINFO	D0T8XD	Imidazo[1,2-b]pyridazine derivative 1	Patented
T07173	DRUGINFO	D0M8UO	Imidazo[1,2-b]pyridazine derivative 2	Patented
T07173	DRUGINFO	D0N1CF	Imidazo[1,2-b]pyridazine derivative 3	Patented
T07173	DRUGINFO	D0FS4S	Imidazo[1,2-b]pyridazine derivative 4	Patented
T07173	DRUGINFO	D0DO4I	Imidazo[1,2-b]pyridazine derivative 5	Patented
T07173	DRUGINFO	D0W0UF	Imidazo[1,2-b]pyridazine derivative 6	Patented
T07173	DRUGINFO	D04QHI	Imidazo[1,2-b]pyridazine derivative 7	Patented
T07173	DRUGINFO	D0C3RK	N-(phenylpyrazolyl)benzamide derivative 1	Patented
T07173	DRUGINFO	D0BP9B	N,N-bis(5-pyrazoyl)urea derivative 1	Patented
T07173	DRUGINFO	D00XXZ	N-acylpiperidine ether derivative 1	Patented
T07173	DRUGINFO	D04RXX	N-acylpiperidine ether derivative 2	Patented
T07173	DRUGINFO	D0X1LP	N-acylpiperidine ether derivative 3	Patented
T07173	DRUGINFO	D00FJH	N-acylpiperidine ether derivative 4	Patented
T07173	DRUGINFO	D03BAY	N-acylpiperidine ether derivative 5	Patented
T07173	DRUGINFO	D04GCC	N-acylpiperidine ether derivative 6	Patented
T07173	DRUGINFO	D02OLJ	N-acylpiperidine ether derivative 7	Patented
T07173	DRUGINFO	D0X4LA	N-acylpyrrolidine ether derivative 1	Patented
T07173	DRUGINFO	D08BIH	N-acylpyrrolidine ether derivative 2	Patented
T07173	DRUGINFO	D0I5DM	N-arylmethyl-N-phenyl cyclic urea derivative 1	Patented
T07173	DRUGINFO	D02QWP	N-arylmethyl-N-phenyl cyclic urea derivative 2	Patented
T07173	DRUGINFO	D05NBR	PMID28270010-Compound-Figure16-a	Patented
T07173	DRUGINFO	D0W9RH	PMID28270010-Compound-Figure16-b-1	Patented
T07173	DRUGINFO	D0YM2S	PMID28270010-Compound-Figure16-b-2	Patented
T07173	DRUGINFO	D0P3VK	PMID28270010-Compound-Figure17-1	Patented
T07173	DRUGINFO	D0T5OF	PMID28270010-Compound-Figure17-2	Patented
T07173	DRUGINFO	D0D7EG	PMID28270010-Compound-Figure17-3	Patented
T07173	DRUGINFO	D0X9VS	PMID28270010-Compound-Figure24-a	Patented
T07173	DRUGINFO	D07RLB	PMID28270010-Compound-Figure24-b	Patented
T07173	DRUGINFO	D0J9ZG	PMID28270010-Compound-Figure5-1	Patented
T07173	DRUGINFO	D0T2OX	PMID28270010-Compound-Figure5-2	Patented
T07173	DRUGINFO	D0V5AG	PMID28270010-Compound-Figure5-3	Patented
T07173	DRUGINFO	D0J4CA	PMID28270021-Compound-WO2010077680 103	Patented
T07173	DRUGINFO	D0T0HM	PMID28270021-Compound-WO2010077680 109	Patented
T07173	DRUGINFO	D0PY0G	PMID28270021-Compound-WO2010077680 201	Patented
T07173	DRUGINFO	D0FL8A	PMID28270021-Compound-WO2010077680 481	Patented
T07173	DRUGINFO	D0K6IM	PMID28270021-Compound-WO2010077680 495	Patented
T07173	DRUGINFO	D0F2BF	PMID28270021-Compound-WO2010077680 803	Patented
T07173	DRUGINFO	D07KVL	PMID28270021-Compound-WO2010077680 811	Patented
T07173	DRUGINFO	D02ZQN	PMID28270021-Compound-WO2013009582Example16	Patented
T07173	DRUGINFO	D0Y0XJ	PMID28270021-Compound-WO2013009582Example76	Patented
T07173	DRUGINFO	D0I2OO	PMID28270021-Compound-WO2013161919Example85-117	Patented
T07173	DRUGINFO	D05AQT	PMID28270021-Compound-WO2014078408Example1	Patented
T07173	DRUGINFO	D0YN0I	PMID28270021-Compound-WO2014078408Example26	Patented
T07173	DRUGINFO	D0QT8L	PMID28270021-Compound-WO2014129431Example8-1	Patented
T07173	DRUGINFO	D02ETU	PMID28270021-Compound-WO2014152663 701	Patented
T07173	DRUGINFO	D0U5XI	PMID28270021-Compound-WO2015042088Example11	Patented
T07173	DRUGINFO	D0VD5J	PMID28270021-Compound-WO2015042088Example12	Patented
T07173	DRUGINFO	D0M8VS	PMID28270021-Compound-WO2015042088Example4	Patented
T07173	DRUGINFO	D00MGO	PMID28270021-Compound-WO2016054807Example1	Patented
T07173	DRUGINFO	D0LK8E	PMID28270021-Compound-WO2016054807Example112	Patented
T07173	DRUGINFO	D08CZY	PMID28270021-Compound-WO2016054807Example71	Patented
T07173	DRUGINFO	D0BO1H	PMID28270021-Compound-WO2016054807Example80	Patented
T07173	DRUGINFO	D00EUL	PMID28270021-Compound-WO2016054807Example82	Patented
T07173	DRUGINFO	D0DN3Q	Pyrazolo[1,5-a]pyridine derivative 1	Patented
T07173	DRUGINFO	D0V9ZJ	Pyrazolo[1,5-a]pyridine derivative 2	Patented
T07173	DRUGINFO	D0H8XH	Pyrazolo[1,5-a]pyrimidine derivative 14	Patented
T07173	DRUGINFO	D0BI5I	Pyrazolo[1,5-a]pyrimidine derivative 15	Patented
T07173	DRUGINFO	D0BZ0T	Pyrazolo[1,5-a]pyrimidine derivative 16	Patented
T07173	DRUGINFO	D00DIZ	Pyrazolo[1,5-a]pyrimidine derivative 17	Patented
T07173	DRUGINFO	D05RKT	Pyrazolo[1,5-a]pyrimidine derivative 18	Patented
T07173	DRUGINFO	D05KHT	Pyrazolo[1,5-a]pyrimidine derivative 19	Patented
T07173	DRUGINFO	D0Z5PA	Pyrazolo[1,5-a]pyrimidine derivative 20	Patented
T07173	DRUGINFO	D0D6UF	Pyrazolo[1,5-a]pyrimidine derivative 21	Patented
T07173	DRUGINFO	D0U2GJ	Pyrazolo[1,5-a]pyrimidine derivative 22	Patented
T07173	DRUGINFO	D06NPZ	Pyrazolo[1,5-a]pyrimidine derivative 23	Patented
T07173	DRUGINFO	D04KQB	Pyrazolo[1,5-a]pyrimidine derivative 24	Patented
T07173	DRUGINFO	D03USW	Pyrazolo[1,5-a]pyrimidine derivative 25	Patented
T07173	DRUGINFO	D09SYD	Pyrazolo[1,5-a]pyrimidine derivative 26	Patented
T07173	DRUGINFO	D08IWT	Pyrazolo[1,5-a]pyrimidine derivative 27	Patented
T07173	DRUGINFO	D0RK6W	Pyrazolo[4,3-c]pyridine derivative 1	Patented
T07173	DRUGINFO	D0O8SX	Pyrazolo[4,3-h]quinazoline-3-carboxamide derivative 1	Patented
T07173	DRUGINFO	D0RR8O	Pyrido[3,2-d]pyrimidine derivative 2	Patented
T07173	DRUGINFO	D0U3RD	Pyrido[3,2-d]pyrimidine derivative 3	Patented
T07173	DRUGINFO	D0I8AY	Pyrrolidinyl urea derivative 10	Patented
T07173	DRUGINFO	D00ICS	Pyrrolidinyl urea derivative 11	Patented
T07173	DRUGINFO	D0K2GH	Pyrrolidinyl urea derivative 12	Patented
T07173	DRUGINFO	D0Z6LB	Pyrrolidinyl urea derivative 13	Patented
T07173	DRUGINFO	D0JJ0T	Pyrrolidinyl urea derivative 2	Patented
T07173	DRUGINFO	D0LB7Z	Pyrrolidinyl urea derivative 3	Patented
T07173	DRUGINFO	D0K3QT	Pyrrolidinyl urea derivative 4	Patented
T07173	DRUGINFO	D0ME5D	Pyrrolidinyl urea derivative 5	Patented
T07173	DRUGINFO	D0J5OO	Pyrrolidinyl urea derivative 6	Patented
T07173	DRUGINFO	D0X0YJ	Pyrrolidinyl urea derivative 7	Patented
T07173	DRUGINFO	D0A4YR	Pyrrolidinyl urea derivative 8	Patented
T07173	DRUGINFO	D06YON	Pyrrolidinyl urea derivative 9	Patented
T07173	DRUGINFO	D0P8SR	Pyrrolo[2,3-b]pyridine derivative 1	Patented
T07173	DRUGINFO	D06GOT	Pyrrolo[2,3-b]pyridine derivative 2	Patented
T07173	DRUGINFO	D02IBX	Pyrrolo[2,3-b]pyridine derivative 3	Patented
T07173	DRUGINFO	D0S0II	Pyrrolo[2,3-d]pyrimidine derivative 3	Patented
T07173	DRUGINFO	D0AG2A	Pyrrolo[2,3-d]pyrimidine derivative 4	Patented
T07173	DRUGINFO	D0DQ5G	Pyrrolo[3,2-c]pyridine derivative 1	Patented
T07173	DRUGINFO	D0ZE6H	Six-membered heterocyclic benzamide derivative 1	Patented
T07173	DRUGINFO	D0H3ZG	Six-membered heterocyclic benzamide derivative 2	Patented
T07173	DRUGINFO	D07VFQ	Six-membered heterocyclic benzamide derivative 3	Patented
T07173	DRUGINFO	D0EC4Z	Six-membered heterocyclic benzamide derivative 4	Patented
T07173	DRUGINFO	D0UN4M	Six-membered heterocyclic benzamide derivative 5	Patented
T07173	DRUGINFO	D04JCD	Six-membered heterocyclic benzamide derivative 6	Patented
T07173	DRUGINFO	D05MRY	Six-membered heterocyclic benzamide derivative 7	Patented
T07173	DRUGINFO	D06STX	Thiadiazolyl carboxamide derivative 1	Patented
T07173	DRUGINFO	D0JU4R	Thiazole derivative 4	Patented
T07173	DRUGINFO	D0MZ7K	Triazolo[4,3-b]pyridazine derivative 2	Patented
T07173	DRUGINFO	D0UQ2G	Tri-substituted urea derivative 1	Patented
T07173	DRUGINFO	D0CG8N	Tri-substituted urea derivative 2	Patented
T07173	DRUGINFO	D08SDJ	Ureido-phenyl-substituted triazine derivative 1	Patented
T07173	DRUGINFO	D0V7QU	Ureido-phenyl-substituted triazine derivative 2	Patented
T07173	DRUGINFO	D0LX8D	AZD6918	Discontinued in Phase 1
T07173	DRUGINFO	D07SYN	FX-007	Preclinical
T07173	DRUGINFO	D09QBA	CEP-5104	Investigative
T07173	DRUGINFO	D07IHM	CEP-6331	Investigative
T07173	DRUGINFO	D0Z5TQ	GW-5074	Investigative
T07173	DRUGINFO	D02RWK	K-252a analogue	Investigative
T07173	KEGGPATH	hsa04010:MAPK signaling pathway		
T07173	KEGGPATH	hsa04144:Endocytosis		
T07173	KEGGPATH	hsa04210:Apoptosis		
T07173	KEGGPATH	hsa04722:Neurotrophin signaling pathway		
T07173	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T07173	KEGGPATH	hsa05200:Pathways in cancer		
T07173	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T07173	KEGGPATH	hsa05216:Thyroid cancer		
T07173	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T07173	WIKIPATH	WP1873:NGF signalling via TRKA from the plasma membrane		
T07173	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T07173	WIKIPATH	WP2380:BDNF signaling pathway		
T07173	WIKIPATH	WP382:MAPK Signaling Pathway		
T07173	REACPATH	R-HSA-170968:Frs2-mediated activation		
T07173	REACPATH	R-HSA-170984:ARMS-mediated activation		
T07173	REACPATH	R-HSA-187024:NGF-independant TRKA activation		
T07173	REACPATH	R-HSA-198203:PI3K/AKT activation		
T07173	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T07173	INTEPATH	trkrpathway:Neurotrophic factor-mediated Trk receptor signaling		
				
T85435	TARGETID	T85435		
T85435	FORMERID	TTDS00292		
T85435	UNIPROID	INSR_HUMAN		
T85435	TARGNAME	Insulin receptor (INSR)		
T85435	GENENAME	INSR		
T85435	TARGTYPE	Successful target		
T85435	SYNONYMS	IR; CD220 antigen; CD220		
T85435	FUNCTION	Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). Isoform Short has a higher affinity for IGFII binding. When present in a hybrid receptor with IGF1R, binds IGF1. shows that hybrid receptors composed of IGF1R and INSR isoform Long are activated with a high affinity by IGF1, with low affinity by IGF2 and not significantly activated by insulin, and that hybrid receptors composed of IGF1R and INSR isoform Short are activated by IGF1, IGF2 and insulin. In contrast, shows that hybrid receptors composed of IGF1R and INSR isoform Long and hybrid receptors composed of IGF1R and INSR isoform Short have similar binding characteristics, both bind IGF1 and have a low affinity for insulin. Receptor tyrosine kinase which mediates the pleiotropic actions of insulin.		
T85435	PDBSTRUC	6HN5; 6HN4; 5U1M; 5KQV; 5J3H		
T85435	BIOCLASS	Kinase		
T85435	ECNUMBER	EC 2.7.10.1		
T85435	SEQUENCE	MATGGRRGAAAAPLLVAVAALLLGAAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDICPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHSECLGNCSQPDDPTKCVACRNFYLDGRCVETCPPPYYHFQDWRCVNFSFCQDLHHKCKNSRRQGCHQYVIHNNKCIPECPSGYTMNSSNLLCTPCLGPCPKVCHLLEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGYLKIRRSYALVSLSFFRKLRLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCENELLKFSYIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDGQDACGSNSWTVVDIDPPLRSNDPKSQNHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVFWERQAEDSELFELDYCLKGLKLPSRTWSPPFESEDSQKHNQSEYEDSAGECCSCPKTDSQILKELEESSFRKTFEDYLHNVVFVPRKTSSGTGAEDPRPSRKRRSLGDVGNVTVAVPTVAAFPNTSSTSVPTSPEEHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDTPEERCSVAAYVSARTMPEAKADDIVGPVTHEIFENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCVSRKHFALERGCRLRGLSPGNYSVRIRATSLAGNGSWTEPTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSVVIGSIYLFLRKRQPDGPLGPLYASSNPEYLSASDVFPCSVYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFHSEENKAPESEELEMEFEDMENVPLDRSSHCQREEAGGRDGGSSLGFKRSYEEHIPYTHMNGGKKNGRILTLPRSNPS		
T85435	DRUGINFO	D02EHV	Human neutral insulin	Approved
T85435	DRUGINFO	D03VXG	Insulin Lyspro recombinant	Approved
T85435	DRUGINFO	D06SVW	Insulin recombinant	Approved
T85435	DRUGINFO	D05ELO	Insulin, porcine	Approved
T85435	DRUGINFO	D0M2XE	Insulin-glulisine	Approved
T85435	DRUGINFO	D0L6JE	Insulin-lispro	Approved
T85435	DRUGINFO	D07MEH	Meglitinides	Approved
T85435	DRUGINFO	D09PPG	Metformin arginine-hemisuccinimide	Approved
T85435	DRUGINFO	D0Y3VQ	Ryzodeq	Approved
T85435	DRUGINFO	D0U8YK	NN5401	Phase 3
T85435	DRUGINFO	D0U3LK	Metformin glycinate	Phase 2/3
T85435	DRUGINFO	D0T5YX	DM-71	Phase 2
T85435	DRUGINFO	D06MOY	DM-99	Phase 2
T85435	DRUGINFO	D0D4ZW	EGS-21	Phase 2
T85435	DRUGINFO	D00SWQ	Mitoglitazone	Phase 2
T85435	DRUGINFO	D00AUX	MSDC-0602	Phase 2
T85435	DRUGINFO	D03VCJ	NP-01	Phase 2
T85435	DRUGINFO	D02SXZ	S-707106	Phase 2
T85435	DRUGINFO	D0A6OS	TAK-379	Phase 2
T85435	DRUGINFO	D0ZK7B	Tesofensine	Phase 2
T85435	DRUGINFO	D07NKZ	VVP-808	Phase 2
T85435	DRUGINFO	D07HPJ	AEW-541	Phase 1
T85435	DRUGINFO	D06HPP	AGT-182	Phase 1
T85435	DRUGINFO	D0D5EJ	Insulin oral sublingual	Phase 1
T85435	DRUGINFO	D08TGG	Insulin transdermal	Phase 1
T85435	DRUGINFO	D07DLA	ISF-402	Phase 1
T85435	DRUGINFO	D08XFJ	NN-1218	Phase 1
T85435	DRUGINFO	D05LSY	AKP-020	Discontinued in Phase 2
T85435	DRUGINFO	D0Z8UQ	DM-83	Discontinued in Phase 2
T85435	DRUGINFO	D0F1MU	EML-336	Discontinued in Phase 2
T85435	DRUGINFO	D0M3OR	KW-2450	Discontinued in Phase 1/2
T85435	DRUGINFO	D02IJP	CLX-0900	Terminated
T85435	DRUGINFO	D03CMR	TER-16998	Terminated
T85435	DRUGINFO	D0W9KO	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol	Investigative
T85435	DRUGINFO	D0L7MM	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol	Investigative
T85435	DRUGINFO	D0KC9V	AD10-1025	Investigative
T85435	DRUGINFO	D0XQ0V	DC-9703	Investigative
T85435	DRUGINFO	D03BCE	FPT-038	Investigative
T85435	DRUGINFO	D06PJW	GSK-1838705A	Investigative
T85435	DRUGINFO	D0UG4S	L-betagamma-meATP	Investigative
T85435	DRUGINFO	D0R2WK	NVP-TAE684	Investigative
T85435	DRUGINFO	D0G4CS	PMID24900237C15	Investigative
T85435	DRUGINFO	D08ZLL	Quick-acting insulin	Investigative
T85435	DRUGINFO	D0I4LQ	RHIIP	Investigative
T85435	DRUGINFO	D0YN9H	VVP-100X	Investigative
T85435	DRUGINFO	D02QOL	XMetD	Investigative
T85435	DRUGINFO	D0C7QW	XMetS	Investigative
T85435	KEGGPATH	hsa04014:Ras signaling pathway		
T85435	KEGGPATH	hsa04015:Rap1 signaling pathway		
T85435	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T85435	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T85435	KEGGPATH	hsa04068:FoxO signaling pathway		
T85435	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T85435	KEGGPATH	hsa04152:AMPK signaling pathway		
T85435	KEGGPATH	hsa04520:Adherens junction		
T85435	KEGGPATH	hsa04910:Insulin signaling pathway		
T85435	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T85435	KEGGPATH	hsa04930:Type II diabetes mellitus		
T85435	KEGGPATH	hsa04932:Non-alcoholic fatty liver disease (NAFLD)		
T85435	KEGGPATH	hsa04960:Aldosterone-regulated sodium reabsorption		
T85435	WIKIPATH	WP1403:AMPK Signaling		
T85435	WIKIPATH	WP15:Selenium Micronutrient Network		
T85435	WIKIPATH	WP1533:Vitamin B12 Metabolism		
T85435	WIKIPATH	WP1584:Type II diabetes mellitus		
T85435	WIKIPATH	WP176:Folate Metabolism		
T85435	WIKIPATH	WP1913:Signaling by Insulin receptor		
T85435	WIKIPATH	WP2324:AGE/RAGE pathway		
T85435	WIKIPATH	WP2509:Nanoparticle triggered autophagic cell death		
T85435	WIKIPATH	WP481:Insulin Signaling		
T85435	WIKIPATH	WP710:DNA Damage Response (only ATM dependent)		
T85435	WHIZPATH	PW000454:Insulin Signalling		
T85435	WHIZPATH	PW000659:Leucine Stimulation on Insulin Signaling		
T85435	REACPATH	R-HSA-74713:IRS activation		
T85435	REACPATH	R-HSA-74749:Signal attenuation		
T85435	REACPATH	R-HSA-74751:Insulin receptor signalling cascade		
T85435	REACPATH	R-HSA-77387:Insulin receptor recycling		
T85435	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T85435	INTEPATH	insulin_glucose_pathway:Insulin-mediated glucose transport		
T85435	INTEPATH	insulin_pathway:Insulin Pathway		
T85435	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T85435	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T85435	PANTPATH	P00032:Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade		
T85435	PANTPATH	P00033:Insulin/IGF pathway-protein kinase B signaling cascade		
T85435	PANTPATH	P00048:PI3 kinase pathway		
				
T12499	TARGETID	T12499		
T12499	FORMERID	TTDS00407		
T12499	UNIPROID	LCK_HUMAN		
T12499	TARGNAME	LCK tyrosine protein kinase (LCK)		
T12499	GENENAME	LCK		
T12499	TARGTYPE	Successful target		
T12499	SYNONYMS	p56-LCK; Tyrosine-protein kinase Lck; T cell-specific protein-tyrosine kinase; Proto-oncogene tyrosine-protein kinase LCK; Proto-oncogene Lck; Protein YT16; Lymphocyte cell-specific protein-tyrosine kinase; Leukocyte C-terminal Src kinase; LSK; LCK p59-Fyn; LCK Protooncogene Syn		
T12499	FUNCTION	Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Interacts with FYB2. Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells.		
T12499	PDBSTRUC	6H6A; 5MTN; 5MTM; 4D8K; 4C3F		
T12499	BIOCLASS	Kinase		
T12499	ECNUMBER	EC 2.7.10.2		
T12499	SEQUENCE	MGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVTYEGSNPPASPLQDNLVIALHSYEPSHDGDLGFEKGEQLRILEQSGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGFYISPRITFPGLHELVRHYTNASDGLCTRLSRPCQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP		
T12499	DRUGINFO	D0E6XR	Dasatinib	Approved
T12499	DRUGINFO	D02XNW	VX-680	Phase 2
T12499	DRUGINFO	D06CIJ	ISIS-CRP	Phase 1
T12499	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T12499	DRUGINFO	D07AIB	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine	Investigative
T12499	DRUGINFO	D02BUW	2-(3,4,5-Trihydroxy-benzylidene)-malononitrile	Investigative
T12499	DRUGINFO	D08DVL	3-(4-(o-toluidino)pyrimidin-2-ylamino)benzamide	Investigative
T12499	DRUGINFO	D08WOG	4-(3-Chloro-phenoxy)-6,7-dimethoxy-quinazoline	Investigative
T12499	DRUGINFO	D0O1YH	4,5,6,7-tetrabromo-1H-benzo[d][1,2,3]triazole	Investigative
T12499	DRUGINFO	D0M3CT	4-Phenylsulfanyl-7H-pyrrolo[2,3-d]pyrimidine	Investigative
T12499	DRUGINFO	D09HXU	6-o-tolylquinazolin-2-amine	Investigative
T12499	DRUGINFO	D0BS6R	A-420983	Investigative
T12499	DRUGINFO	D03AER	A-641359	Investigative
T12499	DRUGINFO	D06WGX	A-770041	Investigative
T12499	DRUGINFO	D00ICA	AMP-PNP	Investigative
T12499	DRUGINFO	D0TO6S	Bisindolylmaleimide-I	Investigative
T12499	DRUGINFO	D0M4SY	BMS-536924	Investigative
T12499	DRUGINFO	D09QBA	CEP-5104	Investigative
T12499	DRUGINFO	D0A7FQ	CGP-57380	Investigative
T12499	DRUGINFO	D0B9BU	CI-1040	Investigative
T12499	DRUGINFO	D0C3AD	GW-788388	Investigative
T12499	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T12499	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T12499	DRUGINFO	D0Y4BL	JNJ-28312141	Investigative
T12499	DRUGINFO	D0N6ES	KN-62	Investigative
T12499	DRUGINFO	D06WJA	L-779450	Investigative
T12499	DRUGINFO	D0D9TU	LAVENDUSTIN A	Investigative
T12499	DRUGINFO	D0OZ2S	Lck inhibitor	Investigative
T12499	DRUGINFO	D0GT8N	NM-PP1	Investigative
T12499	DRUGINFO	D0P3JW	PD-0166326	Investigative
T12499	DRUGINFO	D0S1KJ	PD-0173952	Investigative
T12499	DRUGINFO	D03NPX	PD-0173955	Investigative
T12499	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T12499	DRUGINFO	D0Z7GH	PD-0173958	Investigative
T12499	DRUGINFO	D0OH3J	PD-0179483	Investigative
T12499	DRUGINFO	D08RZB	PMID15546730C2	Investigative
T12499	DRUGINFO	D0D5KZ	PMID17280833C30	Investigative
T12499	DRUGINFO	D04TLI	PMID17600705C23	Investigative
T12499	DRUGINFO	D0IZ8M	PMID21855335C19a	Investigative
T12499	DRUGINFO	D0L8HO	RO-316233	Investigative
T12499	DRUGINFO	D0M5FF	Ro31-8220	Investigative
T12499	DRUGINFO	D0L4HJ	RPR-108518A	Investigative
T12499	DRUGINFO	D0GB4V	STAUROSPORINONE	Investigative
T12499	DRUGINFO	D0CE3R	SU 6656	Investigative
T12499	DRUGINFO	D0H1OK	TG-100435	Investigative
T12499	DRUGINFO	D0Y1SR	WH-4-023	Investigative
T12499	DRUGINFO	D07ERV	Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2	Investigative
T12499	DRUGINFO	D0A2LX	Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2	Investigative
T12499	DRUGINFO	D00NWF	ZM-336372	Investigative
T12499	KEGGPATH	hsa04064:NF-kappa B signaling pathway		
T12499	KEGGPATH	hsa04380:Osteoclast differentiation		
T12499	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T12499	KEGGPATH	hsa04660:T cell receptor signaling pathway		
T12499	KEGGPATH	hsa05166:HTLV-I infection		
T12499	KEGGPATH	hsa05340:Primary immunodeficiency		
T12499	WIKIPATH	WP1799:Costimulation by the CD28 family		
T12499	WIKIPATH	WP1927:TCR signaling		
T12499	WIKIPATH	WP2203:TSLP Signaling Pathway		
T12499	WIKIPATH	WP23:B Cell Receptor Signaling Pathway		
T12499	WIKIPATH	WP2583:T-Cell Receptor and Co-stimulatory Signaling		
T12499	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T12499	WIKIPATH	WP2684:Host Interactions of HIV factors		
T12499	WIKIPATH	WP2694:DAP12 interactions		
T12499	WIKIPATH	WP2713:Signaling by SCF-KIT		
T12499	WIKIPATH	WP453:Inflammatory Response Pathway		
T12499	WIKIPATH	WP49:IL-2 Signaling Pathway		
T12499	WIKIPATH	WP585:Interferon type I signaling pathways		
T12499	WIKIPATH	WP61:Notch Signaling Pathway		
T12499	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T12499	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T12499	REACPATH	R-HSA-1433559:Regulation of KIT signaling		
T12499	REACPATH	R-HSA-202427:Phosphorylation of CD3 and TCR zeta chains		
T12499	REACPATH	R-HSA-202430:Translocation of ZAP-70 to Immunological synapse		
T12499	REACPATH	R-HSA-202433:Generation of second messenger molecules		
T12499	REACPATH	R-HSA-210990:PECAM1 interactions		
T12499	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T12499	REACPATH	R-HSA-2424491:DAP12 signaling		
T12499	REACPATH	R-HSA-389356:CD28 co-stimulation		
T12499	REACPATH	R-HSA-389357:CD28 dependent PI3K/Akt signaling		
T12499	REACPATH	R-HSA-389359:CD28 dependent Vav1 pathway		
T12499	REACPATH	R-HSA-389513:CTLA4 inhibitory signaling		
T12499	REACPATH	R-HSA-389948:PD-1 signaling		
T12499	REACPATH	R-HSA-451927:Interleukin-2 signaling		
T12499	NET_PATH	NetPath_11:TCR Signaling Pathway		
T12499	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T12499	INTEPATH	alphasynuclein_pathway:Alpha-synuclein signaling		
T12499	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T12499	INTEPATH	cd8tcrpathway:TCR signaling in na&#xef;ve CD8+ T cells		
T12499	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T12499	INTEPATH	epha_fwdpathway:EPHA forward signaling		
T12499	INTEPATH	ephrinbrevpathway:Ephrin B reverse signaling		
T12499	INTEPATH	glypican_1pathway:Glypican 1 network		
T12499	INTEPATH	il12_2pathway:IL12-mediated signaling events		
T12499	INTEPATH	il2_1pathway:IL2-mediated signaling events		
T12499	INTEPATH	il2_pi3kpathway:IL2 signaling events mediated by PI3K		
T12499	INTEPATH	il2_stat5pathway:IL2 signaling events mediated by STAT5		
T12499	INTEPATH	nfkappabatypicalpathway:Atypical NF-kappaB pathway		
T12499	INTEPATH	p38alphabetapathway:Regulation of p38-alpha and p38-beta		
T12499	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T12499	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T12499	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T12499	INTEPATH	shp2_pathway:SHP2 signaling		
T12499	INTEPATH	tcr_pathway:TCR signaling in na&#xef;ve CD4+ T cells		
T12499	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T12499	PANTPATH	P00049:Parkinson disease		
T12499	PANTPATH	P00053:T cell activation		
				
T60631	TARGETID	T60631		
T60631	FORMERID	TTDS00348		
T60631	UNIPROID	RET_HUMAN		
T60631	TARGNAME	Proto-oncogene c-Ret (RET)		
T60631	GENENAME	RET		
T60631	TARGTYPE	Successful target		
T60631	SYNONYMS	RET51; RET receptor tyrosine kinase; RET mutant Y791F; RET mutant V804M; RET mutant V804L; RET mutant S891A; RET mutant M918T; RET mutant G691S; Proto-oncogene tyrosine-protein kinase receptor Ret; PTC; Cadherin family member 12; CDHR16; CDHF12; C-ret		
T60631	FUNCTION	Phosphorylates PTK2/FAK1. Regulates both cell death/survival balance and positional information. Required for the molecular mechanisms orchestration during intestine organogenesis; involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue. Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e. g. ITGB1 and ITGB3)-dependent manner. Involved in the development of the neural crest. Active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage. Acts as a dependence receptor; in the presence of the ligand GDNF in somatotrophs (within pituitary), promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF. Regulates nociceptor survival and size. Triggers the differentiation of rapidly adapting (RA) mechanoreceptors. Mediator of several diseases such as neuroendocrine cancers; these diseases are characterized by aberrant integrins-regulated cell migration. Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which induces inhibition of food-intake. Activates MAPK- and AKT-signaling pathways. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL. Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands.		
T60631	PDBSTRUC	6FEK; 5FM3; 5FM2; 5AMN; 4UX8		
T60631	BIOCLASS	Kinase		
T60631	ECNUMBER	EC 2.7.10.1		
T60631	SEQUENCE	MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAASTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS		
T60631	DRUGINFO	D0H0EQ	Ponatinib	Approved
T60631	DRUGINFO	D0OD2I	Pralsetinib	Approved
T60631	DRUGINFO	D09GDD	Regorafenib	Approved
T60631	DRUGINFO	D01PZD	Romiplostim	Approved
T60631	DRUGINFO	D01KOA	Selpercatinib	Approved
T60631	DRUGINFO	D0G6QF	Vandetanib	Approved
T60631	DRUGINFO	D05BLN	MGCD516	Phase 2/3
T60631	DRUGINFO	D04MXN	CEP-32496	Phase 1/2
T60631	DRUGINFO	DS7CY4	TPX-0046	Phase 1/2
T60631	DRUGINFO	D1BG7C	BOS172738	Phase 1
T60631	DRUGINFO	D0AX4H	GSK3179106	Phase 1
T60631	DRUGINFO	D0S6TK	tamatinib	Clinical trial
T60631	DRUGINFO	D08LCQ	Benzo(b)carbazol-11-one compound 1	Patented
T60631	DRUGINFO	D0O9JD	Benzo(b)carbazol-11-one compound 2	Patented
T60631	DRUGINFO	D0MX7B	Carboxamide derivative 4	Patented
T60631	DRUGINFO	D0A6RR	Dihydropyridine compound 1	Patented
T60631	DRUGINFO	D0JY9S	Dihydropyridine compound 2	Patented
T60631	DRUGINFO	D0YC7C	Dihydropyridine compound 3	Patented
T60631	DRUGINFO	D03JZP	Dihydropyridine compound 4	Patented
T60631	DRUGINFO	D0X7IS	Dihydropyridine compound 5	Patented
T60631	DRUGINFO	D03ORX	Dihydropyridine compound 6	Patented
T60631	DRUGINFO	D06BNK	Pyrazolo[3,4-d]pyrimidine derivative 5	Patented
T60631	DRUGINFO	D03MMZ	Pyrazolo[3,4-d]pyrimidine derivative 6	Patented
T60631	DRUGINFO	D05HYJ	Pyrazolo[3,4-d]pyrimidine derivative 7	Patented
T60631	DRUGINFO	D01BMX	Pyrazolo[3,4-d]pyrimidine derivative 8	Patented
T60631	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T60631	DRUGINFO	D0T7BE	Pyridine derivative 19	Patented
T60631	DRUGINFO	D0NB1V	Pyridine derivative 20	Patented
T60631	DRUGINFO	D0O0AW	Pyridine derivative 21	Patented
T60631	DRUGINFO	D0O4TA	Pyridine derivative 22	Patented
T60631	DRUGINFO	D0XR9O	Pyrrolo-pyridinone derivative 1	Patented
T60631	DRUGINFO	D0QY6M	Pyrrolo-pyridinone derivative 2	Patented
T60631	DRUGINFO	D05NBB	Pyrrolo-pyridinone derivative 3	Patented
T60631	DRUGINFO	D07QKP	Pyrrolo-pyridinone derivative 4	Patented
T60631	DRUGINFO	D09FBJ	Pyrrolo-pyrimidine derivative 2	Patented
T60631	DRUGINFO	D0FU0I	Pyrrolo-pyrimidine derivative 3	Patented
T60631	DRUGINFO	D0P1AH	Pyrrolo-pyrimidine derivative 4	Patented
T60631	DRUGINFO	D0NH2H	Pyrrolo-pyrimidine derivative 5	Patented
T60631	DRUGINFO	D07OLQ	Pyrrolo-pyrimidine derivative 6	Patented
T60631	DRUGINFO	D0B3GX	Quinazoline derivative 14	Patented
T60631	DRUGINFO	D05PRG	Quinazoline derivative 15	Patented
T60631	DRUGINFO	D0DV4X	Quinazoline derivative 16	Patented
T60631	DRUGINFO	D0J5TN	CEP-751	Terminated
T60631	DRUGINFO	D0Y1UL	(E)-3-(4-hydroxybenzylidene)indolin-2-one	Investigative
T60631	DRUGINFO	D00ATA	(Z)-3-((1H-pyrrol-2-yl)methylene)indolin-2-one	Investigative
T60631	DRUGINFO	D0W4UQ	(Z)-5-Amino-3-(4-methoxybenzylidene)indolin-2-one	Investigative
T60631	DRUGINFO	D0N7AJ	AST-487	Investigative
T60631	DRUGINFO	D02CFR	GW-559768X	Investigative
T60631	DRUGINFO	D0N5TB	ITRI-305	Investigative
T60631	DRUGINFO	D02NNT	PMID21493067C1d	Investigative
T60631	DRUGINFO	D02BXJ	PMID21561767C8h	Investigative
T60631	DRUGINFO	D0H1OK	TG-100435	Investigative
T60631	KEGGPATH	hsa04144:Endocytosis		
T60631	KEGGPATH	hsa05200:Pathways in cancer		
T60631	KEGGPATH	hsa05216:Thyroid cancer		
T60631	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T60631	WIKIPATH	WP2855:Dopaminergic Neurogenesis		
T60631	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T60631	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T60631	INTEPATH	ret_pathway:Signaling events regulated by Ret tyrosine kinase		
				
T68251	TARGETID	T68251		
T68251	FORMERID	TTDC00104		
T68251	UNIPROID	MMP2_HUMAN		
T68251	TARGNAME	Matrix metalloproteinase-2 (MMP-2)		
T68251	GENENAME	MMP2		
T68251	TARGTYPE	Successful target		
T68251	SYNONYMS	TBE-1; Matrix metalloproteinase 2; CLG4A; 72 kDa type IV collagenase; 72 kDa gelatinase		
T68251	FUNCTION	As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14. Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture.		
T68251	PDBSTRUC	3AYU; 1RTG; 1QIB; 1KS0; 1J7M		
T68251	BIOCLASS	Peptidase		
T68251	ECNUMBER	EC 3.4.24.24		
T68251	SEQUENCE	MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKFFGLPQTGDLDQNTIETMRKPRCGNPDVANYNFFPRKPKWDKNQITYRIIGYTPDLDPETVDDAFARAFQVWSDVTPLRFSRIHDGEADIMINFGRWEHGDGYPFDGKDGLLAHAFAPGTGVGGDSHFDDDELWTLGEGQVVRVKYGNADGEYCKFPFLFNGKEYNSCTDTGRSDGFLWCSTTYNFEKDGKYGFCPHEALFTMGGNAEGQPCKFPFRFQGTSYDSCTTEGRTDGYRWCGTTEDYDRDKKYGFCPETAMSTVGGNSEGAPCVFPFTFLGNKYESCTSAGRSDGKMWCATTANYDDDRKWGFCPDQGYSLFLVAAHEFGHAMGLEHSQDPGALMAPIYTYTKNFRLSQDDIKGIQELYGASPDIDLGTGPTPTLGPVTPEICKQDIVFDGIAQIRGEIFFFKDRFIWRTVTPRDKPMGPLLVATFWPELPEKIDAVYEAPQEEKAVFFAGNEYWIYSASTLERGYPKPLTSLGLPPDVQRVDAAFNWSKNKKTYIFAGDKFWRYNEVKKKMDPGFPKLIADAWNAIPDNLDAVVDLQGGGHSYFFKGAYYLKLENQSLKSVKFGSIKSDWLGC		
T68251	DRUGINFO	D00MDP	Prinomastat	Approved
T68251	DRUGINFO	D0U2BH	Epigallocatechin gallate	Phase 3
T68251	DRUGINFO	D05VZE	Marimastat	Phase 3
T68251	DRUGINFO	D0IJ7O	Metastat	Phase 1
T68251	DRUGINFO	D0T4BL	Neovastat	Phase 1
T68251	DRUGINFO	D05GAP	PMID29130358-Compound-Figure10(2a)	Patented
T68251	DRUGINFO	D0Y1LO	PMID29130358-Compound-Figure11(3)	Patented
T68251	DRUGINFO	D0Q4QB	PMID29130358-Compound-Figure13(4)	Patented
T68251	DRUGINFO	D0LS4Y	PMID29130358-Compound-Figure16(9a)	Patented
T68251	DRUGINFO	D0A9ZW	PMID29130358-Compound-Figure16(9b)	Patented
T68251	DRUGINFO	D0S3PN	PMID29130358-Compound-Figure16(9c)	Patented
T68251	DRUGINFO	D0O8RQ	PMID29130358-Compound-Figure18(14)	Patented
T68251	DRUGINFO	D0X6GG	PMID29130358-Compound-Figure18(14a)	Patented
T68251	DRUGINFO	D0W7HO	PMID29130358-Compound-LonimacranthoideVII	Patented
T68251	DRUGINFO	D0DB0Z	PMID29130358-Compound-SB-3CT	Patented
T68251	DRUGINFO	D01EUF	BMS 275291	Discontinued in Phase 3
T68251	DRUGINFO	D0Q1CD	Tanomastat	Discontinued in Phase 3
T68251	DRUGINFO	D05WTZ	Galarubicin	Discontinued in Phase 2
T68251	DRUGINFO	D0T9HG	GM6001	Discontinued in Phase 2
T68251	DRUGINFO	D03BOZ	RS-130830	Discontinued in Phase 2
T68251	DRUGINFO	D0C0ME	RO-26-2853	Preclinical
T68251	DRUGINFO	D05VNG	BB-1101	Terminated
T68251	DRUGINFO	D08WBF	BB-3644	Terminated
T68251	DRUGINFO	D02GYD	CDP-845	Terminated
T68251	DRUGINFO	D08CEE	L-696418	Terminated
T68251	DRUGINFO	D0Y1XT	SC-44463	Terminated
T68251	DRUGINFO	D0G3YZ	(+/-)5-(biphenyl-4-yl)-3-hydroxypentanoic acid	Investigative
T68251	DRUGINFO	D07MJD	[2-(Biphenyl-4-sulfonyl)phenyl]acetic Acid	Investigative
T68251	DRUGINFO	D0E5MB	2-(4'-chloro-biphenyl-4-sulfonyl)-pentanoic acid	Investigative
T68251	DRUGINFO	D05THD	2-(Biphenyl-4-ylsulfonyl)N-hydroxybenzamide	Investigative
T68251	DRUGINFO	D0L4EO	3-(4-(2-phenylethynyl)benzoyl)pentanoic acid	Investigative
T68251	DRUGINFO	D0A5MV	3-(4-Phenylethynylbenzoyl)nonanoic acid	Investigative
T68251	DRUGINFO	D05JPV	4-(4-(dec-1-ynyl)phenyl)-4-oxobutanoic acid	Investigative
T68251	DRUGINFO	D07LTB	5-(4-Phenoxy-phenyl)-pyrimidine-2,4,6-trione	Investigative
T68251	DRUGINFO	D0Y7NV	5-Biphenyl-4-yl-5-ethyl-pyrimidine-2,4,6-trione	Investigative
T68251	DRUGINFO	D0Q9LC	5-Biphenyl-4-yl-5-hexyl-pyrimidine-2,4,6-trione	Investigative
T68251	DRUGINFO	D0K4TI	5-Hexyl-5-phenyl-pyrimidine-2,4,6-trione	Investigative
T68251	DRUGINFO	D0T1FR	Cis-2-aminocyclohexylcarbamoylphosphonic acid	Investigative
T68251	DRUGINFO	D0H9BL	Clinopodic acid C	Investigative
T68251	DRUGINFO	D0P8EY	Folate gamma-hydroxamic acid	Investigative
T68251	DRUGINFO	D0ZB6O	Folate gamma-L-proline-hydroxamic acid	Investigative
T68251	DRUGINFO	D0W2UK	IK-862	Investigative
T68251	DRUGINFO	D06ALC	Lithospermic acid	Investigative
T68251	DRUGINFO	D0B0UI	Methotrexate gamma-hydroxamic acid	Investigative
T68251	DRUGINFO	D01HKU	Methotrexate gamma-L-proline-hydroxamic acid	Investigative
T68251	DRUGINFO	D0A4TC	MMI270	Investigative
T68251	DRUGINFO	D0S9OL	N-Hydroxy-2-(4-phenoxy-benzenesulfonyl)benzamide	Investigative
T68251	DRUGINFO	D00RNA	N-hydroxy-3-(2-oxo-2H-chromen-3-yl)propanamide	Investigative
T68251	DRUGINFO	D08ICI	N-hydroxy-3-(6-methoxy-2-oxo-2H-chromen-3-yl)	Investigative
T68251	DRUGINFO	D02EFQ	PD-169469	Investigative
T68251	DRUGINFO	D0F7BE	PNU-107859	Investigative
T68251	DRUGINFO	D0XL8K	Ro-37-9790	Investigative
T68251	DRUGINFO	D0U7CD	Roche 28-2653	Investigative
T68251	DRUGINFO	D08NSS	SC-74020	Investigative
T68251	DRUGINFO	D03AMR	SR-973	Investigative
T68251	DRUGINFO	D0NP8A	UK-356618	Investigative
T68251	KEGGPATH	hsa04670:Leukocyte transendothelial migration		
T68251	KEGGPATH	hsa04912:GnRH signaling pathway		
T68251	KEGGPATH	hsa04915:Estrogen signaling pathway		
T68251	KEGGPATH	hsa05200:Pathways in cancer		
T68251	KEGGPATH	hsa05205:Proteoglycans in cancer		
T68251	KEGGPATH	hsa05219:Bladder cancer		
T68251	WIKIPATH	WP129:Matrix Metalloproteinases		
T68251	WIKIPATH	WP2324:AGE/RAGE pathway		
T68251	WIKIPATH	WP2769:Activation of Matrix Metalloproteinases		
T68251	REACPATH	R-HSA-1442490:Collagen degradation		
T68251	REACPATH	R-HSA-1474228:Degradation of the extracellular matrix		
T68251	REACPATH	R-HSA-1592389:Activation of Matrix Metalloproteinases		
T68251	REACPATH	R-HSA-381426:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T68251	REACPATH	R-HSA-3928665:EPH-ephrin mediated repulsion of cells		
T68251	NET_PATH	NetPath_11:TCR Signaling Pathway		
T68251	NET_PATH	NetPath_22:Leptin Signaling Pathway		
T68251	NET_PATH	NetPath_5:ID Signaling Pathway		
T68251	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T68251	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T68251	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T68251	INTEPATH	avb3_opn_pathway:Osteopontin-mediated events		
T68251	INTEPATH	betacatenin_nuc_pathway:Regulation of nuclear beta catenin signaling and target gene transcription		
T68251	INTEPATH	er_nongenomic_pathway:Plasma membrane estrogen receptor signaling		
T68251	INTEPATH	foxm1pathway:FOXM1 transcription factor network		
T68251	INTEPATH	fra_pathway:Validated transcriptional targets of AP1 family members Fra1 and Fra2		
T68251	INTEPATH	lysophospholipid_pathway:LPA receptor mediated events		
T68251	INTEPATH	p53downstreampathway:Direct p53 effectors		
T68251	INTEPATH	syndecan_2_pathway:Syndecan-2-mediated signaling events		
T68251	PANTPATH	P00004:Alzheimer disease-presenilin pathway		
				
T00140	TARGETID	T00140		
T00140	FORMERID	TTDS00112		
T00140	UNIPROID	LOX5_HUMAN		
T00140	TARGNAME	Arachidonate 5-lipoxygenase (5-LOX)		
T00140	GENENAME	ALOX5		
T00140	TARGTYPE	Successful target		
T00140	SYNONYMS	LOG5; 5-lipoxygenase; 5-LO		
T00140	FUNCTION	Catalyzes the first step in leukotriene biosynthesis, and thereby plays a role in inflammatory processes.		
T00140	PDBSTRUC	3V99; 3V98; 3V92; 3O8Y; 2ABV		
T00140	BIOCLASS	Oxygenase		
T00140	ECNUMBER	EC 1.13.11.34		
T00140	SEQUENCE	MPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGAVDSYDVTVDEELGEIQLVRIEKRKYWLNDDWYLKYITLKTPHGDYIEFPCYRWITGDVEVVLRDGRAKLARDDQIHILKQHRRKELETRQKQYRWMEWNPGFPLSIDAKCHKDLPRDIQFDSEKGVDFVLNYSKAMENLFINRFMHMFQSSWNDFADFEKIFVKISNTISERVMNHWQEDLMFGYQFLNGCNPVLIRRCTELPEKLPVTTEMVECSLERQLSLEQEVQQGNIFIVDFELLDGIDANKTDPCTLQFLAAPICLLYKNLANKIVPIAIQLNQIPGDENPIFLPSDAKYDWLLAKIWVRSSDFHVHQTITHLLRTHLVSEVFGIAMYRQLPAVHPIFKLLVAHVRFTIAINTKAREQLICECGLFDKANATGGGGHVQMVQRAMKDLTYASLCFPEAIKARGMESKEDIPYYFYRDDGLLVWEAIRTFTAEVVDIYYEGDQVVEEDPELQDFVNDVYVYGMRGRKSSGFPKSVKSREQLSEYLTVVIFTASAQHAAVNFGQYDWCSWIPNAPPTMRAPPPTAKGVVTIEQIVDTLPDRGRSCWHLGAVWALSQFQENELFLGMYPEEHFIEKPVKEAMARFRKNLEAIVSVIAERNKKKQLPYYYLSPDRIPNSVAI		
T00140	DRUGINFO	D06RCB	Diethylcarbamazine	Approved
T00140	DRUGINFO	D09JUG	Zileuton	Approved
T00140	DRUGINFO	D0V9EN	3,4-Dihydroxycinnamic Acid	Phase 4
T00140	DRUGINFO	D0AZ8C	Silymarin	Phase 4
T00140	DRUGINFO	D08PXR	ABT-761	Phase 3
T00140	DRUGINFO	D0C0NH	Avastin+/-Tarceva	Phase 3
T00140	DRUGINFO	D0X8VV	Flobufen	Phase 3
T00140	DRUGINFO	D02YEY	FPL-62064	Phase 3
T00140	DRUGINFO	D02RQT	Tenidap	Phase 3
T00140	DRUGINFO	D0AL8T	Darbufelone	Phase 2/3
T00140	DRUGINFO	D00YEV	BAICALEIN	Phase 2
T00140	DRUGINFO	D04FNQ	BIM23A760	Phase 2
T00140	DRUGINFO	D0D5ZV	CMI-392	Phase 2
T00140	DRUGINFO	D0K9UK	E-6700	Phase 2
T00140	DRUGINFO	D0S2PY	MK-866	Phase 2
T00140	DRUGINFO	D0L5XG	PF-4191834	Phase 2
T00140	DRUGINFO	D05VVX	PTC299	Phase 2
T00140	DRUGINFO	DES36M	Q301	Phase 2
T00140	DRUGINFO	D00RJB	Rilopirox	Phase 2
T00140	DRUGINFO	D0L4SL	TA-270	Phase 2
T00140	DRUGINFO	D04WMR	Tepoxalin	Phase 2
T00140	DRUGINFO	D0Q7UG	Tipelukast	Phase 2
T00140	DRUGINFO	D04JIM	UCB-35440	Phase 2
T00140	DRUGINFO	D0A7JH	WY-50295-tromethamine	Phase 2
T00140	DRUGINFO	D0L6VH	BF-389	Phase 1
T00140	DRUGINFO	D0Y4OI	SKF-105809	Phase 1
T00140	DRUGINFO	D0U2CB	Ibuproxam	Withdrawn from market
T00140	DRUGINFO	D01DAD	CJ-13610	Discontinued in Phase 2
T00140	DRUGINFO	D0V3HG	CV-6504	Discontinued in Phase 2
T00140	DRUGINFO	D06UVO	DuP-654	Discontinued in Phase 2
T00140	DRUGINFO	D0JY4Y	E-3040	Discontinued in Phase 2
T00140	DRUGINFO	D00HFD	E-6080	Discontinued in Phase 2
T00140	DRUGINFO	D0H7GH	ETH615	Discontinued in Phase 2
T00140	DRUGINFO	D04QVN	FPL-64170	Discontinued in Phase 2
T00140	DRUGINFO	D0E8UV	Linetastine	Discontinued in Phase 2
T00140	DRUGINFO	D0M0QX	MK-591	Discontinued in Phase 2
T00140	DRUGINFO	D0K2ER	MK-886	Discontinued in Phase 2
T00140	DRUGINFO	D0P1TZ	MLN-977	Discontinued in Phase 2
T00140	DRUGINFO	D08ORO	OPC-21268	Discontinued in Phase 2
T00140	DRUGINFO	D0G5GJ	R-68151	Discontinued in Phase 2
T00140	DRUGINFO	D0U5EU	SC-45662	Discontinued in Phase 2
T00140	DRUGINFO	D0P3KA	TEBUFELONE	Discontinued in Phase 2
T00140	DRUGINFO	D0P3CF	AZD-4407	Discontinued in Phase 1
T00140	DRUGINFO	D0F5NB	CD-581	Discontinued in Phase 1
T00140	DRUGINFO	D0N1SU	Licofelone	Discontinued in Phase 1
T00140	DRUGINFO	D0X9KE	A-78773	Terminated
T00140	DRUGINFO	D0L1IH	A-79175	Terminated
T00140	DRUGINFO	D0T4EL	A-80263	Terminated
T00140	DRUGINFO	D06XRQ	AA-861	Terminated
T00140	DRUGINFO	D0U6AL	BI-L-357	Terminated
T00140	DRUGINFO	D0C9RZ	BU-4601A	Terminated
T00140	DRUGINFO	D05WPQ	BW A4C	Terminated
T00140	DRUGINFO	D0HJ1Y	BW B70C	Terminated
T00140	DRUGINFO	D0DP8P	BW755C	Terminated
T00140	DRUGINFO	D0QI8I	CGS 8515	Terminated
T00140	DRUGINFO	D02QGM	CGS-26529	Terminated
T00140	DRUGINFO	D0L8RG	CI-986	Terminated
T00140	DRUGINFO	D0V4GT	CMI-206	Terminated
T00140	DRUGINFO	D09JYF	Epocarbazolin-A	Terminated
T00140	DRUGINFO	D0SZ3B	ER-34122	Terminated
T00140	DRUGINFO	D04APY	KC-11404	Terminated
T00140	DRUGINFO	D01LXG	KC-11425	Terminated
T00140	DRUGINFO	D01QAR	LY-221068	Terminated
T00140	DRUGINFO	D0H2RB	NAFAZATROM	Terminated
T00140	DRUGINFO	D0J8RS	PD-146176	Terminated
T00140	DRUGINFO	D0C5HV	R zileuton	Terminated
T00140	DRUGINFO	D0S5DY	R-85355	Terminated
T00140	DRUGINFO	D0O8ZE	REV-5901	Terminated
T00140	DRUGINFO	D08JKK	RWJ-63556	Terminated
T00140	DRUGINFO	D06MPF	Sch-40120	Terminated
T00140	DRUGINFO	D09SCI	SKF-104351	Terminated
T00140	DRUGINFO	D0H0IA	WY-28342	Terminated
T00140	DRUGINFO	D06YOD	ZD-7717	Terminated
T00140	DRUGINFO	D0D8MD	ZM-230487	Terminated
T00140	DRUGINFO	D0H6JC	1,2-Dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D02YPE	1,2-Dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D00BSX	1,3,8-Trihydroxy-6-methyl-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D0Y0KF	1,5-Dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D07OKS	1,8,9-Trimethoxy-9,10-dihydro-anthracene	Investigative
T00140	DRUGINFO	D04MBD	1,8-Dichloro-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D00ENR	1,8-Dihydroxy-2-propionyl-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D08FPY	10-Acetyl-1,8-dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D06XYZ	10-Benzoyl-1,8-dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D01VLQ	15-hydroxyeicosatetraenoic acid	Investigative
T00140	DRUGINFO	D04RQG	1-Benzyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0B0XK	1-furan-2-yl-3-pyridin-2-yl-propenone (FPP-3)	Investigative
T00140	DRUGINFO	D0P8IX	1-Hydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D06CWX	1-Hydroxy-8-methoxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D0A9HL	1-Methyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0R1ER	2-(1H-Indol-3-ylmethyl)-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0L4TM	2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0X8BS	2-(4-Butoxy-phenoxy)-N-hydroxy-acetamide	Investigative
T00140	DRUGINFO	D0T0CY	2-(4-Butoxy-phenoxy)-N-hydroxy-N-methyl-acetamide	Investigative
T00140	DRUGINFO	D0N6CN	2-(4-Butoxy-phenoxy)-N-hydroxy-propionamide	Investigative
T00140	DRUGINFO	D0IF2H	2-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acetamide	Investigative
T00140	DRUGINFO	D0WW1K	2-(4-hydroxylphenyl)-3-(3,5-dihydroxylphenyl) propenoic acid (NNU-hdpa)	Investigative
T00140	DRUGINFO	D05PHI	2-(4-Methoxy-phenyl)-5-phenyl-thiazol-4-ol	Investigative
T00140	DRUGINFO	D08MCE	2-(4-Phenyl-butyl)-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0J7YU	2-Benzyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D02HQK	2-Biphenyl-4-yl-N-hydroxy-N-methyl-acetamide	Investigative
T00140	DRUGINFO	D0SJ3W	2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0U8CM	2-Methyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0F1ZE	2-Naphthalen-1-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0X6SA	2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0PD7X	2'-Nitro-biphenyl-4-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D06HUQ	2-Phenethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0S0PB	2-Phenyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D05KCN	2-Pyridin-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0HZ9X	2-Pyridin-3-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0Z5XD	2-Pyridin-4-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0XQ8P	2-Thiazol-5-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D0X9RM	2-Thiophen-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T00140	DRUGINFO	D08UXT	3-(4-Butoxy-phenyl)-N-hydroxy-N-methyl-acrylamide	Investigative
T00140	DRUGINFO	D0S8UP	3,4-Dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D05RIE	3-Benzoyl-N-hydroxy-benzamide	Investigative
T00140	DRUGINFO	D09WYM	3-Biphenyl-3-yl-N-hydroxy-N-methyl-acrylamide	Investigative
T00140	DRUGINFO	D02TLZ	3-Biphenyl-4-yl-N-hydroxy-N-methyl-acrylamide	Investigative
T00140	DRUGINFO	D08NDV	4-(1H-indol-3-yl)-1-morpholinobutan-1-one	Investigative
T00140	DRUGINFO	D0S6XY	4,5-Dihydroxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D08BNV	4,5-Dimethoxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D0J7AM	4-Bromo-N-hydroxy-benzamide	Investigative
T00140	DRUGINFO	D02RBU	4-Butoxy-N-hydroxy-N-methyl-benzamide	Investigative
T00140	DRUGINFO	D01QDG	4-Hydroxy-5-methoxy-10H-anthracen-9-one	Investigative
T00140	DRUGINFO	D0R2XE	4-Pentadeca-1,3,6-trienylsulfanyl-butyric acid	Investigative
T00140	DRUGINFO	D0AS0V	5,8-Dihydroxy-1,4-naphthoquinone	Investigative
T00140	DRUGINFO	D0U9UL	5-Chloro-N-(4-ethylphenyl)benzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D08HFK	5-Chloro-N-phenylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D0XL5D	5-Methoxy-N-phenylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D04IFV	5-Methyl-2-p-tolyl-thiazol-4-ol	Investigative
T00140	DRUGINFO	D0H4MV	5-Methyl-N-phenylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D07CJR	5S-HETE	Investigative
T00140	DRUGINFO	D02COM	7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30)	Investigative
T00140	DRUGINFO	D0NS1S	ACACETIN	Investigative
T00140	DRUGINFO	D09CXQ	Acanthus ilicifolius Linn	Investigative
T00140	DRUGINFO	D0C1XI	Acetic acid 2-phenyl-5-propyl-thiazol-4-yl ester	Investigative
T00140	DRUGINFO	D0G3VE	Acetic acid 5-butyl-2-phenyl-thiazol-4-yl ester	Investigative
T00140	DRUGINFO	D0CT9V	Anthracene-2-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D0C6BU	ANTHRONE	Investigative
T00140	DRUGINFO	D05QBX	Biphenyl-3-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D04XPJ	Biphenyl-4-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D0O7SM	BUDDLEDIN A	Investigative
T00140	DRUGINFO	D03QNE	BW A360C	Investigative
T00140	DRUGINFO	D0PU1J	BW B218C	Investigative
T00140	DRUGINFO	D0R2MQ	BW-858C	Investigative
T00140	DRUGINFO	D0M6UM	BW-A137C	Investigative
T00140	DRUGINFO	D0U2YL	CGS-23885	Investigative
T00140	DRUGINFO	D0J5OV	Chebulagic acid	Investigative
T00140	DRUGINFO	D0K3AO	CYLINDOL A	Investigative
T00140	DRUGINFO	D00MIM	FR-122788	Investigative
T00140	DRUGINFO	D0UU1I	Heme	Investigative
T00140	DRUGINFO	D0T8TS	Hexanoic acid 2,5-diphenyl-thiazol-4-yl ester	Investigative
T00140	DRUGINFO	D09VTJ	Hyperforin	Investigative
T00140	DRUGINFO	D0F4HT	ICI-211965	Investigative
T00140	DRUGINFO	D00OWE	L-652,343	Investigative
T00140	DRUGINFO	D0E3CO	N-(2-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D0C4KD	N-(3-Bromophenyl)-5-methoxybenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D07XMM	N-(4-Ethylphenyl)-5-methylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D05GZI	N-(4-Ethylphenyl)benzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D04UJI	Naphthalene-2-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D0I9RY	N-Hydroxy-2-methyl-3-naphthalen-2-yl-acrylamide	Investigative
T00140	DRUGINFO	D0KB6Q	N-Hydroxy-2-naphthalen-2-yl-acetamide	Investigative
T00140	DRUGINFO	D09PDD	N-Hydroxy-3-naphthalen-2-yl-acrylamide	Investigative
T00140	DRUGINFO	D0T1HY	N-Hydroxy-3-naphthalen-2-yl-N-phenyl-acrylamide	Investigative
T00140	DRUGINFO	D06AFD	N-Hydroxy-3-naphthalen-2-yl-N-p-tolyl-acrylamide	Investigative
T00140	DRUGINFO	D0H7UQ	N-Hydroxy-3-naphthalen-2-yl-propionamide	Investigative
T00140	DRUGINFO	D07MYE	N-Hydroxy-3-phenyl-acrylamide	Investigative
T00140	DRUGINFO	D03HNC	N-hydroxy-4-(naphthalen-1-yl)benzamide	Investigative
T00140	DRUGINFO	D06MUA	N-Hydroxy-4-iodo-benzamide	Investigative
T00140	DRUGINFO	D0L3BQ	N-Hydroxy-4-isobutyl-benzamide	Investigative
T00140	DRUGINFO	D0K7XU	N-Hydroxy-4-naphthalen-2-yl-benzamide	Investigative
T00140	DRUGINFO	D0K7XQ	N-hydroxy-N-[1-(4-isobutylphenyl)ethyl]urea	Investigative
T00140	DRUGINFO	D06GRW	N-Hydroxy-N-methyl-2,3,3-triphenyl-acrylamide	Investigative
T00140	DRUGINFO	D07PCS	N-Hydroxy-N-methyl-2-naphthalen-2-yl-propionamide	Investigative
T00140	DRUGINFO	D0V8UV	N-Hydroxy-N-methyl-3-naphthalen-1-yl-acrylamide	Investigative
T00140	DRUGINFO	D0E4JU	N-Hydroxy-N-methyl-3-naphthalen-2-yl-acrylamide	Investigative
T00140	DRUGINFO	D06KQD	N-Hydroxy-N-methyl-3-naphthalen-2-yl-propionamide	Investigative
T00140	DRUGINFO	D0C7GT	N-Hydroxy-N-methyl-3-phenanthren-2-yl-acrylamide	Investigative
T00140	DRUGINFO	D0E1NK	N-Hydroxy-N-methyl-3-phenanthren-3-yl-acrylamide	Investigative
T00140	DRUGINFO	D0O6OJ	N-Hydroxy-N-methyl-3-phenanthren-9-yl-acrylamide	Investigative
T00140	DRUGINFO	D0A2QP	N-Hydroxy-N-methyl-benzamide	Investigative
T00140	DRUGINFO	D00JPV	N-Phenylbenzo[d]oxazol-2-amine	Investigative
T00140	DRUGINFO	D0DP9F	Phenanthrene-2-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D04ZGR	Phenanthrene-3-carboxylic acid hydroxyamide	Investigative
T00140	DRUGINFO	D0P1LP	PHENIDONE	Investigative
T00140	DRUGINFO	D06TPF	PYROGALLOL	Investigative
T00140	DRUGINFO	D0Z0ZM	SB-202235	Investigative
T00140	DRUGINFO	D00XKA	SC-41661A	Investigative
T00140	DRUGINFO	D07LMV	SK&F 107649	Investigative
T00140	DRUGINFO	D01SQY	TZI-41127	Investigative
T00140	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T00140	KEGGPATH	hsa01100:Metabolic pathways		
T00140	KEGGPATH	hsa04726:Serotonergic synapse		
T00140	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T00140	KEGGPATH	hsa05145:Toxoplasmosis		
T00140	WIKIPATH	WP15:Selenium Micronutrient Network		
T00140	WIKIPATH	WP167:Eicosanoid Synthesis		
T00140	WIKIPATH	WP2650:Arachidonic acid metabolism		
T00140	WIKIPATH	WP2877:Vitamin D Receptor Pathway		
T00140	WHIZPATH	PW000044:Arachidonic Acid Metabolism		
T00140	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T00140	BIOCPATH	PWY66-375:Leukotriene biosynthesis		
T00140	BIOCPATH	PWY66-392:Lipoxin biosynthesis		
T00140	BIOCPATH	PWY66-393:Aspirin-triggered lipoxin biosynthesis		
T00140	BIOCPATH	PWY66-394:Aspirin triggered resolvin E biosynthesis		
T00140	BIOCPATH	PWY66-395:Aspirin triggered resolvin D biosynthesis		
T00140	BIOCPATH	PWY66-397:Resolvin D biosynthesis		
				
T57700	TARGETID	T57700		
T57700	FORMERID	TTDS00270		
T57700	UNIPROID	KIT_HUMAN		
T57700	TARGNAME	Tyrosine-protein kinase Kit (KIT)		
T57700	GENENAME	KIT		
T57700	TARGTYPE	Successful target		
T57700	SYNONYMS	v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; p145 c-kit; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; Mast/stem cell growth factor receptor Kit; CD117 antigen; CD117; C-kit		
T57700	FUNCTION	In response to KITLG/SCF binding, KIT can activate several signaling pathways. Phosphorylates PIK3R1, PLCG1, SH2B2/APS and CBL. Activates the AKT1 signaling pathway by phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase. Activated KIT also transmits signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3, STAT5A and STAT5B. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KIT signaling is modulated by protein phosphatases, and by rapid internalization and degradation of the receptor. Activated KIT promotes phosphorylation of the protein phosphatases PTPN6/SHP-1 and PTPRU, and of the transcription factors STAT1, STAT3, STAT5A and STAT5B. Promotes phosphorylation of PIK3R1, CBL, CRK (isoform Crk-II), LYN, MAPK1/ERK2 and/or MAPK3/ERK1, PLCG1, SRC and SHC1. Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine KITLG/SCF and plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis.		
T57700	PDBSTRUC	6GQM; 6GQL; 6GQK; 6GQJ; 4U0I		
T57700	BIOCLASS	Kinase		
T57700	ECNUMBER	EC 2.7.10.1		
T57700	SEQUENCE	MRGARGAWDFLCVLLLLLRVQTGSSQPSVSPGEPSPPSIHPGKSDLIVRVGDEIRLLCTDPGFVKWTFEILDETNENKQNEWITEKAEATNTGKYTCTNKHGLSNSIYVFVRDPAKLFLVDRSLYGKEDNDTLVRCPLTDPEVTNYSLKGCQGKPLPKDLRFIPDPKAGIMIKSVKRAYHRLCLHCSVDQEGKSVLSEKFILKVRPAFKAVPVVSVSKASYLLREGEEFTVTCTIKDVSSSVYSTWKRENSQTKLQEKYNSWHHGDFNYERQATLTISSARVNDSGVFMCYANNTFGSANVTTTLEVVDKGFINIFPMINTTVFVNDGENVDLIVEYEAFPKPEHQQWIYMNRTFTDKWEDYPKSENESNIRYVSELHLTRLKGTEGGTYTFLVSNSDVNAAIAFNVYVNTKPEILTYDRLVNGMLQCVAAGFPEPTIDWYFCPGTEQRCSASVLPVDVQTLNSSGPPFGKLVVQSSIDSSAFKHNGTVECKAYNDVGKTSAYFNFAFKGNNKEQIHPHTLFTPLLIGFVIVAGMMCIIVMILTYKYLQKPMYEVQWKVVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKQEDHAEAALYKNLLHSKESSCSDSTNEYMDMKPGVSYVVPTKADKRRSVRIGSYIERDVTPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHIYSNLANCSPNRQKPVVDHSVRINSVGSTASSSQPLLVHDDV		
T57700	DRUGINFO	D0AZ3C	Imatinib	Approved
T57700	DRUGINFO	D0F0ZY	Pazopanib HCl	Approved
T57700	DRUGINFO	D09TAB	Pexidartinib	Approved
T57700	DRUGINFO	D0H0EQ	Ponatinib	Approved
T57700	DRUGINFO	D09GDD	Regorafenib	Approved
T57700	DRUGINFO	D09AAK	Ripretinib	Approved
T57700	DRUGINFO	D01PZD	Romiplostim	Approved
T57700	DRUGINFO	D0W5HK	Sorafenib	Approved
T57700	DRUGINFO	D0Z6MT	Famitinib	Phase 2
T57700	DRUGINFO	D0T1GF	MP470	Phase 2
T57700	DRUGINFO	D00NSD	XL-820	Phase 2
T57700	DRUGINFO	D03MDY	PLX9486	Phase 1/2
T57700	DRUGINFO	D05CFQ	AMG-191	Phase 1
T57700	DRUGINFO	D0E0SH	CART-117 cells	Phase 1
T57700	DRUGINFO	D0N8RV	OSI-930	Phase 1
T57700	DRUGINFO	D0D3FB	PMID25656651-Compound-21a	Patented
T57700	DRUGINFO	D0XQ5F	PMID25656651-Compound-21b	Patented
T57700	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T57700	DRUGINFO	D0T7BE	Pyridine derivative 19	Patented
T57700	DRUGINFO	D0NB1V	Pyridine derivative 20	Patented
T57700	DRUGINFO	D0O0AW	Pyridine derivative 21	Patented
T57700	DRUGINFO	D0O4TA	Pyridine derivative 22	Patented
T57700	DRUGINFO	D00DQX	Motesanib	Discontinued in Phase 3
T57700	DRUGINFO	D0TS2B	CAR-T cells targeting CD117	Preclinical
T57700	DRUGINFO	D0Y9GK	4-(4-aminophenyl)-1H-indazol-3yl-amine	Investigative
T57700	DRUGINFO	D05FFB	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol	Investigative
T57700	DRUGINFO	D08ZWJ	9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	Investigative
T57700	DRUGINFO	D0T4SL	9-Methoxy-5,11-dimethyl-6H-pyrido[4,3-b]carbazole	Investigative
T57700	DRUGINFO	D0T2UB	APCK-110	Investigative
T57700	DRUGINFO	D0N7AJ	AST-487	Investigative
T57700	DRUGINFO	D0I3XZ	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Investigative
T57700	DRUGINFO	D05QBZ	CP-673451	Investigative
T57700	DRUGINFO	D0UN9O	GTP-14564	Investigative
T57700	DRUGINFO	D0Y4BL	JNJ-28312141	Investigative
T57700	DRUGINFO	D08BJR	Ki-20227	Investigative
T57700	DRUGINFO	D0P3JW	PD-0166326	Investigative
T57700	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T57700	DRUGINFO	D0T5OS	Phosphonotyrosine	Investigative
T57700	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T57700	DRUGINFO	D0BL0O	PMID23521020C7k	Investigative
T57700	DRUGINFO	D03SGF	WBZ-7	Investigative
T57700	KEGGPATH	hsa04014:Ras signaling pathway		
T57700	KEGGPATH	hsa04015:Rap1 signaling pathway		
T57700	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T57700	KEGGPATH	hsa04144:Endocytosis		
T57700	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T57700	KEGGPATH	hsa04640:Hematopoietic cell lineage		
T57700	KEGGPATH	hsa04916:Melanogenesis		
T57700	KEGGPATH	hsa05200:Pathways in cancer		
T57700	KEGGPATH	hsa05221:Acute myeloid leukemia		
T57700	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T57700	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T57700	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase		
T57700	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T57700	WIKIPATH	WP2406:Cardiac Progenitor Differentiation		
T57700	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T57700	WIKIPATH	WP2713:Signaling by SCF-KIT		
T57700	WIKIPATH	WP2848:Differentiation Pathway		
T57700	WIKIPATH	WP304:Kit receptor signaling pathway		
T57700	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T57700	REACPATH	R-HSA-1433559:Regulation of KIT signaling		
T57700	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T57700	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T57700	NET_PATH	NetPath_15:IL3 Signaling Pathway		
T57700	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T57700	NET_PATH	NetPath_6:KitReceptor Signaling Pathway		
T57700	INTEPATH	cmyb_pathway:C-MYB transcription factor network		
T57700	INTEPATH	kitpathway:Signaling events mediated by Stem cell factor receptor (c-Kit)		
				
T85943	TARGETID	T85943		
T85943	FORMERID	TTDS00247		
T85943	UNIPROID	SRC_HUMAN		
T85943	TARGNAME	Proto-oncogene c-Src (SRC)		
T85943	GENENAME	SRC		
T85943	TARGTYPE	Successful target		
T85943	SYNONYMS	pp60c-src; Tyrosine kinase (pp60(src)); Src tyrosine kinase; SRC1; Proto-oncogene tyrosine-protein kinase Src; Pp60(src); P60-Src; C-src TK; C-Src		
T85943	FUNCTION	Participates in signaling pathways that control a diverse spectrum of biological activities including gene transcription, immune response, cell adhesion, cell cycle progression, apoptosis, migration, and transformation. Due to functional redundancy between members of the SRC kinase family, identification of the specific role of each SRC kinase is very difficult. SRC appears to be one of the primary kinases activated following engagement of receptors and plays a role in the activation of other protein tyrosine kinase (PTK) families. Receptor clustering or dimerization leads to recruitment of SRC to the receptor complexes where it phosphorylates the tyrosine residues within the receptor cytoplasmic domains. Plays an important role in the regulation of cytoskeletal organization through phosphorylation of specific substrates such as AFAP1. Phosphorylation of AFAP1 allows the SRC SH2 domain to bind AFAP1 and to localize to actin filaments. Cytoskeletal reorganization is also controlled through the phosphorylation of cortactin (CTTN). When cells adhere via focal adhesions to the extracellular matrix, signals are transmitted by integrins into the cell resulting in tyrosine phosphorylation of a number of focal adhesion proteins, including PTK2/FAK1 and paxillin (PXN). In addition to phosphorylating focal adhesion proteins, SRC is also active at the sites of cell-cell contact adherens junctions and phosphorylates substrates such as beta-catenin (CTNNB1), delta-catenin (CTNND1), and plakoglobin (JUP). Another type of cell-cell junction, the gap junction, is also a target for SRC, which phosphorylates connexin-43 (GJA1). SRC is implicated in regulation of pre-mRNA-processing and phosphorylates RNA-binding proteins such as KHDRBS1. Also plays a role in PDGF-mediated tyrosine phosphorylation of both STAT1 and STAT3, leading to increased DNA binding activity of these transcription factors. Involved in the RAS pathway through phosphorylation of RASA1 and RASGRF1. Plays a role in EGF-mediated calcium-activated chloride channel activation. Required for epidermal growth factor receptor (EGFR) internalization through phosphorylation of clathrin heavy chain (CLTC and CLTCL1) at 'Tyr-1477'. Involved in beta-arrestin (ARRB1 and ARRB2) desensitization through phosphorylation and activation of GRK2, leading to beta-arrestin phosphorylation and internalization. Has a critical role in the stimulation of the CDK20/MAPK3 mitogen-activated protein kinase cascade by epidermal growth factor. Might be involved not only in mediating the transduction of mitogenic signals at the level of the plasma membrane but also in controlling progression through the cell cycle via interaction with regulatory proteins in the nucleus. Plays an important role in osteoclastic bone resorption in conjunction with PTK2B/PYK2. Both the formation of a SRC-PTK2B/PYK2 complex and SRC kinase activity are necessary for this function. Recruited to activated integrins by PTK2B/PYK2, thereby phosphorylating CBL, which in turn induces the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in a signaling pathway that is critical for osteoclast function. Promotes energy production in osteoclasts by activating mitochondrial cytochrome C oxidase. Phosphorylates DDR2 on tyrosine residues, thereby promoting its subsequent autophosphorylation. Phosphorylates RUNX3 and COX2 on tyrosine residues, TNK2 on 'Tyr-284' and CBL on 'Tyr-731'. Enhances DDX58/RIG-I-elicited antiviral signaling. Phosphorylates PDPK1 at 'Tyr-9', 'Tyr-373' and 'Tyr-376'. Phosphorylates BCAR1 at 'Tyr-128'. Phosphorylates CBLC at multiple tyrosine residues, phosphorylation at 'Tyr-341' activates CBLC E3 activity. Involved in anchorage-independent cell growth. Required for podosome formation. Non-receptor protein tyrosine kinase which is activated following engagement of many different classes of cellular receptors including immune response receptors, integrins and other adhesion receptors, receptor protein tyrosine kinases, G protein-coupled receptors as well as cytokine receptors.		
T85943	PDBSTRUC	6EHJ; 6C4S; 6ATE; 4MXZ; 4MXY		
T85943	BIOCLASS	Kinase		
T85943	ECNUMBER	EC 2.7.10.2		
T85943	SEQUENCE	MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL		
T85943	DRUGINFO	D0OB0F	Bosutinib	Approved
T85943	DRUGINFO	D0E6XR	Dasatinib	Approved
T85943	DRUGINFO	D07DIM	Herbimycin A	Approved
T85943	DRUGINFO	D03MNN	SKI-758	Approved
T85943	DRUGINFO	D0G2CG	AL3818	Phase 3
T85943	DRUGINFO	D0J1GR	CP-868596	Phase 3
T85943	DRUGINFO	D0TY3L	KX-01	Phase 3
T85943	DRUGINFO	D0MW0N	Masitinib	Phase 3
T85943	DRUGINFO	D0M0XB	Saracatinib	Phase 2
T85943	DRUGINFO	DS7CY4	TPX-0046	Phase 1/2
T85943	DRUGINFO	D06CIJ	ISIS-CRP	Phase 1
T85943	DRUGINFO	D0RE4L	KX2-361	Phase 1
T85943	DRUGINFO	D05YEI	SUN-K0706	Phase 1
T85943	DRUGINFO	D7M8LI	TPX-0022	Phase 1
T85943	DRUGINFO	D0QD5Y	Aromatic bicyclic compound 1	Patented
T85943	DRUGINFO	D0VI7E	Aromatic bicyclic compound 2	Patented
T85943	DRUGINFO	D0M5AG	Aromatic bicyclic compound 3	Patented
T85943	DRUGINFO	D0M9YZ	Aromatic bicyclic compound 4	Patented
T85943	DRUGINFO	D0Q5JV	Aromatic bicyclic compound 5	Patented
T85943	DRUGINFO	D09RTW	Aromatic bicyclic compound 6	Patented
T85943	DRUGINFO	D02VDD	Deuterated 3-cyanoquinoline derivative 1	Patented
T85943	DRUGINFO	D07QBF	PMID28460551-Compound-6	Patented
T85943	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T85943	DRUGINFO	D09WPN	AP22408	Terminated
T85943	DRUGINFO	D0H8KG	PD166285	Terminated
T85943	DRUGINFO	D0R2AT	2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE	Investigative
T85943	DRUGINFO	D0P5ST	3-(3-aminobenzo[e][1,2,4]triazin-7-yl)phenol	Investigative
T85943	DRUGINFO	D0OG1Q	4-Chloro-5,7-diphenyl-7H-pyrrolo[2,3-d]pyrimidine	Investigative
T85943	DRUGINFO	D0H3XF	5,7-Diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol	Investigative
T85943	DRUGINFO	D07RQB	7-(naphthalen-2-yl)benzo[e][1,2,4]triazin-3-amine	Investigative
T85943	DRUGINFO	D0BS6R	A-420983	Investigative
T85943	DRUGINFO	D06WGX	A-770041	Investigative
T85943	DRUGINFO	D0K9TT	Ac-Cys-Ile-cyclo[Phe-Lys]-Tyr-Tyr	Investigative
T85943	DRUGINFO	D08AWZ	Ac-Cys-Ile-Phe(4-NO2)-Lys-Phe(4-NO2)-Tyr	Investigative
T85943	DRUGINFO	D0U1BA	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Phe(4-NO2)	Investigative
T85943	DRUGINFO	D0A5IW	Ac-Cys-Ile-Phe(4-NO2)-Lys-Tyr-Tyr	Investigative
T85943	DRUGINFO	D00JID	Ac-Cys-Ile-Tyr-Lys-Phe(4-Cl)-Tyr	Investigative
T85943	DRUGINFO	D0O8BX	Ac-Cys-Ile-Tyr-Lys-Phe(4-CN)-Tyr	Investigative
T85943	DRUGINFO	D04QEW	Ac-Cys-Ile-Tyr-Lys-Phe(4-I)-Tyr	Investigative
T85943	DRUGINFO	D08YUQ	Ac-Cys-Ile-Tyr-Lys-Phe(4-N3)-Tyr	Investigative
T85943	DRUGINFO	D06MYD	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Phe(4-NO2)	Investigative
T85943	DRUGINFO	D0GN1A	Ac-Cys-Ile-Tyr-Lys-Phe(4-NO2)-Tyr-Phe	Investigative
T85943	DRUGINFO	D0LK4J	Ac-Cys-Ile-Tyr-Lys-Tyr-Phe(4-NO2)	Investigative
T85943	DRUGINFO	D0D3RL	AP-24163	Investigative
T85943	DRUGINFO	D0D8OY	AP-24226	Investigative
T85943	DRUGINFO	D04QUI	BAS-00387275	Investigative
T85943	DRUGINFO	D01GNF	BAS-00387328	Investigative
T85943	DRUGINFO	D03GQI	BAS-00387347	Investigative
T85943	DRUGINFO	D07LYJ	BAS-00672722	Investigative
T85943	DRUGINFO	D0P2QG	BAS-01047341	Investigative
T85943	DRUGINFO	D0LP2M	BAS-01047655	Investigative
T85943	DRUGINFO	D0D8ZN	BAS-01373578	Investigative
T85943	DRUGINFO	D08WEV	BAS-0338868	Investigative
T85943	DRUGINFO	D09QKH	BAS-0338872	Investigative
T85943	DRUGINFO	D0A5MG	BAS-09534324	Investigative
T85943	DRUGINFO	D0J4RY	BAS-450225	Investigative
T85943	DRUGINFO	D01IDD	BAS-4844343	Investigative
T85943	DRUGINFO	D03OKV	BMS-279700	Investigative
T85943	DRUGINFO	D06QUQ	CGP 77675	Investigative
T85943	DRUGINFO	D0M9QM	CGP-191	Investigative
T85943	DRUGINFO	D0BU6T	CGP-62464	Investigative
T85943	DRUGINFO	D0W6WU	Cyclo[Ac-Cys-Ile-Phe]-Lys-Tyr-Tyr	Investigative
T85943	DRUGINFO	D0OB0M	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Phe]	Investigative
T85943	DRUGINFO	D0MI2W	Cyclo[Ac-Cys-Ile-Tyr-Lys-Tyr-Tyr]	Investigative
T85943	DRUGINFO	D0V6UC	Cysteine Sulfenic Acid	Investigative
T85943	DRUGINFO	D0N4FS	DPI59	Investigative
T85943	DRUGINFO	D00TVY	Glu-Pro-Gln-F2Pmp-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	Investigative
T85943	DRUGINFO	D06CYG	Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu	Investigative
T85943	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T85943	DRUGINFO	D05YQC	ISO24	Investigative
T85943	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T85943	DRUGINFO	D0Q7TO	K00244	Investigative
T85943	DRUGINFO	D0N8TQ	N-(4-(phenylamino)quinazolin-6-yl)acrylamide	Investigative
T85943	DRUGINFO	D03DEX	N6-Benzyl Adenosine-5'-Diphosphate	Investigative
T85943	DRUGINFO	D0X7IC	NG-25	Investigative
T85943	DRUGINFO	D0GT8N	NM-PP1	Investigative
T85943	DRUGINFO	D0S3FW	N-Phenyl-5-phenylimidazo[1,5-a]pyrazin-8-amine	Investigative
T85943	DRUGINFO	D0U7BY	Oxalic Acid	Investigative
T85943	DRUGINFO	D07HBR	PAS219	Investigative
T85943	DRUGINFO	D09WNM	PASBN	Investigative
T85943	DRUGINFO	D0P3JW	PD-0166326	Investigative
T85943	DRUGINFO	D0S1KJ	PD-0173952	Investigative
T85943	DRUGINFO	D03NPX	PD-0173955	Investigative
T85943	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T85943	DRUGINFO	D0Z7GH	PD-0173958	Investigative
T85943	DRUGINFO	D0OH3J	PD-0179483	Investigative
T85943	DRUGINFO	D0VF6E	PD173074	Investigative
T85943	DRUGINFO	D03XDN	PD-174265	Investigative
T85943	DRUGINFO	D0S9LT	Phenylphosphate	Investigative
T85943	DRUGINFO	D0T5OS	Phosphonotyrosine	Investigative
T85943	DRUGINFO	D08RZB	PMID15546730C2	Investigative
T85943	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T85943	DRUGINFO	D03EHM	PP121	Investigative
T85943	DRUGINFO	D0R7BX	RU78191	Investigative
T85943	DRUGINFO	D0AJ4T	RU78262	Investigative
T85943	DRUGINFO	D0D1FK	RU78299	Investigative
T85943	DRUGINFO	D02HOG	RU78300	Investigative
T85943	DRUGINFO	D0M5RA	RU78783	Investigative
T85943	DRUGINFO	D0U8UH	RU79072	Investigative
T85943	DRUGINFO	D0U5KF	RU79073	Investigative
T85943	DRUGINFO	D09NGN	RU79256	Investigative
T85943	DRUGINFO	D0KS2T	RU81843	Investigative
T85943	DRUGINFO	D02IYN	RU82129	Investigative
T85943	DRUGINFO	D03NCK	RU82197	Investigative
T85943	DRUGINFO	D0TC1E	RU82209	Investigative
T85943	DRUGINFO	D0R1PD	RU83876	Investigative
T85943	DRUGINFO	D0L4NP	RU84687	Investigative
T85943	DRUGINFO	D02TIO	RU85053	Investigative
T85943	DRUGINFO	D05GYO	RU85493	Investigative
T85943	DRUGINFO	D01JJR	RU90395	Investigative
T85943	DRUGINFO	D03YUW	SBB007833	Investigative
T85943	DRUGINFO	D0D9PD	SKS-927	Investigative
T85943	DRUGINFO	D0CE3R	SU 6656	Investigative
T85943	DRUGINFO	D0H1OK	TG-100435	Investigative
T85943	DRUGINFO	D0Y1SR	WH-4-023	Investigative
T85943	DRUGINFO	D01IZN	Y-c[D-Pen-(2')Nal-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D09DVB	Y-c[D-Pen-(2R,3R)-2-Me-(2')Nal-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D0B4PI	Y-c[D-Pen-(2R,3S)-2-Me-(2')Nal-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D0Q2UZ	Y-c[D-Pen-(2S,3R)-2-Me-(2')Nal-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D0W7LW	Y-c[D-Pen-(2S,3S)-2-Me-(2')Nal-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D07ERV	Y-c[D-Pen-(3,5-diI)Tyr-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D0A2LX	Y-c[D-Pen-(3-I)Tyr-GSFC]KR-NH2	Investigative
T85943	DRUGINFO	D02SRA	Y-c[D-Pen-D-(2')Nal-GSFC]KR-NH2	Investigative
T85943	KEGGPATH	hsa04012:ErbB signaling pathway		
T85943	KEGGPATH	hsa04015:Rap1 signaling pathway		
T85943	KEGGPATH	hsa04062:Chemokine signaling pathway		
T85943	KEGGPATH	hsa04144:Endocytosis		
T85943	KEGGPATH	hsa04370:VEGF signaling pathway		
T85943	KEGGPATH	hsa04510:Focal adhesion		
T85943	KEGGPATH	hsa04520:Adherens junction		
T85943	KEGGPATH	hsa04530:Tight junction		
T85943	KEGGPATH	hsa04540:Gap junction		
T85943	KEGGPATH	hsa04611:Platelet activation		
T85943	KEGGPATH	hsa04727:GABAergic synapse		
T85943	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T85943	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T85943	KEGGPATH	hsa04912:GnRH signaling pathway		
T85943	KEGGPATH	hsa04915:Estrogen signaling pathway		
T85943	KEGGPATH	hsa04917:Prolactin signaling pathway		
T85943	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T85943	KEGGPATH	hsa04921:Oxytocin signaling pathway		
T85943	KEGGPATH	hsa05100:Bacterial invasion of epithelial cells		
T85943	KEGGPATH	hsa05120:Epithelial cell signaling in Helicobacter pylori infection		
T85943	KEGGPATH	hsa05131:Shigellosis		
T85943	KEGGPATH	hsa05152:Tuberculosis		
T85943	KEGGPATH	hsa05161:Hepatitis B		
T85943	KEGGPATH	hsa05203:Viral carcinogenesis		
T85943	KEGGPATH	hsa05205:Proteoglycans in cancer		
T85943	WIKIPATH	WP138:Androgen receptor signaling pathway		
T85943	WIKIPATH	WP1539:Angiogenesis		
T85943	WIKIPATH	WP185:Integrin-mediated Cell Adhesion		
T85943	WIKIPATH	WP2018:RANKL/RANK Signaling Pathway		
T85943	WIKIPATH	WP2034:Leptin signaling pathway		
T85943	WIKIPATH	WP2035:FSH signaling pathway		
T85943	WIKIPATH	WP2038:Regulation of Microtubule Cytoskeleton		
T85943	WIKIPATH	WP2100:Arylhydrocarbon receptor (AhR) signaling pathway		
T85943	WIKIPATH	WP2203:TSLP Signaling Pathway		
T85943	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T85943	WIKIPATH	WP2324:AGE/RAGE pathway		
T85943	WIKIPATH	WP2332:Interleukin-11 Signaling Pathway		
T85943	WIKIPATH	WP2374:Oncostatin M Signaling Pathway		
T85943	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T85943	WIKIPATH	WP2380:BDNF signaling pathway		
T85943	WIKIPATH	WP244:Alpha 6 Beta 4 signaling pathway		
T85943	WIKIPATH	WP2571:Polycystic Kidney Disease Pathway		
T85943	WIKIPATH	WP2643:Nanoparticle-mediated activation of receptor signaling		
T85943	WIKIPATH	WP286:IL-3 Signaling Pathway		
T85943	WIKIPATH	WP2873:Aryl Hydrocarbon Receptor Pathway		
T85943	WIKIPATH	WP2876:Pregnane X Receptor pathway		
T85943	WIKIPATH	WP304:Kit receptor signaling pathway		
T85943	WIKIPATH	WP313:Signaling of Hepatocyte Growth Factor Receptor		
T85943	WIKIPATH	WP366:TGF beta Signaling Pathway		
T85943	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T85943	WIKIPATH	WP581:EPO Receptor Signaling		
T85943	WIKIPATH	WP61:Notch Signaling Pathway		
T85943	WIKIPATH	WP615:Senescence and Autophagy in Cancer		
T85943	WIKIPATH	WP673:ErbB Signaling Pathway		
T85943	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T85943	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T85943	INTEPATH	alphasynuclein_pathway:Alpha-synuclein signaling		
T85943	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T85943	INTEPATH	ar_nongenomic_pathway:Nongenotropic Androgen signaling		
T85943	INTEPATH	ar_tf_pathway:Regulation of Androgen receptor activity		
T85943	INTEPATH	arf6_pathway:Arf6 signaling events		
T85943	INTEPATH	avb3_integrin_pathway:Integrins in angiogenesis		
T85943	INTEPATH	cdc42_pathway:CDC42 signaling events		
T85943	INTEPATH	cxcr3pathway:CXCR3-mediated signaling events		
T85943	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T85943	INTEPATH	ecadherin_keratinocyte_pathway:E-cadherin signaling in keratinocytes		
T85943	INTEPATH	ecadherin_nascentaj_pathway:E-cadherin signaling in the nascent adherens junction		
T85943	INTEPATH	endothelinpathway:Endothelins		
T85943	INTEPATH	epha_fwdpathway:EPHA forward signaling		
T85943	INTEPATH	epha2_fwdpathway:EPHA2 forward signaling		
T85943	INTEPATH	ephbfwdpathway:EPHB forward signaling		
T85943	INTEPATH	ephrinbrevpathway:Ephrin B reverse signaling		
T85943	INTEPATH	er_nongenomic_pathway:Plasma membrane estrogen receptor signaling		
T85943	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T85943	INTEPATH	erbb1_internalization_pathway:Internalization of ErbB1		
T85943	INTEPATH	erbb1_receptor_proximal_pathway:EGF receptor (ErbB1) signaling pathway		
T85943	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T85943	INTEPATH	fak_pathway:Signaling events mediated by focal adhesion kinase		
T85943	INTEPATH	faspathway:FAS (CD95) signaling pathway		
T85943	INTEPATH	fgf_pathway:FGF signaling pathway		
T85943	INTEPATH	glypican_1pathway:Glypican 1 network		
T85943	INTEPATH	integrin_a4b1_pathway:Alpha4 beta1 integrin signaling events		
T85943	INTEPATH	integrin_a9b1_pathway:Alpha9 beta1 integrin signaling events		
T85943	INTEPATH	lysophospholipid_pathway:LPA receptor mediated events		
T85943	INTEPATH	met_pathway:Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)		
T85943	INTEPATH	nectin_pathway:Nectin adhesion pathway		
T85943	INTEPATH	netrin_pathway:Netrin-mediated signaling events		
T85943	INTEPATH	nfkappabatypicalpathway:Atypical NF-kappaB pathway		
T85943	INTEPATH	p38alphabetapathway:Regulation of p38-alpha and p38-beta		
T85943	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T85943	INTEPATH	pi3kciaktpathway:Class I PI3K signaling events mediated by Akt		
T85943	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T85943	INTEPATH	pi3kplctrkpathway:Trk receptor signaling mediated by PI3K and PLC-gamma		
T85943	INTEPATH	prlsignalingeventspathway:Signaling events mediated by PRL		
T85943	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T85943	INTEPATH	ret_pathway:Signaling events regulated by Ret tyrosine kinase		
T85943	INTEPATH	s1p_s1p3_pathway:S1P3 pathway		
T85943	INTEPATH	syndecan_2_pathway:Syndecan-2-mediated signaling events		
T85943	INTEPATH	syndecan_3_pathway:Syndecan-3-mediated signaling events		
T85943	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T85943	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T85943	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling		
T85943	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T85943	PANTPATH	P00005:Angiogenesis		
T85943	PANTPATH	P00012:Cadherin signaling pathway		
T85943	PANTPATH	P00034:Integrin signalling pathway		
T85943	PANTPATH	P00049:Parkinson disease		
T85943	PANTPATH	P06959:CCKR signaling map ST		
				
T51408	TARGETID	T51408		
T51408	FORMERID	TTDC00184		
T51408	UNIPROID	ADRB3_HUMAN		
T51408	TARGNAME	Adrenergic receptor beta-3 (ADRB3)		
T51408	GENENAME	ADRB3		
T51408	TARGTYPE	Successful target		
T51408	SYNONYMS	Beta3AR; Beta3-AR; Beta-3 adrenoreceptor; Beta-3 adrenoceptor; Beta-3 adrenergic receptor; B3AR; ADRB3R		
T51408	FUNCTION	Beta-3 is involved in the regulation of lipolysis and thermogenesis. Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins.		
T51408	PDBSTRUC	2CDW		
T51408	BIOCLASS	GPCR rhodopsin		
T51408	SEQUENCE	MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS		
T51408	DRUGINFO	D0D0YM	Amosulalol	Approved
T51408	DRUGINFO	D06RUL	Bitolterol	Approved
T51408	DRUGINFO	D0H5MB	Bopindolol	Approved
T51408	DRUGINFO	D0O5YZ	Mepindolol	Approved
T51408	DRUGINFO	D0X5UN	Mirabegron	Approved
T51408	DRUGINFO	D09SSC	Nipradilol	Approved
T51408	DRUGINFO	D03NOS	Rimiterol	Approved
T51408	DRUGINFO	D09GFL	Trihexyphenidyl	Approved
T51408	DRUGINFO	D0DH5X	Vibegron	Approved
T51408	DRUGINFO	D00GZW	ONO-2506	Phase 2/3
T51408	DRUGINFO	D00NNI	ASP-3652	Phase 2
T51408	DRUGINFO	D09PYV	AZ-40140	Phase 2
T51408	DRUGINFO	D07WHS	CL-316,243	Phase 2
T51408	DRUGINFO	D03FLT	CP-331684	Phase 2
T51408	DRUGINFO	D0A5EF	GW-427353	Phase 2
T51408	DRUGINFO	D0D1FC	LY-362884	Phase 2
T51408	DRUGINFO	D06UKG	LY-377604	Phase 2
T51408	DRUGINFO	D0U7HL	N-5984	Phase 2
T51408	DRUGINFO	D01VAP	YM-430	Phase 2
T51408	DRUGINFO	D0V9IE	ZD2079	Phase 2
T51408	DRUGINFO	D0W3UH	QLT-091568	Phase 1/2
T51408	DRUGINFO	D07NFW	BMS-196085	Phase 1
T51408	DRUGINFO	D03QKW	KUC-7483	Phase 1
T51408	DRUGINFO	D04UNO	KUL-7211	Phase 1
T51408	DRUGINFO	D03INQ	Laevo-Bambuterol	Phase 1
T51408	DRUGINFO	D05EPU	ZD7114	Phase 1
T51408	DRUGINFO	D0Y0GG	Epanolol	Discontinued in Preregistration
T51408	DRUGINFO	D01KKB	PW-2101	Discontinued in Preregistration
T51408	DRUGINFO	D0E8CZ	Amibegron	Discontinued in Phase 3
T51408	DRUGINFO	D0PU5L	Adaprolol maleate-SME	Discontinued in Phase 2
T51408	DRUGINFO	D0D5DE	ALPRENOXIME HYDROCHLORIDE	Discontinued in Phase 2
T51408	DRUGINFO	D02ZEM	OBERADILOL MONOETHYL MALEATE	Discontinued in Phase 2
T51408	DRUGINFO	D02RHV	PROXODOLOL	Discontinued in Phase 2
T51408	DRUGINFO	D01SWK	Rafabegron	Discontinued in Phase 2
T51408	DRUGINFO	D06TVC	Tienoxolol	Discontinued in Phase 2
T51408	DRUGINFO	D0X5ES	NCX 950	Discontinued in Phase 1/2
T51408	DRUGINFO	D0GT0Y	MN-246	Discontinued in Phase 1
T51408	DRUGINFO	D03ISE	PAFENOLOL	Discontinued in Phase 1
T51408	DRUGINFO	D04NXR	RO-16-8714	Discontinued in Phase 1
T51408	DRUGINFO	D00BKV	SB 418790	Discontinued in Phase 1
T51408	DRUGINFO	D08SIR	CL-314698	Preclinical
T51408	DRUGINFO	D00MIX	CP-114271	Preclinical
T51408	DRUGINFO	D03VGW	GCR-1087	Preclinical
T51408	DRUGINFO	D0MT5C	L-742791	Preclinical
T51408	DRUGINFO	D0WS1V	L-751250	Preclinical
T51408	DRUGINFO	D03GLM	BMS-210285	Terminated
T51408	DRUGINFO	D04DZE	BRL 26830A	Terminated
T51408	DRUGINFO	D0Y1PG	BRL 37344	Terminated
T51408	DRUGINFO	D06XAK	H-216/44	Terminated
T51408	DRUGINFO	D0V4FK	SM 11044	Terminated
T51408	DRUGINFO	D0I9QH	SR-58878	Terminated
T51408	DRUGINFO	D00TVI	SR-58894A	Terminated
T51408	DRUGINFO	D07HTM	(-)-Ro 363	Investigative
T51408	DRUGINFO	D0K6MI	[125I]ICYP	Investigative
T51408	DRUGINFO	D02VPW	[3H](-)CGP 12177	Investigative
T51408	DRUGINFO	D03BZW	[3H]CGP12177	Investigative
T51408	DRUGINFO	D0F7BV	1-(1H-Indol-4-yloxy)-3-phenethylamino-propan-2-ol	Investigative
T51408	DRUGINFO	D0A4FU	1-(2-allylphenoxy)-3-morpholinopropan-2-ol	Investigative
T51408	DRUGINFO	D04HXF	1-(2-isopropylphenoxy)-3-morpholinopropan-2-ol	Investigative
T51408	DRUGINFO	D0A9ED	Carazolol	Investigative
T51408	DRUGINFO	D07ZZG	cicloprolol	Investigative
T51408	DRUGINFO	D0G6RK	ER-23006	Investigative
T51408	DRUGINFO	D0C4NF	FMP-825	Investigative
T51408	DRUGINFO	D0V5OS	H87/07	Investigative
T51408	DRUGINFO	D0R2JT	iodocyanopindolol	Investigative
T51408	DRUGINFO	D0U5HS	L748328	Investigative
T51408	DRUGINFO	D03VHK	L-748337	Investigative
T51408	DRUGINFO	D02DKX	LK 204-545	Investigative
T51408	DRUGINFO	D00PLX	MystiLol	Investigative
T51408	DRUGINFO	D04UNE	NIHP	Investigative
T51408	DRUGINFO	D0JK0I	prenalterol	Investigative
T51408	DRUGINFO	D0XR9Z	SB251023	Investigative
T51408	DRUGINFO	D01OIV	T-0509	Investigative
T51408	DRUGINFO	D0S8RD	Trecadrine	Investigative
T51408	DRUGINFO	D07KMN	Trimetoquinol	Investigative
T51408	DRUGINFO	D01OIK	xamoterol	Investigative
T51408	DRUGINFO	D0A0KP	zinterol	Investigative
T51408	KEGGPATH	hsa04020:Calcium signaling pathway		
T51408	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T51408	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T51408	KEGGPATH	hsa04144:Endocytosis		
T51408	KEGGPATH	hsa04970:Salivary secretion		
T51408	WIKIPATH	WP1824:GPCR downstream signaling		
T51408	WIKIPATH	WP1825:GPCR ligand binding		
T51408	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T51408	WIKIPATH	WP536:Calcium Regulation in the Cardiac Cell		
T51408	WIKIPATH	WP58:Monoamine GPCRs		
T51408	REACPATH	R-HSA-390696:Adrenoceptors		
T51408	REACPATH	R-HSA-418555:G alpha (s) signalling events		
T51408	PANTPATH	P00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway		
T51408	PANTPATH	P04379:Beta3 adrenergic receptor signaling pathway		
				
T99089	TARGETID	T99089		
T99089	FORMERID	TTDS00346		
T99089	UNIPROID	BRAF_HUMAN		
T99089	TARGNAME	Serine/threonine-protein kinase B-raf (BRAF)		
T99089	GENENAME	BRAF		
T99089	TARGTYPE	Successful target		
T99089	SYNONYMS	V-Raf murine sarcoma viral oncogene homolog B1; RAFB1; Proto-oncogene B-Raf; P94; BRAF1; BRAF(V599E); BRAF serine/threonine kinase; B-raf protein; B-Raf		
T99089	FUNCTION	May play a role in the postsynaptic responses of hippocampal neuron. Phosphorylates MAP2K1, and thereby contributes to the MAP kinase signal transduction pathway. Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus.		
T99089	PDBSTRUC	6CAD; 6B8U; 5VYK; 5VR3; 5VAM		
T99089	BIOCLASS	Kinase		
T99089	ECNUMBER	EC 2.7.11.1		
T99089	SEQUENCE	MAALSGGGGGGAEPGQALFNGDMEPEAGAGAGAAASSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSSASMDTVTSSSSSSLSVLPSSLSVFQNPTDVARSNPKSPQKPIVRVFLPNKQRTVVPARCGVTVRDSLKKALMMRGLIPECCAVYRIQDGEKKPIGWDTDISWLTGEELHVEVLENVPLTTHNFVRKTFFTLAFCDFCRKLLFQGFRCQTCGYKFHQRCSTEVPLMCVNYDQLDLLFVSKFFEHHPIPQEEASLAETALTSGSSPSAPASDSIGPQILTSPSPSKSIPIPQPFRPADEDHRNQFGQRDRSSSAPNVHINTIEPVNIDDLIRDQGFRGDGGSTTGLSATPPASLPGSLTNVKALQKSPGPQRERKSSSSSEDRNRMKTLGRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPKIHRSASEPSLNRAGFQTEDFSLYACASPKTPIQAGGYGAFPVH		
T99089	DRUGINFO	D05ROI	Dabrafenib	Approved
T99089	DRUGINFO	D0TK7R	LGX818	Approved
T99089	DRUGINFO	D0Y9EW	Vemurafenib	Approved
T99089	DRUGINFO	D05HTS	PLX8394	Phase 2
T99089	DRUGINFO	D0M5XN	BGB-283	Phase 1/2
T99089	DRUGINFO	D04MXN	CEP-32496	Phase 1/2
T99089	DRUGINFO	DIS4N5	ABM-1310	Phase 1
T99089	DRUGINFO	D04AZM	ARQ 736	Phase 1
T99089	DRUGINFO	D0XL8W	ASN003	Phase 1
T99089	DRUGINFO	D0Z2FD	BMS-908662	Phase 1
T99089	DRUGINFO	D0G0PU	RO-5212054	Phase 1
T99089	DRUGINFO	D0RV7J	RG-7256	Discontinued in Phase 1
T99089	DRUGINFO	D03TTT	AR-00341677	Investigative
T99089	DRUGINFO	D0C0ZC	AZ-628	Investigative
T99089	KEGGPATH	hsa04010:MAPK signaling pathway		
T99089	KEGGPATH	hsa04012:ErbB signaling pathway		
T99089	KEGGPATH	hsa04015:Rap1 signaling pathway		
T99089	KEGGPATH	hsa04024:cAMP signaling pathway		
T99089	KEGGPATH	hsa04062:Chemokine signaling pathway		
T99089	KEGGPATH	hsa04068:FoxO signaling pathway		
T99089	KEGGPATH	hsa04150:mTOR signaling pathway		
T99089	KEGGPATH	hsa04270:Vascular smooth muscle contraction		
T99089	KEGGPATH	hsa04510:Focal adhesion		
T99089	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T99089	KEGGPATH	hsa04720:Long-term potentiation		
T99089	KEGGPATH	hsa04722:Neurotrophin signaling pathway		
T99089	KEGGPATH	hsa04726:Serotonergic synapse		
T99089	KEGGPATH	hsa04730:Long-term depression		
T99089	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T99089	KEGGPATH	hsa04910:Insulin signaling pathway		
T99089	KEGGPATH	hsa04914:Progesterone-mediated oocyte maturation		
T99089	KEGGPATH	hsa05034:Alcoholism		
T99089	KEGGPATH	hsa05160:Hepatitis C		
T99089	KEGGPATH	hsa05200:Pathways in cancer		
T99089	KEGGPATH	hsa05205:Proteoglycans in cancer		
T99089	KEGGPATH	hsa05210:Colorectal cancer		
T99089	KEGGPATH	hsa05211:Renal cell carcinoma		
T99089	KEGGPATH	hsa05212:Pancreatic cancer		
T99089	KEGGPATH	hsa05213:Endometrial cancer		
T99089	KEGGPATH	hsa05214:Glioma		
T99089	KEGGPATH	hsa05215:Prostate cancer		
T99089	KEGGPATH	hsa05216:Thyroid cancer		
T99089	KEGGPATH	hsa05218:Melanoma		
T99089	KEGGPATH	hsa05219:Bladder cancer		
T99089	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T99089	KEGGPATH	hsa05221:Acute myeloid leukemia		
T99089	KEGGPATH	hsa05223:Non-small cell lung cancer		
T99089	WIKIPATH	WP185:Integrin-mediated Cell Adhesion		
T99089	WIKIPATH	WP1873:NGF signalling via TRKA from the plasma membrane		
T99089	WIKIPATH	WP1911:Signaling by FGFR		
T99089	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T99089	WIKIPATH	WP2032:TSH signaling pathway		
T99089	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T99089	WIKIPATH	WP23:B Cell Receptor Signaling Pathway		
T99089	WIKIPATH	WP2355:Corticotropin-releasing hormone		
T99089	WIKIPATH	WP2571:Polycystic Kidney Disease Pathway		
T99089	WIKIPATH	WP2754:Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell		
T99089	WIKIPATH	WP2828:Bladder Cancer		
T99089	WIKIPATH	WP306:Focal Adhesion		
T99089	WIKIPATH	WP382:MAPK Signaling Pathway		
T99089	WIKIPATH	WP422:MAPK Cascade		
T99089	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T99089	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T99089	WIKIPATH	WP615:Senescence and Autophagy in Cancer		
T99089	WIKIPATH	WP712:Estrogen signaling pathway		
T99089	WIKIPATH	WP722:Serotonin HTR1 Group and FOS Pathway		
T99089	WIKIPATH	WP734:Serotonin Receptor 4/6/7 and NR3C Signaling		
T99089	WHIZPATH	PW000445:Intracellular Signalling Through Adenosine Receptor A2a and Adenosine		
T99089	WHIZPATH	PW000446:Intracellular Signalling Through Adenosine Receptor A2b and Adenosine		
T99089	REACPATH	R-HSA-1295596:Spry regulation of FGF signaling		
T99089	REACPATH	R-HSA-170968:Frs2-mediated activation		
T99089	REACPATH	R-HSA-170984:ARMS-mediated activation		
T99089	REACPATH	R-HSA-442742:CREB phosphorylation through the activation of Ras		
T99089	REACPATH	R-HSA-5673000:RAF activation		
T99089	REACPATH	R-HSA-5674135:MAP2K and MAPK activation		
T99089	REACPATH	R-HSA-5674499:Negative feedback regulation of MAPK pathway		
T99089	REACPATH	R-HSA-5675221:Negative regulation of MAPK pathway		
T99089	NET_PATH	NetPath_19:IL-7 Signaling Pathway		
T99089	INTEPATH	cdc42_pathway:CDC42 signaling events		
T99089	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T99089	INTEPATH	mapktrkpathway:Trk receptor signaling mediated by the MAPK pathway		
T99089	INTEPATH	mtor_4pathway:mTOR signaling pathway		
T99089	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T99089	INTEPATH	tcrraspathway:Ras signaling in the CD4+ TCR pathway		
T99089	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T99089	PANTPATH	P00005:Angiogenesis		
T99089	PANTPATH	P00034:Integrin signalling pathway		
T99089	PANTPATH	P00036:Interleukin signaling pathway		
T99089	PANTPATH	P00047:PDGF signaling pathway		
T99089	PANTPATH	P00053:T cell activation		
T99089	PANTPATH	P00056:VEGF signaling pathway		
T99089	PANTPATH	P04393:Ras Pathway		
T99089	PANTPATH	P06959:CCKR signaling map ST		
				
T26623	TARGETID	T26623		
T26623	FORMERID	TTDS00115		
T26623	UNIPROID	ALDR_HUMAN		
T26623	TARGNAME	Aldose reductase (AKR1B1)		
T26623	GENENAME	AKR1B1		
T26623	TARGTYPE	Successful target		
T26623	SYNONYMS	Aldehyde reductase; AKR1B1		
T26623	FUNCTION	Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.		
T26623	PDBSTRUC	6F8O; 6F84; 6F82; 6F81; 6F7R		
T26623	BIOCLASS	Short-chain dehydrogenases reductase		
T26623	ECNUMBER	EC 1.1.1.300		
T26623	SEQUENCE	MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQEKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGKEFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKPAVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAKHNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCALLSCTSHKDYPFHEEF		
T26623	DRUGINFO	D03KOZ	Epalrestat	Approved
T26623	DRUGINFO	D0Z5IU	Sulindac	Approved
T26623	DRUGINFO	D00EWR	Fidarestat	Phase 3
T26623	DRUGINFO	D0K8TI	Ranirestat	Phase 3
T26623	DRUGINFO	D4PL6G	BNV-222	Phase 2/3
T26623	DRUGINFO	D04PBH	CONTIGOSIDE B	Phase 2/3
T26623	DRUGINFO	D0P7SO	ADMVA	Phase 2
T26623	DRUGINFO	D04BFU	LIDORESTAT	Phase 2
T26623	DRUGINFO	D0V4UO	M-16209	Phase 2
T26623	DRUGINFO	D0B4XX	QR-333	Phase 2
T26623	DRUGINFO	D00QKL	T2c-003	Phase 1/2
T26623	DRUGINFO	D07DIX	ALO-1567	Phase 1
T26623	DRUGINFO	D0Q7QY	SSR-125047	Phase 1
T26623	DRUGINFO	D0Q7AW	IMIRESTAT	Discontinued in Phase 3
T26623	DRUGINFO	D0J6JZ	MINALRESTAT	Discontinued in Phase 3
T26623	DRUGINFO	D0U9TM	Ponalrestat	Discontinued in Phase 3
T26623	DRUGINFO	D0O2ET	AD-5467	Discontinued in Phase 2
T26623	DRUGINFO	D03PIB	Alrestatin	Discontinued in Phase 2
T26623	DRUGINFO	D0E0FY	CTL-102-GDEPT	Discontinued in Phase 2
T26623	DRUGINFO	D08VMO	JTT-811	Discontinued in Phase 2
T26623	DRUGINFO	D06EDT	ZOPOLRESTAT	Discontinued in Phase 2
T26623	DRUGINFO	D0M9RE	ARI-809	Preclinical
T26623	DRUGINFO	D0B0GC	E-0722	Terminated
T26623	DRUGINFO	D0RZ0N	FR-62765	Terminated
T26623	DRUGINFO	D02CGC	Sorbinil	Terminated
T26623	DRUGINFO	D0E6LC	SPR-210	Terminated
T26623	DRUGINFO	D09BHF	WF-2421	Terminated
T26623	DRUGINFO	D0C7KK	Zenarestat	Terminated
T26623	DRUGINFO	D0IF8Z	(4-Methyl-2-oxo-2H-quinolin-1-yl)-acetic acid	Investigative
T26623	DRUGINFO	D0F6TM	(6-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Investigative
T26623	DRUGINFO	D0J7MD	(6-Methoxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Investigative
T26623	DRUGINFO	D07GTX	(8-Hydroxy-2-oxo-2H-quinolin-1-yl)-acetic acid	Investigative
T26623	DRUGINFO	D0A9NE	2-(3,4-Dihydroxy-benzyl)-7-hydroxy-chromen-4-one	Investigative
T26623	DRUGINFO	D0YJ3Q	2-(3,4-Dihydroxy-phenyl)-7-hydroxy-chromen-4-one	Investigative
T26623	DRUGINFO	D03LRQ	2-(3-benzoyl-1H-pyrrol-1-yl)acetic acid	Investigative
T26623	DRUGINFO	D01UNC	2-(4-aminophenylsulfonamido)acetic acid	Investigative
T26623	DRUGINFO	D04YIV	2-(Phenylsulfonamido)acetic Acid	Investigative
T26623	DRUGINFO	D09PNQ	2,3-dihydroxypropanal	Investigative
T26623	DRUGINFO	D04GYD	2-Benzhydryl-7-hydroxy-chromen-4-one	Investigative
T26623	DRUGINFO	D0QP9D	2-Benzyl-7-hydroxy-chromen-4-one	Investigative
T26623	DRUGINFO	D0J2FY	2'-Monophosphoadenosine 5'-Diphosphoribose	Investigative
T26623	DRUGINFO	D0CX4E	3-(3-Benzoyl-1H-pyrrol-1-yl)propanoic acid	Investigative
T26623	DRUGINFO	D06SPO	3,5-dichlorosalicylic acid	Investigative
T26623	DRUGINFO	D0T2TW	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	Investigative
T26623	DRUGINFO	D0G4CJ	4-(3-Benzoyl-1H-pyrrol-1-yl)butanoic acid	Investigative
T26623	DRUGINFO	D08ZZX	4-(3-Methoxy-phenyl)-isoxazolidine-3,5-dione	Investigative
T26623	DRUGINFO	D0A2FM	6-(1H-Indole-2-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0O9KV	6-(2-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D00EPD	6-(2-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D06YQS	6-(2-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0R7IJ	6-(3-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0Y7PW	6-(4-Bromo-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D02AAH	6-(4-Chloro-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0XD1Q	6-(4-Fluoro-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0P3AU	6-(4-Methoxy-benzenesulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0R3MB	6-(Benzofuran-2-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D02WZA	6-(Benzothiazole-2-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D07XXK	6-(Biphenyl-2-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0P1ZM	6-(Naphthalene-1-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D08JEI	6-(Naphthalene-2-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D0IB8C	6-(Toluene-4-sulfonyl)-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D05HBF	6,7-Dihydroxy-2-phenyl-chromen-4-one	Investigative
T26623	DRUGINFO	D0OZ4C	6-Benzenesulfonyl-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D08MHU	6-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	Investigative
T26623	DRUGINFO	D03NEF	6-methoxykaempferol 3-O-beta-D-robinobioside	Investigative
T26623	DRUGINFO	D03YBR	6-Phenylmethanesulfonyl-2H-pyridazin-3-one	Investigative
T26623	DRUGINFO	D00WFB	7-Hydroxy-2-(4-hydroxy-benzyl)-chromen-4-one	Investigative
T26623	DRUGINFO	D05SLZ	7-Hydroxy-2-(4-methoxy-benzyl)-chromen-4-one	Investigative
T26623	DRUGINFO	D0OC4B	7-Hydroxy-4-phenylcoumarin	Investigative
T26623	DRUGINFO	D0L7MI	7-Hydroxy-6-nitro-2-phenyl-chromen-4-one	Investigative
T26623	DRUGINFO	D0K8NO	AK198	Investigative
T26623	DRUGINFO	D01AWD	Alpha-D-Glucose-6-Phosphate	Investigative
T26623	DRUGINFO	D00RIX	APIGENIN	Investigative
T26623	DRUGINFO	D01LWJ	Apigenin-7-O-beta-D-glucuronide	Investigative
T26623	DRUGINFO	D0BH6B	Apigenin-7-O-beta-D-glucuronide methyl ester	Investigative
T26623	DRUGINFO	D08BFU	ASTRAGALIN	Investigative
T26623	DRUGINFO	D0R3OQ	BNV-222	Investigative
T26623	DRUGINFO	D01UYI	Chrysin	Investigative
T26623	DRUGINFO	D0SY2M	daidzein	Investigative
T26623	DRUGINFO	D0A4LM	EPALRESTATE	Investigative
T26623	DRUGINFO	D00KCB	Fidarestat(Stereoisomer)	Investigative
T26623	DRUGINFO	D06YEV	Hydroxydimethylarsine Oxide	Investigative
T26623	DRUGINFO	D07JEY	IDD552	Investigative
T26623	DRUGINFO	D0FJ7G	IDD594	Investigative
T26623	DRUGINFO	D00VHG	Inhibitor Idd 384	Investigative
T26623	DRUGINFO	D08NKL	Isorhamnetin 3,7-disulfate	Investigative
T26623	DRUGINFO	D0J7VA	Isorhamnetin 3-O-rhamnoside	Investigative
T26623	DRUGINFO	D0G3TK	KAEMPFEROL	Investigative
T26623	DRUGINFO	D04UYB	MANGIFERIN	Investigative
T26623	DRUGINFO	D09MYF	N-Acetylalanine	Investigative
T26623	DRUGINFO	D01KKU	NSC-94258	Investigative
T26623	DRUGINFO	D08OYH	O5-Acetyl-O7-nitrooxyethyl chrysin	Investigative
T26623	DRUGINFO	D01KAM	O7-Nitrooxyethyl chrysin	Investigative
T26623	DRUGINFO	D03DEO	PALBINONE	Investigative
T26623	DRUGINFO	D0Z3FX	Patuletin 3-O-beta-D-galactoside	Investigative
T26623	DRUGINFO	D08DRD	Patuletin 3-O-beta-D-robinobioside	Investigative
T26623	DRUGINFO	D0G1OW	Quercetin 3-O-neohesperidoside	Investigative
T26623	DRUGINFO	D07DJS	QUERCITRIN	Investigative
T26623	DRUGINFO	D0U8GZ	Tamarixetin 3-glucoside-7-sulfate	Investigative
T26623	DRUGINFO	D0BU5K	TINGENIN B	Investigative
T26623	DRUGINFO	D0F6AI	TINGENONE	Investigative
T26623	DRUGINFO	D02DYB	TRIPTOCALLINE A	Investigative
T26623	KEGGPATH	hsa00040:Pentose and glucuronate interconversions		
T26623	KEGGPATH	hsa00051:Fructose and mannose metabolism		
T26623	KEGGPATH	hsa00052:Galactose metabolism		
T26623	KEGGPATH	hsa00561:Glycerolipid metabolism		
T26623	KEGGPATH	hsa01100:Metabolic pathways		
T26623	WIKIPATH	WP2749:Metabolism of steroid hormones and vitamin D		
T26623	WIKIPATH	WP690:Polyol Pathway		
T26623	WIKIPATH	WP702:Metapathway biotransformation		
T26623	WHIZPATH	PW000025:Fructose and Mannose Degradation		
T26623	WHIZPATH	PW000054:Pyruvate Metabolism		
T26623	WHIZPATH	PW000140:Pterine Biosynthesis		
T26623	WHIZPATH	PW000144:Glycerolipid Metabolism		
T26623	WHIZPATH	PW000159:Galactose Metabolism		
T26623	NET_PATH	NetPath_13:IL1 Signaling Pathway		
T26623	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T26623	BIOCPATH	PWY-5451:Acetone degradation I (to methylglyoxal)		
T26623	BIOCPATH	PWY-5453:Methylglyoxal degradation III		
				
T53524	TARGETID	T53524		
T53524	FORMERID	TTDC00311		
T53524	UNIPROID	PGFRA_HUMAN		
T53524	TARGNAME	Platelet-derived growth factor receptor alpha (PDGFRA)		
T53524	GENENAME	PDGFRA		
T53524	TARGTYPE	Successful target		
T53524	SYNONYMS	RHEPDGFRA; Platelet-derived growth factor receptor 2; Platelet-derived growth factor alpha receptor; PDGFR2; PDGFR-alpha; PDGFR-2; PDGF-R-alpha; CD140a antigen; CD140a; CD140 antigen-like family member A; Alpha-type platelet-derived growth factor receptor; Alpha platelet-derived growth factor receptor		
T53524	FUNCTION	Depending on the context, promotes or inhibits cell proliferation and cell migration. Plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells. Required for normal skeleton development and cephalic closure during embryonic development. Required for normal development of the mucosa lining the gastrointestinal tract, and for recruitment of mesenchymal cells and normal development of intestinal villi. Plays a role in cell migration and chemotaxis in wound healing. Plays a role in platelet activation, secretion of agonists from platelet granules, and in thrombin-induced platelet aggregation. Binding of its cognate ligands - homodimeric PDGFA, homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFC -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PIK3R1, PLCG1, and PTPN11. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylates PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and thereby mediates activation of the AKT1 signaling pathway. Mediates activation of HRAS and of the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. Promotes activation of STAT family members STAT1, STAT3 and STAT5A and/or STAT5B. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. Tyrosine-protein kinase that acts as a cell-surface receptor for PDGFA, PDGFB and PDGFC and plays an essential role in the regulation of embryonic development, cell proliferation, survival and chemotaxis.		
T53524	PDBSTRUC	5K5X; 5GRN; 1GQ5		
T53524	BIOCLASS	Kinase		
T53524	ECNUMBER	EC 2.7.10.1		
T53524	SEQUENCE	MGTSHPAFLVLGCLLTGLSLILCQLSLPSILPNENEKVVQLNSSFSLRCFGESEVSWQYPMSEEESSDVEIRNEENNSGLFVTVLEVSSASAAHTGLYTCYYNHTQTEENELEGRHIYIYVPDPDVAFVPLGMTDYLVIVEDDDSAIIPCRTTDPETPVTLHNSEGVVPASYDSRQGFNGTFTVGPYICEATVKGKKFQTIPFNVYALKATSELDLEMEALKTVYKSGETIVVTCAVFNNEVVDLQWTYPGEVKGKGITMLEEIKVPSIKLVYTLTVPEATVKDSGDYECAARQATREVKEMKKVTISVHEKGFIEIKPTFSQLEAVNLHEVKHFVVEVRAYPPPRISWLKNNLTLIENLTEITTDVEKIQEIRYRSKLKLIRAKEEDSGHYTIVAQNEDAVKSYTFELLTQVPSSILDLVDDHHGSTGGQTVRCTAEGTPLPDIEWMICKDIKKCNNETSWTILANNVSNIITEIHSRDRSTVEGRVTFAKVEETIAVRCLAKNLLGAENRELKLVAPTLRSELTVAAAVLVLLVIVIISLIVLVVIWKQKPRYEIRWRVIESISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRVLGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDSFLSHHPEKPKKELDIFGLNPADESTRSYVILSFENNGDYMDMKQADTTQYVPMLERKEVSKYSDIQRSLYDRPASYKKKSMLDSEVKNLLSDDNSEGLTLLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMMVDSTFYNKIKSGYRMAKPDHATSEVYEIMVKCWNSEPEKRPSFYHLSEIVENLLPGQYKKSYEKIHLDFLKSDHPAVARMRVDSDNAYIGVTYKNEEDKLKDWEGGLDEQRLSADSGYIIPLPDIDPVPEEEDLGKRNRHSSQTSEESAIETGSSSSTFIKREDETIEDIDMMDDIGIDSSDLVEDSFL		
T53524	DRUGINFO	D0UO2P	Avapritinib	Approved
T53524	DRUGINFO	D09QZS	Olaratumab	Approved
T53524	DRUGINFO	D09AAK	Ripretinib	Approved
T53524	DRUGINFO	D01PZD	Romiplostim	Approved
T53524	DRUGINFO	D0J1GR	CP-868596	Phase 3
T53524	DRUGINFO	D02WVT	E-3810	Phase 3
T53524	DRUGINFO	D0Z6MT	Famitinib	Phase 2
T53524	DRUGINFO	D0AG7N	MEDI-575	Phase 2
T53524	DRUGINFO	D0T1GF	MP470	Phase 2
T53524	DRUGINFO	D00NSD	XL-820	Phase 2
T53524	DRUGINFO	D0IH3I	PMID28460551-Compound-1	Patented
T53524	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T53524	DRUGINFO	D0T7BE	Pyridine derivative 19	Patented
T53524	DRUGINFO	D0NB1V	Pyridine derivative 20	Patented
T53524	DRUGINFO	D0O0AW	Pyridine derivative 21	Patented
T53524	DRUGINFO	D0O4TA	Pyridine derivative 22	Patented
T53524	DRUGINFO	D00QCB	SRI-62-834	Discontinued in Phase 2
T53524	DRUGINFO	D0KX1E	CEP-2563	Discontinued in Phase 1
T53524	DRUGINFO	D06GBK	AG1295	Terminated
T53524	DRUGINFO	D03WTT	RG-13022	Terminated
T53524	DRUGINFO	D09OLH	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D0G0KQ	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D0D7ZL	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D0H7MF	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D0XS9E	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D00YCU	1-Phenyl-1H-benzoimidazol-5-ol	Investigative
T53524	DRUGINFO	D01FWD	1-Phenyl-1H-benzoimidazole	Investigative
T53524	DRUGINFO	D07JDY	3-((E)-Styryl)-quinoline	Investigative
T53524	DRUGINFO	D06MCJ	3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0GN3E	3-(1H-Indol-3-yl)-quinoline	Investigative
T53524	DRUGINFO	D0K9ON	3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0P0RD	3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0AO6T	3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D08SUH	3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0A6YP	3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0I0GL	3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D06VNR	3-Benzyloxy-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D08KWL	3-Cyclohexylethynyl-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0KF3N	3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D00LRC	3-Cyclopentyl-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0IR5I	3-Pyridin-3-yl-quinoline-6,7-diol	Investigative
T53524	DRUGINFO	D0H9TO	3-Pyridin-4-yl-quinolin-7-ol	Investigative
T53524	DRUGINFO	D0Q3DS	3-Pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0K9VE	3-Pyridin-4-yl-quinoline-5,7-diol	Investigative
T53524	DRUGINFO	D05GBY	3-Thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0YE1X	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T53524	DRUGINFO	D0K2YG	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	Investigative
T53524	DRUGINFO	D03MQI	4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid	Investigative
T53524	DRUGINFO	D0H4JB	4-(6,7-Dimethoxy-quinolin-3-yl)-phenol	Investigative
T53524	DRUGINFO	D01MUN	4-Benzoimidazol-1-yl-phenylamine	Investigative
T53524	DRUGINFO	D01UYS	5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one	Investigative
T53524	DRUGINFO	D05FFB	5,11-Dimethyl-6H-pyrido[4,3-b]carbazol-9-ol	Investigative
T53524	DRUGINFO	D0SG0G	5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0P0WT	5,7-Dimethoxy-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0RD5S	5,7-Dimethoxy-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D07ZWN	5,7-Dimethyl-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0N4VR	5-Fluoro-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D02XKJ	5-Methoxy-1-phenyl-1H-benzoimidazole	Investigative
T53524	DRUGINFO	D0CF9B	6,7-Dichloro-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0QT4X	6,7-Difluoro-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D06LLF	6,7-Dimethoxy-3-((E)-styryl)-quinoline	Investigative
T53524	DRUGINFO	D05EDW	6,7-Dimethoxy-3-(2-methoxy-phenyl)-quinoline	Investigative
T53524	DRUGINFO	D07CFT	6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline	Investigative
T53524	DRUGINFO	D0G0KN	6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline	Investigative
T53524	DRUGINFO	D08JGS	6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline	Investigative
T53524	DRUGINFO	D0WW8M	6,7-Dimethoxy-3-phenylethynyl-quinoline	Investigative
T53524	DRUGINFO	D0G6SA	6,7-Dimethoxy-3-phenyl-quinoline	Investigative
T53524	DRUGINFO	D0C1BE	6,7-Dimethoxy-3-p-tolyl-quinoline	Investigative
T53524	DRUGINFO	D00RBV	6,7-Dimethoxy-3-pyridin-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0T9FQ	6,7-Dimethoxy-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0G0ZQ	6,7-Dimethoxy-3-thiophen-2-yl-quinoline	Investigative
T53524	DRUGINFO	D04PQX	6-Methoxy-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0W7IN	6-Methoxy-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0Z4HV	7-Chloro-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D05SNG	7-Fluoro-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D02PZZ	7-Methoxy-3-pyridin-4-yl-quinoline	Investigative
T53524	DRUGINFO	D0V8QI	7-Methoxy-3-thiophen-3-yl-quinoline	Investigative
T53524	DRUGINFO	D0A6AA	7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline	Investigative
T53524	DRUGINFO	D02CUF	Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine	Investigative
T53524	DRUGINFO	D0I3XZ	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Investigative
T53524	DRUGINFO	D0M4SY	BMS-536924	Investigative
T53524	DRUGINFO	D05QBZ	CP-673451	Investigative
T53524	DRUGINFO	D03DJR	D-65476	Investigative
T53524	DRUGINFO	D0G5YI	Di(1H-indol-2-yl)methanone	Investigative
T53524	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T53524	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T53524	DRUGINFO	D0P3JW	PD-0166326	Investigative
T53524	DRUGINFO	D0S1KJ	PD-0173952	Investigative
T53524	DRUGINFO	D03NPX	PD-0173955	Investigative
T53524	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T53524	DRUGINFO	D0Z7GH	PD-0173958	Investigative
T53524	DRUGINFO	D0OH3J	PD-0179483	Investigative
T53524	DRUGINFO	D02BXJ	PMID21561767C8h	Investigative
T53524	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T53524	DRUGINFO	D03EHM	PP121	Investigative
T53524	DRUGINFO	D09XIL	Ro-4396686	Investigative
T53524	DRUGINFO	D0W9BF	RPR-101511	Investigative
T53524	DRUGINFO	D0FH3M	RPR-108514A	Investigative
T53524	DRUGINFO	D09LPL	SU-11652	Investigative
T53524	KEGGPATH	hsa04010:MAPK signaling pathway		
T53524	KEGGPATH	hsa04014:Ras signaling pathway		
T53524	KEGGPATH	hsa04015:Rap1 signaling pathway		
T53524	KEGGPATH	hsa04020:Calcium signaling pathway		
T53524	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T53524	KEGGPATH	hsa04144:Endocytosis		
T53524	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T53524	KEGGPATH	hsa04510:Focal adhesion		
T53524	KEGGPATH	hsa04540:Gap junction		
T53524	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T53524	KEGGPATH	hsa05166:HTLV-I infection		
T53524	KEGGPATH	hsa05200:Pathways in cancer		
T53524	KEGGPATH	hsa05206:MicroRNAs in cancer		
T53524	KEGGPATH	hsa05214:Glioma		
T53524	KEGGPATH	hsa05215:Prostate cancer		
T53524	KEGGPATH	hsa05218:Melanoma		
T53524	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T53524	KEGGPATH	hsa05231:Choline metabolism in cancer		
T53524	WIKIPATH	WP1539:Angiogenesis		
T53524	WIKIPATH	WP1916:Signaling by PDGF		
T53524	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T53524	WIKIPATH	WP2328:Allograft Rejection		
T53524	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T53524	WIKIPATH	WP2406:Cardiac Progenitor Differentiation		
T53524	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T53524	WIKIPATH	WP2839:Hair Follicle Development: Organogenesis (Part 2 of 3)		
T53524	WIKIPATH	WP306:Focal Adhesion		
T53524	WIKIPATH	WP322:Osteoblast Signaling		
T53524	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T53524	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T53524	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T53524	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T53524	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T53524	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T53524	INTEPATH	pdgf_pathway:PDGF receptor signaling network		
T53524	INTEPATH	pdgfrapathway:PDGFR-alpha signaling pathway		
T53524	PANTPATH	P00005:Angiogenesis		
T53524	PANTPATH	P00047:PDGF signaling pathway		
				
T83875	TARGETID	T83875		
T83875	FORMERID	TTDS00289		
T83875	UNIPROID	AOFA_HUMAN		
T83875	TARGNAME	Monoamine oxidase type A (MAO-A)		
T83875	GENENAME	MAOA		
T83875	TARGTYPE	Successful target		
T83875	SYNONYMS	Monoamine oxidase A; Amine oxidase [flavin-containing] A		
T83875	FUNCTION	MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine. Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues.		
T83875	PDBSTRUC	2Z5Y; 2Z5X; 2BXS; 2BXR; 1H8Q		
T83875	BIOCLASS	CH-NH(2) donor oxidoreductase		
T83875	ECNUMBER	EC 1.4.3.4		
T83875	SEQUENCE	MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHVDYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRGAFPPVWNPIAYLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNINVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKLNHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPMGAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADRLAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYGRVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKDVPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLLPRS		
T83875	DRUGINFO	D09QDP	Clorgyline	Approved
T83875	DRUGINFO	D0I2VK	Isocarboxazid	Approved
T83875	DRUGINFO	D01ZSO	Moclobemide	Approved
T83875	DRUGINFO	D0H0HJ	Tranylcypromine	Approved
T83875	DRUGINFO	D00VUI	Psoralen	Phase 3
T83875	DRUGINFO	D08CJK	TRYPTAMINE	Phase 3
T83875	DRUGINFO	D04RCT	CHF-3381	Phase 2
T83875	DRUGINFO	D00RWQ	CX157	Phase 2
T83875	DRUGINFO	D0C3UC	Ladostigil	Phase 2
T83875	DRUGINFO	D0H7PW	PIPERINE	Phase 1/2
T83875	DRUGINFO	D0T5AW	Desoxypeganine	Phase 1
T83875	DRUGINFO	D0XY6I	AphanamgrandiolA	Patented
T83875	DRUGINFO	D04OEV	Cyclic peptide derivative 1	Patented
T83875	DRUGINFO	D03YOU	GypensapogeninA	Patented
T83875	DRUGINFO	D0R2YC	GypensapogeninB	Patented
T83875	DRUGINFO	D00OWF	Harmine	Patented
T83875	DRUGINFO	D07NTA	Heteroaryl-cyclopropylamine derivative 1	Patented
T83875	DRUGINFO	D0P1PC	HouttuynoidA	Patented
T83875	DRUGINFO	D0LZ2M	IncarviatoneA	Patented
T83875	DRUGINFO	D0G3TH	KadcoccitoneA	Patented
T83875	DRUGINFO	D0I9CK	MyriberineA	Patented
T83875	DRUGINFO	D08IOP	N-(2-phenylcyclopropyl) amino acid derivative 3	Patented
T83875	DRUGINFO	D07MEE	PhyllanthoidA	Patented
T83875	DRUGINFO	D0TX9E	PMID25399762-Compound-Figure1-Aphanamixoid A	Patented
T83875	DRUGINFO	D0K3UV	PMID25399762-Compound-Figure1-Chukrasone A	Patented
T83875	DRUGINFO	D0Y9VB	PMID25399762-Compound-Figure1-Chukrasone B	Patented
T83875	DRUGINFO	D0N1CG	PMID25399762-Compound-Figure1-Eryngiolide A	Patented
T83875	DRUGINFO	D0V6TF	PMID25399762-Compound-Figure1-Neonectrolide A	Patented
T83875	DRUGINFO	D05GWJ	PMID25399762-Compound-Figure1-Sarcaboside A	Patented
T83875	DRUGINFO	D05MYL	PMID25399762-Compound-Figure1-Sarcaboside B	Patented
T83875	DRUGINFO	D03QMA	PMID25399762-Compound-Figure2-Artoxanthochromane	Patented
T83875	DRUGINFO	D0I5DV	PMID25399762-Compound-Figure2-Spirooliganone B	Patented
T83875	DRUGINFO	D08HOV	PMID25399762-Compound-Figure3-Aspeverin	Patented
T83875	DRUGINFO	D0KW7O	PMID25399762-Compound-Figure3-Fluevirosine A	Patented
T83875	DRUGINFO	D0M0EP	PMID25399762-Compound-Figure3-Lycojaponicumin A	Patented
T83875	DRUGINFO	D0E7OQ	PMID25399762-Compound-Figure3-Lycojaponicumin B	Patented
T83875	DRUGINFO	D0H7HH	PMID25399762-Compound-Figure3-Lycojaponicumin C	Patented
T83875	DRUGINFO	D03EHC	PMID25399762-Compound-Table 5-8	Patented
T83875	DRUGINFO	D03VGN	PMID25399762-Compound-Table 5-O-methyl-M30	Patented
T83875	DRUGINFO	D0AH9P	PMID29324067-Compound-25	Patented
T83875	DRUGINFO	D0AA7U	PMID29757691-Compound-4	Patented
T83875	DRUGINFO	D05RJG	Schiff base compound 1	Patented
T83875	DRUGINFO	D01OGR	Secondary and tertiary (hetero)arylamide derivative 2	Patented
T83875	DRUGINFO	D0T9JB	Tacrine-coumarin hybrid derivative 1	Patented
T83875	DRUGINFO	D04OHC	Tarnylcypromine derivative 2	Patented
T83875	DRUGINFO	D0O7IH	Tarnylcypromine derivative 3	Patented
T83875	DRUGINFO	D04AXC	Tetra-hydro-isoquinoline derivative 1	Patented
T83875	DRUGINFO	D0NB7Z	Tetra-hydro-isoquinoline derivative 2	Patented
T83875	DRUGINFO	D02EME	Tetra-hydro-isoquinoline derivative 3	Patented
T83875	DRUGINFO	D0R6RT	Tetra-hydro-isoquinoline derivative 4	Patented
T83875	DRUGINFO	D05WEP	Befloxatone	Discontinued in Phase 3
T83875	DRUGINFO	D0IZ1D	Brofaromine	Discontinued in Phase 2
T83875	DRUGINFO	D0H9DE	CS-722	Discontinued in Phase 2
T83875	DRUGINFO	D0ZM5W	Esuprone	Discontinued in Phase 2
T83875	DRUGINFO	D06QOJ	RS-8359	Discontinued in Phase 2
T83875	DRUGINFO	D01OLO	AS602868	Discontinued in Phase 1
T83875	DRUGINFO	D0E8UJ	BW-1370U87	Discontinued in Phase 1
T83875	DRUGINFO	D02CGY	Bifemelane	Terminated
T83875	DRUGINFO	D0G9AP	E-2011	Terminated
T83875	DRUGINFO	D0D6OR	(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	Investigative
T83875	DRUGINFO	D0M4GR	(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	Investigative
T83875	DRUGINFO	D0T3XC	(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	Investigative
T83875	DRUGINFO	D0D5KD	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	Investigative
T83875	DRUGINFO	D0J0QW	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	Investigative
T83875	DRUGINFO	D0ID3Y	(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	Investigative
T83875	DRUGINFO	D08TFN	(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	Investigative
T83875	DRUGINFO	D0Z5BU	(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	Investigative
T83875	DRUGINFO	D08FXH	(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	Investigative
T83875	DRUGINFO	D04FLL	(+/-)-2-Phenylthiomorpholin-5-one	Investigative
T83875	DRUGINFO	D0HU4J	(+/-)-2-Phenylthiomorpholine	Investigative
T83875	DRUGINFO	D03HXD	(6-Benzyloxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0V7RM	(6-Butoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0L5EW	(6-Ethoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D02IDM	(6-Methoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0R4TI	(6-methylthio-2-naphthyl)isopropylamine	Investigative
T83875	DRUGINFO	D0IP7L	(6-Propoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D02TFD	(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	Investigative
T83875	DRUGINFO	D06AJP	(E)-5-(3-Chlorostyryl)isatin	Investigative
T83875	DRUGINFO	D0X8HH	(E)-5-(3-Fluorostyryl)isatin	Investigative
T83875	DRUGINFO	D09XSB	(E)-5-Styrylisatin	Investigative
T83875	DRUGINFO	D0S7FP	(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	Investigative
T83875	DRUGINFO	D04UYZ	(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0M0XR	(R/R)BEFLOXATONE	Investigative
T83875	DRUGINFO	D0Z0ZU	(S)-2-amino-1-(4-butylthiophenyl)-propane	Investigative
T83875	DRUGINFO	D02ZZA	(S)-2-amino-1-(4-ethylthiophenyl)-propane	Investigative
T83875	DRUGINFO	D0Q2QA	(S)-2-amino-1-(4-methylthiophenyl)-propane	Investigative
T83875	DRUGINFO	D08SSS	(S)-2-amino-1-(4-propylthiophenyl)-propane	Investigative
T83875	DRUGINFO	D0BE0S	1-(1-Naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D00YVE	1-(2-Naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0B5CR	1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine	Investigative
T83875	DRUGINFO	D0WI3V	1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine	Investigative
T83875	DRUGINFO	D0O4XF	1-(3-benzylquinoxalin-2-yl)hydrazine	Investigative
T83875	DRUGINFO	D01SBZ	1-(4-(benzyloxy)phenyl)propan-2-amine	Investigative
T83875	DRUGINFO	D00KQB	1-(4-butoxyphenyl)propan-2-amine	Investigative
T83875	DRUGINFO	D0X0PA	1-(4-ethoxyphenyl)propan-2-amine	Investigative
T83875	DRUGINFO	D0H6UA	1-(4-propoxyphenyl)propan-2-amine	Investigative
T83875	DRUGINFO	D0C1SE	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	Investigative
T83875	DRUGINFO	D0Q1IP	2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	Investigative
T83875	DRUGINFO	D00WVG	2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	Investigative
T83875	DRUGINFO	D0C0MP	2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D0H1GQ	2-(3-benzylquinoxalin-2-ylamino)ethanol	Investigative
T83875	DRUGINFO	D0A4AB	2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	Investigative
T83875	DRUGINFO	D0K8SK	2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D0P1UC	2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D04ZPU	2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D0M7WE	2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	Investigative
T83875	DRUGINFO	D0S3QN	2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	Investigative
T83875	DRUGINFO	D08SCH	2-Amino-1-(4-methylthiophenyl)propane	Investigative
T83875	DRUGINFO	D0LI3J	2-BFi	Investigative
T83875	DRUGINFO	D02BBT	2-Bromo-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D0R5EW	2-Chloro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D0NS9X	2-Chloro-N-(3-morpholinopropyl)nicotinamide	Investigative
T83875	DRUGINFO	D09ZDQ	2-Furan-2-yl-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D00WSM	2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	Investigative
T83875	DRUGINFO	D03PXS	2-oxo-N-phenyl-2H-chromene-3-carboxamide	Investigative
T83875	DRUGINFO	D0H0GZ	2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	Investigative
T83875	DRUGINFO	D0Z7NC	2-Phenethyl-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D0N9FH	2-Phenoxymethyl-4,5-dihydro-1H-imidazole	Investigative
T83875	DRUGINFO	D0W3BX	2-phenyl-5H-indeno[1,2-d]pyrimidine	Investigative
T83875	DRUGINFO	D0Q9NC	2-phenyl-9H-indeno[2,1-d]pyrimidine	Investigative
T83875	DRUGINFO	D0P4GF	3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	Investigative
T83875	DRUGINFO	D0TL3S	3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	Investigative
T83875	DRUGINFO	D0Y1XS	3,4-Benzo-7-acetonyloxy-8-methylcoumarin	Investigative
T83875	DRUGINFO	D09NNZ	3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	Investigative
T83875	DRUGINFO	D0O0QN	3-aminoacetamido-4'-methylfuro[3,2-g]coumarin	Investigative
T83875	DRUGINFO	D0KW6V	3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine	Investigative
T83875	DRUGINFO	D0D6QI	3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	Investigative
T83875	DRUGINFO	D0P0XO	3-methyl-2(1H)-thioxo-4(3H)-quinazolinone	Investigative
T83875	DRUGINFO	D0E8IE	4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	Investigative
T83875	DRUGINFO	D0T1FJ	4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	Investigative
T83875	DRUGINFO	D01LUB	4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	Investigative
T83875	DRUGINFO	D0G8BT	4,9-Dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D0S9JC	4-Chloro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D06IAE	4-Chloro-N-(3-morpholinopropyl)nicotinamide	Investigative
T83875	DRUGINFO	D00JUD	4-methyl-2H-benzofuro[3,2-g]chromen-2-one	Investigative
T83875	DRUGINFO	D0A1RE	4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	Investigative
T83875	DRUGINFO	D0J3IA	5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D0ZA4J	5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide	Investigative
T83875	DRUGINFO	D07LCW	5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Investigative
T83875	DRUGINFO	D0L8ND	5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D08HAM	5-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D08QVY	5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Investigative
T83875	DRUGINFO	D00NSA	5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0V6XA	5-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D06FXI	5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Investigative
T83875	DRUGINFO	D0E5VT	6,11-dihydro-5H-benzo[a]carbazole	Investigative
T83875	DRUGINFO	D0S0JH	6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	Investigative
T83875	DRUGINFO	D05GQQ	6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D04GVX	6-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D05GGH	6-Chloro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D04SJC	6-Chloro-N-(3-morpholinopropyl)nicotinamide	Investigative
T83875	DRUGINFO	D04EDK	6-Fluoro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D0D0SC	6-Hydroxy-N-(2-morpholinoethyl)nicotinamide	Investigative
T83875	DRUGINFO	D0J3SN	6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0C7PD	6-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D0C9WW	7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	Investigative
T83875	DRUGINFO	D08FFH	7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	Investigative
T83875	DRUGINFO	D00OQL	7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	Investigative
T83875	DRUGINFO	D0R4PR	7-acetonyloxy-3-acetylamino-8-methoxycoumarin	Investigative
T83875	DRUGINFO	D02UVG	7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0W4TW	7-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D05GDP	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D05FQN	7-Methoxy-9H-beta-carboline	Investigative
T83875	DRUGINFO	D07NBB	8-(3-Bromobenzyloxy)caffeine	Investigative
T83875	DRUGINFO	D08YCE	8-(3-Chlorobenzyloxy)caffeine	Investigative
T83875	DRUGINFO	D04LPY	8-(3-Fluorobenzyloxy)caffeine	Investigative
T83875	DRUGINFO	D0B6MV	8-(3-Methoxybenzyloxy)caffeine	Investigative
T83875	DRUGINFO	D00OLX	8-(3-Methylbenzyloxy)caffeine	Investigative
T83875	DRUGINFO	D02FJX	8-[(3-Trifluoromethyl)benzyloxy]caffeine	Investigative
T83875	DRUGINFO	D0JN9R	8-Benzyloxycaffeine	Investigative
T83875	DRUGINFO	D06BAC	8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0G2EF	8-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D0Q3VI	8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0Y1GL	8-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83875	DRUGINFO	D0U9VX	9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one	Investigative
T83875	DRUGINFO	D0D2YR	9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83875	DRUGINFO	D0R7ZC	Beta-methoxyamphetamine	Investigative
T83875	DRUGINFO	D05FMZ	C-(1H-Indol-3-yl)-methylamine	Investigative
T83875	DRUGINFO	D0D1PE	CGS-19281A	Investigative
T83875	DRUGINFO	D0H1VT	Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	Investigative
T83875	DRUGINFO	D0X8RN	Cis-2-phenylcyclopropylamine	Investigative
T83875	DRUGINFO	D0B0JK	DECYL(DIMETHYL)PHOSPHINE OXIDE	Investigative
T83875	DRUGINFO	D05HJT	Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate	Investigative
T83875	DRUGINFO	D01UPT	FA-70	Investigative
T83875	DRUGINFO	D00IMW	Flavin-Adenine Dinucleotide	Investigative
T83875	DRUGINFO	D0A4IY	HYDRAZINECARBOXAMIDE	Investigative
T83875	DRUGINFO	D08CNS	IPRONIAZIDE	Investigative
T83875	DRUGINFO	D0I4ME	MMDA	Investigative
T83875	DRUGINFO	D08QZP	N-((1H-indol-2-yl)methyl)(phenyl)methanamine	Investigative
T83875	DRUGINFO	D0Y0LQ	N-((1H-indol-2-yl)methyl)-2-phenylethanamine	Investigative
T83875	DRUGINFO	D08PEW	N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine	Investigative
T83875	DRUGINFO	D00KDZ	N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	Investigative
T83875	DRUGINFO	D01PES	N-(1H-Indol-2-ylmethyl)-N-phenylamine	Investigative
T83875	DRUGINFO	D0KB2R	N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine	Investigative
T83875	DRUGINFO	D0C9RO	N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D05WQN	N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	Investigative
T83875	DRUGINFO	D02PSR	N'-(2-phenylallyl)hydrazine hydrochloride	Investigative
T83875	DRUGINFO	D0N8UE	N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D0YO7C	N-(2-Phenylethyl)-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D07LCU	N-(3-Phenylpropyl)-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0Y4JQ	N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0B1WD	N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	Investigative
T83875	DRUGINFO	D08HNJ	N-(4-Phenylbutyl)-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0P3DV	N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0O2UK	N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D0G4BG	N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D0T6XC	N2-[4-(benzyloxy)benzyl]glycinamide	Investigative
T83875	DRUGINFO	D02QBV	N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	Investigative
T83875	DRUGINFO	D03XKJ	N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	Investigative
T83875	DRUGINFO	D0SN3L	N-2-phenylethyl-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D02AQG	N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0M0HM	N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane	Investigative
T83875	DRUGINFO	D0V0TN	N-Benzyl,N-methyl-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0C8RD	N-benzyl,N-methyl-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0Z5YO	N-Benzyl-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0A4FA	N-benzyl-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D05ANK	N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	Investigative
T83875	DRUGINFO	D0MO1O	N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D03KDD	N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83875	DRUGINFO	D0F7JK	N-Methyl,N-phenyl-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D07ULQ	N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0K9UN	N-Phenyl-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0KU2D	N-phenyl-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D05OXR	N-Phenyl-1-methyl-1H-indole-2-carboxamide	Investigative
T83875	DRUGINFO	D0H5MV	N-propargyl-1H-pyrrole-2-carboxamide	Investigative
T83875	DRUGINFO	D0B4CA	NSC-656158	Investigative
T83875	DRUGINFO	D08SRB	Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	Investigative
T83875	DRUGINFO	D04QRS	PNU-22394	Investigative
T83875	DRUGINFO	D0V3NT	TOLOXATONE	Investigative
T83875	DRUGINFO	D09BIV	TRACIZOLINE	Investigative
T83875	DRUGINFO	D07WFU	Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	Investigative
T83875	DRUGINFO	D03LGV	Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	Investigative
T83875	DRUGINFO	D08PHY	Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	Investigative
T83875	DRUGINFO	D09HBX	Trans-2-fluoro-2-phenylcyclopropylamin	Investigative
T83875	DRUGINFO	D0F2DC	Trans-2-fluoro-2-p-tolylcyclopropanamine	Investigative
T83875	DRUGINFO	D03LPH	TRYPTOLINE	Investigative
T83875	KEGGPATH	hsa00260:Glycine, serine and threonine metabolism		
T83875	KEGGPATH	hsa00330:Arginine and proline metabolism		
T83875	KEGGPATH	hsa00340:Histidine metabolism		
T83875	KEGGPATH	hsa00350:Tyrosine metabolism		
T83875	KEGGPATH	hsa00360:Phenylalanine metabolism		
T83875	KEGGPATH	hsa00380:Tryptophan metabolism		
T83875	KEGGPATH	hsa00982:Drug metabolism - cytochrome P450		
T83875	KEGGPATH	hsa01100:Metabolic pathways		
T83875	KEGGPATH	hsa04726:Serotonergic synapse		
T83875	KEGGPATH	hsa04728:Dopaminergic synapse		
T83875	KEGGPATH	hsa05030:Cocaine addiction		
T83875	KEGGPATH	hsa05031:Amphetamine addiction		
T83875	KEGGPATH	hsa05034:Alcoholism		
T83875	WIKIPATH	WP1455:Serotonin Transporter Activity		
T83875	WIKIPATH	WP1870:Neurotransmitter Clearance In The Synaptic Cleft		
T83875	WIKIPATH	WP1871:Neurotransmitter Release Cycle		
T83875	WIKIPATH	WP1879:Phase 1 - Functionalization of compounds		
T83875	WIKIPATH	WP2436:Dopamine metabolism		
T83875	WIKIPATH	WP408:Oxidative Stress		
T83875	WIKIPATH	WP550:Biogenic Amine Synthesis		
T83875	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T83875	WHIZPATH	PW000043:Histidine Metabolism		
T83875	WHIZPATH	PW000142:Tyrosine Metabolism		
T83875	WHIZPATH	PW000157:Glycine and Serine Metabolism		
T83875	REACPATH	R-HSA-181430:Norepinephrine Neurotransmitter Release Cycle		
T83875	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T83875	PANTPATH	P00001:Adrenaline and noradrenaline biosynthesis		
T83875	PANTPATH	P04372:5-Hydroxytryptamine degredation		
T83875	PANTPATH	P05912:Dopamine receptor mediated signaling pathway		
T83875	BIOCPATH	PWY-0:Putrescine degradation III		
T83875	BIOCPATH	PWY-6313:Serotonin degradation		
T83875	BIOCPATH	PWY-6342:Noradrenaline and adrenaline degradation		
T83875	BIOCPATH	PWY-6399:Melatonin degradation II		
T83875	BIOCPATH	PWY-6402:Superpathway of melatonin degradation		
T83875	BIOCPATH	PWY66-401:Superpathway of tryptophan utilization		
T83875	BIOCPATH	PWY6666-2:Dopamine degradation		
				
T58454	TARGETID	T58454		
T58454	FORMERID	TTDS00171		
T58454	UNIPROID	FGFR2_HUMAN		
T58454	TARGNAME	Fibroblast growth factor receptor 2 (FGFR2)		
T58454	GENENAME	FGFR2		
T58454	TARGTYPE	Successful target		
T58454	SYNONYMS	Keratinocyte growth factor receptor 2; Keratinocyte growth factor receptor; KSAM; KGFR; K-sam; FGFR-2; FGF-2 receptor; CD332; BEK		
T58454	FUNCTION	Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development.		
T58454	PDBSTRUC	5UI0; 5UHN; 5UGX; 5UGL; 5EG3		
T58454	BIOCLASS	Kinase		
T58454	ECNUMBER	EC 2.7.10.1		
T58454	SEQUENCE	MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLEQYSPSYPDTRSSCSSGDDSVFSPDPMPYEPCLPQYPHINGSVKT		
T58454	DRUGINFO	D09PMV	Interferon Alfa-2a, Recombinant	Approved
T58454	DRUGINFO	D0O7GU	Palifermin	Approved
T58454	DRUGINFO	D0O6UY	Pemigatinib	Approved
T58454	DRUGINFO	D02WVT	E-3810	Phase 3
T58454	DRUGINFO	D0KV1Q	Trafermin	Phase 3
T58454	DRUGINFO	D0XT0W	Debio 1347	Phase 2
T58454	DRUGINFO	D0D4VV	LY2874455	Phase 2
T58454	DRUGINFO	D0G2QH	AEE-788	Phase 1/2
T58454	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T58454	DRUGINFO	D47MOS	Alofanib	Phase 1
T58454	DRUGINFO	D0L6RF	BAY1179470	Phase 1
T58454	DRUGINFO	DU1DL0	RLY-4008	Phase 1
T58454	DRUGINFO	D0Z0KD	PD-0183812	Terminated
T58454	DRUGINFO	D0R6OM	ACTB-1003	Investigative
T58454	DRUGINFO	D02VPS	Anti-FGFR2 humanized mab	Investigative
T58454	DRUGINFO	D0VN4K	PK 11195	Investigative
T58454	DRUGINFO	D0IE6Z	Platelet factor 4 (PF-4)	Investigative
T58454	DRUGINFO	D09XIL	Ro-4396686	Investigative
T58454	DRUGINFO	D0H1OK	TG-100435	Investigative
T58454	KEGGPATH	hsa04010:MAPK signaling pathway		
T58454	KEGGPATH	hsa04014:Ras signaling pathway		
T58454	KEGGPATH	hsa04015:Rap1 signaling pathway		
T58454	KEGGPATH	hsa04144:Endocytosis		
T58454	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T58454	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T58454	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T58454	KEGGPATH	hsa05200:Pathways in cancer		
T58454	KEGGPATH	hsa05215:Prostate cancer		
T58454	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T58454	WIKIPATH	WP1539:Angiogenesis		
T58454	WIKIPATH	WP1544:MicroRNAs in cardiomyocyte hypertrophy		
T58454	WIKIPATH	WP1911:Signaling by FGFR		
T58454	WIKIPATH	WP2064:Neural Crest Differentiation		
T58454	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T58454	WIKIPATH	WP2795:Cardiac Hypertrophic Response		
T58454	WIKIPATH	WP2804:Hair Follicle Development: Induction (Part 1 of 3)		
T58454	WIKIPATH	WP2839:Hair Follicle Development: Organogenesis (Part 2 of 3)		
T58454	WIKIPATH	WP2858:Ectoderm Differentiation		
T58454	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T58454	REACPATH	R-HSA-2033519:Activated point mutants of FGFR2		
T58454	NET_PATH	NetPath_13:IL1 Signaling Pathway		
T58454	INTEPATH	fgf_pathway:FGF signaling pathway		
T58454	PANTPATH	P00021:FGF signaling pathway		
				
T30082	TARGETID	T30082		
T30082	FORMERID	TTDS00140		
T30082	UNIPROID	ACES_HUMAN		
T30082	TARGNAME	Acetylcholinesterase (AChE)		
T30082	GENENAME	ACHE		
T30082	TARGTYPE	Successful target		
T30082	SYNONYMS	YT; N-ACHE; ARACHE		
T30082	FUNCTION	Role in neuronal apoptosis. Terminates signal transduction at the neuromuscular junction by rapid hydrolysis of the acetylcholine released into the synaptic cleft.		
T30082	PDBSTRUC	6O69; 6F25; 6CQZ; 6CQY; 6CQX		
T30082	BIOCLASS	Carboxylic ester hydrolase		
T30082	ECNUMBER	EC 3.1.1.7		
T30082	SEQUENCE	MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRGIRLKTPGGPVSAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPNRELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSMNYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASVGMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTELVACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVGVVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPEDPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGYEIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQYVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLDEAERQWKAEFHRWSSYMVHWKNQFDHYSKQDRCSDL		
T30082	DRUGINFO	D06IAQ	Ambenonium	Approved
T30082	DRUGINFO	D06IDT	Demecarium bromide	Approved
T30082	DRUGINFO	D0NS6H	Donepezil	Approved
T30082	DRUGINFO	D0U8AT	Echothiophate Iodide	Approved
T30082	DRUGINFO	D0S5LH	Edrophonium	Approved
T30082	DRUGINFO	D0R9VR	Galantamine	Approved
T30082	DRUGINFO	D06XWB	Huperzine A	Approved
T30082	DRUGINFO	D0B2OT	Isoflurophate	Approved
T30082	DRUGINFO	D0K3LW	Malathion	Approved
T30082	DRUGINFO	D08USJ	Neostigmine	Approved
T30082	DRUGINFO	D0X7NU	Pralidoxime Chloride	Approved
T30082	DRUGINFO	D0O2WB	Pyridostigmine	Approved
T30082	DRUGINFO	D0WY5Q	Rivastigmine	Approved
T30082	DRUGINFO	D0E6YQ	Tacrine	Approved
T30082	DRUGINFO	D00WVW	YM443	Approved
T30082	DRUGINFO	D07CIN	(-)-Phenserine	Phase 3
T30082	DRUGINFO	D0SH2X	Amocarzine	Phase 3
T30082	DRUGINFO	D01LYX	Eptastigmine	Phase 3
T30082	DRUGINFO	D05UXU	INM-176	Phase 3
T30082	DRUGINFO	D0MZ9A	Suronacrine maleate	Phase 3
T30082	DRUGINFO	D0C3UC	Ladostigil	Phase 2
T30082	DRUGINFO	D0W3BA	Methanesulfonyl fluoride	Phase 2
T30082	DRUGINFO	D0O5GK	R-phenserine	Phase 2
T30082	DRUGINFO	D0PC1V	T-82	Phase 2
T30082	DRUGINFO	D0X1XK	CPC-212	Phase 1
T30082	DRUGINFO	D0WI9W	CPC-250	Phase 1
T30082	DRUGINFO	D0T5AW	Desoxypeganine	Phase 1
T30082	DRUGINFO	D01KDM	GTP-004	Phase 1
T30082	DRUGINFO	D08ZRR	KW-5092	Phase 1
T30082	DRUGINFO	D0JA7V	PRX-105	Phase 1
T30082	DRUGINFO	D05REB	ZT-1	Phase 1
T30082	DRUGINFO	D0C0LQ	2-PAM derivative 1	Patented
T30082	DRUGINFO	D0G4YS	4-PAM derivative 1	Patented
T30082	DRUGINFO	D01RZG	Amidine oxime derivative 1	Patented
T30082	DRUGINFO	D0Y4CG	Decyle nelycorine dibromo salt derivative 1	Patented
T30082	DRUGINFO	D0K3EB	Di-substituted piperidine derivative 2	Patented
T30082	DRUGINFO	D03DIQ	Egonol compound 1	Patented
T30082	DRUGINFO	D0XS3N	Fluorinated donepezil derivative 1	Patented
T30082	DRUGINFO	D0AH3R	Fluorinated donepezil derivative 2	Patented
T30082	DRUGINFO	D0W9ZU	Galantamine analog 1	Patented
T30082	DRUGINFO	D0J3OD	Indoline derivative 1	Patented
T30082	DRUGINFO	D0OE6G	Isochroman-4-ketone derivative 1	Patented
T30082	DRUGINFO	D03VUN	Lycorine dimer salt derivative 1	Patented
T30082	DRUGINFO	D0QJ5H	PMID27967267-Compound-12	Patented
T30082	DRUGINFO	D02SQQ	PMID27967267-Compound-13	Patented
T30082	DRUGINFO	D0UX5I	PMID27967267-Compound-14	Patented
T30082	DRUGINFO	D01FRI	PMID27967267-Compound-15	Patented
T30082	DRUGINFO	D0I6UA	PMID27967267-Compound-27	Patented
T30082	DRUGINFO	D0ZX8C	PMID27967267-Compound-28	Patented
T30082	DRUGINFO	D04TGJ	PMID27967267-Compound-3	Patented
T30082	DRUGINFO	D00AQW	PMID27967267-Compound-36	Patented
T30082	DRUGINFO	D04XHE	PMID27967267-Compound-39	Patented
T30082	DRUGINFO	D07HNU	PMID27967267-Compound-42	Patented
T30082	DRUGINFO	D0YF7A	PMID27967267-Compound-43	Patented
T30082	DRUGINFO	D01EGC	PMID27967267-Compound-47	Patented
T30082	DRUGINFO	D0HI1R	PMID27967267-Compound-48	Patented
T30082	DRUGINFO	D0OG8Z	PMID27967267-Compound-49	Patented
T30082	DRUGINFO	D0X5KA	PMID27967267-Compound-51	Patented
T30082	DRUGINFO	D06GSR	PMID27967267-Compound-52	Patented
T30082	DRUGINFO	D0T0CB	PMID27967267-Compound-7	Patented
T30082	DRUGINFO	D03WGA	PMID27967267-Compound-neostenine	Patented
T30082	DRUGINFO	D0V2JR	PMID27967267-Compound-neotuberostemonine	Patented
T30082	DRUGINFO	D02GCZ	PMID27967267-Compound-stenine	Patented
T30082	DRUGINFO	D0X9CR	PMID29757691-Compound-10	Patented
T30082	DRUGINFO	D0H3YG	PMID29757691-Compound-2a	Patented
T30082	DRUGINFO	D0WD0M	PMID29757691-Compound-2a-i	Patented
T30082	DRUGINFO	D0AA7U	PMID29757691-Compound-4	Patented
T30082	DRUGINFO	D0W9OC	PMID29757691-Compound-7	Patented
T30082	DRUGINFO	D0RS6O	PMID29757691-Compound-8a	Patented
T30082	DRUGINFO	D04FAS	PMID29757691-Compound-8b	Patented
T30082	DRUGINFO	D0VQ2N	PMID29757691-Compound-8c	Patented
T30082	DRUGINFO	D0B9TI	PMID29757691-Compound-8d	Patented
T30082	DRUGINFO	D01SQO	Quinazoline alkaloid derivative 1	Patented
T30082	DRUGINFO	D0CB1C	Tacrine heterodimer derivative 1	Patented
T30082	DRUGINFO	D05WPG	Tacrine-caffeic acid hybrid derivative 1	Patented
T30082	DRUGINFO	D0SW0V	Tacrine-caffeic acid hybrid derivative 2	Patented
T30082	DRUGINFO	D0C1UA	Tacrine-dihydropyridine hybrid derivative 1	Patented
T30082	DRUGINFO	D0G9HY	Tacrine-indole hybrid derivative 1	Patented
T30082	DRUGINFO	D0I7KU	Tacrine-indole hybrid derivative 2	Patented
T30082	DRUGINFO	D05QVX	Tacrine-indole hybrid derivative 3	Patented
T30082	DRUGINFO	D0I2FM	Tacrine-phenothiazine hybrid derivative 1	Patented
T30082	DRUGINFO	D04AXC	Tetra-hydro-isoquinoline derivative 1	Patented
T30082	DRUGINFO	D0NB7Z	Tetra-hydro-isoquinoline derivative 2	Patented
T30082	DRUGINFO	D02EME	Tetra-hydro-isoquinoline derivative 3	Patented
T30082	DRUGINFO	D0R6RT	Tetra-hydro-isoquinoline derivative 4	Patented
T30082	DRUGINFO	D0L8QQ	VELNACRINE	Discontinued in Phase 3
T30082	DRUGINFO	D0AM8W	Zanapezil	Discontinued in Phase 3
T30082	DRUGINFO	D0R5UZ	Caracemide	Discontinued in Phase 2
T30082	DRUGINFO	D09PTA	HP-290	Discontinued in Phase 2
T30082	DRUGINFO	D0B2BQ	Icopezil maleate	Discontinued in Phase 2
T30082	DRUGINFO	D09JVV	Physostigmine	Discontinued in Phase 2
T30082	DRUGINFO	D0F3FB	S-9977	Discontinued in Phase 2
T30082	DRUGINFO	D05UHJ	SM-10888	Discontinued in Phase 2
T30082	DRUGINFO	D03GAX	TAK-802	Discontinued in Phase 2
T30082	DRUGINFO	D0F1VQ	ZIFROSILONE	Discontinued in Phase 2
T30082	DRUGINFO	D04UKJ	NP-61	Discontinued in Phase 1
T30082	DRUGINFO	D0SR4T	PHENSERINE TARTRATE	Preclinical
T30082	DRUGINFO	D0V7FG	SPH-1285	Preclinical
T30082	DRUGINFO	D0S1VV	7-methoxytacrine	Terminated
T30082	DRUGINFO	D02UQU	ABS-301	Terminated
T30082	DRUGINFO	D0M2GI	CI-1002	Terminated
T30082	DRUGINFO	D09IUG	F-3796	Terminated
T30082	DRUGINFO	D0J4GQ	FR-152558	Terminated
T30082	DRUGINFO	D06ZAM	MF268	Terminated
T30082	DRUGINFO	D0K0XG	MF-8615	Terminated
T30082	DRUGINFO	D03DFY	NP-7557	Terminated
T30082	DRUGINFO	D0TK0W	Ro-46-5934	Terminated
T30082	DRUGINFO	D04ZJO	(-)-huperzine B	Investigative
T30082	DRUGINFO	D04FHZ	(-)-Tolserine	Investigative
T30082	DRUGINFO	D07EMX	(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE	Investigative
T30082	DRUGINFO	D01GWN	(24S)-ethylcholesta-7,9(11),22(E)-triene-3b-ol	Investigative
T30082	DRUGINFO	D0SE8T	(2-Butyryloxy-ethyl)-trimethyl-ammonium iodide	Investigative
T30082	DRUGINFO	D0J3EU	(2-Chloro-ethyl)-trimethyl-ammonium chloride	Investigative
T30082	DRUGINFO	D08TRN	(2-Ethoxy-ethyl)-trimethyl-ammonium iodide	Investigative
T30082	DRUGINFO	D0GT6I	(2-Mercapto-ethyl)-trimethyl-ammonium iodide	Investigative
T30082	DRUGINFO	D00RLO	(3-Bromo-propyl)-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D08JOR	(3-Hydroxy-2-methyl-phenyl)-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D0R1FR	(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine	Investigative
T30082	DRUGINFO	D03FZK	(4-Bromo-butyl)-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D0P8KQ	(4-Iodo-butyl)-trimethyl-ammonium iodide	Investigative
T30082	DRUGINFO	D05KZH	(5-Bromo-pentyl)-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D0A9IM	(R)-tacrine(10)-hupyridone	Investigative
T30082	DRUGINFO	D09FAU	(RS)-tacrine(10)-hupyridone	Investigative
T30082	DRUGINFO	D0T4UO	(S)-tacrine(10)-hupyridone	Investigative
T30082	DRUGINFO	D0Y3LO	(S,S)-(-)-bis(10)-hupyridone	Investigative
T30082	DRUGINFO	D09DJX	(S,S)-(-)-bis(12)-hupyridone	Investigative
T30082	DRUGINFO	D0D5QT	1-(3-Bromomethyl-phenyl)-2,2,2-trifluoro-ethanone	Investigative
T30082	DRUGINFO	D0Z6WU	1,10-bis(pyridinium)-decane dibromide	Investigative
T30082	DRUGINFO	D07YJG	1,11-bis(pyridinium)-undecane dibromide	Investigative
T30082	DRUGINFO	D0K2FQ	1,2-Di(berberine-9-O-yl)ethane dibromide	Investigative
T30082	DRUGINFO	D0W9VA	1,2-NAPHTHOQUINONE	Investigative
T30082	DRUGINFO	D05QXU	1,3-Bis-(3-imidazolidin-2-yl-phenyl)-urea	Investigative
T30082	DRUGINFO	D0P5BT	1,3-Di(berberine-9-O-yl)ethane dibromide	Investigative
T30082	DRUGINFO	D00FPI	1,4-Di(berberine-9-O-yl)ethane dibromide	Investigative
T30082	DRUGINFO	D0L5QJ	1,9-bis(pyridinium)-nonane dibromide	Investigative
T30082	DRUGINFO	D0FI9G	10-Hydroxy-infractopicrin	Investigative
T30082	DRUGINFO	D03KMG	1-benzene sulfonyl-cis-2,6-dimethyl piperidine	Investigative
T30082	DRUGINFO	D04OUJ	1-Deoxy-1-Thio-Heptaethylene Glycol	Investigative
T30082	DRUGINFO	D0L3IS	1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE	Investigative
T30082	DRUGINFO	D06IEN	2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose	Investigative
T30082	DRUGINFO	D07KZA	2-(N-Morpholino)-Ethanesulfonic Acid	Investigative
T30082	DRUGINFO	D0MV0T	2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-imine	Investigative
T30082	DRUGINFO	D0V3LC	24-ethylcholest-6-ene-3,5-diol	Investigative
T30082	DRUGINFO	D0J4LR	24-ethyl-cholest-7-ene-3,5,6-triol	Investigative
T30082	DRUGINFO	D09ZGN	2-Hex-5-enyl-5-non-8-enyl-3,4-dihydro-2H-pyrrole	Investigative
T30082	DRUGINFO	D0C6QF	2-Hex-5-enyl-5-non-8-enyl-pyrrolidine	Investigative
T30082	DRUGINFO	D0O1JC	2-Hex-5-enyl-5-nonyl-pyrrolidine	Investigative
T30082	DRUGINFO	D0K8AU	2-morpholino-N-phenethylpyrimidin-4-amine	Investigative
T30082	DRUGINFO	D02AFZ	2-Propyl-beta-carboline-2-ium iodide	Investigative
T30082	DRUGINFO	D09JAB	3-(2,5-Dioxo-pyrrolidin-1-yl)-benzoic acid	Investigative
T30082	DRUGINFO	D07VIO	3-(2-Diethylamino-acetamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D03DIP	3-(2-Diethylamino-propionamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D0E0ZV	3-(2-N-Piperidyl-acetamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D0C3IS	3-(2-N-Piperidyl-propionamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D0LT0T	3-(2-N-Pyrrolyl-acetamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D0F6VM	3-(2-N-Pyrrolyl-propionamino)-rutaecarpine	Investigative
T30082	DRUGINFO	D0H5XD	3-(3-Carboxy-propionylamino)-benzoic acid	Investigative
T30082	DRUGINFO	D0V7EA	3-(4-Benzoylpiperazine-1-carbonyl)coumarin	Investigative
T30082	DRUGINFO	D08WRG	3-(4-o-Tolylpiperazine-1-carbonyl)coumarin	Investigative
T30082	DRUGINFO	D0S7HC	3-(4-Phenylpiperazin-1-carbonyl)coumarin	Investigative
T30082	DRUGINFO	D01OND	3-(dimethylamino)phenyl phenylcarbamate	Investigative
T30082	DRUGINFO	D0N0HK	3,4,5,6-Tetrachloro-[1,2]benzoquinone	Investigative
T30082	DRUGINFO	D02DWE	3,6,9,12,15-Pentaoxaheptadecane	Investigative
T30082	DRUGINFO	D05CCT	3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM	Investigative
T30082	DRUGINFO	D0J9FT	3-[(1s)-1-(Dimethylamino)Ethyl]Phenol	Investigative
T30082	DRUGINFO	D0E2LR	3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-1H-indazole	Investigative
T30082	DRUGINFO	D0L9YJ	3-[3-(benzylmethylamino)propoxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D01EZC	3-[4-(benzylmethylamino)butoxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D0H3BC	3-[5-(benzylmethylamino)pentyloxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D0O8DZ	3-[6-(benzylmethylamino)hexyloxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D09GXM	3-[7-(benzylmethylamino)-heptyloxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D0B4DT	3-[8-(benzylmethylamino)octyloxy]xanthen-9-one	Investigative
T30082	DRUGINFO	D03PQH	3-hydroxy-N,N,N-trimethylbenzenaminium iodide	Investigative
T30082	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T30082	DRUGINFO	D0R2QC	4-[4-(benzhydryloxy)piperidino]butyl benzoate	Investigative
T30082	DRUGINFO	D0C0NS	4ALPHA-(HYDROXYMETHYL)-4ALPHA-DEMETHYLTERRITREM B	Investigative
T30082	DRUGINFO	D02ELG	4-formylphenyl-O-beta-Dglucopyranoside	Investigative
T30082	DRUGINFO	D0FS3L	4-formylphenyl-O-beta-D-ribopyranoside	Investigative
T30082	DRUGINFO	D0O2OH	4-ISOPROPYLPHENSERINE	Investigative
T30082	DRUGINFO	D0WX6R	5,6-dinitroacenaphthoquinone	Investigative
T30082	DRUGINFO	D03WOS	5-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Investigative
T30082	DRUGINFO	D0D3TG	5-Hex-5-enyl-2-nonyl-3,4-dihydro-2H-pyrrole	Investigative
T30082	DRUGINFO	D0D4SK	6,8-Dichloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Investigative
T30082	DRUGINFO	D0M0BM	6-chlorotacrine hydrochloride	Investigative
T30082	DRUGINFO	D0G5TL	6-hydroxy-1,2,9-trimethyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D09CGV	6-hydroxy-1,2-dimethyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D0ER5C	6-hydroxy-2,9-dimethyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D02LWX	6-hydroxy-2-methyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D00MFR	6-methoxy-1,2-dimethyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D0ZI7F	6-methoxy-1,9-dimethyl-9H-pyrido[3,4-b]indole	Investigative
T30082	DRUGINFO	D0DV9Z	6-methoxy-2,9-dimethyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D0XI4U	6-methoxy-2-methyl-9H-beta-carbolin-2-ium	Investigative
T30082	DRUGINFO	D09NEH	6-Methyl-4-(4-benzoylpiperazin-1-yl)coumarin	Investigative
T30082	DRUGINFO	D04JAX	6-Methyl-4-(4-o-tolylpiperazin-1-yl)coumarin	Investigative
T30082	DRUGINFO	D03XXV	6-Methyl-4-(4-phenylpiperazin-1-yl)coumarin	Investigative
T30082	DRUGINFO	D0MB3S	7-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Investigative
T30082	DRUGINFO	D0I3UA	7-Oxo-7H-dibenzo[de,g]quinoline	Investigative
T30082	DRUGINFO	D0X4EV	8-Chloro-1,2,3,4-tetrahydro-acridin-9-ylamine	Investigative
T30082	DRUGINFO	D0V0PS	9-Amino-1,2,3,4-tetrahydro-acridine-1,7-diol	Investigative
T30082	DRUGINFO	D0N9DB	9-amino-7H-dibenzo[de,h]quinolin-7-one	Investigative
T30082	DRUGINFO	D0W8NK	9-Ethyl-2-methyl-beta-carboline-2-ium iodide	Investigative
T30082	DRUGINFO	D0H4DW	9-Ethyl-beta-carboline	Investigative
T30082	DRUGINFO	D08XPP	9-hydrazino-1,2,3,4-tetrahydroacridine	Investigative
T30082	DRUGINFO	D01DHW	9-O-[2-(Phenylol-1-yloxy)ethyl]berberine bromide	Investigative
T30082	DRUGINFO	D02WKB	9-O-[2-(Phenylol-1-yloxy)hexyl]berberine bromide	Investigative
T30082	DRUGINFO	D02QMU	9-O-[3-(2-Pyridinoxyl)butyl]-berberine bromide	Investigative
T30082	DRUGINFO	D0ZL9I	9-O-[3-(4-Bromo-phenoxyl)butyl]-berberine bromide	Investigative
T30082	DRUGINFO	D0P2VL	9-O-[3-(4-Nitro-phenoxyl)butyl]-berberine bromide	Investigative
T30082	DRUGINFO	D00NIX	9-O-[3-(Phenylamino)propyl]-berberine bromide	Investigative
T30082	DRUGINFO	D0W7XL	9-O-[3-(Phenylol-1-yloxy)propyl]berberine bromide	Investigative
T30082	DRUGINFO	D01TLN	9-O-[4-(Phenylol-1-yloxy)butyl]berberine bromide	Investigative
T30082	DRUGINFO	D09XSI	9-O-[5-(Phenylol-1-yloxy)pentyl]berberine bromide	Investigative
T30082	DRUGINFO	D0M1CG	Allyl-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D0S2DW	AP-2238	Investigative
T30082	DRUGINFO	D0S1MC	AP-2243	Investigative
T30082	DRUGINFO	D0M2EM	BENZOQUINONE	Investigative
T30082	DRUGINFO	D08QQR	Beta-L-fucose	Investigative
T30082	DRUGINFO	D06EJS	BIS(12)-HUPERZINE B	Investigative
T30082	DRUGINFO	D04KWA	Bis(14)-Huperzine B	Investigative
T30082	DRUGINFO	D0P5CV	BIS(16)-HUPERZINE B	Investigative
T30082	DRUGINFO	D03EPB	BIS(18)-HUPERZINE B	Investigative
T30082	DRUGINFO	D04ZJK	BIS(20)-HUPERZINE B	Investigative
T30082	DRUGINFO	D0N8EC	BIS(8)-HUPERZINE B	Investigative
T30082	DRUGINFO	D0UF9K	BIS(9)-HUPERZINE B	Investigative
T30082	DRUGINFO	D0M4IE	Bis-7-tacrine	Investigative
T30082	DRUGINFO	D04ZQL	But-3-enyl-trimethyl-ammonium bromide	Investigative
T30082	DRUGINFO	D0O1QB	BW284C51	Investigative
T30082	DRUGINFO	D06ACI	BZYX	Investigative
T30082	DRUGINFO	D0NJ5W	CAPROCTAMINE	Investigative
T30082	DRUGINFO	D07FFB	Carinatumins B (2)	Investigative
T30082	DRUGINFO	D04GTP	CHF-2819	Investigative
T30082	DRUGINFO	D0D0BI	CHLORANIL	Investigative
T30082	DRUGINFO	D0W6PT	Chlorphrifos oxon	Investigative
T30082	DRUGINFO	D0M5ES	CHLORPYRIFOS	Investigative
T30082	DRUGINFO	D0Q2DE	CHOLINE IODIDE	Investigative
T30082	DRUGINFO	D09JZY	Cis-2,6-dimethyl-1-methyl sulfonyl piperidine	Investigative
T30082	DRUGINFO	D0A2BE	CLEBOPRIDE	Investigative
T30082	DRUGINFO	D04XXE	CORONARIDINE	Investigative
T30082	DRUGINFO	D0G2WI	CP-126998	Investigative
T30082	DRUGINFO	D01XRG	CRYPTADINE B	Investigative
T30082	DRUGINFO	D02VFM	DECIDIUM	Investigative
T30082	DRUGINFO	D0T7ZN	Dimethyl-pent-4-enyl-ammonium bromide	Investigative
T30082	DRUGINFO	D0K6GY	Ethyl octylfluorophosphonate	Investigative
T30082	DRUGINFO	D0XL1R	ETHYLPHENSERINE	Investigative
T30082	DRUGINFO	D0G6XS	Fucose	Investigative
T30082	DRUGINFO	D0ST5U	Galanthamine derivative	Investigative
T30082	DRUGINFO	D0L4OW	GANSTIGMINE	Investigative
T30082	DRUGINFO	D02DUJ	GENESERINE	Investigative
T30082	DRUGINFO	D0G5SM	HALOXYSTEROL A	Investigative
T30082	DRUGINFO	D0X3FF	HALOXYSTEROL B	Investigative
T30082	DRUGINFO	D0E0LL	Haloxysterol C	Investigative
T30082	DRUGINFO	D09MCN	Haloxysterol D	Investigative
T30082	DRUGINFO	D0U1SE	Hexyl-trimethyl-ammonium	Investigative
T30082	DRUGINFO	D09RJH	Huprine X	Investigative
T30082	DRUGINFO	D0A0FK	Huprine Y	Investigative
T30082	DRUGINFO	D09JCF	Huprine-Tacrine Heterodimer	Investigative
T30082	DRUGINFO	D0XN8A	Infractopicrin	Investigative
T30082	DRUGINFO	D09QDC	Iso-OMPA	Investigative
T30082	DRUGINFO	D0HQ4M	Isopropyl dodecylfluorophosphonate	Investigative
T30082	DRUGINFO	D0K8BT	Isosorbide-2-(methylcarbamate)-5-benzoate	Investigative
T30082	DRUGINFO	D04SYM	Isosorbide-2-(methylcarbamate)-5-mononitrate	Investigative
T30082	DRUGINFO	D01QRR	Isosorbide-2-benzylcarbamate-5-cyclopentanoate	Investigative
T30082	DRUGINFO	D0T5MD	Isosorbide-2-benzylcarbamate-5-cyclopropanoate	Investigative
T30082	DRUGINFO	D0VI6N	Isosorbide-2-benzylcarbamate-5-tosylate	Investigative
T30082	DRUGINFO	D05EPI	Isosorbide-di-(4-nitrophenyl carbamate)	Investigative
T30082	DRUGINFO	D01AJQ	Isosorbide-di-(benzylcarbamate)	Investigative
T30082	DRUGINFO	D0O8AQ	Isosorbide-di-(ethylcarbamate)	Investigative
T30082	DRUGINFO	D06LRC	Isosorbide-di-phenylcarbamate	Investigative
T30082	DRUGINFO	D0Z6RT	LAWSARITOL	Investigative
T30082	DRUGINFO	D0F5EJ	LIPOCRINE	Investigative
T30082	DRUGINFO	D01RUH	LYSICAMINE	Investigative
T30082	DRUGINFO	D01KVT	MEMOQUIN	Investigative
T30082	DRUGINFO	D03FHV	MESUAGENIN A	Investigative
T30082	DRUGINFO	D0A6MF	MESUAGENIN B	Investigative
T30082	DRUGINFO	D00FEH	Mesuagenin D	Investigative
T30082	DRUGINFO	D0J4QH	Methyl Phosphinic Acid	Investigative
T30082	DRUGINFO	D04LMJ	MMB-4	Investigative
T30082	DRUGINFO	D0W8RP	Monoisopropylphosphorylserine	Investigative
T30082	DRUGINFO	D00YHI	N-(14-methylallyl)norgalanthamine	Investigative
T30082	DRUGINFO	D0MC3U	N,N'-(1',10'-decylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D02JXK	N,N'-(1',11'-undecydene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0F0PY	N,N'-(1',12'-dodecydene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0A8OX	N,N'-(1',5'-pentylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0Y7UG	N,N'-(1',6-hexylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0EX1R	N,N'-(1',7'-heptylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0Y0VQ	N,N'-(1',8'-octylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D05QNR	N,N'-(1',9'-nonylene)-bis-(-)-nor-MEP	Investigative
T30082	DRUGINFO	D0D3TB	N-ALLYLNORGALANTHAMINE	Investigative
T30082	DRUGINFO	D0H7OP	N-allylnorlitebamine	Investigative
T30082	DRUGINFO	D0Z6GG	N-benzyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	Investigative
T30082	DRUGINFO	D0Z4OS	N-benzyl-2-morpholinopyrimidin-4-amine	Investigative
T30082	DRUGINFO	D0E4BT	N-benzyl-2-thiomorpholinopyrimidin-4-amine	Investigative
T30082	DRUGINFO	D07YQY	N-benzylnorlitebamine	Investigative
T30082	DRUGINFO	D08LBC	N-butylnorlitebamine	Investigative
T30082	DRUGINFO	D0O9OW	N-isobutylnorlitebamine	Investigative
T30082	DRUGINFO	D01ZHK	N-isopropylnorlitebamine	Investigative
T30082	DRUGINFO	D0PF3Z	N-isopropylnorlitebamineN-methoiodide	Investigative
T30082	DRUGINFO	D0G0GZ	N-Methyl-1'H-phenothiazine-1'-carboxamide	Investigative
T30082	DRUGINFO	D03JRX	N-n-dodecyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D0C0XU	N-n-heptyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D0O9YQ	N-n-hexyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D0H2UG	N-n-nonyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D0Q3EV	N-n-octyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D05UJV	N-n-pentyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D08PWL	N-n-propyl-7-methoxytacrine hydrochloride	Investigative
T30082	DRUGINFO	D0ZY4C	N-phenethyl-2-(pyrrolidin-1-yl)pyrimidin-4-amine	Investigative
T30082	DRUGINFO	D0B2JV	N-propylnorlitebamine	Investigative
T30082	DRUGINFO	D0FY2N	NPRx-30	Investigative
T30082	DRUGINFO	D0F5VY	NSC-23180	Investigative
T30082	DRUGINFO	D0E3OZ	OBIDOXIME	Investigative
T30082	DRUGINFO	D08XQI	PARAOXON	Investigative
T30082	DRUGINFO	D0M9JF	Petrosamine	Investigative
T30082	DRUGINFO	D08UET	Propidium	Investigative
T30082	DRUGINFO	D0RA5T	Pseudocolumbamine trifluoroacetate	Investigative
T30082	DRUGINFO	D0L8UL	Pseudopalmatine trifluoroacetate	Investigative
T30082	DRUGINFO	D01MVX	TACRINE(8)-4-AMINOQUINOLINE	Investigative
T30082	DRUGINFO	D0L0ZH	TASPINE	Investigative
T30082	DRUGINFO	D0P5YS	TERRITREM B	Investigative
T30082	DRUGINFO	D0D9PI	Tetraethylene Glycol	Investigative
T30082	DRUGINFO	D0P6PQ	THIOCTIC ACID	Investigative
T30082	DRUGINFO	D0PF7F	TOLSERINE	Investigative
T30082	DRUGINFO	D0G5QX	TRIMEDOXIME	Investigative
T30082	DRUGINFO	D0M8SQ	Trimethyl-(3-nitro-phenyl)-ammonium iodide	Investigative
T30082	DRUGINFO	D0O6AH	Trimethyl-(4-oxo-pentyl)-ammonium iodide	Investigative
T30082	DRUGINFO	D0I0EN	TURBINATINE	Investigative
T30082	DRUGINFO	D00AJB	Voacangine	Investigative
T30082	DRUGINFO	D0X4HG	XANTHOSTIGMINE	Investigative
T30082	KEGGPATH	hsa00564:Glycerophospholipid metabolism		
T30082	KEGGPATH	hsa04725:Cholinergic synapse		
T30082	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T30082	WIKIPATH	WP528:Acetylcholine Synthesis		
T30082	WIKIPATH	WP550:Biogenic Amine Synthesis		
T30082	WIKIPATH	WP727:Monoamine Transport		
T30082	WHIZPATH	PW000048:Phospholipid Biosynthesis		
T30082	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T30082	PANTPATH	P00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway		
T30082	PANTPATH	P00043:Muscarinic acetylcholine receptor 2 and 4 signaling pathway		
T30082	PANTPATH	P00044:Nicotinic acetylcholine receptor signaling pathway		
				
T53378	TARGETID	T53378		
T53378	FORMERID	TTDR00209		
T53378	UNIPROID	CAH4_HUMAN		
T53378	TARGNAME	Carbonic anhydrase IV (CA-IV)		
T53378	GENENAME	CA4		
T53378	TARGTYPE	Successful target		
T53378	SYNONYMS	Carbonic anhydrase 4; Carbonate dehydratase IV; CAIV		
T53378	FUNCTION	May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis. It is essential for acid overload removal from the retina and retina epithelium, and acid release in the choriocapillaris in the choroid. Reversible hydration of carbon dioxide.		
T53378	PDBSTRUC	5KU6; 5JNC; 5JNA; 5JN9; 5JN8		
T53378	BIOCLASS	Alpha-carbonic anhydrase		
T53378	ECNUMBER	EC 4.2.1.1		
T53378	SEQUENCE	MRMLLALLALSAARPSASAESHWCYEVQAESSNYPCLVPVKWGGNCQKDRQSPINIVTTKAKVDKKLGRFFFSGYDKKQTWTVQNNGHSVMMLLENKASISGGGLPAPYQAKQLHLHWSDLPYKGSEHSLDGEHFAMEMHIVHEKEKGTSRNVKEAQDPEDEIAVLAFLVEAGTQVNEGFQPLVEALSNIPKPEMSTTMAESSLLDLLPKEEKLRHYFRYLGSLTTPTCDEKVVWTVFREPIQLHREQILAFSQKLYYDKEQTVSMKDNVRPLQQLGQRTVIKSGAPGRPLPWALPALLGPMLACLLAGFLR		
T53378	DRUGINFO	D01MUR	Brinzolamide	Approved
T53378	DRUGINFO	D07HBX	Salicyclic acid	Approved
T53378	DRUGINFO	D0K1QD	Sulfamylon	Approved
T53378	DRUGINFO	D07SDQ	Curcumin	Phase 3
T53378	DRUGINFO	D0A8JP	PARABEN	Phase 3
T53378	DRUGINFO	D0L6HN	PHENOL	Phase 2/3
T53378	DRUGINFO	D0Y6OA	Coumate	Phase 2
T53378	DRUGINFO	D02ECG	Sodium pyruvate	Phase 1/2
T53378	DRUGINFO	D0V0UK	SULFAMIDE	Phase 1
T53378	DRUGINFO	D03SLR	FERULIC ACID	Patented
T53378	DRUGINFO	D0LD9S	SPERMINE	Terminated
T53378	DRUGINFO	D0L2GD	[Cu(CN)2]-	Investigative
T53378	DRUGINFO	D01ENA	[Fe(CN)6]4-	Investigative
T53378	DRUGINFO	D09UQM	1-(3,4-dichlorophenyl)-3-hydroxyurea	Investigative
T53378	DRUGINFO	D0M3PO	2,4-Disulfamyltrifluoromethylaniline	Investigative
T53378	DRUGINFO	D0H3NS	2-oxo-2H-chromene-3-carboxylic acid	Investigative
T53378	DRUGINFO	D0EX9Q	2-Propyl-pentanoic acid 4-sulfamoyl-benzyl ester	Investigative
T53378	DRUGINFO	D0S1OY	2-Propyl-pentanoic acid 4-sulfamoyl-benzylamide	Investigative
T53378	DRUGINFO	D0J2AE	3-Amino-benzenesulfonamide	Investigative
T53378	DRUGINFO	D04NSN	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Investigative
T53378	DRUGINFO	D0P6AM	4-Amino-3-bromo-benzenesulfonamide	Investigative
T53378	DRUGINFO	D0YU8J	4-Amino-3-chloro-benzenesulfonamide	Investigative
T53378	DRUGINFO	D04CVC	4-Amino-3-fluoro-benzenesulfonamide	Investigative
T53378	DRUGINFO	D01STY	4-Amino-3-iodo-benzenesulfonamide	Investigative
T53378	DRUGINFO	D0NN3Q	4-Hydrazino-benzenesulfonamide	Investigative
T53378	DRUGINFO	D0N1AW	6-(aminomethyl)-2H-chromen-2-one	Investigative
T53378	DRUGINFO	D0L5TZ	6-(hydroxymethyl)-2H-chromen-2-one	Investigative
T53378	DRUGINFO	D0G3BI	6-methyl-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T53378	DRUGINFO	D00RNZ	7-(benzyloxy)-2H-chromen-2-one	Investigative
T53378	DRUGINFO	D0H0PQ	Aminocarbonyl dihydrogen phosphate	Investigative
T53378	DRUGINFO	D0E8CC	BENZOLAMIDE	Investigative
T53378	DRUGINFO	D0Y6EL	Carbamoyl phosphate disodium	Investigative
T53378	DRUGINFO	D0V7AA	CATECHIN	Investigative
T53378	DRUGINFO	D07QJJ	CATECHOL	Investigative
T53378	DRUGINFO	D0VD7H	CL-5343	Investigative
T53378	DRUGINFO	D03ZMQ	COUMARIN	Investigative
T53378	DRUGINFO	D00YEF	Decane-1,10-diyl disulfamate	Investigative
T53378	DRUGINFO	D09WSJ	Decyl sulfamate	Investigative
T53378	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T53378	DRUGINFO	D07TAJ	Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate	Investigative
T53378	DRUGINFO	D0Y3TZ	GALLICACID	Investigative
T53378	DRUGINFO	D0U4BB	HERNIARIN	Investigative
T53378	DRUGINFO	D09JPC	Hexane-1,6-diamine	Investigative
T53378	DRUGINFO	D03MXZ	Malonate sodium	Investigative
T53378	DRUGINFO	D0S4NO	N-(5-ethyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T53378	DRUGINFO	D06JVR	N-(5-phenyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T53378	DRUGINFO	D04HQK	N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-benzamide	Investigative
T53378	DRUGINFO	D0T2VH	N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)sulfamide	Investigative
T53378	DRUGINFO	D0L6CN	N-(phosphonacetyl)-L-aspartate	Investigative
T53378	DRUGINFO	D0E3VJ	N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T53378	DRUGINFO	D04PSK	N-[5-(methylthio)-1,3,4-thiadiazol-2-yl]sulfamide	Investigative
T53378	DRUGINFO	D0X5HL	N1-(naphthalen-1-yl)ethane-1,2-diamine	Investigative
T53378	DRUGINFO	D00BMI	N-1,3,4-thiadiazol-2-ylsulfamide	Investigative
T53378	DRUGINFO	D03EAQ	N-hydroxysulfonamides	Investigative
T53378	DRUGINFO	D0D4OV	Octane-1,8-diyl disulfamate	Investigative
T53378	DRUGINFO	D05TLB	Octyl sulfamate	Investigative
T53378	DRUGINFO	D0AU0M	P-Coumaric Acid	Investigative
T53378	DRUGINFO	D02QGI	Pentane-1,5-diamine	Investigative
T53378	DRUGINFO	D0EJ9B	Phenyl Boronic acid	Investigative
T53378	DRUGINFO	D0M6RM	Phenylarsonic acid	Investigative
T53378	DRUGINFO	D00CIW	Phenyl-phosphonic acid	Investigative
T53378	DRUGINFO	D05KTE	SODIUM CITRATE	Investigative
T53378	DRUGINFO	D0GQ9A	Sodium phenylarsonate	Investigative
T53378	DRUGINFO	D0Q4VO	SODIUM PHOSPHATE, DIBASIC, ANHYDROUS	Investigative
T53378	DRUGINFO	D0H7JJ	Sodium sulfamate	Investigative
T53378	DRUGINFO	D0D5XC	Sodium trithiocarbonate	Investigative
T53378	DRUGINFO	D03VDJ	SULFAMATE	Investigative
T53378	DRUGINFO	D0R3DQ	SYL-040003	Investigative
T53378	DRUGINFO	D0Q7DJ	Syringic Acid	Investigative
T53378	DRUGINFO	D0S8RD	Trecadrine	Investigative
T53378	DRUGINFO	D01DOW	Trisodium phosphate	Investigative
T53378	KEGGPATH	hsa00910:Nitrogen metabolism		
T53378	KEGGPATH	hsa04964:Proximal tubule bicarbonate reclamation		
T53378	WIKIPATH	WP2681:Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes		
T53378	WIKIPATH	WP2744:Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes		
T53378	WIKIPATH	WP2770:Reversible Hydration of Carbon Dioxide		
T53378	REACPATH	R-HSA-1237044:Erythrocytes take up carbon dioxide and release oxygen		
T53378	REACPATH	R-HSA-1247673:Erythrocytes take up oxygen and release carbon dioxide		
T53378	REACPATH	R-HSA-1475029:Reversible hydration of carbon dioxide		
				
T80975	TARGETID	T80975		
T80975	FORMERID	TTDS00008		
T80975	UNIPROID	VGFR2_HUMAN		
T80975	TARGNAME	Vascular endothelial growth factor receptor 2 (KDR)		
T80975	GENENAME	KDR		
T80975	TARGTYPE	Successful target		
T80975	SYNONYMS	VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; Fetal liver kinase 1; FLK1; FLK-1; CD309		
T80975	FUNCTION	Plays an essential role in the regulation of angiogenesis, vascular development, vascular permeability, and embryonic hematopoiesis. Promotes proliferation, survival, migration and differentiation of endothelial cells. Promotes reorganization of the actin cytoskeleton. Isoforms lacking a transmembrane domain, such as isoform 2 and isoform 3, may function as decoy receptors for VEGFA, VEGFC and/or VEGFD. Isoform 2 plays an important role as negative regulator of VEGFA- and VEGFC-mediated lymphangiogenesis by limiting the amount of free VEGFA and/or VEGFC and preventing their binding to FLT4. Modulates FLT1 and FLT4 signaling by forming heterodimers. Binding of vascular growth factors to isoform 1 leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate and the activation of protein kinase C. Mediates activation of MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. Mediates phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, reorganization of the actin cytoskeleton and activation of PTK2/FAK1. Required for VEGFA-mediated induction of NOS2 and NOS3, leading to the production of the signaling molecule nitric oxide (NO) by endothelial cells. Phosphorylates PLCG1. Promotes phosphorylation of FYN, NCK1, NOS3, PIK3R1, PTK2/FAK1 and SRC. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFC and VEGFD.		
T80975	PDBSTRUC	6GQQ; 6GQP; 6GQO; 5OYJ; 5EW3		
T80975	BIOCLASS	Kinase		
T80975	ECNUMBER	EC 2.7.10.1		
T80975	SEQUENCE	MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKANTTLQITCRGQRDLDWLWPNNQSGSEQRVEVTECSDGLFCKTLTIPKVIGNDTGAYKCFYRETDLASVIYVYVQDYRSPFIASVSDQHGVVYITENKNKTVVIPCLGSISNLNVSLCARYPEKRFVPDGNRISWDSKKGFTIPSYMISYAGMVFCEAKINDESYQSIMYIVVVVGYRIYDVVLSPSHGIELSVGEKLVLNCTARTELNVGIDFNWEYPSSKHQHKKLVNRDLKTQSGSEMKKFLSTLTIDGVTRSDQGLYTCAASSGLMTKKNSTFVRVHEKPFVAFGSGMESLVEATVGERVRIPAKYLGYPPPEIKWYKNGIPLESNHTIKAGHVLTIMEVSERDTGNYTVILTNPISKEKQSHVVSLVVYVPPQIGEKSLISPVDSYQYGTTQTLTCTVYAIPPPHHIHWYWQLEEECANEPSQAVSVTNPYPCEEWRSVEDFQGGNKIEVNKNQFALIEGKNKTVSTLVIQAANVSALYKCEAVNKVGRGERVISFHVTRGPEITLQPDMQPTEQESVSLWCTADRSTFENLTWYKLGPQPLPIHVGELPTPVCKNLDTLWKLNATMFSNSTNDILIMELKNASLQDQGDYVCLAQDRKTKKRHCVVRQLTVLERVAPTITGNLENQTTSIGESIEVSCTASGNPPPQIMWFKDNETLVEDSGIVLKDGNRNLTIRRVRKEDEGLYTCQACSVLGCAKVEAFFIIEGAQEKTNLEIIILVGTAVIAMFFWLLLVIILRTVKRANGGELKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQDGKDYIVLPISETLSMEEDSGLSLPTSPVSCMEEEEVCDPKFHYDNTAGISQYLQNSKRKSRPVSVKTFEDIPLEEPEVKVIPDDNQTDSGMVLASEELKTLEDRTKLSPSFGGMVPSKSRESVASEGSNQTSGYQSGYHSDDTDTTVYSSEEAELLKLIEIGVQTGSTAQILQPDSGTTLSSPPV		
T80975	DRUGINFO	D01ZRI	Axitinib	Approved
T80975	DRUGINFO	D0IQ6P	Cabozantinib	Approved
T80975	DRUGINFO	D0R0FO	Lenvatinib	Approved
T80975	DRUGINFO	D0F0ZY	Pazopanib HCl	Approved
T80975	DRUGINFO	D09HVD	Ramucirumab	Approved
T80975	DRUGINFO	D09GDD	Regorafenib	Approved
T80975	DRUGINFO	D01PZD	Romiplostim	Approved
T80975	DRUGINFO	D0W5HK	Sorafenib	Approved
T80975	DRUGINFO	D0R0MW	Sunitinib	Approved
T80975	DRUGINFO	D0W7JZ	Tivozanib	Approved
T80975	DRUGINFO	D0G6QF	Vandetanib	Approved
T80975	DRUGINFO	D0SZ6E	YN-968D1	Approved
T80975	DRUGINFO	D0HS5V	Brivanib	Phase 3
T80975	DRUGINFO	D09VMI	Cediranib	Phase 3
T80975	DRUGINFO	D02WVT	E-3810	Phase 3
T80975	DRUGINFO	D03JTG	Fruquintinib	Phase 3
T80975	DRUGINFO	D0Q9CY	HKI-272	Phase 3
T80975	DRUGINFO	D0D7BX	Rivoceranib	Phase 3
T80975	DRUGINFO	D0A1AQ	Rosiglitazone + metformin	Phase 3
T80975	DRUGINFO	D05PWX	Sulfatinib	Phase 3
T80975	DRUGINFO	D05BLN	MGCD516	Phase 2/3
T80975	DRUGINFO	D0HN7I	Alacizumab pegol	Phase 2
T80975	DRUGINFO	D07NOI	BAY-57-9352	Phase 2
T80975	DRUGINFO	D0R6UV	BMS-690514	Phase 2
T80975	DRUGINFO	D00YPR	CP-547632	Phase 2
T80975	DRUGINFO	D0ZN1R	Delphinidin	Phase 2
T80975	DRUGINFO	D0Z6MT	Famitinib	Phase 2
T80975	DRUGINFO	DN3Z5D	L-DOS47	Phase 2
T80975	DRUGINFO	D03AND	RAF265	Phase 2
T80975	DRUGINFO	D09LOZ	TTAC-0001	Phase 2
T80975	DRUGINFO	D0P6DJ	VATALANIB	Phase 2
T80975	DRUGINFO	D0D1GF	XL880	Phase 2
T80975	DRUGINFO	D0U6BQ	Anti-VEGFR2 CD8 cell therapy	Phase 1/2
T80975	DRUGINFO	D0Q0HZ	Elpamotide	Phase 1/2
T80975	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T80975	DRUGINFO	D04NOE	OTSGC-A24	Phase 1/2
T80975	DRUGINFO	D0FA6S	Altiratinib	Phase 1
T80975	DRUGINFO	D0FD6D	CEP-11981	Phase 1
T80975	DRUGINFO	D0CY1B	CYC116	Phase 1
T80975	DRUGINFO	D09ETH	E-7050	Phase 1
T80975	DRUGINFO	D07HRU	KRN633	Phase 1
T80975	DRUGINFO	D0N8RV	OSI-930	Phase 1
T80975	DRUGINFO	D0GM6E	Pegdinetanib	Phase 1
T80975	DRUGINFO	D0ZI5A	PF-00337210	Phase 1
T80975	DRUGINFO	D0F5JZ	PLX-4720	Phase 1
T80975	DRUGINFO	D0T2ER	TAK-593	Phase 1
T80975	DRUGINFO	D07PNT	XL999	Phase 1
T80975	DRUGINFO	D01AXK	Antibodie derivative 10	Patented
T80975	DRUGINFO	D08XAY	Antibodie derivative 6	Patented
T80975	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T80975	DRUGINFO	D0JU8E	Pyrimidine derivative 12	Patented
T80975	DRUGINFO	D0G1YI	Pyrimidine derivative 13	Patented
T80975	DRUGINFO	D06BTN	Pyrimidine derivative 14	Patented
T80975	DRUGINFO	D06HEO	Pyrimidine derivative 4	Patented
T80975	DRUGINFO	D05PRG	Quinazoline derivative 15	Patented
T80975	DRUGINFO	D0DV4X	Quinazoline derivative 16	Patented
T80975	DRUGINFO	D08OXH	Quinoline and quinazoline derivative 1	Patented
T80975	DRUGINFO	D00DQX	Motesanib	Discontinued in Phase 3
T80975	DRUGINFO	D09DJU	SU-14813	Discontinued in Phase 2
T80975	DRUGINFO	D0E8VF	IMC-1C11	Discontinued in Phase 1
T80975	DRUGINFO	D06GBK	AG1295	Terminated
T80975	DRUGINFO	D0H4GI	CEP-5214	Terminated
T80975	DRUGINFO	D06GJO	(2-Methoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	Investigative
T80975	DRUGINFO	D0A9ZQ	(3-Phenoxy-phenyl)-(5-phenyl-oxazol-2-yl)-amine	Investigative
T80975	DRUGINFO	D07AIB	(4-Phenoxy-phenyl)-quinazolin-4-yl-amine	Investigative
T80975	DRUGINFO	D0D3YL	(5-Phenyl-oxazol-2-yl)-m-tolyl-amine	Investigative
T80975	DRUGINFO	D0V9DQ	[3-(5-Phenyl-oxazol-2-ylamino)-phenyl]-methanol	Investigative
T80975	DRUGINFO	D0XC6G	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	Investigative
T80975	DRUGINFO	D03HQK	2-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	Investigative
T80975	DRUGINFO	D0E9DI	2-(p-toluidino)-4-phenylpyrimidine-5-carbonitrile	Investigative
T80975	DRUGINFO	D0J3OZ	2-(pyrimidin-4-ylamino)thiazole-5-carbonitrile	Investigative
T80975	DRUGINFO	D01LEV	3-((3-bromothiophen-2-yl)methylene)indolin-2-one	Investigative
T80975	DRUGINFO	D0M9OF	3-(1H-Indol-2-yl)-1H-quinolin-2-one	Investigative
T80975	DRUGINFO	D00YWZ	3-(4-aminophenyl)thieno[3,2-c]pyridin-4-amine	Investigative
T80975	DRUGINFO	D0EK0G	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T80975	DRUGINFO	D0J2XD	3-(5-Phenyl-oxazol-2-ylamino)-benzonitrile	Investigative
T80975	DRUGINFO	D0UX3T	3-(5-Thiophen-3-yl-pyridin-3-yl)-1H-indole	Investigative
T80975	DRUGINFO	D00NYT	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Investigative
T80975	DRUGINFO	D0C3WY	3,4-diphenyl-1H-pyrrole-2,5-dione	Investigative
T80975	DRUGINFO	D0YN1E	3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine	Investigative
T80975	DRUGINFO	D07QMC	3-Benzimidazol-2-ylhydroquinolin-2-one	Investigative
T80975	DRUGINFO	D0F0AU	3-methyl-1H-thieno[2,3-c]pyrazole-5-carboxamide	Investigative
T80975	DRUGINFO	D09TQP	3-phenyl-1,4-dihydroindeno[1,2-c]pyrazole	Investigative
T80975	DRUGINFO	D0Y9GK	4-(4-aminophenyl)-1H-indazol-3yl-amine	Investigative
T80975	DRUGINFO	D09AKX	4-(4-m-Tolylamino-phthalazin-1-yl)-benzamide	Investigative
T80975	DRUGINFO	D08JSJ	4-(4-p-Tolylamino-phthalazin-1-yl)-benzamide	Investigative
T80975	DRUGINFO	D09LEK	4-(5-Phenyl-oxazol-2-ylamino)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D0D3QA	4-(isoquinolin-5-yl)-N-m-tolylphthalazin-1-amine	Investigative
T80975	DRUGINFO	D03HTT	4-(isoquinolin-5-yl)-N-o-tolylphthalazin-1-amine	Investigative
T80975	DRUGINFO	D0KH5T	4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline	Investigative
T80975	DRUGINFO	D0UZ5W	4-Chloro-N-(2-chloro-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D0V4BR	4-Chloro-N-(2-methyl-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D05THI	4-Chloro-N-(3-chloro-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D09MSA	4-Chloro-N-(4-chloro-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D0C6OD	4-Chloro-N-(4-nitro-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D06BVH	4-phenyl-2-(phenylamino)pyrimidine-5-carbonitrile	Investigative
T80975	DRUGINFO	D0U3ZP	5-(4-Methoxy-phenyl)-1-phenyl-1H-benzoimidazole	Investigative
T80975	DRUGINFO	D00MCJ	6-(1H-Benzoimidazol-2-yl)-benzocyclohepten-7-one	Investigative
T80975	DRUGINFO	D09HXU	6-o-tolylquinazolin-2-amine	Investigative
T80975	DRUGINFO	D04RQU	8-methyl-4H,7H-indolo[6,5,4-cd]indol-5-one	Investigative
T80975	DRUGINFO	D0EE6A	AAL-993	Investigative
T80975	DRUGINFO	D07SRX	AG-E-85378	Investigative
T80975	DRUGINFO	D0AK4H	AMG-429	Investigative
T80975	DRUGINFO	D0N7AJ	AST-487	Investigative
T80975	DRUGINFO	D05GMB	BIBF-1202	Investigative
T80975	DRUGINFO	D0M4SY	BMS-536924	Investigative
T80975	DRUGINFO	D0Z7TM	BMS-645737	Investigative
T80975	DRUGINFO	D0RG0Z	BX-795	Investigative
T80975	DRUGINFO	D0IX7Y	BX-912	Investigative
T80975	DRUGINFO	D0C6KI	CB-676475	Investigative
T80975	DRUGINFO	D09QBA	CEP-5104	Investigative
T80975	DRUGINFO	D0R3IK	EPI-0030	Investigative
T80975	DRUGINFO	D0ST4P	IM-023911	Investigative
T80975	DRUGINFO	D0Z8TR	IM-094261	Investigative
T80975	DRUGINFO	D0A9ZP	IM-094882	Investigative
T80975	DRUGINFO	D00GVV	Indolin-2-one deriv. 4b	Investigative
T80975	DRUGINFO	D02AOT	Isoindolinone Urea derivative	Investigative
T80975	DRUGINFO	D0Q4EQ	JNJ-38158471	Investigative
T80975	DRUGINFO	D02RWK	K-252a analogue	Investigative
T80975	DRUGINFO	D08BJR	Ki-20227	Investigative
T80975	DRUGINFO	D0E3HC	L000021649	Investigative
T80975	DRUGINFO	D07XBW	N-(2,4-Dichloro-benzoyl)-benzenesulfonamide	Investigative
T80975	DRUGINFO	D0M2QA	N-(3-Bromo-benzoyl)-4-chloro-benzenesulfonamide	Investigative
T80975	DRUGINFO	D0BM4F	Phenyl-(5-phenyl-oxazol-2-yl)-amine	Investigative
T80975	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T80975	DRUGINFO	D0PP6Y	PMID23639540C13a	Investigative
T80975	DRUGINFO	D03EHM	PP121	Investigative
T80975	DRUGINFO	D09LKM	Pyrazolo[1,5-a]pyrimidine 3G	Investigative
T80975	DRUGINFO	D07OIZ	R-84	Investigative
T80975	DRUGINFO	D09XIL	Ro-4396686	Investigative
T80975	DRUGINFO	D09LPL	SU-11652	Investigative
T80975	DRUGINFO	D0H1OK	TG-100435	Investigative
T80975	DRUGINFO	D07OSK	VEGF receptor 2 kinase inhibitor I	Investigative
T80975	KEGGPATH	hsa04014:Ras signaling pathway		
T80975	KEGGPATH	hsa04015:Rap1 signaling pathway		
T80975	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T80975	KEGGPATH	hsa04144:Endocytosis		
T80975	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T80975	KEGGPATH	hsa04370:VEGF signaling pathway		
T80975	KEGGPATH	hsa04510:Focal adhesion		
T80975	KEGGPATH	hsa05205:Proteoglycans in cancer		
T80975	WIKIPATH	WP1539:Angiogenesis		
T80975	WIKIPATH	WP1919:Signaling by VEGF		
T80975	WIKIPATH	WP2406:Cardiac Progenitor Differentiation		
T80975	WIKIPATH	WP259:Nifedipine Activity		
T80975	WIKIPATH	WP306:Focal Adhesion		
T80975	REACPATH	R-HSA-194306:Neurophilin interactions with VEGF and VEGFR		
T80975	REACPATH	R-HSA-195399:VEGF binds to VEGFR leading to receptor dimerization		
T80975	REACPATH	R-HSA-216083:Integrin cell surface interactions		
T80975	REACPATH	R-HSA-3928663:EPHA-mediated growth cone collapse		
T80975	REACPATH	R-HSA-4420097:VEGFA-VEGFR2 Pathway		
T80975	REACPATH	R-HSA-5218921:VEGFR2 mediated cell proliferation		
T80975	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T80975	INTEPATH	avb3_integrin_pathway:Integrins in angiogenesis		
T80975	INTEPATH	hes_heypathway:Notch-mediated HES/HEY network		
T80975	INTEPATH	hif2pathway:HIF-2-alpha transcription factor network		
T80975	INTEPATH	integrin3_pathway:Beta3 integrin cell surface interactions		
T80975	INTEPATH	s1p_s1p1_pathway:S1P1 pathway		
T80975	INTEPATH	shp2_pathway:SHP2 signaling		
T80975	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T80975	INTEPATH	vegf_vegfr_pathway:VEGF and VEGFR signaling network		
T80975	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T80975	PANTPATH	P00005:Angiogenesis		
T80975	PANTPATH	P00056:VEGF signaling pathway		
				
T74312	TARGETID	T74312		
T74312	FORMERID	TTDS00090		
T74312	UNIPROID	FLT3_HUMAN		
T74312	TARGNAME	Fms-like tyrosine kinase 3 (FLT-3)		
T74312	GENENAME	FLT3		
T74312	TARGTYPE	Successful target		
T74312	SYNONYMS	Stem cell tyrosine kinase 1; STK1; STK-1; Receptor-type tyrosine-protein kinase FLT3; Fetal liver kinase-2; FLT-3; FLK2; FLK-2; FL cytokine receptor; CD135		
T74312	FUNCTION	Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or STAT5B. Activation of wild-type FLT3 causes only marginal activation of STAT5A or STAT5B. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways.		
T74312	PDBSTRUC	6IL3; 5X02; 4XUF; 4RT7; 3QS9		
T74312	BIOCLASS	Kinase		
T74312	ECNUMBER	EC 2.7.10.1		
T74312	SEQUENCE	MPALARDGGQLPLLVVFSAMIFGTITNQDLPVIKCVLINHKNNDSSVGKSSSYPMVSESPEDLGCALRPQSSGTVYEAAAVEVDVSASITLQVLVDAPGNISCLWVFKHSSLNCQPHFDLQNRGVVSMVILKMTETQAGEYLLFIQSEATNYTILFTVSIRNTLLYTLRRPYFRKMENQDALVCISESVPEPIVEWVLCDSQGESCKEESPAVVKKEEKVLHELFGTDIRCCARNELGRECTRLFTIDLNQTPQTTLPQLFLKVGEPLWIRCKAVHVNHGFGLTWELENKALEEGNYFEMSTYSTNRTMIRILFAFVSSVARNDTGYYTCSSSKHPSQSALVTIVEKGFINATNSSEDYEIDQYEEFCFSVRFKAYPQIRCTWTFSRKSFPCEQKGLDNGYSISKFCNHKHQPGEYIFHAENDDAQFTKMFTLNIRRKPQVLAEASASQASCFSDGYPLPSWTWKKCSDKSPNCTEEITEGVWNRKANRKVFGQWVSSSTLNMSEAIKGFLVKCCAYNSLGTSCETILLNSPGPFPFIQDNISFYATIGVCLLFIVVLTLLICHKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFHRTWTEIFKEHNFSFYPTFQSHPNSSMPGSREVQIHPDSDQISGLHGNSFHSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNVDGRVSECPHTYQNRRPFSREMDLGLLSPQAQVEDS		
T74312	DRUGINFO	D04KZY	Gilteritinib	Approved
T74312	DRUGINFO	D09HNV	Intedanib	Approved
T74312	DRUGINFO	D0V9WF	Lestaurtinib	Approved (orphan drug)
T74312	DRUGINFO	D07NVU	Midostaurin	Approved
T74312	DRUGINFO	D09TAB	Pexidartinib	Approved
T74312	DRUGINFO	D0H0EQ	Ponatinib	Approved
T74312	DRUGINFO	D01XYJ	Zidovudine	Approved
T74312	DRUGINFO	D07KYT	AC220	Phase 3
T74312	DRUGINFO	D0PN8H	Pacritinib	Phase 3
T74312	DRUGINFO	D0R6UV	BMS-690514	Phase 2
T74312	DRUGINFO	D0Q8CV	CDX-301	Phase 2
T74312	DRUGINFO	D0Z6MT	Famitinib	Phase 2
T74312	DRUGINFO	D06KTJ	TAK-659	Phase 2
T74312	DRUGINFO	D28HJI	FF-10101	Phase 1/2
T74312	DRUGINFO	DI1VM3	HM43239	Phase 1/2
T74312	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T74312	DRUGINFO	D0V2ZC	SEL24	Phase 1/2
T74312	DRUGINFO	D0X8ID	SEL-24	Phase 1/2
T74312	DRUGINFO	D07UUB	4SC-203	Phase 1
T74312	DRUGINFO	D91CMX	AMG 427	Phase 1
T74312	DRUGINFO	D0YQ9I	FF-10101-01	Phase 1
T74312	DRUGINFO	DKCU40	FN-1501	Phase 1
T74312	DRUGINFO	D07ZNF	IMC-EB10	Phase 1
T74312	DRUGINFO	D0D1HS	Ki23819	Phase 1
T74312	DRUGINFO	D00ABO	KW-2449	Phase 1
T74312	DRUGINFO	D10LNV	MRX-2843	Phase 1
T74312	DRUGINFO	DIA08F	SKI-G-801	Phase 1
T74312	DRUGINFO	D0MX7B	Carboxamide derivative 4	Patented
T74312	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T74312	DRUGINFO	D0IT6Q	Tandutinib	Discontinued in Phase 2
T74312	DRUGINFO	D04GFO	MC-2001	Preclinical
T74312	DRUGINFO	D06GBK	AG1295	Terminated
T74312	DRUGINFO	D01MIP	SU5614	Terminated
T74312	DRUGINFO	D09OLH	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0G0KQ	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0D7ZL	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0H7MF	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0XS9E	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0I7QX	(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0ZO8Z	2-(3,4-dimethoxybenzamido)thiophene-3-carboxamide	Investigative
T74312	DRUGINFO	D0Y9GK	4-(4-aminophenyl)-1H-indazol-3yl-amine	Investigative
T74312	DRUGINFO	D0D0TQ	AKN-028	Investigative
T74312	DRUGINFO	D0N7AJ	AST-487	Investigative
T74312	DRUGINFO	D0L0MZ	Bis(5-acetoxybenzo[b]furan-2-yl)methanone	Investigative
T74312	DRUGINFO	D07AXL	Bis(5-aminobenzo[b]furan-2-yl)methanone	Investigative
T74312	DRUGINFO	D0I3XZ	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Investigative
T74312	DRUGINFO	D02OBA	Bis(5-hydroxybenzo[b]furan-2-yl)methanone	Investigative
T74312	DRUGINFO	D03VAA	Bis(6-hydroxybenzo[b]furan-2-yl)methanone	Investigative
T74312	DRUGINFO	D0Z3DW	Bis(benzo[b]furan-2-yl)methanone	Investigative
T74312	DRUGINFO	D0G5YI	Di(1H-indol-2-yl)methanone	Investigative
T74312	DRUGINFO	D0N3XP	G749	Investigative
T74312	DRUGINFO	D0UN9O	GTP-14564	Investigative
T74312	DRUGINFO	D0X1JO	IN1479	Investigative
T74312	DRUGINFO	D0Y4BL	JNJ-28312141	Investigative
T74312	DRUGINFO	D0X6KS	N-[4-(3-amino-1H-indazol-4-yl)phenyl]benzamide	Investigative
T74312	DRUGINFO	D06UKS	PMID21982499C14k	Investigative
T74312	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T74312	DRUGINFO	D0E7VO	PMID24900538C2c	Investigative
T74312	DRUGINFO	D0X7JK	TCS-359	Investigative
T74312	DRUGINFO	D07ADX	URMC-099	Investigative
T74312	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T74312	KEGGPATH	hsa04640:Hematopoietic cell lineage		
T74312	KEGGPATH	hsa05200:Pathways in cancer		
T74312	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T74312	KEGGPATH	hsa05221:Acute myeloid leukemia		
T74312	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
				
T75243	TARGETID	T75243		
T75243	FORMERID	TTDS00265		
T75243	UNIPROID	MTOR_HUMAN		
T75243	TARGNAME	Serine/threonine-protein kinase mTOR (mTOR)		
T75243	GENENAME	MTOR		
T75243	TARGTYPE	Successful target		
T75243	SYNONYMS	Target of rapamycin; TOR kinase; Rapamycin target protein 1; Rapamycin target protein; Rapamycin and FKBP12 target 1; RAPT1; RAFT1; Mechanistic target of rapamycin; Mammalian target of rapamycin; FRAP2; FRAP1; FRAP; FKBP12-rapamycin complex-associated protein; FKBP-rapamycin associated protein; FK506-binding protein 12-rapamycin complex-associated protein 1		
T75243	FUNCTION	MTOR directly or indirectly regulates the phosphorylation of at least 800 proteins. Functions as part of 2 structurally and functionally distinct signaling complexes mTORC1 and mTORC2 (mTOR complex 1 and 2). Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. This includes phosphorylation of EIF4EBP1 and release of its inhibition toward the elongation initiation factor 4E (eiF4E). Moreover, phosphorylates and activates RPS6KB1 and RPS6KB2 that promote protein synthesis by modulating the activity of their downstream targets including ribosomal protein S6, eukaryotic translation initiation factor EIF4B, and the inhibitor of translation initiation PDCD4. Stimulates the pyrimidine biosynthesis pathway, both by acute regulation through RPS6KB1-mediated phosphorylation of the biosynthetic enzyme CAD, and delayed regulation, through transcriptional enhancement of the pentose phosphate pathway which produces 5-phosphoribosyl-1-pyrophosphate (PRPP), an allosteric activator of CAD at a later step in synthesis, this function is dependent on the mTORC1 complex. Regulates ribosome synthesis by activating RNA polymerase III-dependent transcription through phosphorylation and inhibition of MAF1 an RNA polymerase III-repressor. In parallel to protein synthesis, also regulates lipid synthesis through SREBF1/SREBP1 and LPIN1. To maintain energy homeostasis mTORC1 may also regulate mitochondrial biogenesis through regulation of PPARGC1A. mTORC1 also negatively regulates autophagy through phosphorylation of ULK1. Under nutrient sufficiency, phosphorylates ULK1 at 'Ser-758', disrupting the interaction with AMPK and preventing activation of ULK1. Also prevents autophagy through phosphorylation of the autophagy inhibitor DAP. Also prevents autophagy by phosphorylating RUBCNL/Pacer under nutrient-rich conditions. mTORC1 exerts a feedback control on upstream growth factor signaling that includes phosphorylation and activation of GRB10 a INSR-dependent signaling suppressor. Among other potential targets mTORC1 may phosphorylate CLIP1 and regulate microtubules. As part of the mTORC2 complex MTOR may regulate other cellular processes including survival and organization of the cytoskeleton. Plays a critical role in the phosphorylation at 'Ser-473' of AKT1, a pro-survival effector of phosphoinositide 3-kinase, facilitating its activation by PDK1. mTORC2 may regulate the actin cytoskeleton, through phosphorylation of PRKCA, PXN and activation of the Rho-type guanine nucleotide exchange factors RHOA and RAC1A or RAC1B. mTORC2 also regulates the phosphorylation of SGK1 at 'Ser-422'. Regulates osteoclastogenesis by adjusting the expression of CEBPB isoforms. Plays an important regulatory role in the circadian clock function; regulates period length and rhythm amplitude of the suprachiasmatic nucleus (SCN) and liver clocks. Serine/threonine protein kinase which is a central regulator of cellular metabolism, growth and survival in response to hormones, growth factors, nutrients, energy and stress signals.		
T75243	PDBSTRUC	6BCX; 6BCU; 5ZCS; 5WBY; 5WBU		
T75243	BIOCLASS	Kinase		
T75243	ECNUMBER	EC 2.7.11.1		
T75243	SEQUENCE	MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW		
T75243	DRUGINFO	D0K3QS	Everolimus	Approved
T75243	DRUGINFO	D03FCF	Novolimus	Approved
T75243	DRUGINFO	D0S5LO	PF-04449913	Approved
T75243	DRUGINFO	D03LJR	Sirolimus	Approved
T75243	DRUGINFO	D0ES1Q	Temsirolimus	Approved
T75243	DRUGINFO	D0V7WS	Zotarolimus	Approved
T75243	DRUGINFO	D0O3CV	Ridaforolimus	Phase 3
T75243	DRUGINFO	D0W3UV	ABI-009	Phase 2
T75243	DRUGINFO	D0Z2UQ	AZD2014	Phase 2
T75243	DRUGINFO	D0VG0D	BEZ235	Phase 2
T75243	DRUGINFO	D0O6VZ	GDC-0980/RG7422	Phase 2
T75243	DRUGINFO	D03DPZ	INK128	Phase 2
T75243	DRUGINFO	D0H1WC	LY3023414	Phase 2
T75243	DRUGINFO	D00BUO	MM-141	Phase 2
T75243	DRUGINFO	D0H7XL	OSI-027	Phase 2
T75243	DRUGINFO	D0N5JZ	PF-04691502	Phase 2
T75243	DRUGINFO	D0D8JB	PF-05212384	Phase 2
T75243	DRUGINFO	D0TU7B	PQR309	Phase 2
T75243	DRUGINFO	D00KTV	Salirasib	Phase 2
T75243	DRUGINFO	D01PGR	SAR245409	Phase 2
T75243	DRUGINFO	D03NJY	SF1126	Phase 2
T75243	DRUGINFO	D0X7IN	BGT226	Phase 1/2
T75243	DRUGINFO	D05EXN	CC-223	Phase 1/2
T75243	DRUGINFO	D03IXK	ME-344	Phase 1/2
T75243	DRUGINFO	D08PSC	BI 860585	Phase 1
T75243	DRUGINFO	D0R9VX	DS-3078	Phase 1
T75243	DRUGINFO	D0X4RT	DS-7423	Phase 1
T75243	DRUGINFO	D0U8QH	GDC-0349	Phase 1
T75243	DRUGINFO	D0QN5M	LAM-001	Phase 1
T75243	DRUGINFO	D0Y0FE	PWT-33597	Phase 1
T75243	DRUGINFO	D0U3DP	VS-5584	Phase 1
T75243	DRUGINFO	D0X5VI	PMID25726713-Compound-47	Patented
T75243	DRUGINFO	D0WJ3W	PMID25726713-Compound-48	Patented
T75243	DRUGINFO	D07TVO	PMID25726713-Compound-49	Patented
T75243	DRUGINFO	D0Y8JF	PMID25726713-Compound-50	Patented
T75243	DRUGINFO	D0KH7Q	PMID25726713-Compound-51	Patented
T75243	DRUGINFO	D0K1VK	AZD8055	Discontinued in Phase 1/2
T75243	DRUGINFO	D0H5MX	TAFA-93	Discontinued in Phase 1
T75243	DRUGINFO	D05SXC	SCR-44001	Terminated
T75243	DRUGINFO	D00GQM	(4-(6-morpholino-9H-purin-2-yl)phenyl)methanol	Investigative
T75243	DRUGINFO	D0X7TB	2-(2-Methyl-morpholin-4-yl)-benzo[h]chromen-4-one	Investigative
T75243	DRUGINFO	D07JKB	2-(6-morpholino-9H-purin-2-yl)phenol	Investigative
T75243	DRUGINFO	D0P0UV	2-chloro-N-(6-cyanopyridin-3-yl)propanamide	Investigative
T75243	DRUGINFO	D0T0BY	2-Morpholin-4-yl-pyrimido[2,1-a]isoquinolin-4-one	Investigative
T75243	DRUGINFO	D0TC5H	3-(6-morpholino-9H-purin-2-yl)phenol	Investigative
T75243	DRUGINFO	D0Y1DR	4-(2-(1H-indol-6-yl)-9H-purin-6-yl)morpholine	Investigative
T75243	DRUGINFO	D0AH8Q	4-(2-(thiophen-2-yl)-9H-purin-6-yl)morpholine	Investigative
T75243	DRUGINFO	D0F1SI	4-(2-(thiophen-3-yl)-9H-purin-6-yl)morpholine	Investigative
T75243	DRUGINFO	D09FBN	4-(6-morpholino-9H-purin-2-yl)phenol	Investigative
T75243	DRUGINFO	D0U8GR	AP-21967	Investigative
T75243	DRUGINFO	D0N9TK	AR-mTOR-26	Investigative
T75243	DRUGINFO	D02TCF	C-16-(S)-3-methylindolerapamycin	Investigative
T75243	DRUGINFO	D0JD4S	CU-906	Investigative
T75243	DRUGINFO	D0H4KF	EC-0565	Investigative
T75243	DRUGINFO	D0A8ES	EC-0845	Investigative
T75243	DRUGINFO	D09VHS	EM-101	Investigative
T75243	DRUGINFO	D0W1ST	Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate	Investigative
T75243	DRUGINFO	D02ELN	HM-5016699	Investigative
T75243	DRUGINFO	D0J9PK	OXA-01	Investigative
T75243	DRUGINFO	D07NFT	P-2281	Investigative
T75243	DRUGINFO	D0QE9F	P-6915	Investigative
T75243	DRUGINFO	D05RSS	PF-03772304	Investigative
T75243	DRUGINFO	D03XRZ	PF-05094037	Investigative
T75243	DRUGINFO	D03EHM	PP121	Investigative
T75243	DRUGINFO	D0H2CM	PP-242	Investigative
T75243	DRUGINFO	D01AQN	Rapamycin complexed with immunophilin FKBP12	Investigative
T75243	DRUGINFO	D0E1YN	SB-2280	Investigative
T75243	DRUGINFO	D05SOW	SX-MTR1	Investigative
T75243	DRUGINFO	D0H0HR	torin 1	Investigative
T75243	DRUGINFO	D2B7WM	Torin2	Investigative
T75243	DRUGINFO	D08BTX	X-387	Investigative
T75243	KEGGPATH	hsa04012:ErbB signaling pathway		
T75243	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T75243	KEGGPATH	hsa04150:mTOR signaling pathway		
T75243	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T75243	KEGGPATH	hsa04152:AMPK signaling pathway		
T75243	KEGGPATH	hsa04910:Insulin signaling pathway		
T75243	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T75243	KEGGPATH	hsa04920:Adipocytokine signaling pathway		
T75243	KEGGPATH	hsa04930:Type II diabetes mellitus		
T75243	KEGGPATH	hsa05200:Pathways in cancer		
T75243	KEGGPATH	hsa05205:Proteoglycans in cancer		
T75243	KEGGPATH	hsa05206:MicroRNAs in cancer		
T75243	KEGGPATH	hsa05214:Glioma		
T75243	KEGGPATH	hsa05215:Prostate cancer		
T75243	KEGGPATH	hsa05221:Acute myeloid leukemia		
T75243	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T75243	KEGGPATH	hsa05231:Choline metabolism in cancer		
T75243	WIKIPATH	WP1403:AMPK Signaling		
T75243	WIKIPATH	WP1471:TOR Signaling		
T75243	WIKIPATH	WP1544:MicroRNAs in cardiomyocyte hypertrophy		
T75243	WIKIPATH	WP1584:Type II diabetes mellitus		
T75243	WIKIPATH	WP1799:Costimulation by the CD28 family		
T75243	WIKIPATH	WP1913:Signaling by Insulin receptor		
T75243	WIKIPATH	WP1982:SREBP signalling		
T75243	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T75243	WIKIPATH	WP2011:SREBF and miR33 in cholesterol and lipid homeostasis		
T75243	WIKIPATH	WP2018:RANKL/RANK Signaling Pathway		
T75243	WIKIPATH	WP2032:TSH signaling pathway		
T75243	WIKIPATH	WP2034:Leptin signaling pathway		
T75243	WIKIPATH	WP2035:FSH signaling pathway		
T75243	WIKIPATH	WP2203:TSLP Signaling Pathway		
T75243	WIKIPATH	WP2263:Prostate Cancer		
T75243	WIKIPATH	WP2374:Oncostatin M Signaling Pathway		
T75243	WIKIPATH	WP2380:BDNF signaling pathway		
T75243	WIKIPATH	WP244:Alpha 6 Beta 4 signaling pathway		
T75243	WIKIPATH	WP2571:Polycystic Kidney Disease Pathway		
T75243	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T75243	WIKIPATH	WP2677:Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)		
T75243	WIKIPATH	WP2795:Cardiac Hypertrophic Response		
T75243	WIKIPATH	WP2870:Extracellular vesicle-mediated signaling in recipient cells		
T75243	WIKIPATH	WP363:Wnt Signaling Pathway Netpath		
T75243	WIKIPATH	WP437:EGF/EGFR Signaling Pathway		
T75243	WIKIPATH	WP481:Insulin Signaling		
T75243	WIKIPATH	WP585:Interferon type I signaling pathways		
T75243	WIKIPATH	WP615:Senescence and Autophagy in Cancer		
T75243	WIKIPATH	WP673:ErbB Signaling Pathway		
T75243	WHIZPATH	PW000659:Leucine Stimulation on Insulin Signaling		
T75243	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T75243	REACPATH	R-HSA-1632852:Macroautophagy		
T75243	REACPATH	R-HSA-166208:mTORC1-mediated signalling		
T75243	REACPATH	R-HSA-3371571:HSF1-dependent transactivation		
T75243	REACPATH	R-HSA-389357:CD28 dependent PI3K/Akt signaling		
T75243	REACPATH	R-HSA-5218920:VEGFR2 mediated vascular permeability		
T75243	REACPATH	R-HSA-5628897:TP53 Regulates Metabolic Genes		
T75243	REACPATH	R-HSA-5674400:Constitutive Signaling by AKT1 E17K in Cancer		
T75243	INTEPATH	cdc42_pathway:CDC42 signaling events		
T75243	INTEPATH	cxcr3pathway:CXCR3-mediated signaling events		
T75243	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T75243	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T75243	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T75243	INTEPATH	et_egfrpathway:EGFR-dependent Endothelin signaling events		
T75243	INTEPATH	ifngpathway:IFN-gamma pathway		
T75243	INTEPATH	il12_2pathway:IL12-mediated signaling events		
T75243	INTEPATH	il2_pi3kpathway:IL2 signaling events mediated by PI3K		
T75243	INTEPATH	il4_2pathway:IL4-mediated signaling events		
T75243	INTEPATH	lkb1_pathway:LKB1 signaling events		
T75243	INTEPATH	met_pathway:Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)		
T75243	INTEPATH	mtor_4pathway:mTOR signaling pathway		
T75243	INTEPATH	pi3kciaktpathway:Class I PI3K signaling events mediated by Akt		
T75243	INTEPATH	telomerasepathway:Regulation of Telomerase		
T75243	PANTPATH	P00030:Hypoxia response via HIF activation		
T75243	PANTPATH	P00036:Interleukin signaling pathway		
				
T25005	TARGETID	T25005		
T25005	FORMERID	TTDR00233		
T25005	UNIPROID	BTK_HUMAN		
T25005	TARGNAME	Tyrosine-protein kinase BTK (ATK)		
T25005	GENENAME	BTK		
T25005	TARGTYPE	Successful target		
T25005	SYNONYMS	Bruton's tyrosine kinase; Bruton tyrosine kinase; BPK; B-cell progenitor kinase; B cell progenitor kinase; Agammaglobulinemia tyrosine kinase; Agammaglobulinaemia tyrosine kinase; AGMX1		
T25005	FUNCTION	Binding of antigen to the B-cell antigen receptor (BCR) triggers signaling that ultimately leads to B-cell activation. After BCR engagement and activation at the plasma membrane, phosphorylates PLCG2 at several sites, igniting the downstream signaling pathway through calcium mobilization, followed by activation of the protein kinase C (PKC) family members. PLCG2 phosphorylation is performed in close cooperation with the adapter protein B-cell linker protein BLNK. BTK acts as a platform to bring together a diverse array of signaling proteins and is implicated in cytokine receptor signaling pathways. Plays an important role in the function of immune cells of innate as well as adaptive immunity, as a component of the Toll-like receptors (TLR) pathway. The TLR pathway acts as a primary surveillance system for the detection of pathogens and are crucial to the activation of host defense. Especially, is a critical molecule in regulating TLR9 activation in splenic B-cells. Within the TLR pathway, induces tyrosine phosphorylation of TIRAP which leads to TIRAP degradation. BTK plays also a critical role in transcription regulation. Induces the activity of NF-kappa-B, which is involved in regulating the expression of hundreds of genes. BTK is involved on the signaling pathway linking TLR8 and TLR9 to NF-kappa-B. Transiently phosphorylates transcription factor GTF2I on tyrosine residues in response to BCR. GTF2I then translocates to the nucleus to bind regulatory enhancer elements to modulate gene expression. ARID3A and NFAT are other transcriptional target of BTK. BTK is required for the formation of functional ARID3A DNA-binding complexes. There is however no evidence that BTK itself binds directly to DNA. BTK has a dual role in the regulation of apoptosis. Non-receptor tyrosine kinase indispensable for B lymphocyte development, differentiation and signaling.		
T25005	PDBSTRUC	6O8I; 6NFI; 6NFH; 6N9P; 6HRT		
T25005	BIOCLASS	Kinase		
T25005	ECNUMBER	EC 2.7.10.2		
T25005	SEQUENCE	MAAVILESIFLKRSQQKKKTSPLNFKKRLFLLTVHKLSYYEYDFERGRRGSKKGSIDVEKITCVETVVPEKNPPPERQIPRRGEESSEMEQISIIERFPYPFQVVYDEGPLYVFSPTEELRKRWIHQLKNVIRYNSDLVQKYHPCFWIDGQYLCCSQTAKNAMGCQILENRNGSLKPGSSHRKTKKPLPPTPEEDQILKKPLPPEPAAAPVSTSELKKVVALYDYMPMNANDLQLRKGDEYFILEESNLPWWRARDKNGQEGYIPSNYVTEAEDSIEMYEWYSKHMTRSQAEQLLKQEGKEGGFIVRDSSKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQYYLAEKHLFSTIPELINYHQHNSAGLISRLKYPVSQQNKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES		
T25005	DRUGINFO	D09PQZ	Acalabrutinib	Approved
T25005	DRUGINFO	D09KTS	Ibrutinib	Approved
T25005	DRUGINFO	D0UT4W	Zanubrutinib	Approved
T25005	DRUGINFO	D0A9PN	GDC-0853	Phase 3
T25005	DRUGINFO	DUTJ12	ICP-022	Phase 3
T25005	DRUGINFO	DXP04H	Pirtobrutinib	Phase 3
T25005	DRUGINFO	D0KQ7M	ARQ 531	Phase 2
T25005	DRUGINFO	D0E8PG	BGB-3112	Phase 2
T25005	DRUGINFO	D08AOZ	BMS-986142	Phase 2
T25005	DRUGINFO	D04BFC	CC-292	Phase 2
T25005	DRUGINFO	DVS81T	DTRM-555	Phase 2
T25005	DRUGINFO	D0H0KH	GS-4059	Phase 2
T25005	DRUGINFO	D0C0OB	LOU064	Phase 2
T25005	DRUGINFO	D0QX8X	M2951	Phase 2
T25005	DRUGINFO	D0GH7L	PRN1008	Phase 2
T25005	DRUGINFO	D0UF0N	ACP-319	Phase 1/2
T25005	DRUGINFO	DT3BA1	CG-806	Phase 1/2
T25005	DRUGINFO	D0YI4F	Vecabrutinib	Phase 1/2
T25005	DRUGINFO	D0KT8D	AC0058TA	Phase 1
T25005	DRUGINFO	D05SGI	BGB-3113	Phase 1
T25005	DRUGINFO	D0WP9A	BIIB068	Phase 1
T25005	DRUGINFO	D3Q4SZ	DTRMWXHS-12	Phase 1
T25005	DRUGINFO	DTF20P	HM71224	Phase 1
T25005	DRUGINFO	DBO39X	JNJ-64264681	Phase 1
T25005	DRUGINFO	D08SGE	M7583	Phase 1
T25005	DRUGINFO	D02MRX	ONO-4059	Phase 1
T25005	DRUGINFO	D09NVR	PRN2246	Phase 1
T25005	DRUGINFO	D0VS3U	TAK-020	Phase 1
T25005	DRUGINFO	DQ21NM	TG-1701	Phase 1
T25005	DRUGINFO	D0P3UH	Imidazopyridine derivative 4	Patented
T25005	DRUGINFO	D0NK1R	PMID27774824-Compound-Figure12Example1	Patented
T25005	DRUGINFO	D0UH8J	PMID27774824-Compound-Figure12Example10	Patented
T25005	DRUGINFO	D00BYK	PMID27774824-Compound-Figure12Example61	Patented
T25005	DRUGINFO	D09PIS	Pyrazolo[4,3-c]pyridine derivative 2	Patented
T25005	DRUGINFO	D0QW4H	Pyrrolo[2,3-d]pyrimidine derivative 12	Patented
T25005	DRUGINFO	D03ULH	Pyrrolo[2,3-d]pyrimidine derivative 13	Patented
T25005	DRUGINFO	D00KEX	Pyrrolo[2,3-d]pyrimidine derivative 14	Patented
T25005	DRUGINFO	D09TKO	Pyrrolo[2,3-d]pyrimidine derivative 15	Patented
T25005	DRUGINFO	D06ZNU	Pyrrolo[2,3-d]pyrimidine derivative 16	Patented
T25005	DRUGINFO	D0V8JZ	Pyrrolo[2,3-d]pyrimidine derivative 17	Patented
T25005	DRUGINFO	D0WN2X	Pyrrolo[2,3-d]pyrimidine derivative 18	Patented
T25005	DRUGINFO	D00KPQ	Pyrrolo[2,3-d]pyrimidine derivative 19	Patented
T25005	DRUGINFO	D0Q1BE	Pyrrolo[2,3-d]pyrimidine derivative 20	Patented
T25005	DRUGINFO	D0TI0R	Pyrrolo[2,3-d]pyrimidine derivative 21	Patented
T25005	DRUGINFO	D0SR0U	Pyrrolo[2,3-d]pyrimidine derivative 22	Patented
T25005	DRUGINFO	D09IOW	Pyrrolo[2,3-d]pyrimidine derivative 23	Patented
T25005	DRUGINFO	D0CG3V	Pyrrolo[2,3-d]pyrimidine derivative 25	Patented
T25005	DRUGINFO	D0R9HP	Pyrrolo[2,3-d]pyrimidine derivative 26	Patented
T25005	DRUGINFO	D0IX7O	Pyrrolo[2,3-d]pyrimidine derivative 27	Patented
T25005	DRUGINFO	D00GTY	Pyrrolo[2,3-d]pyrimidine derivative 28	Patented
T25005	DRUGINFO	D05UXK	Pyrrolo[2,3-d]pyrimidine derivative 29	Patented
T25005	DRUGINFO	D05YNZ	Pyrrolo[2,3-d]pyrimidine derivative 30	Patented
T25005	DRUGINFO	D0W3BE	Pyrrolo[2,3-d]pyrimidine derivative 31	Patented
T25005	DRUGINFO	D0Q8LH	Pyrrolo[2,3-d]pyrimidine derivative 32	Patented
T25005	DRUGINFO	D0J8UO	Pyrrolo[2,3-d]pyrimidine derivative 33	Patented
T25005	DRUGINFO	D0D4AQ	PCI-45292	Preclinical
T25005	DRUGINFO	D03FUO	GDC-0834	Terminated
T25005	DRUGINFO	D0H3JH	CGI-1316	Investigative
T25005	DRUGINFO	D0MH9X	Inositol 1,3,4,5-Tetrakisphosphate	Investigative
T25005	DRUGINFO	D08NTB	LFM-A13	Investigative
T25005	DRUGINFO	D0E7VO	PMID24900538C2c	Investigative
T25005	DRUGINFO	D01RHR	PMID24915291C31	Investigative
T25005	DRUGINFO	D06BJG	PMID24915291C38	Investigative
T25005	DRUGINFO	D0N0LN	RN486	Investigative
T25005	KEGGPATH	hsa04064:NF-kappa B signaling pathway		
T25005	KEGGPATH	hsa04380:Osteoclast differentiation		
T25005	KEGGPATH	hsa04611:Platelet activation		
T25005	KEGGPATH	hsa04662:B cell receptor signaling pathway		
T25005	KEGGPATH	hsa04664:Fc epsilon RI signaling pathway		
T25005	KEGGPATH	hsa05340:Primary immunodeficiency		
T25005	WIKIPATH	WP127:IL-5 Signaling Pathway		
T25005	WIKIPATH	WP1449:Regulation of toll-like receptor signaling pathway		
T25005	WIKIPATH	WP2203:TSLP Signaling Pathway		
T25005	WIKIPATH	WP23:B Cell Receptor Signaling Pathway		
T25005	WIKIPATH	WP2694:DAP12 interactions		
T25005	WIKIPATH	WP2746:Signaling by the B Cell Receptor (BCR)		
T25005	WIKIPATH	WP2761:MyD88:Mal cascade initiated on plasma membrane		
T25005	WIKIPATH	WP304:Kit receptor signaling pathway		
T25005	WHIZPATH	PW000453:Fc Epsilon Receptor I Signaling in Mast Cells		
T25005	REACPATH	R-HSA-166058:MyD88:Mal cascade initiated on plasma membrane		
T25005	REACPATH	R-HSA-2029482:Regulation of actin dynamics for phagocytic cup formation		
T25005	REACPATH	R-HSA-2424491:DAP12 signaling		
T25005	REACPATH	R-HSA-2871809:FCERI mediated Ca+2 mobilization		
T25005	REACPATH	R-HSA-5602498:MyD88 deficiency (TLR2/4)		
T25005	REACPATH	R-HSA-5603041:IRAK4 deficiency (TLR2/4)		
T25005	REACPATH	R-HSA-5663213:RHO GTPases Activate WASPs and WAVEs		
T25005	REACPATH	R-HSA-983695:Antigen activates B Cell Receptor (BCR) leading to generation of second messengers		
T25005	INTEPATH	bcr_5pathway:BCR signaling pathway		
T25005	INTEPATH	epopathway:EPO signaling pathway		
T25005	INTEPATH	faspathway:FAS (CD95) signaling pathway		
T25005	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T25005	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T25005	PANTPATH	P00010:B cell activation		
				
T01318	TARGETID	T01318		
T01318	FORMERID	TTDS00059		
T01318	UNIPROID	PYRD_PLAF7		
T01318	TARGNAME	Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase)		
T01318	GENENAME	Malaria DHOdehase		
T01318	TARGTYPE	Successful target		
T01318	SYNONYMS	PFF0160c; Mitochondrially bound dihydroorotate-ubiqui oxidoreductase; Dihydroorotate oxidase of Plasmodium falciparum; Dihydroorotate dehydrogenase of Plasmodium falciparum; DHOdehase of Plasmodium falciparum; DHODase; DHODH of Plasmodium falciparum; DHOD		
T01318	FUNCTION	Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.		
T01318	PDBSTRUC	6GJG; 6E0B; 5TBO; 5FI8; 5DEL		
T01318	BIOCLASS	CH-CH donor oxidoreductase		
T01318	ECNUMBER	EC 1.3.5.2		
T01318	SEQUENCE	MISKLKPQFMFLPKKHILSYCRKDVLNLFEQKFYYTSKRKESNNMKNESLLRLINYNRYYNKIDSNNYYNGGKILSNDRQYIYSPLCEYKKKINDISSYVSVPFKINIRNLGTSNFVNNKKDVLDNDYIYENIKKEKSKHKKIIFLLFVSLFGLYGFFESYNPEFFLYDIFLKFCLKYIDGEICHDLFLLLGKYNILPYDTSNDSIYACTNIKHLDFINPFGVAAGFDKNGVCIDSILKLGFSFIEIGTITPRGQTGNAKPRIFRDVESRSIINSCGFNNMGCDKVTENLILFRKRQEEDKLLSKHIVGVSIGKNKDTVNIVDDLKYCINKIGRYADYIAINVSSPNTPGLRDNQEAGKLKNIILSVKEEIDNLEKNNIMNDESTYNEDNKIVEKKNNFNKNNSHMMKDAKDNFLWFNTTKKKPLVFVKLAPDLNQEQKKEIADVLLETNIDGMIISNTTTQINDIKSFENKKGGVSGAKLKDISTKFICEMYNYTNKQIPIIASGGIFSGLDALEKIEAGASVCQLYSCLVFNGMKSAVQIKRELNHLLYQRGYYNLKEAIGRKHSKS		
T01318	DRUGINFO	D0S3WH	Artemisinin	Approved
T01318	DRUGINFO	D06ZEE	Atovaquone	Approved
T01318	DRUGINFO	D08ROP	Leflunomide	Approved
T01318	DRUGINFO	D07QFP	Teriflunomide	Approved
T01318	DRUGINFO	D0C0NH	Avastin+/-Tarceva	Phase 3
T01318	DRUGINFO	D0DQ6Z	1,4-Naphthoquinone	Investigative
T01318	DRUGINFO	D0S8AC	1-hydroxy-2-dodecyl-4(1H)quinolone	Investigative
T01318	DRUGINFO	D04HZA	2-(2-bromo-2-naphthamido)benzoic acid	Investigative
T01318	DRUGINFO	D05SXU	2-(2-naphthamido)benzoic acid	Investigative
T01318	DRUGINFO	D03QKF	2-(3-(3,5-dichlorophenyl)ureido)benzoic acid	Investigative
T01318	DRUGINFO	D0R1GF	2-[(biphenyl-4-carbonyl)-amino]-benzoic acid	Investigative
T01318	DRUGINFO	D08LMT	3,6,9,12,15-PENTAOXATRICOSAN-1-OL	Investigative
T01318	DRUGINFO	D00YPH	3-hydroxy-2-phenylquinoline-4-carboxylic acid	Investigative
T01318	DRUGINFO	D0C1LW	5,8-hydroxy-naphthoquinone	Investigative
T01318	DRUGINFO	D0E2WX	5-Fluoro orotate	Investigative
T01318	DRUGINFO	D0YN5P	8-aminoquinolines	Investigative
T01318	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T01318	DRUGINFO	D04LBT	Antimycin A	Investigative
T01318	DRUGINFO	D00LCE	Antiproliferative Agent A771726	Investigative
T01318	DRUGINFO	D02UVH	B-Octylglucoside	Investigative
T01318	DRUGINFO	D07NYQ	Cinchoninic acid	Investigative
T01318	DRUGINFO	D0WV5R	Cyanide	Investigative
T01318	DRUGINFO	D0S8YD	Decylamine-N,N-Dimethyl-N-Oxide	Investigative
T01318	DRUGINFO	D00CQT	Dichloroallyl lawsone	Investigative
T01318	DRUGINFO	D02YDM	Dichloroally-lawsone	Investigative
T01318	DRUGINFO	D04FYN	Diethyl 2-((biphenyl-3-ylamino)methylene)malonate	Investigative
T01318	DRUGINFO	D0AZ4T	Dihydroorotate	Investigative
T01318	DRUGINFO	D07PUS	DSM1	Investigative
T01318	DRUGINFO	D09WBQ	DSM2	Investigative
T01318	DRUGINFO	D05YJP	Ethyl 3-(biphenyl-3-ylamino)-2-cyanoacrylate	Investigative
T01318	DRUGINFO	D0HQ1I	GNF-PF-85	Investigative
T01318	DRUGINFO	D0V8EH	Isoxazol	Investigative
T01318	DRUGINFO	D0C7PY	Lauryl Dimethylamine-N-Oxide	Investigative
T01318	DRUGINFO	D09EAO	LY214352	Investigative
T01318	DRUGINFO	D0C1NU	N-(3,5-dichlorophenyl)-2-methyl-3-nitrobenzamide	Investigative
T01318	DRUGINFO	D01NWQ	N-(4-bromo-2-methylphenyl)-2-naphthamide	Investigative
T01318	DRUGINFO	D06IPT	N-(Biphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide	Investigative
T01318	DRUGINFO	D07TKG	NSC 665564	Investigative
T01318	DRUGINFO	D0B1TS	Orotate	Investigative
T01318	DRUGINFO	D0S7BK	Orotic acid	Investigative
T01318	DRUGINFO	D0P0IE	Plumbagin	Investigative
T01318	DRUGINFO	D0X4NX	Polyporic acid	Investigative
T01318	DRUGINFO	D0B1SW	Redoxal	Investigative
T01318	DRUGINFO	D0H6QL	Salicylhydroxamic acid	Investigative
T01318	DRUGINFO	D02TJY	Triazine	Investigative
T01318	DRUGINFO	D0YQ2A	Undecylamine-n,n-dimethyl-n-oxide	Investigative
T01318	KEGGPATH	hsa00240:Pyrimidine metabolism		
T01318	KEGGPATH	hsa01100:Metabolic pathways		
T01318	WIKIPATH	WP1851:Metabolism of nucleotides		
T01318	WHIZPATH	PW000160:Pyrimidine Metabolism		
T01318	REACPATH	R-HSA-500753:Pyrimidine biosynthesis		
				
T68547	TARGETID	T68547		
T68547	FORMERID	TTDS00095		
T68547	UNIPROID	HDAC1_HUMAN		
T68547	TARGNAME	Histone deacetylase 1 (HDAC1)		
T68547	GENENAME	HDAC1		
T68547	TARGTYPE	Successful target		
T68547	SYNONYMS	RPD3L1; HD1		
T68547	FUNCTION	Gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation. Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4).		
T68547	PDBSTRUC	5ICN; 4BKX; 1TYI		
T68547	BIOCLASS	Carbon-nitrogen hydrolase		
T68547	ECNUMBER	EC 3.5.1.98		
T68547	SEQUENCE	MAQTQGTRRKVCYYYDGDVGNYYYGQGHPMKPHRIRMTHNLLLNYGLYRKMEIYRPHKANAEEMTKYHSDDYIKFLRSIRPDNMSEYSKQMQRFNVGEDCPVFDGLFEFCQLSTGGSVASAVKLNKQQTDIAVNWAGGLHHAKKSEASGFCYVNDIVLAILELLKYHQRVLYIDIDIHHGDGVEEAFYTTDRVMTVSFHKYGEYFPGTGDLRDIGAGKGKYYAVNYPLRDGIDDESYEAIFKPVMSKVMEMFQPSAVVLQCGSDSLSGDRLGCFNLTIKGHAKCVEFVKSFNLPMLMLGGGGYTIRNVARCWTYETAVALDTEIPNELPYNDYFEYFGPDFKLHISPSNMTNQNTNEYLEKIKQRLFENLRMLPHAPGVQMQAIPEDAIPEESGDEDEDDPDKRISICSSDKRIACEEEFSDSEEEGEGGRKNSSNFKKAKRVKTEDEKEKDPEEKKEVTEEEKTKEEKPEAKGVKEEVKLA		
T68547	DRUGINFO	D0E3SH	Panobinostat	Approved
T68547	DRUGINFO	D0L7LC	Romidepsin	Approved
T68547	DRUGINFO	D0E7PQ	Vorinostat	Approved
T68547	DRUGINFO	D00SQN	HBI-8000	Registered
T68547	DRUGINFO	D0GH3Q	ITF2357	Phase 3
T68547	DRUGINFO	D0B3FV	NVP-LAQ824	Phase 3
T68547	DRUGINFO	D0M8FD	SNDX-275	Phase 3
T68547	DRUGINFO	D00FHR	MGCD-0103	Phase 2
T68547	DRUGINFO	D0B7CH	Phenylbutyrate	Phase 2
T68547	DRUGINFO	D01UXJ	Resminostat	Phase 2
T68547	DRUGINFO	D0VE1W	SB-623	Phase 2
T68547	DRUGINFO	D0I7IB	Sodium butyrate	Phase 2
T68547	DRUGINFO	D06TKI	CHR-3996	Phase 1/2
T68547	DRUGINFO	D00SSZ	OBP-801	Phase 1
T68547	DRUGINFO	D0GE5B	RG-2833	Phase 1
T68547	DRUGINFO	D07FPY	SB-639	Phase 1
T68547	DRUGINFO	D0S7NE	Diaryl amine derivative 2	Patented
T68547	DRUGINFO	D0KA3X	Diaryl amine derivative 3	Patented
T68547	DRUGINFO	D0QR1Z	Isosteric imidazolyl pyrimidine derivative 1	Patented
T68547	DRUGINFO	D00XWZ	PMID28092474-Compound-32a	Patented
T68547	DRUGINFO	D04VQE	PMID28092474-Compound-32b	Patented
T68547	DRUGINFO	D0DH7R	PMID28092474-Compound-32c	Patented
T68547	DRUGINFO	D0N1RX	PMID28092474-Compound-32d	Patented
T68547	DRUGINFO	D0M7XL	PMID28092474-Compound-32e	Patented
T68547	DRUGINFO	D0S3ZB	PMID28092474-Compound-32f	Patented
T68547	DRUGINFO	D03EUD	PMID28092474-Compound-32g	Patented
T68547	DRUGINFO	D0EU5A	PMID28092474-Compound-32h	Patented
T68547	DRUGINFO	D0SK9K	PMID28092474-Compound-32i	Patented
T68547	DRUGINFO	D01LCZ	PMID28092474-Compound-32j	Patented
T68547	DRUGINFO	D0QF0Y	PMID28092474-Compound-32k	Patented
T68547	DRUGINFO	D0W1AX	PMID28092474-Compound-32l	Patented
T68547	DRUGINFO	D0MQ2D	PMID28092474-Compound-32m	Patented
T68547	DRUGINFO	D0O6SJ	PMID28092474-Compound-32n	Patented
T68547	DRUGINFO	D06IIL	PMID28092474-Compound-32o	Patented
T68547	DRUGINFO	D0MR7U	PMID28092474-Compound-32p	Patented
T68547	DRUGINFO	D0TH3L	PMID28092474-Compound-32q	Patented
T68547	DRUGINFO	D0ET4U	PMID28092474-Compound-32r	Patented
T68547	DRUGINFO	D0YC2M	PMID28092474-Compound-32s	Patented
T68547	DRUGINFO	D0CX1Y	PMID28092474-Compound-32t	Patented
T68547	DRUGINFO	D00GLJ	PMID28092474-Compound-32u	Patented
T68547	DRUGINFO	D08ZJZ	PMID28092474-Compound-32v	Patented
T68547	DRUGINFO	D04KQU	PMID28092474-Compound-32x	Patented
T68547	DRUGINFO	D0HM6Y	PMID28092474-Compound-32y	Patented
T68547	DRUGINFO	D02YDG	PMID28092474-Compound-32z	Patented
T68547	DRUGINFO	D00LLN	PMID28092474-Compound-33a	Patented
T68547	DRUGINFO	D04MVN	PMID28092474-Compound-33b	Patented
T68547	DRUGINFO	D0L3CU	PMID28092474-Compound-33c	Patented
T68547	DRUGINFO	D00ACL	PMID28092474-Compound-33d	Patented
T68547	DRUGINFO	D0CH4M	PMID28092474-Compound-33e	Patented
T68547	DRUGINFO	D0K2UF	PMID28092474-Compound-33f	Patented
T68547	DRUGINFO	D08GBR	PMID28092474-Compound-33g	Patented
T68547	DRUGINFO	D0JN0A	PMID28092474-Compound-33h	Patented
T68547	DRUGINFO	D0E5CO	PMID28092474-Compound-33i	Patented
T68547	DRUGINFO	D08GQL	PMID28092474-Compound-33j	Patented
T68547	DRUGINFO	D0Q9XK	PMID28092474-Compound-33k	Patented
T68547	DRUGINFO	D0SF8N	PMID28092474-Compound-33l	Patented
T68547	DRUGINFO	D08XLK	PMID28092474-Compound-33m	Patented
T68547	DRUGINFO	D0RD7T	PMID28092474-Compound-33o	Patented
T68547	DRUGINFO	D08SNJ	PMID28092474-Compound-33p	Patented
T68547	DRUGINFO	D0QN8W	PMID28092474-Compound-34a	Patented
T68547	DRUGINFO	D0BY1R	PMID28092474-Compound-34b	Patented
T68547	DRUGINFO	D04AMI	PMID28092474-Compound-34c	Patented
T68547	DRUGINFO	D0EH2K	PMID29671355-Compound-11	Patented
T68547	DRUGINFO	D0ZG5X	PMID29671355-Compound-13	Patented
T68547	DRUGINFO	D0TN6E	PMID29671355-Compound-18	Patented
T68547	DRUGINFO	D0LV6K	PMID29671355-Compound-19	Patented
T68547	DRUGINFO	D0LP1K	PMID29671355-Compound-21	Patented
T68547	DRUGINFO	D0QX3G	PMID29671355-Compound-22	Patented
T68547	DRUGINFO	D00HXJ	PMID29671355-Compound-23	Patented
T68547	DRUGINFO	D09PVH	PMID29671355-Compound-24	Patented
T68547	DRUGINFO	D0RA0D	PMID29671355-Compound-25	Patented
T68547	DRUGINFO	D0R3RJ	PMID29671355-Compound-26	Patented
T68547	DRUGINFO	D0V5IQ	PMID29671355-Compound-27	Patented
T68547	DRUGINFO	D0Z7QI	PMID29671355-Compound-28	Patented
T68547	DRUGINFO	D0DI9S	PMID29671355-Compound-31	Patented
T68547	DRUGINFO	D0JR9L	PMID29671355-Compound-38a	Patented
T68547	DRUGINFO	D0YD7B	PMID29671355-Compound-38b	Patented
T68547	DRUGINFO	D0L7HG	PMID29671355-Compound-39	Patented
T68547	DRUGINFO	D0YT8O	PMID29671355-Compound-42	Patented
T68547	DRUGINFO	D0BP8I	PMID29671355-Compound-43	Patented
T68547	DRUGINFO	D0N2DK	PMID29671355-Compound-44	Patented
T68547	DRUGINFO	D0OU0J	PMID29671355-Compound-55	Patented
T68547	DRUGINFO	D0CH8Q	PMID29671355-Compound-56	Patented
T68547	DRUGINFO	D0UD9R	PMID29671355-Compound-57	Patented
T68547	DRUGINFO	D0C9NX	PMID29671355-Compound-59	Patented
T68547	DRUGINFO	D0JB4S	PMID29671355-Compound-61	Patented
T68547	DRUGINFO	D07WAT	PMID29671355-Compound-62	Patented
T68547	DRUGINFO	D0F3TB	PMID29671355-Compound-65a	Patented
T68547	DRUGINFO	D0M0RE	PMID29671355-Compound-67	Patented
T68547	DRUGINFO	D0T7OQ	PMID29671355-Compound-73	Patented
T68547	DRUGINFO	D0LN1T	PMID29671355-Compound-8	Patented
T68547	DRUGINFO	D0Q1QY	PMID29671355-Compound-9	Patented
T68547	DRUGINFO	D0MP2U	AN-9	Discontinued in Phase 2
T68547	DRUGINFO	D0W9NH	Tacedinaline	Discontinued in Phase 2
T68547	DRUGINFO	D0N3SH	Pyroxamide	Discontinued in Phase 1
T68547	DRUGINFO	D0L5DZ	4SC-202	Preclinical
T68547	DRUGINFO	D0UC6H	Chlamydocin	Preclinical
T68547	DRUGINFO	D0W8JE	Depudecin	Preclinical
T68547	DRUGINFO	D06RQU	HC-Toxin	Preclinical
T68547	DRUGINFO	D03SZR	M-carboxycinnamic acid bishydroxamide	Preclinical
T68547	DRUGINFO	D0J8OC	Scriptaid	Preclinical
T68547	DRUGINFO	D0UL5X	SK-7041	Preclinical
T68547	DRUGINFO	D0DO5U	SK-7068	Preclinical
T68547	DRUGINFO	D03YVR	Oxamflatin	Terminated
T68547	DRUGINFO	D0KE3I	(E)-8-Biphenyl-4-yl-1-oxazol-2-yl-oct-7-en-1-one	Investigative
T68547	DRUGINFO	D06BKA	1,1,1-Trifluoro-8-(4-phenoxy-phenoxy)-octan-2-one	Investigative
T68547	DRUGINFO	D04ETX	1,1,1-Trifluoro-8-phenoxy-octan-2-one	Investigative
T68547	DRUGINFO	D0H1FZ	2-(methylsulfonylthio)ethyl 2-propylpentanoate	Investigative
T68547	DRUGINFO	D02VVU	4-Benzenesulfonylamino-N-hydroxy-benzamide	Investigative
T68547	DRUGINFO	D09ZNU	4-Benzoylamino-N-hydroxy-benzamide	Investigative
T68547	DRUGINFO	D05LLX	4-Butyrylamino-N-hydroxy-benzamide	Investigative
T68547	DRUGINFO	D0A5LS	4-Chloro-N-(5-hydroxycarbamoyl-pentyl)-benzamide	Investigative
T68547	DRUGINFO	D06XNP	4-Dimethylamino-N-(6-mercapto-hexyl)-benzamide	Investigative
T68547	DRUGINFO	D04NSP	4-Hydroxy-N-(5-hydroxycarbamoyl-pentyl)-benzamide	Investigative
T68547	DRUGINFO	D02NWS	4-Phenylbutyrohydroxamic acid	Investigative
T68547	DRUGINFO	D03FOD	4-tert-butyl-N-hydroxybenzamide	Investigative
T68547	DRUGINFO	D0V2ZO	5-(4-Chloro-phenyl)-pentanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D06IQB	5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione	Investigative
T68547	DRUGINFO	D0D2KE	5-Mercapto-pentanoic acid phenylamide	Investigative
T68547	DRUGINFO	D02MQM	6-(2-Bromo-acetylamino)-hexanoic acid phenylamide	Investigative
T68547	DRUGINFO	D00GBB	6-(3-Benzoyl-ureido)-hexanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D06FAK	6-(9H-carbazol-9-yl)-N-hydroxyhexanamide	Investigative
T68547	DRUGINFO	D00ZSD	6-benzenesulfinylhexanoic acid hydroxamide	Investigative
T68547	DRUGINFO	D05AHZ	6-benzenesulfonylhexanoic acid hydroxamide	Investigative
T68547	DRUGINFO	D0B3ZM	6-Mercapto-hexanoic acid phenylamide	Investigative
T68547	DRUGINFO	D09YBN	6-Phenoxy-hexane-1-thiol	Investigative
T68547	DRUGINFO	D0S9JF	6-phenylsulfanylhexanoic acid hydroxamide	Investigative
T68547	DRUGINFO	D0G0OF	7-(1H-indol-5-yloxy)-N-hydroxyheptanamide	Investigative
T68547	DRUGINFO	D0T0BE	7-(3-Benzoyl-ureido)-heptanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D07HUH	7-(4-(dimethylamino)phenoxy)-N-hydroxyheptanamide	Investigative
T68547	DRUGINFO	D0B2ZJ	7-(Biphenyl-3-yloxy)-1-oxazol-2-yl-heptan-1-one	Investigative
T68547	DRUGINFO	D0Z3BM	7-(Biphenyl-4-yloxy)-1,1,1-trifluoro-heptan-2-one	Investigative
T68547	DRUGINFO	D02WZK	7-(Biphenyl-4-yloxy)-1-oxazol-2-yl-heptan-1-one	Investigative
T68547	DRUGINFO	D04LLD	7-(Biphenyl-4-yloxy)-heptanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D05VFP	7-(Naphthalen-2-yloxy)-1-oxazol-2-yl-heptan-1-one	Investigative
T68547	DRUGINFO	D01RJY	7-Biphenyl-4-yl-heptanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D0Z5KX	7-Mercapto-heptanoic acid benzothiazol-2-ylamide	Investigative
T68547	DRUGINFO	D05XAN	7-Mercapto-heptanoic acid biphenyl-3-ylamide	Investigative
T68547	DRUGINFO	D01XWZ	7-Mercapto-heptanoic acid biphenyl-4-ylamide	Investigative
T68547	DRUGINFO	D00SEE	7-Mercapto-heptanoic acid phenylamide	Investigative
T68547	DRUGINFO	D07FJU	7-Mercapto-heptanoic acid pyridin-3-ylamide	Investigative
T68547	DRUGINFO	D0T4IY	7-Mercapto-heptanoic acid quinolin-3-ylamide	Investigative
T68547	DRUGINFO	D02HVH	7-mercapto-N-(4-phenylthiazol-2-yl)heptanamide	Investigative
T68547	DRUGINFO	D05ZGM	7-Phenoxy-heptanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D03ZUZ	8-(3-Benzoyl-ureido)-octanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D0GJ1E	8-(4-bromophenyl)-N-hydroxy-8-oxooctanamide	Investigative
T68547	DRUGINFO	D0NL6C	8-(Biphenyl-3-yloxy)-1,1,1-trifluoro-octan-2-one	Investigative
T68547	DRUGINFO	D0A6CB	8-(biphenyl-4-yl)-N-hydroxy-8-oxooctanamide	Investigative
T68547	DRUGINFO	D0AX7B	8-(Biphenyl-4-yloxy)-1,1,1-trifluoro-octan-2-one	Investigative
T68547	DRUGINFO	D03XXI	8-(Biphenyl-4-yloxy)-2-oxo-octanoic acid	Investigative
T68547	DRUGINFO	D0XZ9Q	8-Mercapto-octanoic acid phenylamide	Investigative
T68547	DRUGINFO	D0RU1X	8-Oxo-8-phenyl-octanoic acid	Investigative
T68547	DRUGINFO	D0S0WK	8-Oxo-8-phenyl-octanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D0H9DS	8-Phenyl-octanoic acid hydroxyamide	Investigative
T68547	DRUGINFO	D05FEJ	9-(Biphenyl-4-yloxy)-1,1,1-trifluoro-nonan-2-one	Investigative
T68547	DRUGINFO	D00KFF	9,9,9-Trifluoro-8-oxo-nonanoic acid phenylamide	Investigative
T68547	DRUGINFO	D0Q8QA	ADS-100380	Investigative
T68547	DRUGINFO	D0M0QJ	ADS-102550	Investigative
T68547	DRUGINFO	D0P9CQ	Azithromycinarylalkylhydroxamic Acid	Investigative
T68547	DRUGINFO	D06ONC	Azithromycin-N-benzyltriazolyldecahydroxamic Acid	Investigative
T68547	DRUGINFO	D0I5XM	Azithromycin-N-benzyltriazolylhexahydroxamic Acid	Investigative
T68547	DRUGINFO	D0H3RO	Azithromycin-N-benzyltriazolylnonahydroxamic Acid	Investigative
T68547	DRUGINFO	D0D7KH	Azithromycin-N-benzyltriazolyloctahydroxamic Acid	Investigative
T68547	DRUGINFO	D0M1ZI	AZUMAMIDE B	Investigative
T68547	DRUGINFO	D0Q9PO	AZUMAMIDE C	Investigative
T68547	DRUGINFO	D0E9DD	AZUMAMIDE E	Investigative
T68547	DRUGINFO	D02NVY	Cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D0R3XO	Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D0N5RV	Cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)	Investigative
T68547	DRUGINFO	D0X4QC	Cyclo(-L-Am7(S2Py)-Aib-L-Ph4-D-Pro-)	Investigative
T68547	DRUGINFO	D03PRG	Cyclo(-L-Am7(S2Py)-Aib-L-Ph5-D-Pro-)	Investigative
T68547	DRUGINFO	D0Z6MI	Cyclo(-L-Am7(S2Py)-Aib-L-Phe-D-Pro-)	Investigative
T68547	DRUGINFO	D0G1EX	Cyclo(-L-Am7(S2Py)-Aib-L-Phg-D-Pro-)	Investigative
T68547	DRUGINFO	D0E8UH	Cyclo(-L-Am7(S2Py)-Aib-L-Ser(Bzl)-D-Pro-)	Investigative
T68547	DRUGINFO	D0U0EZ	Cyclo(-L-Am7(S2Py)-Aib-L-Ser-D-Pro-)	Investigative
T68547	DRUGINFO	D04CDZ	Cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D02NAF	Cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D0Z6HR	Cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D00XTC	Cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)	Investigative
T68547	DRUGINFO	D0C0VP	Cyclostellettamine derivative	Investigative
T68547	DRUGINFO	D06THS	Desclasinose Azithromycinarylalkyl Hydroxamate	Investigative
T68547	DRUGINFO	D0B1YM	Gymnochrome E	Investigative
T68547	DRUGINFO	D0Z8PX	LARGAZOLE	Investigative
T68547	DRUGINFO	D01AMS	N-(2,3-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D05GRZ	N-(2,4-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0B8RC	N-(2,5-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0SQ1F	N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0Q2GM	N-(2-amino-5-(thiophen-2-yl)phenyl)nicotinamide	Investigative
T68547	DRUGINFO	D0P1RQ	N-(2-aminophenyl)-4-(chroman-3-ylmethyl)benzamide	Investigative
T68547	DRUGINFO	D0YO6M	N-(2-aminophenyl)-4-methoxybenzamide	Investigative
T68547	DRUGINFO	D04UVL	N-(2-aminophenyl)nicotinamide	Investigative
T68547	DRUGINFO	D01FYB	N-(2-aminophenyl)quinoxaline-6-carboxamide	Investigative
T68547	DRUGINFO	D01ZMJ	N-(2-Ethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0F0KS	N-(2-Mercapto-ethyl)-N'-phenyl-oxalamide	Investigative
T68547	DRUGINFO	D01MFV	N-(2-Mercapto-ethyl)-N'-phenyl-succinamide	Investigative
T68547	DRUGINFO	D0L5KP	N-(3,4-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D08TIJ	N-(3,5-Dimethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0J3CY	N-(3-Ethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0M9LJ	N-(4-aminobiphenyl-3-yl)nicotinamide	Investigative
T68547	DRUGINFO	D08ICY	N-(4-Ethylphenyl)-N'-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0E0TA	N-(4-hydroxybiphenyl-3-yl)benzamide	Investigative
T68547	DRUGINFO	D0C2KD	N-(5-Hydroxycarbamoyl-pentyl)-4-nitro-benzamide	Investigative
T68547	DRUGINFO	D0YY9M	N-(6-Hydroxycarbamoyl-hexyl)-benzamide	Investigative
T68547	DRUGINFO	D04HSS	N-(6-Mercapto-hexyl)-benzamide	Investigative
T68547	DRUGINFO	D00LSZ	N,8-dihydroxy-8-(naphthalen-2-yl)octanamide	Investigative
T68547	DRUGINFO	D08XMS	N1-(biphenyl-3-yl)-N8-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D04DOL	N1-(biphenyl-4-yl)-N8-hydroxyoctanediamide	Investigative
T68547	DRUGINFO	D0YP4F	N1-hydroxy-N8-(4-phenylthiazol-2-yl)octanediamide	Investigative
T68547	DRUGINFO	D0Q5DI	nexturastat A	Investigative
T68547	DRUGINFO	D0PP3Q	N-hydroxy-2,2'-bithiophene-5-carboxamide	Investigative
T68547	DRUGINFO	D04ZDI	N-Hydroxy-4-((R)-2-phenyl-butyrylamino)-benzamide	Investigative
T68547	DRUGINFO	D0QO0L	N-Hydroxy-4-((S)-2-phenyl-butyrylamino)-benzamide	Investigative
T68547	DRUGINFO	D06VBN	N-Hydroxy-4-(2-phenyl-butyrylamino)-benzamide	Investigative
T68547	DRUGINFO	D0R4BS	N-Hydroxy-4-(3-phenyl-propionylamino)-benzamide	Investigative
T68547	DRUGINFO	D0S7WQ	N-Hydroxy-4-(4-phenyl-butyrylamino)-benzamide	Investigative
T68547	DRUGINFO	D0R5VG	N-Hydroxy-4-(5-phenyl-pentanoylamino)-benzamide	Investigative
T68547	DRUGINFO	D0Z7YS	N-Hydroxy-4-(pentanoylamino-methyl)-benzamide	Investigative
T68547	DRUGINFO	D02UTC	N-Hydroxy-4-(phenylacetylamino-methyl)-benzamide	Investigative
T68547	DRUGINFO	D01XXN	N-Hydroxy-4-phenylacetylamino-benzamide	Investigative
T68547	DRUGINFO	D05PYF	N-hydroxy-5-(pyridin-2-yl)thiophene-2-carboxamide	Investigative
T68547	DRUGINFO	D00PLM	N-hydroxy-5-(pyridin-3-yl)thiophene-2-carboxamide	Investigative
T68547	DRUGINFO	D0A7IF	N-hydroxy-5-(pyridin-4-yl)thiophene-2-carboxamide	Investigative
T68547	DRUGINFO	D06NVX	N-hydroxy-5-phenylthiophene-2-carboxamide	Investigative
T68547	DRUGINFO	D0L4ML	N-hydroxy-6-oxo-6-phenylhexanamide	Investigative
T68547	DRUGINFO	D0K8MF	N-hydroxy-7-(4-methoxyphenyl)-7-oxoheptanamide	Investigative
T68547	DRUGINFO	D03FFI	N-hydroxy-7-(naphthalen-2-yl)-7-oxoheptanamide	Investigative
T68547	DRUGINFO	D03OYL	N-hydroxy-7-(naphthalen-2-yloxy)heptanamide	Investigative
T68547	DRUGINFO	D0QX6R	N-hydroxy-7-oxo-7-phenylheptanamide	Investigative
T68547	DRUGINFO	D0KM7H	N-hydroxy-8-(2-methoxyphenyl)-8-oxooctanamide	Investigative
T68547	DRUGINFO	D0O7UF	N-hydroxy-8-(4-methoxyphenyl)-8-oxooctanamide	Investigative
T68547	DRUGINFO	D04XPZ	N-hydroxy-8-(naphthalen-2-yl)non-8-enamide	Investigative
T68547	DRUGINFO	D0CJ7L	N-hydroxy-8-(naphthalen-2-yl)oct-7-enamide	Investigative
T68547	DRUGINFO	D0L5WI	N-hydroxy-8-(naphthalen-2-yl)octanamide	Investigative
T68547	DRUGINFO	D00RGD	N-hydroxy-8-oxo-8-(pyridin-3-yl)octanamide	Investigative
T68547	DRUGINFO	D0Z2VP	N-hydroxy-9-oxo-9-phenylnonanamide	Investigative
T68547	DRUGINFO	D0D3XC	N-hydroxybenzo[b]thiophene-2-carboxamide	Investigative
T68547	DRUGINFO	D0Q2CC	N-Hydroxy-N'-(2-methylphenyl)octanediamide	Investigative
T68547	DRUGINFO	D0H7QA	N-Hydroxy-N'-(3-methylphenyl)octanediamide	Investigative
T68547	DRUGINFO	D0L6YF	N-Hydroxy-N'-(4-methoxyphenyl)octanediamide	Investigative
T68547	DRUGINFO	D00HFS	N-Hydroxy-N'-(4-methylphenyl)octanediamide	Investigative
T68547	DRUGINFO	D01EDB	NSC-746457	Investigative
T68547	DRUGINFO	D07YZZ	Octanedioic acid bis-hydroxyamide	Investigative
T68547	DRUGINFO	D0E8KR	Octanedioic acid hydroxyamide pyridin-2-ylamide	Investigative
T68547	DRUGINFO	D04GGW	Octanedioic acid hydroxyamide pyridin-4-ylamide	Investigative
T68547	DRUGINFO	D0N0TS	PSAMMAPLIN A	Investigative
T68547	DRUGINFO	D0U3MB	SK-683	Investigative
T68547	DRUGINFO	D0N9AK	ST-2986	Investigative
T68547	DRUGINFO	D0T0SK	ST-2987	Investigative
T68547	DRUGINFO	D01YBR	ST-3050	Investigative
T68547	DRUGINFO	D05GVY	Thioacetic acid S-(6-phenylcarbamoyl-hexyl) ester	Investigative
T68547	KEGGPATH	hsa04110:Cell cycle		
T68547	KEGGPATH	hsa04330:Notch signaling pathway		
T68547	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T68547	KEGGPATH	hsa05016:Huntington's disease		
T68547	KEGGPATH	hsa05031:Amphetamine addiction		
T68547	KEGGPATH	hsa05034:Alcoholism		
T68547	KEGGPATH	hsa05169:Epstein-Barr virus infection		
T68547	KEGGPATH	hsa05200:Pathways in cancer		
T68547	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T68547	KEGGPATH	hsa05203:Viral carcinogenesis		
T68547	KEGGPATH	hsa05206:MicroRNAs in cancer		
T68547	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T68547	WIKIPATH	WP138:Androgen receptor signaling pathway		
T68547	WIKIPATH	WP179:Cell Cycle		
T68547	WIKIPATH	WP1815:Factors involved in megakaryocyte development and platelet production		
T68547	WIKIPATH	WP1858:Mitotic G1-G1/S phases		
T68547	WIKIPATH	WP1905:RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription		
T68547	WIKIPATH	WP1976:Signalling by NGF		
T68547	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T68547	WIKIPATH	WP2036:TWEAK Signaling Pathway		
T68547	WIKIPATH	WP2064:Neural Crest Differentiation		
T68547	WIKIPATH	WP2446:Retinoblastoma (RB) in Cancer		
T68547	WIKIPATH	WP268:Notch Signaling Pathway		
T68547	WIKIPATH	WP2755:Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer		
T68547	WIKIPATH	WP2864:Apoptosis-related network due to altered Notch3 in ovarian cancer		
T68547	WIKIPATH	WP364:IL-6 signaling pathway		
T68547	WIKIPATH	WP366:TGF beta Signaling Pathway		
T68547	WIKIPATH	WP61:Notch Signaling Pathway		
T68547	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T68547	REACPATH	R-HSA-1538133:G0 and Early G1		
T68547	REACPATH	R-HSA-193670:p75NTR negatively regulates cell cycle via SC1		
T68547	REACPATH	R-HSA-201722:Formation of the beta-catenin:TCF transactivating complex		
T68547	REACPATH	R-HSA-2122947:NOTCH1 Intracellular Domain Regulates Transcription		
T68547	REACPATH	R-HSA-2173796:SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription		
T68547	REACPATH	R-HSA-2644606:Constitutive Signaling by NOTCH1 PEST Domain Mutants		
T68547	REACPATH	R-HSA-2894862:Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants		
T68547	REACPATH	R-HSA-3214815:HDACs deacetylate histones		
T68547	REACPATH	R-HSA-3769402:Deactivation of the beta-catenin transactivating complex		
T68547	REACPATH	R-HSA-427413:NoRC negatively regulates rRNA expression		
T68547	REACPATH	R-HSA-73762:RNA Polymerase I Transcription Initiation		
T68547	REACPATH	R-HSA-983231:Factors involved in megakaryocyte development and platelet production		
T68547	NET_PATH	NetPath_11:TCR Signaling Pathway		
T68547	INTEPATH	ar_tf_pathway:Regulation of Androgen receptor activity		
T68547	INTEPATH	betacatenin_nuc_pathway:Regulation of nuclear beta catenin signaling and target gene transcription		
T68547	INTEPATH	e2f_pathway:E2F transcription factor network		
T68547	INTEPATH	era_genomic_pathway:Validated nuclear estrogen receptor alpha network		
T68547	INTEPATH	hdac_classi_pathway:Signaling events mediated by HDAC Class I		
T68547	INTEPATH	hedgehog_glipathway:Hedgehog signaling events mediated by Gli proteins		
T68547	INTEPATH	hes_heypathway:Notch-mediated HES/HEY network		
T68547	INTEPATH	il3_pathway:IL3-mediated signaling events		
T68547	INTEPATH	myc_represspathway:Validated targets of C-MYC transcriptional repression		
T68547	INTEPATH	notch_pathway:Notch signaling pathway		
T68547	INTEPATH	ps1pathway:Presenilin action in Notch and Wnt signaling		
T68547	INTEPATH	ranbp2pathway:Sumoylation by RanBP2 regulates transcriptional repression		
T68547	INTEPATH	rb_1pathway:Regulation of retinoblastoma protein		
T68547	INTEPATH	reg_gr_pathway:Glucocorticoid receptor regulatory network		
T68547	INTEPATH	retinoic_acid_pathway:Retinoic acid receptors-mediated signaling		
T68547	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
T68547	INTEPATH	telomerasepathway:Regulation of Telomerase		
T68547	PANTPATH	P00057:Wnt signaling pathway		
T68547	PANTPATH	P00059:p53 pathway		
				
T93344	TARGETID	T93344		
T93344	FORMERID	TTDS00302		
T93344	UNIPROID	ERG1_HUMAN		
T93344	TARGNAME	Squalene monooxygenase (SQLE)		
T93344	GENENAME	SQLE		
T93344	TARGTYPE	Successful target		
T93344	SYNONYMS	Squalene epoxidase; SQLE; SE; Oxidosqaulene cyclase		
T93344	FUNCTION	Catalyzes the first oxygenation step in sterol biosynthesis and is suggested to be one of the rate-limiting enzymes in this pathway.		
T93344	PDBSTRUC	6C6R; 6C6P; 6C6N		
T93344	BIOCLASS	Paired donor oxygen oxidoreductase		
T93344	ECNUMBER	EC 1.14.14.17		
T93344	SEQUENCE	MWTFLGIATFTYFYKKFGDFITLANREVLLCVLVFLSLGLVLSYRCRHRNGGLLGRQQSGSQFALFSDILSGLPFIGFFWAKSPPESENKEQLEARRRRKGTNISETSLIGTAACTSTSSQNDPEVIIVGAGVLGSALAAVLSRDGRKVTVIERDLKEPDRIVGEFLQPGGYHVLKDLGLGDTVEGLDAQVVNGYMIHDQESKSEVQIPYPLSENNQVQSGRAFHHGRFIMSLRKAAMAEPNAKFIEGVVLQLLEEDDVVMGVQYKDKETGDIKELHAPLTVVADGLFSKFRKSLVSNKVSVSSHFVGFLMKNAPQFKANHAELILANPSPVLIYQISSSETRVLVDIRGEMPRNLREYMVEKIYPQIPDHLKEPFLEATDNSHLRSMPASFLPPSSVKKRGVLLLGDAYNMRHPLTGGGMTVAFKDIKLWRKLLKGIPDLYDDAAIFEAKKSFYWARKTSHSFVVNILAQALYELFSATDDSLHQLRKACFLYFKLGGECVAGPVGLLSVLSPNPLVLIGHFFAVAIYAVYFCFKSEPWITKPRALLSSGAVLYKACSVIFPLIYSEMKYMVH		
T93344	DRUGINFO	D00HPK	Naftifine	Approved
T93344	DRUGINFO	D02NTO	Tolnaftate	Approved
T93344	DRUGINFO	D0U2BH	Epigallocatechin gallate	Phase 3
T93344	DRUGINFO	D04DMO	FR-194738	Terminated
T93344	DRUGINFO	D0I3XW	NB-598	Terminated
T93344	DRUGINFO	D06MUZ	SDZ-87-469	Terminated
T93344	DRUGINFO	D0F9KV	1(beta)-O-galloylpedunculagin	Investigative
T93344	DRUGINFO	D00QDR	1,2,3,4,6-penta-O-galloyl-beta-D-glucose	Investigative
T93344	DRUGINFO	D07WLU	1,2,6-tri-O-galloyl-beta-D-glucose	Investigative
T93344	DRUGINFO	D0F9RE	Allylamines	Investigative
T93344	DRUGINFO	D0Z9YK	Chebulinic acid	Investigative
T93344	DRUGINFO	D03SPJ	CORILAGIN	Investigative
T93344	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T93344	DRUGINFO	D06CPD	ETHYLGALLATE	Investigative
T93344	DRUGINFO	D0K2XJ	EUGENIIN	Investigative
T93344	DRUGINFO	D0G3SL	FUROSIN	Investigative
T93344	DRUGINFO	D0C6QS	GERANIIN	Investigative
T93344	DRUGINFO	D0L1XR	Green tea	Investigative
T93344	DRUGINFO	D05UWZ	Mallotinic acid	Investigative
T93344	DRUGINFO	D0QN6H	Mallotusinic acid	Investigative
T93344	DRUGINFO	D01VEP	N-cetylgallate	Investigative
T93344	DRUGINFO	D0VS1V	N-dodecylgallate	Investigative
T93344	DRUGINFO	D02ZSX	OCTYL_GALLATE	Investigative
T93344	DRUGINFO	D0Z2TG	Pedunculagin	Investigative
T93344	DRUGINFO	D06YCQ	Procyanidin B-2 3,3'-di-O-gallate	Investigative
T93344	DRUGINFO	D0J1QQ	Sanguiin H-6	Investigative
T93344	DRUGINFO	D0A1QJ	Tellurium	Investigative
T93344	DRUGINFO	D0T0XY	THEASINENSIN A	Investigative
T93344	DRUGINFO	D0F3KP	Thiocarbamate	Investigative
T93344	DRUGINFO	D0Z9PB	Trisnorsqualene alcohol	Investigative
T93344	DRUGINFO	D0J1DW	Trisnorsqualene cyclopropylamine	Investigative
T93344	DRUGINFO	D03RKP	Trisnorsqualene difluoromethylidene	Investigative
T93344	KEGGPATH	sce00100:Steroid biosynthesis		
T93344	KEGGPATH	sce00909:Sesquiterpenoid and triterpenoid biosynthesis		
T93344	KEGGPATH	sce01100:Metabolic pathways		
T93344	KEGGPATH	sce01110:Biosynthesis of secondary metabolites		
T93344	KEGGPATH	sce01130:Biosynthesis of antibiotics		
T93344	WHIZPATH	PW000050:Steroid Biosynthesis		
T93344	REACPATH	R-HSA-191273:Cholesterol biosynthesis		
T93344	REACPATH	R-HSA-2426168:Activation of gene expression by SREBF (SREBP)		
				
T92057	TARGETID	T92057		
T92057	FORMERID	TTDC00114		
T92057	UNIPROID	ERBB4_HUMAN		
T92057	TARGNAME	Erbb4 tyrosine kinase receptor (Erbb-4)		
T92057	GENENAME	ERBB4		
T92057	TARGTYPE	Successful target		
T92057	SYNONYMS	Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4		
T92057	FUNCTION	Required for normal cardiac muscle differentiation during embryonic development, and for postnatal cardiomyocyte proliferation. Required for normal development of the embryonic central nervous system, especially for normal neural crest cell migration and normal axon guidance. Required for mammary gland differentiation, induction of milk proteins and lactation. Acts as cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and the EGF family members BTC, EREG and HBEGF. Ligand binding triggers receptor dimerization and autophosphorylation at specific tyrosine residues that then serve as binding sites for scaffold proteins and effectors. Ligand specificity and signaling is modulated by alternative splicing, proteolytic processing, and by the formation of heterodimers with other ERBB family members, thereby creating multiple combinations of intracellular phosphotyrosines that trigger ligand- and context-specific cellular responses. Mediates phosphorylation of SHC1 and activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the activation of phosphatidylinositol 3-kinase and AKT1 and protect cells against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate reorganization of the actin cytoskeleton and promote cell migration in response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the phosphotyrosine that mediates interaction with PIK3R1, and hence do not phosphorylate PIK3R1, do not protect cells against apoptosis, and do not promote reorganization of the actin cytoskeleton and cell migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-A CYT-2 gives rise to the corresponding soluble intracellular domains (4ICD) that translocate to the nucleus, promote nuclear import of STAT5A, activation of STAT5A, mammary epithelium differentiation, cell proliferation and activation of gene expression. The ERBB4 soluble intracellular domains (4ICD) colocalize with STAT5A at the CSN2 promoter to regulate transcription of milk proteins during lactation. The ERBB4 soluble intracellular domains can also translocate to mitochondria and promote apoptosis. Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins and EGF family members and regulates development of the heart, the central nervous system and the mammary gland, gene transcription, cell proliferation, differentiation, migration and apoptosis.		
T92057	PDBSTRUC	3U9U; 3U7U; 3U2P; 3BCE; 3BBW		
T92057	BIOCLASS	Kinase		
T92057	ECNUMBER	EC 2.7.10.1		
T92057	SEQUENCE	MKPATGLWVWVSLLVAAGTVQPSDSQSVCAGTENKLSSLSDLEQQYRALRKYYENCEVVMGNLEITSIEHNRDLSFLRSVREVTGYVLVALNQFRYLPLENLRIIRGTKLYEDRYALAIFLNYRKDGNFGLQELGLKNLTEILNGGVYVDQNKFLCYADTIHWQDIVRNPWPSNLTLVSTNGSSGCGRCHKSCTGRCWGPTENHCQTLTRTVCAEQCDGRCYGPYVSDCCHRECAGGCSGPKDTDCFACMNFNDSGACVTQCPQTFVYNPTTFQLEHNFNAKYTYGAFCVKKCPHNFVVDSSSCVRACPSSKMEVEENGIKMCKPCTDICPKACDGIGTGSLMSAQTVDSSNIDKFINCTKINGNLIFLVTGIHGDPYNAIEAIDPEKLNVFRTVREITGFLNIQSWPPNMTDFSVFSNLVTIGGRVLYSGLSLLILKQQGITSLQFQSLKEISAGNIYITDNSNLCYYHTINWTTLFSTINQRIVIRDNRKAENCTAEGMVCNHLCSSDGCWGPGPDQCLSCRRFSRGRICIESCNLYDGEFREFENGSICVECDPQCEKMEDGLLTCHGPGPDNCTKCSHFKDGPNCVEKCPDGLQGANSFIFKYADPDRECHPCHPNCTQGCNGPTSHDCIYYPWTGHSTLPQHARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKKKRALRRFLETELVEPLTPSGTAPNQAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDEEDLEDMMDAEEYLVPQAFNIPPPIYTSRARIDSNRSEIGHSPPPAYTPMSGNQFVYRDGGFAAEQGVSVPYRAPTSTIPEAPVAQGATAEIFDDSCCNGTLRKPVAPHVQEDSSTQRYSADPTVFAPERSPRGELDEEGYMTPMRDKPKQEYLNPVEENPFVSRRKNGDLQALDNPEYHNASNGPPKAEDEYVNEPLYLNTFANTLGKAEYLKNNILSMPEKAKKAFDNPDYWNHSLPPRSTLQHPDYLQEYSTKYFYKQNGRIRPIVAENPEYLSEFSLKPGTVLPPPPYRHRNTVV		
T92057	DRUGINFO	D06XXH	Dacomitinib	Approved
T92057	DRUGINFO	D0OC4O	RG7388	Phase 3
T92057	DRUGINFO	D0YB3W	CI-1033	Phase 2
T92057	DRUGINFO	D0Z7IW	JI-101	Phase 2
T92057	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T92057	DRUGINFO	D05FFT	HDS-029	Investigative
T92057	DRUGINFO	D06BJG	PMID24915291C38	Investigative
T92057	KEGGPATH	hsa04012:ErbB signaling pathway		
T92057	KEGGPATH	hsa04020:Calcium signaling pathway		
T92057	KEGGPATH	hsa04144:Endocytosis		
T92057	KEGGPATH	hsa05205:Proteoglycans in cancer		
T92057	WIKIPATH	WP3297:EV release from cardiac cells and their functional effects		
T92057	WIKIPATH	WP673:ErbB Signaling Pathway		
T92057	PANTPATH	P00004:Alzheimer disease-presenilin pathway		
T92057	PANTPATH	P00012:Cadherin signaling pathway		
T92057	PANTPATH	P00018:EGF receptor signaling pathway		
				
T67849	TARGETID	T67849		
T67849	FORMERID	TTDR00930		
T67849	UNIPROID	PK3CD_HUMAN		
T67849	TARGNAME	PI3-kinase delta (PIK3CD)		
T67849	GENENAME	PIK3CD		
T67849	TARGTYPE	Successful target		
T67849	SYNONYMS	PtdIns-3-kinase subunit p110-delta; PtdIns-3-kinase subunit delta; Phosphoinositide 3-kinase delta; Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit, delta isoform; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta; PI3Kdelta; PI3K-delta; PI3-kinase subunit delta; PI3-kinase p110 subunit delta; P110delta		
T67849	FUNCTION	Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Have a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Have important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function. Isoform 2 may be involved in stabilizing total RAS levels, resulting in increased ERK phosphorylation and increased PI3K activity.		
T67849	PDBSTRUC	6G6W; 5VLR; 5UBT; 5T8F; 5M6U		
T67849	BIOCLASS	Kinase		
T67849	ECNUMBER	EC 2.7.1.153		
T67849	SEQUENCE	MPPGVDCPMEFWTKEENQSVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSGPEAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQYICSCLHSGLTPHLTMVHSSSILAMRDEQSNPAPQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAQMLYLLCSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLDRALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGSVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDFVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFRVKFNEALRESWKTKVNWLAHNVSKDNRQ		
T67849	DRUGINFO	D0S5LD	BAY 80-6946	Approved
T67849	DRUGINFO	D0J5VR	Idelalisib	Approved
T67849	DRUGINFO	D0RU0O	IPI-145	Approved
T67849	DRUGINFO	D0O8SJ	Umbralisib	Approved
T67849	DRUGINFO	D01QSO	Buparlisib	Phase 3
T67849	DRUGINFO	D07RHP	INCB50465	Phase 2
T67849	DRUGINFO	DGO2C1	Leniolisib	Phase 2
T67849	DRUGINFO	DP1SE6	Parsaclisib	Phase 2
T67849	DRUGINFO	D0LG7X	RP6530	Phase 2
T67849	DRUGINFO	D07CWH	INCB40093	Phase 1/2
T67849	DRUGINFO	D05CBJ	PA-799	Phase 1/2
T67849	DRUGINFO	D03FOP	AMG 319	Phase 1
T67849	DRUGINFO	DA02DE	BGB-10188	Phase 1
T67849	DRUGINFO	D03IJO	GS-9820	Phase 1
T67849	DRUGINFO	D0U5PT	GS-9901	Phase 1
T67849	DRUGINFO	DDE3Z4	HMPL-689	Phase 1
T67849	DRUGINFO	D08WLY	ME-401	Phase 1
T67849	DRUGINFO	D00GTY	Pyrrolo[2,3-d]pyrimidine derivative 28	Patented
T67849	DRUGINFO	D08TAB	XL-499	Preclinical
T67849	DRUGINFO	D0P1JI	Wortmannin	Terminated
T67849	DRUGINFO	D0W1ST	Ethyl 1-[(1H-benzimidazol-2(3H)one-5-yl)sulfonyl]-1H-pyrrole-2-carboxylate	Investigative
T67849	DRUGINFO	DOR1I0	ETP-46321	Investigative
T67849	DRUGINFO	D00ZIK	IC87114	Investigative
T67849	DRUGINFO	D0O2HL	IC980033	Investigative
T67849	DRUGINFO	D07APP	LY-292223	Investigative
T67849	KEGGPATH	hsa00562:Inositol phosphate metabolism		
T67849	KEGGPATH	hsa04012:ErbB signaling pathway		
T67849	KEGGPATH	hsa04014:Ras signaling pathway		
T67849	KEGGPATH	hsa04015:Rap1 signaling pathway		
T67849	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T67849	KEGGPATH	hsa04024:cAMP signaling pathway		
T67849	KEGGPATH	hsa04062:Chemokine signaling pathway		
T67849	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T67849	KEGGPATH	hsa04068:FoxO signaling pathway		
T67849	KEGGPATH	hsa04070:Phosphatidylinositol signaling system		
T67849	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T67849	KEGGPATH	hsa04150:mTOR signaling pathway		
T67849	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T67849	KEGGPATH	hsa04152:AMPK signaling pathway		
T67849	KEGGPATH	hsa04210:Apoptosis		
T67849	KEGGPATH	hsa04261:Adrenergic signaling in cardiomyocytes		
T67849	KEGGPATH	hsa04370:VEGF signaling pathway		
T67849	KEGGPATH	hsa04380:Osteoclast differentiation		
T67849	KEGGPATH	hsa04510:Focal adhesion		
T67849	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T67849	KEGGPATH	hsa04611:Platelet activation		
T67849	KEGGPATH	hsa04620:Toll-like receptor signaling pathway		
T67849	KEGGPATH	hsa04630:Jak-STAT signaling pathway		
T67849	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T67849	KEGGPATH	hsa04660:T cell receptor signaling pathway		
T67849	KEGGPATH	hsa04662:B cell receptor signaling pathway		
T67849	KEGGPATH	hsa04664:Fc epsilon RI signaling pathway		
T67849	KEGGPATH	hsa04666:Fc gamma R-mediated phagocytosis		
T67849	KEGGPATH	hsa04668:TNF signaling pathway		
T67849	KEGGPATH	hsa04670:Leukocyte transendothelial migration		
T67849	KEGGPATH	hsa04722:Neurotrophin signaling pathway		
T67849	KEGGPATH	hsa04725:Cholinergic synapse		
T67849	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T67849	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T67849	KEGGPATH	hsa04910:Insulin signaling pathway		
T67849	KEGGPATH	hsa04914:Progesterone-mediated oocyte maturation		
T67849	KEGGPATH	hsa04915:Estrogen signaling pathway		
T67849	KEGGPATH	hsa04917:Prolactin signaling pathway		
T67849	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T67849	KEGGPATH	hsa04921:Oxytocin signaling pathway		
T67849	KEGGPATH	hsa04923:Regulation of lipolysis in adipocytes		
T67849	KEGGPATH	hsa04930:Type II diabetes mellitus		
T67849	KEGGPATH	hsa04932:Non-alcoholic fatty liver disease (NAFLD)		
T67849	KEGGPATH	hsa04960:Aldosterone-regulated sodium reabsorption		
T67849	KEGGPATH	hsa04973:Carbohydrate digestion and absorption		
T67849	KEGGPATH	hsa05100:Bacterial invasion of epithelial cells		
T67849	KEGGPATH	hsa05142:Chagas disease (American trypanosomiasis)		
T67849	KEGGPATH	hsa05145:Toxoplasmosis		
T67849	KEGGPATH	hsa05146:Amoebiasis		
T67849	KEGGPATH	hsa05160:Hepatitis C		
T67849	KEGGPATH	hsa05161:Hepatitis B		
T67849	KEGGPATH	hsa05162:Measles		
T67849	KEGGPATH	hsa05164:Influenza A		
T67849	KEGGPATH	hsa05166:HTLV-I infection		
T67849	KEGGPATH	hsa05169:Epstein-Barr virus infection		
T67849	KEGGPATH	hsa05200:Pathways in cancer		
T67849	KEGGPATH	hsa05203:Viral carcinogenesis		
T67849	KEGGPATH	hsa05205:Proteoglycans in cancer		
T67849	KEGGPATH	hsa05210:Colorectal cancer		
T67849	KEGGPATH	hsa05211:Renal cell carcinoma		
T67849	KEGGPATH	hsa05212:Pancreatic cancer		
T67849	KEGGPATH	hsa05213:Endometrial cancer		
T67849	KEGGPATH	hsa05214:Glioma		
T67849	KEGGPATH	hsa05215:Prostate cancer		
T67849	KEGGPATH	hsa05218:Melanoma		
T67849	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T67849	KEGGPATH	hsa05221:Acute myeloid leukemia		
T67849	KEGGPATH	hsa05222:Small cell lung cancer		
T67849	KEGGPATH	hsa05223:Non-small cell lung cancer		
T67849	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T67849	KEGGPATH	hsa05231:Choline metabolism in cancer		
T67849	WIKIPATH	WP1403:AMPK Signaling		
T67849	WIKIPATH	WP1449:Regulation of toll-like receptor signaling pathway		
T67849	WIKIPATH	WP1544:MicroRNAs in cardiomyocyte hypertrophy		
T67849	WIKIPATH	WP1840:Interleukin-3, 5 and GM-CSF signaling		
T67849	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T67849	WIKIPATH	WP2643:Nanoparticle-mediated activation of receptor signaling		
T67849	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T67849	WIKIPATH	WP2732:Interleukin-2 signaling		
T67849	WIKIPATH	WP2746:Signaling by the B Cell Receptor (BCR)		
T67849	WIKIPATH	WP2747:PI Metabolism		
T67849	WIKIPATH	WP286:IL-3 Signaling Pathway		
T67849	WIKIPATH	WP306:Focal Adhesion		
T67849	WIKIPATH	WP395:IL-4 Signaling Pathway		
T67849	WIKIPATH	WP481:Insulin Signaling		
T67849	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T67849	WIKIPATH	WP524:G13 Signaling Pathway		
T67849	WIKIPATH	WP585:Interferon type I signaling pathways		
T67849	WIKIPATH	WP710:DNA Damage Response (only ATM dependent)		
T67849	WIKIPATH	WP75:Toll-like receptor signaling pathway		
T67849	WHIZPATH	PW000168:Phosphatidylinositol Phosphate Metabolism		
T67849	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T67849	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T67849	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T67849	REACPATH	R-HSA-392451:G beta:gamma signalling through PI3Kgamma		
T67849	REACPATH	R-HSA-512988:Interleukin-3, 5 and GM-CSF signaling		
T67849	REACPATH	R-HSA-912526:Interleukin receptor SHC signaling		
T67849	REACPATH	R-HSA-912631:Regulation of signaling by CBL		
T67849	REACPATH	R-HSA-983695:Antigen activates B Cell Receptor (BCR) leading to generation of second messengers		
T67849	NET_PATH	NetPath_25:FSH Signaling Pathway		
T67849	INTEPATH	cxcr3pathway:CXCR3-mediated signaling events		
T67849	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T67849	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T67849	INTEPATH	erbb1_internalization_pathway:Internalization of ErbB1		
T67849	INTEPATH	erbb1_receptor_proximal_pathway:EGF receptor (ErbB1) signaling pathway		
T67849	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T67849	INTEPATH	erbb4_pathway:ErbB4 signaling events		
T67849	INTEPATH	faspathway:FAS (CD95) signaling pathway		
T67849	INTEPATH	nephrin_neph1_pathway:Nephrin/Neph1 signaling in the kidney podocyte		
T67849	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T67849	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T67849	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T67849	INTEPATH	trail_pathway:TRAIL signaling pathway		
T67849	PANTPATH	P00005:Angiogenesis		
T67849	PANTPATH	P00006:Apoptosis signaling pathway		
T67849	PANTPATH	P00009:Axon guidance mediated by netrin		
T67849	PANTPATH	P00010:B cell activation		
T67849	PANTPATH	P00018:EGF receptor signaling pathway		
T67849	PANTPATH	P00019:Endothelin signaling pathway		
T67849	PANTPATH	P00021:FGF signaling pathway		
T67849	PANTPATH	P00030:Hypoxia response via HIF activation		
T67849	PANTPATH	P00031:Inflammation mediated by chemokine and cytokine signaling pathway		
T67849	PANTPATH	P00033:Insulin/IGF pathway-protein kinase B signaling cascade		
T67849	PANTPATH	P00034:Integrin signalling pathway		
T67849	PANTPATH	P00047:PDGF signaling pathway		
T67849	PANTPATH	P00053:T cell activation		
T67849	PANTPATH	P00056:VEGF signaling pathway		
T67849	PANTPATH	P00059:p53 pathway		
T67849	PANTPATH	P04393:Ras Pathway		
T67849	PANTPATH	P04398:p53 pathway feedback loops 2		
T67849	BIOCPATH	PWY-6352:3-phosphoinositide biosynthesis		
T67849	BIOCPATH	PWY-6371:Superpathway of inositol phosphate compounds		
				
T10897	TARGETID	T10897		
T10897	FORMERID	TTDS00516		
T10897	UNIPROID	ACOD_HUMAN		
T10897	TARGNAME	Acyl-CoA desaturase (SCD)		
T10897	GENENAME	SCD		
T10897	TARGTYPE	Successful target		
T10897	SYNONYMS	hSCD1; Stearoyl-coenzyme A (Delta9) desaturase; Stearoyl-CoA desaturase; Membrane-bound 9 desaturase; Fatty acid desaturase; DesA3; Des A3; Delta-9-stearoyl desaturase; Delta-9 desaturase; Delta(9)-desaturase; 9 stearoyl-desaturase		
T10897	FUNCTION	Catalyzes the insertion of a cis double bond at the delta-9 position into fatty acyl-CoA substrates including palmitoyl-CoA and stearoyl-CoA. Gives rise to a mixture of 16:1 and 18:1 unsaturated fatty acids. Plays an important role in lipid biosynthesis. Plays an important role in regulating the expression of genes that are involved in lipogenesis and in regulating mitochondrial fatty acid oxidation. Plays an important role in body energy homeostasis. Contributes to the biosynthesis of membrane phospholipids, cholesterol esters and triglycerides. Stearyl-CoA desaturase that utilizes O(2) and electrons from reduced cytochrome b5 to introduce the first double bond into saturated fatty acyl-CoA substrates.		
T10897	PDBSTRUC	4ZYO		
T10897	BIOCLASS	Paired donor oxygen oxidoreductase		
T10897	ECNUMBER	EC 1.14.19.1		
T10897	SEQUENCE	MPAHLLQDDISSSYTTTTTITAPPSRVLQNGGDKLETMPLYLEDDIRPDIKDDIYDPTYKDKEGPSPKVEYVWRNIILMSLLHLGALYGITLIPTCKFYTWLWGVFYYFVSALGITAGAHRLWSHRSYKARLPLRLFLIIANTMAFQNDVYEWARDHRAHHKFSETHADPHNSRRGFFFSHVGWLLVRKHPAVKEKGSTLDLSDLEAEKLVMFQRRYYKPGLLMMCFILPTLVPWYFWGETFQNSVFVATFLRYAVVLNATWLVNSAAHLFGYRPYDKNISPRENILVSLGAVGEGFHNYHHSFPYDYSASEYRWHINFTTFFIDCMAALGLAYDRKKVSKAAILARIKRTGDGNYKSG		
T10897	DRUGINFO	D0I8CA	Isoxyl	Approved
T10897	DRUGINFO	D09PVO	Aramchol	Phase 2/3
T10897	DRUGINFO	D0S0RS	MK-8245	Phase 2
T10897	DRUGINFO	D0N1QW	2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide	Investigative
T10897	DRUGINFO	D0O7DP	CVT-12012	Investigative
T10897	DRUGINFO	D0D9QN	ISIS 147919	Investigative
T10897	DRUGINFO	D0O3TT	MF-152	Investigative
T10897	DRUGINFO	D00GQC	Sterculic acid	Investigative
T10897	KEGGPATH	mtc01100:Metabolic pathways		
				
T16987	TARGETID	T16987		
T16987	FORMERID	TTDR00212		
T16987	UNIPROID	CAH12_HUMAN		
T16987	TARGNAME	Carbonic anhydrase XII (CA-XII)		
T16987	GENENAME	CA12		
T16987	TARGTYPE	Successful target		
T16987	SYNONYMS	Tumor antigen HOM-RCC-3.1.3; Carbonic anhydrase 12; Carbonate dehydratase XII		
T16987	FUNCTION	Reversible hydration of carbon dioxide.		
T16987	PDBSTRUC	6G7A; 6G5L; 5MSB; 5MSA; 5LLP		
T16987	BIOCLASS	Alpha-carbonic anhydrase		
T16987	ECNUMBER	EC 4.2.1.1		
T16987	SEQUENCE	MPRRSLHAAAVLLLVILKEQPSSPAPVNGSKWTYFGPDGENSWSKKYPSCGGLLQSPIDLHSDILQYDASLTPLEFQGYNLSANKQFLLTNNGHSVKLNLPSDMHIQGLQSRYSATQLHLHWGNPNDPHGSEHTVSGQHFAAELHIVHYNSDLYPDASTASNKSEGLAVLAVLIEMGSFNPSYDKIFSHLQHVKYKGQEAFVPGFNIEELLPERTAEYYRYRGSLTTPPCNPTVLWTVFRNPVQISQEQLLALETALYCTHMDDPSPREMINNFRQVQKFDERLVYTSFSQVQVCTAAGLSLGIILSLALAGILGICIVVVVSIWLFRRKSIKKGDNKGVIYKPATKMETEAHA		
T16987	DRUGINFO	D07HBX	Salicyclic acid	Approved
T16987	DRUGINFO	D0K1QD	Sulfamylon	Approved
T16987	DRUGINFO	D07SDQ	Curcumin	Phase 3
T16987	DRUGINFO	D0A8JP	PARABEN	Phase 3
T16987	DRUGINFO	D0L6HN	PHENOL	Phase 2/3
T16987	DRUGINFO	D0Y6OA	Coumate	Phase 2
T16987	DRUGINFO	D03SLR	FERULIC ACID	Patented
T16987	DRUGINFO	D05RAB	1,4-Dihydro-1-methyl-4-oxo-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D04SNH	1-Benzyl-1,4-dihydro-4-oxo-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D0RK7J	2,2,2-Trifluoro-N-(4-sulfamoyl-phenyl)-acetamide	Investigative
T16987	DRUGINFO	D03DAM	2,2-Dimethyl-N-(4-sulfamoyl-phenyl)-propionamide	Investigative
T16987	DRUGINFO	D0LC0F	2,3-dihydro-1H-indene-5-sulfonamide	Investigative
T16987	DRUGINFO	D0M3PO	2,4-Disulfamyltrifluoromethylaniline	Investigative
T16987	DRUGINFO	D09TES	2-acetamido-2,3-dihydro-1H-indene-5-sulfonic acid	Investigative
T16987	DRUGINFO	D07CYN	2-amino-2,3-dihydro-1H-indene-5-sulfonamide	Investigative
T16987	DRUGINFO	D0OI1H	2-Amino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0C4QB	2-Amino-indan-5-sulfonic acid	Investigative
T16987	DRUGINFO	D0G0FJ	2-hydrazinylbenzenesulfonamide	Investigative
T16987	DRUGINFO	D0H3NS	2-oxo-2H-chromene-3-carboxylic acid	Investigative
T16987	DRUGINFO	D0D6UR	2-oxo-2H-thiochromene-3-carboxylic acid	Investigative
T16987	DRUGINFO	D0H4CF	3-((4-aminophenyl)diazenyl)benzenesulfonamide	Investigative
T16987	DRUGINFO	D0C7WG	3-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Investigative
T16987	DRUGINFO	D06ZMH	3-(3-Phenyl-ureido)-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0BD0K	3-(4'-Hydroxyphenyl)diazenylbenzenesulfonamide	Investigative
T16987	DRUGINFO	D0J2AE	3-Amino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D04HRS	4-((4-hydroxyphenyl)diazenyl)benzenesulfonamide	Investigative
T16987	DRUGINFO	D04NSN	4-(2-AMINOETHYL)BENZENESULFONAMIDE	Investigative
T16987	DRUGINFO	D04VLI	4-(2-Hydroxy-ethyl)-benzenesulfonamide	Investigative
T16987	DRUGINFO	D05ETN	4-(2-Methyl-8-quinolinoxy)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D02BMV	4-(2-Propynylthio)pyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D05EBZ	4-(4-Cyanophenoxy)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D08JCC	4-(4-Fluorophenoxy)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D00RDE	4-(4'-N-Methylphenyl)diazenylbenzenesulfonamide	Investigative
T16987	DRUGINFO	D0R4KQ	4-(5-Methyl-2-pirazolino)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D09TKG	4-(Allylamino)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D0V5OW	4-(Carbamolymethylthio)pyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D01OTW	4-(Cyanomethylthio)pyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D05XZM	4-(hydroxymethyl)benzenesulfonamide	Investigative
T16987	DRUGINFO	D0Q5VB	4-(Methylhydrazino)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D0M7VN	4-(N-Methyl-hydrazino)-benzenesulfonamide	Investigative
T16987	DRUGINFO	D02NQK	4-(N-Oxide-2-pyridylthio)pyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D05JAJ	4-(Quinolinoxy)-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D03KRB	4,4'-thiodipyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D09LUD	4-[2-(3-Phenyl-ureido)-ethyl]-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0P6AM	4-Amino-3-bromo-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0YU8J	4-Amino-3-chloro-benzenesulfonamide	Investigative
T16987	DRUGINFO	D04CVC	4-Amino-3-fluoro-benzenesulfonamide	Investigative
T16987	DRUGINFO	D01STY	4-Amino-3-iodo-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0YD9F	4-Benzenesulfonylamino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D06IOI	4-Benzythiopyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D00IUB	4-CYANOPHENOL	Investigative
T16987	DRUGINFO	D04VSP	4-Ethoxy-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D0UM1I	4-Hydrazino-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D0NN3Q	4-Hydrazino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D00NUK	4-Methanesulfonylamino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D00IKQ	4-Methoxy-3-pyridinesulfonamide	Investigative
T16987	DRUGINFO	D07AGM	4-Methylamino-benzenesulfonamide	Investigative
T16987	DRUGINFO	D0J7GU	4-Methylthiopyridine-3-sulfonamide	Investigative
T16987	DRUGINFO	D0N1AW	6-(aminomethyl)-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D0L5TZ	6-(hydroxymethyl)-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D0Q2LL	6-Hydroxy-benzothiazole-2-sulfonic acid amide	Investigative
T16987	DRUGINFO	D00XJA	6-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T16987	DRUGINFO	D0G3BI	6-methyl-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T16987	DRUGINFO	D00RNZ	7-(benzyloxy)-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D0LU4S	7-butoxy-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D0RB0D	7-methoxy-2-oxo-2H-chromene-4-carboxylic acid	Investigative
T16987	DRUGINFO	D05QUG	7-phenethoxy-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D0OT5L	7-propoxy-2H-chromen-2-one	Investigative
T16987	DRUGINFO	D06DYP	8-methoxy-2-oxo-2H-chromene-3-carboxylic acid	Investigative
T16987	DRUGINFO	D04POB	ACETYLSULFANILAMIDE	Investigative
T16987	DRUGINFO	D0E8CC	BENZOLAMIDE	Investigative
T16987	DRUGINFO	D09PWX	Carzenide	Investigative
T16987	DRUGINFO	D0V7AA	CATECHIN	Investigative
T16987	DRUGINFO	D07QJJ	CATECHOL	Investigative
T16987	DRUGINFO	D0VD7H	CL-5343	Investigative
T16987	DRUGINFO	D03ZMQ	COUMARIN	Investigative
T16987	DRUGINFO	D00YEF	Decane-1,10-diyl disulfamate	Investigative
T16987	DRUGINFO	D09WSJ	Decyl sulfamate	Investigative
T16987	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T16987	DRUGINFO	D05VSK	ETHOXYCOUMARIN	Investigative
T16987	DRUGINFO	D07TAJ	Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate	Investigative
T16987	DRUGINFO	D0Y3TZ	GALLICACID	Investigative
T16987	DRUGINFO	D0U4BB	HERNIARIN	Investigative
T16987	DRUGINFO	D09JPC	Hexane-1,6-diamine	Investigative
T16987	DRUGINFO	D0M4EV	N-(4-cyanophenyl)sulfamide	Investigative
T16987	DRUGINFO	D0KB6T	N-(4-Sulfamoyl-phenyl)-benzamide	Investigative
T16987	DRUGINFO	D0K3LN	N-(4-Sulfamoyl-phenyl)-butyramide	Investigative
T16987	DRUGINFO	D0T2YZ	N-(4-Sulfamoyl-phenyl)-isobutyramide	Investigative
T16987	DRUGINFO	D0N8LR	N-(4-Sulfamoyl-phenyl)-propionamide	Investigative
T16987	DRUGINFO	D0PA5L	N-(pentafluorophenyl)sulfamide	Investigative
T16987	DRUGINFO	D09WVV	N1-(2-aminoethyl)ethane-1,2-diamine	Investigative
T16987	DRUGINFO	D0X5HL	N1-(naphthalen-1-yl)ethane-1,2-diamine	Investigative
T16987	DRUGINFO	D09CXX	N-hydroxysulfamide	Investigative
T16987	DRUGINFO	D01XFH	N-propynyl amidebenzenesulphonide	Investigative
T16987	DRUGINFO	D0D4OV	Octane-1,8-diyl disulfamate	Investigative
T16987	DRUGINFO	D05TLB	Octyl sulfamate	Investigative
T16987	DRUGINFO	D0AU0M	P-Coumaric Acid	Investigative
T16987	DRUGINFO	D02QGI	Pentane-1,5-diamine	Investigative
T16987	DRUGINFO	D0Q0XO	Pentanoic acid (4-sulfamoyl-phenyl)-amide	Investigative
T16987	DRUGINFO	D00IAE	Prop-2-ynyl 4-sulfamoylbenzoate	Investigative
T16987	DRUGINFO	D0ZC3W	P-toluenesulfonamide	Investigative
T16987	DRUGINFO	D02DBP	RESORCINOL	Investigative
T16987	DRUGINFO	D0A0YX	SACCHARIN	Investigative
T16987	DRUGINFO	D0M9IQ	Sodium N-methylphenylaminomethanesulfonate	Investigative
T16987	DRUGINFO	D07UCQ	Sodium phenylaminomethanesulfonate	Investigative
T16987	DRUGINFO	D0Q7DJ	Syringic Acid	Investigative
T16987	DRUGINFO	D0I0RT	Thioureido sulfonamide	Investigative
T16987	KEGGPATH	hsa00910:Nitrogen metabolism		
T16987	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T16987	WIKIPATH	WP2003:miR-targeted genes in leukocytes - TarBase		
T16987	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T16987	WIKIPATH	WP2770:Reversible Hydration of Carbon Dioxide		
T16987	REACPATH	R-HSA-1475029:Reversible hydration of carbon dioxide		
T16987	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
				
T19433	TARGETID	T19433		
T19433	FORMERID	TTDS00192		
T19433	UNIPROID	HPGDS_HUMAN		
T19433	TARGNAME	Glutathione-dependent PGD synthase (HPGDS)		
T19433	GENENAME	HPGDS		
T19433	TARGTYPE	Successful target		
T19433	SYNONYMS	HPGDS; Glutathione-S-transferase; GST class-alpha		
T19433	FUNCTION	Bifunctional enzyme which catalyzes both the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation, and the conjugation of glutathione with a widerange of aryl halides and organic isothiocyanates. Also exhibits low glutathione-peroxidase activity towards cumene hydroperoxide.		
T19433	PDBSTRUC	6N4E; 5YX1; 5YWX; 5YWE; 5AIX		
T19433	BIOCLASS	Intramolecular oxidoreductases		
T19433	ECNUMBER	EC 5.3.99.2		
T19433	SEQUENCE	MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLTLHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELLTYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKKVQAIPAVANWIKRRPQTKL		
T19433	DRUGINFO	D0L9ZR	Praziquantel	Approved
T19433	DRUGINFO	D02AOD	HF-0220	Phase 2
T19433	DRUGINFO	D06GJP	Cibacron blue	Investigative
T19433	DRUGINFO	D06EWG	Formic Acid	Investigative
T19433	DRUGINFO	D0PI1C	HQL-79	Investigative
T19433	DRUGINFO	D0AF3A	Protoporphyrin IX	Investigative
T19433	DRUGINFO	D08IXW	S-hexylglutathione	Investigative
T19433	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T19433	KEGGPATH	hsa01100:Metabolic pathways		
T19433	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T19433	WIKIPATH	WP2586:Aryl Hydrocarbon Receptor		
T19433	WIKIPATH	WP2650:Arachidonic acid metabolism		
T19433	BIOCPATH	PWY66-374:C20 prostanoid biosynthesis		
				
T94033	TARGETID	T94033		
T94033	FORMERID	TTDS00202		
T94033	UNIPROID	THRB_HUMAN		
T94033	TARGNAME	Coagulation factor IIa (F2)		
T94033	GENENAME	F2		
T94033	TARGTYPE	Successful target		
T94033	SYNONYMS	Prothrombin; Coagulation factor II		
T94033	FUNCTION	Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing.		
T94033	PDBSTRUC	8KME; 7KME; 6EO9; 6EO8; 6EO7		
T94033	BIOCLASS	Peptidase		
T94033	ECNUMBER	EC 3.4.21.5		
T94033	SEQUENCE	MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE		
T94033	DRUGINFO	D09WKB	Anisindione	Approved
T94033	DRUGINFO	D07UWV	Argatroban	Approved
T94033	DRUGINFO	D0AW9T	ATryn antithrombin	Approved
T94033	DRUGINFO	D09HVL	Bivalirudin	Approved
T94033	DRUGINFO	D0M7JT	Dabigatran	Approved
T94033	DRUGINFO	D03LWO	Desirudin Recombinant	Approved
T94033	DRUGINFO	D07KFG	Human prothrombin complex concentrate	Approved
T94033	DRUGINFO	D09LPN	Lepirudin	Approved
T94033	DRUGINFO	D06JGH	Pyridoxal Phosphate	Approved
T94033	DRUGINFO	D0B5LF	Ximelegatran	Approved
T94033	DRUGINFO	D0F3SZ	Hirudin	Phase 4
T94033	DRUGINFO	D01MUU	MELAGATRAN	Phase 3
T94033	DRUGINFO	D0VL4V	SR-123781A	Phase 2/3
T94033	DRUGINFO	D09DFB	EFEGATRAN SULFATE HYDRATE	Phase 2
T94033	DRUGINFO	D0UK1L	EP-217609	Phase 2
T94033	DRUGINFO	D0I7MX	LB-30870	Phase 2
T94033	DRUGINFO	D0H9RN	NU-172	Phase 2
T94033	DRUGINFO	D0N6EA	Odiparcil	Phase 2
T94033	DRUGINFO	D0K8FI	Pegmusirudin	Phase 2
T94033	DRUGINFO	D0GG5I	Recombinant RGD-hirudin	Phase 2
T94033	DRUGINFO	D0PX0N	TF0023	Phase 2
T94033	DRUGINFO	D0K4FP	AZD-8165	Phase 1
T94033	DRUGINFO	D05HAD	DP-4088	Phase 1
T94033	DRUGINFO	D0G6UQ	EP-42675	Phase 1
T94033	DRUGINFO	D00LOB	RWJ-671818	Phase 1
T94033	DRUGINFO	D0L2XU	Solulin	Phase 1
T94033	DRUGINFO	D02UIC	SSR-128428	Phase 1
T94033	DRUGINFO	D0JQ7Y	Ximelagatran	Withdrawn from market
T94033	DRUGINFO	D0B1KK	AZD0837	Discontinued in Phase 2
T94033	DRUGINFO	D0B9EH	Dermolastin	Discontinued in Phase 2
T94033	DRUGINFO	D0H4UJ	INOGATRAN	Discontinued in Phase 2
T94033	DRUGINFO	D0Q3WN	Napsagatran	Discontinued in Phase 2
T94033	DRUGINFO	D06DUO	SSR-182289	Discontinued in Phase 2
T94033	DRUGINFO	D07MZC	Vasoflux	Discontinued in Phase 2
T94033	DRUGINFO	D0W5XT	ARC-183	Discontinued in Phase 1
T94033	DRUGINFO	D01IBO	BCX-1470	Discontinued in Phase 1
T94033	DRUGINFO	D05KTK	CJC-1004	Discontinued in Phase 1
T94033	DRUGINFO	D02MHE	CVS-1123	Discontinued in Phase 1
T94033	DRUGINFO	D05MXK	GW-473178	Discontinued in Phase 1
T94033	DRUGINFO	D09CKF	Licostinel	Discontinued in Phase 1
T94033	DRUGINFO	D0UF5I	MPC-0920	Discontinued in Phase 1
T94033	DRUGINFO	D0H2ZQ	S-18326	Discontinued in Phase 1
T94033	DRUGINFO	D0G0XN	UK-156406	Discontinued in Phase 1
T94033	DRUGINFO	D06ALB	BCH-2763	Terminated
T94033	DRUGINFO	D0G7YZ	BMS-189664	Terminated
T94033	DRUGINFO	D0J6VU	CVS-995	Terminated
T94033	DRUGINFO	D0Y5EX	DuP 714	Terminated
T94033	DRUGINFO	D02QTV	Efegatran	Terminated
T94033	DRUGINFO	D0S6XJ	GS-522	Terminated
T94033	DRUGINFO	D0WL1C	Hementin	Terminated
T94033	DRUGINFO	D05WYW	L-373890	Terminated
T94033	DRUGINFO	D0L6UZ	L-374,087	Terminated
T94033	DRUGINFO	D0S2JG	LB30057	Terminated
T94033	DRUGINFO	D0SF5F	Org-34092	Terminated
T94033	DRUGINFO	D0RP8F	PPACK	Terminated
T94033	DRUGINFO	D02ZWG	SR-80027A	Terminated
T94033	DRUGINFO	D0X1OY	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone	Investigative
T94033	DRUGINFO	D08WQJ	(3-nitro-1H-pyrazol-1-yl)(phenyl)methanone	Investigative
T94033	DRUGINFO	D08OCS	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone	Investigative
T94033	DRUGINFO	D05ZIP	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone	Investigative
T94033	DRUGINFO	D00WFQ	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone	Investigative
T94033	DRUGINFO	D06LPR	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone	Investigative
T94033	DRUGINFO	D0E1NH	1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE	Investigative
T94033	DRUGINFO	D00QDR	1,2,3,4,6-penta-O-galloyl-beta-D-glucose	Investigative
T94033	DRUGINFO	D0IU5E	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide	Investigative
T94033	DRUGINFO	D08OLP	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	Investigative
T94033	DRUGINFO	D0N0PI	2-NAPHTHALENESULFONIC ACID	Investigative
T94033	DRUGINFO	D0SP2I	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine	Investigative
T94033	DRUGINFO	D0P3OH	3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate	Investigative
T94033	DRUGINFO	D0N1HV	4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL	Investigative
T94033	DRUGINFO	D0CT8A	4-(3,4-Diethoxy-benzylamino)-benzamidine	Investigative
T94033	DRUGINFO	D02XPB	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	Investigative
T94033	DRUGINFO	D09CVG	4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE	Investigative
T94033	DRUGINFO	D0G6RI	4-hydroxyphenylpyruvic acid	Investigative
T94033	DRUGINFO	D05MJU	4-iodobenzo[b]thiophene 2-carboxamidine	Investigative
T94033	DRUGINFO	D0D9NT	4-TERT-BUTYLBENZENESULFONIC ACID	Investigative
T94033	DRUGINFO	D07HWB	5-desgalloylstachyurin	Investigative
T94033	DRUGINFO	D06KCW	6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE	Investigative
T94033	DRUGINFO	D09QZJ	AC-(D)PHE-PRO-BOROHOMOLYS-OH	Investigative
T94033	DRUGINFO	D0E9ON	AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH	Investigative
T94033	DRUGINFO	D0R4AV	AC-(D)PHE-PRO-BOROLYS-OH	Investigative
T94033	DRUGINFO	D0T5WR	Bbs-Arg-(D-Pip)-Gly-(EQKLISEEDL)-Gly-Hir	Investigative
T94033	DRUGINFO	D0KQ1K	Bbs-Arg-(D-Pip)-Gly-(SPH(pY)EKVS)-Gly-Hir	Investigative
T94033	DRUGINFO	D0P0LG	Bbs-Arg-(D-Pip)-Gly-(SPHYEKVS)-Gly-Hir	Investigative
T94033	DRUGINFO	D07BJZ	Bbs-Arg-(D-Pip)-Gly-S-(GS)11-Gly-Hir	Investigative
T94033	DRUGINFO	D09HFC	Bbs-Arg-(D-Pip)-Gly-S-(GS)13-Gly-Hir	Investigative
T94033	DRUGINFO	D0CV4F	Bbs-Arg-(D-Pip)-Gly-S-(GS)1-Gly-Hir	Investigative
T94033	DRUGINFO	D01ARY	Bbs-Arg-(D-Pip)-Gly-S-(GS)3-Gly-Hir	Investigative
T94033	DRUGINFO	D07BMA	Bbs-Arg-(D-Pip)-Gly-S-(GS)5-Gly-Hir	Investigative
T94033	DRUGINFO	D04VYT	Bbs-Arg-(D-Pip)-Gly-S-(GS)7-Gly-Hir	Investigative
T94033	DRUGINFO	D0WF2C	Bbs-Arg-(D-Pip)-Gly-S-(GS)9-Gly-Hir	Investigative
T94033	DRUGINFO	D07NYX	BENZOTHIAZOLE	Investigative
T94033	DRUGINFO	D0N0YX	Beta-(2-Naphthyl)-Alanine	Investigative
T94033	DRUGINFO	D03LGM	Beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide	Investigative
T94033	DRUGINFO	D0J1QT	BMS-344577	Investigative
T94033	DRUGINFO	D0JU9N	BMS-740808	Investigative
T94033	DRUGINFO	D0I6DO	bufrudin	Investigative
T94033	DRUGINFO	D0I1UF	CASUARIIN	Investigative
T94033	DRUGINFO	D01NEZ	CHLORODYSINOSIN A	Investigative
T94033	DRUGINFO	D0X0IF	COCHINCHINENENE B	Investigative
T94033	DRUGINFO	D0U4HG	COCHINCHINENIN B	Investigative
T94033	DRUGINFO	D0K7YL	CRA_8696	Investigative
T94033	DRUGINFO	D0Y8QU	CVS-1578	Investigative
T94033	DRUGINFO	D0D8AK	Cyclotheonamide E	Investigative
T94033	DRUGINFO	D0M1AC	Cyclotheonamide E4	Investigative
T94033	DRUGINFO	D0CF3B	Cyclotheonamide E5	Investigative
T94033	DRUGINFO	D0H8OB	Desirudine	Investigative
T94033	DRUGINFO	D0P1JQ	D-leucyl-N-(3-chlorobenzyl)-L-prolinamide	Investigative
T94033	DRUGINFO	D05BMA	D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide	Investigative
T94033	DRUGINFO	D0O1DU	D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide	Investigative
T94033	DRUGINFO	D07YNF	D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide	Investigative
T94033	DRUGINFO	D0K3JC	D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide	Investigative
T94033	DRUGINFO	D08EUH	D-phenylalanyl-N-benzyl-L-prolinamide	Investigative
T94033	DRUGINFO	D0M4VZ	D-Pro-Phe-Arg chloromethyl ketone	Investigative
T94033	DRUGINFO	D0V7RD	DYSINOSIN A	Investigative
T94033	DRUGINFO	D06YJX	Enoxaprin	Investigative
T94033	DRUGINFO	D06UUK	Gamma-Carboxy-Glutamic Acid	Investigative
T94033	DRUGINFO	D07IBU	GR-133686	Investigative
T94033	DRUGINFO	D08YGD	Haempatch	Investigative
T94033	DRUGINFO	D02KKL	Hemi-Babim	Investigative
T94033	DRUGINFO	D04CQG	Heparin-Cantithrombin III	Investigative
T94033	DRUGINFO	D0I0NY	L-370,518	Investigative
T94033	DRUGINFO	D02NHS	L-375378	Investigative
T94033	DRUGINFO	D0QQ4Z	LB30812	Investigative
T94033	DRUGINFO	D03MYL	Lysophosphotidylserine	Investigative
T94033	DRUGINFO	D0RQ2T	Macrocyclic tripeptide motif	Investigative
T94033	DRUGINFO	D08MEC	Melogatran	Investigative
T94033	DRUGINFO	D0I8WD	Methyl L-phenylalaninate	Investigative
T94033	DRUGINFO	D01RTU	METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE	Investigative
T94033	DRUGINFO	D05NRZ	N4-(N,N-diphenylcarbamoyl)-aminoguanidine	Investigative
T94033	DRUGINFO	D0H5WV	OSCILLARIN	Investigative
T94033	DRUGINFO	D0Z2TG	Pedunculagin	Investigative
T94033	DRUGINFO	D0ON2Z	RAZAXABAN	Investigative
T94033	DRUGINFO	D09OBJ	RWJ-50353	Investigative
T94033	DRUGINFO	D01WDB	S-2238	Investigative
T94033	DRUGINFO	D0W5AW	SC-79407	Investigative
T94033	DRUGINFO	D0F4VK	TB-101	Investigative
T94033	DRUGINFO	D03KFJ	TB-102	Investigative
T94033	DRUGINFO	D0E6SO	Tellimagrandin II	Investigative
T94033	DRUGINFO	D05RFC	Tumor vascular thrombogen	Investigative
T94033	DRUGINFO	D04PPE	VE-04051645	Investigative
T94033	DRUGINFO	D07QPA	Vitamin K	Investigative
T94033	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T94033	KEGGPATH	hsa04610:Complement and coagulation cascades		
T94033	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T94033	WIKIPATH	WP15:Selenium Micronutrient Network		
T94033	WIKIPATH	WP1533:Vitamin B12 Metabolism		
T94033	WIKIPATH	WP176:Folate Metabolism		
T94033	WIKIPATH	WP1794:Cell surface interactions at the vascular wall		
T94033	WIKIPATH	WP1818:Formation of Fibrin Clot (Clotting Cascade)		
T94033	WIKIPATH	WP1824:GPCR downstream signaling		
T94033	WIKIPATH	WP1825:GPCR ligand binding		
T94033	WIKIPATH	WP1884:Platelet Aggregation (Plug Formation)		
T94033	WIKIPATH	WP1929:Thrombin signalling through proteinase activated receptors (PARs)		
T94033	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T94033	WIKIPATH	WP272:Blood Clotting Cascade		
T94033	WIKIPATH	WP2762:PTM: gamma carboxylation, hypusine formation and arylsulfatase activation		
T94033	WIKIPATH	WP2799:Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T94033	WIKIPATH	WP2865:IL1 and megakaryotyces in obesity		
T94033	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T94033	WIKIPATH	WP558:Complement and Coagulation Cascades		
T94033	WHIZPATH	PW000047:Vitamin K Metabolism		
T94033	WHIZPATH	PW000562:Coagulation		
T94033	REACPATH	R-HSA-140837:Intrinsic Pathway of Fibrin Clot Formation		
T94033	REACPATH	R-HSA-140875:Common Pathway of Fibrin Clot Formation		
T94033	REACPATH	R-HSA-159740:Gamma-carboxylation of protein precursors		
T94033	REACPATH	R-HSA-159763:Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus		
T94033	REACPATH	R-HSA-159782:Removal of aminoterminal propeptides from gamma-carboxylated proteins		
T94033	REACPATH	R-HSA-202733:Cell surface interactions at the vascular wall		
T94033	REACPATH	R-HSA-375276:Peptide ligand-binding receptors		
T94033	REACPATH	R-HSA-381426:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T94033	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T94033	REACPATH	R-HSA-456926:Thrombin signalling through proteinase activated receptors (PARs)		
T94033	NET_PATH	NetPath_11:TCR Signaling Pathway		
T94033	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T94033	INTEPATH	hnf3bpathway:FOXA2 and FOXA3 transcription factor networks		
T94033	INTEPATH	syndecan_4_pathway:Syndecan-4-mediated signaling events		
T94033	INTEPATH	thrombin_par1_pathway:PAR1-mediated thrombin signaling events		
T94033	INTEPATH	thrombin_par4_pathway:PAR4-mediated thrombin signaling events		
T94033	INTEPATH	thrombin_pathway:Thrombin/protease-activated receptor (PAR) pathway		
T94033	PANTPATH	P00011:Blood coagulation		
				
T83369	TARGETID	T83369		
T83369	FORMERID	TTDC00078		
T83369	UNIPROID	FA9_HUMAN		
T83369	TARGNAME	Coagulation factor IX (F9)		
T83369	GENENAME	F9		
T83369	TARGTYPE	Successful target		
T83369	SYNONYMS	Plasma thromboplastin component; PTC protein; Factor IX; Christmas factor		
T83369	FUNCTION	Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa.		
T83369	PDBSTRUC	6MV4; 5VYG; 5TNT; 5TNO; 5JBC		
T83369	BIOCLASS	Peptidase		
T83369	ECNUMBER	EC 3.4.21.22		
T83369	SEQUENCE	MQRVNMIMAESPGLITICLLGYLLSAECTVFLDHENANKILNRPKRYNSGKLEEFVQGNLERECMEEKCSFEEAREVFENTERTTEFWKQYVDGDQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCELDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTRAETVFPDVDYVNSTEAETILDNITQSTQSFNDFTRVVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT		
T83369	DRUGINFO	D09XTN	Emicizumab	Approved
T83369	DRUGINFO	D0P8QN	Recombinant Factor IX	Approved
T83369	DRUGINFO	DBHO19	AMT-061	Phase 3
T83369	DRUGINFO	D04AYZ	CSL-654	Phase 3
T83369	DRUGINFO	DN87BL	Fidanacogene elaparvovec	Phase 3
T83369	DRUGINFO	D08YTF	RG6013	Phase 3
T83369	DRUGINFO	D0VT1S	TTP889	Phase 2
T83369	DRUGINFO	D0A9PW	AMT-060	Phase 1/2
T83369	DRUGINFO	DH40QT	SB-FIX	Phase 1/2
T83369	DRUGINFO	D00TXL	AAV2-hFIX16	Phase 1
T83369	DRUGINFO	D05RBH	N9-GP	Phase 1
T83369	DRUGINFO	D03MCV	RB-006	Discontinued in Phase 3
T83369	DRUGINFO	D03PJP	Trenonacog alfa	Discontinued in Phase 3
T83369	DRUGINFO	D07JQO	SB 249417	Discontinued in Phase 1
T83369	DRUGINFO	D0K9KS	Draculin	Terminated
T83369	DRUGINFO	D0Z2PJ	4-Benzyloxybenzo[b]thiophene-2-carboxamidine	Investigative
T83369	DRUGINFO	D05MJU	4-iodobenzo[b]thiophene 2-carboxamidine	Investigative
T83369	DRUGINFO	D0EK9T	4-Phenyl-benzo[b]thiophene-2-carboxamidine	Investigative
T83369	DRUGINFO	D0Y4KJ	5-Benzyloxy-benzo[b]thiophene-2-carboxamidine	Investigative
T83369	DRUGINFO	D0LX0D	6-Benzyloxybenzo[b]thiophene-2-carboxamidine	Investigative
T83369	DRUGINFO	D0Z2UT	BNP-FIX	Investigative
T83369	DRUGINFO	D09PDK	F-9TG	Investigative
T83369	DRUGINFO	D06IGE	Factor IX-XTEN	Investigative
T83369	DRUGINFO	D06UUK	Gamma-Carboxy-Glutamic Acid	Investigative
T83369	DRUGINFO	D0YX8X	MG-1104	Investigative
T83369	DRUGINFO	D0Q4XG	MOD-3012	Investigative
T83369	DRUGINFO	D0G4LX	PMID20121197C57	Investigative
T83369	DRUGINFO	D0ON2Z	RAZAXABAN	Investigative
T83369	KEGGPATH	hsa04610:Complement and coagulation cascades		
T83369	WIKIPATH	WP1818:Formation of Fibrin Clot (Clotting Cascade)		
T83369	WIKIPATH	WP272:Blood Clotting Cascade		
T83369	WIKIPATH	WP2762:PTM: gamma carboxylation, hypusine formation and arylsulfatase activation		
T83369	WIKIPATH	WP558:Complement and Coagulation Cascades		
T83369	WHIZPATH	PW000562:Coagulation		
T83369	REACPATH	R-HSA-140834:Extrinsic Pathway of Fibrin Clot Formation		
T83369	REACPATH	R-HSA-140837:Intrinsic Pathway of Fibrin Clot Formation		
T83369	REACPATH	R-HSA-159740:Gamma-carboxylation of protein precursors		
T83369	REACPATH	R-HSA-159763:Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus		
T83369	REACPATH	R-HSA-159782:Removal of aminoterminal propeptides from gamma-carboxylated proteins		
T83369	PANTPATH	P00011:Blood coagulation		
				
T84631	TARGETID	T84631		
T84631	FORMERID	TTDS00203		
T84631	UNIPROID	FA10_HUMAN		
T84631	TARGNAME	Coagulation factor Xa (F10)		
T84631	GENENAME	F10		
T84631	TARGTYPE	Successful target		
T84631	SYNONYMS	Fxa; Factor Xa; F10; Activated coagulation factor X		
T84631	FUNCTION	Factor Xa is avitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting.		
T84631	PDBSTRUC	6RK9; 5VOF; 5VOE; 5K0H; 5JZU		
T84631	BIOCLASS	Peptidase		
T84631	ECNUMBER	EC 3.4.21.6		
T84631	SEQUENCE	MGRPLHLVLLSASLAGLLLLGESLFIRREQANNILARVTRANSFLEEMKKGHLERECMEETCSYEEAREVFEDSDKTNEFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRSVAQATSSSGEAPDSITWKPYDAADLDPTENPFDLLDFNQTQPERGDNNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK		
T84631	DRUGINFO	D0I5HF	Apixaban	Approved
T84631	DRUGINFO	D0J0BU	BETRIXABAN	Approved
T84631	DRUGINFO	D0U7HJ	Certoparin sodium	Approved
T84631	DRUGINFO	D0Q5KL	Coagulation Factor IX	Approved
T84631	DRUGINFO	D0P3SY	Danaparoid	Approved
T84631	DRUGINFO	D0C3BS	DU-176b	Approved
T84631	DRUGINFO	D09XTN	Emicizumab	Approved
T84631	DRUGINFO	D0NE9T	Fondaparinux sodium	Approved
T84631	DRUGINFO	D08PSU	Lmw heparin	Approved
T84631	DRUGINFO	D0N2BX	Nadroparin calcium	Approved
T84631	DRUGINFO	D0KG3R	Rivaroxaban	Approved
T84631	DRUGINFO	D07JEW	Human coagulation factor X	BLA submitted
T84631	DRUGINFO	D01MUU	MELAGATRAN	Phase 3
T84631	DRUGINFO	D00ITC	PRT4445	Phase 3
T84631	DRUGINFO	D0P2RO	SSR-126517E	Phase 3
T84631	DRUGINFO	D0VL4V	SR-123781A	Phase 2/3
T84631	DRUGINFO	D01FFG	Antistasin	Phase 2
T84631	DRUGINFO	D0UK1L	EP-217609	Phase 2
T84631	DRUGINFO	D0ID3W	GW-813893	Phase 2
T84631	DRUGINFO	D07BRZ	LY-517717	Phase 2
T84631	DRUGINFO	D00ZPT	BI-11634	Phase 1
T84631	DRUGINFO	D0X2NN	BIBT986	Phase 1
T84631	DRUGINFO	D0G6UQ	EP-42675	Phase 1
T84631	DRUGINFO	D00RGF	GCC-4401	Phase 1
T84631	DRUGINFO	D08UUD	R-1663	Phase 1
T84631	DRUGINFO	D02UIC	SSR-128428	Phase 1
T84631	DRUGINFO	D07OGZ	Darexaban maleate	Discontinued in Phase 3
T84631	DRUGINFO	D0CY3A	Idraparinux	Discontinued in Phase 3
T84631	DRUGINFO	D0E2MJ	Otamixaban	Discontinued in Phase 3
T84631	DRUGINFO	D09TGX	Valspodar	Discontinued in Phase 3
T84631	DRUGINFO	D0L9YS	Octopamine	Discontinued in Phase 2a
T84631	DRUGINFO	D0V2OS	DX-9065	Discontinued in Phase 2
T84631	DRUGINFO	D0JH6W	DX-9065a	Discontinued in Phase 2
T84631	DRUGINFO	D0T4UL	PD-348292	Discontinued in Phase 2
T84631	DRUGINFO	D0G5GJ	R-68151	Discontinued in Phase 2
T84631	DRUGINFO	D0D5RH	TAK-442	Discontinued in Phase 2
T84631	DRUGINFO	D0L4PM	AVE-3247	Discontinued in Phase 1
T84631	DRUGINFO	D03QJN	DPC 423	Discontinued in Phase 1
T84631	DRUGINFO	D00CIF	EMD-503982	Discontinued in Phase 1
T84631	DRUGINFO	D0N8JP	JTV-803	Discontinued in Phase 1
T84631	DRUGINFO	D0G6UP	YM-75466	Discontinued in Phase 1
T84631	DRUGINFO	D0PG5J	ZD-4927	Discontinued in Phase 1
T84631	DRUGINFO	D0K5WM	CS-3030	Preclinical
T84631	DRUGINFO	D0X1ZV	Trimidox	Preclinical
T84631	DRUGINFO	D0K9KS	Draculin	Terminated
T84631	DRUGINFO	D0Q1JW	Hirufaxin	Terminated
T84631	DRUGINFO	D0J9UI	YM60828	Terminated
T84631	DRUGINFO	D00QDR	1,2,3,4,6-penta-O-galloyl-beta-D-glucose	Investigative
T84631	DRUGINFO	D0P3OH	3-chlorophenyl 2-oxo-2H-chromene-3-carboxylate	Investigative
T84631	DRUGINFO	D02XPB	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	Investigative
T84631	DRUGINFO	D07HWB	5-desgalloylstachyurin	Investigative
T84631	DRUGINFO	D0Z8VP	Beta-Hydroxy Aspartic Acid	Investigative
T84631	DRUGINFO	D06HOI	BMS-269223	Investigative
T84631	DRUGINFO	D0J1QT	BMS-344577	Investigative
T84631	DRUGINFO	D0JU9N	BMS-740808	Investigative
T84631	DRUGINFO	D0I1UF	CASUARIIN	Investigative
T84631	DRUGINFO	D0R5KV	CI-1031	Investigative
T84631	DRUGINFO	D0M4VZ	D-Pro-Phe-Arg chloromethyl ketone	Investigative
T84631	DRUGINFO	D09TXU	DT-831j	Investigative
T84631	DRUGINFO	D0Q2VA	EP-37	Investigative
T84631	DRUGINFO	D06UUK	Gamma-Carboxy-Glutamic Acid	Investigative
T84631	DRUGINFO	D0QR3J	GC-2107	Investigative
T84631	DRUGINFO	D09KKU	Lefaxin	Investigative
T84631	DRUGINFO	D0I8WY	M55113	Investigative
T84631	DRUGINFO	D0ES5A	Molecule 11	Investigative
T84631	DRUGINFO	D0Z2TG	Pedunculagin	Investigative
T84631	DRUGINFO	D0FV9Y	PhSO2-Gly-(Me-Gly)-Arg-(2-thiazole)	Investigative
T84631	DRUGINFO	D0SP5Q	PRT-064445	Investigative
T84631	DRUGINFO	D0ON2Z	RAZAXABAN	Investigative
T84631	DRUGINFO	D0K7NJ	Recombinant coagulation factors	Investigative
T84631	DRUGINFO	D08CEU	Recombinant Factor X	Investigative
T84631	DRUGINFO	D06BPU	SC-83157	Investigative
T84631	DRUGINFO	D01AUI	SF303	Investigative
T84631	DRUGINFO	D00MZS	SK509	Investigative
T84631	DRUGINFO	D0Z9TY	SK549	Investigative
T84631	DRUGINFO	D04QZF	SK554	Investigative
T84631	DRUGINFO	D03QAQ	SN429	Investigative
T84631	DRUGINFO	D0E6SO	Tellimagrandin II	Investigative
T84631	DRUGINFO	D07NYR	YM-96765	Investigative
T84631	DRUGINFO	D0R9CH	ZK-810388	Investigative
T84631	DRUGINFO	D02AVL	ZK-813039	Investigative
T84631	DRUGINFO	D02PAU	ZK-814048	Investigative
T84631	KEGGPATH	hsa04610:Complement and coagulation cascades		
T84631	WIKIPATH	WP1818:Formation of Fibrin Clot (Clotting Cascade)		
T84631	WIKIPATH	WP272:Blood Clotting Cascade		
T84631	WIKIPATH	WP2762:PTM: gamma carboxylation, hypusine formation and arylsulfatase activation		
T84631	WIKIPATH	WP2806:Human Complement System		
T84631	WIKIPATH	WP558:Complement and Coagulation Cascades		
T84631	WHIZPATH	PW000562:Coagulation		
T84631	REACPATH	R-HSA-140834:Extrinsic Pathway of Fibrin Clot Formation		
T84631	REACPATH	R-HSA-140837:Intrinsic Pathway of Fibrin Clot Formation		
T84631	REACPATH	R-HSA-140875:Common Pathway of Fibrin Clot Formation		
T84631	REACPATH	R-HSA-159740:Gamma-carboxylation of protein precursors		
T84631	REACPATH	R-HSA-159763:Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus		
T84631	REACPATH	R-HSA-159782:Removal of aminoterminal propeptides from gamma-carboxylated proteins		
T84631	INTEPATH	integrin2_pathway:Beta2 integrin cell surface interactions		
T84631	PANTPATH	P00011:Blood coagulation		
				
T89034	TARGETID	T89034		
T89034	FORMERID	TTDS00392		
T89034	UNIPROID	PLMN_HUMAN		
T89034	TARGNAME	Plasminogen (PLG)		
T89034	GENENAME	PLG		
T89034	TARGTYPE	Successful target		
T89034	SYNONYMS	Plasmin		
T89034	FUNCTION	In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells. Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation.		
T89034	PDBSTRUC	6D40; 6D3Z; 6D3Y; 6D3X; 5UGG		
T89034	BIOCLASS	Peptidase		
T89034	ECNUMBER	EC 3.4.21.7		
T89034	SEQUENCE	MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTEQLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN		
T89034	DRUGINFO	D07BQE	Alteplase	Approved
T89034	DRUGINFO	D0FD0H	Aminocaproic Acid	Approved
T89034	DRUGINFO	D0K4DI	Anistreplase	Approved
T89034	DRUGINFO	D03HYQ	Ranolazine	Approved
T89034	DRUGINFO	D0T1UJ	Reteplase	Approved
T89034	DRUGINFO	D04URO	Streptokinase	Approved
T89034	DRUGINFO	D0FX8A	Tenecteplase	Approved
T89034	DRUGINFO	D05HXX	Tranexamic Acid	Approved
T89034	DRUGINFO	D0TC4R	Desmoteplase	Phase 3
T89034	DRUGINFO	D01MUU	MELAGATRAN	Phase 3
T89034	DRUGINFO	D0S4YT	Plasminogen	Phase 2/3
T89034	DRUGINFO	D0RD0Y	RetinoStat	Phase 2
T89034	DRUGINFO	D09IOF	Troplasminogen alfa	Phase 2
T89034	DRUGINFO	D0PK7J	bis-triazole derivative 10	Clinical trial
T89034	DRUGINFO	D0A9HM	1-(2-Oxo-2-p-tolyl-ethyl)-1H-indole-2,3-dione	Investigative
T89034	DRUGINFO	D0VP6M	1-(3,3-Dimethyl-2-oxo-butyl)-1H-indole-2,3-dione	Investigative
T89034	DRUGINFO	D0K4PK	1-guanidino-7-isoquinolinesulphonamide	Investigative
T89034	DRUGINFO	D00PEJ	1-guanidino-N-phenyl-7-isoquinolinesulphonamide	Investigative
T89034	DRUGINFO	D08OLP	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	Investigative
T89034	DRUGINFO	D0V2MR	Bicine	Investigative
T89034	DRUGINFO	D0Y5IQ	Grassystatin a	Investigative
T89034	DRUGINFO	D0LJ7R	M5	Investigative
T89034	DRUGINFO	D01JUI	N-(4-Chloro-7-p-tolyl-isoquinolin-1-yl)-guanidine	Investigative
T89034	DRUGINFO	D04DYA	SMTP-0	Investigative
T89034	DRUGINFO	D0ND8N	Textilinin	Investigative
T89034	DRUGINFO	D0M9XH	XP-21510	Investigative
T89034	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T89034	KEGGPATH	hsa04610:Complement and coagulation cascades		
T89034	KEGGPATH	hsa05150:Staphylococcus aureus infection		
T89034	KEGGPATH	hsa05164:Influenza A		
T89034	WIKIPATH	WP15:Selenium Micronutrient Network		
T89034	WIKIPATH	WP1533:Vitamin B12 Metabolism		
T89034	WIKIPATH	WP176:Folate Metabolism		
T89034	WIKIPATH	WP1802:Dissolution of Fibrin Clot		
T89034	WIKIPATH	WP272:Blood Clotting Cascade		
T89034	WIKIPATH	WP2769:Activation of Matrix Metalloproteinases		
T89034	WIKIPATH	WP2799:Regulation of Insulin-like Growth Factor (IGF) Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T89034	WIKIPATH	WP2806:Human Complement System		
T89034	WIKIPATH	WP558:Complement and Coagulation Cascades		
T89034	WHIZPATH	PW000562:Coagulation		
T89034	REACPATH	R-HSA-114608:Platelet degranulation		
T89034	REACPATH	R-HSA-1474228:Degradation of the extracellular matrix		
T89034	REACPATH	R-HSA-1592389:Activation of Matrix Metalloproteinases		
T89034	REACPATH	R-HSA-381426:Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)		
T89034	REACPATH	R-HSA-75205:Dissolution of Fibrin Clot		
T89034	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T89034	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T89034	INTEPATH	p75ntrpathway:p75(NTR)-mediated signaling		
T89034	INTEPATH	syndecan_4_pathway:Syndecan-4-mediated signaling events		
T89034	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling		
T89034	PANTPATH	P00011:Blood coagulation		
T89034	PANTPATH	P00050:Plasminogen activating cascade		
				
T17758	TARGETID	T17758		
T17758	FORMERID	TTDC00312		
T17758	UNIPROID	UROK_HUMAN		
T17758	TARGNAME	Urokinase-type plasminogen activator (PLAU)		
T17758	GENENAME	PLAU		
T17758	TARGTYPE	Successful target		
T17758	SYNONYMS	UPA; U-plasminogen activator		
T17758	FUNCTION	Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.		
T17758	PDBSTRUC	6NMB; 5ZC5; 5ZAJ; 5ZAH; 5ZAG		
T17758	BIOCLASS	Peptidase		
T17758	ECNUMBER	EC 3.4.21.73		
T17758	SEQUENCE	MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL		
T17758	DRUGINFO	D03VNX	Pro-urokinase	Approved
T17758	DRUGINFO	D0E8UO	Urokinase	Approved
T17758	DRUGINFO	D03ZJE	PAI-1	Phase 4
T17758	DRUGINFO	D0G6ZG	Amediplase	Phase 3
T17758	DRUGINFO	D0G5UW	Saruplase	Phase 2
T17758	DRUGINFO	D03KGH	Upamostat	Phase 2
T17758	DRUGINFO	D01HHJ	HTU-PA	Phase 1/2
T17758	DRUGINFO	D00EPS	PMID18163548C4	Clinical trial
T17758	DRUGINFO	D0G0YZ	UK-356202	Clinical trial
T17758	DRUGINFO	D0D3VA	PAI-2	Discontinued in Phase 2
T17758	DRUGINFO	D08INO	WX-UK1	Discontinued in Phase 1/2
T17758	DRUGINFO	D0K1PR	B-428	Terminated
T17758	DRUGINFO	D03NLL	(2R)-1-(2,6-dimethylphenoxy)propan-2-amine	Investigative
T17758	DRUGINFO	D0X1OY	(3,4-dichlorophenyl)(1H-pyrazol-1-yl)methanone	Investigative
T17758	DRUGINFO	D08OCS	(3-nitro-1H-pyrazol-1-yl)(p-tolyl)methanone	Investigative
T17758	DRUGINFO	D05ZIP	(4-bromo-1H-pyrazol-1-yl)(p-tolyl)methanone	Investigative
T17758	DRUGINFO	D0F6EZ	(4-guanidino-benzyl)-carbamic acid benzyl ester	Investigative
T17758	DRUGINFO	D00WFQ	(4-nitro-1H-pyrazol-1-yl)(o-tolyl)methanone	Investigative
T17758	DRUGINFO	D06LPR	(4-nitro-1H-pyrazol-1-yl)(phenyl)methanone	Investigative
T17758	DRUGINFO	D0ZM9M	1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine	Investigative
T17758	DRUGINFO	D0IU5E	1-benzoyl-N-phenyl-1H-pyrazole-3-carboxamide	Investigative
T17758	DRUGINFO	D0K4PK	1-guanidino-7-isoquinolinesulphonamide	Investigative
T17758	DRUGINFO	D00PEJ	1-guanidino-N-phenyl-7-isoquinolinesulphonamide	Investigative
T17758	DRUGINFO	D08OLP	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	Investigative
T17758	DRUGINFO	D09KKF	2-Amino-5-Hydroxy-Benzimidazole	Investigative
T17758	DRUGINFO	D0SP2I	2-nas-phe(3-am)-4-(2-guanidinoethyl)piperidine	Investigative
T17758	DRUGINFO	D06CJP	4-chloro-1-guanidino-7-isoquinolinesulphonamide	Investigative
T17758	DRUGINFO	D05MJU	4-iodobenzo[b]thiophene 2-carboxamidine	Investigative
T17758	DRUGINFO	D02AKP	4-methoxy-N'-(2-phenylacetyl)benzohydrazide	Investigative
T17758	DRUGINFO	D02XJW	5-Methylsulfanyl-thiophene-2-carboxamidine	Investigative
T17758	DRUGINFO	D0A8WP	6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine	Investigative
T17758	DRUGINFO	D05ABK	ATF-HI-8	Investigative
T17758	DRUGINFO	D03BWQ	ATN-658	Investigative
T17758	DRUGINFO	D05DNW	B-623	Investigative
T17758	DRUGINFO	D07SFI	Benzamidine	Investigative
T17758	DRUGINFO	D01LCS	CRA_10655	Investigative
T17758	DRUGINFO	D0K7YL	CRA_8696	Investigative
T17758	DRUGINFO	D0G6XS	Fucose	Investigative
T17758	DRUGINFO	D0EV6B	N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea	Investigative
T17758	DRUGINFO	D0D1TX	Recombinant human pro-urokinase	Investigative
T17758	DRUGINFO	D0B1AK	Thieno[2,3-B]Pyridine-2-Carboxamidine	Investigative
T17758	DRUGINFO	D00LDI	UPA-targeted oncolytic Sendai virus	Investigative
T17758	KEGGPATH	hsa04064:NF-kappa B signaling pathway		
T17758	KEGGPATH	hsa04610:Complement and coagulation cascades		
T17758	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T17758	KEGGPATH	hsa05205:Proteoglycans in cancer		
T17758	KEGGPATH	hsa05206:MicroRNAs in cancer		
T17758	WIKIPATH	WP1434:Osteopontin Signaling		
T17758	WIKIPATH	WP1802:Dissolution of Fibrin Clot		
T17758	WIKIPATH	WP272:Blood Clotting Cascade		
T17758	WIKIPATH	WP399:Wnt Signaling Pathway and Pluripotency		
T17758	WIKIPATH	WP428:Wnt Signaling Pathway		
T17758	WIKIPATH	WP474:Endochondral Ossification		
T17758	WIKIPATH	WP558:Complement and Coagulation Cascades		
T17758	WIKIPATH	WP615:Senescence and Autophagy in Cancer		
T17758	WIKIPATH	WP710:DNA Damage Response (only ATM dependent)		
T17758	REACPATH	R-HSA-75205:Dissolution of Fibrin Clot		
T17758	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T17758	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T17758	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T17758	INTEPATH	ap1_pathway:AP-1 transcription factor network		
T17758	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T17758	INTEPATH	avb3_opn_pathway:Osteopontin-mediated events		
T17758	INTEPATH	e2f_pathway:E2F transcription factor network		
T17758	INTEPATH	fgf_pathway:FGF signaling pathway		
T17758	INTEPATH	fra_pathway:Validated transcriptional targets of AP1 family members Fra1 and Fra2		
T17758	INTEPATH	integrin1_pathway:Beta1 integrin cell surface interactions		
T17758	INTEPATH	integrin2_pathway:Beta2 integrin cell surface interactions		
T17758	INTEPATH	integrin3_pathway:Beta3 integrin cell surface interactions		
T17758	INTEPATH	integrin5_pathway:Beta5 beta6 beta7 and beta8 integrin cell surface interactions		
T17758	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling		
T17758	PANTPATH	P00011:Blood coagulation		
T17758	PANTPATH	P00050:Plasminogen activating cascade		
T17758	PANTPATH	P06959:CCKR signaling map ST		
				
T61622	TARGETID	T61622		
T61622	FORMERID	TTDS00451		
T61622	UNIPROID	RENI_HUMAN		
T61622	TARGNAME	Angiotensinogenase renin (REN)		
T61622	GENENAME	REN		
T61622	TARGTYPE	Successful target		
T61622	SYNONYMS	Renin; Angiotensinogenase		
T61622	FUNCTION	Renin is a highly specific endopeptidase, whose only knownfunction is to generate angiotensin I from angiotensinogen in the plasma, initiating a cascade of reactions that produce an elevation of blood pressure and increased sodium retention by the kidney.		
T61622	PDBSTRUC	6I3F; 5VRP; 5VPM; 5V8V; 5TMK		
T61622	BIOCLASS	Peptidase		
T61622	ECNUMBER	EC 3.4.23.15		
T61622	SEQUENCE	MDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEWSQPMKRLTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR		
T61622	DRUGINFO	D03SVX	Aliskiren	Approved
T61622	DRUGINFO	D0C2EP	Remikiren	Approved
T61622	DRUGINFO	D0V3UN	CP-80794	Phase 2
T61622	DRUGINFO	D07JXN	SPP-600	Phase 2
T61622	DRUGINFO	D0H8WZ	SR-43845	Phase 2
T61622	DRUGINFO	D0A5SA	TAK-272	Phase 2
T61622	DRUGINFO	D03XHS	ACT-178882	Phase 1
T61622	DRUGINFO	D0U7OS	CARD-024	Phase 1
T61622	DRUGINFO	D01QSG	VTP-27999	Phase 1
T61622	DRUGINFO	D09ELW	Enalkiren	Discontinued in Phase 2
T61622	DRUGINFO	D01SGM	FK-906	Discontinued in Phase 2
T61622	DRUGINFO	D0J5GT	ZANKIREN	Discontinued in Phase 2
T61622	DRUGINFO	D0V4LG	RS-8891	Discontinued in Phase 1
T61622	DRUGINFO	D0L4VZ	SPP-1148	Discontinued in Phase 1
T61622	DRUGINFO	D02KEY	SPP-676	Discontinued in Phase 1
T61622	DRUGINFO	D0K1AF	A-74273	Terminated
T61622	DRUGINFO	D08IDQ	BILA-2157BS	Terminated
T61622	DRUGINFO	D02KBO	Ciprokiren	Terminated
T61622	DRUGINFO	D05FTY	ES-1005	Terminated
T61622	DRUGINFO	D01EZY	JTP-2724	Terminated
T61622	DRUGINFO	D00MIF	JTP-4761	Terminated
T61622	DRUGINFO	D0V5XL	KRI-1314	Terminated
T61622	DRUGINFO	D06ZKG	SC-56525	Terminated
T61622	DRUGINFO	D0M7HO	SQ-33800	Terminated
T61622	DRUGINFO	D04DZP	(H-261)Boc-His-Pro-Phe-His-Leu(OH)-Val-Ile-His-OH	Investigative
T61622	DRUGINFO	D06OBP	1-Hydroxy-2-Amino-3-Cyclohexylpropane	Investigative
T61622	DRUGINFO	D0V4EK	1-Hydroxy-3-Methylbutane	Investigative
T61622	DRUGINFO	D0A9BK	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	Investigative
T61622	DRUGINFO	D09RQD	2-Cyclopropylmethylenepropanal	Investigative
T61622	DRUGINFO	D02MBW	2-Methyl-3-(2-Aminothiazolo)Propanal	Investigative
T61622	DRUGINFO	D09QXR	3-Phenyl-1,2-Propandiol	Investigative
T61622	DRUGINFO	D0P7NP	CP-305202	Investigative
T61622	DRUGINFO	D0E1KX	Dimethylformamide	Investigative
T61622	DRUGINFO	D0TD2F	ES-6864	Investigative
T61622	DRUGINFO	D0K0OY	Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro	Investigative
T61622	DRUGINFO	D00FHV	Iva-His-Pro-Phe-His-ACHPA-Leu-Phe-NH2	Investigative
T61622	DRUGINFO	D0G9DJ	Iva-His-Pro-Phe-His-AHPPA-Leu-Phe-NH2	Investigative
T61622	DRUGINFO	D09PZT	Iva-His-Pro-Phe-His-Sta-Leu-Phe-NH2	Investigative
T61622	DRUGINFO	D0Q8VT	JT-2724	Investigative
T61622	DRUGINFO	D02MME	N-Methyl-N-(Methylbenzyl)Formamide	Investigative
T61622	DRUGINFO	D0J6QC	PP1-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Investigative
T61622	DRUGINFO	D0VI7P	PP2-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Investigative
T61622	DRUGINFO	D08BRJ	Pro-His-Pro-His-Leu-Phe-Val-Tyr	Investigative
T61622	DRUGINFO	D01FJQ	Pro-His-Pro-His-Phe-Phe-Val-Tyr	Investigative
T61622	DRUGINFO	D0Q3IE	Pro-His-Pro-His-Phe-Phe-Val-Tyr-Lys	Investigative
T61622	DRUGINFO	D0KH9Z	Pro-His-Pro-Phe-His-Leu(CH2NH)Val-Ile-His-Lys	Investigative
T61622	DRUGINFO	D0E5QB	Ro-65-7219	Investigative
T61622	DRUGINFO	D04QIA	Ro-66-1168	Investigative
T61622	DRUGINFO	D06JQM	SPP-800	Investigative
T61622	DRUGINFO	D0A3LJ	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp	Investigative
T61622	DRUGINFO	D04GXL	Sul-Pro-Phe-N-MeHis-LVA-Ile-Amp-(O)	Investigative
T61622	KEGGPATH	hsa04614:Renin-angiotensin system		
T61622	WIKIPATH	WP2729:Metabolism of Angiotensinogen to Angiotensins		
T61622	WIKIPATH	WP554:ACE Inhibitor Pathway		
T61622	WHIZPATH	PW000563:Angiotensin Metabolism		
T61622	REACPATH	R-HSA-2022377:Metabolism of Angiotensinogen to Angiotensins		
				
T56915	TARGETID	T56915		
T56915	FORMERID	TTDS00320		
T56915	UNIPROID	POL_HV1B1		
T56915	TARGNAME	Human immunodeficiency virus Protease (HIV PR)		
T56915	GENENAME	HIV PR		
T56915	TARGTYPE	Successful target		
T56915	SYNONYMS	HIV Retropepsin; HIV PR		
T56915	FUNCTION	Gag-Pol polyprotein: Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi). Gag-Pol polyprotein may regulate its own translation, by the binding genomic RNA in the 5'-UTR. At low concentration, the polyprotein would promote translation, whereas at high concentration, the polyprotein would encapsidate genomic RNA and then shut off translation.		
T56915	PDBSTRUC	6OE3; 6HAK; 6ELI; 6DUH; 6DUG		
T56915	BIOCLASS	Peptidase		
T56915	ECNUMBER	EC 3.4.23.16		
T56915	SEQUENCE	PQITLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF		
T56915	DRUGINFO	D0A0OO	Amprenavir	Approved
T56915	DRUGINFO	D07IQS	Atazanavir	Approved
T56915	DRUGINFO	D03IGH	Darunavir	Approved
T56915	DRUGINFO	D0F5MT	Fosamprenavir	Approved
T56915	DRUGINFO	D0V7CF	Indinavir	Approved
T56915	DRUGINFO	D0ZU9R	Ritonavir	Approved
T56915	DRUGINFO	D0WI3T	Saquinavir	Approved
T56915	DRUGINFO	D0EV6T	Tipranavir	Approved
T56915	DRUGINFO	D06KJQ	BI 201335	Phase 3
T56915	DRUGINFO	D07OHT	ABT-450	Phase 2
T56915	DRUGINFO	D07ZAH	ACH-1625	Phase 2
T56915	DRUGINFO	D04MCY	BMS 650032	Phase 2
T56915	DRUGINFO	D0R9MN	Danoprevir	Phase 2
T56915	DRUGINFO	D0Y3JI	DG-17	Phase 2
T56915	DRUGINFO	D05TKB	GS-9256	Phase 2
T56915	DRUGINFO	D0W9JM	KNI-272	Phase 2
T56915	DRUGINFO	D07SMH	MK-5172	Phase 2
T56915	DRUGINFO	D01ZNQ	TMC-310911	Phase 2
T56915	DRUGINFO	D01RXW	Vaniprevir	Phase 2
T56915	DRUGINFO	D0W6LW	BIT225	Phase 1
T56915	DRUGINFO	D04CJN	CTP-298	Phase 1
T56915	DRUGINFO	D08FYH	PF-04776548	Phase 1
T56915	DRUGINFO	D09QKI	PPL-100	Phase 1
T56915	DRUGINFO	D02MMP	VX-500	Phase 1
T56915	DRUGINFO	D07MPJ	A-75925	Discontinued in Phase 2
T56915	DRUGINFO	D07FJM	BRECANAVIR	Discontinued in Phase 2
T56915	DRUGINFO	D0J9AK	MK-944a	Discontinued in Phase 2
T56915	DRUGINFO	D0E4FG	Mozenavir	Discontinued in Phase 2
T56915	DRUGINFO	D05UMD	R-87366	Discontinued in Phase 2
T56915	DRUGINFO	D04GWY	Telinavir	Discontinued in Phase 2
T56915	DRUGINFO	D09HEV	GS-9005	Discontinued in Phase 1/2
T56915	DRUGINFO	D0U7WN	A-80987	Discontinued in Phase 1
T56915	DRUGINFO	D01KIS	CGP-53437	Discontinued in Phase 1
T56915	DRUGINFO	D0U8AR	DMP-851	Discontinued in Phase 1
T56915	DRUGINFO	D0N3ZY	DPC-681	Discontinued in Phase 1
T56915	DRUGINFO	D07JJC	DPC-684	Discontinued in Phase 1
T56915	DRUGINFO	D0X8AU	KNI-764	Discontinued in Phase 1
T56915	DRUGINFO	D0R5AU	LASINAVIR	Discontinued in Phase 1
T56915	DRUGINFO	D08JTU	R-944	Discontinued in Phase 1
T56915	DRUGINFO	D03MIP	SPI-256	Discontinued in Phase 1
T56915	DRUGINFO	D06KPW	U-103017	Discontinued in Phase 1
T56915	DRUGINFO	D09CAC	U-96988	Discontinued in Phase 1
T56915	DRUGINFO	D0PB4P	XM-323	Discontinued in Phase 1
T56915	DRUGINFO	D0GM4S	AG-1284	Terminated
T56915	DRUGINFO	D07PIA	AG-1350	Terminated
T56915	DRUGINFO	D05UMO	BAY-793	Terminated
T56915	DRUGINFO	D00XRK	BMS-182193	Terminated
T56915	DRUGINFO	D01RCC	BMS-186318	Terminated
T56915	DRUGINFO	D06FMY	CGP-70726	Terminated
T56915	DRUGINFO	D0V8PN	Droxinavir hydrochloride	Terminated
T56915	DRUGINFO	D02TGW	GE-20372A	Terminated
T56915	DRUGINFO	D0R3JE	GS-2992	Terminated
T56915	DRUGINFO	D05GQL	KNI-102	Terminated
T56915	DRUGINFO	D0T4OE	Palinavir	Terminated
T56915	DRUGINFO	D0P6DF	PD-153103	Terminated
T56915	DRUGINFO	D0QH0R	SB-206343	Terminated
T56915	DRUGINFO	D07PSP	U-75875	Terminated
T56915	DRUGINFO	D0G6HC	JG-365	Investigative
T56915	DRUGINFO	D0B0XX	KH-164	Investigative
				
T31595	TARGETID	T31595		
T31595	FORMERID	TTDS00174		
T31595	UNIPROID	NRAM_I33A0		
T31595	TARGNAME	Influenza Neuraminidase (Influ NA)		
T31595	GENENAME	Influ NA		
T31595	TARGTYPE	Successful target		
T31595	SYNONYMS	STNA; NEU1; NANase; N-acylneuraminate glycohydrolase; Influ Sialidase		
T31595	FUNCTION	Unlike other strains, A/WSN/33 neuraminidase binds and activates plasminogen into plasmin in the vicinity of HA so that activated plasmin cleaves HA rendering the virus infectious.		
T31595	BIOCLASS	Glycosylase		
T31595	ECNUMBER	EC 3.2.1.18		
T31595	SEQUENCE	MNPNQKIITIGSICMVVGIISLILQIGNIISIWISHSIQTGNQNHTGICNQGIITYNVVAGQDSTSVILTGNSSLCPIRGWAIHSKDNGIRIGSKGDVFVIREPFISCSHLECRTFFLTQGALLNDKHSNGTVKDRSPYRALMSCPVGEAPSPYNSRFESVAWSASACHDGMGWLTIGISGPDNGAVAVLKYNGIITETIKSWRKKILRTQESECTCVNGSCFTIMTDGPSNGLASYKIFKIEKGKVTKSIELNAPNSHYEECSCYPDTGKVMCVCRDNWHGSNRPWVSFDQNLDYQIGYICSGVFGDNPRPKDGPGSCGPVSADGANGVKGFSYRYGNGVWIGRTKSDSSRHGFEMIWDPNGWTETDSRFSVRQDVVAMTDRSGYSGSFVQHPELTGLDCMRPCFWVELIRGRPEEETIWTSGSIISFCGVNSDTVDWSWPDGAELPFTIDK		
T31595	DRUGINFO	D0O5NK	Oseltamivir	Approved
T31595	DRUGINFO	D0P2IW	Peramivir	Approved
T31595	DRUGINFO	D00NPP	Zanamivir	Approved
T31595	DRUGINFO	D04VSM	CS-8958	Phase 3
T31595	DRUGINFO	D03ZKM	UX-001	Phase 3
T31595	DRUGINFO	D0YO7Y	DAS-181	Phase 2
T31595	DRUGINFO	D0XJ0P	BCX-140	Terminated
T31595	DRUGINFO	D0Q3ZN	GS-3435	Terminated
T31595	DRUGINFO	D0IH6W	(E,E)-1,7-Diphenyl-4,6-heptadien-3-one	Investigative
T31595	DRUGINFO	D0D9NX	(E,E)-5-Hydroxy-1,7-diphenyl-4,6-heptadien-3-one	Investigative
T31595	DRUGINFO	D03XVT	(S)-1,7-Diphenyl-6(E)-hepten-3-ol	Investigative
T31595	DRUGINFO	D0D8WQ	2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid	Investigative
T31595	DRUGINFO	D06BSN	2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid	Investigative
T31595	DRUGINFO	D0F8CH	4-(Acetylamino)-3-Amino Benzoic Acid	Investigative
T31595	DRUGINFO	D0Q8HV	4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID	Investigative
T31595	DRUGINFO	D08UEU	4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID	Investigative
T31595	DRUGINFO	D0C4GE	4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid	Investigative
T31595	DRUGINFO	D01FEA	8-DEOXYGARTANIN	Investigative
T31595	DRUGINFO	D0P3BL	A-192558	Investigative
T31595	DRUGINFO	D06LUX	A-315675	Investigative
T31595	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T31595	DRUGINFO	D00RIX	APIGENIN	Investigative
T31595	DRUGINFO	D0PE5T	BCX-1827	Investigative
T31595	DRUGINFO	D0I1BA	BCX-1898	Investigative
T31595	DRUGINFO	D0R6YP	BCX-1923	Investigative
T31595	DRUGINFO	D0SD9H	Beta-D-Mannose	Investigative
T31595	DRUGINFO	D05FLL	CALOPOCARPIN	Investigative
T31595	DRUGINFO	D00PAS	Cristacarpin	Investigative
T31595	DRUGINFO	D02HYW	CUDRATRICUSXANTHONE	Investigative
T31595	DRUGINFO	D0UR7U	Cudratricusxanthone F	Investigative
T31595	DRUGINFO	D0I6EH	Cudraxanthone D	Investigative
T31595	DRUGINFO	D0A2OH	Cudraxanthone L	Investigative
T31595	DRUGINFO	D05KWF	Cudraxanthone M	Investigative
T31595	DRUGINFO	D05BUX	Cyclopentane amide derivatives 1	Investigative
T31595	DRUGINFO	D09YOY	Cyclopentane amide derivatives 2	Investigative
T31595	DRUGINFO	D0B1NY	Cyclopentane amide derivatives 3	Investigative
T31595	DRUGINFO	D0W0BO	Cyclopentane amide derivatives 4	Investigative
T31595	DRUGINFO	D0G5PT	DEMETHYLMEDICARPIN	Investigative
T31595	DRUGINFO	D0P5MJ	ERYSTAGALLIN A	Investigative
T31595	DRUGINFO	D0UD1U	Erysubin D	Investigative
T31595	DRUGINFO	D0M7ZZ	Erysubin E	Investigative
T31595	DRUGINFO	D00PZM	Erythribyssin D	Investigative
T31595	DRUGINFO	D0E8VD	Erythribyssin L	Investigative
T31595	DRUGINFO	D02QCC	Erythribyssin M	Investigative
T31595	DRUGINFO	D01FQZ	Erythribyssin O	Investigative
T31595	DRUGINFO	D02NRI	Eryvarin D	Investigative
T31595	DRUGINFO	D00LEQ	FANA	Investigative
T31595	DRUGINFO	D0G6XS	Fucose	Investigative
T31595	DRUGINFO	D05IWY	Gamma-mangostin	Investigative
T31595	DRUGINFO	D05YJR	GARCINONE D	Investigative
T31595	DRUGINFO	D0O8EB	GARTANIN	Investigative
T31595	DRUGINFO	D0Z7EL	GOSSYPETIN	Investigative
T31595	DRUGINFO	D06IDO	GS4071	Investigative
T31595	DRUGINFO	D09YVT	HERBACETIN	Investigative
T31595	DRUGINFO	D05GSS	ISONEORAUTENOL	Investigative
T31595	DRUGINFO	D0G3TK	KAEMPFEROL	Investigative
T31595	DRUGINFO	D0UK4O	KATSUMADAIN A	Investigative
T31595	DRUGINFO	D0K8XC	Lactose	Investigative
T31595	DRUGINFO	D0U8AU	MACLURAXANTHONE	Investigative
T31595	DRUGINFO	D04UYB	MANGIFERIN	Investigative
T31595	DRUGINFO	D01WTQ	MANGOSTANIN	Investigative
T31595	DRUGINFO	D0G5MS	MANGOSTANOL	Investigative
T31595	DRUGINFO	D0J7YV	MANGOSTENONE F	Investigative
T31595	DRUGINFO	D0MA3M	MANGOSTENONE G	Investigative
T31595	DRUGINFO	D06PRC	MANGOSTIN	Investigative
T31595	DRUGINFO	D01EJH	NEORAUTENOL	Investigative
T31595	DRUGINFO	D08WQM	O-Sialic Acid	Investigative
T31595	DRUGINFO	D07TDM	PHASEOLIN	Investigative
T31595	DRUGINFO	D0A9CZ	PHASEOLLIDIN	Investigative
T31595	DRUGINFO	D0I0WF	RHODIOLININ	Investigative
T31595	DRUGINFO	D0K6FM	SMEATHXANTHONE A	Investigative
T31595	KEGGPATH	stm00511:Other glycan degradation		
				
T31479	TARGETID	T31479		
T31479	FORMERID	TTDS00065		
T31479	UNIPROID	PA21B_HUMAN		
T31479	TARGNAME	Phospholipase A2 (PLA2G1B)		
T31479	GENENAME	PLA2G1B		
T31479	TARGTYPE	Successful target		
T31479	SYNONYMS	Secreted phospholipase A(2); Phosphatidylcholine 2-acylhydrolase 1B; PLA2G1B; Group IB phospholipase A2		
T31479	FUNCTION	PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides, this releases glycerophospholipids and arachidonic acid that serve as the precursors of signal molecules.		
T31479	PDBSTRUC	3ELO; 1YSK		
T31479	BIOCLASS	Carboxylic ester hydrolase		
T31479	ECNUMBER	EC 3.1.1.4		
T31479	SEQUENCE	MKLLVLAVLLTVAAADSGISPRAVWQFRKMIKCVIPGSDPFLEYNNYGCYCGLGGSGTPVDELDKCCQTHDNCYDQAKKLDSCKFLLDNPYTHTYSYSCSGSAITCSSKNKECEAFICNCDRNAAICFSKAPYNKAHKNLDTKKYCQS		
T31479	DRUGINFO	D0OR2L	Cholic Acid	Approved
T31479	DRUGINFO	D0FL5V	Clobetasol	Approved
T31479	DRUGINFO	D00GOS	Clocortolone	Approved
T31479	DRUGINFO	D0G7KJ	Diflorasone	Approved
T31479	DRUGINFO	D00FGR	Miltefosine	Approved
T31479	DRUGINFO	D0C0KP	AllerB	Phase 2b
T31479	DRUGINFO	D00XQO	MANOALIDE	Phase 2
T31479	DRUGINFO	D03VYZ	MRX-4	Phase 2
T31479	DRUGINFO	D07RKO	MRX-6	Phase 2
T31479	DRUGINFO	D07LUJ	URSOLIC ACID	Phase 2
T31479	DRUGINFO	D05GZD	Rilapladib	Phase 1
T31479	DRUGINFO	D0L5UO	Darapladib	Discontinued in Phase 3
T31479	DRUGINFO	D08VGT	BMY-30129	Discontinued in Phase 2
T31479	DRUGINFO	D03RNX	EPC-K1	Discontinued in Phase 2
T31479	DRUGINFO	D0D3KY	SC-106	Discontinued in Phase 2
T31479	DRUGINFO	D0MF3C	WAY-123641	Discontinued in Phase 2
T31479	DRUGINFO	D08YFD	PF-05212372	Discontinued in Phase 1
T31479	DRUGINFO	D09NBM	SB-435495	Discontinued in Phase 1
T31479	DRUGINFO	D07OGR	YM-26734	Terminated
T31479	DRUGINFO	D06GOK	2-Methyl-2,4-Pentanediol	Investigative
T31479	DRUGINFO	D0H1JX	3,9-dihydroxy-2,10-diprenylpterocap-6a-ene	Investigative
T31479	DRUGINFO	D05SQA	4'-hydroxy-6,3',5'-triprenylisoflavonone	Investigative
T31479	DRUGINFO	D0L3IQ	ABYSSINONE V	Investigative
T31479	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T31479	DRUGINFO	D0HZ3Q	AGN-190383	Investigative
T31479	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T31479	DRUGINFO	D0P0DA	BM-162115	Investigative
T31479	DRUGINFO	D0T3CM	BOLINAQUINONE	Investigative
T31479	DRUGINFO	D02IVU	CACOSPONGIONOLIDE	Investigative
T31479	DRUGINFO	D0B9VV	CACOSPONGIONOLIDE B	Investigative
T31479	DRUGINFO	D03BAB	Cacospongionolide E	Investigative
T31479	DRUGINFO	D0V4NV	folipastatin	Investigative
T31479	DRUGINFO	D02FVV	HELENAQUINONE	Investigative
T31479	DRUGINFO	D0H2RZ	Heptanoic Acid	Investigative
T31479	DRUGINFO	D0O0ZU	Hexane-1,6-Diol	Investigative
T31479	DRUGINFO	D0YD6H	Hyrtiosulawesine	Investigative
T31479	DRUGINFO	D0SS5D	Lpc-Ether	Investigative
T31479	DRUGINFO	D0TN4X	LY178002	Investigative
T31479	DRUGINFO	D00XNF	LY256548	Investigative
T31479	DRUGINFO	D0O2DQ	Mepacrine	Investigative
T31479	DRUGINFO	D0G4CI	methylglyoxal	Investigative
T31479	DRUGINFO	D06YGT	N-Tridecanoic Acid	Investigative
T31479	DRUGINFO	D07IRQ	P-Anisic Acid	Investigative
T31479	DRUGINFO	D05DUX	Petrosaspongiolide M	Investigative
T31479	DRUGINFO	D02COQ	Petrosaspongiolide P	Investigative
T31479	DRUGINFO	D06PLG	SB-203347	Investigative
T31479	DRUGINFO	D03IDX	WA-8242-A1	Investigative
T31479	KEGGPATH	hsa00564:Glycerophospholipid metabolism		
T31479	KEGGPATH	hsa00565:Ether lipid metabolism		
T31479	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T31479	KEGGPATH	hsa00591:Linoleic acid metabolism		
T31479	KEGGPATH	hsa00592:alpha-Linolenic acid metabolism		
T31479	KEGGPATH	hsa01100:Metabolic pathways		
T31479	KEGGPATH	hsa04014:Ras signaling pathway		
T31479	KEGGPATH	hsa04270:Vascular smooth muscle contraction		
T31479	KEGGPATH	hsa04972:Pancreatic secretion		
T31479	KEGGPATH	hsa04975:Fat digestion and absorption		
T31479	WIKIPATH	WP2740:Glycerophospholipid biosynthesis		
T31479	REACPATH	R-HSA-1482788:Acyl chain remodelling of PC		
T31479	REACPATH	R-HSA-1482839:Acyl chain remodelling of PE		
T31479	REACPATH	R-HSA-1482922:Acyl chain remodelling of PI		
T31479	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T31479	BIOCPATH	LIPASYN-PWY:Phospholipases		
				
T40016	TARGETID	T40016		
T40016	FORMERID	TTDS00283		
T40016	UNIPROID	GCR_HUMAN		
T40016	TARGNAME	Glucocorticoid receptor (NR3C1)		
T40016	GENENAME	NR3C1		
T40016	TARGTYPE	Successful target		
T40016	SYNONYMS	Nuclear receptor subfamily 3 group C member 1; GRL; GR		
T40016	FUNCTION	Receptor for glucocorticoids (GC). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors. Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling. Plays a role in rapid mRNA degradation by binding to the 5' UTR of target mRNAs and interacting with PNRC2 in a ligand-dependent manner which recruits the RNA helicase UPF1 and the mRNA-decapping enzyme DCP1A, leading to RNA decay. Could act as a coactivator for STAT5-dependent transcription upon growth hormone (GH) stimulation and could reveal an essential role of hepatic GR in the control of body growth (By similarity).		
T40016	PDBSTRUC	6EL9; 6EL7; 6EL6; 6DXK; 6CFN		
T40016	BIOCLASS	Nuclear hormone receptor		
T40016	SEQUENCE	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAVASQSDSKQRRLLVDFPKGSVSNAQQPDLSKAVSLSMGLYMGETETKVMGNDLGFPQQGQISLSSGETDLKLLEESIANLNRSTSVPENPKSSASTAVSAAPTEKEFPKTHSDVSSEQQHLKGQTGTNGGNVKLYTTDQSTFDILQDLEFSSGSPGKETNESPWRSDLLIDENCLLSPLAGEDDSFLLEGNSNEDCKPLILPDTKPKIKDNGDLVLSSPSNVTLPQVKTEKEDFIELCTPGVIKQEKLGTVYCQASFPGANIIGNKMSAISVHGVSTSGGQMYHYDMNTASLSQQQDQKPIFNVIPPIPVGSENWNRCQGSGDDNLTSLGTLNFPGRTVFSNGYSSPSMRPDVSSPPSSSSTATTGPPPKLCLVCSDEASGCHYGVLTCGSCKVFFKRAVEGQHNYLCAGRNDCIIDKIRRKNCPACRYRKCLQAGMNLEARKTKKKIKGIQQATTGVSQETSENPGNKTIVPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK		
T40016	DRUGINFO	D0CW1P	Betamethasone	Approved
T40016	DRUGINFO	D06CWH	Betamethasone Benzoate	Approved
T40016	DRUGINFO	D03SXE	Betamethasone Valerate	Approved
T40016	DRUGINFO	D0Y7IU	Budesonide	Approved
T40016	DRUGINFO	D09WYX	Deflazacort	Approved
T40016	DRUGINFO	D0IT2G	Dexamethasone	Approved
T40016	DRUGINFO	D0NA8U	Dexamethasone sodium phosphate	Approved
T40016	DRUGINFO	D0FM2P	Flunisolide	Approved
T40016	DRUGINFO	D02QJH	Fluocinolone Acetonide	Approved
T40016	DRUGINFO	D0P0HT	Fluorometholone	Approved
T40016	DRUGINFO	D0LC6K	Fluticasone	Approved
T40016	DRUGINFO	D0Y7JU	GW685698X	Approved
T40016	DRUGINFO	D05RXI	Hydrocortamate	Approved
T40016	DRUGINFO	D0KR5B	Hydrocortisone	Approved
T40016	DRUGINFO	D0I5DS	Meprednisone	Approved
T40016	DRUGINFO	D08PIQ	Methylprednisolone	Approved
T40016	DRUGINFO	D0Z4EI	Mifepristone	Approved
T40016	DRUGINFO	D03HYX	Mometasone	Approved
T40016	DRUGINFO	D0D1SG	Prednisolone	Approved
T40016	DRUGINFO	D0IL7L	Prednisone	Approved
T40016	DRUGINFO	D03BLF	Triamcinolone	Approved
T40016	DRUGINFO	D03WNG	CORT-125134	Phase 3
T40016	DRUGINFO	D00TPW	FST-201	Phase 3
T40016	DRUGINFO	D01IUS	Mapracorat	Phase 3
T40016	DRUGINFO	D0L3HU	BAY 86-5044	Phase 2
T40016	DRUGINFO	D0I1DZ	DE-110	Phase 2
T40016	DRUGINFO	D0OR8W	ETIPREDNOL DICLOACETATE	Phase 2
T40016	DRUGINFO	D0M8VL	GW-870086-X	Phase 2
T40016	DRUGINFO	D06XSB	GW-870086-X	Phase 2
T40016	DRUGINFO	D01HYQ	IONIS-GCCRRX	Phase 2
T40016	DRUGINFO	D05RXW	LAS-41002	Phase 2
T40016	DRUGINFO	D0E2WF	ORG 34517/34850	Phase 2
T40016	DRUGINFO	D05MDJ	ORG-34517	Phase 2
T40016	DRUGINFO	D0T5TU	TPI-1020	Phase 2
T40016	DRUGINFO	D0J6UV	IBI-20089	Phase 1
T40016	DRUGINFO	D0OS8C	NCX-1015	Phase 1
T40016	DRUGINFO	D09UFV	AZD-5423	Discontinued in Phase 2
T40016	DRUGINFO	D01NUG	GSK870086	Discontinued in Phase 2
T40016	DRUGINFO	D03RCP	NM-135	Discontinued in Phase 2
T40016	DRUGINFO	D0G2CQ	WC-3027	Discontinued in Phase 2
T40016	DRUGINFO	D03CHE	PF-251802	Discontinued in Phase 1
T40016	DRUGINFO	D0I7EX	Org-34116	Terminated
T40016	DRUGINFO	D02UVH	B-Octylglucoside	Investigative
T40016	DRUGINFO	D0O0ZU	Hexane-1,6-Diol	Investigative
T40016	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T40016	WIKIPATH	WP170:Nuclear Receptors		
T40016	WIKIPATH	WP1797:Circadian Clock		
T40016	WIKIPATH	WP236:Adipogenesis		
T40016	WIKIPATH	WP2840:Hair Follicle Development: Cytodifferentiation (Part 3 of 3)		
T40016	WIKIPATH	WP2853:Endoderm Differentiation		
T40016	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T40016	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T40016	WIKIPATH	WP734:Serotonin Receptor 4/6/7 and NR3C Signaling		
T40016	REACPATH	R-HSA-1368108:BMAL1:CLOCK,NPAS2 activates circadian gene expression		
T40016	NET_PATH	NetPath_11:TCR Signaling Pathway		
T40016	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T40016	INTEPATH	ap1_pathway:AP-1 transcription factor network		
T40016	INTEPATH	ar_tf_pathway:Regulation of Androgen receptor activity		
T40016	INTEPATH	hdac_classii_pathway:Signaling events mediated by HDAC Class II		
T40016	INTEPATH	hnf3bpathway:FOXA2 and FOXA3 transcription factor networks		
T40016	INTEPATH	reg_gr_pathway:Glucocorticoid receptor regulatory network		
T40016	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
				
T30081	TARGETID	T30081		
T30081	FORMERID	TTDR00500		
T30081	UNIPROID	KITH_HUMAN		
T30081	TARGNAME	Thymidine kinase 1 (TK1)		
T30081	GENENAME	TK1		
T30081	TARGTYPE	Successful target		
T30081	SYNONYMS	Thymidine kinase, cytosolic		
T30081	FUNCTION	cytosol, identical protein binding, thymidine kinase activity, zinc ion binding, DNA metabolic process, nucleobase-containing compound metabolic process, protein homotetramerization, pyrimidine nucleoside salvage, thymidine metabolic process		
T30081	PDBSTRUC	2WVJ; 2ORV; 1XBT; 1W4R		
T30081	BIOCLASS	Kinase		
T30081	ECNUMBER	EC 2.7.1.21		
T30081	SEQUENCE	MSCINLPTVLPGSPSKTRGQIQVILGPMFSGKSTELMRRVRRFQIAQYKCLVIKYAKDTRYSSSFCTHDRNTMEALPACLLRDVAQEALGVAVIGIDEGQFFPDIVEFCEAMANAGKTVIVAALDGTFQRKPFGAILNLVPLAESVVKLTAVCMECFREAAYTKRLGTEKEVEVIGGADKYHSVCRLCYFKKASGQPAGPDNKENCPVPGKPGEAVAARKLFAPQQILQCSPAN		
T30081	DRUGINFO	D0RX7Z	DEOXYCYTIDINE	Approved
T30081	DRUGINFO	D07BYK	Penciclovir	Approved
T30081	DRUGINFO	D08AMJ	TK-DLI	Preregistration
T30081	DRUGINFO	D04QPD	FV-100	Phase 3
T30081	DRUGINFO	D0X4NF	Radiosensitizer gene therapy	Phase 3
T30081	DRUGINFO	D0Z9LP	RP101	Phase 2/3
T30081	DRUGINFO	D05RRA	HQK-1004	Phase 2
T30081	DRUGINFO	D02KBE	Ad-OC-hsvTK/valacyclovir	Phase 1
T30081	DRUGINFO	D05GZD	Rilapladib	Phase 1
T30081	DRUGINFO	D0FY1W	Thymidine kinase-expressing adenovirus and ganciclovir suicide gene therapy	Phase 1
T30081	DRUGINFO	D0W8RX	Sitimagene ceradenovec	Discontinued in Phase 3
T30081	DRUGINFO	D07OOW	(South)-Methanocarba-Thymidine	Investigative
T30081	DRUGINFO	D0I6UV	1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine	Investigative
T30081	DRUGINFO	D07GKK	1-[2-(2-triphenylmethoxyethoxy)ethyl]thymine	Investigative
T30081	DRUGINFO	D00KWL	1-[5-(triphenylmethoxy)pentyl]thymine	Investigative
T30081	DRUGINFO	D02CCD	1-[6-(triphenylmethoxy)hexyl]thymine	Investigative
T30081	DRUGINFO	D0W8AD	1-[7-(triphenylmethoxy)heptyl]thymine	Investigative
T30081	DRUGINFO	D09WYY	2'-deoxythymidine triphosphate	Investigative
T30081	DRUGINFO	D00CVB	2'-Deoxyuridine	Investigative
T30081	DRUGINFO	D0S4SQ	2-phenylamino-9-(4-hydroxy-butyl)-6-oxopurine	Investigative
T30081	DRUGINFO	D0O7GD	3'-(1,2,3-Triazol-1-yl)-3'-deoxy-beta-D-thymidine	Investigative
T30081	DRUGINFO	D01CUJ	3-(2-propyn-1-yl)thymidine	Investigative
T30081	DRUGINFO	D0ST5A	5-Bromothienyldeoxyuridine	Investigative
T30081	DRUGINFO	D04GXW	5-Iodo-2'-Deoxyuridine-5'-Monophosphate	Investigative
T30081	DRUGINFO	D0C7YS	5-propyl-2'-deoxyuridine	Investigative
T30081	DRUGINFO	D08AOD	6-(Dihydroxy-Isobutyl)-Thymine	Investigative
T30081	DRUGINFO	D00CEO	6-Hydroxypropylthymine	Investigative
T30081	DRUGINFO	D0G5VO	9-(4-Hydroxybutyl)-N2-Phenylguanine	Investigative
T30081	DRUGINFO	D0X1HX	9-Hydroxypropyladenine, R-Isomer	Investigative
T30081	DRUGINFO	D0R0EI	9-Hydroxypropyladenine, S-Isomer	Investigative
T30081	DRUGINFO	D0PC2Y	BVDU-MP	Investigative
T30081	DRUGINFO	D01GLG	Deoxythymidine	Investigative
T30081	DRUGINFO	D0Y4MD	Edoxudine	Investigative
T30081	DRUGINFO	D01VKE	ITdU	Investigative
T30081	DRUGINFO	D0D7FB	L-5-(bromovinyl)deoxyuridine	Investigative
T30081	DRUGINFO	D0HO0W	L-5-iodo-2'-deoxyuridine	Investigative
T30081	DRUGINFO	D0YJ5W	N2-(3-trifluoromethylphenyl)guanine	Investigative
T30081	DRUGINFO	D04BBF	P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate	Investigative
T30081	DRUGINFO	D0ZH0I	Thymidine-5'-Phosphate	Investigative
				
T89041	TARGETID	T89041		
T89041	FORMERID	TTDS00241		
T89041	UNIPROID	CP17A_HUMAN		
T89041	TARGNAME	Steroid 17-alpha-monooxygenase (S17AH)		
T89041	GENENAME	CYP17A1		
T89041	TARGTYPE	Successful target		
T89041	SYNONYMS	Steroid 17-alpha-hydroxylase/17,20 lyase; P450c17; P450-C17; P450 17; CYPXVII; CYP17A1; CYP 17; 17 alpha-Hydroxylase/C17-20-lyase		
T89041	FUNCTION	Conversion of pregnenolone and progesterone to their 17- alpha-hydroxylated products and subsequently to dehydroepiandrosterone (DHEA) and androstenedione. Catalyzes both the 17-alpha-hydroxylation and the 17,20-lyase reaction. Involved in sexual development during fetal life and at puberty.		
T89041	PDBSTRUC	6CIZ; 6CIR; 6CHI; 5UYS; 5IRV		
T89041	BIOCLASS	Paired donor oxygen oxidoreductase		
T89041	ECNUMBER	EC 1.14.14.19		
T89041	SEQUENCE	MWELVALLLLTLAYLFWPKRRCPGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGST		
T89041	DRUGINFO	D02STN	ABIRATERONE	Approved
T89041	DRUGINFO	D06CNP	Abiraterone acetate	Approved
T89041	DRUGINFO	D0X3OI	TAK-700	Phase 3
T89041	DRUGINFO	D0Q9KR	Seviteronel	Phase 2
T89041	DRUGINFO	D05RVA	CFG920	Phase 1/2
T89041	DRUGINFO	D01ARU	DST-2970	Phase 1
T89041	DRUGINFO	D00ZME	1-((9H-Fluoren-2-yl)ethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0MM7G	1-((9H-Fluoren-2-yl)methyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0X1DV	1-(1-(4'-Ethylbiphenyl-4-yl)propyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D00IUN	1-(1-(4-thiophen-3-ylphenyl)ethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0B9XL	1-(1-(4-thiophen-3-yl-phenyl)propyl)-1Himidazole	Investigative
T89041	DRUGINFO	D0RI7T	1-(1-(Biphenyl-4-yl)allyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D05LXA	1-(1-Biphenyl-4-yl-2-methyl-propyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0M8JE	1-(1-Biphenyl-4-yl-2-phenyl-ethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0RD3C	1-(1-Biphenyl-4-yl-3-methyl-butyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0SU0Y	1-(1-Biphenyl-4-yl-butyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D08YCD	1-(1-Biphenyl-4-yl-ethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0Q1LG	1-(1-Biphenyl-4-yl-pentyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D09GEH	1-(1-Biphenyl-4-yl-propyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D00GIK	1-(3-(4-chlorophenyl)propyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0D0DR	1-(3-(4-fluorophenyl)propyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0AL3G	1-(3,4-dichlorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0X4XX	1-(3,4-difluorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D08OHU	1-(3,5-bis(trifluoromethyl)benzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D00GIW	1-(3,5-dibromobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D07ORY	1-(3,5-dichlorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D02HTG	1-(3,5-difluorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D09TTR	1-(3-phenylpropyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D03VRC	1-(4-Bromobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0P8PG	1-(4-bromophenethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D01JZO	1-(4-chlorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0T3BL	1-(4-chlorophenethyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D05QPR	1-(4-fluorobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0U6QM	1-(4-iodobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0N5GZ	1-(4-methyl-benzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0S0EP	1-(4-nitrobenzyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D0L6HY	1-(Bis-biphenyl-4-yl-methyl)-1H-imidazole	Investigative
T89041	DRUGINFO	D06FHE	1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole	Investigative
T89041	DRUGINFO	D07CTI	1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one	Investigative
T89041	DRUGINFO	D01SZX	1-Imidazol-1-ylmethylxanthen-9-one	Investigative
T89041	DRUGINFO	D0U5GF	2-(1-Imidazol-1-yl-ethyl)-9H-carbazole	Investigative
T89041	DRUGINFO	D05VLU	2,3,4,5-Tetrafluoro-6-pentafluorophenylazo-phenol	Investigative
T89041	DRUGINFO	D07ZNR	2,3,5,6-Tetrafluoro-4-pentafluorophenylazo-phenol	Investigative
T89041	DRUGINFO	D04ISG	3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine	Investigative
T89041	DRUGINFO	D0MA9G	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T89041	DRUGINFO	D0K5KG	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T89041	DRUGINFO	D0R0TE	3-(6-Ethoxy-naphthalen-2-yl)-pyridine	Investigative
T89041	DRUGINFO	D0NX0M	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T89041	DRUGINFO	D0N1PQ	3-(6-methoxynaphthalen-2-yl)pyridine	Investigative
T89041	DRUGINFO	D06AKB	3-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T89041	DRUGINFO	D0L1JF	3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D0J4VA	3-fluoro-4'-(1-(pyridin-4-yl)propyl)biphenyl-4-ol	Investigative
T89041	DRUGINFO	D0Q0BK	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol	Investigative
T89041	DRUGINFO	D09HEA	4-((1H-imidazol-1-yl)methyl)benzonitrile	Investigative
T89041	DRUGINFO	D0QW7W	4-((1H-imidazol-1-yl)methyl)phenol	Investigative
T89041	DRUGINFO	D09VQZ	4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine	Investigative
T89041	DRUGINFO	D0U6JI	4'-(1-(pyridin-4-yl)propyl)biphenyl-3-ol	Investigative
T89041	DRUGINFO	D00YHD	4'-(2-methyl-1-(pyridin-4-yl)propyl)biphenyl-3-ol	Investigative
T89041	DRUGINFO	D0LJ9D	4-(4-(thiophen-2-yl)benzyl)pyridine	Investigative
T89041	DRUGINFO	D0Z3GX	4-(4-(thiophen-3-yl)benzyl)pyridine	Investigative
T89041	DRUGINFO	D00DSE	4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine	Investigative
T89041	DRUGINFO	D02BXS	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine	Investigative
T89041	DRUGINFO	D01REI	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol	Investigative
T89041	DRUGINFO	D0WN9P	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine	Investigative
T89041	DRUGINFO	D0Y5KX	4'-(Pyridin-4-ylmethyl)biphenyl-4-amine	Investigative
T89041	DRUGINFO	D0P5CT	4'-(Pyridin-4-ylmethyl)biphenyl-4-carboxamide	Investigative
T89041	DRUGINFO	D0I1YH	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T89041	DRUGINFO	D03EXD	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T89041	DRUGINFO	D0T1CH	4-[1-(4'-Methoxybiphenyl-4-yl)propyl]pyridine	Investigative
T89041	DRUGINFO	D05PKT	4-[4-(6-methoxynaphthalen-2-yl)benzyl]pyridine	Investigative
T89041	DRUGINFO	D09VPA	4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D0D9FR	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D0YD9J	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D0F5YU	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D03MKT	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D09HOE	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T89041	DRUGINFO	D07IQG	4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one	Investigative
T89041	DRUGINFO	D02CSU	4-Indan-(1Z)-ylidenemethyl-pyridine	Investigative
T89041	DRUGINFO	D04CFP	5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole	Investigative
T89041	DRUGINFO	D06HFV	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine	Investigative
T89041	DRUGINFO	D0LC7Z	6-(3-(pyridin-4-yl)phenyl)naphthalen-2-ol	Investigative
T89041	DRUGINFO	D0N1GH	6-(pyridin-3-yl)-2-naphthonitrile	Investigative
T89041	DRUGINFO	D07VGT	6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol	Investigative
T89041	DRUGINFO	D0E8DX	6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione	Investigative
T89041	DRUGINFO	D02ALK	6-Pyridin-3-yl-naphthalen-2-ol	Investigative
T89041	DRUGINFO	D09GJI	7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol	Investigative
T89041	DRUGINFO	D0M1YW	ANG-3407	Investigative
T89041	DRUGINFO	D0GJ7J	ISOCONAZOLE	Investigative
T89041	DRUGINFO	D0E0ZS	N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide	Investigative
T89041	DRUGINFO	D02ZQK	N-3-(4-bromophenyl)propyl imidazole	Investigative
T89041	DRUGINFO	D0N7CQ	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,4-diol	Investigative
T89041	DRUGINFO	D04SHY	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3,5-diol	Investigative
T89041	DRUGINFO	D0Q1FX	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-3-ol	Investigative
T89041	DRUGINFO	D0SM4F	Rac-4'-(1-Imidazol-1-yl-propyl)-biphenyl-4-ol	Investigative
T89041	DRUGINFO	D03EDD	VN/107-1	Investigative
T89041	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T89041	KEGGPATH	hsa01100:Metabolic pathways		
T89041	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T89041	KEGGPATH	hsa04917:Prolactin signaling pathway		
T89041	WIKIPATH	WP1879:Phase 1 - Functionalization of compounds		
T89041	WIKIPATH	WP2263:Prostate Cancer		
T89041	WIKIPATH	WP237:Glucocorticoid & Mineralcorticoid Metabolism		
T89041	WIKIPATH	WP2749:Metabolism of steroid hormones and vitamin D		
T89041	WIKIPATH	WP43:Oxidation by Cytochrome P450		
T89041	WIKIPATH	WP496:Steroid Biosynthesis		
T89041	WIKIPATH	WP702:Metapathway biotransformation		
T89041	WHIZPATH	PW000045:Androgen and Estrogen Metabolism		
T89041	WHIZPATH	PW000141:Steroidogenesis		
T89041	REACPATH	R-HSA-193048:Androgen biosynthesis		
T89041	REACPATH	R-HSA-194002:Glucocorticoid biosynthesis		
T89041	REACPATH	R-HSA-211976:Endogenous sterols		
T89041	BIOCPATH	PWY66-378:Androgen biosynthesis		
T89041	BIOCPATH	PWY66-381:Glucocorticoid biosynthesis		
T89041	BIOCPATH	PWY-7305:Superpathway of steroid hormone biosynthesis		
				
T47107	TARGETID	T47107		
T47107	FORMERID	TTDC00015		
T47107	UNIPROID	KPCG_HUMAN		
T47107	TARGNAME	Protein kinase C gamma (PRKCG)		
T47107	GENENAME	PRKCG		
T47107	TARGTYPE	Successful target		
T47107	SYNONYMS	PRKCG; PKCG; PKC-gamma		
T47107	FUNCTION	Calcium-activated, phospholipid-and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance ofmorphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation anddegradation of opioid receptors. May also contributes to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress. Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component ARNTL/BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resultingin phase resetting of the cerebral cortex clock.		
T47107	PDBSTRUC	2UZP; 2.00E+73		
T47107	BIOCLASS	Kinase		
T47107	ECNUMBER	EC 2.7.11.13		
T47107	SEQUENCE	MAGLGPGVGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIGKQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTADEIHVTVGEARNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTRTVKATLNPVWNETFVFNLKPGDVERRLSVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQKFEACNYPLELYERVRMGPSSSPIPSPSPSPTDPKRCFFGASPGRLHISDFSFLMVLGKGSFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQLHSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRDLKLDNVMLDAEGHIKITDFGMCKENVFPGTTTRTFCGTPDYIAPEIIAYQPYGKSVDWWSFGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPGKRLGSGPDGEPTIRAHGFFRWIDWERLERLEIPPPFRPRPCGRSGENFDKFFTRAAPALTPPDRLVLASIDQADFQGFTYVNPDFVHPDARSPTSPVPVPVM		
T47107	DRUGINFO	D07NVU	Midostaurin	Approved
T47107	DRUGINFO	D0R2TM	BALANOL	Terminated
T47107	DRUGINFO	D0X0HN	LY-317644	Terminated
T47107	DRUGINFO	D0R5ZR	RO-320432	Terminated
T47107	DRUGINFO	D0L1YA	(-)-Cercosporamide	Investigative
T47107	DRUGINFO	D00TWA	[2,2':5',2'']Terthiophen-4-yl-methanol	Investigative
T47107	DRUGINFO	D05LRV	[2,2':5',2'']Terthiophene-4,5''-dicarbaldehyde	Investigative
T47107	DRUGINFO	D0D3MR	[2,2':5',2'']Terthiophene-4-carbaldehyde	Investigative
T47107	DRUGINFO	D02QME	2-(4-Hydroxy-phenyl)-3,3-diphenyl-acrylonitrile	Investigative
T47107	DRUGINFO	D0S9UK	2,3,3-Triphenyl-acrylonitrile	Investigative
T47107	DRUGINFO	D09XIE	3-(4-Hydroxy-phenyl)-2,3-diphenyl-acrylonitrile	Investigative
T47107	DRUGINFO	D0EK0G	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T47107	DRUGINFO	D06AOY	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T47107	DRUGINFO	D0T0UH	3,3-Bis-(4-hydroxy-phenyl)-2-phenyl-acrylonitrile	Investigative
T47107	DRUGINFO	D0A8MN	3,3-Bis-(4-methoxy-phenyl)-2-phenyl-acrylonitrile	Investigative
T47107	DRUGINFO	D00NYT	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Investigative
T47107	DRUGINFO	D0C3WY	3,4-diphenyl-1H-pyrrole-2,5-dione	Investigative
T47107	DRUGINFO	D02PUV	4-[1-(4-hydroxyphenyl)-3-methyl-1-butenyl]phenol	Investigative
T47107	DRUGINFO	D0Q3GQ	4-cycloheptyliden(4-hydroxyphenyl)methylphenol	Investigative
T47107	DRUGINFO	D0V9SW	4-cyclohexyliden(4-hydroxyphenyl)methylphenol	Investigative
T47107	DRUGINFO	D04OHM	4-cyclopentyliden(4-hydroxyphenyl)methylphenol	Investigative
T47107	DRUGINFO	D04AXH	8-Octyl-benzolactam-V9	Investigative
T47107	DRUGINFO	D0TO6S	Bisindolylmaleimide-I	Investigative
T47107	DRUGINFO	D06TLL	Go 6983	Investigative
T47107	DRUGINFO	D06ZCX	LY-326449	Investigative
T47107	DRUGINFO	D08GFG	Monoctanoin component C	Investigative
T47107	DRUGINFO	D04JNZ	PROSTRATIN	Investigative
T47107	DRUGINFO	D0L8HO	RO-316233	Investigative
T47107	DRUGINFO	D09TSC	Ro-32-0557	Investigative
T47107	KEGGPATH	hsa04010:MAPK signaling pathway		
T47107	KEGGPATH	hsa04012:ErbB signaling pathway		
T47107	KEGGPATH	hsa04014:Ras signaling pathway		
T47107	KEGGPATH	hsa04015:Rap1 signaling pathway		
T47107	KEGGPATH	hsa04020:Calcium signaling pathway		
T47107	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T47107	KEGGPATH	hsa04070:Phosphatidylinositol signaling system		
T47107	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T47107	KEGGPATH	hsa04150:mTOR signaling pathway		
T47107	KEGGPATH	hsa04270:Vascular smooth muscle contraction		
T47107	KEGGPATH	hsa04310:Wnt signaling pathway		
T47107	KEGGPATH	hsa04370:VEGF signaling pathway		
T47107	KEGGPATH	hsa04510:Focal adhesion		
T47107	KEGGPATH	hsa04530:Tight junction		
T47107	KEGGPATH	hsa04540:Gap junction		
T47107	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T47107	KEGGPATH	hsa04666:Fc gamma R-mediated phagocytosis		
T47107	KEGGPATH	hsa04670:Leukocyte transendothelial migration		
T47107	KEGGPATH	hsa04713:Circadian entrainment		
T47107	KEGGPATH	hsa04720:Long-term potentiation		
T47107	KEGGPATH	hsa04723:Retrograde endocannabinoid signaling		
T47107	KEGGPATH	hsa04724:Glutamatergic synapse		
T47107	KEGGPATH	hsa04725:Cholinergic synapse		
T47107	KEGGPATH	hsa04726:Serotonergic synapse		
T47107	KEGGPATH	hsa04727:GABAergic synapse		
T47107	KEGGPATH	hsa04728:Dopaminergic synapse		
T47107	KEGGPATH	hsa04730:Long-term depression		
T47107	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T47107	KEGGPATH	hsa04911:Insulin secretion		
T47107	KEGGPATH	hsa04916:Melanogenesis		
T47107	KEGGPATH	hsa04918:Thyroid hormone synthesis		
T47107	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T47107	KEGGPATH	hsa04921:Oxytocin signaling pathway		
T47107	KEGGPATH	hsa04960:Aldosterone-regulated sodium reabsorption		
T47107	KEGGPATH	hsa04961:Endocrine and other factor-regulated calcium reabsorption		
T47107	KEGGPATH	hsa04970:Salivary secretion		
T47107	KEGGPATH	hsa04971:Gastric acid secretion		
T47107	KEGGPATH	hsa04972:Pancreatic secretion		
T47107	KEGGPATH	hsa05031:Amphetamine addiction		
T47107	KEGGPATH	hsa05032:Morphine addiction		
T47107	KEGGPATH	hsa05110:Vibrio cholerae infection		
T47107	KEGGPATH	hsa05143:African trypanosomiasis		
T47107	KEGGPATH	hsa05146:Amoebiasis		
T47107	KEGGPATH	hsa05161:Hepatitis B		
T47107	KEGGPATH	hsa05200:Pathways in cancer		
T47107	KEGGPATH	hsa05205:Proteoglycans in cancer		
T47107	KEGGPATH	hsa05206:MicroRNAs in cancer		
T47107	KEGGPATH	hsa05214:Glioma		
T47107	KEGGPATH	hsa05223:Non-small cell lung cancer		
T47107	KEGGPATH	hsa05231:Choline metabolism in cancer		
T47107	WIKIPATH	WP1903:Response to elevated platelet cytosolic Ca2+		
T47107	WIKIPATH	WP1978:Opioid Signalling		
T47107	WIKIPATH	WP2012:miRs in Muscle Cell Differentiation		
T47107	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T47107	WIKIPATH	WP2688:DAG and IP3 signaling		
T47107	WIKIPATH	WP289:Myometrial Relaxation and Contraction Pathways		
T47107	WIKIPATH	WP35:G Protein Signaling Pathways		
T47107	WIKIPATH	WP363:Wnt Signaling Pathway Netpath		
T47107	WIKIPATH	WP382:MAPK Signaling Pathway		
T47107	WIKIPATH	WP399:Wnt Signaling Pathway and Pluripotency		
T47107	WIKIPATH	WP428:Wnt Signaling Pathway		
T47107	WIKIPATH	WP536:Calcium Regulation in the Cardiac Cell		
T47107	REACPATH	R-HSA-111933:Calmodulin induced events		
T47107	REACPATH	R-HSA-114516:Disinhibition of SNARE formation		
T47107	REACPATH	R-HSA-416993:Trafficking of GluR2-containing AMPA receptors		
T47107	REACPATH	R-HSA-418597:G alpha (z) signalling events		
T47107	REACPATH	R-HSA-5099900:WNT5A-dependent internalization of FZD4		
T47107	REACPATH	R-HSA-76005:Response to elevated platelet cytosolic Ca2+		
T47107	INTEPATH	endothelinpathway:Endothelins		
T47107	INTEPATH	il8cxcr1_pathway:IL8- and CXCR1-mediated signaling events		
T47107	INTEPATH	il8cxcr2_pathway:IL8- and CXCR2-mediated signaling events		
T47107	INTEPATH	nfat_3pathway:Role of Calcineurin-dependent NFAT signaling in lymphocytes		
T47107	INTEPATH	retinoic_acid_pathway:Retinoic acid receptors-mediated signaling		
T47107	INTEPATH	thrombin_par1_pathway:PAR1-mediated thrombin signaling events		
T47107	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T47107	PANTPATH	P00002:Alpha adrenergic receptor signaling pathway		
T47107	PANTPATH	P00003:Alzheimer disease-amyloid secretase pathway		
T47107	PANTPATH	P00005:Angiogenesis		
T47107	PANTPATH	P00006:Apoptosis signaling pathway		
T47107	PANTPATH	P00018:EGF receptor signaling pathway		
T47107	PANTPATH	P00019:Endothelin signaling pathway		
T47107	PANTPATH	P00021:FGF signaling pathway		
T47107	PANTPATH	P00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway		
T47107	PANTPATH	P00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway		
T47107	PANTPATH	P00056:VEGF signaling pathway		
T47107	PANTPATH	P00057:Wnt signaling pathway		
T47107	PANTPATH	P04374:5HT2 type receptor mediated signaling pathway		
T47107	PANTPATH	P04385:Histamine H1 receptor mediated signaling pathway		
T47107	PANTPATH	P04391:Oxytocin receptor mediated signaling pathway		
T47107	PANTPATH	P04394:Thyrotropin-releasing hormone receptor signaling pathway		
				
T17980	TARGETID	T17980		
T17980	FORMERID	TTDS00406		
T17980	UNIPROID	FYN_HUMAN		
T17980	TARGNAME	Fyn tyrosine protein kinase (FYN)		
T17980	GENENAME	FYN		
T17980	TARGTYPE	Successful target		
T17980	SYNONYMS	Tyrosine-protein kinase Fyn; Src-like kinase; SLK; Proto-oncogene tyrosine-protein kinase Fyn; Proto-oncogene c-Fyn; Proto-oncogene Syn; Fyn p59-Fyn; Fyn Protooncogene Syn		
T17980	FUNCTION	Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain. Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions. Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT. Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage. Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL1 and TRPC6. Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein. Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation. Phosphorylates PTK2B/PYK2 in response to T-cell receptor activation. Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains LCK and FYN in an inactive form. Promotes CD28-induced phosphorylation of VAV1. Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance.		
T17980	PDBSTRUC	6IPZ; 6IPY; 6EDF; 4ZNX; 4U1P		
T17980	BIOCLASS	Kinase		
T17980	ECNUMBER	EC 2.7.10.2		
T17980	SEQUENCE	MGCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL		
T17980	DRUGINFO	D0E6XR	Dasatinib	Approved
T17980	DRUGINFO	D0U3XL	JNJ-26483327	Phase 1
T17980	DRUGINFO	D0OD8N	1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane	Investigative
T17980	DRUGINFO	D09QBA	CEP-5104	Investigative
T17980	DRUGINFO	D07IHM	CEP-6331	Investigative
T17980	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T17980	DRUGINFO	D08RZB	PMID15546730C2	Investigative
T17980	DRUGINFO	D09XIL	Ro-4396686	Investigative
T17980	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T17980	KEGGPATH	hsa04360:Axon guidance		
T17980	KEGGPATH	hsa04380:Osteoclast differentiation		
T17980	KEGGPATH	hsa04510:Focal adhesion		
T17980	KEGGPATH	hsa04520:Adherens junction		
T17980	KEGGPATH	hsa04611:Platelet activation		
T17980	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T17980	KEGGPATH	hsa04660:T cell receptor signaling pathway		
T17980	KEGGPATH	hsa04664:Fc epsilon RI signaling pathway		
T17980	KEGGPATH	hsa04725:Cholinergic synapse		
T17980	KEGGPATH	hsa05020:Prion diseases		
T17980	KEGGPATH	hsa05130:Pathogenic Escherichia coli infection		
T17980	KEGGPATH	hsa05162:Measles		
T17980	KEGGPATH	hsa05416:Viral myocarditis		
T17980	WIKIPATH	WP1794:Cell surface interactions at the vascular wall		
T17980	WIKIPATH	WP1799:Costimulation by the CD28 family		
T17980	WIKIPATH	WP1826:GPVI-mediated activation cascade		
T17980	WIKIPATH	WP185:Integrin-mediated Cell Adhesion		
T17980	WIKIPATH	WP1866:NCAM signaling for neurite out-growth		
T17980	WIKIPATH	WP1867:Nephrin interactions		
T17980	WIKIPATH	WP1868:Netrin-1 signaling		
T17980	WIKIPATH	WP1883:Platelet Adhesion to exposed collagen		
T17980	WIKIPATH	WP1907:Semaphorin interactions		
T17980	WIKIPATH	WP2034:Leptin signaling pathway		
T17980	WIKIPATH	WP205:IL-7 Signaling Pathway		
T17980	WIKIPATH	WP2203:TSLP Signaling Pathway		
T17980	WIKIPATH	WP2272:Pathogenic Escherichia coli infection		
T17980	WIKIPATH	WP23:B Cell Receptor Signaling Pathway		
T17980	WIKIPATH	WP2332:Interleukin-11 Signaling Pathway		
T17980	WIKIPATH	WP2380:BDNF signaling pathway		
T17980	WIKIPATH	WP2572:Primary Focal Segmental Glomerulosclerosis FSGS		
T17980	WIKIPATH	WP2583:T-Cell Receptor and Co-stimulatory Signaling		
T17980	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T17980	WIKIPATH	WP2684:Host Interactions of HIV factors		
T17980	WIKIPATH	WP2694:DAP12 interactions		
T17980	WIKIPATH	WP2713:Signaling by SCF-KIT		
T17980	WIKIPATH	WP2746:Signaling by the B Cell Receptor (BCR)		
T17980	WIKIPATH	WP2759:Fc epsilon receptor (FCERI) signaling		
T17980	WIKIPATH	WP2858:Ectoderm Differentiation		
T17980	WIKIPATH	WP286:IL-3 Signaling Pathway		
T17980	WIKIPATH	WP304:Kit receptor signaling pathway		
T17980	WIKIPATH	WP49:IL-2 Signaling Pathway		
T17980	WIKIPATH	WP585:Interferon type I signaling pathways		
T17980	WIKIPATH	WP69:TCR Signaling Pathway		
T17980	WHIZPATH	PW000453:Fc Epsilon Receptor I Signaling in Mast Cells		
T17980	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T17980	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T17980	REACPATH	R-HSA-1433559:Regulation of KIT signaling		
T17980	REACPATH	R-HSA-202733:Cell surface interactions at the vascular wall		
T17980	REACPATH	R-HSA-2029481:FCGR activation		
T17980	REACPATH	R-HSA-210990:PECAM1 interactions		
T17980	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T17980	REACPATH	R-HSA-2424491:DAP12 signaling		
T17980	REACPATH	R-HSA-2682334:EPH-Ephrin signaling		
T17980	REACPATH	R-HSA-2730905:Role of LAT2/NTAL/LAB on calcium mobilization		
T17980	REACPATH	R-HSA-373753:Nephrin interactions		
T17980	REACPATH	R-HSA-375165:NCAM signaling for neurite out-growth		
T17980	REACPATH	R-HSA-389356:CD28 co-stimulation		
T17980	REACPATH	R-HSA-389357:CD28 dependent PI3K/Akt signaling		
T17980	REACPATH	R-HSA-389359:CD28 dependent Vav1 pathway		
T17980	REACPATH	R-HSA-389513:CTLA4 inhibitory signaling		
T17980	REACPATH	R-HSA-3928662:EPHB-mediated forward signaling		
T17980	REACPATH	R-HSA-3928663:EPHA-mediated growth cone collapse		
T17980	REACPATH	R-HSA-3928665:EPH-ephrin mediated repulsion of cells		
T17980	REACPATH	R-HSA-399956:CRMPs in Sema3A signaling		
T17980	REACPATH	R-HSA-418885:DCC mediated attractive signaling		
T17980	REACPATH	R-HSA-418886:Netrin mediated repulsion signals		
T17980	REACPATH	R-HSA-4420097:VEGFA-VEGFR2 Pathway		
T17980	REACPATH	R-HSA-5621480:Dectin-2 family		
T17980	REACPATH	R-HSA-5621575:CD209 (DC-SIGN) signaling		
T17980	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T17980	REACPATH	R-HSA-75892:Platelet Adhesion to exposed collagen		
T17980	REACPATH	R-HSA-912631:Regulation of signaling by CBL		
T17980	REACPATH	R-HSA-983695:Antigen activates B Cell Receptor (BCR) leading to generation of second messengers		
T17980	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T17980	NET_PATH	NetPath_23:TSH Signaling Pathway		
T17980	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T17980	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T17980	INTEPATH	alphasynuclein_pathway:Alpha-synuclein signaling		
T17980	INTEPATH	amb2_neutrophils_pathway:amb2 Integrin signaling		
T17980	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T17980	INTEPATH	cd8tcrpathway:TCR signaling in na&#xef;ve CD8+ T cells		
T17980	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T17980	INTEPATH	ecadherin_keratinocyte_pathway:E-cadherin signaling in keratinocytes		
T17980	INTEPATH	epha_fwdpathway:EPHA forward signaling		
T17980	INTEPATH	ephrinarevpathway:Ephrin A  reverse signaling		
T17980	INTEPATH	ephrinbrevpathway:Ephrin B reverse signaling		
T17980	INTEPATH	erbb4_pathway:ErbB4 signaling events		
T17980	INTEPATH	fak_pathway:Signaling events mediated by focal adhesion kinase		
T17980	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T17980	INTEPATH	glypican_1pathway:Glypican 1 network		
T17980	INTEPATH	il2_1pathway:IL2-mediated signaling events		
T17980	INTEPATH	nephrin_neph1_pathway:Nephrin/Neph1 signaling in the kidney podocyte		
T17980	INTEPATH	netrin_pathway:Netrin-mediated signaling events		
T17980	INTEPATH	p38alphabetapathway:Regulation of p38-alpha and p38-beta		
T17980	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T17980	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T17980	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T17980	INTEPATH	reelinpathway:Reelin signaling pathway		
T17980	INTEPATH	syndecan_3_pathway:Syndecan-3-mediated signaling events		
T17980	INTEPATH	tcr_pathway:TCR signaling in na&#xef;ve CD4+ T cells		
T17980	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T17980	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T17980	PANTPATH	P00007:Axon guidance mediated by semaphorins		
T17980	PANTPATH	P00012:Cadherin signaling pathway		
T17980	PANTPATH	P00034:Integrin signalling pathway		
T17980	PANTPATH	P00049:Parkinson disease		
				
T27602	TARGETID	T27602		
T27602	FORMERID	TTDS00282		
T27602	UNIPROID	TRY1_HUMAN		
T27602	TARGNAME	Cationic trypsinogen (PRSS1)		
T27602	GENENAME	PRSS1		
T27602	TARGTYPE	Successful target		
T27602	SYNONYMS	Trypsin-1; Trypsin I; TRYP1; TRY1; TRP1; Serine protease 1; Beta-trypsin		
T27602	FUNCTION	Has activity against the synthetic substrates Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec and Boc-Val-Pro-Arg-Mec. The single-chain form is more active than the two-chain form against all of these substrates.		
T27602	PDBSTRUC	4WXV; 4WWY; 2RA3; 1TRN; 1FXY		
T27602	BIOCLASS	Peptidase		
T27602	ECNUMBER	EC 3.4.21.4		
T27602	SEQUENCE	MNPLLILTFVAAALAAPFDDDDKIVGGYNCEENSVPYQVSLNSGYHFCGGSLINEQWVVSAGHCYKSRIQVRLGEHNIEVLEGNEQFINAAKIIRHPQYDRKTLNNDIMLIKLSSRAVINARVSTISLPTAPPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPGKITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQLQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKNTIAANS		
T27602	DRUGINFO	D0SH3I	Bortezomib	Approved
T27602	DRUGINFO	D01MUU	MELAGATRAN	Phase 3
T27602	DRUGINFO	D0DF1R	Ulinastatin	Phase 3
T27602	DRUGINFO	D04TEF	Alpha-1 antitrypsin	Phase 2
T27602	DRUGINFO	D0B9EH	Dermolastin	Discontinued in Phase 2
T27602	DRUGINFO	D05QMJ	RWJ-56423	Discontinued in Phase 1
T27602	DRUGINFO	D0GR2H	BMY-44621	Terminated
T27602	DRUGINFO	D0CV7T	Patamostat	Terminated
T27602	DRUGINFO	D09TNA	1-(3-Amino-benzyl)-1H-indole-5-carboxamidine	Investigative
T27602	DRUGINFO	D0EH1F	1-(3-Nitro-benzyl)-1H-indole-5-carboxamidine	Investigative
T27602	DRUGINFO	D0F2YC	1,3-Dibenzyl-[1,3]diazetidine-2,4-dione	Investigative
T27602	DRUGINFO	D05ICF	1,3-Di-p-tolyl-[1,3]diazetidine-2,4-dione	Investigative
T27602	DRUGINFO	D0M2PE	1-Benzyl-1H-indole-5-carboxamidine	Investigative
T27602	DRUGINFO	D08OLP	2-(2-Hydroxy-phenyl)-1H-indole-5-carboxamidine	Investigative
T27602	DRUGINFO	D0J2SM	2-(2-Iodo-phenyl)-benzo[d][1,3]oxazin-4-one	Investigative
T27602	DRUGINFO	D0Z7YI	2-Propionyl-1H-indole-6-carboxamidine	Investigative
T27602	DRUGINFO	D0CT8A	4-(3,4-Diethoxy-benzylamino)-benzamidine	Investigative
T27602	DRUGINFO	D02XPB	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	Investigative
T27602	DRUGINFO	D08OCL	4-(5-Nitro-indol-1-ylmethyl)-benzamidine	Investigative
T27602	DRUGINFO	D0N1PW	4-Indol-1-ylmethyl-benzamidine	Investigative
T27602	DRUGINFO	D00POF	6-Styryl-naphthalene-2-carboxamidine	Investigative
T27602	DRUGINFO	D0S4MQ	8-Bromo-6-styryl-naphthalene-2-carboxamidine	Investigative
T27602	DRUGINFO	D0K0GU	8-Furan-3-yl-6-styryl-naphthalene-2-carboxamidine	Investigative
T27602	DRUGINFO	D05ABK	ATF-HI-8	Investigative
T27602	DRUGINFO	D07SFI	Benzamidine	Investigative
T27602	DRUGINFO	D0O0GT	CVS-2139	Investigative
T27602	DRUGINFO	D0C1TS	CVS-2359	Investigative
T27602	DRUGINFO	D07IBU	GR-133686	Investigative
T27602	DRUGINFO	D0Y5IQ	Grassystatin a	Investigative
T27602	DRUGINFO	D0JR9V	JBP-1	Investigative
T27602	DRUGINFO	D02NHS	L-375378	Investigative
T27602	DRUGINFO	D0RQ2T	Macrocyclic tripeptide motif	Investigative
T27602	DRUGINFO	D0M1LO	Piperidine-1-carboxamidine	Investigative
T27602	DRUGINFO	D0F9YV	PMID3514912C9	Investigative
T27602	DRUGINFO	D08SMN	POP-1	Investigative
T27602	DRUGINFO	D08SKX	recAAT, PPL Therapeutics/Bayer	Investigative
T27602	DRUGINFO	D09OBJ	RWJ-50353	Investigative
T27602	DRUGINFO	D03ZUM	Tert-butyloxy carbonyl-D-Phe-pro-Arg-H	Investigative
T27602	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T27602	KEGGPATH	hsa04972:Pancreatic secretion		
T27602	KEGGPATH	hsa04974:Protein digestion and absorption		
T27602	KEGGPATH	hsa05164:Influenza A		
T27602	WIKIPATH	WP2769:Activation of Matrix Metalloproteinases		
T27602	REACPATH	R-HSA-1592389:Activation of Matrix Metalloproteinases		
T27602	REACPATH	R-HSA-196741:Cobalamin (Cbl, vitamin B12) transport and metabolism		
				
T18477	TARGETID	T18477		
T18477	FORMERID	TTDC00018		
T18477	UNIPROID	HS90A_HUMAN		
T18477	TARGNAME	Heat shock protein 90 alpha (HSP90A)		
T18477	GENENAME	HSP90AA1		
T18477	TARGTYPE	Successful target		
T18477	SYNONYMS	Renal carcinoma antigen NY-REN-38; Lipopolysaccharide-associated protein 2; LPS-associated protein 2; LAP-2; Heat shock protein HSP 90-alpha; Heat shock 86 kDa; HSPCA; HSPC1; HSP90A; HSP86; HSP 86		
T18477	FUNCTION	Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself. Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle. Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels. In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues(). Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment. Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression. Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes. Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation. Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction.		
T18477	PDBSTRUC	6GR5; 6GR4; 6GR3; 6GR1; 6GQU		
T18477	BIOCLASS	Heat shock protein		
T18477	SEQUENCE	MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEDKEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD		
T18477	DRUGINFO	D0G5UB	Amlexanox	Approved
T18477	DRUGINFO	D06NSS	Cromoglicate	Approved
T18477	DRUGINFO	D05HWN	BIIB-021	Phase 2
T18477	DRUGINFO	D0Y9PZ	Efungumab	Phase 2
T18477	DRUGINFO	D08PYO	KW-2478	Phase 2
T18477	DRUGINFO	D05BYA	NVP-AUY922	Phase 2
T18477	DRUGINFO	D0SC2J	Tanespimycin	Phase 2
T18477	DRUGINFO	D09XGB	VER 50589	Phase 2
T18477	DRUGINFO	D07MPL	SNX-5422	Phase 1/2
T18477	DRUGINFO	D03LRU	Alvespimycin hydrochloride	Phase 1
T18477	DRUGINFO	D06YSP	AT13387	Phase 1
T18477	DRUGINFO	D0H3VK	BIIB 028	Phase 1
T18477	DRUGINFO	D02TTL	Debio 0932	Phase 1
T18477	DRUGINFO	D02PGP	PU3	Phase 1
T18477	DRUGINFO	D0V9MT	PU-AD	Phase 1
T18477	DRUGINFO	D0ME2T	RTA-901	Phase 1
T18477	DRUGINFO	D03IKZ	HBP-347	Discontinued in Phase 3
T18477	DRUGINFO	D03PKI	Geldanamycin	Discontinued in Phase 2
T18477	DRUGINFO	D0BM6S	IPI-493	Discontinued in Phase 1
T18477	DRUGINFO	D00OCB	CCT-018159	Preclinical
T18477	DRUGINFO	D0X5YU	KOS-2484	Preclinical
T18477	DRUGINFO	D0KC7K	EC-154	Terminated
T18477	DRUGINFO	D05RTH	17-desmethoxy-17-aminogeldanamycin	Investigative
T18477	DRUGINFO	D0K4RN	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	Investigative
T18477	DRUGINFO	D06GOK	2-Methyl-2,4-Pentanediol	Investigative
T18477	DRUGINFO	D08CZD	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	Investigative
T18477	DRUGINFO	D0D3BP	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	Investigative
T18477	DRUGINFO	D00PMS	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	Investigative
T18477	DRUGINFO	D01GGU	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	Investigative
T18477	DRUGINFO	D05UTX	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	Investigative
T18477	DRUGINFO	D0H6OS	Geldanamycin-estradiol hybrid	Investigative
T18477	DRUGINFO	D07WDQ	GNF-PF-67	Investigative
T18477	DRUGINFO	D02IIL	KOSN1559	Investigative
T18477	DRUGINFO	D0H0KA	Macbecin	Investigative
T18477	DRUGINFO	D0D5KQ	PU24S	Investigative
T18477	DRUGINFO	D0ZA6G	Radicicol	Investigative
T18477	DRUGINFO	D0M2TY	RHEIN	Investigative
T18477	DRUGINFO	D0K0TJ	SNX-2112	Investigative
T18477	DRUGINFO	D0T4MS	VER-49009	Investigative
T18477	DRUGINFO	D05GKC	ZEARALANONE	Investigative
T18477	KEGGPATH	hsa04141:Protein processing in endoplasmic reticulum		
T18477	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T18477	KEGGPATH	hsa04612:Antigen processing and presentation		
T18477	KEGGPATH	hsa04621:NOD-like receptor signaling pathway		
T18477	KEGGPATH	hsa04914:Progesterone-mediated oocyte maturation		
T18477	KEGGPATH	hsa04915:Estrogen signaling pathway		
T18477	KEGGPATH	hsa05200:Pathways in cancer		
T18477	KEGGPATH	hsa05215:Prostate cancer		
T18477	WIKIPATH	WP1433:NOD pathway		
T18477	WIKIPATH	WP1850:Metabolism of nitric oxide		
T18477	WIKIPATH	WP1859:Mitotic G2-G2/M phases		
T18477	WIKIPATH	WP1907:Semaphorin interactions		
T18477	WIKIPATH	WP1910:Signaling by EGFR		
T18477	WIKIPATH	WP2100:Arylhydrocarbon receptor (AhR) signaling pathway		
T18477	WIKIPATH	WP231:TNF alpha Signaling Pathway		
T18477	WIKIPATH	WP2355:Corticotropin-releasing hormone		
T18477	WIKIPATH	WP2586:Aryl Hydrocarbon Receptor		
T18477	WIKIPATH	WP262:EBV LMP1 signaling		
T18477	WIKIPATH	WP2683:Influenza Life Cycle		
T18477	WIKIPATH	WP2719:Fcgamma receptor (FCGR) dependent phagocytosis		
T18477	WIKIPATH	WP2780:Signaling by ERBB2		
T18477	WIKIPATH	WP2784:Binding and Uptake of Ligands by Scavenger Receptors		
T18477	WIKIPATH	WP2873:Aryl Hydrocarbon Receptor Pathway		
T18477	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T18477	WIKIPATH	WP2884:NRF2 pathway		
T18477	REACPATH	R-HSA-1236382:Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants		
T18477	REACPATH	R-HSA-1474151:Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation		
T18477	REACPATH	R-HSA-2029482:Regulation of actin dynamics for phagocytic cup formation		
T18477	REACPATH	R-HSA-203615:eNOS activation		
T18477	REACPATH	R-HSA-2565942:Regulation of PLK1 Activity at G2/M Transition		
T18477	REACPATH	R-HSA-3371568:Attenuation phase		
T18477	REACPATH	R-HSA-3371571:HSF1-dependent transactivation		
T18477	REACPATH	R-HSA-380259:Loss of Nlp from mitotic centrosomes		
T18477	REACPATH	R-HSA-380270:Recruitment of mitotic centrosome proteins and complexes		
T18477	REACPATH	R-HSA-380284:Loss of proteins required for interphase microtubule organization?from the centrosome		
T18477	REACPATH	R-HSA-3928663:EPHA-mediated growth cone collapse		
T18477	REACPATH	R-HSA-4420097:VEGFA-VEGFR2 Pathway		
T18477	REACPATH	R-HSA-5218920:VEGFR2 mediated vascular permeability		
T18477	REACPATH	R-HSA-5620912:Anchoring of the basal body to the plasma membrane		
T18477	REACPATH	R-HSA-5637810:Constitutive Signaling by EGFRvIII		
T18477	NET_PATH	NetPath_11:TCR Signaling Pathway		
T18477	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T18477	INTEPATH	ar_tf_pathway:Regulation of Androgen receptor activity		
T18477	INTEPATH	avb3_integrin_pathway:Integrins in angiogenesis		
T18477	INTEPATH	erbb_network_pathway:ErbB receptor signaling network		
T18477	INTEPATH	hdac_classii_pathway:Signaling events mediated by HDAC Class II		
T18477	INTEPATH	hif1apathway:Hypoxic and oxygen homeostasis regulation of HIF-1-alpha		
T18477	INTEPATH	il2_pi3kpathway:IL2 signaling events mediated by PI3K		
T18477	INTEPATH	ilk_pathway:Integrin-linked kinase signaling		
T18477	INTEPATH	lkb1_pathway:LKB1 signaling events		
T18477	INTEPATH	myc_activpathway:Validated targets of C-MYC transcriptional activation		
T18477	INTEPATH	pi3kciaktpathway:Class I PI3K signaling events mediated by Akt		
T18477	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T18477	INTEPATH	reg_gr_pathway:Glucocorticoid receptor regulatory network		
T18477	INTEPATH	telomerasepathway:Regulation of Telomerase		
T18477	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T18477	INTEPATH	vegfr1_pathway:VEGFR1 specific signals		
				
T48069	TARGETID	T48069		
T48069	FORMERID	TTDS00269		
T48069	UNIPROID	IGF1R_HUMAN		
T48069	TARGNAME	Insulin-like growth factor I receptor (IGF1R)		
T48069	GENENAME	IGF1R		
T48069	TARGTYPE	Successful target		
T48069	SYNONYMS	Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221		
T48069	FUNCTION	Binds IGF1 with high affinity and IGF2 and insulin (INS) with a lower affinity. The activated IGF1R is involved in cell growth and survival control. IGF1R is crucial for tumor transformation and survival of malignant cell. Ligand binding activates the receptor kinase, leading to receptor autophosphorylation, and tyrosines phosphorylation of multiple substrates, that function as signaling adapter proteins including, the insulin-receptor substrates (IRS1/2), Shc and 14-3-3 proteins. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway and the Ras-MAPK pathway. The result of activating the MAPK pathway is increased cellular proliferation, whereas activating the PI3K pathway inhibits apoptosis and stimulates protein synthesis. Phosphorylated IRS1 can activate the 85 kDa regulatory subunit of PI3K (PIK3R1), leading to activation of several downstream substrates, including protein AKT/PKB. AKT phosphorylation, in turn, enhances protein synthesis through mTOR activation and triggers the antiapoptotic effects of IGFIR through phosphorylation and inactivation of BAD. In parallel to PI3K-driven signaling, recruitment of Grb2/SOS by phosphorylated IRS1 or Shc leads to recruitment of Ras and activation of the ras-MAPK pathway. In addition to these two main signaling pathways IGF1R signals also through the Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT). Phosphorylation of JAK proteins can lead to phosphorylation/activation of signal transducers and activators of transcription (STAT) proteins. In particular activation of STAT3, may be essential for the transforming activity of IGF1R. The JAK/STAT pathway activates gene transcription and may be responsible for the transforming activity. JNK kinases can also be activated by the IGF1R. IGF1 exerts inhibiting activities on JNK activation via phosphorylation and inhibition of MAP3K5/ASK1, which is able to directly associate with the IGF1R. Receptor tyrosine kinase which mediates actions of insulin-like growth factor 1 (IGF1).		
T48069	PDBSTRUC	5U8R; 5U8Q; 5HZN; 5FXS; 5FXR		
T48069	BIOCLASS	Kinase		
T48069	ECNUMBER	EC 2.7.10.1		
T48069	SEQUENCE	MKSGSGGGSPTSLWGLLFLSAALSLWPTSGEICGPGIDIRNDYQQLKRLENCTVIEGYLHILLISKAEDYRSYRFPKLTVITEYLLLFRVAGLESLGDLFPNLTVIRGWKLFYNYALVIFEMTNLKDIGLYNLRNITRGAIRIEKNADLCYLSTVDWSLILDAVSNNYIVGNKPPKECGDLCPGTMEEKPMCEKTTINNEYNYRCWTTNRCQKMCPSTCGKRACTENNECCHPECLGSCSAPDNDTACVACRHYYYAGVCVPACPPNTYRFEGWRCVDRDFCANILSAESSDSEGFVIHDGECMQECPSGFIRNGSQSMYCIPCEGPCPKVCEEEKKTKTIDSVTSAQMLQGCTIFKGNLLINIRRGNNIASELENFMGLIEVVTGYVKIRHSHALVSLSFLKNLRLILGEEQLEGNYSFYVLDNQNLQQLWDWDHRNLTIKAGKMYFAFNPKLCVSEIYRMEEVTGTKGRQSKGDINTRNNGERASCESDVLHFTSTTTSKNRIIITWHRYRPPDYRDLISFTVYYKEAPFKNVTEYDGQDACGSNSWNMVDVDLPPNKDVEPGILLHGLKPWTQYAVYVKAVTLTMVENDHIRGAKSEILYIRTNASVPSIPLDVLSASNSSSQLIVKWNPPSLPNGNLSYYIVRWQRQPQDGYLYRHNYCSKDKIPIRKYADGTIDIEEVTENPKTEVCGGEKGPCCACPKTEAEKQAEKEEAEYRKVFENFLHNSIFVPRPERKRRDVMQVANTTMSSRSRNTTAADTYNITDPEELETEYPFFESRVDNKERTVISNLRPFTLYRIDIHSCNHEAEKLGCSASNFVFARTMPAEGADDIPGPVTWEPRPENSIFLKWPEPENPNGLILMYEIKYGSQVEDQRECVSRQEYRKYGGAKLNRLNPGNYTARIQATSLSGNGSWTDPVFFYVQAKTGYENFIHLIIALPVAVLLIVGGLVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEENKLPEPEELDLEPENMESVPLDPSASSSSLPLPDRHSGHKAENGPGPGVLVLRASFDERQPYAHMNGGRKNERALPLPQSSTC		
T48069	DRUGINFO	D0F3JT	Mecasermin	Approved
T48069	DRUGINFO	D0N3NZ	Somatomedin-1	Approved
T48069	DRUGINFO	D0EN0W	Teprotumumab	Approved
T48069	DRUGINFO	D01GFX	OSI-906	Phase 3
T48069	DRUGINFO	D06APK	Rinfabate	Phase 2/3
T48069	DRUGINFO	D00AKR	AMG 479	Phase 2
T48069	DRUGINFO	D01SJS	AXL-1717	Phase 2
T48069	DRUGINFO	D0E5DP	Cixutumumab	Phase 2
T48069	DRUGINFO	D00BUO	MM-141	Phase 2
T48069	DRUGINFO	D03BHM	R1507	Phase 2
T48069	DRUGINFO	D0T5JS	TT-100	Phase 2
T48069	DRUGINFO	D00VKK	VPI-2690B	Phase 2
T48069	DRUGINFO	D07HPJ	AEW-541	Phase 1
T48069	DRUGINFO	D0O7QQ	BIIB 022	Phase 1
T48069	DRUGINFO	D01OYS	Cyclolignan picropodophyllin	Phase 1
T48069	DRUGINFO	D4JYH3	FPI-1434	Phase 1
T48069	DRUGINFO	D0L1ZM	HF-0299	Phase 1
T48069	DRUGINFO	D03WNN	RG-7010	Phase 1
T48069	DRUGINFO	D00BPE	AVE-1642	Discontinued in Phase 2
T48069	DRUGINFO	D0M3OR	KW-2450	Discontinued in Phase 1/2
T48069	DRUGINFO	D0U6KH	Figitumumab	Discontinued in Phase 1
T48069	DRUGINFO	D0LF0O	BMS-695735	Preclinical
T48069	DRUGINFO	D0TI4U	EGFR/IGFR tandem adnectin	Preclinical
T48069	DRUGINFO	D0W9KO	4-((1H-indazol-6-ylamino)methyl)benzene-1,2-diol	Investigative
T48069	DRUGINFO	D0L7MM	4-((naphthalen-2-ylamino)methyl)benzene-1,2-diol	Investigative
T48069	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T48069	DRUGINFO	D00ICA	AMP-PNP	Investigative
T48069	DRUGINFO	D0M4SY	BMS-536924	Investigative
T48069	DRUGINFO	D0G6XS	Fucose	Investigative
T48069	DRUGINFO	D0O0RY	JB-1	Investigative
T48069	DRUGINFO	D06NMZ	NVP-ADW742	Investigative
T48069	KEGGPATH	hsa04014:Ras signaling pathway		
T48069	KEGGPATH	hsa04015:Rap1 signaling pathway		
T48069	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T48069	KEGGPATH	hsa04068:FoxO signaling pathway		
T48069	KEGGPATH	hsa04114:Oocyte meiosis		
T48069	KEGGPATH	hsa04144:Endocytosis		
T48069	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T48069	KEGGPATH	hsa04152:AMPK signaling pathway		
T48069	KEGGPATH	hsa04510:Focal adhesion		
T48069	KEGGPATH	hsa04520:Adherens junction		
T48069	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T48069	KEGGPATH	hsa04730:Long-term depression		
T48069	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T48069	KEGGPATH	hsa04914:Progesterone-mediated oocyte maturation		
T48069	KEGGPATH	hsa05200:Pathways in cancer		
T48069	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T48069	KEGGPATH	hsa05205:Proteoglycans in cancer		
T48069	KEGGPATH	hsa05214:Glioma		
T48069	KEGGPATH	hsa05215:Prostate cancer		
T48069	KEGGPATH	hsa05218:Melanoma		
T48069	WIKIPATH	WP1544:MicroRNAs in cardiomyocyte hypertrophy		
T48069	WIKIPATH	WP2032:TSH signaling pathway		
T48069	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T48069	WIKIPATH	WP254:Apoptosis		
T48069	WIKIPATH	WP2677:Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)		
T48069	WIKIPATH	WP306:Focal Adhesion		
T48069	WIKIPATH	WP474:Endochondral Ossification		
T48069	WIKIPATH	WP481:Insulin Signaling		
T48069	WIKIPATH	WP615:Senescence and Autophagy in Cancer		
T48069	REACPATH	R-HSA-2428928:IRS-related events triggered by IGF1R		
T48069	REACPATH	R-HSA-2428933:SHC-related events triggered by IGF1R		
T48069	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T48069	INTEPATH	avb3_integrin_pathway:Integrins in angiogenesis		
T48069	INTEPATH	ecadherin_stabilization_pathway:Stabilization and expansion of the E-cadherin adherens junction		
T48069	INTEPATH	er_nongenomic_pathway:Plasma membrane estrogen receptor signaling		
T48069	INTEPATH	igf1_pathway:IGF1 pathway		
T48069	INTEPATH	shp2_pathway:SHP2 signaling		
T48069	PANTPATH	P00032:Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade		
T48069	PANTPATH	P00033:Insulin/IGF pathway-protein kinase B signaling cascade		
				
T25258	TARGETID	T25258		
T25258	FORMERID	TTDR00007		
T25258	UNIPROID	MDR1_HUMAN		
T25258	TARGNAME	Multidrug resistance protein 1 (ABCB1)		
T25258	GENENAME	ABCB1		
T25258	TARGTYPE	Successful target		
T25258	SYNONYMS	PGY1; P-glycoprotein 1; MDR1; CD243 antigen; CD243; ATP-binding cassette sub-family B member 1		
T25258	FUNCTION	Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.		
T25258	PDBSTRUC	6QEX; 6FN4; 6FN1; 6C0V		
T25258	BIOCLASS	ABC transporter		
T25258	ECNUMBER	EC 7.6.2.2		
T25258	SEQUENCE	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAIIHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSGIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVSKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFTDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIGAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARGAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSGQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLFATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAGFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRSSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAIINGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEAIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFGAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDSYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVVSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLDEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTKRQ		
T25258	DRUGINFO	D06XVF	CBT-1	Phase 3
T25258	DRUGINFO	D09LSY	EDP-322	Phase 1
T25258	DRUGINFO	D0GS2W	W-198	Phase 1
T25258	DRUGINFO	D06DCL	LY335979	Discontinued in Phase 3
T25258	DRUGINFO	D02VJY	Biricodar	Discontinued in Phase 2
T25258	DRUGINFO	D04RLX	Tariquidar	Discontinued in Phase 2
T25258	DRUGINFO	D09FGX	ELACRIDAR	Discontinued in Phase 1
T25258	DRUGINFO	D0SR4G	ONT-093	Discontinued in Phase 1
T25258	DRUGINFO	D03PLP	[1,1':2',1'']-terphenyl-4,3'',5''-triol	Investigative
T25258	DRUGINFO	D0AW4W	4,3'',5''-trimethoxy-[1,1':2',1'']-terphenyl	Investigative
T25258	DRUGINFO	D05XGZ	6-(3,5-dimethoxy-phenyl)-naphthalen-2-ol	Investigative
T25258	DRUGINFO	D0O9NE	TRISMETHOXYRESVERATROL	Investigative
T25258	DRUGINFO	D04GYT	XR-9456	Investigative
T25258	DRUGINFO	D09HIM	XR-9504	Investigative
T25258	DRUGINFO	D0A4TF	XR-9544	Investigative
T25258	DRUGINFO	D0S8CE	XR-9577	Investigative
T25258	KEGGPATH	hsa02010:ABC transporters		
T25258	KEGGPATH	hsa04976:Bile secretion		
T25258	KEGGPATH	hsa05206:MicroRNAs in cancer		
T25258	WIKIPATH	WP1604:Codeine and Morphine Metabolism		
T25258	WIKIPATH	WP2289:Drug Induction of Bile Acid Pathway		
T25258	WIKIPATH	WP2328:Allograft Rejection		
T25258	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T25258	WIKIPATH	WP2489:Multi Drug Resistance Protein 1 (Glycoprotein 1) Regulation		
T25258	WIKIPATH	WP2712:Abacavir transport and metabolism		
T25258	WIKIPATH	WP299:Nuclear Receptors in Lipid Metabolism and Toxicity		
T25258	REACPATH	R-HSA-382556:ABC-family proteins mediated transport		
T25258	NET_PATH	NetPath_11:TCR Signaling Pathway		
T25258	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T25258	INTEPATH	hif1_tfpathway:HIF-1-alpha transcription factor network		
				
T40474	TARGETID	T40474		
T40474	FORMERID	TTDC00110		
T40474	UNIPROID	MET_HUMAN		
T40474	TARGNAME	Proto-oncogene c-Met (MET)		
T40474	GENENAME	MET		
T40474	TARGTYPE	Successful target		
T40474	SYNONYMS	Tyrosine-protein kinase Met; Scatter factor receptor; SF receptor; Met proto-oncogene tyrosine kinase; Hepatocyte growth factor receptor; HGF/SF receptor; HGF-SF receptor; HGF receptor; C-met; C-Met receptor tyrosine kinase		
T40474	FUNCTION	Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis. Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand.		
T40474	PDBSTRUC	6I04; 6GCU; 5YA5; 5UAF; 5UAD		
T40474	BIOCLASS	Kinase		
T40474	ECNUMBER	EC 2.7.10.1		
T40474	SEQUENCE	MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECILTEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVDTRPASFWETS		
T40474	DRUGINFO	D0IQ6P	Cabozantinib	Approved
T40474	DRUGINFO	D07OJZ	Capmatinib	Approved
T40474	DRUGINFO	D03ZBT	Crizotinib	Approved
T40474	DRUGINFO	D0R8QG	Tepotinib	Approved
T40474	DRUGINFO	DQ5X1Z	Amivantamab	Phase 3
T40474	DRUGINFO	D0N1YF	Beperminogene perplasmid	Phase 3
T40474	DRUGINFO	D0H9PT	RG3638	Phase 3
T40474	DRUGINFO	D0LW0T	Savolitinib	Phase 3
T40474	DRUGINFO	D0ZI1F	Tivantinib	Phase 3
T40474	DRUGINFO	D05BLN	MGCD516	Phase 2/3
T40474	DRUGINFO	D0OK2N	AMG 208	Phase 2
T40474	DRUGINFO	D0G0BL	AMG 337	Phase 2
T40474	DRUGINFO	DV3Y7F	APL-101	Phase 2
T40474	DRUGINFO	D01TBJ	CMX-2043	Phase 2
T40474	DRUGINFO	D0FE7D	Emibetuzumab	Phase 2
T40474	DRUGINFO	D0R0YW	HM-5016504	Phase 2
T40474	DRUGINFO	D06EGV	LY2801653	Phase 2
T40474	DRUGINFO	D03SXS	LY-2875358	Phase 2
T40474	DRUGINFO	D07ARN	SAR-125844	Phase 2
T40474	DRUGINFO	D42TUS	Telisotuzumab vedotin	Phase 2
T40474	DRUGINFO	D0D1GF	XL880	Phase 2
T40474	DRUGINFO	D0A3OE	Anti-C-met CAR-T cells	Phase 1/2
T40474	DRUGINFO	D0O6WV	BMS-777607	Phase 1/2
T40474	DRUGINFO	D09ZNL	ChronSeal	Phase 1/2
T40474	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T40474	DRUGINFO	D0B4OK	Sym015	Phase 1/2
T40474	DRUGINFO	D02EOR	ABBV-399	Phase 1
T40474	DRUGINFO	D0I2IY	ABT-700	Phase 1
T40474	DRUGINFO	D0FA6S	Altiratinib	Phase 1
T40474	DRUGINFO	D0D1HI	Autologous T Cells Expressing MET scFv CAR	Phase 1
T40474	DRUGINFO	D95YSW	BPI-9016 M	Phase 1
T40474	DRUGINFO	D04XUJ	CBT-101	Phase 1
T40474	DRUGINFO	D03GTO	C-Met/PD-L1 CAR-T Cell	Phase 1
T40474	DRUGINFO	D09ETH	E-7050	Phase 1
T40474	DRUGINFO	D0Y8UV	EMD-1204831	Phase 1
T40474	DRUGINFO	D0N6VK	Hepapoietin	Phase 1
T40474	DRUGINFO	D0YT8P	JNJ-38877605	Phase 1
T40474	DRUGINFO	D01IJM	LY3164530	Phase 1
T40474	DRUGINFO	D05OMT	MK-8033	Phase 1
T40474	DRUGINFO	D01LCC	PF-4217903	Phase 1
T40474	DRUGINFO	D01FSX	REGN5093	Phase 1
T40474	DRUGINFO	D7HZ3T	RXDX-106	Phase 1
T40474	DRUGINFO	D0ZU5F	SGX523	Phase 1
T40474	DRUGINFO	D7M8LI	TPX-0022	Phase 1
T40474	DRUGINFO	DU6H8Z	TR1801-ADC	Phase 1
T40474	DRUGINFO	D1TNJ2	XL092	Phase 1
T40474	DRUGINFO	D0NO6E	Mteron-F1	Preclinical
T40474	DRUGINFO	D1AD6L	NPS-1034	Preclinical
T40474	DRUGINFO	D0S1II	1-(2-nitrophenethyl)-1H-pyrrolo[3,2-b]pyridine	Investigative
T40474	DRUGINFO	D0U4JW	1-(phenylsulfonyl)-1H-pyrrolo[3,2-b]pyridine	Investigative
T40474	DRUGINFO	D0N5XG	1-benzyl-1H-pyrrolo[3,2-b]pyridine	Investigative
T40474	DRUGINFO	D0S0GT	3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine	Investigative
T40474	DRUGINFO	D00FZA	ALD-805	Investigative
T40474	DRUGINFO	D0T1YH	ALD-806	Investigative
T40474	DRUGINFO	D07OXC	AM7	Investigative
T40474	DRUGINFO	D07CFW	Anti-cMET mab	Investigative
T40474	DRUGINFO	D03LZK	APS-3010	Investigative
T40474	DRUGINFO	D0NX6F	BAY-85-3474	Investigative
T40474	DRUGINFO	D0M4SY	BMS-536924	Investigative
T40474	DRUGINFO	D0I2PS	CMET Avimer polypeptides	Investigative
T40474	DRUGINFO	D0W8GP	DP-3590	Investigative
T40474	DRUGINFO	D0PS7U	GE-137	Investigative
T40474	DRUGINFO	D0Z4RX	HuMax-cMet	Investigative
T40474	DRUGINFO	D05GSI	LA-480	Investigative
T40474	DRUGINFO	D0AD6Z	mab 224G11	Investigative
T40474	DRUGINFO	D0G3ZN	PF-00614435	Investigative
T40474	DRUGINFO	D00TBD	PHA-665752	Investigative
T40474	DRUGINFO	D0RO9R	PMID21123062C27	Investigative
T40474	DRUGINFO	D00EMH	PMID21967808CR-16	Investigative
T40474	DRUGINFO	D04CUA	PMID24210504C1o	Investigative
T40474	DRUGINFO	D0M0SV	PRS-110	Investigative
T40474	DRUGINFO	D0N6QO	RP-1040	Investigative
T40474	DRUGINFO	D0E1QI	SU11274	Investigative
T40474	DRUGINFO	D0BS6B	TP-801	Investigative
T40474	KEGGPATH	hsa04014:Ras signaling pathway		
T40474	KEGGPATH	hsa04015:Rap1 signaling pathway		
T40474	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T40474	KEGGPATH	hsa04144:Endocytosis		
T40474	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T40474	KEGGPATH	hsa04360:Axon guidance		
T40474	KEGGPATH	hsa04510:Focal adhesion		
T40474	KEGGPATH	hsa04520:Adherens junction		
T40474	KEGGPATH	hsa05100:Bacterial invasion of epithelial cells		
T40474	KEGGPATH	hsa05120:Epithelial cell signaling in Helicobacter pylori infection		
T40474	KEGGPATH	hsa05144:Malaria		
T40474	KEGGPATH	hsa05200:Pathways in cancer		
T40474	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T40474	KEGGPATH	hsa05205:Proteoglycans in cancer		
T40474	KEGGPATH	hsa05206:MicroRNAs in cancer		
T40474	KEGGPATH	hsa05211:Renal cell carcinoma		
T40474	KEGGPATH	hsa05218:Melanoma		
T40474	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T40474	WIKIPATH	WP1907:Semaphorin interactions		
T40474	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T40474	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase		
T40474	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T40474	WIKIPATH	WP2006:miR-targeted genes in squamous cell - TarBase		
T40474	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T40474	WIKIPATH	WP2870:Extracellular vesicle-mediated signaling in recipient cells		
T40474	WIKIPATH	WP306:Focal Adhesion		
T40474	WIKIPATH	WP313:Signaling of Hepatocyte Growth Factor Receptor		
T40474	WIKIPATH	WP366:TGF beta Signaling Pathway		
T40474	REACPATH	R-HSA-416550:Sema4D mediated inhibition of cell attachment and migration		
T40474	INTEPATH	a6b1_a6b4_integrin_pathway:a6b1 and a6b4 Integrin signaling		
T40474	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T40474	INTEPATH	arf6_pathway:Arf6 signaling events		
T40474	INTEPATH	ecadherin_stabilization_pathway:Stabilization and expansion of the E-cadherin adherens junction		
T40474	INTEPATH	fgf_pathway:FGF signaling pathway		
T40474	INTEPATH	met_pathway:Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)		
T40474	INTEPATH	p53downstreampathway:Direct p53 effectors		
T40474	INTEPATH	rb_1pathway:Regulation of retinoblastoma protein		
T40474	INTEPATH	syndecan_1_pathway:Syndecan-1-mediated signaling events		
T40474	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
				
T43332	TARGETID	T43332		
T43332	FORMERID	TTDR00947		
T43332	UNIPROID	FA7_HUMAN		
T43332	TARGNAME	Coagulation factor VII (F7)		
T43332	GENENAME	F7		
T43332	TARGTYPE	Successful target		
T43332	SYNONYMS	Serum prothrombin conversion accelerator; SPCA; Proconvertin; Eptacog alfa		
T43332	FUNCTION	Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.		
T43332	PDBSTRUC	5U6J; 5TQG; 5TQF; 5TQE; 5PB6		
T43332	BIOCLASS	Peptidase		
T43332	ECNUMBER	EC 3.4.21.21		
T43332	SEQUENCE	MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEEQCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP		
T43332	DRUGINFO	D0C9IW	Factor viia	Approved
T43332	DRUGINFO	D09SHH	BAX-817	Phase 3
T43332	DRUGINFO	D00VMA	Vatreptacog alfa (activated)	Phase 3
T43332	DRUGINFO	D0C0CE	Activated recombinant FVII-albumin fusion protein	Phase 2/3
T43332	DRUGINFO	D0HZ2A	Recombinant factor VIIa PEGylated liposomal	Phase 1/2
T43332	DRUGINFO	D0R4YQ	CB-813	Phase 1
T43332	DRUGINFO	D05GPB	Eptacog alfa	Phase 1
T43332	DRUGINFO	D00EYC	F-7TG	Phase 1
T43332	DRUGINFO	D0J3YX	BAY 86-6150	Discontinued in Phase 2/3
T43332	DRUGINFO	D0K3LX	RNAPc2	Discontinued in Phase 2
T43332	DRUGINFO	D0CT8A	4-(3,4-Diethoxy-benzylamino)-benzamidine	Investigative
T43332	DRUGINFO	D02XPB	4-(4-Benzyloxy-3-methoxy-benzylamino)-benzamidine	Investigative
T43332	DRUGINFO	D01NCC	Factor-VIIa-XTEN	Investigative
T43332	DRUGINFO	D0G6XS	Fucose	Investigative
T43332	DRUGINFO	D02PKV	Human recombinant factor VIIa	Investigative
T43332	DRUGINFO	D0R9UQ	Long-acting Factor VII conjugate	Investigative
T43332	DRUGINFO	D0O9RV	MOD-5023	Investigative
T43332	KEGGPATH	hsa04610:Complement and coagulation cascades		
T43332	WIKIPATH	WP15:Selenium Micronutrient Network		
T43332	WIKIPATH	WP1533:Vitamin B12 Metabolism		
T43332	WIKIPATH	WP176:Folate Metabolism		
T43332	WIKIPATH	WP1797:Circadian Clock		
T43332	WIKIPATH	WP1818:Formation of Fibrin Clot (Clotting Cascade)		
T43332	WIKIPATH	WP272:Blood Clotting Cascade		
T43332	WIKIPATH	WP2762:PTM: gamma carboxylation, hypusine formation and arylsulfatase activation		
T43332	WIKIPATH	WP558:Complement and Coagulation Cascades		
T43332	WHIZPATH	PW000562:Coagulation		
T43332	REACPATH	R-HSA-1368108:BMAL1:CLOCK,NPAS2 activates circadian gene expression		
T43332	REACPATH	R-HSA-140834:Extrinsic Pathway of Fibrin Clot Formation		
T43332	REACPATH	R-HSA-159740:Gamma-carboxylation of protein precursors		
T43332	REACPATH	R-HSA-159763:Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus		
T43332	REACPATH	R-HSA-159782:Removal of aminoterminal propeptides from gamma-carboxylated proteins		
T43332	PANTPATH	P00005:Angiogenesis		
T43332	PANTPATH	P00011:Blood coagulation		
				
T33489	TARGETID	T33489		
T33489	FORMERID	TTDC00149		
T33489	UNIPROID	STS_HUMAN		
T33489	TARGNAME	Steryl-sulfatase (STS)		
T33489	GENENAME	STS		
T33489	TARGTYPE	Successful target		
T33489	SYNONYMS	Steryl-sulfate sulfohydrolase; Steroid sulfatase; STS; Estrone sulfatase; Arylsulfatase C; ASC		
T33489	FUNCTION	Conversion of sulfated steroid precursors to estrogens during pregnancy.		
T33489	PDBSTRUC	1P49		
T33489	BIOCLASS	Sulfuric ester hydrolase		
T33489	ECNUMBER	EC 3.1.6.2		
T33489	SEQUENCE	MPLRKMKIPFLLLFFLWEAESHAASRPNIILVMADDLGIGDPGCYGNKTIRTPNIDRLASGGVKLTQHLAASPLCTPSRAAFMTGRYPVRSGMASWSRTGVFLFTASSGGLPTDEITFAKLLKDQGYSTALIGKWHLGMSCHSKTDFCHHPLHHGFNYFYGISLTNLRDCKPGEGSVFTTGFKRLVFLPLQIVGVTLLTLAALNCLGLLHVPLGVFFSLLFLAALILTLFLGFLHYFRPLNCFMMRNYEIIQQPMSYDNLTQRLTVEAAQFIQRNTETPFLLVLSYLHVHTALFSSKDFAGKSQHGVYGDAVEEMDWSVGQILNLLDELRLANDTLIYFTSDQGAHVEEVSSKGEIHGGSNGIYKGGKANNWEGGIRVPGILRWPRVIQAGQKIDEPTSNMDIFPTVAKLAGAPLPEDRIIDGRDLMPLLEGKSQRSDHEFLFHYCNAYLNAVRWHPQNSTSIWKAFFFTPNFNPVGSNGCFATHVCFCFGSYVTHHDPPLLFDISKDPRERNPLTPASEPRFYEILKVMQEAADRHTQTLPEVPDQFSWNNFLWKPWLQLCCPSTGLSCQCDREKQDKRLSR		
T33489	DRUGINFO	D0E6OC	Tranilast	Approved
T33489	DRUGINFO	D0Y6OA	Coumate	Phase 2
T33489	DRUGINFO	D0I3RN	PGL-2	Phase 2
T33489	DRUGINFO	D04ZND	PGL-2001	Phase 2
T33489	DRUGINFO	D07ZNI	STX-140	Phase 2
T33489	DRUGINFO	D05NJI	STX 64	Phase 1
T33489	DRUGINFO	D08BTV	2-(4-cyclohexylthiosemicarbazono)methyl-phenol	Investigative
T33489	DRUGINFO	D0I4LL	2',4'-dicyanobiphenyl-4-yl sulfamate	Investigative
T33489	DRUGINFO	D03XJE	2-Adamantan-2-ylidenemethyl-benzooxazol-6-ol	Investigative
T33489	DRUGINFO	D07GRM	2-Amino-3-Oxo-4-Sulfo-Butyric Acid	Investigative
T33489	DRUGINFO	D0N8VZ	2-ethylestradiol 3,17-O,O-bis-sulfamate	Investigative
T33489	DRUGINFO	D0FH1V	2-methylsulfanylestradiol 3,17-O,O-bis-sulfamate	Investigative
T33489	DRUGINFO	D06IMK	3-(4-cyclohexylthiosemicarbazono)methyl-phenol	Investigative
T33489	DRUGINFO	D0Y9SI	3-(4-hexylthiosemicarbazono)methyl-benzoic acid	Investigative
T33489	DRUGINFO	D04HNO	3-{3-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Investigative
T33489	DRUGINFO	D04YVS	3-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Investigative
T33489	DRUGINFO	D09BUM	4-(4-cyclohexylthiosemicarbazono)methyl-phenol	Investigative
T33489	DRUGINFO	D0AL2D	4-{4-[(aminosulfonyl)oxy]benzoyl}phenyl sulfamate	Investigative
T33489	DRUGINFO	D0P6IO	4-Sulfamoyloxy-benzoic acid butyl ester	Investigative
T33489	DRUGINFO	D05TRN	4-Sulfamoyloxy-benzoic acid cycloheptyl ester	Investigative
T33489	DRUGINFO	D0P9ZV	4-Sulfamoyloxy-benzoic acid cyclohexyl ester	Investigative
T33489	DRUGINFO	D0T5OD	4-Sulfamoyloxy-benzoic acid cyclooctyl ester	Investigative
T33489	DRUGINFO	D0U7PV	4-Sulfamoyloxy-benzoic acid cyclopentyl ester	Investigative
T33489	DRUGINFO	D06YDQ	4-Sulfamoyloxy-benzoic acid heptyl ester	Investigative
T33489	DRUGINFO	D0D1CV	4-Sulfamoyloxy-benzoic acid hexyl ester	Investigative
T33489	DRUGINFO	D06SMY	4-Sulfamoyloxy-benzoic acid nonyl ester	Investigative
T33489	DRUGINFO	D03NUT	4-Sulfamoyloxy-benzoic acid octyl ester	Investigative
T33489	DRUGINFO	D00OZS	4-Sulfamoyloxy-benzoic acid pentyl ester	Investigative
T33489	DRUGINFO	D01ACT	4-Sulfamoyloxy-benzoic acid propyl ester	Investigative
T33489	DRUGINFO	D0W6GB	Benzomate	Investigative
T33489	DRUGINFO	D02UVH	B-Octylglucoside	Investigative
T33489	DRUGINFO	D0R7QY	EMATE	Investigative
T33489	DRUGINFO	D00LFX	Estradiol 17-O-sulfamate	Investigative
T33489	DRUGINFO	D0S3RZ	Estradiol 3,17-O,O-bis-sulfamate	Investigative
T33489	DRUGINFO	D0G1XC	MHL cyclohexylthiosemicarbazone	Investigative
T33489	DRUGINFO	D09ROV	Nortropinyl-arylsulfonylurea 3	Investigative
T33489	DRUGINFO	D00AON	Sulfamic acid 2-nonyl-4-oxo-4H-chromen-6-yl ester	Investigative
T33489	DRUGINFO	D06DVJ	Sulfamic acid 3-(3-hydroxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D02RJA	Sulfamic acid 3-(3-methoxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D0S5BA	Sulfamic acid 3-(4-hydroxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D05KKB	Sulfamic acid 3-(4-methoxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D0G8HD	Sulfamic acid 3-benzoyl-phenyl ester	Investigative
T33489	DRUGINFO	D0M2WG	Sulfamic acid 4-(2-hydroxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D0B1JM	Sulfamic acid 4-(2-methoxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D06ADL	Sulfamic acid 4-(3-methoxy-benzoyl)-phenyl ester	Investigative
T33489	DRUGINFO	D0B2XN	Sulfamic acid 4-benzoyl-phenyl ester	Investigative
T33489	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T33489	WIKIPATH	WP2788:Sphingolipid metabolism		
T33489	WIKIPATH	WP2877:Vitamin D Receptor Pathway		
T33489	WIKIPATH	WP697:Estrogen metabolism		
T33489	WHIZPATH	PW000045:Androgen and Estrogen Metabolism		
T33489	REACPATH	R-HSA-1660662:Glycosphingolipid metabolism		
				
T69128	TARGETID	T69128		
T69128	FORMERID	TTDNS00597		
T69128	UNIPROID	ROS1_HUMAN		
T69128	TARGNAME	Proto-oncogene c-Ros (ROS1)		
T69128	GENENAME	ROS1		
T69128	TARGTYPE	Successful target		
T69128	SYNONYMS	c-Ros receptor tyrosine kinase; Receptor tyrosine kinase c-ros oncogene 1; ROS; Proto-oncogene tyrosine-protein kinase ROS; Proto-oncogene c-Ros-1; MCF3		
T69128	FUNCTION	Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2.		
T69128	PDBSTRUC	4UXL; 3ZBF		
T69128	BIOCLASS	Kinase		
T69128	ECNUMBER	EC 2.7.10.1		
T69128	SEQUENCE	MKNIYCLIPKLVNFATLGCLWISVVQCTVLNSCLKSCVTNLGQQLDLGTPHNLSEPCIQGCHFWNSVDQKNCALKCRESCEVGCSSAEGAYEEEVLENADLPTAPFASSIGSHNMTLRWKSANFSGVKYIIQWKYAQLLGSWTYTKTVSRPSYVVKPLHPFTEYIFRVVWIFTAQLQLYSPPSPSYRTHPHGVPETAPLIRNIESSSPDTVEVSWDPPQFPGGPILGYNLRLISKNQKLDAGTQRTSFQFYSTLPNTIYRFSIAAVNEVGEGPEAESSITTSSSAVQQEEQWLFLSRKTSLRKRSLKHLVDEAHCLRLDAIYHNITGISVDVHQQIVYFSEGTLIWAKKAANMSDVSDLRIFYRGSGLISSISIDWLYQRMYFIMDELVCVCDLENCSNIEEITPPSISAPQKIVADSYNGYVFYLLRDGIYRADLPVPSGRCAEAVRIVESCTLKDFAIKPQAKRIIYFNDTAQVFMSTFLDGSASHLILPRIPFADVKSFACENNDFLVTDGKVIFQQDALSFNEFIVGCDLSHIEEFGFGNLVIFGSSSQLHPLPGRPQELSVLFGSHQALVQWKPPALAIGANVILISDIIELFELGPSAWQNWTYEVKVSTQDPPEVTHIFLNISGTMLNVPELQSAMKYKVSVRASSPKRPGPWSEPSVGTTLVPASEPPFIMAVKEDGLWSKPLNSFGPGEFLSSDIGNVSDMDWYNNSLYYSDTKGDVFVWLLNGTDISENYHLPSIAGAGALAFEWLGHFLYWAGKTYVIQRQSVLTGHTDIVTHVKLLVNDMVVDSVGGYLYWTTLYSVESTRLNGESSLVLQTQPWFSGKKVIALTLDLSDGLLYWLVQDSQCIHLYTAVLRGQSTGDTTITEFAAWSTSEISQNALMYYSGRLFWINGFRIITTQEIGQKTSVSVLEPARFNQFTIIQTSLKPLPGNFSFTPKVIPDSVQESSFRIEGNASSFQILWNGPPAVDWGVVFYSVEFSAHSKFLASEQHSLPVFTVEGLEPYALFNLSVTPYTYWGKGPKTSLSLRAPETVPSAPENPRIFILPSGKCCNKNEVVVEFRWNKPKHENGVLTKFEIFYNISNQSITNKTCEDWIAVNVTPSVMSFQLEGMSPRCFIAFQVRAFTSKGPGPYADVVKSTTSEINPFPHLITLLGNKIVFLDMDQNQVVWTFSAERVISAVCYTADNEMGYYAEGDSLFLLHLHNRSSSELFQDSLVFDITVITIDWISRHLYFALKESQNGMQVFDVDLEHKVKYPREVKIHNRNSTIISFSVYPLLSRLYWTEVSNFGYQMFYYSIISHTLHRILQPTATNQQNKRNQCSCNVTEFELSGAMAIDTSNLEKPLIYFAKAQEIWAMDLEGCQCWRVITVPAMLAGKTLVSLTVDGDLIYWIITAKDSTQIYQAKKGNGAIVSQVKALRSRHILAYSSVMQPFPDKAFLSLASDTVEPTILNATNTSLTIRLPLAKTNLTWYGITSPTPTYLVYYAEVNDRKNSSDLKYRILEFQDSIALIEDLQPFSTYMIQIAVKNYYSDPLEHLPPGKEIWGKTKNGVPEAVQLINTTVRSDTSLIISWRESHKPNGPKESVRYQLAISHLALIPETPLRQSEFPNGRLTLLVTRLSGGNIYVLKVLACHSEEMWCTESHPVTVEMFNTPEKPYSLVPENTSLQFNWKAPLNVNLIRFWVELQKWKYNEFYHVKTSCSQGPAYVCNITNLQPYTSYNVRVVVVYKTGENSTSLPESFKTKAGVPNKPGIPKLLEGSKNSIQWEKAEDNGCRITYYILEIRKSTSNNLQNQNLRWKMTFNGSCSSVCTWKSKNLKGIFQFRVVAANNLGFGEYSGISENIILVGDDFWIPETSFILTIIVGIFLVVTIPLTFVWHRRLKNQKSAKEGVTVLINEDKELAELRGLAAGVGLANACYAIHTLPTQEEIENLPAFPREKLTLRLLLGSGAFGEVYEGTAVDILGVGSGEIKVAVKTLKKGSTDQEKIEFLKEAHLMSKFNHPNILKQLGVCLLNEPQYIILELMEGGDLLTYLRKARMATFYGPLLTLVDLVDLCVDISKGCVYLERMHFIHRDLAARNCLVSVKDYTSPRIVKIGDFGLARDIYKNDYYRKRGEGLLPVRWMAPESLMDGIFTTQSDVWSFGILIWEILTLGHQPYPAHSNLDVLNYVQTGGRLEPPRNCPDDLWNLMTQCWAQEPDQRPTFHRIQDQLQLFRNFFLNSIYKSRDEANNSGVINESFEGEDGDVICLNSDDIMPVALMETKNREGLNYMVLATECGQGEEKSEGPLGSQESESCGLRKEEKEPHADKDFCQEKQVAYCPSGKPEGLNYACLTHSGYGDGSD		
T69128	DRUGINFO	D03ZBT	Crizotinib	Approved
T69128	DRUGINFO	D0O0LS	Entrectinib	Approved
T69128	DRUGINFO	D0AF6O	Lorlatinib	Approved
T69128	DRUGINFO	D2KV8B	AB-106	Phase 2
T69128	DRUGINFO	D05NFR	TPX-0005	Phase 1/2
T69128	DRUGINFO	D0N0DU	DS-6051	Phase 1
T69128	DRUGINFO	D0MX7B	Carboxamide derivative 4	Patented
T69128	DRUGINFO	D0T8XD	Imidazo[1,2-b]pyridazine derivative 1	Patented
T69128	DRUGINFO	D0M8UO	Imidazo[1,2-b]pyridazine derivative 2	Patented
T69128	DRUGINFO	D0N1CF	Imidazo[1,2-b]pyridazine derivative 3	Patented
T69128	DRUGINFO	D0N8YJ	PMID28270010-Compound-Figure21-b	Patented
T69128	DRUGINFO	D0K5UF	PMID24432909C8e	Investigative
T69128	WIKIPATH	WP2431:Spinal Cord Injury		
				
T73475	TARGETID	T73475		
T73475	FORMERID	TTDR00029		
T73475	UNIPROID	MMP7_HUMAN		
T73475	TARGNAME	Matrix metalloproteinase-7 (MMP-7)		
T73475	GENENAME	MMP7		
T73475	TARGTYPE	Successful target		
T73475	SYNONYMS	Uterine metalloproteinase; Pump-1 protease; PUMP1; Matrin; Matrilysin; MPSL1		
T73475	FUNCTION	Activates procollagenase. Degrades casein, gelatins of types I, III, IV, and V, and fibronectin.		
T73475	PDBSTRUC	5UE5; 5UE2; 2Y6D; 2Y6C; 2MZI		
T73475	BIOCLASS	Peptidase		
T73475	ECNUMBER	EC 3.4.24.23		
T73475	SEQUENCE	MRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK		
T73475	DRUGINFO	D00MDP	Prinomastat	Approved
T73475	DRUGINFO	D05VZE	Marimastat	Phase 3
T73475	DRUGINFO	D01EUF	BMS 275291	Discontinued in Phase 3
T73475	DRUGINFO	D08WBF	BB-3644	Terminated
T73475	DRUGINFO	D0Y1XT	SC-44463	Terminated
T73475	DRUGINFO	D08ELY	3-Benzenesulfonyl-heptanoic acid hydroxyamide	Investigative
T73475	DRUGINFO	D0N6CD	3-Cyclohexanesulfonyl-heptanoic acid hydroxyamide	Investigative
T73475	DRUGINFO	D0P8EY	Folate gamma-hydroxamic acid	Investigative
T73475	DRUGINFO	D06HSC	Folate gamma-L-phenylalaninehydroxamic acid	Investigative
T73475	DRUGINFO	D0ZB6O	Folate gamma-L-proline-hydroxamic acid	Investigative
T73475	DRUGINFO	D0W2UK	IK-862	Investigative
T73475	DRUGINFO	D0A4TC	MMI270	Investigative
T73475	DRUGINFO	D07SPC	N-hydroxy-2,3-bis(phenylsulfonamido)propanamide	Investigative
T73475	DRUGINFO	D0BI8T	RS-39066	Investigative
T73475	DRUGINFO	D07GEL	SL422	Investigative
T73475	DRUGINFO	D03AMR	SR-973	Investigative
T73475	KEGGPATH	hsa04310:Wnt signaling pathway		
T73475	WIKIPATH	WP129:Matrix Metalloproteinases		
T73475	WIKIPATH	WP2324:AGE/RAGE pathway		
T73475	WIKIPATH	WP2769:Activation of Matrix Metalloproteinases		
T73475	WIKIPATH	WP399:Wnt Signaling Pathway and Pluripotency		
T73475	REACPATH	R-HSA-1442490:Collagen degradation		
T73475	REACPATH	R-HSA-1474228:Degradation of the extracellular matrix		
T73475	REACPATH	R-HSA-1592389:Activation of Matrix Metalloproteinases		
T73475	REACPATH	R-HSA-2022090:Assembly of collagen fibrils and other multimeric structures		
T73475	NET_PATH	NetPath_8:Wnt Signaling Pathway		
T73475	INTEPATH	ajdiss_2pathway:Posttranslational regulation of adherens junction stability and dissassembly		
T73475	INTEPATH	p75ntrpathway:p75(NTR)-mediated signaling		
T73475	INTEPATH	syndecan_1_pathway:Syndecan-1-mediated signaling events		
T73475	PANTPATH	P00004:Alzheimer disease-presenilin pathway		
T73475	PANTPATH	P00057:Wnt signaling pathway		
T73475	PANTPATH	P06959:CCKR signaling map ST		
				
T59102	TARGETID	T59102		
T59102	FORMERID	TTDR01217		
T59102	UNIPROID	PGFRB_HUMAN		
T59102	TARGNAME	Platelet-derived growth factor receptor beta (PDGFRB)		
T59102	GENENAME	PDGFRB		
T59102	TARGTYPE	Successful target		
T59102	SYNONYMS	Platelet-derived growth factor receptor 1; PDGFR1; PDGFR-beta; PDGFR-1; PDGFR; PDGF-R-beta; CD140b antigen; CD140b; CD140 antigen-like family member B; Beta-type platelet-derived growth factor receptor; Beta-PDGFR; Beta platelet-derived growth factor receptor		
T59102	FUNCTION	Plays an essential role in blood vessel development by promoting proliferation, migration and recruitment of pericytes and smooth muscle cells to endothelial cells. Plays a role in the migration of vascular smooth muscle cells and the formation of neointima at vascular injury sites. Required for normal development of the cardiovascular system. Required for normal recruitment of pericytes (mesangial cells) in the kidney glomerulus, and for normal formation of a branched network of capillaries in kidney glomeruli. Promotes rearrangement of the actin cytoskeleton and the formation of membrane ruffles. Binding of its cognate ligands - homodimeric PDGFB, heterodimers formed by PDGFA and PDGFB or homodimeric PDGFD -leads to the activation of several signaling cascades; the response depends on the nature of the bound ligand and is modulated by the formation of heterodimers between PDGFRA and PDGFRB. Phosphorylates PLCG1, PIK3R1, PTPN11, RASA1/GAP, CBL, SHC1 and NCK1. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate, mobilization of cytosolic Ca(2+) and the activation of protein kinase C. Phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, leads to the activation of the AKT1 signaling pathway. Phosphorylation of SHC1, or of the C-terminus of PTPN11, creates a binding site for GRB2, resulting in the activation of HRAS, RAF1 and down-stream MAP kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation and activation of SRC family kinases. Promotes phosphorylation of PDCD6IP/ALIX and STAM. Receptor signaling is down-regulated by protein phosphatases that dephosphorylate the receptor and its down-stream effectors, and by rapid internalization of the activated receptor. Tyrosine-protein kinase that acts as cell-surface receptor for homodimeric PDGFB and PDGFD and for heterodimers formed by PDGFA and PDGFB, and plays an essential role in the regulation of embryonic development, cell proliferation, survival, differentiation, chemotaxis and migration.		
T59102	PDBSTRUC	3MJG; 2PLE; 2PLD; 2L6W; 2IUI		
T59102	BIOCLASS	Kinase		
T59102	ECNUMBER	EC 2.7.10.1		
T59102	SEQUENCE	MRLPGAMPALALKGELLLLSLLLLLEPQISQGLVVTPPGPELVLNVSSTFVLTCSGSAPVVWERMSQEPPQEMAKAQDGTFSSVLTLTNLTGLDTGEYFCTHNDSRGLETDERKRLYIFVPDPTVGFLPNDAEELFIFLTEITEITIPCRVTDPQLVVTLHEKKGDVALPVPYDHQRGFSGIFEDRSYICKTTIGDREVDSDAYYVYRLQVSSINVSVNAVQTVVRQGENITLMCIVIGNEVVNFEWTYPRKESGRLVEPVTDFLLDMPYHIRSILHIPSAELEDSGTYTCNVTESVNDHQDEKAINITVVESGYVRLLGEVGTLQFAELHRSRTLQVVFEAYPPPTVLWFKDNRTLGDSSAGEIALSTRNVSETRYVSELTLVRVKVAEAGHYTMRAFHEDAEVQLSFQLQINVPVRVLELSESHPDSGEQTVRCRGRGMPQPNIIWSACRDLKRCPRELPPTLLGNSSEEESQLETNVTYWEEEQEFEVVSTLRLQHVDRPLSVRCTLRNAVGQDTQEVIVVPHSLPFKVVVISAILALVVLTIISLIILIMLWQKKPRYEIRWKVIESVSSDGHEYIYVDPMQLPYDSTWELPRDQLVLGRTLGSGAFGQVVEATAHGLSHSQATMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNVVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQHHSDKRRPPSAELYSNALPVGLPLPSHVSLTGESDGGYMDMSKDESVDYVPMLDMKGDVKYADIESSNYMAPYDNYVPSAPERTCRATLINESPVLSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNSLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAQPAHASDEIYEIMQKCWEEKFEIRPPFSQLVLLLERLLGEGYKKKYQQVDEEFLRSDHPAILRSQARLPGFHGLRSPLDTSSVLYTAVQPNEGDNDYIIPLPDPKPEVADEGPLEGSPSLASSTLNEVNTSSTISCDSPLEPQDEPEPEPQLELQVEPEPELEQLPDSGCPAPRAEAEDSFL		
T59102	DRUGINFO	D0T5QT	Becaplermin	Approved
T59102	DRUGINFO	D01PZD	Romiplostim	Approved
T59102	DRUGINFO	D0W5HK	Sorafenib	Approved
T59102	DRUGINFO	D02WVT	E-3810	Phase 3
T59102	DRUGINFO	D0Z6MT	Famitinib	Phase 2
T59102	DRUGINFO	D00NSD	XL-820	Phase 2
T59102	DRUGINFO	D00DRL	MK-2461	Phase 1/2
T59102	DRUGINFO	D0GB2L	SNN-0031	Phase 1/2
T59102	DRUGINFO	D0T2ER	TAK-593	Phase 1
T59102	DRUGINFO	D0D3FB	PMID25656651-Compound-21a	Patented
T59102	DRUGINFO	D0XQ5F	PMID25656651-Compound-21b	Patented
T59102	DRUGINFO	D0YX2B	PMID28460551-Compound-2	Patented
T59102	DRUGINFO	D0AK1F	Pyridine derivative 18	Patented
T59102	DRUGINFO	D08PAV	CDP-860	Discontinued in Phase 2
T59102	DRUGINFO	D00QCB	SRI-62-834	Discontinued in Phase 2
T59102	DRUGINFO	D0KX1E	CEP-2563	Discontinued in Phase 1
T59102	DRUGINFO	D06GBK	AG1295	Terminated
T59102	DRUGINFO	D03WTT	RG-13022	Terminated
T59102	DRUGINFO	D09OLH	(1H-indol-2-yl)(5-methoxy-1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D0G0KQ	(1H-indol-2-yl)(5-phenoxy-1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D0D7ZL	(1H-indol-2-yl)(6-methoxy-1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D05WTI	(2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine	Investigative
T59102	DRUGINFO	D0H7MF	(5-fluoro-1H-indol-2-yl)-(1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D0XS9E	(5-hydroxy-1H-indol-2-yl)(1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D0I7QX	(benzo[b]furan-2-yl)-(1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D00YCU	1-Phenyl-1H-benzoimidazol-5-ol	Investigative
T59102	DRUGINFO	D01FWD	1-Phenyl-1H-benzoimidazole	Investigative
T59102	DRUGINFO	D0XC6G	2-(1H-indazol-3-yl)-1H-benzo[d]imidazole	Investigative
T59102	DRUGINFO	D07JDY	3-((E)-Styryl)-quinoline	Investigative
T59102	DRUGINFO	D06MCJ	3-(1H-Indol-3-yl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0GN3E	3-(1H-Indol-3-yl)-quinoline	Investigative
T59102	DRUGINFO	D0K9ON	3-(2-Cyclohexyl-ethyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0P0RD	3-(3,4-Dichloro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0AO6T	3-(3,4-Difluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D08SUH	3-(3,4-Dimethoxy-phenyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0A6YP	3-(3-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D00QPG	3-(4-dimethylamino-benzylidenyl)-2-indolinone	Investigative
T59102	DRUGINFO	D0I0GL	3-(4-Fluoro-phenyl)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0K3CJ	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenol	Investigative
T59102	DRUGINFO	D02QBH	3-(6,7-Dimethoxy-quinolin-4-yloxy)-phenylamine	Investigative
T59102	DRUGINFO	D07QMC	3-Benzimidazol-2-ylhydroquinolin-2-one	Investigative
T59102	DRUGINFO	D06VNR	3-Benzyloxy-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D08KWL	3-Cyclohexylethynyl-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0KF3N	3-Cyclopent-1-enyl-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D00LRC	3-Cyclopentyl-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0IR5I	3-Pyridin-3-yl-quinoline-6,7-diol	Investigative
T59102	DRUGINFO	D0H9TO	3-Pyridin-4-yl-quinolin-7-ol	Investigative
T59102	DRUGINFO	D0Q3DS	3-Pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0K9VE	3-Pyridin-4-yl-quinoline-5,7-diol	Investigative
T59102	DRUGINFO	D05GBY	3-Thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D0F1RU	4-(2,3-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0YE1X	4-(3,4-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0C2KK	4-(3,5-Dimethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D03HLH	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinazoline	Investigative
T59102	DRUGINFO	D05QMN	4-(3-Bromo-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0Y1CJ	4-(3-Ethoxy-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D03FCU	4-(3-Ethyl-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D03IPZ	4-(3-Fluoro-phenoxy)-6,7-dimethoxy-quinoline	Investigative
T59102	DRUGINFO	D0K2YG	4-(5-Methoxy-benzoimidazol-1-yl)-phenylamine	Investigative
T59102	DRUGINFO	D03MQI	4-(6,7-Dimethoxy-quinolin-3-yl)-benzoic acid	Investigative
T59102	DRUGINFO	D0H4JB	4-(6,7-Dimethoxy-quinolin-3-yl)-phenol	Investigative
T59102	DRUGINFO	D01MUN	4-Benzoimidazol-1-yl-phenylamine	Investigative
T59102	DRUGINFO	D01UYS	5-(6,7-Dimethoxy-quinolin-3-yl)-1H-pyridin-2-one	Investigative
T59102	DRUGINFO	D0SG0G	5,6,7-Trimethoxy-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0P0WT	5,7-Dimethoxy-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0RD5S	5,7-Dimethoxy-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D07ZWN	5,7-Dimethyl-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D02XKJ	5-Methoxy-1-phenyl-1H-benzoimidazole	Investigative
T59102	DRUGINFO	D0CF9B	6,7-Dichloro-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D0QT4X	6,7-Difluoro-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D06LLF	6,7-Dimethoxy-3-((E)-styryl)-quinoline	Investigative
T59102	DRUGINFO	D07CFT	6,7-Dimethoxy-3-(3-methoxy-phenyl)-quinoline	Investigative
T59102	DRUGINFO	D0G0KN	6,7-Dimethoxy-3-(4-methoxy-phenyl)-quinoline	Investigative
T59102	DRUGINFO	D08JGS	6,7-Dimethoxy-3-(4-nitro-phenyl)-quinoline	Investigative
T59102	DRUGINFO	D0WW8M	6,7-Dimethoxy-3-phenylethynyl-quinoline	Investigative
T59102	DRUGINFO	D0G6SA	6,7-Dimethoxy-3-phenyl-quinoline	Investigative
T59102	DRUGINFO	D0C1BE	6,7-Dimethoxy-3-p-tolyl-quinoline	Investigative
T59102	DRUGINFO	D00RBV	6,7-Dimethoxy-3-pyridin-3-yl-quinoline	Investigative
T59102	DRUGINFO	D0T9FQ	6,7-Dimethoxy-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0G0ZQ	6,7-Dimethoxy-3-thiophen-2-yl-quinoline	Investigative
T59102	DRUGINFO	D01XDV	6,7-Dimethoxy-4-(2-methoxy-phenoxy)-quinoline	Investigative
T59102	DRUGINFO	D09QTC	6,7-Dimethoxy-4-(3-methoxy-phenoxy)-quinoline	Investigative
T59102	DRUGINFO	D0ZS3F	6,7-Dimethoxy-4-(3-nitro-phenoxy)-quinoline	Investigative
T59102	DRUGINFO	D0R8BC	6,7-Dimethoxy-4-(4-methoxy-phenoxy)-quinoline	Investigative
T59102	DRUGINFO	D0VJ5W	6,7-Dimethoxy-4-m-tolyloxy-quinoline	Investigative
T59102	DRUGINFO	D0CW1Q	6,7-Dimethoxy-4-phenoxy-quinoline	Investigative
T59102	DRUGINFO	D04PQX	6-Methoxy-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0W7IN	6-Methoxy-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D0Z4HV	7-Chloro-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D05SNG	7-Fluoro-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D02PZZ	7-Methoxy-3-pyridin-4-yl-quinoline	Investigative
T59102	DRUGINFO	D0V8QI	7-Methoxy-3-thiophen-3-yl-quinoline	Investigative
T59102	DRUGINFO	D0A6AA	7-Thiophen-3-yl-[1,3]dioxolo[4,5-g]quinoline	Investigative
T59102	DRUGINFO	D0U3WQ	AGL 2043	Investigative
T59102	DRUGINFO	D02CUF	Benzyl-(6,7-dimethoxy-quinolin-3-yl)-amine	Investigative
T59102	DRUGINFO	D0L0MZ	Bis(5-acetoxybenzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D07AXL	Bis(5-aminobenzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D0I3XZ	Bis-(5-hydroxy-1H-indol-2-yl)-methanone	Investigative
T59102	DRUGINFO	D02OBA	Bis(5-hydroxybenzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D09PUW	Bis(5-methoxybenzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D03VAA	Bis(6-hydroxybenzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D0Z3DW	Bis(benzo[b]furan-2-yl)methanone	Investigative
T59102	DRUGINFO	D0M4SY	BMS-536924	Investigative
T59102	DRUGINFO	D05QBZ	CP-673451	Investigative
T59102	DRUGINFO	D0G5YI	Di(1H-indol-2-yl)methanone	Investigative
T59102	DRUGINFO	D0UN9O	GTP-14564	Investigative
T59102	DRUGINFO	D0D5EW	HKI-9924129	Investigative
T59102	DRUGINFO	D0YZ7H	JNJ-10198409	Investigative
T59102	DRUGINFO	D06ZUA	Ki-11502	Investigative
T59102	DRUGINFO	D08BJR	Ki-20227	Investigative
T59102	DRUGINFO	D0P3JW	PD-0166326	Investigative
T59102	DRUGINFO	D0S1KJ	PD-0173952	Investigative
T59102	DRUGINFO	D03NPX	PD-0173955	Investigative
T59102	DRUGINFO	D0GW4Q	PD-0173956	Investigative
T59102	DRUGINFO	D0Z7GH	PD-0173958	Investigative
T59102	DRUGINFO	D0OH3J	PD-0179483	Investigative
T59102	DRUGINFO	D0BW4G	PDGF receptor tyrosine kinase inhibitor III	Investigative
T59102	DRUGINFO	D0C2GE	PMID22765894C8h	Investigative
T59102	DRUGINFO	D09XIL	Ro-4396686	Investigative
T59102	DRUGINFO	D0W9BF	RPR-101511	Investigative
T59102	DRUGINFO	D0FH3M	RPR-108514A	Investigative
T59102	DRUGINFO	D09LPL	SU-11652	Investigative
T59102	DRUGINFO	D0H1OK	TG-100435	Investigative
T59102	DRUGINFO	D00YNJ	XB-387	Investigative
T59102	KEGGPATH	hsa04010:MAPK signaling pathway		
T59102	KEGGPATH	hsa04014:Ras signaling pathway		
T59102	KEGGPATH	hsa04015:Rap1 signaling pathway		
T59102	KEGGPATH	hsa04020:Calcium signaling pathway		
T59102	KEGGPATH	hsa04060:Cytokine-cytokine receptor interaction		
T59102	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T59102	KEGGPATH	hsa04510:Focal adhesion		
T59102	KEGGPATH	hsa04540:Gap junction		
T59102	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T59102	KEGGPATH	hsa05166:HTLV-I infection		
T59102	KEGGPATH	hsa05200:Pathways in cancer		
T59102	KEGGPATH	hsa05206:MicroRNAs in cancer		
T59102	KEGGPATH	hsa05214:Glioma		
T59102	KEGGPATH	hsa05215:Prostate cancer		
T59102	KEGGPATH	hsa05218:Melanoma		
T59102	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T59102	KEGGPATH	hsa05231:Choline metabolism in cancer		
T59102	WIKIPATH	WP1916:Signaling by PDGF		
T59102	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T59102	WIKIPATH	WP2526:PDGF Pathway		
T59102	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T59102	WIKIPATH	WP306:Focal Adhesion		
T59102	WIKIPATH	WP322:Osteoblast Signaling		
T59102	WIKIPATH	WP382:MAPK Signaling Pathway		
T59102	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T59102	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T59102	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T59102	REACPATH	R-HSA-5673001:RAF/MAP kinase cascade		
T59102	INTEPATH	integrin3_pathway:Beta3 integrin cell surface interactions		
T59102	INTEPATH	myc_represspathway:Validated targets of C-MYC transcriptional repression		
T59102	INTEPATH	nectin_pathway:Nectin adhesion pathway		
T59102	INTEPATH	pdgf_pathway:PDGF receptor signaling network		
T59102	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T59102	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T59102	INTEPATH	s1p_s1p1_pathway:S1P1 pathway		
T59102	INTEPATH	s1p_s1p3_pathway:S1P3 pathway		
T59102	INTEPATH	shp2_pathway:SHP2 signaling		
T59102	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T59102	INTEPATH	upa_upar_pathway:Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling		
T59102	PANTPATH	P00005:Angiogenesis		
T59102	PANTPATH	P00047:PDGF signaling pathway		
				
T76024	TARGETID	T76024		
T76024	FORMERID	TTDC00085		
T76024	UNIPROID	C1S_HUMAN		
T76024	TARGNAME	Complement C1s component (C1S)		
T76024	GENENAME	C1S		
T76024	TARGTYPE	Successful target		
T76024	SYNONYMS	Complement component 1 subcomponent s; Complement C1s subcomponent; C1-esterase; C1 esterase		
T76024	FUNCTION	C1r activates C1s so that it can, in turn, activate C2 and C4. C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system.		
T76024	PDBSTRUC	6F1H; 6F1C; 4LOT; 4LOS; 4LOR		
T76024	BIOCLASS	Peptidase		
T76024	ECNUMBER	EC 3.4.21.42		
T76024	SEQUENCE	MWCIVLFSLLAWVYAEPTMYGEILSPNYPQAYPSEVEKSWDIEVPEGYGIHLYFTHLDIELSENCAYDSVQIISGDTEEGRLCGQRSSNNPHSPIVEEFQVPYNKLQVIFKSDFSNEERFTGFAAYYVATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHDDMKNCGVNCSGDVFTALIGEIASPNYPKPYPENSRCEYQIRLEKGFQVVVTLRREDFDVEAADSAGNCLDSLVFVAGDRQFGPYCGHGFPGPLNIETKSNALDIIFQTDLTGQKKGWKLRYHGDPMPCPKEDTPNSVWEPAKAKYVFRDVVQITCLDGFEVVEGRVGATSFYSTCQSNGKWSNSKLKCQPVDCGIPESIENGKVEDPESTLFGSVIRYTCEEPYYYMENGGGGEYHCAGNGSWVNEVLGPELPKCVPVCGVPREPFEEKQRIIGGSDADIKNFPWQVFFDNPWAGGALINEYWVLTAAHVVEGNREPTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLEVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDRAVRLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCGTYGLYTRVKNYVDWIMKTMQENSTPRED		
T76024	DRUGINFO	D0BK4X	Cinryze	Approved
T76024	DRUGINFO	DJ0L4K	Sutimlimab	Phase 3
T76024	DRUGINFO	D0OC5T	ANX005	Phase 1
T76024	DRUGINFO	D06SHZ	SHP616	Phase 1
T76024	DRUGINFO	D0X1EV	TNT009	Phase 1
T76024	DRUGINFO	D05TDJ	TS01	Phase 1
T76024	DRUGINFO	D0G6XS	Fucose	Investigative
T76024	DRUGINFO	D0J1CC	PMID16460935C28	Investigative
T76024	KEGGPATH	hsa04610:Complement and coagulation cascades		
T76024	KEGGPATH	hsa05133:Pertussis		
T76024	KEGGPATH	hsa05150:Staphylococcus aureus infection		
T76024	KEGGPATH	hsa05322:Systemic lupus erythematosus		
T76024	WIKIPATH	WP1798:Complement cascade		
T76024	WIKIPATH	WP2806:Human Complement System		
T76024	WIKIPATH	WP545:Complement Activation, Classical Pathway		
T76024	WIKIPATH	WP558:Complement and Coagulation Cascades		
T76024	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
				
T06273	TARGETID	T06273		
T06273	FORMERID	TTDS00191		
T06273	UNIPROID	PARP1_HUMAN		
T06273	TARGNAME	Poly [ADP-ribose] polymerase 1 (PARP1)		
T06273	GENENAME	PARP1		
T06273	TARGTYPE	Successful target		
T06273	SYNONYMS	Protein poly-ADP-ribosyltransferase PARP1; Poly[ADP-ribose] synthetase-1; Poly[ADP-ribose] synthase 1; Poly(ADP-ribose)polymerase-1; PPOL; PARP-1; NAD(+)Poly [ADP-ribose] polymerase-1 ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase-1; NAD(+) ADP-ribosyltransferase 1; DNA ADP-ribosyltransferase PARP1; ARTD1; ADPRT 1; ADPRT; ADP-ribosyltransferase diphtheria toxin-like 1		
T06273	FUNCTION	Mainly mediates glutamate and aspartate ADP-ribosylation of target proteins: the ADP-D-ribosyl group of NAD(+) is transferred to the acceptor carboxyl group of glutamate and aspartate residues and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 20-30 units. Mediates the poly(ADP-ribosyl)ation of a number of proteins, including itself, APLF and CHFR. Also mediates serine ADP-ribosylation of target proteins following interaction with HPF1; HPF1 conferring serine specificity. Probably also catalyzes tyrosine ADP-ribosylation of target proteins following interaction with HPF1. Catalyzes the poly-ADP-ribosylation of histones in a HPF1-dependent manner. Involved in the base excision repair (BER) pathway by catalyzing the poly-ADP-ribosylation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. ADP-ribosylation follows DNA damage and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. In addition to base excision repair (BER) pathway, also involved in double-strand breaks (DSBs) repair: together with TIMELESS, accumulates at DNA damage sites and promotes homologous recombination repair by mediating poly-ADP-ribosylation. In addition to proteins, also able to ADP-ribosylate DNA: catalyzes ADP-ribosylation of DNA strand break termini containing terminal phosphates and a 2'-OH group in single- and double-stranded DNA, respectively. Required for PARP9 and DTX3L recruitment to DNA damage sites. PARP1-dependent PARP9-DTX3L-mediated ubiquitination promotes the rapid and specific recruitment of 53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites. Acts as a regulator of transcription: positively regulates the transcription of MTUS1 and negatively regulates the transcription of MTUS2/TIP150. With EEF1A1 and TXK, forms a complex that acts as a T-helper 1 (Th1) cell-specific transcription factor and binds the promoter of IFN-gamma to directly regulate its transcription, and is thus involved importantly in Th1 cytokine production. Involved in the synthesis of ATP in the nucleus, together with NMNAT1, PARG and NUDT5. Nuclear ATP generation is required for extensive chromatin remodeling events that are energy-consuming. Poly-ADP-ribosyltransferase that mediates poly-ADP-ribosylation of proteins and plays a key role in DNA repair.		
T06273	PDBSTRUC	6GHK; 6BHV; 5XSU; 5XST; 5XSR		
T06273	BIOCLASS	Glycosyltransferases		
T06273	ECNUMBER	EC 2.4.2.30		
T06273	SEQUENCE	MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVAATPPPSTASAPAAVNSSASADKPLSNMKILTLGKLSRNKDEVKAMIEKLGGKLTGTANKASLCISTKKEVEKMNKKMEEVKEANIRVVSEDFLQDVSASTKSLQELFLAHILSPWGAEVKAEPVEVVAPRGKSGAALSKKSKGQVKEEGINKSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLW		
T06273	DRUGINFO	D09LSX	KU-0058948	Approved
T06273	DRUGINFO	D06NVJ	Nicotinamide	Approved
T06273	DRUGINFO	D0DN0W	Niraparib Tosylate	Approved
T06273	DRUGINFO	D09NTC	CC-486	Phase 3
T06273	DRUGINFO	D0Z2UW	Nicaraven	Phase 3
T06273	DRUGINFO	D06KZL	AG140699	Phase 2
T06273	DRUGINFO	D0F5TD	PMID27841036-Compound-37	Phase 2
T06273	DRUGINFO	DP48WE	Stenoparib	Phase 2
T06273	DRUGINFO	D8TE4F	AMXI 5001	Phase 1/2
T06273	DRUGINFO	DO0LP3	NMS-03305293	Phase 1
T06273	DRUGINFO	D01KFW	3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 1	Patented
T06273	DRUGINFO	D0M0WS	3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 2	Patented
T06273	DRUGINFO	D09HUV	3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 3	Patented
T06273	DRUGINFO	D02QFM	3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 4	Patented
T06273	DRUGINFO	D09ZIM	3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivative 5	Patented
T06273	DRUGINFO	D0TD8R	3-phenyl isoquinolin-1(2H) derivative 1	Patented
T06273	DRUGINFO	D0G8HX	3-phenyl isoquinolin-1(2H) derivative 2	Patented
T06273	DRUGINFO	D0O9FC	4-Carboxamido-isoindolinone derivative 1	Patented
T06273	DRUGINFO	D08YPU	4-Carboxamido-isoindolinone derivative 2	Patented
T06273	DRUGINFO	D0R0PO	4-Carboxamido-isoindolinone derivative 3	Patented
T06273	DRUGINFO	D0Z5DI	4-Carboxamido-isoindolinone derivative 4	Patented
T06273	DRUGINFO	D0GH4V	4-Carboxamido-isoindolinone derivative 5	Patented
T06273	DRUGINFO	D09WUA	7-azaindole derivative 8	Patented
T06273	DRUGINFO	D01PYO	Benzimidazole carboxamide derivative 1	Patented
T06273	DRUGINFO	D0P3YA	Dihydrodiazepinocarbazolone derivative 1	Patented
T06273	DRUGINFO	D0B3QI	Dihydropyrido phthalazinone derivative 1	Patented
T06273	DRUGINFO	D0J4GY	Dihydropyrido phthalazinone derivative 2	Patented
T06273	DRUGINFO	D0M9TG	Phthalazine derivative 3	Patented
T06273	DRUGINFO	D05ZBB	Phthalazine ketone derivative 1	Patented
T06273	DRUGINFO	D0B4FV	Phthalazine ketone derivative 2	Patented
T06273	DRUGINFO	D0AN7Z	Phthalazine ketone derivative 3	Patented
T06273	DRUGINFO	D02KMI	PMID27841036-Compound-33	Patented
T06273	DRUGINFO	D0J2SR	Quinazolinedione derivative 1	Patented
T06273	DRUGINFO	D0IX2C	Quinazolinedione derivative 2	Patented
T06273	DRUGINFO	D08KAH	Quinazolinedione derivative 3	Patented
T06273	DRUGINFO	D0Z8IR	Tetra-cyclic pyridophthalazinone derivative 1	Patented
T06273	DRUGINFO	D0MP4W	Tetra-hydro-quinoline derivative 1	Patented
T06273	DRUGINFO	D0E9JI	Tricyclic indole compound 13	Patented
T06273	DRUGINFO	D04ABS	CPH-102	Preclinical
T06273	DRUGINFO	D04WDX	PJ34	Preclinical
T06273	DRUGINFO	D0O3FX	NU1025	Terminated
T06273	DRUGINFO	D04ZQJ	(E)-N-(4-Phenylthiazol-2-yl) cinnamamide	Investigative
T06273	DRUGINFO	D09SZG	[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala	Investigative
T06273	DRUGINFO	D0FF4M	1,2,3,4,4a,5-hexahydrophenanthridin-6(10bH)-one	Investigative
T06273	DRUGINFO	D0NU5Z	1,7,8,9-tetrahydro-1,5-diaza-trindene-4,6-dione	Investigative
T06273	DRUGINFO	D0TH7S	2-(2-Chlorophenyl)-2H-indazole-7-carboxamide	Investigative
T06273	DRUGINFO	D0XZ5D	2-(3-Chlorophenyl)-2H-indazole-7-carboxamide	Investigative
T06273	DRUGINFO	D01YIR	2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide	Investigative
T06273	DRUGINFO	D0U5WY	2-(3-Piperidin-1-yl-propyl)-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D00TUB	2-(4-Amino-phenyl)-8-hydroxy-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0GA0Y	2-(4-Amino-phenyl)-8-methyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0WO3P	2-(4-Azido-phenyl)-8-methoxy-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0PT1K	2-(4-Chlorophenyl)-2H-indazole-7-carboxamide	Investigative
T06273	DRUGINFO	D08ZVM	2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide	Investigative
T06273	DRUGINFO	D0Y1MH	2-(4-Hydroxy-phenyl)-8-methyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0B2WX	2-(4-Methoxy-phenyl)-8-methyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D04TDX	2-(4-methoxyphenyl)quinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D05HJG	2,3-dihydro-1H-benzo[de]isoquinolin-1-one	Investigative
T06273	DRUGINFO	D07SRJ	2,8-Dimethyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D02QZF	2-Benzyl-2H-indazole-7-carboxamide	Investigative
T06273	DRUGINFO	D0Z3PB	2-ethylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D07CRG	2H-Isoquinolin-1-one	Investigative
T06273	DRUGINFO	D0S8HZ	2-Methylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0I2AF	2-phenyl-2H-benzo[d][1,2,3]triazole-4-carboxamide	Investigative
T06273	DRUGINFO	D0IX3I	2-phenyl-2H-indazole-7-carboxamide	Investigative
T06273	DRUGINFO	D08OUR	2-phenylpyrazolo-[1,5-a]pyridine-7-carboxamide	Investigative
T06273	DRUGINFO	D0Z9DY	2-phenylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D08GMO	3-(4-aminophenyl)quinoxaline-5-carboxamide	Investigative
T06273	DRUGINFO	D0M9TW	3-(4-cyanophenyl)quinoxaline-5-carboxamide	Investigative
T06273	DRUGINFO	D0L1RZ	3-(4-methoxyphenyl)quinoxaline-5-carboxamide	Investigative
T06273	DRUGINFO	D0K2PD	3-aminobenzamide	Investigative
T06273	DRUGINFO	D0EI6X	3-aminobenzo[c][1,5]naphthyridin-6(5H)-one	Investigative
T06273	DRUGINFO	D0K7JT	3-Ethenylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0UF0U	3-Ethylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D00OZA	3-Ethynylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D05ZTI	3-Hydroxy-benzamide	Investigative
T06273	DRUGINFO	D02MPP	3-Methoxybenzamide	Investigative
T06273	DRUGINFO	D08XPZ	3-Methylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0F8ZI	3-Morpholin-4-ylmethyl-5H-phenanthridin-6-one	Investigative
T06273	DRUGINFO	D0L1NQ	3-Phenylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0T5TT	3-Prop-1-ynylquinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0GJ8U	4-(4-Morpholin-4-yl-butyl)-2H-phthalazin-1-one	Investigative
T06273	DRUGINFO	D05WYN	4-(5-Morpholin-4-yl-pentyl)-2H-phthalazin-1-one	Investigative
T06273	DRUGINFO	D03JTS	4-amino-1,8-naphthalimide	Investigative
T06273	DRUGINFO	D08QWR	4-benzylphthalazin-1(2H)-one	Investigative
T06273	DRUGINFO	D05GMW	4-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Investigative
T06273	DRUGINFO	D05RXG	5-amino-3,4-dihydroisoquinolin-1(2H)-one	Investigative
T06273	DRUGINFO	D07WPL	5-aminoisoquinolin-1(2H)-one	Investigative
T06273	DRUGINFO	D01EVX	5-Chloro-2-methyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D02XLC	5-methylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Investigative
T06273	DRUGINFO	D04ATU	8-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	Investigative
T06273	DRUGINFO	D0O0GA	8-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Investigative
T06273	DRUGINFO	D0G5VD	8-Hydroxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0O6WW	8-Hydroxy-2-phenyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0OF1I	8-Methoxy-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0T3SY	8-Methoxy-2-methyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D06NKJ	8-Methoxy-2-phenyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D07BPT	8-Methyl-2-(4-nitro-phenyl)-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0E5EW	8-Methyl-2-phenyl-3H-quinazolin-4-one	Investigative
T06273	DRUGINFO	D0E0QT	8-Nitro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Investigative
T06273	DRUGINFO	D04UPQ	9-Amino-6H,11H-indeno[1,2-c]isoquinolin-5-one	Investigative
T06273	DRUGINFO	D07BBR	9-Fluoro-6H,11H-indeno[1,2-c]isoquinolin-5-one	Investigative
T06273	DRUGINFO	D0VY5O	A-620223	Investigative
T06273	DRUGINFO	D05XMG	AG-014376	Investigative
T06273	DRUGINFO	D05APM	ANG-2684	Investigative
T06273	DRUGINFO	D02JHW	ANG-2864	Investigative
T06273	DRUGINFO	D0M6WJ	Benzo[c][1,5]naphthyridin-6(5H)-one	Investigative
T06273	DRUGINFO	D0R7FS	BPI-704001	Investigative
T06273	DRUGINFO	D01RXM	BZ3	Investigative
T06273	DRUGINFO	D0ZK3L	BZ5	Investigative
T06273	DRUGINFO	D04LDH	BZ6	Investigative
T06273	DRUGINFO	D0JD1O	Carba-Nicotinamide-Adenine-Dinucleotide	Investigative
T06273	DRUGINFO	D02GPJ	CEP-6800	Investigative
T06273	DRUGINFO	D0W7XH	DR2313	Investigative
T06273	DRUGINFO	D04AYN	EB-47	Investigative
T06273	DRUGINFO	D0CA2S	HYDAMTIQ	Investigative
T06273	DRUGINFO	D08AOV	INO-1002	Investigative
T06273	DRUGINFO	D05SYO	KR-33889	Investigative
T06273	DRUGINFO	D07QPV	KU-58684	Investigative
T06273	DRUGINFO	D04QRM	ME0328	Investigative
T06273	DRUGINFO	D00WMC	N-(4-Phenylthiazol-2-yl)isonicotinamide	Investigative
T06273	DRUGINFO	D0E2VC	PD-128763	Investigative
T06273	DRUGINFO	D0R7HU	Pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione	Investigative
T06273	DRUGINFO	D03VNZ	Pyrrolo[3,4-e]indole-1,3(2H,6H)-dione	Investigative
T06273	DRUGINFO	D07AGU	Quinoline-8-carboxamide	Investigative
T06273	DRUGINFO	D0P4DG	S-070	Investigative
T06273	DRUGINFO	D0EQ1J	S-111	Investigative
T06273	DRUGINFO	D0EW8Y	Thieno-phenanthridin-6-one	Investigative
T06273	DRUGINFO	D0E7UW	TI3	Investigative
T06273	DRUGINFO	D0L6LO	TI4	Investigative
T06273	KEGGPATH	hsa03410:Base excision repair		
T06273	KEGGPATH	hsa04064:NF-kappa B signaling pathway		
T06273	WIKIPATH	WP2355:Corticotropin-releasing hormone		
T06273	WIKIPATH	WP2513:Nanoparticle triggered regulated necrosis		
T06273	WIKIPATH	WP2755:Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer		
T06273	WIKIPATH	WP314:FAS pathway and Stress induction of HSP regulation		
T06273	REACPATH	R-HSA-5696400:Dual Incision in GG-NER		
T06273	INTEPATH	caspase_pathway:Caspase Cascade in Apoptosis		
T06273	INTEPATH	hes_heypathway:Notch-mediated HES/HEY network		
T06273	INTEPATH	ilk_pathway:Integrin-linked kinase signaling		
T06273	PANTPATH	P00020:FAS signaling pathway		
				
T03691	TARGETID	T03691		
T03691	FORMERID	TTDC00130		
T03691	UNIPROID	LKHA4_HUMAN		
T03691	TARGNAME	Leukotriene A-4 hydrolase (LTA4H)		
T03691	GENENAME	LTA4H		
T03691	TARGTYPE	Successful target		
T03691	SYNONYMS	Leukotriene A4 hydrolase; Leukotriene A(4)Leukotriene A-4 hydrolase hydrolase; Leukotriene A(4) hydrolase; LTA4; LTA-H; LTA-4hydrolase; LTA-4 hydrolase		
T03691	FUNCTION	Has also aminopeptidase activity. Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4.		
T03691	PDBSTRUC	6END; 6ENC; 6ENB; 5NIE; 5NID		
T03691	BIOCLASS	Ether bond hydrolase		
T03691	ECNUMBER	EC 3.3.2.6		
T03691	SEQUENCE	MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD		
T03691	DRUGINFO	D0RA5Q	Bestatin	Approved
T03691	DRUGINFO	D07VNH	Acebilustat	Phase 1
T03691	DRUGINFO	D06XEL	DG051	Discontinued in Phase 2
T03691	DRUGINFO	D0I4OV	(4-(thiophen-2-yl)phenyl)methanamine	Investigative
T03691	DRUGINFO	D0J0WO	(4-fluorophenyl)(pyridin-4-yl)methanone	Investigative
T03691	DRUGINFO	D0C1XE	(R)-2-((4-benzylphenoxy)methyl)piperidine	Investigative
T03691	DRUGINFO	D00FDS	(R)-2-((4-phenoxyphenoxy)methyl)piperidine	Investigative
T03691	DRUGINFO	D06SMN	(R)-2-(4-Benzylphenoxymethyl)pyrrolidine	Investigative
T03691	DRUGINFO	D01RVF	(R)-N-benzyl-4-(pyrrolidin-2-ylmethoxy)aniline	Investigative
T03691	DRUGINFO	D0H9NZ	(R/S)-2-((4-benzylphenoxy)methyl)piperazine	Investigative
T03691	DRUGINFO	D07ZJS	(R/S)-2-((4-benzylphenoxy)methyl)piperidine	Investigative
T03691	DRUGINFO	D00TNN	(R/S)-2-((4-phenoxyphenoxy)methyl)piperidine	Investigative
T03691	DRUGINFO	D05NXQ	(S)-2-((4-phenoxyphenoxy)methyl)piperidine	Investigative
T03691	DRUGINFO	D0R7BT	1-(2,2'-bithiophen-5-yl)methanamine	Investigative
T03691	DRUGINFO	D0V0MH	1-(4-Phenoxyphenyl)piperazine	Investigative
T03691	DRUGINFO	D07LTR	1-(pentyloxy)-4-phenoxybenzene	Investigative
T03691	DRUGINFO	D0P7DF	1-[4-(4-Iodophenoxy)phenyl]piperazine	Investigative
T03691	DRUGINFO	D09BWE	1-[4-(Benzothiazol-2-yloxy)benzyl]piperidin-4-ol	Investigative
T03691	DRUGINFO	D07TVA	1-butoxy-4-phenoxybenzene	Investigative
T03691	DRUGINFO	D0W2OP	2-(4-benzylphenoxy)ethanamine	Investigative
T03691	DRUGINFO	D02AYI	2-(4-phenoxyphenoxy)ethanamine	Investigative
T03691	DRUGINFO	D0PF9Q	2-(4-Piperidin-1-ylmethylphenoxy)benzothiazole	Investigative
T03691	DRUGINFO	D0C8MT	2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine	Investigative
T03691	DRUGINFO	D03GON	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzooxazole	Investigative
T03691	DRUGINFO	D08UIO	2-[4-(2-Azepan-1-ylethoxy)phenoxy]benzothiazole	Investigative
T03691	DRUGINFO	D09PGC	2-[4-(2-Morpholin-4-ylethoxy)phenoxy]benzooxazole	Investigative
T03691	DRUGINFO	D0Q8LS	2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole	Investigative
T03691	DRUGINFO	D06RWH	2-Amino-N-[4-(phenylmethoxy)phenyl]-acetamide	Investigative
T03691	DRUGINFO	D09DRF	3-(Benzyloxy)Pyridin-2-Amine	Investigative
T03691	DRUGINFO	D01KOI	4-(2-amino-1,3-thiazol-4-yl)phenol	Investigative
T03691	DRUGINFO	D0I7MC	4-(4-(pentyloxy)phenoxy)phenol	Investigative
T03691	DRUGINFO	D01QWO	4-(4-butoxyphenoxy)phenol	Investigative
T03691	DRUGINFO	D0Y6IV	4-(4-propoxyphenoxy)phenol	Investigative
T03691	DRUGINFO	D0VN8V	4-[2-(4-Benzylphenoxy)ethyl]pyridine	Investigative
T03691	DRUGINFO	D09MDO	4-amino-N-[4-(benzyloxy)phenyl]butanamide	Investigative
T03691	DRUGINFO	D0M2CY	4S-4,5-Diamino-N-(4-phenoxyphenyl)pentanamide	Investigative
T03691	DRUGINFO	D00YCG	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	Investigative
T03691	DRUGINFO	D00TWK	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	Investigative
T03691	DRUGINFO	D0SZ9E	8(S)-amino-2(R)-methyl-7-oxononanoic acid	Investigative
T03691	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T03691	DRUGINFO	D00UIN	JNJ-10392980	Investigative
T03691	DRUGINFO	D0G0JC	N-(pyridin-3-ylmethyl)aniline	Investigative
T03691	DRUGINFO	D0U1UV	N1-[4-(Phenylmethoxy)phenyl]-D-aspartamine	Investigative
T03691	DRUGINFO	D04DRM	N1-[4-(Phenylmethoxy)phenyl]-D-glutamine	Investigative
T03691	DRUGINFO	D0LZ3O	N1-[4-(Phenylmethoxy)phenyl]-L-aspartamine	Investigative
T03691	DRUGINFO	D0HA1K	N1-[4-(Phenylmethoxy)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D04ZLZ	N4-[4-(Phenylmethoxy)phenyl]-L-aspartamine	Investigative
T03691	DRUGINFO	D09OWF	N5-(4-Phenoxyphenyl)-L-glutamine	Investigative
T03691	DRUGINFO	D02TMR	N5-[(4-Phenoxy)-3-pyridyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D08WZB	N5-[4-(1H-pyrrol-1-yl)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D07KBF	N5-[4-(2-methylphenoxy)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D0DI4I	N5-[4-(2-Oxo-3-phenylpropoxy)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D0N6TC	N5-[4-(2-phenylethoxy)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D00FCJ	N5-[4-(3-methylphenoxy)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D01YJJ	N5-[4-(3-Phenylpropoxy)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D0B9UW	N5-[4-(4-(3-Furyl)phenoxy)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D0G8SW	N5-[4-(4-methylphenoxy)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D0Z6DL	N5-[4-(N-Phenylamino)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D0U1EV	N5-[4-(Phenylmethoxy)phenyl]-D-glutamine	Investigative
T03691	DRUGINFO	D04CZF	N5-[4-(Phenylmethoxy)phenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D08TNQ	N5-[4-(Phenylmethoxy)phenyl]-L-glutamine	Investigative
T03691	DRUGINFO	D0U2AM	N5-[4-Benzylphenyl]-L-glutamamide	Investigative
T03691	DRUGINFO	D0B0DP	N6-[4-(4-methylphenoxy)phenyl]-L-homoglutamine	Investigative
T03691	DRUGINFO	D0A2YG	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	Investigative
T03691	DRUGINFO	D03UIF	SA-6541	Investigative
T03691	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T03691	KEGGPATH	hsa01100:Metabolic pathways		
T03691	WIKIPATH	WP167:Eicosanoid Synthesis		
T03691	WIKIPATH	WP2650:Arachidonic acid metabolism		
T03691	WHIZPATH	PW000044:Arachidonic Acid Metabolism		
T03691	BIOCPATH	PWY66-375:Leukotriene biosynthesis		
				
T11211	TARGETID	T11211		
T11211	FORMERID	TTDS00367		
T11211	UNIPROID	ANDR_HUMAN		
T11211	TARGNAME	Androgen receptor (AR)		
T11211	GENENAME	AR		
T11211	TARGTYPE	Successful target		
T11211	SYNONYMS	Testosterone receptor; Nuclear receptor subfamily 3 group C member 4; NR3C4; Dihydrotestosterone receptor; DHTR		
T11211	FUNCTION	Transcription factor activity is modulated by bound coactivator and corepressor proteins like ZBTB7A that recruits NCOR1 and NCOR2 to the androgen response elements/ARE on target genes, negatively regulating androgen receptor signaling and androgen-induced cell proliferation. Transcription activation is also down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3. Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues.		
T11211	PDBSTRUC	5VO4; 5V8Q; 5T8J; 5T8E; 5JJM		
T11211	BIOCLASS	Nuclear hormone receptor		
T11211	SEQUENCE	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ		
T11211	DRUGINFO	D0S7LG	ARN-509	Approved
T11211	DRUGINFO	D0V9BD	Bicalutamide	Approved
T11211	DRUGINFO	D08TEJ	Clascoterone	Approved
T11211	DRUGINFO	D06AEO	Cyproterone	Approved
T11211	DRUGINFO	D0DV6D	Darolutamide	Approved
T11211	DRUGINFO	D09NNA	Dromostanolone	Approved
T11211	DRUGINFO	D0QK5X	Enzalutamide	Approved
T11211	DRUGINFO	D0SC8F	Ethylestrenol	Approved
T11211	DRUGINFO	D0R7JT	Fludrocortisone	Approved
T11211	DRUGINFO	D0B2WJ	Flufenamic Acid	Approved
T11211	DRUGINFO	D0L2LS	Fluoxymesterone	Approved
T11211	DRUGINFO	D0Y0SW	Flutamide	Approved
T11211	DRUGINFO	D0BC2E	Hydroxyflutamide	Approved
T11211	DRUGINFO	D00YWP	Nandrolone	Approved
T11211	DRUGINFO	D0SN9T	Nilutamide	Approved
T11211	DRUGINFO	D0U3GL	Oxandrolone	Approved
T11211	DRUGINFO	D0K0EK	Prasterone	Approved
T11211	DRUGINFO	D06XMU	Testosterone	Approved
T11211	DRUGINFO	D04DJN	Dihydrotestosterone	Phase 4
T11211	DRUGINFO	DE4AO8	HC-1119	Phase 3
T11211	DRUGINFO	D04NNJ	ZANOTERONE	Phase 3
T11211	DRUGINFO	D04KYB	ASCJ-9	Phase 2
T11211	DRUGINFO	DZTX12	ASC-J9	Phase 2
T11211	DRUGINFO	D0C9EN	AZD5312	Phase 2
T11211	DRUGINFO	D0RV6F	MK-0773	Phase 2
T11211	DRUGINFO	D0G1IV	Testogen TDS	Phase 2
T11211	DRUGINFO	D0U0BU	TOK-001	Phase 2
T11211	DRUGINFO	D0N7DQ	APC-100	Phase 1/2
T11211	DRUGINFO	D3ZY1K	ARV-110	Phase 1/2
T11211	DRUGINFO	DS41PJ	ARV-471	Phase 1/2
T11211	DRUGINFO	D03CVT	ONC1-13B	Phase 1/2
T11211	DRUGINFO	D08AAV	AZD-3514	Phase 1
T11211	DRUGINFO	DNY63Z	CC-94676	Phase 1
T11211	DRUGINFO	D0D3FP	Drug 2881078	Phase 1
T11211	DRUGINFO	D0C4FS	DT-200	Phase 1
T11211	DRUGINFO	DY7Q1O	EPI-7386	Phase 1
T11211	DRUGINFO	D04XWX	PS-178990	Phase 1
T11211	DRUGINFO	D09ZLZ	RAD-140	Phase 1
T11211	DRUGINFO	D0N5NC	TAS3681	Phase 1
T11211	DRUGINFO	D05VNP	TESTOSTERONE BUCICLATE	Phase 1
T11211	DRUGINFO	D09IZX	GW-275919	Discontinued in Phase 2
T11211	DRUGINFO	D0F7WQ	HE-2000	Discontinued in Phase 2
T11211	DRUGINFO	D0E3EK	NP-619	Discontinued in Phase 2
T11211	DRUGINFO	D08NNR	Testosterone glucoside	Discontinued in Phase 2
T11211	DRUGINFO	D03SHP	GSK2849466	Discontinued in Phase 1
T11211	DRUGINFO	D03KTE	LGD2941	Discontinued in Phase 1
T11211	DRUGINFO	D05BCA	MX-4509	Discontinued in Phase 1
T11211	DRUGINFO	D00ABW	Opterone	Discontinued in Phase 1
T11211	DRUGINFO	D0S7UU	PF-06260414	Discontinued in Phase 1
T11211	DRUGINFO	D0BJ7W	GLPG-0492	Preclinical
T11211	DRUGINFO	D0G6PL	LG-2293	Terminated
T11211	DRUGINFO	D07VUD	ZD-3980	Terminated
T11211	DRUGINFO	D01ETZ	[3H]methyltrienolone	Investigative
T11211	DRUGINFO	D06VZE	[3H]mibolerone	Investigative
T11211	DRUGINFO	D06BLF	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane	Investigative
T11211	DRUGINFO	D07TLT	11-methyl-6,11-dihydro-5H-benzo[a]carbazol-9-ol	Investigative
T11211	DRUGINFO	D00QVP	6,11-dihydrothiochromeno[4,3-b]indol-8-ol	Investigative
T11211	DRUGINFO	D0W8AI	Andromustine	Investigative
T11211	DRUGINFO	D0D8QN	ARN34	Investigative
T11211	DRUGINFO	D02RZC	ASC-JMX2	Investigative
T11211	DRUGINFO	D0O0II	ASC-JMZ1	Investigative
T11211	DRUGINFO	D09HQH	Boldenone	Investigative
T11211	DRUGINFO	D03KYW	Calusterone	Investigative
T11211	DRUGINFO	D0W5IF	CH-4933468	Investigative
T11211	DRUGINFO	D0Z3WA	Delta1-dihydrotestosterone	Investigative
T11211	DRUGINFO	D04MFW	DL-3	Investigative
T11211	DRUGINFO	D0T1DZ	EPI-001	Investigative
T11211	DRUGINFO	D04QFY	GTx-027	Investigative
T11211	DRUGINFO	D0NH0U	HYG-440	Investigative
T11211	DRUGINFO	D0MM9P	OXENDLONE	Investigative
T11211	DRUGINFO	D0A7YH	Palodesangren C	Investigative
T11211	DRUGINFO	D0I3LL	Palodesangren D	Investigative
T11211	DRUGINFO	D0JI4G	Palodesangren E	Investigative
T11211	DRUGINFO	D07KOY	RU-59063	Investigative
T11211	DRUGINFO	D0JC4J	SARMs	Investigative
T11211	DRUGINFO	D0C1UP	SX-ARPC	Investigative
T11211	DRUGINFO	D09XGK	Testetrol	Investigative
T11211	KEGGPATH	hsa04114:Oocyte meiosis		
T11211	KEGGPATH	hsa05200:Pathways in cancer		
T11211	KEGGPATH	hsa05215:Prostate cancer		
T11211	WIKIPATH	WP138:Androgen receptor signaling pathway		
T11211	WIKIPATH	WP170:Nuclear Receptors		
T11211	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T11211	WIKIPATH	WP2263:Prostate Cancer		
T11211	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T11211	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T11211	REACPATH	R-HSA-383280:Nuclear Receptor transcription pathway		
T11211	REACPATH	R-HSA-5625886:Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3		
T11211	NET_PATH	NetPath_2:AndrogenReceptor Signaling Pathway		
T11211	NET_PATH	NetPath_25:FSH Signaling Pathway		
T11211	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T11211	INTEPATH	ar_nongenomic_pathway:Nongenotropic Androgen signaling		
T11211	INTEPATH	ar_pathway:Coregulation of Androgen receptor activity		
T11211	INTEPATH	ar_tf_pathway:Regulation of Androgen receptor activity		
T11211	INTEPATH	betacatenin_nuc_pathway:Regulation of nuclear beta catenin signaling and target gene transcription		
T11211	INTEPATH	hes_heypathway:Notch-mediated HES/HEY network		
T11211	INTEPATH	hnf3apathway:FOXA1 transcription factor network		
T11211	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
				
T63484	TARGETID	T63484		
T63484	FORMERID	TTDR00008		
T63484	UNIPROID	G6PD_HUMAN		
T63484	TARGNAME	Glucose-6-phosphate dehydrogenase (G6PD)		
T63484	GENENAME	G6PD		
T63484	TARGTYPE	Successful target		
T63484	SYNONYMS	Glucose-6-phosphate 1-dehydrogenase		
T63484	FUNCTION	The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis. Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis.		
T63484	PDBSTRUC	6.00E+08; 6.00E+07; 5UKW; 2BHL; 2BH9		
T63484	BIOCLASS	CH-OH donor oxidoreductase		
T63484	ECNUMBER	EC 1.1.1.49		
T63484	SEQUENCE	MAEQVALSRTQVCGILREELFQGDAFHQSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPASTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVNPHKL		
T63484	DRUGINFO	D0K0EK	Prasterone	Approved
T63484	DRUGINFO	D0O8FW	EPIANDROSTERONE	Phase 3
T63484	DRUGINFO	D05JCG	CBF-BS2	Discontinued in Phase 2
T63484	DRUGINFO	D0J2FY	2'-Monophosphoadenosine 5'-Diphosphoribose	Investigative
T63484	DRUGINFO	D01HNP	Hydroxyacetic Acid	Investigative
T63484	DRUGINFO	D0FF3D	Metazamide	Investigative
T63484	KEGGPATH	hsa00030:Pentose phosphate pathway		
T63484	KEGGPATH	hsa00480:Glutathione metabolism		
T63484	KEGGPATH	hsa01100:Metabolic pathways		
T63484	KEGGPATH	hsa01130:Biosynthesis of antibiotics		
T63484	KEGGPATH	hsa01200:Carbon metabolism		
T63484	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T63484	WIKIPATH	WP100:Glutathione metabolism		
T63484	WIKIPATH	WP134:Pentose Phosphate Pathway		
T63484	WIKIPATH	WP1848:Metabolism of carbohydrates		
T63484	WIKIPATH	WP1946:Cori Cycle		
T63484	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T63484	WIKIPATH	WP2003:miR-targeted genes in leukocytes - TarBase		
T63484	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase		
T63484	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T63484	WIKIPATH	WP2877:Vitamin D Receptor Pathway		
T63484	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T63484	WIKIPATH	WP2884:NRF2 pathway		
T63484	WIKIPATH	WP692:Sulfation Biotransformation Reaction		
T63484	WHIZPATH	PW000055:Pentose Phosphate Pathway		
T63484	WHIZPATH	PW000630:Warburg Effect		
T63484	REACPATH	R-HSA-5628897:TP53 Regulates Metabolic Genes		
T63484	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T63484	BIOCPATH	OXIDATIVEPENT-PWY-1:Pentose phosphate pathway (oxidative branch)		
T63484	BIOCPATH	PENTOSE-P-PWY:Pentose phosphate pathway		
				
T34234	TARGETID	T34234		
T34234	FORMERID	TTDS00251		
T34234	UNIPROID	VDR_HUMAN		
T34234	TARGNAME	Vitamin D3 receptor (VDR)		
T34234	GENENAME	VDR		
T34234	TARGTYPE	Successful target		
T34234	SYNONYMS	Vitamin D(3) receptor; Nuclear vitamin D receptor; Nuclear receptor subfamily 1 group I member 1; NR1I1; 1,25-dihydroxyvitamin D3 receptor		
T34234	FUNCTION	Enters the nucleus upon vitamin D3 binding where it forms heterodimers with the retinoid X receptor/RXR. The VDR-RXR heterodimers bind to specific response elements on DNA and activate the transcription of vitamin D3-responsive target genes. Plays a central role in calcium homeostasis. Nuclear receptor for calcitriol, the active form of vitamin D3 which mediates the action of this vitamin on cells.		
T34234	PDBSTRUC	5YT2; 5YSY; 5V39; 5GT4; 4ITF		
T34234	BIOCLASS	Nuclear hormone receptor		
T34234	SEQUENCE	MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTCPFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSGDSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS		
T34234	DRUGINFO	D02VPX	Calcidiol	Approved
T34234	DRUGINFO	D01QUS	Calcipotriol	Approved
T34234	DRUGINFO	D0T2PL	Calcitriol	Approved
T34234	DRUGINFO	D0K5WS	Cholecalciferol	Approved
T34234	DRUGINFO	D0G8OC	Dihydrotachysterol	Approved
T34234	DRUGINFO	D0G5CF	Doxercalciferol	Approved
T34234	DRUGINFO	D06JPB	Ergocalciferol	Approved
T34234	DRUGINFO	D01UFN	Falecalcitrol	Approved
T34234	DRUGINFO	D0N1TP	Paricalcitol	Approved
T34234	DRUGINFO	D0U8CR	S-06911	Phase 3
T34234	DRUGINFO	D09ZJQ	Seocalcitol	Phase 3
T34234	DRUGINFO	D0R8IE	Inecalcitol oral	Phase 2
T34234	DRUGINFO	D05SOH	CTAP-201	Phase 1
T34234	DRUGINFO	D00CGH	RO-23-7553	Phase 1
T34234	DRUGINFO	D0P1KV	PMID27454349-Compound-100	Patented
T34234	DRUGINFO	D0WT4I	PMID27454349-Compound-101	Patented
T34234	DRUGINFO	D0O2HK	PMID27454349-Compound-102	Patented
T34234	DRUGINFO	D0UK7K	PMID27454349-Compound-91	Patented
T34234	DRUGINFO	D0P8CM	PMID27454349-Compound-92	Patented
T34234	DRUGINFO	D09KWM	PMID27454349-Compound-93	Patented
T34234	DRUGINFO	D0WV1W	PMID27454349-Compound-94	Patented
T34234	DRUGINFO	D0JC8M	PMID27454349-Compound-95	Patented
T34234	DRUGINFO	D0UY3J	PMID27454349-Compound-96	Patented
T34234	DRUGINFO	D03ZXP	PMID27454349-Compound-97	Patented
T34234	DRUGINFO	D00SZR	PMID27454349-Compound-98	Patented
T34234	DRUGINFO	D0PJ2C	PMID27454349-Compound-99	Patented
T34234	DRUGINFO	D06SBK	Atocalcitol	Discontinued in Phase 2
T34234	DRUGINFO	D0RF9T	Lexacalcitol	Discontinued in Phase 2
T34234	DRUGINFO	D0I4GI	RO-26-9228	Discontinued in Phase 2
T34234	DRUGINFO	D07BDY	Tisocalcitate	Discontinued in Phase 2
T34234	DRUGINFO	D08KZR	BXL-746	Discontinued in Phase 1
T34234	DRUGINFO	D0KK4U	CB-1267	Terminated
T34234	DRUGINFO	D0T9SJ	CEP-4186	Terminated
T34234	DRUGINFO	D0O6WJ	Ecalcidene	Terminated
T34234	DRUGINFO	D02EHY	2MD	Investigative
T34234	DRUGINFO	D06RBG	3-keto-lithocholic acid	Investigative
T34234	DRUGINFO	D06DEL	calcitriol-26,23-lactone	Investigative
T34234	DRUGINFO	D0K8VA	gemini	Investigative
T34234	DRUGINFO	D0X3DK	KSP-BCS-1-alpha-CHF2-1624F2-2	Investigative
T34234	DRUGINFO	D0XZ2P	KSP-BCS-1-alpha-CHF2-20-epi-22-oxabishomo-26-OH	Investigative
T34234	DRUGINFO	D07AHG	LG190178	Investigative
T34234	DRUGINFO	D0C7NV	MC-1301	Investigative
T34234	DRUGINFO	D0D6XV	TEI-9647	Investigative
T34234	DRUGINFO	D0X0AM	ZK159222	Investigative
T34234	KEGGPATH	hsa04961:Endocrine and other factor-regulated calcium reabsorption		
T34234	KEGGPATH	hsa04978:Mineral absorption		
T34234	KEGGPATH	hsa05152:Tuberculosis		
T34234	WIKIPATH	WP1531:Vitamin D Metabolism		
T34234	WIKIPATH	WP170:Nuclear Receptors		
T34234	WIKIPATH	WP2289:Drug Induction of Bile Acid Pathway		
T34234	WIKIPATH	WP2877:Vitamin D Receptor Pathway		
T34234	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T34234	WIKIPATH	WP299:Nuclear Receptors in Lipid Metabolism and Toxicity		
T34234	WIKIPATH	WP34:Ovarian Infertility Genes		
T34234	REACPATH	R-HSA-383280:Nuclear Receptor transcription pathway		
T34234	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T34234	INTEPATH	deltanp63pathway:Validated transcriptional targets of deltaNp63 isoforms		
T34234	INTEPATH	p53downstreampathway:Direct p53 effectors		
T34234	INTEPATH	retinoic_acid_pathway:Retinoic acid receptors-mediated signaling		
T34234	INTEPATH	rxr_vdr_pathway:RXR and RAR heterodimerization with other nuclear receptor		
T34234	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
T34234	INTEPATH	tap63pathway:Validated transcriptional targets of TAp63 isoforms		
T34234	PANTPATH	P04396:Vitamin D metabolism and pathway		
				
T13260	TARGETID	T13260		
T13260	FORMERID	TTDS00252		
T13260	UNIPROID	CP19A_HUMAN		
T13260	TARGNAME	Aromatase (CYP19A1)		
T13260	GENENAME	CYP19A1		
T13260	TARGTYPE	Successful target		
T13260	SYNONYMS	P-450AROM; Estrogen synthetase; Estrogen synthase; Cytochrome P450 19A1; Cytochrome P-450AROM; CYPXIX; CYP19; CYAR; ARO1		
T13260	FUNCTION	Catalyzes the formation of aromatic C18 estrogens from C19 androgens.		
T13260	PDBSTRUC	5JL9; 5JL7; 5JL6; 5JKW; 5JKV		
T13260	BIOCLASS	Paired donor oxygen oxidoreductase		
T13260	ECNUMBER	EC 1.14.14.14		
T13260	SEQUENCE	MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGPGYCMGIGPLISHGRFLWMGIGSACNYYNRVYGEFMRVWISGEETLIISKSSSMFHIMKHNHYSSRFGSKLGLQCIGMHEKGIIFNNNPELWKTTRPFFMKALSGPGLVRMVTVCAESLKTHLDRLEEVTNESGYVDVLTLLRRVMLDTSNTLFLRIPLDESAIVVKIQGYFDAWQALLIKPDIFFKISWLYKKYEKSVKDLKDAIEVLIAEKRRRISTEEKLEECMDFATELILAEKRGDLTRENVNQCILEMLIAAPDTMSVSLFFMLFLIAKHPNVEEAIIKEIQTVIGERDIKIDDIQKLKVMENFIYESMRYQPVVDLVMRKALEDDVIDGYPVKKGTNIILNIGRMHRLEFFPKPNEFTLENFAKNVPYRYFQPFGFGPRGCAGKYIAMVMMKAILVTLLRRFHVKTLQGQCVESIQKIHDLSLHPDETKNMLEMIFTPRNSDRCLEH		
T13260	DRUGINFO	D0M6DO	Aminoglutethimide	Approved
T13260	DRUGINFO	D0W0BF	Anastrozole	Approved
T13260	DRUGINFO	D0D2VS	Exemestane	Approved
T13260	DRUGINFO	D0ZX1P	FADROZOLE	Approved
T13260	DRUGINFO	D0C1WH	Letrozole	Approved
T13260	DRUGINFO	D0C7JF	Testolactone	Approved
T13260	DRUGINFO	D0B4ES	Atamestane + Toremifene	Phase 3
T13260	DRUGINFO	D08UGX	LIAROZOLE	Phase 2/3
T13260	DRUGINFO	D02XMD	BGS-649	Phase 2
T13260	DRUGINFO	D0Y6OA	Coumate	Phase 2
T13260	DRUGINFO	D0J8RR	Dextromethorphan+quinidine	Phase 2
T13260	DRUGINFO	D02ABO	NARINGENIN	Phase 1
T13260	DRUGINFO	D0B6PZ	FORMESTANE	Withdrawn from market
T13260	DRUGINFO	D04PSL	FINROZOLE	Discontinued in Phase 2
T13260	DRUGINFO	D0U9LL	NKS-01	Discontinued in Phase 2
T13260	DRUGINFO	D0D3PF	VOROZOLE	Discontinued in Phase 2
T13260	DRUGINFO	D0Y2OG	YM-511	Discontinued in Phase 2
T13260	DRUGINFO	D0FS9K	MINAMESTANE	Terminated
T13260	DRUGINFO	D06JUR	Rogletimide	Terminated
T13260	DRUGINFO	D00HVZ	(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one	Investigative
T13260	DRUGINFO	D0A2FO	(+/-)-7-methoxy-2-phenylchroman-4-one	Investigative
T13260	DRUGINFO	D09XKH	(2S)-5,7,2',4'-tetrahydroxyflavanone	Investigative
T13260	DRUGINFO	D0NH6T	(2S)-abyssinone II	Investigative
T13260	DRUGINFO	D09OPA	(2S)-euchrenone a7	Investigative
T13260	DRUGINFO	D0D7GG	1-(1-Benzyl-2-biphenyl-4-yl-ethyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D01IJX	1-(2-(benzo[b]thiophen-4-yl)ethyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D08TKB	1-(2-phenoxybenzyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D0D0DR	1-(3-(4-fluorophenyl)propyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D03KLN	1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole	Investigative
T13260	DRUGINFO	D0XS6T	1-(4-Aminophenyl)-2-(1H-imidazol-1-yl)ethanone	Investigative
T13260	DRUGINFO	D05FFY	1-(4-Cyanobenzyl)-5-methyl-1H-imidazole	Investigative
T13260	DRUGINFO	D0V3MV	1-(4-nitro-2-phenoxybenzyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D0F4WQ	1-(4-Nitro-2-phenylsulfanylbenzyl)-1H-imidazole	Investigative
T13260	DRUGINFO	D0S0OV	1-(7-Methoxy-2-phenyl-chroman-4-yl)-1H-imidazole	Investigative
T13260	DRUGINFO	D07TIJ	1-(9H-fluoren-9-yl)-1H-imidazole	Investigative
T13260	DRUGINFO	D0GL0L	1-(9-phenyl-9H-fluoren-9-yl)-1H-1,2,4-triazole	Investigative
T13260	DRUGINFO	D02SIT	1-(9-Phenyl-9H-fluoren-9-yl)1H-imidazole	Investigative
T13260	DRUGINFO	D0I5PY	1-(biphenyl-3-ylmethyl)-1H-1,2,4-triazole	Investigative
T13260	DRUGINFO	D0P3ND	1-[(7-Fluoronaphth-2-yl)methyl]-1H-imidazole	Investigative
T13260	DRUGINFO	D0C3XU	10-EPI-8-DEOXY-CUMAMBRIN B	Investigative
T13260	DRUGINFO	D04TBB	11BETA,13-DIHYDRO-10-EPI-8-DEOXYCUMAM-BRIN B	Investigative
T13260	DRUGINFO	D07PHV	1-Bromo-4-imidazol-1-ylmethyl-xanthen-9-one	Investigative
T13260	DRUGINFO	D06FHE	1-Ethyl-5-(imidazol-1-yl-phenyl-methyl)-1H-indole	Investigative
T13260	DRUGINFO	D07CTI	1-Imidazol-1-ylmethyl-4-nitro-xanthen-9-one	Investigative
T13260	DRUGINFO	D01SZX	1-Imidazol-1-ylmethylxanthen-9-one	Investigative
T13260	DRUGINFO	D0G6QL	1-Naphthalen-2-yl-1H-imidazole	Investigative
T13260	DRUGINFO	D08UQH	2-(1H-Imidazol-1-yl)-1-(4-nitrophenyl)ethanone	Investigative
T13260	DRUGINFO	D0B8PE	2-(3-hydroxyphenyl)-7-methoxychroman-4-one	Investigative
T13260	DRUGINFO	D0W3LM	2-(4-hydroxyphenyl)-7-methoxychroman-4-one	Investigative
T13260	DRUGINFO	D0K5GG	2,3,4-Trimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0G2JV	2,3,5-Trimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0F4MF	2,3-Dimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0A7PA	2,4-Dimethoxy-3'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0I1SI	2,4-Dimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0W7GU	2,5-Dimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0W4IB	2-Imidazol-1-yl-7-methoxy-3-phenyl-chromen-4-one	Investigative
T13260	DRUGINFO	D0AW7Q	2-Imidazol-1-ylmethylxanthen-9-one	Investigative
T13260	DRUGINFO	D08FOJ	2-phenyl-2,3-dihydrobenzo[h]chromen-4-one	Investigative
T13260	DRUGINFO	D07FGX	2-Phenyl-3-pyridin-4-ylmethylene-chroman-4-one	Investigative
T13260	DRUGINFO	D0O0BL	2-Phenyl-4-[1,2,4]triazol-1-yl-chroman-7-ol	Investigative
T13260	DRUGINFO	D04WJN	3-((1H-imidazol-1-yl)methyl)-9H-xanthen-9-one	Investigative
T13260	DRUGINFO	D0MA9G	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T13260	DRUGINFO	D0K5KG	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T13260	DRUGINFO	D02XTS	3-(2,2-Diphenyl-vinyl)-pyridine	Investigative
T13260	DRUGINFO	D0I5NW	3-(3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D08HPU	3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D01MPK	3-(4-Amino-phenyl)-1-methyl-pyrrolidine-2,5-dione	Investigative
T13260	DRUGINFO	D0B5MZ	3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione	Investigative
T13260	DRUGINFO	D0Z1OI	3-(4-Amino-phenyl)-3-ethyl-pyrrolidine-2,5-dione	Investigative
T13260	DRUGINFO	D0E2RV	3-(4-Amino-phenyl)-3-heptyl-piperidine-2,6-dione	Investigative
T13260	DRUGINFO	D0O1ZM	3-(4-Amino-phenyl)-3-hexyl-piperidine-2,6-dione	Investigative
T13260	DRUGINFO	D05HRP	3-(4-Amino-phenyl)-3-methyl-pyrrolidine-2,5-dione	Investigative
T13260	DRUGINFO	D0A2GB	3-(4-Amino-phenyl)-3-pentyl-piperidine-2,6-dione	Investigative
T13260	DRUGINFO	D0AM2Z	3-(4-Amino-phenyl)-3-propyl-piperidine-2,6-dione	Investigative
T13260	DRUGINFO	D0H1LK	3-(4-Amino-phenyl)-pyrrolidine-2,5-dione	Investigative
T13260	DRUGINFO	D0X1QS	3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D04IBH	3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine	Investigative
T13260	DRUGINFO	D08ZTZ	3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine	Investigative
T13260	DRUGINFO	D0R0TE	3-(6-Ethoxy-naphthalen-2-yl)-pyridine	Investigative
T13260	DRUGINFO	D0NX0M	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D0N1PQ	3-(6-methoxynaphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D00BVP	3-(imidazolylmethyl)-4'-methoxyflavone	Investigative
T13260	DRUGINFO	D08EZA	3-(imidazolylmethyl)-4'-nitroflavone	Investigative
T13260	DRUGINFO	D04VRY	3-(imidazolylmethyl)-7-methoxy-4'-nitroflavone	Investigative
T13260	DRUGINFO	D07SOM	3-(imidazolylmethyl)flavone	Investigative
T13260	DRUGINFO	D08FAB	3-(naphthalen-2-yl)pyridine	Investigative
T13260	DRUGINFO	D08KLN	3,4'-(Ethane-1,2-diyl)dibenzenamine	Investigative
T13260	DRUGINFO	D0NB8V	3,4,5-Trimethoxy-3'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D09MQF	3,4,5-Trimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D07JKK	3,4-bis(3,4-dimethoxyphenyl)furan-2(5H)-one	Investigative
T13260	DRUGINFO	D0T0CK	3,4-Dimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0S7VY	3,5-Diacetoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D03FBI	3,5-Diamino-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0J4VR	3,5-Dihydroxyl-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0Q8UZ	3,5-Dimethoxy-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0TM4K	3-[3-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D02BWQ	3-[3-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0Y0CT	3-[3-Phenyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0V3YH	3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D05MQE	3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D04QPK	3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0L1JF	3-[4-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D04CLL	3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0AH1B	3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D08AZK	3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0U7RR	3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D02NAG	3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D04ELJ	3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0N9PY	3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0Q3JZ	3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0V8CR	3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0M7FS	3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D09YXV	3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D08PNF	3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D00VUO	3-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0AY4E	3-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0Y7RB	3-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0YS2F	3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0Q6XB	3-Amino-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D00GCK	3-Fluoren-9-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D0Q0BK	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol	Investigative
T13260	DRUGINFO	D01SUE	3-Indan-(1E)-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D07PYC	3-Indan-(1Z)-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D07UVN	3-Methoxyl-4'-amino-trans-stilbene	Investigative
T13260	DRUGINFO	D0J8FS	3-Nitro-4'-nitro-trans-stilbene	Investigative
T13260	DRUGINFO	D0M5EW	4-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	Investigative
T13260	DRUGINFO	D09HEA	4-((1H-imidazol-1-yl)methyl)benzonitrile	Investigative
T13260	DRUGINFO	D0N7QV	4-(1-Imidazol-1-yl-vinyl)-benzonitrile	Investigative
T13260	DRUGINFO	D0U6NJ	4-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	Investigative
T13260	DRUGINFO	D0Z4GR	4-(2,2-Diphenyl-vinyl)-pyridine	Investigative
T13260	DRUGINFO	D04HVL	4-(3,4,5-Trimethoxyphenethyl)aniline	Investigative
T13260	DRUGINFO	D0O6ZM	4-(3,4-Dimethoxyphenethyl)aniline	Investigative
T13260	DRUGINFO	D0WK9Q	4-(3,5-Dimethoxyphenethyl)benzenamine	Investigative
T13260	DRUGINFO	D01REI	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol	Investigative
T13260	DRUGINFO	D0WN9P	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine	Investigative
T13260	DRUGINFO	D0I1YH	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T13260	DRUGINFO	D03EXD	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T13260	DRUGINFO	D0D9FR	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0YD9J	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0F5YU	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D03MKT	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D09HOE	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D09HGK	4-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D07ZYL	4-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0K3CE	4-[6-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0J2WW	4-[6-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0D8GU	4-[6-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D07ZCD	4-[6-Methyl-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T13260	DRUGINFO	D0M8RO	4-ANDROSTENE-3-17-DIONE	Investigative
T13260	DRUGINFO	D07IQG	4-Bromo-1-imidazol-1-ylmethyl-xanthen-9-one	Investigative
T13260	DRUGINFO	D06WPP	4'-bromo-3-(imidazolylmethyl)-7-methoxyflavone	Investigative
T13260	DRUGINFO	D09ZHX	4'-bromo-3-(imidazolylmethyl)flavone	Investigative
T13260	DRUGINFO	D05PXK	4'-cyano-3-(imidazolylmethyl)-7-methoxyflavone	Investigative
T13260	DRUGINFO	D0CR6B	4'-cyano-3-(imidazolylmethyl)flavone	Investigative
T13260	DRUGINFO	D04IJE	4-Fluoren-9-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D0J3PK	4-Imidazol-1-yl-2-phenyl-chroman-7-ol	Investigative
T13260	DRUGINFO	D0W9ZC	4-Imidazol-1-ylmethyl-1-nitrothioxanthen-9-one	Investigative
T13260	DRUGINFO	D01LOU	4-Imidazol-1-ylmethyl-1-nitro-xanthen-9-one	Investigative
T13260	DRUGINFO	D0HC9U	4-Imidazol-1-ylmethyl-2-nitroxanthen-9-one	Investigative
T13260	DRUGINFO	D0K5JU	4-Imidazol-1-ylmethyl-3-nitroxanthen-9-one	Investigative
T13260	DRUGINFO	D0I2UE	4-Imidazol-1-ylmethylthioxanthen-9-one	Investigative
T13260	DRUGINFO	D0F5AC	4-Imidazol-1-ylmethylxanthen-9-one	Investigative
T13260	DRUGINFO	D05YNW	4-Indan-(1E)-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D02CSU	4-Indan-(1Z)-ylidenemethyl-pyridine	Investigative
T13260	DRUGINFO	D0Y0QI	5-((1H-imidazol-1-yl)methyl)-7,8-dihydroquinoline	Investigative
T13260	DRUGINFO	D0X8UK	5-(2-(1H-imidazol-1-yl)ethyl)quinoline	Investigative
T13260	DRUGINFO	D0E9WX	5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole	Investigative
T13260	DRUGINFO	D02XHH	5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole	Investigative
T13260	DRUGINFO	D06HFV	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine	Investigative
T13260	DRUGINFO	D04REX	5-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyrimidine	Investigative
T13260	DRUGINFO	D0C8EO	5-[5-Methoxy-indan-(1E)-ylidenemethyl]-thiazole	Investigative
T13260	DRUGINFO	D0U6IT	5-[5-Methoxy-indan-(1Z)-ylidenemethyl]-thiazole	Investigative
T13260	DRUGINFO	D0UI8Q	5-Bromo-8-imidazol-1-ylmethyl-chromen-4-one	Investigative
T13260	DRUGINFO	D03TRM	5-Indan-(1E)-ylidenemethyl-1H-imidazole	Investigative
T13260	DRUGINFO	D09QDY	5-Indan-(1Z)-ylidenemethyl-1H-imidazole	Investigative
T13260	DRUGINFO	D0K2DR	5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one	Investigative
T13260	DRUGINFO	D0G9WP	5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one	Investigative
T13260	DRUGINFO	D0T2IX	6-((1H-imidazol-1-yl)methyl)-2H-chromene-2-thione	Investigative
T13260	DRUGINFO	D08PKR	6-Imidazol-1-yl-isoquinoline	Investigative
T13260	DRUGINFO	D0OY1J	7-((1H-imidazol-1-yl)methyl)-2H-chromen-2-one	Investigative
T13260	DRUGINFO	D0DJ3R	7-((1H-imidazol-1-yl)methyl)-4H-chromen-4-one	Investigative
T13260	DRUGINFO	D0PU5V	7-((1H-imidazol-1-yl)methyl)isoquinoline	Investigative
T13260	DRUGINFO	D07TUX	7-(2-(1H-imidazol-1-yl)ethoxy)-2H-chromen-2-one	Investigative
T13260	DRUGINFO	D0SY6C	7,4'-Dihydroxyflavone	Investigative
T13260	DRUGINFO	D0L9BT	7-[1,2,4]Triazol-4-ylmethyl-chromen-4-one	Investigative
T13260	DRUGINFO	D0Y0EK	7-hydroxy-2-(3-hydroxyphenyl)chroman-4-one	Investigative
T13260	DRUGINFO	D05ZPO	7-hydroxy-2-phenylchroman-4-one	Investigative
T13260	DRUGINFO	D0V8SM	8-Imidazol-1-ylmethyl-5-nitro-chromen-4-one	Investigative
T13260	DRUGINFO	D0V0DB	9-Hydroxy-7,8-benzoflavone	Investigative
T13260	DRUGINFO	D01OQW	ALBANOL A	Investigative
T13260	DRUGINFO	D0I7GE	ALPHA-NAPHTHOFLAVONE	Investigative
T13260	DRUGINFO	D0W9PF	ANDROSTENEDONE	Investigative
T13260	DRUGINFO	D00RIX	APIGENIN	Investigative
T13260	DRUGINFO	D0QL1V	Benzyl-biphenyl-4-ylmethyl-imidazol-1-yl-amine	Investigative
T13260	DRUGINFO	D0S9YX	biochanin A	Investigative
T13260	DRUGINFO	D0W3LG	Broussoflavonol F	Investigative
T13260	DRUGINFO	D0V1UY	CGS-18320B	Investigative
T13260	DRUGINFO	D01UYI	Chrysin	Investigative
T13260	DRUGINFO	D0U9QB	DEHYDROLEUCODIN	Investigative
T13260	DRUGINFO	D0Y8XJ	Docosapentaenoic acid	Investigative
T13260	DRUGINFO	D0S0RK	flavone	Investigative
T13260	DRUGINFO	D05IWY	Gamma-mangostin	Investigative
T13260	DRUGINFO	D05YJR	GARCINONE D	Investigative
T13260	DRUGINFO	D0Z7EL	GOSSYPETIN	Investigative
T13260	DRUGINFO	D09ZIW	Isogemichalcone C	Investigative
T13260	DRUGINFO	D0E5FV	ISOLICOFLAVONOL	Investigative
T13260	DRUGINFO	D0K4PY	LIQUIRTIGENIN	Investigative
T13260	DRUGINFO	D06HJB	LUDARTIN	Investigative
T13260	DRUGINFO	D0M2IB	MDL-18962	Investigative
T13260	DRUGINFO	D0F8IB	MONODICTYOCHROMONE B	Investigative
T13260	DRUGINFO	D0U8JC	MORACHALCONE A	Investigative
T13260	DRUGINFO	D08IIW	MR-16089	Investigative
T13260	DRUGINFO	D0DO1T	MR-20492	Investigative
T13260	DRUGINFO	D02LTV	MR-20494	Investigative
T13260	DRUGINFO	D0R4WW	MR-20496	Investigative
T13260	DRUGINFO	D00AVS	MR-20814	Investigative
T13260	DRUGINFO	D0C5ZP	N-(2-benzyloxy-4-nitrophenyl)methanesulfonamide	Investigative
T13260	DRUGINFO	D0F9MQ	N-(2-hexyloxy-4-nitrophenyl)methanesulfonamide	Investigative
T13260	DRUGINFO	D04DZZ	N-(2-nonyloxy-4-nitrophenyl)methanesulfonamide	Investigative
T13260	DRUGINFO	D0E3IK	N-(2-Propyloxy-4-nitrophenyl)methanesulfonamide	Investigative
T13260	DRUGINFO	D0M0FE	N-[2-(4'-Nitrophenyl)ethyl]-imidazole	Investigative
T13260	DRUGINFO	D0R2YN	NSC-122427	Investigative
T13260	DRUGINFO	D00ZPJ	NSC-12999	Investigative
T13260	DRUGINFO	D06AZC	NSC-131736	Investigative
T13260	DRUGINFO	D07PHT	NSC-289311	Investigative
T13260	DRUGINFO	D06GIV	NSC-356483	Investigative
T13260	DRUGINFO	D0S8MJ	NSC-356781	Investigative
T13260	DRUGINFO	D08ARY	NSC-368272	Investigative
T13260	DRUGINFO	D02QSH	NSC-368280	Investigative
T13260	DRUGINFO	D0Y4TE	NSC-369087	Investigative
T13260	DRUGINFO	D0M4CX	NSC-613604	Investigative
T13260	DRUGINFO	D0Y9HD	NSC-625409	Investigative
T13260	DRUGINFO	D0T3ED	NSC-666292	Investigative
T13260	DRUGINFO	D0HR9S	NSC-683634	Investigative
T13260	DRUGINFO	D08AAP	NSC-75308	Investigative
T13260	DRUGINFO	D09MYQ	NSC-93358	Investigative
T13260	DRUGINFO	D01KKU	NSC-94258	Investigative
T13260	DRUGINFO	D0P5ZV	NSC-94891	Investigative
T13260	DRUGINFO	D0Y1EX	Org-33201	Investigative
T13260	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T13260	KEGGPATH	hsa01100:Metabolic pathways		
T13260	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T13260	WIKIPATH	WP1879:Phase 1 - Functionalization of compounds		
T13260	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T13260	WIKIPATH	WP2035:FSH signaling pathway		
T13260	WIKIPATH	WP2749:Metabolism of steroid hormones and vitamin D		
T13260	WIKIPATH	WP34:Ovarian Infertility Genes		
T13260	WIKIPATH	WP43:Oxidation by Cytochrome P450		
T13260	WIKIPATH	WP465:Tryptophan metabolism		
T13260	WIKIPATH	WP702:Metapathway biotransformation		
T13260	WHIZPATH	PW000045:Androgen and Estrogen Metabolism		
T13260	REACPATH	R-HSA-211976:Endogenous sterols		
T13260	NET_PATH	NetPath_25:FSH Signaling Pathway		
T13260	PANTPATH	P02727:Androgen/estrogene/progesterone biosynthesis		
T13260	BIOCPATH	PWY66-380:Estradiol biosynthesis I		
T13260	BIOCPATH	PWY-7305:Superpathway of steroid hormone biosynthesis		
T13260	BIOCPATH	PWY-7306:Estradiol biosynthesis II		
				
T85799	TARGETID	T85799		
T85799	FORMERID	TTDC00165		
T85799	UNIPROID	CDK4_HUMAN		
T85799	TARGNAME	Cyclin-dependent kinase 4 (CDK4)		
T85799	GENENAME	CDK4		
T85799	TARGTYPE	Successful target		
T85799	SYNONYMS	PSK-J3; Cell division protein kinase 4		
T85799	FUNCTION	Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex. Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition.		
T85799	PDBSTRUC	5FWP; 5FWM; 5FWL; 5FWK; 3G33		
T85799	BIOCLASS	Kinase		
T85799	ECNUMBER	EC 2.7.11.22		
T85799	SEQUENCE	MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGNPE		
T85799	DRUGINFO	D07ESC	Apremilast	Approved
T85799	DRUGINFO	D05SBO	LY2835219	Approved
T85799	DRUGINFO	D00UZR	Palbociclib	Approved
T85799	DRUGINFO	D01HVT	Ribociclib Succinate	Approved
T85799	DRUGINFO	D0AP9E	Trilaciclib	Approved
T85799	DRUGINFO	D08MXP	LEE011	Phase 3
T85799	DRUGINFO	D0WU1O	G1T38	Phase 2
T85799	DRUGINFO	D0W8IY	P-276	Phase 2
T85799	DRUGINFO	D05IRT	P276-00	Phase 2
T85799	DRUGINFO	D01UMT	Ro 31-7453	Phase 2
T85799	DRUGINFO	D8ZV2Q	FCN-437	Phase 1/2
T85799	DRUGINFO	D4IS0G	GLR2007	Phase 1/2
T85799	DRUGINFO	D0IX4B	AG-024322	Phase 1
T85799	DRUGINFO	DKCU40	FN-1501	Phase 1
T85799	DRUGINFO	D01XZG	G1T28-1	Phase 1
T85799	DRUGINFO	D0DX4J	P1446A-05	Phase 1
T85799	DRUGINFO	DZJ3D5	PF-07220060	Phase 1
T85799	DRUGINFO	D0P1CV	PHA-793887	Phase 1
T85799	DRUGINFO	D03DKV	RGB-286638	Phase 1
T85799	DRUGINFO	D0WT7D	Imidazo pyridine derivative 3	Patented
T85799	DRUGINFO	D0LX6X	Indole-based analog 13	Patented
T85799	DRUGINFO	D0W4MN	Isoquinoline 1,3-dione derivative 1	Patented
T85799	DRUGINFO	D0M5DX	Oxazolyl methylthiothiazole derivative 1	Patented
T85799	DRUGINFO	D03HED	Palbociclib/ribociclib analog 1	Patented
T85799	DRUGINFO	D0X5VI	PMID25726713-Compound-47	Patented
T85799	DRUGINFO	D0WJ3W	PMID25726713-Compound-48	Patented
T85799	DRUGINFO	D07TVO	PMID25726713-Compound-49	Patented
T85799	DRUGINFO	D0Y8JF	PMID25726713-Compound-50	Patented
T85799	DRUGINFO	D0KH7Q	PMID25726713-Compound-51	Patented
T85799	DRUGINFO	D0H4HD	PMID25991433-Compound-A1	Patented
T85799	DRUGINFO	D0FQ6V	PMID26161698-Compound-17	Patented
T85799	DRUGINFO	D04AKA	Pyrrolo[2,3-d]pyrimidine derivative 10	Patented
T85799	DRUGINFO	D08KKC	Pyrrolo[2,3-d]pyrimidine derivative 9	Patented
T85799	DRUGINFO	D0NV9O	BAY 10-00394	Discontinued in Phase 2
T85799	DRUGINFO	D04FHB	R547	Discontinued in Phase 1
T85799	DRUGINFO	D00VBT	ZK 304709	Discontinued in Phase 1
T85799	DRUGINFO	D07ZJC	INOC-005	Preclinical
T85799	DRUGINFO	D0Y6HA	CYC-103	Terminated
T85799	DRUGINFO	D0Z0KD	PD-0183812	Terminated
T85799	DRUGINFO	D0G4JS	1-(1H-Indazol-6-yl)-3-pyridin-2-yl-urea	Investigative
T85799	DRUGINFO	D0M8CO	1-(7-Hydroxy-naphthalen-1-yl)-3-pyridin-2-yl-urea	Investigative
T85799	DRUGINFO	D0X1NW	1-(9-Oxo-9H-fluoren-4-yl)-3-pyridin-2-yl-urea	Investigative
T85799	DRUGINFO	D0W6CE	10-hydroxy-18-methoxybetaenone	Investigative
T85799	DRUGINFO	D0T2VG	1-Pyridin-2-yl-3-quinolin-5-yl-urea	Investigative
T85799	DRUGINFO	D0EK0G	3-(4-methoxyphenyl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T85799	DRUGINFO	D06AOY	3-(indole-3-yl)-4-phenyl-1H-pyrrole-2,5-dione	Investigative
T85799	DRUGINFO	D00NYT	3,4-di-(4-methoxyphenyl)-1H-pyrrole-2,5-dione	Investigative
T85799	DRUGINFO	D0C3WY	3,4-diphenyl-1H-pyrrole-2,5-dione	Investigative
T85799	DRUGINFO	D0A5RM	4-[(3,5-diamino-1H-pyrazol-4-yl)diazenyl]phenol	Investigative
T85799	DRUGINFO	D07HPE	Cdk4 inhibitor III	Investigative
T85799	DRUGINFO	D09OAH	Fascaplysin	Investigative
T85799	DRUGINFO	D0D5HQ	K00024	Investigative
T85799	DRUGINFO	D03VDM	N-(2-(1H-Indol-3-yl)ethyl)biphenyl-4-carboxamide	Investigative
T85799	DRUGINFO	D0VD8B	NSC-625987	Investigative
T85799	DRUGINFO	D0Y5RO	NU-6102	Investigative
T85799	DRUGINFO	D04WFN	NU6140	Investigative
T85799	DRUGINFO	D0P6JS	PMID18986805C9b	Investigative
T85799	DRUGINFO	D02DLC	PYRAZOLOPYRIDAZINE 1	Investigative
T85799	DRUGINFO	D0O0VP	PYRAZOLOPYRIDAZINE 2	Investigative
T85799	DRUGINFO	D09RYV	Ro-0505124	Investigative
T85799	KEGGPATH	hsa04110:Cell cycle		
T85799	KEGGPATH	hsa04115:p53 signaling pathway		
T85799	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T85799	KEGGPATH	hsa04530:Tight junction		
T85799	KEGGPATH	hsa04660:T cell receptor signaling pathway		
T85799	KEGGPATH	hsa05161:Hepatitis B		
T85799	KEGGPATH	hsa05162:Measles		
T85799	KEGGPATH	hsa05166:HTLV-I infection		
T85799	KEGGPATH	hsa05200:Pathways in cancer		
T85799	KEGGPATH	hsa05203:Viral carcinogenesis		
T85799	KEGGPATH	hsa05212:Pancreatic cancer		
T85799	KEGGPATH	hsa05214:Glioma		
T85799	KEGGPATH	hsa05218:Melanoma		
T85799	KEGGPATH	hsa05219:Bladder cancer		
T85799	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T85799	KEGGPATH	hsa05222:Small cell lung cancer		
T85799	KEGGPATH	hsa05223:Non-small cell lung cancer		
T85799	WIKIPATH	WP1530:miRNA Regulation of DNA Damage Response		
T85799	WIKIPATH	WP179:Cell Cycle		
T85799	WIKIPATH	WP1858:Mitotic G1-G1/S phases		
T85799	WIKIPATH	WP1971:Integrated Cancer pathway		
T85799	WIKIPATH	WP1984:Integrated Breast Cancer Pathway		
T85799	WIKIPATH	WP2032:TSH signaling pathway		
T85799	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T85799	WIKIPATH	WP2263:Prostate Cancer		
T85799	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T85799	WIKIPATH	WP2431:Spinal Cord Injury		
T85799	WIKIPATH	WP2446:Retinoblastoma (RB) in Cancer		
T85799	WIKIPATH	WP2698:Meiotic Recombination		
T85799	WIKIPATH	WP2751:Transcriptional Regulation of White Adipocyte Differentiation		
T85799	WIKIPATH	WP2772:S Phase		
T85799	WIKIPATH	WP2828:Bladder Cancer		
T85799	WIKIPATH	WP2878:PPAR Alpha Pathway		
T85799	WIKIPATH	WP34:Ovarian Infertility Genes		
T85799	WIKIPATH	WP45:G1 to S cell cycle control		
T85799	WIKIPATH	WP707:DNA Damage Response		
T85799	REACPATH	R-HSA-2559580:Oxidative Stress Induced Senescence		
T85799	REACPATH	R-HSA-2559582:Senescence-Associated Secretory Phenotype (SASP)		
T85799	REACPATH	R-HSA-2559585:Oncogene Induced Senescence		
T85799	REACPATH	R-HSA-3214858:RMTs methylate histone arginines		
T85799	REACPATH	R-HSA-381340:Transcriptional regulation of white adipocyte differentiation		
T85799	REACPATH	R-HSA-69229:Ubiquitin-dependent degradation of Cyclin D1		
T85799	REACPATH	R-HSA-69231:Cyclin D associated events in G1		
T85799	REACPATH	R-HSA-912446:Meiotic recombination		
T85799	NET_PATH	NetPath_11:TCR Signaling Pathway		
T85799	NET_PATH	NetPath_21:RANKL Signaling Pathway		
T85799	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T85799	INTEPATH	atf2_pathway:ATF-2 transcription factor network		
T85799	INTEPATH	foxm1pathway:FOXM1 transcription factor network		
T85799	INTEPATH	myc_activpathway:Validated targets of C-MYC transcriptional activation		
T85799	INTEPATH	nfat_tfpathway:Calcineurin-regulated NFAT-dependent transcription in lymphocytes		
T85799	INTEPATH	rb_1pathway:Regulation of retinoblastoma protein		
T85799	INTEPATH	smad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling		
				
T60366	TARGETID	T60366		
T60366	FORMERID	TTDS00313		
T60366	UNIPROID	DCOR_HUMAN		
T60366	TARGNAME	Ornithine decarboxylase (ODC1)		
T60366	GENENAME	ODC1		
T60366	TARGTYPE	Successful target		
T60366	SYNONYMS	ODC		
T60366	FUNCTION	Polyamines are essential for cell proliferation and are implicated in cellular processes, ranging from DNA replication to apoptosis. Catalyzes the first and rate-limiting step of polyamine biosynthesis that converts ornithine into putrescine, which is the precursor for the polyamines, spermidine and spermine.		
T60366	PDBSTRUC	5BWA; 4ZGY; 2OO0; 2ON3; 1D7K		
T60366	BIOCLASS	Carbon-carbon lyase		
T60366	ECNUMBER	EC 4.1.1.17		
T60366	SEQUENCE	MNNFGNEEFDCHFLDEGFTAKDILDQKINEVSSSDDKDAFYVADLGDILKKHLRWLKALPRVTPFYAVKCNDSKAIVKTLAATGTGFDCASKTEIQLVQSLGVPPERIIYANPCKQVSQIKYAANNGVQMMTFDSEVELMKVARAHPKAKLVLRIATDDSKAVCRLSVKFGATLRTSRLLLERAKELNIDVVGVSFHVGSGCTDPETFVQAISDARCVFDMGAEVGFSMYLLDIGGGFPGSEDVKLKFEEITGVINPALDKYFPSDSGVRIIAEPGRYYVASAFTLAVNIIAKKIVLKEQTGSDDEDESSEQTFMYYVNDGVYGSFNCILYDHAHVKPLLQKRPKPDEKYYSSSIWGPTCDGLDRIVERCDLPEMHVGDWMLFENMGAYTVAAASTFNGFQRPTIYYVMSGPAWQLMQQFQNPDFPPEVEEQDASTLPVSCAWESGMKRHRAACASASINV		
T60366	DRUGINFO	D0X7JR	Eflornithine	Approved
T60366	DRUGINFO	D00FMV	Putrescine	Discontinued in Phase 2
T60366	DRUGINFO	D02XYV	(2R,5R)-delta-methyl-alpha-acetylenic putrescine	Investigative
T60366	DRUGINFO	D0XR2J	1-Amino-3-(aminoxy)-2-propanol Dihydrochloride	Investigative
T60366	DRUGINFO	D0K6WI	3-(Aminooxy)propan-1-amine hydrochloride	Investigative
T60366	DRUGINFO	D0N4YR	3-methoxy-4-hydroxylonchocarpin	Investigative
T60366	DRUGINFO	D0F3QP	4-hydroxylonchocarpin	Investigative
T60366	DRUGINFO	D08TLJ	Alpha-monofluoromethyl-3,4-dehydroornithine	Investigative
T60366	DRUGINFO	D0H2OA	Alpha-monofluoromethyl-3,4-dehydroornithine ethyl ester	Investigative
T60366	DRUGINFO	D08CKE	Alpha-monofluoromethyl-3,4-dehydroornithine methyl ester	Investigative
T60366	DRUGINFO	D01OHD	AMXT-1501	Investigative
T60366	DRUGINFO	D01IGU	APA	Investigative
T60366	DRUGINFO	D03LMM	G418	Investigative
T60366	DRUGINFO	D04ZDD	LONCHOCARPUSONE	Investigative
T60366	DRUGINFO	D09AHL	N-Pyridoxyl-Glycine-5-Monophosphate	Investigative
T60366	DRUGINFO	D0I5PZ	N'-Pyridoxyl-Lysine-5'-Monophosphate	Investigative
T60366	DRUGINFO	D0B8JD	Pyridoxine-5'-Phosphate	Investigative
T60366	DRUGINFO	D04FIN	ZAPOTIN	Investigative
T60366	WHIZPATH	PW000037:Spermidine and Spermine Biosynthesis		
T60366	NET_PATH	NetPath_11:TCR Signaling Pathway		
T60366	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T60366	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T60366	INTEPATH	myc_activpathway:Validated targets of C-MYC transcriptional activation		
T60366	PANTPATH	P02758:Ornithine degradation		
T60366	PANTPATH	P06959:CCKR signaling map ST		
T60366	BIOCPATH	PWY-46:Putrescine biosynthesis I		
				
T52227	TARGETID	T52227		
T52227	FORMERID	TTDS00301		
T52227	UNIPROID	TYSY_CANAL		
T52227	TARGNAME	Candida Thymidylate synthase (Candi TMP1)		
T52227	GENENAME	Candi TMP1		
T52227	TARGTYPE	Successful target		
T52227	SYNONYMS	Tsase of Candida albicans; TS of Candida albicans; TMP1; Human recombinant thymidylate synthase; HrTS		
T52227	FUNCTION	Contributes to thede novo mitochondrial thymidylate biosynthesis pathway.		
T52227	BIOCLASS	Methyltransferase		
T52227	ECNUMBER	EC 2.1.1.45		
T52227	SEQUENCE	MTVSPNTAEQAYLDLCKRIIDEGEHRPDRTGTGTKSLFAPPQLRFDLSNDTFPLLTTKKVFSKGIIHELLWFVAGSTDAKILSEKGVKIWEGNGSREFLDKLGLTHRREGDLGPVYGFQWRHFGAEYKDCDSDYTGQGFDQLQDVIKKLKTNPYDRRIIMSAWNPPDFAKMALPPCHVFCQFYVNFPTSSPDPNNPKQAKTAKPKLSCLLYQRSCDMGLGVPFNIASYALLTKMIAHVVDMDCGEFIHTLGDAHVYLDHIDALKEQFERIPKQFPKLVIKEERKNEIKSIDDFKFEDFEIVGYEPYPPIKMKMSV		
T52227	DRUGINFO	D00HCQ	Capecitabine	Approved
T52227	DRUGINFO	D0O1WX	Ciprofloxacin XR	Approved
T52227	DRUGINFO	D0TS1Z	Floxuridine	Approved
T52227	DRUGINFO	D0S5WG	Flucytosine	Approved
T52227	DRUGINFO	D05LEO	Fluorouracil	Approved
T52227	DRUGINFO	D0M3MN	Leucovorin/5-fluorouracil	Approved
T52227	DRUGINFO	D0Y4GO	Pemetrexed	Approved
T52227	DRUGINFO	D01KKQ	Raltitrexed	Approved
T52227	DRUGINFO	D05RHI	Trifluridine	Approved
T52227	DRUGINFO	D06WQT	Nolatrexed	Phase 3
T52227	DRUGINFO	D0I9GR	Plevitrexed	Phase 2
T52227	DRUGINFO	D04FYZ	Plevitrexed (R)-isomer	Phase 2
T52227	DRUGINFO	D0Q0UA	UFT/leucovorin calcium	Phase 2
T52227	DRUGINFO	D05CQS	NB1011	Phase 1/2
T52227	DRUGINFO	D0S9MD	DFP-11207	Phase 1
T52227	DRUGINFO	D0U2CT	EMITEFUR	Discontinued in Preregistration
T52227	DRUGINFO	D0Y4AZ	Galocitabine	Discontinued in Phase 3
T52227	DRUGINFO	D0E8JO	FO-152	Discontinued in Phase 2
T52227	DRUGINFO	D0B6GJ	TT-62	Discontinued in Phase 2
T52227	DRUGINFO	D0C4YA	AG-331	Discontinued in Phase 1
T52227	DRUGINFO	D0L0AU	DMPDDF	Terminated
T52227	DRUGINFO	D03BTP	Fosfluridine tidoxil	Terminated
T52227	DRUGINFO	D00BNE	(6s)-5,6,7,8-Tetrahydrofolate	Investigative
T52227	DRUGINFO	D0G6CU	1,3-propanediphosphonic acid	Investigative
T52227	DRUGINFO	D01GMJ	1,4-Dithiothreitol	Investigative
T52227	DRUGINFO	D0PG5D	10-Propargyl-5,8-Dideazafolic Acid	Investigative
T52227	DRUGINFO	D08STR	2'-5'dideoxyuridine	Investigative
T52227	DRUGINFO	D05HOO	2-bromophenol	Investigative
T52227	DRUGINFO	D06FMH	2'-Deoxycytidine-5'-Monophosphate	Investigative
T52227	DRUGINFO	D0G9XX	2'-Deoxyguanosine-5'-Monophosphate	Investigative
T52227	DRUGINFO	D00CVB	2'-Deoxyuridine	Investigative
T52227	DRUGINFO	D0CZ3C	2'-deoxyuridylic acid	Investigative
T52227	DRUGINFO	D0Q5FV	2-Sulfhydryl-Ethanol	Investigative
T52227	DRUGINFO	D0F2VL	3-Amino-5,6-dihydro-2H-benzo[f]quinazolin-1-one	Investigative
T52227	DRUGINFO	D0UL7N	3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE	Investigative
T52227	DRUGINFO	D09QPT	3-Methyl-2H-benzo[f]quinazolin-1-one	Investigative
T52227	DRUGINFO	D02MUO	4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN	Investigative
T52227	DRUGINFO	D0A6BH	5,10-Methylene-6-Hydrofolic Acid	Investigative
T52227	DRUGINFO	D0I0OH	5-Fluoro-2'-Deoxyuridine-5'-Monophosphate	Investigative
T52227	DRUGINFO	D0JY6J	6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE	Investigative
T52227	DRUGINFO	D04IRR	Ly231514 Tetra Glu	Investigative
T52227	DRUGINFO	D0X9QV	LY341770	Investigative
T52227	DRUGINFO	D0XV3B	Methionine Sulfoxide	Investigative
T52227	DRUGINFO	D0F1LA	N,O-Didansyl-L-Tyrosine	Investigative
T52227	DRUGINFO	D0U0VO	N-[Tosyl-D-Prolinyl]Amino-Ethanethiol	Investigative
T52227	DRUGINFO	D0YX9D	N-Carboxymethionine	Investigative
T52227	DRUGINFO	D01OVV	OVI-117	Investigative
T52227	DRUGINFO	D0UZ9U	PREMETREXED	Investigative
T52227	DRUGINFO	D0P7JE	S,S-(2-Hydroxyethyl)Thiocysteine	Investigative
T52227	DRUGINFO	D01FCH	Sp-722	Investigative
T52227	DRUGINFO	D0K7CR	Sp-876	Investigative
T52227	DRUGINFO	D0ZH0I	Thymidine-5'-Phosphate	Investigative
T52227	DRUGINFO	D07LML	Tosyl-D-Proline	Investigative
T52227	DRUGINFO	D0H9DJ	Uridine-5'-Monophosphate	Investigative
T52227	DRUGINFO	D0VZ0I	ZD1604	Investigative
T52227	KEGGPATH	hsa00240:Pyrimidine metabolism		
T52227	KEGGPATH	hsa00670:One carbon pool by folate		
T52227	KEGGPATH	hsa01100:Metabolic pathways		
T52227	WIKIPATH	WP1601:Fluoropyrimidine Activity		
T52227	WIKIPATH	WP1851:Metabolism of nucleotides		
T52227	WIKIPATH	WP2002:miR-targeted genes in epithelium - TarBase		
T52227	WIKIPATH	WP2003:miR-targeted genes in leukocytes - TarBase		
T52227	WIKIPATH	WP2004:miR-targeted genes in lymphocytes - TarBase		
T52227	WIKIPATH	WP2005:miR-targeted genes in muscle cell - TarBase		
T52227	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T52227	WIKIPATH	WP241:One Carbon Metabolism		
T52227	WIKIPATH	WP2446:Retinoblastoma (RB) in Cancer		
T52227	WIKIPATH	WP2525:Trans-sulfuration and one carbon metabolism		
T52227	WHIZPATH	PW000160:Pyrimidine Metabolism		
T52227	REACPATH	R-HSA-113510:E2F mediated regulation of DNA replication		
T52227	REACPATH	R-HSA-500753:Pyrimidine biosynthesis		
T52227	REACPATH	R-HSA-69205:G1/S-Specific Transcription		
T52227	INTEPATH	e2f_pathway:E2F transcription factor network		
T52227	PANTPATH	P02739:De novo pyrimidine deoxyribonucleotide biosynthesis		
T52227	PANTPATH	P02743:Formyltetrahydroformate biosynthesis		
T52227	BIOCPATH	PWY66-385:DTMP de novo biosynthesis (mitochondrial)		
T52227	BIOCPATH	PWY-7184:Pyrimidine deoxyribonucleotides de novo biosynthesis		
T52227	BIOCPATH	PWY-7199:Pyrimidine deoxyribonucleosides salvage		
T52227	BIOCPATH	PWY-7200:Superpathway of pyrimidine deoxyribonucleoside salvage		
T52227	BIOCPATH	PWY-7210:Pyrimidine deoxyribonucleotides biosynthesis from CTP		
T52227	BIOCPATH	PWY-7211:Superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis		
				
T82577	TARGETID	T82577		
T82577	FORMERID	TTDS00181		
T82577	UNIPROID	ACE_HUMAN		
T82577	TARGNAME	Angiotensin-converting enzyme (ACE)		
T82577	GENENAME	SLC33A1		
T82577	TARGTYPE	Successful target		
T82577	SYNONYMS	Kininase II; Dipeptidyl carboxypeptidase I; DCP1; DCP; CD143 antigen; CD143; ACE		
T82577	FUNCTION	Able to inactivate bradykinin, a potent vasodilator. Has also a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. Converts angiotensin I to angiotensin II by release of the terminal His-Leu, this results in an increase of the vasoconstrictor activity of angiotensin.		
T82577	PDBSTRUC	6QS1; 6H5X; 6H5W; 6F9V; 6F9U		
T82577	BIOCLASS	Glycosylase		
T82577	ECNUMBER	EC 3.2.1.-		
T82577	SEQUENCE	MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQPVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGIDLVTDEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPNSARSEGPLPDSGRVSFLGLDLDAQQARVGQWLLLFLGIALLVATLGLSQRLFSIRHRSLHRHSHGPQFGSEVELRHS		
T82577	DRUGINFO	D0X5SJ	Alacepril	Approved
T82577	DRUGINFO	D0U3EC	Benazepril	Approved
T82577	DRUGINFO	D0I0EG	Captopril	Approved
T82577	DRUGINFO	D04GKO	Cilazapril	Approved
T82577	DRUGINFO	D0G8QW	Delapril	Approved
T82577	DRUGINFO	D09HDR	Deserpidine	Approved
T82577	DRUGINFO	D00SEB	Enalapril	Approved
T82577	DRUGINFO	D0N5HJ	Enalaprilat	Approved
T82577	DRUGINFO	D0X8KY	Fosinopril	Approved
T82577	DRUGINFO	D0U4UQ	Hydrochlorothiazide	Approved
T82577	DRUGINFO	D0S0ES	Imidapril	Approved
T82577	DRUGINFO	D07HGR	Lisinopril	Approved
T82577	DRUGINFO	D00HDU	Moexipril	Approved
T82577	DRUGINFO	D03KYG	Perindopril	Approved
T82577	DRUGINFO	D0I7SZ	Quinapril	Approved
T82577	DRUGINFO	D01STB	Ramipril	Approved
T82577	DRUGINFO	D0G8NJ	Rescinnamine	Approved
T82577	DRUGINFO	D05MFG	Spirapril	Approved
T82577	DRUGINFO	D02DSZ	Temocapril hydrochloride	Approved
T82577	DRUGINFO	D0M5OC	Trandolapril	Approved
T82577	DRUGINFO	D04PBH	CONTIGOSIDE B	Phase 2/3
T82577	DRUGINFO	D00ERV	Gallopamil	Phase 2
T82577	DRUGINFO	D0C1AY	GW-796406	Phase 1
T82577	DRUGINFO	D0K6SM	Ilepatril	Discontinued in Phase 2/3
T82577	DRUGINFO	D05NRI	Ceronapril	Discontinued in Phase 2
T82577	DRUGINFO	D08DWH	Idrapril	Discontinued in Phase 2
T82577	DRUGINFO	D0N5HN	M-100240	Discontinued in Phase 2
T82577	DRUGINFO	D02JUM	METIAPRIL	Discontinued in Phase 2
T82577	DRUGINFO	D03DRW	UTIBAPRIL	Discontinued in Phase 2
T82577	DRUGINFO	D00FHI	Zabiciprilat	Discontinued in Phase 2
T82577	DRUGINFO	D04MBS	BMS-182657	Terminated
T82577	DRUGINFO	D0KR3X	CGS-30440	Terminated
T82577	DRUGINFO	D05COG	DU-1777	Terminated
T82577	DRUGINFO	D0F9BX	GW-660511	Terminated
T82577	DRUGINFO	D05UQD	Omapatrilat	Terminated
T82577	DRUGINFO	D0K9YR	SCH-54470	Terminated
T82577	DRUGINFO	D0I5QZ	SQ-26332	Terminated
T82577	DRUGINFO	D0U7TM	[Cyclopentyl-(2-nitro-benzoyl)-amino]-acetic acid	Investigative
T82577	DRUGINFO	D06IEN	2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose	Investigative
T82577	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T82577	DRUGINFO	D08BFU	ASTRAGALIN	Investigative
T82577	DRUGINFO	D07BNP	BRL-36378	Investigative
T82577	DRUGINFO	D0EW3L	BUTEIN	Investigative
T82577	DRUGINFO	D04DHD	fasidotrilat	Investigative
T82577	DRUGINFO	D0HC9P	Kaempferol-3-O-(2''-O-galloyl)-glucoside	Investigative
T82577	DRUGINFO	D0B8WQ	lisinopril-tryptophan	Investigative
T82577	DRUGINFO	D07APP	LY-292223	Investigative
T82577	DRUGINFO	D0R6KV	moexiprilat	Investigative
T82577	DRUGINFO	D0K8ED	N-Carboxymethyl-N-cyclopentyl-phthalamic acid	Investigative
T82577	DRUGINFO	D09GXF	RB-105	Investigative
T82577	DRUGINFO	D0A1RG	RIP	Investigative
T82577	DRUGINFO	D0OZ3S	RJM-0035-K002	Investigative
T82577	DRUGINFO	D02FMN	RXP-407	Investigative
T82577	KEGGPATH	hsa04614:Renin-angiotensin system		
T82577	KEGGPATH	hsa05142:Chagas disease (American trypanosomiasis)		
T82577	KEGGPATH	hsa05410:Hypertrophic cardiomyopathy (HCM)		
T82577	WIKIPATH	WP2729:Metabolism of Angiotensinogen to Angiotensins		
T82577	WIKIPATH	WP554:ACE Inhibitor Pathway		
T82577	WHIZPATH	PW000563:Angiotensin Metabolism		
T82577	REACPATH	R-HSA-2022377:Metabolism of Angiotensinogen to Angiotensins		
				
T97587	TARGETID	T97587		
T97587	FORMERID	TTDS00445		
T97587	UNIPROID	ITA4_HUMAN		
T97587	TARGNAME	Integrin alpha-4 (ITGA4)		
T97587	GENENAME	ITGA4		
T97587	TARGTYPE	Successful target		
T97587	SYNONYMS	Very late antigen 4; VLA4 subunit alpha; VLA-4 subunit alpha; VLA-4; Integrin alphaIV; Integrin alpha4; Integrin alpha-IV; CD49d; CD49 antigenlike family member D; CD49 antigen-like family member D		
T97587	FUNCTION	Integrins alpha-4/beta-1 (VLA-4) and alpha-4/beta-7 are receptors for fibronectin. They recognize one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha-4/beta-1 recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-4/beta-7 is also a receptor for MADCAM1. It recognizes the sequence L-D-T in MADCAM1. On activated endothelial cells integrin VLA-4 triggers homotypic aggregation for most VLA-4-positive leukocyte cell lines. It may also participate in cytolytic T-cell interactions with target cells. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling. ITGA4:ITGB1 binds to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1.		
T97587	PDBSTRUC	5FPI; 5C7Z; 4HKC; 3V4V; 3V4P		
T97587	BIOCLASS	Integrin		
T97587	SEQUENCE	MAWEARREPGPRRAAVRETVMLLLCLGVPTGRPYNVDTESALLYQGPHNTLFGYSVVLHSHGANRWLLVGAPTANWLANASVINPGAIYRCRIGKNPGQTCEQLQLGSPNGEPCGKTCLEERDNQWLGVTLSRQPGENGSIVTCGHRWKNIFYIKNENKLPTGGCYGVPPDLRTELSKRIAPCYQDYVKKFGENFASCQAGISSFYTKDLIVMGAPGSSYWTGSLFVYNITTNKYKAFLDKQNQVKFGSYLGYSVGAGHFRSQHTTEVVGGAPQHEQIGKAYIFSIDEKELNILHEMKGKKLGSYFGASVCAVDLNADGFSDLLVGAPMQSTIREEGRVFVYINSGSGAVMNAMETNLVGSDKYAARFGESIVNLGDIDNDGFEDVAIGAPQEDDLQGAIYIYNGRADGISSTFSQRIEGLQISKSLSMFGQSISGQIDADNNGYVDVAVGAFRSDSAVLLRTRPVVIVDASLSHPESVNRTKFDCVENGWPSVCIDLTLCFSYKGKEVPGYIVLFYNMSLDVNRKAESPPRFYFSSNGTSDVITGSIQVSSREANCRTHQAFMRKDVRDILTPIQIEAAYHLGPHVISKRSTEEFPPLQPILQQKKEKDIMKKTINFARFCAHENCSADLQVSAKIGFLKPHENKTYLAVGSMKTLMLNVSLFNAGDDAYETTLHVKLPVGLYFIKILELEEKQINCEVTDNSGVVQLDCSIGYIYVDHLSRIDISFLLDVSSLSRAEEDLSITVHATCENEEEMDNLKHSRVTVAIPLKYEVKLTVHGFVNPTSFVYGSNDENEPETCMVEKMNLTFHVINTGNSMAPNVSVEIMVPNSFSPQTDKLFNILDVQTTTGECHFENYQRVCALEQQKSAMQTLKGIVRFLSKTDKRLLYCIKADPHCLNFLCNFGKMESGKEASVHIQLEGRPSILEMDETSALKFEIRATGFPEPNPRVIELNKDENVAHVLLEGLHHQRPKRYFTIVIISSSLLLGLIVLLLISYVMWKAGFFKRQYKSILQEENRRDSWSYINSKSNDD		
T97587	DRUGINFO	D09EBL	Antegren	Approved
T97587	DRUGINFO	D0N5ZS	Vedolizmab	Approved
T97587	DRUGINFO	D04WQJ	AMG-181	Phase 2
T97587	DRUGINFO	D0Q5LF	BIO-1211	Phase 2
T97587	DRUGINFO	D0C9XA	GSK683699	Phase 2
T97587	DRUGINFO	D05ZWG	Senktide	Phase 2
T97587	DRUGINFO	D01CYT	ELND-002	Phase 1
T97587	DRUGINFO	D05JPJ	ELND-004	Phase 1
T97587	DRUGINFO	D0FU1J	PTG-100	Phase 1
T97587	DRUGINFO	D05SHQ	ASP-2002	Investigative
T97587	DRUGINFO	D00GWR	CT301	Investigative
T97587	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T97587	KEGGPATH	hsa04510:Focal adhesion		
T97587	KEGGPATH	hsa04512:ECM-receptor interaction		
T97587	KEGGPATH	hsa04514:Cell adhesion molecules (CAMs)		
T97587	KEGGPATH	hsa04640:Hematopoietic cell lineage		
T97587	KEGGPATH	hsa04670:Leukocyte transendothelial migration		
T97587	KEGGPATH	hsa04672:Intestinal immune network for IgA production		
T97587	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T97587	KEGGPATH	hsa05140:Leishmaniasis		
T97587	KEGGPATH	hsa05410:Hypertrophic cardiomyopathy (HCM)		
T97587	KEGGPATH	hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC)		
T97587	KEGGPATH	hsa05414:Dilated cardiomyopathy		
T97587	WIKIPATH	WP1794:Cell surface interactions at the vascular wall		
T97587	WIKIPATH	WP1829:Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell		
T97587	WIKIPATH	WP1833:Integrin cell surface interactions		
T97587	WIKIPATH	WP185:Integrin-mediated Cell Adhesion		
T97587	WIKIPATH	WP2118:Arrhythmogenic Right Ventricular Cardiomyopathy		
T97587	WIKIPATH	WP306:Focal Adhesion		
T97587	REACPATH	R-HSA-198933:Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell		
T97587	REACPATH	R-HSA-202733:Cell surface interactions at the vascular wall		
T97587	REACPATH	R-HSA-216083:Integrin cell surface interactions		
T97587	INTEPATH	a4b7_pathway:a4b7 Integrin signaling		
T97587	INTEPATH	arf6_traffickingpathway:Arf6 trafficking events		
T97587	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T97587	INTEPATH	integrin_a4b1_pathway:Alpha4 beta1 integrin signaling events		
T97587	INTEPATH	integrin_cs_pathway:Integrin family cell surface interactions		
T97587	INTEPATH	integrin1_pathway:Beta1 integrin cell surface interactions		
T97587	INTEPATH	integrin5_pathway:Beta5 beta6 beta7 and beta8 integrin cell surface interactions		
T97587	INTEPATH	lymphangiogenesis_pathway:VEGFR3 signaling in lymphatic endothelium		
T97587	INTEPATH	plexind1_pathway:Plexin-D1 Signaling		
T97587	PANTPATH	P00034:Integrin signalling pathway		
				
T84621	TARGETID	T84621		
T84621	FORMERID	TTDS00420		
T84621	UNIPROID	C11B1_HUMAN		
T84621	TARGNAME	Steroid 11-beta-hydroxylase (CYP11B1)		
T84621	GENENAME	CYP11B1		
T84621	TARGTYPE	Successful target		
T84621	SYNONYMS	S11BH; P450C11; P-450c11; CYPXIB1; CYP11B1		
T84621	FUNCTION	Has steroid 11-beta-hydroxylase activity. In addition to this activity, the 18 or 19-hydroxylation of steroids and the aromatization of androstendione to estrone have also been ascribed to cytochrome P450 XIB.		
T84621	PDBSTRUC	6M7X		
T84621	BIOCLASS	Paired donor oxygen oxidoreductase		
T84621	ECNUMBER	EC 1.14.15.4		
T84621	SEQUENCE	MALRAKAEVCMAVPWLSLQRAQALGTRAARVPRTVLPFEAMPRRPGNRWLRLLQIWREQGYEDLHLEVHQTFQELGPIFRYDLGGAGMVCVMLPEDVEKLQQVDSLHPHRMSLEPWVAYRQHRGHKCGVFLLNGPEWRFNRLRLNPEVLSPNAVQRFLPMVDAVARDFSQALKKKVLQNARGSLTLDVQPSIFHYTIEASNLALFGERLGLVGHSPSSASLNFLHALEVMFKSTVQLMFMPRSLSRWTSPKVWKEHFEAWDCIFQYGDNCIQKIYQELAFSRPQQYTSIVAELLLNAELSPDAIKANSMELTAGSVDTTVFPLLMTLFELARNPNVQQALRQESLAAAASISEHPQKATTELPLLRAALKETLRLYPVGLFLERVASSDLVLQNYHIPAGTLVRVFLYSLGRNPALFPRPERYNPQRWLDIRGSGRNFYHVPFGFGMRQCLGRRLAEAEMLLLLHHVLKHLQVETLTQEDIKMVYSFILRPSMFPLLTFRAIN		
T84621	DRUGINFO	D0ZX1P	FADROZOLE	Approved
T84621	DRUGINFO	D0Q9JT	Metyrapone	Approved
T84621	DRUGINFO	D03AJU	Osilodrostat	Approved
T84621	DRUGINFO	D08WHC	(3-((1H-imidazol-1-yl)methyl)phenyl)methanol	Investigative
T84621	DRUGINFO	D0N8QD	(4-((1H-imidazol-1-yl)methyl)phenyl)methanol	Investigative
T84621	DRUGINFO	D0R8NE	1-(2-Phenoxy-ethyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0N4VI	1-(3,4-dihydronaphthalen-2-yl)-1H-imidazole	Investigative
T84621	DRUGINFO	D07JMO	1-(3-Bromobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0S4WQ	1-(3-Chlorobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D08HHA	1-(3-Fluorobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D03KLN	1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0HL9S	1-(4-Aminobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D03VRC	1-(4-Bromobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D07DQJ	1-(4-Bromobenzyl)-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D0W8IZ	1-(4-Chlorobenzyl)-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D0NV7W	1-(4-Cyanobenzyl)-5-(2-fluorophenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0I2UH	1-(4-Cyanobenzyl)-5-(2-methylphenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D00PXF	1-(4-Cyanobenzyl)-5-(3-fluorophenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D02PSL	1-(4-Cyanobenzyl)-5-(3-methylphenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0P1UO	1-(4-Cyanobenzyl)-5-(4-fluorophenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0V6QN	1-(4-Cyanobenzyl)-5-(4-methylphenyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D06RSD	1-(4-Cyanobenzyl)-5-(4-pyridyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D0L2QD	1-(4-Cyanobenzyl)-5-bromo-1H-imidazole	Investigative
T84621	DRUGINFO	D07EJK	1-(4-Cyanobenzyl)-5-formyl-1H-imidazole	Investigative
T84621	DRUGINFO	D08ORG	1-(4-Cyanobenzyl)-5-hydroxymethyl-1H-imidazole	Investigative
T84621	DRUGINFO	D05FFY	1-(4-Cyanobenzyl)-5-methyl-1H-imidazole	Investigative
T84621	DRUGINFO	D0Q8KM	1-(4-Cyanobenzyl)-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D05QPR	1-(4-fluorobenzyl)-1H-imidazole	Investigative
T84621	DRUGINFO	D06NFC	1-(4-Fluorobenzyl)-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D0T8JU	1-(4-Methoxybenzyl)-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D0M9VK	1-(6-Methoxy-naphthalen-2-yl)-1H-imidazole	Investigative
T84621	DRUGINFO	D08YGW	1-Benzyl-5-phenyl-1H-imidazole	Investigative
T84621	DRUGINFO	D05VAN	1-Ethyl-3-imidazol-1-ylmethyl-1H-indole	Investigative
T84621	DRUGINFO	D0G6QL	1-Naphthalen-2-yl-1H-imidazole	Investigative
T84621	DRUGINFO	D0Y2AK	1-Phenyl-2-pyridin-3-yl-propan-1-one	Investigative
T84621	DRUGINFO	D0P9JF	2-Methyl-1,2-di-pyridin-3-yl-1-methoxypropane	Investigative
T84621	DRUGINFO	D0HV5D	2-Methyl-1,2-di-pyridin-3-yl-propan-1-one oxime	Investigative
T84621	DRUGINFO	D0G3RD	2-Methyl-1,2-di-pyridin-3-yl-propane	Investigative
T84621	DRUGINFO	D04QWX	2-Methyl-1,2-di-pyridin-3-yl-propylchloride	Investigative
T84621	DRUGINFO	D04MEE	2-Methyl-1,2-di-pyridin-3-yl-propyliodide	Investigative
T84621	DRUGINFO	D07SAF	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-ol	Investigative
T84621	DRUGINFO	D08UWI	2-Methyl-1-phenyl-2-pyridin-3-yl-propan-1-one	Investigative
T84621	DRUGINFO	D0C7YL	3-((1H-imidazol-1-yl)methyl)aniline	Investigative
T84621	DRUGINFO	D0V9JS	3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine	Investigative
T84621	DRUGINFO	D0D7YL	3-(1,2-dihydroacenaphthylen-3-yl)pyridine	Investigative
T84621	DRUGINFO	D04PKP	3-(1,2-dihydroacenaphthylen-5-yl)pyridine	Investigative
T84621	DRUGINFO	D0D8KN	3-(1-Benzyl-1H-imidazol-5-yl)-1-propanol	Investigative
T84621	DRUGINFO	D04ISG	3-(1-Chloro-7-methoxy-naphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D0MA9G	3-(1-ethyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D02LWB	3-(1H-inden-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0K5KG	3-(1-methyl-3,4-dihydronaphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D0I9PA	3-(2,3-Dihydro-1,4-benzodioxin-6-yl)pyridine	Investigative
T84621	DRUGINFO	D02FRA	3-(2-Chloro-1,1-dimethyl-2-phenyl-ethyl)-pyridine	Investigative
T84621	DRUGINFO	D0I5NW	3-(3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0Q5ZZ	3-(3-Benzyl-6-methoxynaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D05IXU	3-(3-Benzylnaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D08HPU	3-(3-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0L4NG	3-(4-ethyl-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0X1QS	3-(4-methyl-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0VL3R	3-(5,6,7,8-Tetrahydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D04IBH	3-(5-Bromo-6-methoxy-naphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D08ZTZ	3-(5-Chloro-6-methoxy-naphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D0D8YE	3-(5-methoxy-1H-inden-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0RJ6S	3-(6-Bromo-naphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D0R0TE	3-(6-Ethoxy-naphthalen-2-yl)-pyridine	Investigative
T84621	DRUGINFO	D0NX0M	3-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0S8FV	3-(6-Methoxy-3-methylnaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0B2UM	3-(6-Methoxynaphthalen-2-yl)-4-methylpyridine	Investigative
T84621	DRUGINFO	D0Q6BJ	3-(6-Methoxynaphthalen-2-yl)-5-phenylpyridine	Investigative
T84621	DRUGINFO	D02GFK	3-(6-Methoxynaphthalen-2-yl)pyridin-4-amine	Investigative
T84621	DRUGINFO	D0N1PQ	3-(6-methoxynaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D08FAB	3-(naphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D02UZI	3-[(Z)-2-phenylvinyl]pyridine	Investigative
T84621	DRUGINFO	D0AK9S	3-[1-(4-Bromobenzyl)-1H-imidazol-5-yl]-1-propanol	Investigative
T84621	DRUGINFO	D0PH1G	3-[1-(4-Cyanobenzyl)-1H-imidazol-5-yl]-1-propanol	Investigative
T84621	DRUGINFO	D06JYY	3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine	Investigative
T84621	DRUGINFO	D0V3YH	3-[4-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D05MQE	3-[4-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D04QPK	3-[4-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D04CLL	3-[4-Methyl-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D08AZK	3-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0U7RR	3-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D02NAG	3-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D04ELJ	3-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0N9PY	3-[5-Ethoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0Q3JZ	3-[5-Ethoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0V8CR	3-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0M7FS	3-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D09YXV	3-[5-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D08PNF	3-[5-Methoxy-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0YS2F	3-[7-Methoxy-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0Y3AV	3-Ethoxy-5-(6-methoxynaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0Q0BK	3-Fluoro-4'-(pyridin-4-ylmethyl)biphenyl-4-ol	Investigative
T84621	DRUGINFO	D00RRV	3-Imidazol-1-ylmethyl-1H-indole	Investigative
T84621	DRUGINFO	D01CGR	3-Imidazol-1-ylmethyl-2-isopropyl-1H-indole	Investigative
T84621	DRUGINFO	D07JCO	3-Imidazol-1-yl-quinoline	Investigative
T84621	DRUGINFO	D01SUE	3-Indan-(1E)-ylidenemethyl-pyridine	Investigative
T84621	DRUGINFO	D07PYC	3-Indan-(1Z)-ylidenemethyl-pyridine	Investigative
T84621	DRUGINFO	D0X4LQ	3-MeSO2-DDE	Investigative
T84621	DRUGINFO	D08IDC	3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D00DUJ	3-Phenanthren-9-yl-pyridine	Investigative
T84621	DRUGINFO	D09HEA	4-((1H-imidazol-1-yl)methyl)benzonitrile	Investigative
T84621	DRUGINFO	D09VQZ	4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine	Investigative
T84621	DRUGINFO	D0Y1YZ	4-(2-Imidazol-1-yl-ethoxy)-benzamide	Investigative
T84621	DRUGINFO	D0LJ9D	4-(4-(thiophen-2-yl)benzyl)pyridine	Investigative
T84621	DRUGINFO	D0Z3GX	4-(4-(thiophen-3-yl)benzyl)pyridine	Investigative
T84621	DRUGINFO	D00DSE	4-(4'-Fluoro-biphenyl-4-ylmethyl)pyridine	Investigative
T84621	DRUGINFO	D0C6US	4-(6-methoxy-3,4-dihydronaphthalen-2-yl)pyridine	Investigative
T84621	DRUGINFO	D0S4KP	4-(6-Methoxy-3-methylnaphthalen-2-yl)isoquinoline	Investigative
T84621	DRUGINFO	D06CWR	4-(6-Methoxynaphthalen-2-yl)isoquinoline	Investigative
T84621	DRUGINFO	D02BXS	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diamine	Investigative
T84621	DRUGINFO	D01REI	4'-(Pyridin-4-ylmethyl)biphenyl-3,4-diol	Investigative
T84621	DRUGINFO	D0WN9P	4'-(Pyridin-4-ylmethyl)biphenyl-3-amine	Investigative
T84621	DRUGINFO	D0Y5KX	4'-(Pyridin-4-ylmethyl)biphenyl-4-amine	Investigative
T84621	DRUGINFO	D0I1YH	4-[(3'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T84621	DRUGINFO	D03EXD	4-[(4'-Hydroxybiphenyl-4-yl)methyl]pyridine	Investigative
T84621	DRUGINFO	D09VPA	4-[5-Bromo-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0D9FR	4-[5-Bromo-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0YD9J	4-[5-Chloro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D0F5YU	4-[5-Chloro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D03MKT	4-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D09HOE	4-[5-Fluoro-indan-(1Z)-ylidenemethyl]-pyridine	Investigative
T84621	DRUGINFO	D02CSU	4-Indan-(1Z)-ylidenemethyl-pyridine	Investigative
T84621	DRUGINFO	D02JUJ	5-(6-Methoxynaphthalen-2-yl)pyridin-3-ol	Investigative
T84621	DRUGINFO	D04CFP	5-[4-(Pyridin-4-ylmethyl)phenyl]-1H-indole	Investigative
T84621	DRUGINFO	D0E9WX	5-[5-Bromo-indan-(1E)-ylidenemethyl]-1H-imidazole	Investigative
T84621	DRUGINFO	D02XHH	5-[5-Bromo-indan-(1Z)-ylidenemethyl]-1H-imidazole	Investigative
T84621	DRUGINFO	D06HFV	5-[5-Fluoro-indan-(1E)-ylidenemethyl]-pyrimidine	Investigative
T84621	DRUGINFO	D03TRM	5-Indan-(1E)-ylidenemethyl-1H-imidazole	Investigative
T84621	DRUGINFO	D09QDY	5-Indan-(1Z)-ylidenemethyl-1H-imidazole	Investigative
T84621	DRUGINFO	D07NAH	5-Naphthalen-2-yl-1H-imidazole	Investigative
T84621	DRUGINFO	D0L8KL	5-Naphthalen-2-yl-oxazole	Investigative
T84621	DRUGINFO	D0K2DR	5-Pyridin-3-yl-1,3-dihydro-2H-indol-2-one	Investigative
T84621	DRUGINFO	D0G9WP	5-Pyridin-3-yl-2,3-dihydro-1H-inden-1-one	Investigative
T84621	DRUGINFO	D0Q3CX	6-(4-Methylpyridin-3-yl)-2-naphthonitrile	Investigative
T84621	DRUGINFO	D0N1GH	6-(pyridin-3-yl)-2-naphthonitrile	Investigative
T84621	DRUGINFO	D07VGT	6-[4-(Pyridin-4-ylmethyl)phenyl]naphthalen-2-ol	Investigative
T84621	DRUGINFO	D03YHZ	6-Isoquinolin-4-yl-3,4-dihydroquinolin-2(1H)-one	Investigative
T84621	DRUGINFO	D02ZQM	6-Pyridin-3-yl-1,2,3,4-tetrahydronaphthalen-2-ol	Investigative
T84621	DRUGINFO	D09CPC	6-Pyridin-3-yl-3,4-dihydro-1H-quinolin-2-one	Investigative
T84621	DRUGINFO	D07WLT	6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one	Investigative
T84621	DRUGINFO	D0E8DX	6-Pyridin-3-yl-3,4-dihydroquinoline-2(1H)-thione	Investigative
T84621	DRUGINFO	D02ALK	6-Pyridin-3-yl-naphthalen-2-ol	Investigative
T84621	DRUGINFO	D09GJI	7-(1-(1H-imidazol-1-yl)ethyl)-9H-fluoren-2-ol	Investigative
T84621	DRUGINFO	D0O7TC	7-Pyridin-3-yl-2H-1,4-benzothiazin-3(4H)-one	Investigative
T84621	DRUGINFO	D0X0IH	BENZYLIMIDAZOLE	Investigative
T84621	DRUGINFO	D03CWL	Methyl 3-(1-Benzyl-1H-imidazol-5-yl)-propanoate	Investigative
T84621	DRUGINFO	D0WW4F	METYRAPOL	Investigative
T84621	DRUGINFO	D0E0ZS	N-(4'-Isonicotinoylbiphenyl-3-yl)acetamide	Investigative
T84621	DRUGINFO	D0JE1I	R-fadrozole	Investigative
T84621	DRUGINFO	D0I0NP	SL125	Investigative
T84621	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T84621	KEGGPATH	hsa01100:Metabolic pathways		
T84621	WIKIPATH	WP2355:Corticotropin-releasing hormone		
T84621	WIKIPATH	WP2749:Metabolism of steroid hormones and vitamin D		
T84621	WIKIPATH	WP43:Oxidation by Cytochrome P450		
T84621	WIKIPATH	WP702:Metapathway biotransformation		
T84621	WHIZPATH	PW000141:Steroidogenesis		
T84621	REACPATH	R-HSA-194002:Glucocorticoid biosynthesis		
T84621	REACPATH	R-HSA-211976:Endogenous sterols		
T84621	BIOCPATH	PWY66-381:Glucocorticoid biosynthesis		
T84621	BIOCPATH	PWY66-382:Mineralocorticoid biosynthesis		
T84621	BIOCPATH	PWY-7305:Superpathway of steroid hormone biosynthesis		
				
T55922	TARGETID	T55922		
T55922	FORMERID	TTDR00414		
T55922	UNIPROID	DCAM_HUMAN		
T55922	TARGNAME	S-adenosylmethionine decarboxylase proenzyme (AMD1)		
T55922	GENENAME	AMD1		
T55922	TARGTYPE	Successful target		
T55922	SYNONYMS	SamDC; S-adenosylmethioninedecarboxylase; AdoMetDC; AMD		
T55922	FUNCTION	Promotes maintenance and self-renewal of embryonic stem cells, by maintaining spermine levels. Essential for biosynthesis of the polyamines spermidine and spermine.		
T55922	PDBSTRUC	3H0W; 3H0V; 3EPB; 3EPA; 3EP9		
T55922	BIOCLASS	Carbon-carbon lyase		
T55922	ECNUMBER	EC 4.1.1.50		
T55922	SEQUENCE	MEAAHFFEGTEKLLEVWFSRQQPDANQGSGDLRTIPRSEWDILLKDVQCSIISVTKTDKQEAYVLSESSMFVSKRRFILKTCGTTLLLKALVPLLKLARDYSGFDSIQSFFYSRKNFMKPSHQGYPHRNFQEEIEFLNAIFPNGAAYCMGRMNSDCWYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGSVIDATMFNPCGYSMNGMKSDGTYWTIHITPEPEFSYVSFETNLSQTSYDDLIRKVVEVFKPGKFVTTLFVNQSSKCRTVLASPQKIEGFKRLDCQSAMFNDYNFVFTSFAKKQQQQQS		
T55922	DRUGINFO	D03ZFN	Tromethamine	Approved
T55922	DRUGINFO	D0E2WF	ORG 34517/34850	Phase 2
T55922	DRUGINFO	D00FMV	Putrescine	Discontinued in Phase 2
T55922	DRUGINFO	D0S6VX	CGP-40215A	Terminated
T55922	DRUGINFO	D05FFR	MGBG	Terminated
T55922	DRUGINFO	D0P5YR	[(2-aminooxyethyl)methylamino]-5'-deoxyadenosine	Investigative
T55922	DRUGINFO	D0Y7YL	5'-([(Z)-4-amino-2-butenyl]methylamino)-5'-deoxyadenosine	Investigative
T55922	DRUGINFO	D0YM6B	5'-Deoxy-5'-(N,N-dimethylamino)-8-methyladenosine	Investigative
T55922	DRUGINFO	D03OLX	5'-Deoxy-5'-(N,N-dimethylamino)adenosine	Investigative
T55922	DRUGINFO	D0V2QF	5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine	Investigative
T55922	DRUGINFO	D0I7IA	5'-Deoxy-5'-dimethylsulfonioadenosine chloride	Investigative
T55922	DRUGINFO	D0BI4H	Hydroxyalanine	Investigative
T55922	KEGGPATH	hsa00270:Cysteine and methionine metabolism		
T55922	KEGGPATH	hsa00330:Arginine and proline metabolism		
T55922	KEGGPATH	hsa01100:Metabolic pathways		
T55922	WIKIPATH	WP2693:Metabolism of amino acids and derivatives		
T55922	WHIZPATH	PW000037:Spermidine and Spermine Biosynthesis		
T55922	WHIZPATH	PW000056:Methionine Metabolism		
T55922	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T55922	BIOCPATH	ARGSPECAT-PWY:Spermine biosynthesis		
T55922	BIOCPATH	BSUBPOLYAMSYN-PWY:Spermidine biosynthesis		
T55922	BIOCPATH	PWY-7527:Methionine salvage cycle III		
				
T59929	TARGETID	T59929		
T59929	FORMERID	TTDR00251		
T59929	UNIPROID	TYPH_HUMAN		
T59929	TARGNAME	Thymidine phosphorylase (TYMP)		
T59929	GENENAME	TYMP		
T59929	TARGTYPE	Successful target		
T59929	SYNONYMS	TdRPase; TYMP; TP; Platelet-derived endothelial cell growth factor; PDECGF; PD-ECGF; Gliostatin		
T59929	FUNCTION	Catalyzes the reversible phosphorolysis of thymidine. The produced molecules are then utilized as carbon and energy sources or in the rescue of pyrimidine bases for nucleotide synthesis.		
T59929	PDBSTRUC	2WK6; 2WK5; 2J0F; 1UOU		
T59929	BIOCLASS	Pentosyltransferase		
T59929	ECNUMBER	EC 2.4.2.4		
T59929	SEQUENCE	MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ		
T59929	DRUGINFO	D0Y7DP	Uridine	Approved
T59929	DRUGINFO	D03ITH	1-(cyclohexyl)methyl-5'-O-tritylinosine	Investigative
T59929	DRUGINFO	D04OWX	1-(cyclopropyl)methyl-5'-O-tritylinosine	Investigative
T59929	DRUGINFO	D06BMN	1-allyl-5'-O-tritylinosine	Investigative
T59929	DRUGINFO	D0W6LJ	1-benzyl-5'-O-tritylinosine	Investigative
T59929	DRUGINFO	D05OUP	1-propyl-5'-O-tritylinosine	Investigative
T59929	DRUGINFO	D0CQ1J	2'-aminoimidazolylmethyluracils	Investigative
T59929	DRUGINFO	D09TBA	5-benzyl-6-chloropyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0Y5UF	5-bromo-6-(cyclopropylamino)uracil hydrochloride	Investigative
T59929	DRUGINFO	D00PMF	5-bromo-6-hydrazinouracil hydrochloride	Investigative
T59929	DRUGINFO	D0RE9X	5-butyl-6-chloropyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0G1DS	5-chloro-6-hydrazinouracil hydrochloride	Investigative
T59929	DRUGINFO	D01DAQ	5-fluoro-6-[(2-aminoimidazol-1-yl)methyl]uracil	Investigative
T59929	DRUGINFO	D0X5RA	6-amino-5-bromouracil	Investigative
T59929	DRUGINFO	D0VW6H	6-amino-5-chlorouracil hydrochloride	Investigative
T59929	DRUGINFO	D0I7IF	6-bromo-5-phenylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0C0HN	6-chloro-5-(2-thienyl)pyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D03IMY	6-chloro-5-heptylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0CO5S	6-chloro-5-hexylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0E7SH	6-chloro-5-pentylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D01IGW	6-chloro-5-phenylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0DX8A	6-chloro-5-propylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0E9PL	6-fluoro-5-phenylpyrimidine-2,4(1H,3H)-dione	Investigative
T59929	DRUGINFO	D0F4KL	Thymine	Investigative
T59929	KEGGPATH	hsa00240:Pyrimidine metabolism		
T59929	KEGGPATH	hsa00983:Drug metabolism - other enzymes		
T59929	KEGGPATH	hsa01100:Metabolic pathways		
T59929	KEGGPATH	hsa05219:Bladder cancer		
T59929	WIKIPATH	WP1601:Fluoropyrimidine Activity		
T59929	WIKIPATH	WP1851:Metabolism of nucleotides		
T59929	WIKIPATH	WP2828:Bladder Cancer		
T59929	WHIZPATH	PW000160:Pyrimidine Metabolism		
T59929	NET_PATH	NetPath_23:TSH Signaling Pathway		
T59929	BIOCPATH	PWY-7181:Pyrimidine deoxyribonucleosides degradation		
				
T67684	TARGETID	T67684		
T67684	FORMERID	TTDS00004		
T67684	UNIPROID	ACM3_HUMAN		
T67684	TARGNAME	Muscarinic acetylcholine receptor M3 (CHRM3)		
T67684	GENENAME	CHRM3		
T67684	TARGTYPE	Successful target		
T67684	SYNONYMS	M3 receptor; CHRM3		
T67684	FUNCTION	The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Primary transducing effect is Pi turnover.		
T67684	PDBSTRUC	2CSA		
T67684	BIOCLASS	GPCR rhodopsin		
T67684	SEQUENCE	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFSSPDGTTDDPLGGHTVWQVVFIAFLTGILALVTIIGNILVIVSFKVNKQLKTVNNYFLLSLACADLIIGVISMNLFTTYIIMNRWALGNLACDLWLAIDYVASNASVMNLLVISFDRYFSITRPLTYRAKRTTKRAGVMIGLAWVISFVLWAPAILFWQYFVGKRTVPPGECFIQFLSEPTITFGTAIAAFYMPVTIMTILYWRIYKETEKRTKELAGLQASGTEAETENFVHPTGSSRSCSSYELQQQSMKRSNRRKYGRCHFWFTTKSWKPSSEQMDQDHSSSDSWNNNDAAASLENSASSDEEDIGSETRAIYSIVLKLPGHSTILNSTKLPSSDNLQVPEEELGMVDLERKADKLQAQKSVDDGGSFPKSFSKLPIQLESAVDTAKTSDVNSSVGKSTATLPLSFKEATLAKRFALKTRSQITKRKRMSLVKEKKAAQTLSAILLAFIITWTPYNIMVLVNTFCDSCIPKTFWNLGYWLCYINSTVNPVCYALCNKTFRTTFKMLLLCQCDKKKRRKQQYQQRQSVIFHKRAPEQAL		
T67684	DRUGINFO	D0R7WU	ACECLIDINE	Approved
T67684	DRUGINFO	D0Q4CS	Cevimeline	Approved
T67684	DRUGINFO	D0Y5AM	Darifenacin	Approved
T67684	DRUGINFO	D0S0AS	Ipratropium	Approved
T67684	DRUGINFO	D07KHH	LAS-34273	Approved
T67684	DRUGINFO	D04MWJ	Methacholine Chloride	Approved
T67684	DRUGINFO	D04LHJ	Methscopolamine Bromide	Approved
T67684	DRUGINFO	D0M6VK	Methylscopolamine	Approved
T67684	DRUGINFO	D05KZK	SMT-D002	Approved
T67684	DRUGINFO	D0L4YD	Solifenacin	Approved
T67684	DRUGINFO	D0Q7ZQ	Succinylcholine	Approved
T67684	DRUGINFO	D0P1WA	Tiotropium	Approved
T67684	DRUGINFO	D0BZ7W	Tolterodine	Approved
T67684	DRUGINFO	D04YEW	Tarafenacin	Phase 2
T67684	DRUGINFO	D02TXV	TRN-157	Phase 2
T67684	DRUGINFO	D0V0JQ	CHF 5407	Phase 1
T67684	DRUGINFO	D04SBH	Zamifenacin	Discontinued in Phase 3
T67684	DRUGINFO	D06GCP	PSD-506	Discontinued in Phase 2
T67684	DRUGINFO	D09LMX	Revatropate	Discontinued in Phase 1
T67684	DRUGINFO	D0X8MZ	Alvameline	Terminated
T67684	DRUGINFO	D0G4CG	[3H]oxotremorine-M	Investigative
T67684	DRUGINFO	D02VGM	[3H]QNB	Investigative
T67684	DRUGINFO	D00JTE	1,1-diphenyl-2-(3-tropanyl)ethanol	Investigative
T67684	DRUGINFO	D05EML	1'-Benzyl-3-phenyl-[3,4']bipiperidinyl-2,6-dione	Investigative
T67684	DRUGINFO	D02PFJ	1-Methyl-1-(4-pyrrolidin-1-yl-but-2-ynyl)-urea	Investigative
T67684	DRUGINFO	D05MDY	2,8-Dimethyl-1-oxa-8-aza-spiro[4.5]decan-3-one	Investigative
T67684	DRUGINFO	D0U2IL	2-Methyl-6-pyrrolidin-1-yl-hex-4-ynal oxime	Investigative
T67684	DRUGINFO	D06UOE	3-(1-carbamoyl-1,1-diphenylmethyl)-1-(4-methoxyphenylethyl)pyrrolidine (APP)	Investigative
T67684	DRUGINFO	D07DEY	3-(3-benzylamino)-piperidin-2-one	Investigative
T67684	DRUGINFO	D06VST	3-Methyl-7-pyrrolidin-1-yl-hept-5-yn-2-one	Investigative
T67684	DRUGINFO	D0OE0K	3-Tetrazol-2-yl-1-aza-bicyclo[2.2.2]octane	Investigative
T67684	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T67684	DRUGINFO	D0A2KT	4-DAMP	Investigative
T67684	DRUGINFO	D08ZTA	6-Dimethylamino-2-methyl-hex-4-ynal oxime	Investigative
T67684	DRUGINFO	D0QL1X	7-Dimethylamino-3-methyl-hept-5-yn-2-one	Investigative
T67684	DRUGINFO	D0R8FS	7-Dimethylamino-hept-5-yn-2-one	Investigative
T67684	DRUGINFO	D0B8AQ	7-Pyrrolidin-1-yl-hept-5-yn-2-one	Investigative
T67684	DRUGINFO	D0F9QT	A-987306	Investigative
T67684	DRUGINFO	D01UDC	Acetic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Investigative
T67684	DRUGINFO	D0IM7C	AE-9C90CB	Investigative
T67684	DRUGINFO	D0I9LU	arecaidine propargyl ester	Investigative
T67684	DRUGINFO	D0C9ZE	Benzoic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Investigative
T67684	DRUGINFO	D07VZG	BRL-55473	Investigative
T67684	DRUGINFO	D0H2UT	brucine	Investigative
T67684	DRUGINFO	D0Z5RQ	Cremastrine	Investigative
T67684	DRUGINFO	D05EEV	DAU-5750	Investigative
T67684	DRUGINFO	D0R8AZ	DAU-5884	Investigative
T67684	DRUGINFO	D0HV3A	FLUMEZAPINE	Investigative
T67684	DRUGINFO	D06IUC	FM1-10	Investigative
T67684	DRUGINFO	D0AR0H	FM1-43	Investigative
T67684	DRUGINFO	D0PL0Y	furtrethonium	Investigative
T67684	DRUGINFO	D02EXX	GNF-PF-5618	Investigative
T67684	DRUGINFO	D07OAK	Go7874	Investigative
T67684	DRUGINFO	D0I9AL	guanylpirenzepine	Investigative
T67684	DRUGINFO	D0W8XI	hexahydrodifenidol	Investigative
T67684	DRUGINFO	D07LDP	hexahydrosiladifenidol	Investigative
T67684	DRUGINFO	D0P0IX	ISOCLOZAPINE	Investigative
T67684	DRUGINFO	D0Q2GP	ISOLOXAPINE	Investigative
T67684	DRUGINFO	D0BP7C	J-104135	Investigative
T67684	DRUGINFO	D03DMR	lithocholylcholine	Investigative
T67684	DRUGINFO	D02BOW	McN-A-343	Investigative
T67684	DRUGINFO	D0WO3A	methylfurmethide	Investigative
T67684	DRUGINFO	D00WNA	ML381	Investigative
T67684	DRUGINFO	D0C9VH	N-(4-Dimethylamino-but-2-ynyl)-N-methyl-acetamide	Investigative
T67684	DRUGINFO	D08KNP	N-benzyl brucine	Investigative
T67684	DRUGINFO	D08BGK	N-chloromethyl-brucine	Investigative
T67684	DRUGINFO	D0R2JE	N-methoxyquinuclidine-3-carboximidoyl chloride	Investigative
T67684	DRUGINFO	D0X2JU	N-methoxyquinuclidine-3-carboximidoyl fluoride	Investigative
T67684	DRUGINFO	D02MJE	NNC 11-1314	Investigative
T67684	DRUGINFO	D07CAB	NNC 11-1585	Investigative
T67684	DRUGINFO	D08XBQ	NNC 11-1607	Investigative
T67684	DRUGINFO	D09YBC	NOCARDIMICIN A	Investigative
T67684	DRUGINFO	D05YBO	Nocardimicin C	Investigative
T67684	DRUGINFO	D0I2XG	Nocardimicin D	Investigative
T67684	DRUGINFO	D0J4DJ	Nocardimicin F	Investigative
T67684	DRUGINFO	D07QGQ	Noccardimicin E	Investigative
T67684	DRUGINFO	D07TDE	Olterodine	Investigative
T67684	DRUGINFO	D0F5LH	Oxybutynine	Investigative
T67684	DRUGINFO	D0T6ID	pentylthio-TZTP	Investigative
T67684	DRUGINFO	D0K3VR	p-F-HHSiD	Investigative
T67684	DRUGINFO	D04XNH	Propionic acid 8-aza-bicyclo[3.2.1]oct-6-yl ester	Investigative
T67684	DRUGINFO	D09AAZ	PTAC	Investigative
T67684	DRUGINFO	D00NRJ	silahexocyclium	Investigative
T67684	DRUGINFO	D0O1BN	SULFOARECOLINE	Investigative
T67684	DRUGINFO	D05WXF	thiochrome	Investigative
T67684	DRUGINFO	D07GPQ	tripitramine	Investigative
T67684	DRUGINFO	D02ZPV	UCB-101333-3	Investigative
T67684	DRUGINFO	D03LSH	UH-AH 37	Investigative
T67684	DRUGINFO	D0S4DT	vinburnine	Investigative
T67684	DRUGINFO	D02UNX	VU0255035	Investigative
T67684	DRUGINFO	D05PSD	WIN 51,708	Investigative
T67684	DRUGINFO	D02IIN	WIN 62,577	Investigative
T67684	KEGGPATH	hsa04020:Calcium signaling pathway		
T67684	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T67684	KEGGPATH	hsa04725:Cholinergic synapse		
T67684	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T67684	KEGGPATH	hsa04911:Insulin secretion		
T67684	KEGGPATH	hsa04970:Salivary secretion		
T67684	KEGGPATH	hsa04971:Gastric acid secretion		
T67684	KEGGPATH	hsa04972:Pancreatic secretion		
T67684	WIKIPATH	WP117:GPCRs, Other		
T67684	WIKIPATH	WP1824:GPCR downstream signaling		
T67684	WIKIPATH	WP1825:GPCR ligand binding		
T67684	WIKIPATH	WP1831:Integration of energy metabolism		
T67684	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T67684	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T67684	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T67684	WIKIPATH	WP536:Calcium Regulation in the Cardiac Cell		
T67684	WIKIPATH	WP58:Monoamine GPCRs		
T67684	WHIZPATH	PW000565:Gastric Acid Production		
T67684	REACPATH	R-HSA-390648:Muscarinic acetylcholine receptors		
T67684	REACPATH	R-HSA-399997:Acetylcholine regulates insulin secretion		
T67684	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T67684	PANTPATH	P00003:Alzheimer disease-amyloid secretase pathway		
T67684	PANTPATH	P00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway		
T67684	PANTPATH	P00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway		
				
T62193	TARGETID	T62193		
T62193	FORMERID	TTDS00361		
T62193	UNIPROID	DDC_HUMAN		
T62193	TARGNAME	Aromatic-L-amino-acid decarboxylase (DDC)		
T62193	GENENAME	DDC		
T62193	TARGTYPE	Successful target		
T62193	SYNONYMS	DOPA decarboxylase; AADC		
T62193	FUNCTION	Catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine.		
T62193	PDBSTRUC	3RCH; 3RBL; 3RBF		
T62193	BIOCLASS	Carbon-carbon lyase		
T62193	ECNUMBER	EC 4.1.1.28		
T62193	SEQUENCE	MNASEFRRRGKEMVDYMANYMEGIEGRQVYPDVEPGYLRPLIPAAAPQEPDTFEDIINDVEKIIMPGVTHWHSPYFFAYFPTASSYPAMLADMLCGAIGCIGFSWAASPACTELETVMMDWLGKMLELPKAFLNEKAGEGGGVIQGSASEATLVALLAARTKVIHRLQAASPELTQAAIMEKLVAYSSDQAHSSVERAGLIGGVKLKAIPSDGNFAMRASALQEALERDKAAGLIPFFMVATLGTTTCCSFDNLLEVGPICNKEDIWLHVDAAYAGSAFICPEFRHLLNGVEFADSFNFNPHKWLLVNFDCSAMWVKKRTDLTGAFRLDPTYLKHSHQDSGLITDYRHWQIPLGRRFRSLKMWFVFRMYGVKGLQAYIRKHVQLSHEFESLVRQDPRFEICVEVILGLVCFRLKGSNKVNEALLQRINSAKKIHLVPCHLRDKFVLRFAICSRTVESAHVQRAWEHIKELAADVLRAERE		
T62193	DRUGINFO	D0P7JZ	Carbidopa	Approved
T62193	DRUGINFO	D07MUN	Vitamin B6	Approved
T62193	DRUGINFO	D0X8ED	Benserazide	Phase 3
T62193	DRUGINFO	D03QFN	Patrome	Phase 3
T62193	DRUGINFO	D02ITL	AV-201	Phase 2
T62193	DRUGINFO	DX9KC2	GT-AADC	Phase 2
T62193	DRUGINFO	DH1W0G	VY-AADC	Phase 2
T62193	DRUGINFO	D72UDH	OXB-102	Phase 1/2
T62193	DRUGINFO	D05ICS	ProSavin	Phase 1/2
T62193	DRUGINFO	D0P9BM	3-hydroxybenzylhydrazine	Investigative
T62193	DRUGINFO	D0IB8N	Noradrenalone (arterenone)	Investigative
T62193	KEGGPATH	hsa00340:Histidine metabolism		
T62193	KEGGPATH	hsa00350:Tyrosine metabolism		
T62193	KEGGPATH	hsa00360:Phenylalanine metabolism		
T62193	KEGGPATH	hsa00380:Tryptophan metabolism		
T62193	KEGGPATH	hsa01100:Metabolic pathways		
T62193	KEGGPATH	hsa04726:Serotonergic synapse		
T62193	KEGGPATH	hsa04728:Dopaminergic synapse		
T62193	KEGGPATH	hsa05030:Cocaine addiction		
T62193	KEGGPATH	hsa05031:Amphetamine addiction		
T62193	KEGGPATH	hsa05034:Alcoholism		
T62193	WIKIPATH	WP1602:Nicotine Activity on Dopaminergic Neurons		
T62193	WIKIPATH	WP2371:Parkinsons Disease Pathway		
T62193	WIKIPATH	WP2436:Dopamine metabolism		
T62193	WIKIPATH	WP2693:Metabolism of amino acids and derivatives		
T62193	WIKIPATH	WP2855:Dopaminergic Neurogenesis		
T62193	WIKIPATH	WP465:Tryptophan metabolism		
T62193	WIKIPATH	WP550:Biogenic Amine Synthesis		
T62193	WIKIPATH	WP706:SIDS Susceptibility Pathways		
T62193	WHIZPATH	PW000017:Catecholamine Biosynthesis		
T62193	WHIZPATH	PW000142:Tyrosine Metabolism		
T62193	WHIZPATH	PW000163:Tryptophan Metabolism		
T62193	PANTPATH	P00001:Adrenaline and noradrenaline biosynthesis		
T62193	PANTPATH	P04371:5-Hydroxytryptamine biosynthesis		
T62193	PANTPATH	P05912:Dopamine receptor mediated signaling pathway		
T62193	PANTPATH	P06587:Nicotine pharmacodynamics pathway		
T62193	BIOCPATH	PWY-6030:Serotonin and melatonin biosynthesis		
T62193	BIOCPATH	PWY-6307:Tryptophan degradation via tryptamine		
T62193	BIOCPATH	PWY66-301:Catecholamine biosynthesis		
T62193	BIOCPATH	PWY66-401:Superpathway of tryptophan utilization		
				
T13852	TARGETID	T13852		
T13852	FORMERID	TTDC00258		
T13852	UNIPROID	S1PR1_HUMAN		
T13852	TARGNAME	Sphingosine-1-phosphate receptor 1 (S1PR1)		
T13852	GENENAME	S1PR1		
T13852	TARGTYPE	Successful target		
T13852	SYNONYMS	Sphingosine 1-phosphate receptor Edg-1; S1P1; S1P receptor Edg-1; S1P receptor 1; Endothelial differentiation G-protein coupled receptor 1; CHEDG1; CD363		
T13852	FUNCTION	Signaling leads to the activation of RAC1, SRC, PTK2/FAK1 and MAP kinases. Plays an important role in cell migration, probably via its role in the reorganization of the actin cytoskeleton and the formation of lamellipodia in response to stimuli that increase the activity of the sphingosine kinase SPHK1. Required for normal chemotaxis toward sphingosine 1-phosphate. Required for normal embryonic heart development and normal cardiac morphogenesis. Plays an important role in the regulation of sprouting angiogenesis and vascular maturation. Inhibits sprouting angiogenesis to prevent excessive sprouting during blood vessel development. Required for normal egress of mature T-cells from the thymus into the blood stream and into peripheral lymphoid organs. Plays a role in the migration of osteoclast precursor cells, the regulation of bone mineralization and bone homeostasis. Plays a role in responses to oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine by pulmonary endothelial cells and in the protection against ventilator-induced lung injury. G-protein coupled receptor for the bioactive lysosphingolipid sphingosine 1-phosphate (S1P) that seems to be coupled to the G(i) subclass of heteromeric G proteins.		
T13852	PDBSTRUC	3V2Y; 3V2W		
T13852	BIOCLASS	GPCR rhodopsin		
T13852	SEQUENCE	MGPTSVPLVKAHRSSVSDYVNYDIIVRHYNYTGKLNISADKENSIKLTSVVFILICCFIILENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLSGATTYKLTPAQWFLREGSMFVALSASVFSLLAIAIERYITMLKMKLHNGSNNFRLFLLISACWVISLILGGLPIMGWNCISALSSCSTVLPLYHKHYILFCTTVFTLLLLSIVILYCRIYSLVRTRSRRLTFRKNISKASRSSEKSLALLKTVIIVLSVFIACWAPLFILLLLDVGCKVKTCDILFRAEYFLVLAVLNSGTNPIIYTLTNKEMRRAFIRIMSCCKCPSGDSAGKFKRPIIAGMEFSRSKSDNSSHPQKDEGDNPETIMSSGNVNSSS		
T13852	DRUGINFO	D07UHS	Fingolimod	Approved
T13852	DRUGINFO	D07EDB	Ozanimod	Approved
T13852	DRUGINFO	D0Y4SI	Ponesimod	Approved
T13852	DRUGINFO	D07FKQ	Siponimod	Approved
T13852	DRUGINFO	D0L9KH	APD-334	Phase 3
T13852	DRUGINFO	D0Y5ZT	KRP-203	Phase 2
T13852	DRUGINFO	D00ISN	MT-1303	Phase 2
T13852	DRUGINFO	D0I2RB	ONO-4641	Phase 2
T13852	DRUGINFO	D0Q0JI	ASP-4058	Phase 1
T13852	DRUGINFO	D0GG7L	BMS-986104	Phase 1
T13852	DRUGINFO	D0X8XT	CS-0777	Phase 1
T13852	DRUGINFO	D0B4CD	GSK-2018682	Phase 1
T13852	DRUGINFO	D0XE5M	SAR247799	Phase 1
T13852	DRUGINFO	D0KV2E	Sonepcizumab	Phase 1
T13852	DRUGINFO	D07UGA	Sphingosine-1-phosphate	Phase 1
T13852	DRUGINFO	D0N8AB	PF-4629991	Discontinued in Phase 1
T13852	DRUGINFO	D0Y0BC	XL-541	Terminated
T13852	DRUGINFO	D06XMB	(3-Tetradecylamino-cyclohexyl)-phosphonic acid	Investigative
T13852	DRUGINFO	D0N0BN	(3-Tetradecylamino-cyclopentyl)-phosphonic acid	Investigative
T13852	DRUGINFO	D0O4JU	(S)-FTY720P	Investigative
T13852	DRUGINFO	D0D5QS	[3-(4-Nonyl-benzylamino)-propyl]-phosphonic acid	Investigative
T13852	DRUGINFO	D0P2AZ	1-(4-nonylbenzyl)azetidine-3-carboxylic acid	Investigative
T13852	DRUGINFO	D0LO4T	1-(4-nonylbenzyl)pyrrolidin-3-ylphosphonic acid	Investigative
T13852	DRUGINFO	D07EAB	1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid	Investigative
T13852	DRUGINFO	D00VHN	3-(N-alkylamino) propylphosphonic acid derivative	Investigative
T13852	DRUGINFO	D0P1TY	3-(tetradecylamino)propylphosphonic acid	Investigative
T13852	DRUGINFO	D04XCB	3-amino-5-(4-octylphenyl)pentanoic acid	Investigative
T13852	DRUGINFO	D08VLT	4-amino-6-(4-octylphenyl)hexanoic acid	Investigative
T13852	DRUGINFO	D05KEE	AFD(R)	Investigative
T13852	DRUGINFO	D09NWW	AMG-247	Investigative
T13852	DRUGINFO	D03BRM	AUY954	Investigative
T13852	DRUGINFO	D0YC1R	BMS-520	Investigative
T13852	DRUGINFO	D05SYL	CYM5181	Investigative
T13852	DRUGINFO	D00ZXX	CYM5442	Investigative
T13852	DRUGINFO	D06DYN	FTY720-phosphate	Investigative
T13852	DRUGINFO	D09ESF	GNF-PF-78	Investigative
T13852	DRUGINFO	D0R2ZN	GNF-PF-826	Investigative
T13852	DRUGINFO	D0T4LT	GSK-1842799C	Investigative
T13852	DRUGINFO	D0U7YK	KRP 203-phosphate	Investigative
T13852	DRUGINFO	D0IL7V	KRP-107	Investigative
T13852	DRUGINFO	D0X0UR	LPA	Investigative
T13852	DRUGINFO	D02LTS	NIBR-0213	Investigative
T13852	DRUGINFO	D02OCD	NIBR-785	Investigative
T13852	DRUGINFO	D0G6KH	NOX-S91	Investigative
T13852	DRUGINFO	D0ZU0O	SEW2871	Investigative
T13852	DRUGINFO	D0W1ZW	VPC03090-P	Investigative
T13852	DRUGINFO	D05EDD	VPC23019	Investigative
T13852	DRUGINFO	D06GFH	VPC44116	Investigative
T13852	DRUGINFO	D03AAC	W146	Investigative
T13852	KEGGPATH	hsa04068:FoxO signaling pathway		
T13852	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T13852	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T13852	WIKIPATH	WP117:GPCRs, Other		
T13852	WIKIPATH	WP1824:GPCR downstream signaling		
T13852	WIKIPATH	WP1825:GPCR ligand binding		
T13852	WIKIPATH	WP247:Small Ligand GPCRs		
T13852	WIKIPATH	WP26:Signal Transduction of S1P Receptor		
T13852	REACPATH	R-HSA-418594:G alpha (i) signalling events		
T13852	REACPATH	R-HSA-419408:Lysosphingolipid and LPA receptors		
T13852	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T13852	NET_PATH	NetPath_16:IL4 Signaling Pathway		
T13852	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T13852	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T13852	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T13852	INTEPATH	s1p_meta_pathway:Sphingosine 1-phosphate (S1P) pathway		
T13852	INTEPATH	s1p_s1p1_pathway:S1P1 pathway		
T13852	INTEPATH	s1p_s1p3_pathway:S1P3 pathway		
				
T76904	TARGETID	T76904		
T76904	FORMERID	TTDS00362		
T76904	UNIPROID	COMT_HUMAN		
T76904	TARGNAME	Catechol-O-methyl-transferase (COMT)		
T76904	GENENAME	COMT		
T76904	TARGTYPE	Successful target		
T76904	SYNONYMS	S-COMT; MB-COMT; Catechol-O-methyltransferase; COMT		
T76904	FUNCTION	Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol.		
T76904	PDBSTRUC	5LSA; 4XUE; 4XUD; 4XUC; 4PYK		
T76904	BIOCLASS	Methyltransferase		
T76904	ECNUMBER	EC 2.1.1.6		
T76904	SEQUENCE	MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLLMGDTKEQRILNHVLQHAEPGNAQSVLEAIDTYCEQKEWAMNVGDKKGKIVDAVIQEHQPSVLLELGAYCGYSAVRMARLLSPGARLITIEINPDCAAITQRMVDFAGVKDKVTLVVGASQDIIPQLKKKYDVDTLDMVFLDHWKDRYLPDTLLLEECGLLRKGTVLLADNVICPGAPDFLAHVRGSSCFECTHYQSFLEYREVVDGLEKAIYKGPGSEAGP		
T76904	DRUGINFO	D0J1VY	Entacapone	Approved
T76904	DRUGINFO	D01SGK	Opicapone	Approved
T76904	DRUGINFO	D0Y7PG	Tolcapone	Approved
T76904	DRUGINFO	D0R2NE	Entacapone+levodopa+carbidopa	Phase 3
T76904	DRUGINFO	D0G4DE	BIA 3-202	Phase 2
T76904	DRUGINFO	D0P5TR	CGP-28014	Phase 2
T76904	DRUGINFO	D08LVF	Nitecapone	Discontinued in Phase 2
T76904	DRUGINFO	D0U1CL	PGX-200097	Preclinical
T76904	DRUGINFO	D0OE1R	(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE	Investigative
T76904	DRUGINFO	D0C0OT	1-(3,4-dihydroxy-2-nitrophenyl)-2-phenylethanone	Investigative
T76904	DRUGINFO	D01AFH	1-(3,4-dihydroxy-5-nitrophenyl)-2-phenoxyethanone	Investigative
T76904	DRUGINFO	D09AYR	3,5-Dinitrocatechol	Investigative
T76904	DRUGINFO	D0HW3Y	5,6-dihydroxy-7-nitro-2,3-dihydroinden-1-one	Investigative
T76904	DRUGINFO	D0M3PG	6,7-dihydroxy-8-nitro-1-tetralone	Investigative
T76904	DRUGINFO	D06LED	7,8-dihydroxy-4-phenyl-2H-chromen-2-one	Investigative
T76904	DRUGINFO	D0XT0I	BIA	Investigative
T76904	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T76904	KEGGPATH	hsa00350:Tyrosine metabolism		
T76904	KEGGPATH	hsa01100:Metabolic pathways		
T76904	KEGGPATH	hsa04728:Dopaminergic synapse		
T76904	WIKIPATH	WP1870:Neurotransmitter Clearance In The Synaptic Cleft		
T76904	WIKIPATH	WP1880:Phase II conjugation		
T76904	WIKIPATH	WP2436:Dopamine metabolism		
T76904	WIKIPATH	WP550:Biogenic Amine Synthesis		
T76904	WIKIPATH	WP697:Estrogen metabolism		
T76904	WIKIPATH	WP702:Metapathway biotransformation		
T76904	WIKIPATH	WP704:Methylation Pathways		
T76904	WHIZPATH	PW000142:Tyrosine Metabolism		
T76904	PANTPATH	P00001:Adrenaline and noradrenaline biosynthesis		
T76904	PANTPATH	P05912:Dopamine receptor mediated signaling pathway		
T76904	BIOCPATH	PWY-6334:L-dopa degradation		
T76904	BIOCPATH	PWY-6342:Noradrenaline and adrenaline degradation		
T76904	BIOCPATH	PWY6666-2:Dopamine degradation		
				
T76369	TARGETID	T76369		
T76369	FORMERID	TTDR00274		
T76369	UNIPROID	EST1_HUMAN		
T76369	TARGNAME	Liver carboxylesterase (CES1)		
T76369	GENENAME	CES1		
T76369	TARGTYPE	Successful target		
T76369	SYNONYMS	Serine esterase 1; Monocyte/macrophage serine esterase; Human carboxylesterase 1; HMSE; HCE1; CES1; Brain carboxylesterase hBr1; Acyl coenzyme A:cholesterol acyltransferase		
T76369	FUNCTION	Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs. Hydrolyzes aromatic and aliphatic esters, but has no catalytic activity toward amides or a fatty acyl coa ester.		
T76369	PDBSTRUC	5A7H; 5A7G; 5A7F; 4AB1; 3K9B		
T76369	BIOCLASS	Carboxylic ester hydrolase		
T76369	ECNUMBER	EC 3.1.1.1		
T76369	SEQUENCE	MWLRAFILATLSASAAWGHPSSPPVVDTVHGKVLGKFVSLEGFAQPVAIFLGIPFAKPPLGPLRFTPPQPAEPWSFVKNATSYPPMCTQDPKAGQLLSELFTNRKENIPLKLSEDCLYLNIYTPADLTKKNRLPVMVWIHGGGLMVGAASTYDGLALAAHENVVVVTIQYRLGIWGFFSTGDEHSRGNWGHLDQVAALRWVQDNIASFGGNPGSVTIFGESAGGESVSVLVLSPLAKNLFHRAISESGVALTSVLVKKGDVKPLAEQIAITAGCKTTTSAVMVHCLRQKTEEELLETTLKMKFLSLDLQGDPRESQPLLGTVIDGMLLLKTPEELQAERNFHTVPYMVGINKQEFGWLIPMQLMSYPLSEGQLDQKTAMSLLWKSYPLVCIAKELIPEATEKYLGGTDDTVKKKDLFLDLIADVMFGVPSVIVARNHRDAGAPTYMYEFQYRPSFSSDMKPKTVIGDHGDELFSVFGAPFLKEGASEEEIRLSKMVMKFWANFARNGNPNGEGLPHWPEYNQKEGYLQIGANTQAAQKLKDKEVAFWTNLFAKKAVEKPPQTEHIEL		
T76369	DRUGINFO	D0OR2L	Cholic Acid	Approved
T76369	DRUGINFO	D02GWF	PACTIMIBE	Phase 2/3
T76369	DRUGINFO	D0YB4D	Eldacimibe	Phase 2
T76369	DRUGINFO	D03PYD	K-604	Phase 2
T76369	DRUGINFO	D05EMV	GR148672X	Clinical trial
T76369	DRUGINFO	D0O1KX	Avasimibe	Discontinued in Phase 3
T76369	DRUGINFO	D0D1XG	CI-976	Discontinued in Phase 2
T76369	DRUGINFO	D0E1UZ	CL-283796	Discontinued in Phase 2
T76369	DRUGINFO	D01IDE	E-5324	Discontinued in Phase 2
T76369	DRUGINFO	D0W0ED	Eflucimibe	Discontinued in Phase 2
T76369	DRUGINFO	D07DBS	RP-64477	Discontinued in Phase 2
T76369	DRUGINFO	D04ODQ	447C88	Discontinued in Phase 1
T76369	DRUGINFO	D06FCR	CL-277082	Discontinued in Phase 1
T76369	DRUGINFO	D03QZB	F-1394	Discontinued in Phase 1
T76369	DRUGINFO	D0IZ7T	YM-17E	Discontinued in Phase 1
T76369	DRUGINFO	D0D9AD	YM-750	Discontinued in Phase 1
T76369	DRUGINFO	D09MJO	HL-004	Preclinical
T76369	DRUGINFO	D0J8TH	CEB-925	Terminated
T76369	DRUGINFO	D0PG0S	CI-999	Terminated
T76369	DRUGINFO	D0K8KJ	DuP-129	Terminated
T76369	DRUGINFO	D00KQT	FR-129169	Terminated
T76369	DRUGINFO	D0O2AC	FR-145237	Terminated
T76369	DRUGINFO	D03EHR	Lecimibide	Terminated
T76369	DRUGINFO	D03JRJ	NTE-122	Terminated
T76369	DRUGINFO	D03YPL	RP-70676	Terminated
T76369	DRUGINFO	D06KFR	RP-73163	Terminated
T76369	DRUGINFO	D0OK8M	TEI-6522	Terminated
T76369	DRUGINFO	D0Y8RM	(1r)-1,2,2-trimethylpropyl (r)-methylphosphinate	Investigative
T76369	DRUGINFO	D0F0JI	(E)-Octadec-9-enoic acid phenylamide	Investigative
T76369	DRUGINFO	D0JI0H	1-(2-bromoethyl)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D05PNO	1-(2-iodoethyl)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D07EDG	1-(3,4-dichlorobenzyl)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0N8YZ	1-(3,4-Dimethyl-phenyl)-2-phenyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0C9AD	1-(4-chlorobenzyl)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0F3RN	1-(4-Chloro-phenyl)-2-phenyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0L1ST	1-(4-Chloro-phenyl)-2-p-tolyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0T5XC	1-(4-Methoxy-phenyl)-2-phenyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0D7FN	1-(4-Nitro-phenyl)-2-phenyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0F7NU	1,1,1-trifluoro-3-(hexylsulfinyl)propan-2-one	Investigative
T76369	DRUGINFO	D04JVA	1,1,1-trifluoro-3-(hexylsulfonyl)propan-2-one	Investigative
T76369	DRUGINFO	D0Z7WK	1,1,1-trifluoro-3-(hexylthio)propan-2-one	Investigative
T76369	DRUGINFO	D04UEN	1,1,1-trifluoro-3-(octylsulfinyl)propan-2-one	Investigative
T76369	DRUGINFO	D00IAK	1,1,1-trifluoro-3-(octylsulfonyl)propan-2-one	Investigative
T76369	DRUGINFO	D0Q3GH	1,1,1-trifluoro-3-(octylthio)propan-2-one	Investigative
T76369	DRUGINFO	D0I7FF	1,1,1-trifluorododecan-2-one	Investigative
T76369	DRUGINFO	D0JH7C	1,10-phenanthroline-5,6-dione	Investigative
T76369	DRUGINFO	D06GYH	1,2-bis(2,3,4-trifluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D0P1IK	1,2-bis(2,3,4-trifluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0D2HH	1,2-bis(2,3,5-trifluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D08UOB	1,2-bis(2,3,5-trifluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0E2IG	1,2-bis(2,3,6-trifluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0M2ZD	1,2-bis(2,3-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D05LTW	1,2-bis(2,3-fluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0ZT5C	1,2-bis(2,4-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D02HQS	1,2-bis(2,4-difluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D00PLH	1,2-bis(2,5-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D05EMT	1,2-bis(2,5-difluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D04CDV	1,2-bis(2,6-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D01VCS	1,2-bis(2,6-difluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D03HZT	1,2-Bis-(2-chloro-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D05VUC	1,2-bis(2-fluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D02GJG	1,2-bis(2-fluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D01HZN	1,2-bis(3,4,5-trifluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D0CN8Z	1,2-bis(3,4,5-trifluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0U0BV	1,2-bis(3,4-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D0K6OM	1,2-bis(3,4-difluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0L4MF	1,2-bis(3,5-difluorophenyl)-2-hydroxyethanone	Investigative
T76369	DRUGINFO	D09LSR	1,2-bis(3,5-difluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0AW4P	1,2-bis(3-fluorophenyl)-2-hydroxyethanon	Investigative
T76369	DRUGINFO	D0Y6RZ	1,2-bis(3-fluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D01VAU	1,2-Bis-(3-methoxy-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0UT1X	1,2-Bis-(3-nitro-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D06FFD	1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D05EYA	1,2-Bis-(4-chloro-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0DW9J	1,2-bis(4-fluorophenyl)ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0UZ8R	1,2-Bis-(4-methoxy-phenyl)-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0LJ2F	1,2-dicyclohexylethane-1,2-dione	Investigative
T76369	DRUGINFO	D03WOU	1,2-Di-naphthalen-2-yl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D0UK5A	1,2-Di-p-tolyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D01XGP	1,2-indanedione	Investigative
T76369	DRUGINFO	D0W9VA	1,2-NAPHTHOQUINONE	Investigative
T76369	DRUGINFO	D05XRY	11,12-dihydro-dibenzo[a,e]cyclooctene-5,6-dione	Investigative
T76369	DRUGINFO	D0O0LU	1-benzyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0M5NR	1-butyryl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D00ANJ	1-dodecyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0ZL6B	1-hexadecyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0U3JD	1-methyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D01HRG	1-phenyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0B8YX	1-Phenyl-2-p-tolyl-ethane-1,2-dione	Investigative
T76369	DRUGINFO	D02TLP	1-Phenyl-propane-1,2-dione	Investigative
T76369	DRUGINFO	D07CFJ	1-propionyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D08AOG	2,2-Dimethoxy-1,2-diphenyl-ethanone	Investigative
T76369	DRUGINFO	D01NDE	2,2-dimethyl-3-methyleneheptadecane	Investigative
T76369	DRUGINFO	D0H5II	2-methoxy-3,4-methylenedioxybenzophenone	Investigative
T76369	DRUGINFO	D0O9EB	3-(butylsulfinyl)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D0FO4J	3-(butylthio)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D00VKB	3-(decylsulfinyl)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D0Y0FN	3-(decylsulfonyl)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D0E5CF	3-(decylthio)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D0B4GJ	3-(dodecylsulfinyl)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D02SDT	3-(dodecylsulfonyl)-1,1,1-trifluoropropan-2-one	Investigative
T76369	DRUGINFO	D0N0HK	3,4,5,6-Tetrachloro-[1,2]benzoquinone	Investigative
T76369	DRUGINFO	D0Z1WQ	3,5-Di-tert-butyl-[1,2]benzoquinone	Investigative
T76369	DRUGINFO	D0BB2U	4-(2-Oxo-2-phenyl-acetyl)-benzoic acid	Investigative
T76369	DRUGINFO	D0Z6CZ	4,5-dichloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D04EXR	4,6-dichloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0EK7H	4,7-dichloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D04AXR	4-chloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0B1TQ	4-chloro-7-methyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D07WHV	4-Piperidino-Piperidine	Investigative
T76369	DRUGINFO	D0ZR2T	5-(trifluoromethoxy)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0WX6R	5,6-dinitroacenaphthoquinone	Investigative
T76369	DRUGINFO	D0NJ4G	5,7-dichloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D03TPH	5-chloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0Z8HX	6,7-dichloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0N9ZR	6-bromo-5-methyl-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0E5ZP	7-(trifluoromethyl)-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0X0ER	7-chloro-1H-indole-2,3-dione	Investigative
T76369	DRUGINFO	D0K6PO	Acenanthrene-9,10-dione	Investigative
T76369	DRUGINFO	D06VGD	ACENAPHTHOQUINONE	Investigative
T76369	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T76369	DRUGINFO	D0Y7FX	BENZIL	Investigative
T76369	DRUGINFO	D0Z5KQ	Benzoin	Investigative
T76369	DRUGINFO	D0D0BI	CHLORANIL	Investigative
T76369	DRUGINFO	D02VYI	Dibutyl 2,2,2-trifluoro-1-phenylethyl phosphate	Investigative
T76369	DRUGINFO	D01GSO	Diethyl 2,2,2-trifluoro-1-phenylethyl phosphate	Investigative
T76369	DRUGINFO	D0XP0J	Dimethyl 2,2,2-trifluoro-1-phenylethyl phosphate	Investigative
T76369	DRUGINFO	D05AVX	Heptane-2,3-dione	Investigative
T76369	DRUGINFO	D0V9MG	KY-382	Investigative
T76369	DRUGINFO	D06ZPI	N-Methylnaloxonium	Investigative
T76369	DRUGINFO	D0F5VY	NSC-23180	Investigative
T76369	DRUGINFO	D0T7YM	Oleic acid anilide	Investigative
T76369	DRUGINFO	D08WQM	O-Sialic Acid	Investigative
T76369	DRUGINFO	D0Q2YJ	Phenanthrene-9,10-dione	Investigative
T76369	DRUGINFO	D0A2NK	PYRIPYROPENE A	Investigative
T76369	DRUGINFO	D0W0PH	SCH-48375	Investigative
T76369	DRUGINFO	D02EZF	SMP-797	Investigative
T76369	DRUGINFO	D0F4QX	Thenoyltrifluoroacetone	Investigative
T76369	DRUGINFO	D05ZCX	Thieno[3,2-e][1]benzothiophene-4,5-dione	Investigative
T76369	DRUGINFO	D0OH1O	VULM-1457	Investigative
T76369	KEGGPATH	hsa00983:Drug metabolism - other enzymes		
T76369	KEGGPATH	hsa01100:Metabolic pathways		
T76369	WIKIPATH	WP136:Phase I biotransformations, non P450		
T76369	WIKIPATH	WP1601:Fluoropyrimidine Activity		
T76369	WIKIPATH	WP229:Irinotecan Pathway		
T76369	WIKIPATH	WP2645:Heroin metabolism		
T76369	WIKIPATH	WP2882:Nuclear Receptors Meta-Pathway		
T76369	WIKIPATH	WP2884:NRF2 pathway		
T76369	INTEPATH	e2f_pathway:E2F transcription factor network		
				
T60529	TARGETID	T60529		
T60529	FORMERID	TTDS00040		
T60529	UNIPROID	PGH1_HUMAN		
T60529	TARGNAME	Prostaglandin G/H synthase 1 (COX-1)		
T60529	GENENAME	PTGS1		
T60529	TARGTYPE	Successful target		
T60529	SYNONYMS	Prostaglandin-endoperoxide synthase 1; Prostaglandin H2 synthase 1; PHS 1; PGHS-1; PGH synthase 1; Cyclooxygenase-1; COX1; COX-1		
T60529	FUNCTION	Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Involved in the constitutive production of prostanoids in particular in the stomach and platelets. In gastric epithelial cells, it is a key step in the generation of prostaglandins, such as prostaglandin E2 (PGE2), which plays an important role in cytoprotection. In platelets, it is involved in the generation of thromboxane A2 (TXA2), which promotes platelet activation and aggregation, vasoconstriction and proliferation of vascular smooth muscle cells.		
T60529	BIOCLASS	Paired donor oxygen oxidoreductase		
T60529	ECNUMBER	EC 1.14.99.1		
T60529	SEQUENCE	MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRSNLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRFLLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQYQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLYATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKFDPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEALVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQELVGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICSPEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL		
T60529	DRUGINFO	D01WJL	Aminosalicylic Acid	Approved
T60529	DRUGINFO	D0A6KR	Balsalazide	Approved
T60529	DRUGINFO	D0U1OM	Bromfenac	Approved
T60529	DRUGINFO	D0Q5XX	Eicosapentaenoic acid/docosa-hexaenoic acid	Approved
T60529	DRUGINFO	D06LHG	FENBUFEN	Approved
T60529	DRUGINFO	D0B2WJ	Flufenamic Acid	Approved
T60529	DRUGINFO	D0O1TC	Gamma-Homolinolenic acid	Approved
T60529	DRUGINFO	D0MN9K	Meclofenamate Sodium	Approved
T60529	DRUGINFO	D0C4YC	Mesalazine	Approved
T60529	DRUGINFO	D0DJ1B	Naproxen	Approved
T60529	DRUGINFO	D00IBN	Piroxicam	Approved
T60529	DRUGINFO	D07HBX	Salicyclic acid	Approved
T60529	DRUGINFO	D0Y0JH	Salsalate	Approved
T60529	DRUGINFO	D07BPS	Suprofen	Approved
T60529	DRUGINFO	D0AL8M	IMRECOXIB	Phase 4
T60529	DRUGINFO	D0G2IC	(S)-FLURBIPROFEN	Preregistration
T60529	DRUGINFO	D07SDQ	Curcumin	Phase 3
T60529	DRUGINFO	D0U3EP	Resveratrol	Phase 3
T60529	DRUGINFO	D0C4DZ	ThermoProfen	Phase 3
T60529	DRUGINFO	D05TPI	EPICATECHIN	Phase 1/2
T60529	DRUGINFO	D0F5BL	EXO-230	Phase 1/2
T60529	DRUGINFO	D0S8TB	Carbamate derivative 2	Patented
T60529	DRUGINFO	D0Q5PL	INDOPROFEN	Withdrawn from market
T60529	DRUGINFO	D06JRD	Metamizole	Withdrawn from market
T60529	DRUGINFO	D0O2IE	Phenacetin	Withdrawn from market
T60529	DRUGINFO	D0BZ1Q	CRx-401	Discontinued in Phase 2
T60529	DRUGINFO	D0ZL4F	R-ketoprofen	Discontinued in Phase 2
T60529	DRUGINFO	D0P3KA	TEBUFELONE	Discontinued in Phase 2
T60529	DRUGINFO	D03AKL	ATLIPROFEN METHYL ESTER	Terminated
T60529	DRUGINFO	D0O9JX	SC-58451	Terminated
T60529	DRUGINFO	D08BPE	(-)-3-O-acetylspectaline	Investigative
T60529	DRUGINFO	D0N0YS	(11H-Dibenzo[b,e][1,4]dioxepin-2-yl)-acetic acid	Investigative
T60529	DRUGINFO	D0X5RR	(11H-Dibenzo[b,e][1,4]dioxepin-7-yl)-acetic acid	Investigative
T60529	DRUGINFO	D0GF9J	(11H-Dibenzo[b,e][1,4]dioxepin-8-yl)-acetic acid	Investigative
T60529	DRUGINFO	D02HVL	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	Investigative
T60529	DRUGINFO	D0A4LW	(R)-2-(4-Isobutyl-phenyl)-N-phenyl-propionamide	Investigative
T60529	DRUGINFO	D0D6UC	(Z)-2'-des-methyl sulindac sulfide	Investigative
T60529	DRUGINFO	D0LL9E	1-(4-(methylsulfonyl)phenyl)-3-phenylurea	Investigative
T60529	DRUGINFO	D0T7BP	1-(4-(methylsulfonyl)phenyl)-3-p-tolylurea	Investigative
T60529	DRUGINFO	D0V9AU	1-(4-aminosulfonylphenyl)-2-(2-pyridyl)acetylene	Investigative
T60529	DRUGINFO	D0Q8TK	1-(4-aminosulfonylphenyl)-2-(4-pyridyl)acetylene	Investigative
T60529	DRUGINFO	D0OX0B	1,2-dihydro-3-(2,3,4-trimethoxyphenyl)naphthalene	Investigative
T60529	DRUGINFO	D06FTI	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	Investigative
T60529	DRUGINFO	D0U0YE	2-(2-(2,6-dimethylphenylamino)phenyl)acetic acid	Investigative
T60529	DRUGINFO	D02CCB	2-(2,3,4-trimethoxyphenyl)-1H-indene	Investigative
T60529	DRUGINFO	D0N7OP	2-(2-methoxyphenyl)-1H-indene	Investigative
T60529	DRUGINFO	D0R1UO	2-(2-Methylpropanoyl)-1,3,5-benzenetriol	Investigative
T60529	DRUGINFO	D0M9RL	2-(3'-Allyl-biphenyl-4-yl)-propionic acid	Investigative
T60529	DRUGINFO	D08QAH	2-(3'-Ethyl-biphenyl-4-yl)-propionic acid	Investigative
T60529	DRUGINFO	D02GZX	2-(3'-Ethylsulfanyl-biphenyl-4-yl)-propionic acid	Investigative
T60529	DRUGINFO	D0L4TM	2-(3-Phenyl-propyl)-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D0YI3V	2-(3'-Vinyl-biphenyl-4-yl)-propionic acid	Investigative
T60529	DRUGINFO	D02FGY	2-(N-(2-Ffuorophenyl)pyrrol-3-yl) acetic acid	Investigative
T60529	DRUGINFO	D07STC	2-(N-(2-fluorophenyl)pyrrol-2-yl) acetic acid	Investigative
T60529	DRUGINFO	D00VBX	2-(p-Methylsulfonylbenzoyl)furan	Investigative
T60529	DRUGINFO	D01JYF	2,4'-Dimethoxy-5,3'-di-(2-propenyl)-biphenyl	Investigative
T60529	DRUGINFO	D0JQ1T	2-[4-(1H-Indol-5-yl)-phenyl]-propionic acid	Investigative
T60529	DRUGINFO	D0J7YU	2-Benzyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D05DOM	2-Bromoacetyl Group	Investigative
T60529	DRUGINFO	D05KYE	2'-epi-guianin	Investigative
T60529	DRUGINFO	D0SJ3W	2-Furan-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D0U8CM	2-Methyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D0X6SA	2-Naphthalen-2-ylmethyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D06HUQ	2-Phenethyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D0S0PB	2-Phenyl-1,2-dihydro-indazol-3-one	Investigative
T60529	DRUGINFO	D0ZI8Y	3 beta-O-acetyloleanolic acid	Investigative
T60529	DRUGINFO	D09HWQ	3-(4-Methanesulfonyl-phenyl)-1-phenyl-propynone	Investigative
T60529	DRUGINFO	D0PQ3Q	4-(4-Chlorophenyl)-5-(4-methoxyphenyl)isothiazole	Investigative
T60529	DRUGINFO	D09MDB	4-(4-Chlorophenyl)-5-p-tolyl-1,2-selenazole	Investigative
T60529	DRUGINFO	D0G7RA	4-(4-Chlorophenyl)-5-p-tolyl-3H-1,2-dithiol-3-one	Investigative
T60529	DRUGINFO	D0OW4W	4-(4-Chlorophenyl)-5-p-tolylisothiazole	Investigative
T60529	DRUGINFO	D00VHS	4-(5-(4-Hydroxyphenyl)isothiazol-4-yl)phenol	Investigative
T60529	DRUGINFO	D0E5MK	4,5-Bis(4-chlorophenyl)-1,2-selenazole	Investigative
T60529	DRUGINFO	D01VRB	4,5-Bis(4-chlorophenyl)isothiazole	Investigative
T60529	DRUGINFO	D0D0JE	4,5-Bis(4-methoxyphenyl)-1,2-selenazole	Investigative
T60529	DRUGINFO	D0X4LI	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiol-3-one	Investigative
T60529	DRUGINFO	D02PLG	4,5-Bis(4-methoxyphenyl)-3H-1,2-dithiole-3-thione	Investigative
T60529	DRUGINFO	D0F0JU	4,5-Bis(4-methoxyphenyl)isothiazole	Investigative
T60529	DRUGINFO	D0Y7ND	4-amino-N-(2-chlorophenyl)benzenesulfonamide	Investigative
T60529	DRUGINFO	D02DYG	4-amino-N-(4-chlorophenyl)benzenesulfonamide	Investigative
T60529	DRUGINFO	D04ORY	4-amino-N-p-tolylbenzenesulfonamide	Investigative
T60529	DRUGINFO	D0S7ZQ	4'-Methoxy-5,3'-dipropyl-biphenyl-2ol	Investigative
T60529	DRUGINFO	D07OAV	5-(2-1H-indenyl)-1,3-benzodioxole	Investigative
T60529	DRUGINFO	D04ZGF	5-(2-Imidazol-1-yl-ethyl)-7,8-dihydro-quinoline	Investigative
T60529	DRUGINFO	D0J6TU	5-(4-Chlorophenyl)-4-(4-methoxyphenyl)isothiazole	Investigative
T60529	DRUGINFO	D08RYB	5-(4-Chlorophenyl)-4-p-tolyl-1,2-selenazole	Investigative
T60529	DRUGINFO	D00XIX	5-(4-Chlorophenyl)-4-p-tolyl-3H-1,2-dithiol-3-one	Investigative
T60529	DRUGINFO	D03TLR	5-(4-Chlorophenyl)-4-p-tolylisothiazole	Investigative
T60529	DRUGINFO	D07RTV	5-(4-Methoxyphenyl)-4-p-tolyl-1,2-selenazole	Investigative
T60529	DRUGINFO	D08RCQ	5-(4-Methoxyphenyl)-4-p-tolylisothiazole	Investigative
T60529	DRUGINFO	D0R6ZC	5,3'-Dipropyl-biphenyl-2,4'-diol	Investigative
T60529	DRUGINFO	D06WML	5-Ethyl-3,4-diphenyl-isoxazole	Investigative
T60529	DRUGINFO	D04YPP	5-Methyl-3,4-diphenyl-isoxazole	Investigative
T60529	DRUGINFO	D07ARK	5-Phenyl-pentanoic acid benzyl-hydroxy-amide	Investigative
T60529	DRUGINFO	D02VLR	Acetic acid 2-hept-2-ynylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D0O8XG	Acetic acid 2-hept-3-ynylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D01EWD	Acetic acid 2-heptylselanyl-phenyl ester	Investigative
T60529	DRUGINFO	D0X9VY	Acetic acid 2-heptylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D00RCV	Acetic acid 2-hex-2-ynylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D04KAM	Acetic acid 2-hexylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D0M7EI	Acetic acid 2-pentylsulfanyl-phenyl ester	Investigative
T60529	DRUGINFO	D09XYZ	Acetic Acid Salicyloyl-Amino-Ester	Investigative
T60529	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T60529	DRUGINFO	D0HD9P	Arachidonic Acid	Investigative
T60529	DRUGINFO	D07ONX	Beta-D-Glucose	Investigative
T60529	DRUGINFO	D0SD9H	Beta-D-Mannose	Investigative
T60529	DRUGINFO	D02UVH	B-Octylglucoside	Investigative
T60529	DRUGINFO	D0V7AA	CATECHIN	Investigative
T60529	DRUGINFO	D03EDF	DEMETHOXYCURCUMIN	Investigative
T60529	DRUGINFO	D09CMJ	FR122047	Investigative
T60529	DRUGINFO	D0UU1I	Heme	Investigative
T60529	DRUGINFO	D04DQJ	HONOKIOL	Investigative
T60529	DRUGINFO	D09VTJ	Hyperforin	Investigative
T60529	DRUGINFO	D02HSZ	IODOINDOMETHACIN	Investigative
T60529	DRUGINFO	D0T5DO	IODOSUPROFEN	Investigative
T60529	DRUGINFO	D01OFH	METHYLHONOKIOL	Investigative
T60529	DRUGINFO	D0J7YE	N-(1H-indazol-5-yl)acetamide	Investigative
T60529	DRUGINFO	D01WLL	N-(3-(phenylthio)pyridin-4-yl)methanesulfonamide	Investigative
T60529	DRUGINFO	D0BO9W	N-(3-phenoxy-4-pyridinyl)ethanesulfonamide	Investigative
T60529	DRUGINFO	D0L6TP	N-(3-phenoxy-4-pyridinyl)propanesulfonamide	Investigative
T60529	DRUGINFO	D0VF6F	N-(3-phenoxypyridin-4-yl)methanesulfonamide	Investigative
T60529	DRUGINFO	D06DRL	N-(3-phenylamino-4-pyridinyl)methanesulfonamide	Investigative
T60529	DRUGINFO	D04TNI	Nitroflurbiprofen	Investigative
T60529	DRUGINFO	D0IB5L	O-Acetylserine	Investigative
T60529	DRUGINFO	D0T9QW	Oxametacin	Investigative
T60529	DRUGINFO	D06GSY	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	Investigative
T60529	DRUGINFO	D03IRR	Phenazone	Investigative
T60529	DRUGINFO	D0P1LP	PHENIDONE	Investigative
T60529	DRUGINFO	D00GBX	Prifelone	Investigative
T60529	DRUGINFO	D0T4VL	Primary alcohol metabolite of celecoxib	Investigative
T60529	DRUGINFO	D07SAI	Protoporphyrin Ix Containing Co	Investigative
T60529	DRUGINFO	D02DBP	RESORCINOL	Investigative
T60529	DRUGINFO	D0CW3A	Resveratrol Potassium3-Sulfate	Investigative
T60529	DRUGINFO	D04JZY	Resveratrol Potassium4,-Sulfate	Investigative
T60529	DRUGINFO	D0M5MI	SC-560	Investigative
T60529	DRUGINFO	D01HXN	TRL-382	Investigative
T60529	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T60529	KEGGPATH	hsa01100:Metabolic pathways		
T60529	KEGGPATH	hsa04611:Platelet activation		
T60529	KEGGPATH	hsa04726:Serotonergic synapse		
T60529	WIKIPATH	WP15:Selenium Micronutrient Network		
T60529	WIKIPATH	WP167:Eicosanoid Synthesis		
T60529	WIKIPATH	WP1879:Phase 1 - Functionalization of compounds		
T60529	WIKIPATH	WP2650:Arachidonic acid metabolism		
T60529	WIKIPATH	WP98:Prostaglandin Synthesis and Regulation		
T60529	WHIZPATH	PW000044:Arachidonic Acid Metabolism		
T60529	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T60529	PANTPATH	P00031:Inflammation mediated by chemokine and cytokine signaling pathway		
T60529	BIOCPATH	PWY66-374:C20 prostanoid biosynthesis		
				
T06569	TARGETID	T06569		
T06569	FORMERID	TTDR00210		
T06569	UNIPROID	CAH6_HUMAN		
T06569	TARGNAME	Carbonic anhydrase VI (CA-VI)		
T06569	GENENAME	CA6		
T06569	TARGTYPE	Successful target		
T06569	SYNONYMS	Secreted carbonic anhydrase; Salivary carbonic anhydrase; Carbonic anhydrase 6; Carbonate dehydratase VI		
T06569	FUNCTION	Its role in saliva is unknown. Reversible hydration of carbon dioxide.		
T06569	PDBSTRUC	3FE4		
T06569	BIOCLASS	Alpha-carbonic anhydrase		
T06569	ECNUMBER	EC 4.2.1.1		
T06569	SEQUENCE	MRALVLLLSLFLLGGQAQHVSDWTYSEGALDEAHWPQHYPACGGQRQSPINLQRTKVRYNPSLKGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRMTVADGTVYIAQQMHFHWGGASSEISGSEHTVDGIRHVIEIHIVHYNSKYKSYDIAQDAPDGLAVLAAFVEVKNYPENTYYSNFISHLANIKYPGQRTTLTGLDVQDMLPRNLQHYYTYHGSLTTPPCTENVHWFVLADFVKLSRTQVWKLENSLLDHRNKTIHNDYRRTQPLNHRVVESNFPNQEYTLGSEFQFYLHKIEEILDYLRRALN		
T06569	DRUGINFO	D07HBX	Salicyclic acid	Approved
T06569	DRUGINFO	D0K1QD	Sulfamylon	Approved
T06569	DRUGINFO	D07SDQ	Curcumin	Phase 3
T06569	DRUGINFO	D0A8JP	PARABEN	Phase 3
T06569	DRUGINFO	D0Y6OA	Coumate	Phase 2
T06569	DRUGINFO	D43GZX	SAR566658	Phase 2
T06569	DRUGINFO	D03SLR	FERULIC ACID	Patented
T06569	DRUGINFO	D0LD9S	SPERMINE	Terminated
T06569	DRUGINFO	D0M3PO	2,4-Disulfamyltrifluoromethylaniline	Investigative
T06569	DRUGINFO	D0OI1H	2-Amino-benzenesulfonamide	Investigative
T06569	DRUGINFO	D0G0FJ	2-hydrazinylbenzenesulfonamide	Investigative
T06569	DRUGINFO	D0TY8X	4-(2-aminopyrimidin-4-ylamino)benzenesulfonamide	Investigative
T06569	DRUGINFO	D04VLI	4-(2-Hydroxy-ethyl)-benzenesulfonamide	Investigative
T06569	DRUGINFO	D05XZM	4-(hydroxymethyl)benzenesulfonamide	Investigative
T06569	DRUGINFO	D0P6AM	4-Amino-3-bromo-benzenesulfonamide	Investigative
T06569	DRUGINFO	D0YU8J	4-Amino-3-chloro-benzenesulfonamide	Investigative
T06569	DRUGINFO	D04CVC	4-Amino-3-fluoro-benzenesulfonamide	Investigative
T06569	DRUGINFO	D01STY	4-Amino-3-iodo-benzenesulfonamide	Investigative
T06569	DRUGINFO	D0Z1HY	4-amino-6-chlorobenzene-1,3-disulfonamide	Investigative
T06569	DRUGINFO	D0X6IE	4-amino-N-(4-sulfamoylbenzyl)benzenesulfonamide	Investigative
T06569	DRUGINFO	D00IUB	4-CYANOPHENOL	Investigative
T06569	DRUGINFO	D0NN3Q	4-Hydrazino-benzenesulfonamide	Investigative
T06569	DRUGINFO	D0N1AW	6-(aminomethyl)-2H-chromen-2-one	Investigative
T06569	DRUGINFO	D0L5TZ	6-(hydroxymethyl)-2H-chromen-2-one	Investigative
T06569	DRUGINFO	D0Q2LL	6-Hydroxy-benzothiazole-2-sulfonic acid amide	Investigative
T06569	DRUGINFO	D0LU4S	7-butoxy-2H-chromen-2-one	Investigative
T06569	DRUGINFO	D0OT5L	7-propoxy-2H-chromen-2-one	Investigative
T06569	DRUGINFO	D0E8CC	BENZOLAMIDE	Investigative
T06569	DRUGINFO	D09PWX	Carzenide	Investigative
T06569	DRUGINFO	D0V7AA	CATECHIN	Investigative
T06569	DRUGINFO	D0VD7H	CL-5343	Investigative
T06569	DRUGINFO	D03ZMQ	COUMARIN	Investigative
T06569	DRUGINFO	D00YEF	Decane-1,10-diyl disulfamate	Investigative
T06569	DRUGINFO	D09WSJ	Decyl sulfamate	Investigative
T06569	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T06569	DRUGINFO	D07TAJ	Ethyl 7-methoxy-2-oxo-2H-chromene-3-carboxylate	Investigative
T06569	DRUGINFO	D0Y3TZ	GALLICACID	Investigative
T06569	DRUGINFO	D0U4BB	HERNIARIN	Investigative
T06569	DRUGINFO	D09JPC	Hexane-1,6-diamine	Investigative
T06569	DRUGINFO	D09WVV	N1-(2-aminoethyl)ethane-1,2-diamine	Investigative
T06569	DRUGINFO	D0X5HL	N1-(naphthalen-1-yl)ethane-1,2-diamine	Investigative
T06569	DRUGINFO	D0D4OV	Octane-1,8-diyl disulfamate	Investigative
T06569	DRUGINFO	D05TLB	Octyl sulfamate	Investigative
T06569	DRUGINFO	D0AU0M	P-Coumaric Acid	Investigative
T06569	DRUGINFO	D02QGI	Pentane-1,5-diamine	Investigative
T06569	DRUGINFO	D0ZC3W	P-toluenesulfonamide	Investigative
T06569	DRUGINFO	D0Q7DJ	Syringic Acid	Investigative
T06569	KEGGPATH	hsa00910:Nitrogen metabolism		
T06569	WIKIPATH	WP2770:Reversible Hydration of Carbon Dioxide		
T06569	REACPATH	R-HSA-1475029:Reversible hydration of carbon dioxide		
				
T68334	TARGETID	T68334		
T68334	FORMERID	TTDS00438		
T68334	UNIPROID	FSHR_HUMAN		
T68334	TARGNAME	Follicle-stimulating hormone receptor (FSHR)		
T68334	GENENAME	FSHR		
T68334	TARGTYPE	Successful target		
T68334	SYNONYMS	LGR1; Follitropin receptor; FSH-R		
T68334	FUNCTION	G protein-coupled receptor for follitropin, the follicle-stimulating hormone. Through cAMP production activates the downstream PI3K-AKT and ERK1/ERK2 signaling pathways.		
T68334	PDBSTRUC	4MQW; 4AY9; 1XWD; 1XUN		
T68334	BIOCLASS	GPCR rhodopsin		
T68334	SEQUENCE	MALLLVSLLAFLSLGSGCHHRICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFDYDLCNEVVDVTCSPKPDAFNPCEDIMGYNILRVLIWFISILAITGNIIVLVILTTSQYKLTVPRFLMCNLAFADLCIGIYLLLIASVDIHTKSQYHNYAIDWQTGAGCDAAGFFTVFASELSVYTLTAITLERWHTITHAMQLDCKVQLRHAASVMVMGWIFAFAAALFPIFGISSYMKVSICLPMDIDSPLSQLYVMSLLVLNVLAFVVICGCYIHIYLTVRNPNIVSSSSDTRIAKRMAMLIFTDFLCMAPISFFAISASLKVPLITVSKAKILLVLFHPINSCANPFLYAIFTKNFRRDFFILLSKCGCYEMQAQIYRTETSSTVHNTHPRNGHCSSAPRVTNGSTYILVPLSHLAQN		
T68334	DRUGINFO	D0OM3A	Follitropin beta	Approved
T68334	DRUGINFO	D04WBY	Menotropins	Approved
T68334	DRUGINFO	D02SBQ	Urofollitropin	Approved
T68334	DRUGINFO	D0H2UB	Suramin	Phase 1
T68334	DRUGINFO	D0W3SX	FSHR NAM	Investigative
T68334	DRUGINFO	D09HCE	Long-acting FSH conjugate	Investigative
T68334	DRUGINFO	D08MVV	PRX-111	Investigative
T68334	DRUGINFO	D02FTU	Recombinant follicle stimulating hormone	Investigative
T68334	KEGGPATH	hsa04024:cAMP signaling pathway		
T68334	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T68334	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T68334	WIKIPATH	WP117:GPCRs, Other		
T68334	WIKIPATH	WP1824:GPCR downstream signaling		
T68334	WIKIPATH	WP1825:GPCR ligand binding		
T68334	WIKIPATH	WP2035:FSH signaling pathway		
T68334	WIKIPATH	WP24:Peptide GPCRs		
T68334	WIKIPATH	WP34:Ovarian Infertility Genes		
T68334	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T68334	WHIZPATH	PW000447:Vasopressin Regulation of Water Homeostasis		
T68334	WHIZPATH	PW000448:Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone		
T68334	REACPATH	R-HSA-375281:Hormone ligand-binding receptors		
T68334	REACPATH	R-HSA-418555:G alpha (s) signalling events		
				
T83011	TARGETID	T83011		
T83011	FORMERID	TTDS00341		
T83011	UNIPROID	AOFB_HUMAN		
T83011	TARGNAME	Monoamine oxidase type B (MAO-B)		
T83011	GENENAME	MAOB		
T83011	TARGTYPE	Successful target		
T83011	SYNONYMS	MAO-B; Amine oxidase [flavin-containing] B		
T83011	FUNCTION	Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine.		
T83011	PDBSTRUC	6FWC; 6FW0; 6FVZ; 5MRL; 4CRT		
T83011	BIOCLASS	CH-NH(2) donor oxidoreductase		
T83011	ECNUMBER	EC 1.4.3.4		
T83011	SEQUENCE	MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV		
T83011	DRUGINFO	D0RM9Q	Budipine	Approved
T83011	DRUGINFO	D07TGY	Indeloxazine	Approved
T83011	DRUGINFO	D0R0UJ	Pargyline	Approved
T83011	DRUGINFO	D0P9AC	Phenelzine	Approved
T83011	DRUGINFO	D06OMW	Rasagiline	Approved
T83011	DRUGINFO	D0TV6I	Safinamide	Approved
T83011	DRUGINFO	D0XM1A	Safinamide mesylate	Approved
T83011	DRUGINFO	D0S2UG	Selegiline	Approved
T83011	DRUGINFO	D0J2MJ	Selegiline Hydrochloride	Approved
T83011	DRUGINFO	D07PAO	Sulphadoxine	Approved
T83011	DRUGINFO	D0H0HJ	Tranylcypromine	Approved
T83011	DRUGINFO	D01NKW	P2B-001	Phase 3
T83011	DRUGINFO	D00VUI	Psoralen	Phase 3
T83011	DRUGINFO	D08CJK	TRYPTAMINE	Phase 3
T83011	DRUGINFO	D04RCT	CHF-3381	Phase 2
T83011	DRUGINFO	D06PHS	EVT302	Phase 2
T83011	DRUGINFO	D0C3UC	Ladostigil	Phase 2
T83011	DRUGINFO	D02PSS	RG1577	Phase 2
T83011	DRUGINFO	D0D1UQ	Neu-120	Phase 1/2
T83011	DRUGINFO	D0H7PW	PIPERINE	Phase 1/2
T83011	DRUGINFO	D0W7LO	PF9601N	Phase 1
T83011	DRUGINFO	D03VOJ	3,4-Dihydroxybenzaldehyde	Patented
T83011	DRUGINFO	D00NDF	3-Hydroxy-2-butanone	Patented
T83011	DRUGINFO	D03ZOH	4-Hydroxy-2,5-dimethyl-3(2H)-furanone	Patented
T83011	DRUGINFO	D00BRD	4-hydroxybenzaldehyde	Patented
T83011	DRUGINFO	D0NH9P	4-Hydroxybenzoicacid	Patented
T83011	DRUGINFO	D0X7BT	4-Hydroxybenzylalcohol	Patented
T83011	DRUGINFO	D09SWE	4-Methoxybenzaldehyde	Patented
T83011	DRUGINFO	D0XV2A	Benzylcinnamate	Patented
T83011	DRUGINFO	D0BT3Y	Coumaricacid	Patented
T83011	DRUGINFO	D0L9FL	Coumarin/resveratrol hybrid derivative 1	Patented
T83011	DRUGINFO	D0Z5VD	Coumarin/resveratrol hybrid derivative 2	Patented
T83011	DRUGINFO	D04OEV	Cyclic peptide derivative 1	Patented
T83011	DRUGINFO	D0N9JJ	Ethylvanillin	Patented
T83011	DRUGINFO	D0O4QB	EUGENOL	Patented
T83011	DRUGINFO	D03SLR	FERULIC ACID	Patented
T83011	DRUGINFO	D07NTA	Heteroaryl-cyclopropylamine derivative 1	Patented
T83011	DRUGINFO	D06VMN	Heteroaryl-cyclopropylamine derivative 3	Patented
T83011	DRUGINFO	D06QRW	Lazabemide	Patented
T83011	DRUGINFO	D0C7LB	Lazabemide analog 1	Patented
T83011	DRUGINFO	D0UL9U	N-(2-phenylcyclopropyl) amino acid derivative 1	Patented
T83011	DRUGINFO	D08IOP	N-(2-phenylcyclopropyl) amino acid derivative 3	Patented
T83011	DRUGINFO	D0N3SU	Piperonal	Patented
T83011	DRUGINFO	D0AI6J	PMID25399762-Compound-Table 6-10	Patented
T83011	DRUGINFO	D02WXS	PMID25399762-Compound-Table 6-11	Patented
T83011	DRUGINFO	D0E7SF	PMID25399762-Compound-Table 6-12	Patented
T83011	DRUGINFO	D06KBT	PMID25399762-Compound-Table 6-13	Patented
T83011	DRUGINFO	D0PM2S	PMID25399762-Compound-Table 6-14	Patented
T83011	DRUGINFO	D0Q1EG	PMID25399762-Compound-Table 6-15	Patented
T83011	DRUGINFO	D0IO2A	PMID25399762-Compound-Table 6-9	Patented
T83011	DRUGINFO	D0UA3V	PMID25399762-Compound-Table 7-Vanillic acid	Patented
T83011	DRUGINFO	D0ME4N	PMID25399762-Compound-Table 7-Vanillyl alcohol	Patented
T83011	DRUGINFO	D0TR7N	PMID25399762-Compound-Table 7-Veratraldehyde	Patented
T83011	DRUGINFO	D0Z6ZH	PMID25399762-Compound-Table1-C1	Patented
T83011	DRUGINFO	D00VSX	PMID25399762-Compound-Table1-C10	Patented
T83011	DRUGINFO	D0B2YJ	PMID25399762-Compound-Table1-C11	Patented
T83011	DRUGINFO	D05UNM	PMID25399762-Compound-Table1-C12	Patented
T83011	DRUGINFO	D01JDK	PMID25399762-Compound-Table1-C13	Patented
T83011	DRUGINFO	D0V2NC	PMID25399762-Compound-Table1-C14	Patented
T83011	DRUGINFO	D08YYW	PMID25399762-Compound-Table1-C15	Patented
T83011	DRUGINFO	D0AF7J	PMID25399762-Compound-Table1-C16	Patented
T83011	DRUGINFO	D00KTI	PMID25399762-Compound-Table1-C17	Patented
T83011	DRUGINFO	D02FRR	PMID25399762-Compound-Table1-C18	Patented
T83011	DRUGINFO	D01PCI	PMID25399762-Compound-Table1-C19	Patented
T83011	DRUGINFO	D0K2LB	PMID25399762-Compound-Table1-C2	Patented
T83011	DRUGINFO	D0UL2R	PMID25399762-Compound-Table1-C20	Patented
T83011	DRUGINFO	D0S2LV	PMID25399762-Compound-Table1-C21	Patented
T83011	DRUGINFO	D07GZU	PMID25399762-Compound-Table1-C22	Patented
T83011	DRUGINFO	D0HR6P	PMID25399762-Compound-Table1-C23	Patented
T83011	DRUGINFO	D04FJY	PMID25399762-Compound-Table1-C24	Patented
T83011	DRUGINFO	D0J3JY	PMID25399762-Compound-Table1-C25	Patented
T83011	DRUGINFO	D00YBT	PMID25399762-Compound-Table1-C3	Patented
T83011	DRUGINFO	D0Q1MN	PMID25399762-Compound-Table1-C4	Patented
T83011	DRUGINFO	D06BFA	PMID25399762-Compound-Table1-C5	Patented
T83011	DRUGINFO	D0DM9L	PMID25399762-Compound-Table1-C6	Patented
T83011	DRUGINFO	D0C2EW	PMID25399762-Compound-Table1-C7	Patented
T83011	DRUGINFO	D0GY4F	PMID25399762-Compound-Table1-C8	Patented
T83011	DRUGINFO	D06EIP	PMID25399762-Compound-Table1-C9	Patented
T83011	DRUGINFO	D04OXC	PMID29324067-Compound-38	Patented
T83011	DRUGINFO	D07UZL	PMID29324067-Compound-40	Patented
T83011	DRUGINFO	D0AA7U	PMID29757691-Compound-4	Patented
T83011	DRUGINFO	D05RJG	Schiff base compound 1	Patented
T83011	DRUGINFO	D0DW5P	Schiff base compound 2	Patented
T83011	DRUGINFO	D0J7HR	Secondary and tertiary (hetero)arylamide derivative 1	Patented
T83011	DRUGINFO	D0B5YS	T83193	Patented
T83011	DRUGINFO	D0T9JB	Tacrine-coumarin hybrid derivative 1	Patented
T83011	DRUGINFO	D04OHC	Tarnylcypromine derivative 2	Patented
T83011	DRUGINFO	D0O7IH	Tarnylcypromine derivative 3	Patented
T83011	DRUGINFO	D04AXC	Tetra-hydro-isoquinoline derivative 1	Patented
T83011	DRUGINFO	D0NB7Z	Tetra-hydro-isoquinoline derivative 2	Patented
T83011	DRUGINFO	D02EME	Tetra-hydro-isoquinoline derivative 3	Patented
T83011	DRUGINFO	D0R6RT	Tetra-hydro-isoquinoline derivative 4	Patented
T83011	DRUGINFO	D0GQ2Z	Tetra-hydro-oxazolopyridine derivative 1	Patented
T83011	DRUGINFO	D0DL1O	Tetra-hydro-oxazolopyridine derivative 2	Patented
T83011	DRUGINFO	D01LAC	MOFEGILINE	Discontinued in Phase 3
T83011	DRUGINFO	D01OLO	AS602868	Discontinued in Phase 1
T83011	DRUGINFO	D0P1WB	EVT-301	Discontinued in Phase 1
T83011	DRUGINFO	D0O5QL	HT-1067	Discontinued in Phase 1
T83011	DRUGINFO	D0E3JL	SL-25.1188	Discontinued in Phase 1
T83011	DRUGINFO	D0I9LO	RWJ-416457	Preclinical
T83011	DRUGINFO	D07OLO	Milacemide	Terminated
T83011	DRUGINFO	D0T3ZS	(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholin-5-one	Investigative
T83011	DRUGINFO	D0D6OR	(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	Investigative
T83011	DRUGINFO	D0M4GR	(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	Investigative
T83011	DRUGINFO	D0T3XC	(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	Investigative
T83011	DRUGINFO	D0D5KD	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	Investigative
T83011	DRUGINFO	D0J0QW	(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	Investigative
T83011	DRUGINFO	D0B1XZ	(+/-)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Investigative
T83011	DRUGINFO	D04DCW	(+/-)-2-(4-fluorophenyl)-7-methylchroman-4-one	Investigative
T83011	DRUGINFO	D0ZH0T	(+/-)-2-(4-fluorophenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D0O0MY	(+/-)-2-(4-methoxyphenyl)-7-methylchroman-4-one	Investigative
T83011	DRUGINFO	D0ID3Y	(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	Investigative
T83011	DRUGINFO	D08TFN	(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	Investigative
T83011	DRUGINFO	D0Z5BU	(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	Investigative
T83011	DRUGINFO	D08FXH	(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	Investigative
T83011	DRUGINFO	D04FLL	(+/-)-2-Phenylthiomorpholin-5-one	Investigative
T83011	DRUGINFO	D0HU4J	(+/-)-2-Phenylthiomorpholine	Investigative
T83011	DRUGINFO	D0R3LP	(+/-)-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D0D2JH	(+/-)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D03XQB	(+/-)-7-fluoro-2-(4-methoxyphenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D0IK2S	(+/-)-7-fluoro-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D0Y0KU	(+/-)-7-fluoro-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D00HVZ	(+/-)-7-methoxy-2-(4-methoxyphenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D0A2FO	(+/-)-7-methoxy-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D02KXU	(+/-)-7-methoxy-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D0T1GP	(+/-)-7-methyl-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D0Z2XR	(+/-)-7-methyl-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D03HXD	(6-Benzyloxy-2-naphthyl)-2-aminopropane	Investigative
T83011	DRUGINFO	D0L5EW	(6-Ethoxy-2-naphthyl)-2-aminopropane	Investigative
T83011	DRUGINFO	D02IDM	(6-Methoxy-2-naphthyl)-2-aminopropane	Investigative
T83011	DRUGINFO	D0IP7L	(6-Propoxy-2-naphthyl)-2-aminopropane	Investigative
T83011	DRUGINFO	D02TFD	(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	Investigative
T83011	DRUGINFO	D06AJP	(E)-5-(3-Chlorostyryl)isatin	Investigative
T83011	DRUGINFO	D0X8HH	(E)-5-(3-Fluorostyryl)isatin	Investigative
T83011	DRUGINFO	D09XSB	(E)-5-Styrylisatin	Investigative
T83011	DRUGINFO	D07GUX	(E)-6-Styrylisatin	Investigative
T83011	DRUGINFO	D0TU7I	(E)-8-(3-chlorostyryl)-caffeine	Investigative
T83011	DRUGINFO	D0F2SM	(R)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Investigative
T83011	DRUGINFO	D07WIJ	(R)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D09PBW	(R)(+)-7-fluoro-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D02WOQ	(R)(+)-7-fluoro-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D0B3QN	(R)(+)-7-methyl-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D0P1YC	(R)(+)-7-methyl-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D07BAO	(R)-3-Prop-2-ynylamino-indan-5-ol	Investigative
T83011	DRUGINFO	D0S7FP	(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	Investigative
T83011	DRUGINFO	D0JY9B	(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	Investigative
T83011	DRUGINFO	D05ILO	(R)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	Investigative
T83011	DRUGINFO	D05HVV	(R)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}alaninamide	Investigative
T83011	DRUGINFO	D0M0XR	(R/R)BEFLOXATONE	Investigative
T83011	DRUGINFO	D01KZF	(S)(+)-2-(4-fluorophenyl)-7-methoxychroman-4-one	Investigative
T83011	DRUGINFO	D0L6HE	(S)(+)-7-fluoro-2-(4-fluorophenyl)chroman-4-one	Investigative
T83011	DRUGINFO	D0I5CZ	(S)(+)-7-fluoro-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D00PJT	(S)(+)-7-fluoro-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D0N4DR	(S)(+)-7-methyl-2-phenylchroman-4-one	Investigative
T83011	DRUGINFO	D0TB1E	(S)(+)-7-methyl-2-p-tolylchroman-4-one	Investigative
T83011	DRUGINFO	D0Z0ZU	(S)-2-amino-1-(4-butylthiophenyl)-propane	Investigative
T83011	DRUGINFO	D08SSS	(S)-2-amino-1-(4-propylthiophenyl)-propane	Investigative
T83011	DRUGINFO	D05OTR	(S)-N2-[4-(benzyloxy)benzyl]alaninamide	Investigative
T83011	DRUGINFO	D0U4JD	(S)-N2-[4-(benzyloxy)benzyl]serinamide	Investigative
T83011	DRUGINFO	D03KYZ	(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}alaninamide	Investigative
T83011	DRUGINFO	D0FR3X	(S)-N2-{4-[(3-chlorobenzyl)oxy]benzyl}serinamide	Investigative
T83011	DRUGINFO	D0IN0X	(S)-N2-{4-[(3-fluorobenzyl)oxy]benzyl}serinamide	Investigative
T83011	DRUGINFO	D0G5YA	(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}alaninamide	Investigative
T83011	DRUGINFO	D0T8AD	(S)-N2-{4-[(4-chlorobenzyl)oxy]benzyl}serinamide	Investigative
T83011	DRUGINFO	D09GCE	(S)-N2-{4-[(4-nitrobenzyl)oxy]benzyl}serinamide	Investigative
T83011	DRUGINFO	D0G2LF	[(1e)-4-Phenylbut-1-Enyl]Benzene	Investigative
T83011	DRUGINFO	D01SBZ	1-(4-(benzyloxy)phenyl)propan-2-amine	Investigative
T83011	DRUGINFO	D0UF1R	1,2,3,4-Tetrahydro-naphthalen-1-ylamine	Investigative
T83011	DRUGINFO	D0C1SE	1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	Investigative
T83011	DRUGINFO	D0J0MX	1,4-diphenyl-(1E,3E)-1,3-butadiene	Investigative
T83011	DRUGINFO	D0SP2O	1H-Indole-2,3-dione	Investigative
T83011	DRUGINFO	D01GAX	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Investigative
T83011	DRUGINFO	D0Q3VS	2-(2,4-dichlorophenyl)-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0Q1IP	2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	Investigative
T83011	DRUGINFO	D0E4HB	2-(2-cyclohexylidenehydrazinyl)-4-phenylthiazole	Investigative
T83011	DRUGINFO	D0I2GP	2-(2-cyclohexylidenehydrazinyl)-4-p-tolylthiazole	Investigative
T83011	DRUGINFO	D00WVG	2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	Investigative
T83011	DRUGINFO	D07YZD	2-(3-nitrophenyl)-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0A4AB	2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	Investigative
T83011	DRUGINFO	D01FTB	2-(4-chlorophenyl)-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0G6MA	2-(4-fluorophenyl)-7-methoxy-4H-chromen-4-one	Investigative
T83011	DRUGINFO	D0P7SY	2-(4-methoxyphenyl)-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D0P1UC	2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D04ZPU	2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0M7WE	2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	Investigative
T83011	DRUGINFO	D0S3QN	2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	Investigative
T83011	DRUGINFO	D0LI3J	2-BFi	Investigative
T83011	DRUGINFO	D02BBT	2-Bromo-N-(2-morpholinoethyl)nicotinamide	Investigative
T83011	DRUGINFO	D01JMW	2-Bromo-N-(3-morpholinopropyl)nicotinamide	Investigative
T83011	DRUGINFO	D0R5EW	2-Chloro-N-(2-morpholinoethyl)nicotinamide	Investigative
T83011	DRUGINFO	D0NS9X	2-Chloro-N-(3-morpholinopropyl)nicotinamide	Investigative
T83011	DRUGINFO	D09ZDQ	2-Furan-2-yl-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D02VIV	2-Hydrazino-3-methyl-4(3H)-quinazolinone	Investigative
T83011	DRUGINFO	D0FH5A	2-methyl-9H-indeno[2,1-d]pyrimidin-9-one	Investigative
T83011	DRUGINFO	D00WSM	2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D03PXS	2-oxo-N-phenyl-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D0H0GZ	2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D0Z7NC	2-Phenethyl-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0N9FH	2-Phenoxymethyl-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D0Q9NC	2-phenyl-9H-indeno[2,1-d]pyrimidine	Investigative
T83011	DRUGINFO	D05LMT	2-Phenyl-cyclopropylamine hydrochloride	Investigative
T83011	DRUGINFO	D01DEU	2-p-tolyl-4,5-dihydro-1H-imidazole	Investigative
T83011	DRUGINFO	D03BQJ	2-p-tolyl-4H-chromen-4-one	Investigative
T83011	DRUGINFO	D01VPZ	2-p-tolyl-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D0U8ET	3-(2-Bromophenyl)-6-methylcoumarin	Investigative
T83011	DRUGINFO	D0O1GE	3-(3-methoxyphenyl)-6-methyl-2H-chromen-2-one	Investigative
T83011	DRUGINFO	D01HQV	3-(4-hydroxyphenyl)-6-methyl-2H-chromen-2-one	Investigative
T83011	DRUGINFO	D0R9TX	3-(4-methoxyphenyl)-6-methyl-2H-chromen-2-one	Investigative
T83011	DRUGINFO	D0I6GH	3-(phenoxymethyl)-5H-indeno[1,2-c]pyridazin-5-one	Investigative
T83011	DRUGINFO	D0P4GF	3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	Investigative
T83011	DRUGINFO	D0TL3S	3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	Investigative
T83011	DRUGINFO	D09NNZ	3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	Investigative
T83011	DRUGINFO	D0D6QI	3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	Investigative
T83011	DRUGINFO	D08IDJ	3-phenyl-9H-indeno[1,2-e][1,2,4]triazin-9-one	Investigative
T83011	DRUGINFO	D0E8IE	4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	Investigative
T83011	DRUGINFO	D0T1FJ	4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	Investigative
T83011	DRUGINFO	D01LUB	4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	Investigative
T83011	DRUGINFO	D0G8BT	4,9-Dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D07KIB	4-fluoroselegiline	Investigative
T83011	DRUGINFO	D06ETG	4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN	Investigative
T83011	DRUGINFO	D0A1RE	4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	Investigative
T83011	DRUGINFO	D04TGN	4-oxo-4H-chromene-3-carboxylic acid	Investigative
T83011	DRUGINFO	D07AAZ	4-phenyl-1,2,3,6-tetrahydropyridine	Investigative
T83011	DRUGINFO	D0R7UO	5-Aminomethyl-3-pyrrol-1-yl-oxazolidin-2-one	Investigative
T83011	DRUGINFO	D0L8ND	5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D08HAM	5-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D08QVY	5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	Investigative
T83011	DRUGINFO	D00NSA	5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0V6XA	5-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D08NQM	5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE	Investigative
T83011	DRUGINFO	D0S0JH	6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	Investigative
T83011	DRUGINFO	D05GQQ	6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D04GVX	6-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D0J3SN	6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0C7PD	6-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D0C9WW	7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	Investigative
T83011	DRUGINFO	D08FFH	7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	Investigative
T83011	DRUGINFO	D00OQL	7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	Investigative
T83011	DRUGINFO	D02UVG	7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0W4TW	7-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D0Y5OB	7-fluoro-2-(4-fluorophenyl)-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D0W7XK	7-fluoro-2-(4-methoxyphenyl)-4H-chromen-4-one	Investigative
T83011	DRUGINFO	D0C9GI	7-fluoro-2-p-tolyl-4H-chromen-4-one	Investigative
T83011	DRUGINFO	D0I9AA	7-fluoro-2-p-tolyl-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D05GDP	7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0ZI0S	7-methoxy-2-p-tolyl-4H-chromen-4-one	Investigative
T83011	DRUGINFO	D07HFF	7-methoxy-2-p-tolyl-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D05FQN	7-Methoxy-9H-beta-carboline	Investigative
T83011	DRUGINFO	D08HKC	7-methyl-2-p-tolyl-4H-chromene-4-thione	Investigative
T83011	DRUGINFO	D07NBB	8-(3-Bromobenzyloxy)caffeine	Investigative
T83011	DRUGINFO	D08YCE	8-(3-Chlorobenzyloxy)caffeine	Investigative
T83011	DRUGINFO	D04LPY	8-(3-Fluorobenzyloxy)caffeine	Investigative
T83011	DRUGINFO	D0B6MV	8-(3-Methoxybenzyloxy)caffeine	Investigative
T83011	DRUGINFO	D00OLX	8-(3-Methylbenzyloxy)caffeine	Investigative
T83011	DRUGINFO	D02FJX	8-[(3-Trifluoromethyl)benzyloxy]caffeine	Investigative
T83011	DRUGINFO	D0JN9R	8-Benzyloxycaffeine	Investigative
T83011	DRUGINFO	D06BAC	8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0G2EF	8-Bromo-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D0H3RQ	8-Bromo-6-methyl-3-(4'-methoxyphenyl)coumarin	Investigative
T83011	DRUGINFO	D0K1FE	8-Bromo-6-methyl-3-phenylcoumarin	Investigative
T83011	DRUGINFO	D0Q3VI	8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0Y1GL	8-Methoxy-4,9-dihydro-3H-beta-carboline	Investigative
T83011	DRUGINFO	D0D2YR	9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	Investigative
T83011	DRUGINFO	D0Y0JM	Benzyl-methyl-[1-(1H-pyrrol-2-yl)-vinyl]-amine	Investigative
T83011	DRUGINFO	D0R7ZC	Beta-methoxyamphetamine	Investigative
T83011	DRUGINFO	D07KCC	Butyl-methyl-prop-2-ynyl-amine hydrochloride	Investigative
T83011	DRUGINFO	D05FMZ	C-(1H-Indol-3-yl)-methylamine	Investigative
T83011	DRUGINFO	D0D1PE	CGS-19281A	Investigative
T83011	DRUGINFO	D06ERH	CHALCONE	Investigative
T83011	DRUGINFO	D06AAA	Cis-2-(4-chlorophenyl)-2-fluorocyclopropanamine	Investigative
T83011	DRUGINFO	D0UL6Y	Cis-2-(para-fluorophenyl)cyclopropylamine	Investigative
T83011	DRUGINFO	D0B2TV	Cis-2-Fluoro-2-(4-methoxyphenyl)cyclopropylamine	Investigative
T83011	DRUGINFO	D04TZI	Cis-2-fluoro-2-phenylcyclopropanamine	Investigative
T83011	DRUGINFO	D0X8RN	Cis-2-phenylcyclopropylamine	Investigative
T83011	DRUGINFO	D0US0J	CORDOIN	Investigative
T83011	DRUGINFO	D0Y8AN	Deprenyl	Investigative
T83011	DRUGINFO	D0M0CF	Farnesol	Investigative
T83011	DRUGINFO	D0B4VE	Flavanone	Investigative
T83011	DRUGINFO	D00IMW	Flavin-Adenine Dinucleotide	Investigative
T83011	DRUGINFO	D0Z2NN	Heptyl-methyl-prop-2-ynyl-amine hydrochloride	Investigative
T83011	DRUGINFO	D0A4IY	HYDRAZINECARBOXAMIDE	Investigative
T83011	DRUGINFO	D08CNS	IPRONIAZIDE	Investigative
T83011	DRUGINFO	D0X3SE	Isopropyl-methyl-prop-2-ynyl-amine hydrochloride	Investigative
T83011	DRUGINFO	D09GQS	JD-0100	Investigative
T83011	DRUGINFO	D0F7KG	L-136662	Investigative
T83011	DRUGINFO	D0C7PY	Lauryl Dimethylamine-N-Oxide	Investigative
T83011	DRUGINFO	D0BV8Y	LU-53439	Investigative
T83011	DRUGINFO	D0EX4L	Methyl piperate	Investigative
T83011	DRUGINFO	D0MX1T	Methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amine	Investigative
T83011	DRUGINFO	D0N6JE	Methyl-pentyl-prop-2-ynyl-amine oxalic acid	Investigative
T83011	DRUGINFO	D0I4ME	MMDA	Investigative
T83011	DRUGINFO	D00KDZ	N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	Investigative
T83011	DRUGINFO	D01PES	N-(1H-Indol-2-ylmethyl)-N-phenylamine	Investigative
T83011	DRUGINFO	D02KGZ	N-(2-aminoethyl)-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D0K0SA	N-(2-aminoethyl)-p-chlorobenzamide	Investigative
T83011	DRUGINFO	D08ILX	N-(2-Methyl-1H-indol-5-yl)benzamide	Investigative
T83011	DRUGINFO	D05WQN	N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	Investigative
T83011	DRUGINFO	D0N8UE	N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83011	DRUGINFO	D0YO7C	N-(2-Phenylethyl)-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D07LCU	N-(3-Phenylpropyl)-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D0B1WD	N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D08HNJ	N-(4-Phenylbutyl)-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D0O2UK	N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83011	DRUGINFO	D0G4BG	N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83011	DRUGINFO	D0T6XC	N2-[4-(benzyloxy)benzyl]glycinamide	Investigative
T83011	DRUGINFO	D0T7EJ	N2-{4-[(3-chlorobenzyl)oxy]benzyl}glycinamide	Investigative
T83011	DRUGINFO	D02QBV	N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	Investigative
T83011	DRUGINFO	D03XKJ	N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	Investigative
T83011	DRUGINFO	D08BUB	N2-{4-[(4-nitrobenzyl)oxy]benzyl}glycinamide	Investigative
T83011	DRUGINFO	D0V0TN	N-Benzyl,N-methyl-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D0Z5YO	N-Benzyl-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D06QNN	N-benzyl-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D05ANK	N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	Investigative
T83011	DRUGINFO	D01UFM	N-cyclohexyl-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D09FAD	N-isobutyl-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D0MO1O	N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83011	DRUGINFO	D03KDD	N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	Investigative
T83011	DRUGINFO	D0F7JK	N-Methyl,N-phenyl-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D0W1WE	N-Methyl-N-phenyl-2-oxo-2H-chromene-3-carboxamide	Investigative
T83011	DRUGINFO	D0A2AF	N-Methyl-N-Propargyl-1(R)-Aminoindan	Investigative
T83011	DRUGINFO	D0K9UN	N-Phenyl-1H-indole-2-carboxamide	Investigative
T83011	DRUGINFO	D0K5LJ	N-Propargyl-1(S)-Aminoindan	Investigative
T83011	DRUGINFO	D0T7VA	NSC-50187	Investigative
T83011	DRUGINFO	D0K8EE	NSC-93405	Investigative
T83011	DRUGINFO	D0OW5Y	NW-1772	Investigative
T83011	DRUGINFO	D08SRB	Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	Investigative
T83011	DRUGINFO	D04QRS	PNU-22394	Investigative
T83011	DRUGINFO	D0K4GD	RS-1636	Investigative
T83011	DRUGINFO	D00AHV	SKL-PD	Investigative
T83011	DRUGINFO	D0V3NT	TOLOXATONE	Investigative
T83011	DRUGINFO	D09BIV	TRACIZOLINE	Investigative
T83011	DRUGINFO	D03LGV	Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	Investigative
T83011	DRUGINFO	D08PHY	Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	Investigative
T83011	DRUGINFO	D09HBX	Trans-2-fluoro-2-phenylcyclopropylamin	Investigative
T83011	DRUGINFO	D0F2DC	Trans-2-fluoro-2-p-tolylcyclopropanamine	Investigative
T83011	DRUGINFO	D03LPH	TRYPTOLINE	Investigative
T83011	DRUGINFO	D0V4KL	VAR-10200	Investigative
T83011	DRUGINFO	D02AQM	VAR-10300	Investigative
T83011	KEGGPATH	hsa00260:Glycine, serine and threonine metabolism		
T83011	KEGGPATH	hsa00330:Arginine and proline metabolism		
T83011	KEGGPATH	hsa00340:Histidine metabolism		
T83011	KEGGPATH	hsa00350:Tyrosine metabolism		
T83011	KEGGPATH	hsa00360:Phenylalanine metabolism		
T83011	KEGGPATH	hsa00380:Tryptophan metabolism		
T83011	KEGGPATH	hsa00982:Drug metabolism - cytochrome P450		
T83011	KEGGPATH	hsa01100:Metabolic pathways		
T83011	KEGGPATH	hsa04726:Serotonergic synapse		
T83011	KEGGPATH	hsa04728:Dopaminergic synapse		
T83011	KEGGPATH	hsa05030:Cocaine addiction		
T83011	KEGGPATH	hsa05031:Amphetamine addiction		
T83011	KEGGPATH	hsa05034:Alcoholism		
T83011	WIKIPATH	WP1879:Phase 1 - Functionalization of compounds		
T83011	WIKIPATH	WP2436:Dopamine metabolism		
T83011	WIKIPATH	WP465:Tryptophan metabolism		
T83011	INTEPATH	alphasynuclein_pathway:Alpha-synuclein signaling		
T83011	PANTPATH	P00001:Adrenaline and noradrenaline biosynthesis		
T83011	PANTPATH	P04372:5-Hydroxytryptamine degredation		
T83011	PANTPATH	P05912:Dopamine receptor mediated signaling pathway		
T83011	BIOCPATH	PWY-0:Putrescine degradation III		
T83011	BIOCPATH	PWY-6307:Tryptophan degradation via tryptamine		
T83011	BIOCPATH	PWY-6342:Noradrenaline and adrenaline degradation		
T83011	BIOCPATH	PWY66-401:Superpathway of tryptophan utilization		
T83011	BIOCPATH	PWY6666-2:Dopamine degradation		
				
T31391	TARGETID	T31391		
T31391	FORMERID	TTDS00093		
T31391	UNIPROID	DPP4_HUMAN		
T31391	TARGNAME	Dipeptidyl peptidase 4 (DPP-4)		
T31391	GENENAME	DPP4		
T31391	TARGTYPE	Successful target		
T31391	SYNONYMS	Tcell activation antigen CD26; TP103; T-cell activation antigen CD26; Dipeptidyl peptidase IV; Dipeptidyl peptidase 4 soluble form; DPP-IV; DPP IV; DPP 4; CD26; Adenosine deaminase complexing protein-2; Adenosine deaminase complexing protein 2; ADCP2; ADCP-2; ADABP		
T31391	FUNCTION	Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion. In association with FAP is involved in the pericellular proteolysis of the extracellular matrix (ECM), the migration and invasion of endothelial cells into the ECM. May be involved in the promotion of lymphatic endothelial cells adhesion, migration and tube formation. When overexpressed, enhanced cell proliferation, a process inhibited by GPC3. Acts also as a serine exopeptidase with a dipeptidyl peptidase activity that regulates various physiological processes by cleaving peptides in the circulation, including many chemokines, mitogenic growth factors, neuropeptides and peptide hormones. Removes N-terminal dipeptides sequentially from polypeptides having unsubstituted N-termini provided that the penultimate residue is proline. Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation.		
T31391	PDBSTRUC	6B1O; 6B1E; 5ZID; 5Y7K; 5Y7J		
T31391	BIOCLASS	Peptidase		
T31391	ECNUMBER	EC 3.4.14.5		
T31391	SEQUENCE	MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP		
T31391	DRUGINFO	D0NJ5H	Alogliptin	Approved
T31391	DRUGINFO	D0T8XB	Anagliptin	Approved
T31391	DRUGINFO	D0Y6QC	Dapagliflozin Propanediol; Saxagliptin Hydrochloride	Approved
T31391	DRUGINFO	D05IPF	Kombiglyze XR/Komboglyze FDC	Approved
T31391	DRUGINFO	D02EYG	Linagliptin	Approved
T31391	DRUGINFO	D0K9MY	Saxagliptin	Approved
T31391	DRUGINFO	D0U2JP	Sitagliptin	Approved
T31391	DRUGINFO	D0L3DK	Vildagliptin	Approved
T31391	DRUGINFO	D04XIO	Dutogliptin	Phase 3
T31391	DRUGINFO	D0ZD3C	Gemigliptin	Phase 3
T31391	DRUGINFO	D0V0KJ	IDDBCP161883	Phase 3
T31391	DRUGINFO	D02ZBW	LC-150444	Phase 3
T31391	DRUGINFO	D0M3XR	MK-3102	Phase 3
T31391	DRUGINFO	D0N7JZ	SAND-26	Phase 3
T31391	DRUGINFO	D09XMX	SaxaDapa FDC	Phase 3
T31391	DRUGINFO	D0N6SO	SYR-472	Phase 3
T31391	DRUGINFO	D06VCN	Denagliptin	Phase 2/3
T31391	DRUGINFO	D0E3HY	IP10 C8	Phase 2
T31391	DRUGINFO	D03SKC	KRP-104	Phase 2
T31391	DRUGINFO	D06VMJ	Melogliptin	Phase 2
T31391	DRUGINFO	D0H2IO	P32/98	Phase 2
T31391	DRUGINFO	D07HZG	PF-00734200	Phase 2
T31391	DRUGINFO	D05VXF	YSCMA	Phase 1/2
T31391	DRUGINFO	D0Z1OS	ARI-2243	Phase 1
T31391	DRUGINFO	D05LPW	DA-1229	Phase 1
T31391	DRUGINFO	D03JWU	REC-01	Phase 1
T31391	DRUGINFO	D07EPV	Teneligliptin	Phase 1
T31391	DRUGINFO	D0BA5E	ZYDPLA 1	Phase 1
T31391	DRUGINFO	D0A6LI	Aminopiperidine derivative 1	Patented
T31391	DRUGINFO	D06PIP	Aminopiperidine derivative 2	Patented
T31391	DRUGINFO	D0W6HL	Beta-phe compound 1	Patented
T31391	DRUGINFO	D02UOW	Beta-phe compound 2	Patented
T31391	DRUGINFO	D0IO0M	Beta-phe compound 3	Patented
T31391	DRUGINFO	D0XB0Q	Dihydropyrrolopyrazole derivative 1	Patented
T31391	DRUGINFO	D02SUS	Imidazo cyclohexylamine derivative 1	Patented
T31391	DRUGINFO	D0KS8Y	Imidazo cyclohexylamine derivative 2	Patented
T31391	DRUGINFO	D04UXC	Imidazo cyclohexylamine derivative 3	Patented
T31391	DRUGINFO	D0UV3I	Imidazo pyridine derivative 2	Patented
T31391	DRUGINFO	D0QE8Z	Peptide analog 44	Patented
T31391	DRUGINFO	D0B4CH	Peptide analog 45	Patented
T31391	DRUGINFO	D0E8WW	Peptide analog 46	Patented
T31391	DRUGINFO	D0WE8K	Peptide analog 47	Patented
T31391	DRUGINFO	D05LJQ	Peptide analog 48	Patented
T31391	DRUGINFO	D04XXF	Peptide analog 49	Patented
T31391	DRUGINFO	D0BY2H	Peptide analog 50	Patented
T31391	DRUGINFO	D0J4KQ	Peptide analog 51	Patented
T31391	DRUGINFO	D0N9CV	PMID25482888-Compound-11	Patented
T31391	DRUGINFO	D0LG1I	PMID25482888-Compound-12	Patented
T31391	DRUGINFO	D01MMT	PMID25482888-Compound-13	Patented
T31391	DRUGINFO	D0E9MO	PMID25482888-Compound-14	Patented
T31391	DRUGINFO	D02LNB	PMID25482888-Compound-15	Patented
T31391	DRUGINFO	D06GQG	PMID25482888-Compound-16	Patented
T31391	DRUGINFO	D0G3IL	PMID25482888-Compound-17	Patented
T31391	DRUGINFO	D0KR7R	PMID25482888-Compound-18	Patented
T31391	DRUGINFO	D05GEY	PMID25482888-Compound-21	Patented
T31391	DRUGINFO	D0A5QV	PMID25482888-Compound-34	Patented
T31391	DRUGINFO	D0BJ2X	PMID25482888-Compound-37	Patented
T31391	DRUGINFO	D0XN3O	PMID25482888-Compound-38	Patented
T31391	DRUGINFO	D0K5YJ	PMID25482888-Compound-50	Patented
T31391	DRUGINFO	D06PDK	PMID25482888-Compound-52	Patented
T31391	DRUGINFO	D0T6SD	PMID25482888-Compound-56	Patented
T31391	DRUGINFO	D0JP6A	PMID25482888-Compound-6	Patented
T31391	DRUGINFO	D0J0UN	PMID25482888-Compound-69	Patented
T31391	DRUGINFO	D0T1WB	PMID25482888-Compound-70	Patented
T31391	DRUGINFO	D0G1CF	PMID25482888-Compound-71	Patented
T31391	DRUGINFO	D0PF2W	PMID25482888-Compound-72	Patented
T31391	DRUGINFO	D0RT1R	Pyrimidine derivative 30	Patented
T31391	DRUGINFO	D07JJT	Pyrimidine derivative 31	Patented
T31391	DRUGINFO	D0CW9H	Pyrimidine derivative 32	Patented
T31391	DRUGINFO	D04MAZ	Pyrimidine derivative 33	Patented
T31391	DRUGINFO	D0J5EW	Pyrimidinedione derivative 1	Patented
T31391	DRUGINFO	D0P3DS	Pyrrolo[1,2-f]triazine derivative 1	Patented
T31391	DRUGINFO	D0EL5B	Pyrrolo[1,2-f]triazine derivative 2	Patented
T31391	DRUGINFO	D05HLQ	Quinazoline derivative 1	Patented
T31391	DRUGINFO	D06HJX	Thiomorpholine derivative 1	Patented
T31391	DRUGINFO	D0D4BP	Thiomorpholine derivative 2	Patented
T31391	DRUGINFO	D00GNP	Triazole piperazine derivative 1	Patented
T31391	DRUGINFO	D0PM4N	Triazolo-pyrimidinedione derivative 1	Patented
T31391	DRUGINFO	D0O6SK	Triazolo-pyrimidinedione derivative 2	Patented
T31391	DRUGINFO	D0E8AS	Tricyclic heterocycle derivative 6	Patented
T31391	DRUGINFO	D0ND5K	Xanthine derivative 1	Patented
T31391	DRUGINFO	D0K2ZQ	Xanthine/amino piperidine compound 1	Patented
T31391	DRUGINFO	D0H2KV	ALS 2-0426	Discontinued in Phase 2
T31391	DRUGINFO	D00FYF	NVP-DPP728	Discontinued in Phase 2
T31391	DRUGINFO	D0FD0B	PSN-9301	Discontinued in Phase 2
T31391	DRUGINFO	D0E4EZ	R-1438	Discontinued in Phase 2
T31391	DRUGINFO	D0JA1Z	TA-6666	Discontinued in Phase 2
T31391	DRUGINFO	D0A1NU	ABT-279	Discontinued in Phase 1
T31391	DRUGINFO	D0X5ZO	SSR-162369	Discontinued in Phase 1
T31391	DRUGINFO	D0Q4YP	TAK-100	Discontinued in Phase 1
T31391	DRUGINFO	D0Q6ED	ASP8497	Preclinical
T31391	DRUGINFO	D0XL4I	ER-319711-15	Preclinical
T31391	DRUGINFO	D0O6DC	LY-2463665	Preclinical
T31391	DRUGINFO	D7K0GP	PT630	Preclinical
T31391	DRUGINFO	D0M9SL	DSP-7238	Terminated
T31391	DRUGINFO	D0F3TI	PT-630	Terminated
T31391	DRUGINFO	D05UUA	(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine	Investigative
T31391	DRUGINFO	D0W4GM	(1-phenylcyclopentyl)methanamine	Investigative
T31391	DRUGINFO	D0P5OE	(1R,2R)-1,2-diphenylethane-1,2-diamine	Investigative
T31391	DRUGINFO	D07HWI	(1R,2S)-1,2-diphenylethane-1,2-diamine	Investigative
T31391	DRUGINFO	D00HSG	(2-(2-chlorophenyl)pyridin-3-yl)methanamine	Investigative
T31391	DRUGINFO	D0X2JG	(2-chloro-6-phenoxyphenyl)methanamine	Investigative
T31391	DRUGINFO	D07VDJ	(2s)-Pyrrolidin-2-Ylmethylamine	Investigative
T31391	DRUGINFO	D09BYA	(3S,4R)-3-butyl-1-phenylpiperidin-4-amine	Investigative
T31391	DRUGINFO	D0N5CI	(5-phenyl-3H-benzo[d]imidazol-4-yl)methanamine	Investigative
T31391	DRUGINFO	D04CAR	(R)-1-(2-aminoacetyl)pyrrolidin-2-ylboronic acid	Investigative
T31391	DRUGINFO	D0O9RD	(S)-2-Amino-1-azetidin-1-yl-2-cyclohexyl-ethanone	Investigative
T31391	DRUGINFO	D0L5RI	(S)-2-Amino-1-thiazolidin-3-yl-propane-1-thione	Investigative
T31391	DRUGINFO	D07IJU	(S)-pyrrolidin-1-yl(pyrrolidin-2-yl)methanone	Investigative
T31391	DRUGINFO	D0R5OE	(S)-pyrrolidin-2-yl(thiazolidin-3-yl)methanone	Investigative
T31391	DRUGINFO	D0JI3S	1-benzhydryl-3-butylpiperidin-4-amine	Investigative
T31391	DRUGINFO	D06AUB	1-benzyl-4-(2,4-dichlorophenyl)pyrrolidin-3-amine	Investigative
T31391	DRUGINFO	D09MVE	1-biphenyl-2-ylmethanamine	Investigative
T31391	DRUGINFO	D02WBC	2-(2-chlorophenyl)-2-morpholinoethanamine	Investigative
T31391	DRUGINFO	D0L9XR	2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One	Investigative
T31391	DRUGINFO	D00KMP	3-butyl-1-(naphthalen-1-yl)piperidin-4-amine	Investigative
T31391	DRUGINFO	D06UKY	4-(2,4-dichlorophenyl)-1-phenylpyrrolidin-3-amine	Investigative
T31391	DRUGINFO	D02RIE	4-(2,4-dichlorophenyl)-1-tosylpyrrolidin-3-amine	Investigative
T31391	DRUGINFO	D0PB2M	4-iodophenyl-alaninyl-(S)-2-cyano-pyrrolidine	Investigative
T31391	DRUGINFO	D04QDB	ABT-341	Investigative
T31391	DRUGINFO	D07LUR	Alpha-D-Mannose	Investigative
T31391	DRUGINFO	D0N3YL	ASC-201	Investigative
T31391	DRUGINFO	D01ZWF	BPI-711001	Investigative
T31391	DRUGINFO	D06NRU	C-(2'-Chloro-biphenyl-2-yl)-methylamine	Investigative
T31391	DRUGINFO	D0T2EW	Cyclohexylglycine-(2S)-cyanopyrrolidine	Investigative
T31391	DRUGINFO	D0L1NF	D-420720	Investigative
T31391	DRUGINFO	D0FH8R	DB-160	Investigative
T31391	DRUGINFO	D03FDC	Diisopropylphosphono Group	Investigative
T31391	DRUGINFO	D0N1QQ	DIPROTIN A	Investigative
T31391	DRUGINFO	D01OUJ	D-Val-L-boroPro	Investigative
T31391	DRUGINFO	D0T8UH	E-3024	Investigative
T31391	DRUGINFO	D01KRQ	EMC-0901	Investigative
T31391	DRUGINFO	D05XWX	FE 999011	Investigative
T31391	DRUGINFO	D0G6XS	Fucose	Investigative
T31391	DRUGINFO	D0D9ON	Iodo-Phenylalanine	Investigative
T31391	DRUGINFO	D05LYC	KR-62436	Investigative
T31391	DRUGINFO	D0IQ4S	L-Ala-L-boroPro	Investigative
T31391	DRUGINFO	D0C2NQ	L-Val-L-boroPro	Investigative
T31391	DRUGINFO	D07ALM	N4-(4-chlorobenzyl)-2,4-diaminobutanoylpiperidine	Investigative
T31391	DRUGINFO	D0N1FU	N-isoleucylthiazolidine	Investigative
T31391	DRUGINFO	D05WKT	PK-44	Investigative
T31391	DRUGINFO	D08NMS	PMID20684603C24dd	Investigative
T31391	DRUGINFO	D05TKO	Retagliptin	Investigative
T31391	KEGGPATH	hsa04974:Protein digestion and absorption		
T31391	NET_PATH	NetPath_14:IL2 Signaling Pathway		
T31391	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
				
T61744	TARGETID	T61744		
T61744	FORMERID	TTDS00280		
T61744	UNIPROID	PDE4A_HUMAN		
T61744	TARGNAME	Phosphodiesterase 4A (PDE4A)		
T61744	GENENAME	PDE4A		
T61744	TARGTYPE	Successful target		
T61744	SYNONYMS	cAMP-specific 3',5'-cyclic phosphodiesterase 4A; Type 4A cAMP phosphodiesterase; PDE46; DPDE2		
T61744	FUNCTION	Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.		
T61744	PDBSTRUC	3TVX; 3I8V; 2QYK		
T61744	BIOCLASS	Phosphoric diester hydrolase		
T61744	ECNUMBER	EC 3.1.4.53		
T61744	SEQUENCE	MEPPTVPSERSLSLSLPGPREGQATLKPPPQHLWRQPRTPIRIQQRGYSDSAERAERERQPHRPIERADAMDTSDRPGLRTTRMSWPSSFHGTGTGSGGAGGGSSRRFEAENGPTPSPGRSPLDSQASPGLVLHAGAATSQRRESFLYRSDSDYDMSPKTMSRNSSVTSEAHAEDLIVTPFAQVLASLRSVRSNFSLLTNVPVPSNKRSPLGGPTPVCKATLSEETCQQLARETLEELDWCLEQLETMQTYRSVSEMASHKFKRMLNRELTHLSEMSRSGNQVSEYISTTFLDKQNEVEIPSPTMKEREKQQAPRPRPSQPPPPPVPHLQPMSQITGLKKLMHSNSLNNSNIPRFGVKTDQEELLAQELENLNKWGLNIFCVSDYAGGRSLTCIMYMIFQERDLLKKFRIPVDTMVTYMLTLEDHYHADVAYHNSLHAADVLQSTHVLLATPALDAVFTDLEILAALFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHLAVGFKLLQEDNCDIFQNLSKRQRQSLRKMVIDMVLATDMSKHMTLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLRNMVHCADLSNPTKPLELYRQWTDRIMAEFFQQGDRERERGMEISPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVHPDAQEILDTLEDNRDWYYSAIRQSPSPPPEEESRGPGHPPLPDKFQFELTLEEEEEEEISMAQIPCTAQEALTAQGLSGVEEALDATIAWEASPAQESLEVMAQEASLEAELEAVYLTQQAQSTGSAPVAPDEFSSREEFVVAVSHSSPSALALQSPLLPAWRTLSVSEHAPGLPGLPSTAAEVEAQREHQAAKRACSACAGTFGEDTSALPAPGGGGSGGDPT		
T61744	DRUGINFO	D02PWM	Dyphylline	Approved
T61744	DRUGINFO	D09AMZ	Enprofylline	Approved
T61744	DRUGINFO	D01XHG	DENBUFYLLINE	Phase 3
T61744	DRUGINFO	D06VFP	SOTB07	Phase 3
T61744	DRUGINFO	D00JED	AN-2898	Phase 2
T61744	DRUGINFO	D0F4TV	AWD-12-281	Phase 2
T61744	DRUGINFO	D0U2DH	CC-1088	Phase 2
T61744	DRUGINFO	D01XFZ	GPD-1116	Phase 2
T61744	DRUGINFO	D07OCV	HT-0712	Phase 2
T61744	DRUGINFO	D0F5IY	LIRIMILAST	Phase 2
T61744	DRUGINFO	D0M7CB	MK-0873	Phase 2
T61744	DRUGINFO	D0L8KJ	Oglemilast	Phase 2
T61744	DRUGINFO	D0RJ1W	OX-914	Phase 2
T61744	DRUGINFO	D0Z2FB	Piclamilast	Phase 2
T61744	DRUGINFO	D0X0PW	Revamilast	Phase 2
T61744	DRUGINFO	D02POH	TA-7906	Phase 2
T61744	DRUGINFO	D09TFB	TOFIMILAST	Phase 2
T61744	DRUGINFO	DB82TO	Tofisopam	Phase 2
T61744	DRUGINFO	D01WZL	AVE-8112	Phase 1
T61744	DRUGINFO	D0K9DI	GSK-356278	Phase 1
T61744	DRUGINFO	D03CWX	MEM-1414	Phase 1
T61744	DRUGINFO	D0O8JW	Ronomilast	Phase 1
T61744	DRUGINFO	D02EMR	Cilomilast	Discontinued in Phase 3
T61744	DRUGINFO	D0UG4T	CDP840	Discontinued in Phase 2
T61744	DRUGINFO	D00DBE	CI-1018	Discontinued in Phase 2
T61744	DRUGINFO	D0I0GM	Daxalipram	Discontinued in Phase 2
T61744	DRUGINFO	D0U7PS	GSK256066	Discontinued in Phase 2
T61744	DRUGINFO	D03ZVD	KW-4490	Discontinued in Phase 2
T61744	DRUGINFO	D0V2CN	LAS-37779	Discontinued in Phase 2
T61744	DRUGINFO	D08SNX	V-11294A	Discontinued in Phase 2
T61744	DRUGINFO	D0K1OA	D-4418	Discontinued in Phase 1
T61744	DRUGINFO	D01FXD	SCH-351591	Discontinued in Phase 1
T61744	DRUGINFO	D0C7JT	YM-976	Discontinued in Phase 1
T61744	DRUGINFO	D0R1QJ	D-22888	Terminated
T61744	DRUGINFO	D01QUF	GW-3600	Terminated
T61744	DRUGINFO	D07UHY	NIK-616	Terminated
T61744	DRUGINFO	D01OUA	TJN-598	Terminated
T61744	DRUGINFO	D0F7TV	Torbafylline	Terminated
T61744	DRUGINFO	D0W7BI	(2,5-Diphenyl-furan-3-yl)-phenyl-methanone	Investigative
T61744	DRUGINFO	D01RUN	(R)-Rolipram	Investigative
T61744	DRUGINFO	D02FZD	(S)-Rolipram	Investigative
T61744	DRUGINFO	D00JBC	1-Butyl-3-methyl-3,7-dihydro-purine-2,6-dione	Investigative
T61744	DRUGINFO	D00TQR	1-Methyl-3-propyl-3,7-dihydro-purine-2,6-dione	Investigative
T61744	DRUGINFO	D01CAY	2,5-Bis-(3,4-dimethoxy-phenyl)-furan	Investigative
T61744	DRUGINFO	D0N2KP	2,5-Bis-(3-cyclopentyloxy-4-methoxy-phenyl)-furan	Investigative
T61744	DRUGINFO	D0J4AT	4-(2,5-Diphenyl-furan-3-yl)-morpholine	Investigative
T61744	DRUGINFO	D04XRV	6-Azido-8-(3-iodo-phenyl)-quinoline	Investigative
T61744	DRUGINFO	D0L0NY	6-Imidazol-1-ylmethyl-8-phenyl-quinoline	Investigative
T61744	DRUGINFO	D0V8DB	8-(3-Azido-phenyl)-6-iodo-quinoline	Investigative
T61744	DRUGINFO	D0Z5SB	8-(3-Azido-phenyl)-6-pyridin-4-ylmethyl-quinoline	Investigative
T61744	DRUGINFO	D02NKD	8-(3-Nitro-phenyl)-6-phenyl-[1,7]naphthyridine	Investigative
T61744	DRUGINFO	D0K4HG	8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline	Investigative
T61744	DRUGINFO	D04BMR	AL-59640	Investigative
T61744	DRUGINFO	D0N7HS	ASP-3258	Investigative
T61744	DRUGINFO	D09AUL	Benzyl-(2-imidazol-1-yl-quinazolin-4-yl)-amine	Investigative
T61744	DRUGINFO	D0J7GF	Benzyl-(2-phenyl-quinazolin-4-yl)-amine	Investigative
T61744	DRUGINFO	D01TOR	Benzyl-(2-pyridin-3-yl-quinazolin-4-yl)-amine	Investigative
T61744	DRUGINFO	D0U8YQ	Benzyl-(2-pyridin-4-yl-quinazolin-4-yl)-amine	Investigative
T61744	DRUGINFO	D02NWF	Benzyl-(2-thiophen-2-yl-quinazolin-4-yl)-amine	Investigative
T61744	DRUGINFO	D0U4SS	CD-160130	Investigative
T61744	DRUGINFO	D05YEL	CH-3697	Investigative
T61744	DRUGINFO	D0K9PS	CHF-5480	Investigative
T61744	DRUGINFO	D0DL6J	CI-1044	Investigative
T61744	DRUGINFO	D0R6MT	isobutylmethylxanthine	Investigative
T61744	DRUGINFO	D0E5VP	KF-66490	Investigative
T61744	DRUGINFO	D06GUJ	KURAIDIN	Investigative
T61744	DRUGINFO	D0W4ZU	KURARINOL	Investigative
T61744	DRUGINFO	D0JD4C	L-454560	Investigative
T61744	DRUGINFO	D0V1IM	L-791943	Investigative
T61744	DRUGINFO	D0W7WV	L-869298	Investigative
T61744	DRUGINFO	D0Y3PP	NIS-62949	Investigative
T61744	DRUGINFO	D0V5BX	NITRAQUAZONE	Investigative
T61744	DRUGINFO	D0S6MA	OCID-2987	Investigative
T61744	DRUGINFO	D0T5PO	ROLIPRAM	Investigative
T61744	DRUGINFO	D0O3BL	RS-14491	Investigative
T61744	DRUGINFO	D0P2HX	RS-25344	Investigative
T61744	DRUGINFO	D00QCL	SOPHOFLAVESCENOL	Investigative
T61744	DRUGINFO	D0S1HX	TAS-203	Investigative
T61744	DRUGINFO	D02ZPV	UCB-101333-3	Investigative
T61744	DRUGINFO	D04JNC	ZL-N-91	Investigative
T61744	KEGGPATH	hsa00230:Purine metabolism		
T61744	KEGGPATH	hsa04024:cAMP signaling pathway		
T61744	KEGGPATH	hsa05032:Morphine addiction		
T61744	WIKIPATH	WP35:G Protein Signaling Pathways		
T61744	REACPATH	R-HSA-180024:DARPP-32 events		
T61744	REACPATH	R-HSA-418555:G alpha (s) signalling events		
				
T92072	TARGETID	T92072		
T92072	FORMERID	TTDS00186		
T92072	UNIPROID	AA1R_HUMAN		
T92072	TARGNAME	Adenosine A1 receptor (ADORA1)		
T92072	GENENAME	ADORA1		
T92072	TARGTYPE	Successful target		
T92072	SYNONYMS	Adenosine receptor A1; A(1) adenosine receptor		
T92072	FUNCTION	The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. Receptor for adenosine.		
T92072	PDBSTRUC	6D9H; 5UEN; 5N2S		
T92072	BIOCLASS	GPCR rhodopsin		
T92072	SEQUENCE	MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFCFIVSLAVADVAVGALVIPLAILINIGPQTYFHTCLMVACPVLILTQSSILALLAIAVDRYLRVKIPLRYKMVVTPRRAAVAIAGCWILSFVVGLTPMFGWNNLSAVERAWAANGSMGEPVIKCEFEKVISMEYMVYFNFFVWVLPPLLLMVLIYLEVFYLIRKQLNKKVSASSGDPQKYYGKELKIAKSLALILFLFALSWLPLHILNCITLFCPSCHKPSILTYIAIFLTHGNSAMNPIVYAFRIQKFRVTFLKIWNDHFRCQPAPPIDEDLPEERPDD		
T92072	DRUGINFO	D0B3HD	Caffeine	Approved
T92072	DRUGINFO	D0X0IY	Rolofylline	Phase 3
T92072	DRUGINFO	D0QH7H	AMP-579	Phase 2
T92072	DRUGINFO	D0BA5K	Apaxifylline	Phase 2
T92072	DRUGINFO	D0M7BL	BAY 1067197	Phase 2
T92072	DRUGINFO	D0I3YX	Capadenoson	Phase 2
T92072	DRUGINFO	D0I1EX	DTI-0009	Phase 2
T92072	DRUGINFO	D04YAJ	SELODENOSON	Phase 2
T92072	DRUGINFO	D0F5UN	SLV320	Phase 2
T92072	DRUGINFO	D00SUK	Tonapofylline	Phase 2
T92072	DRUGINFO	D05KBP	INO-8875	Phase 1/2
T92072	DRUGINFO	D0Z9RJ	GS 9667	Phase 1
T92072	DRUGINFO	D0L5VS	KF-17837	Phase 1
T92072	DRUGINFO	D02YQO	SCH-442416	Phase 1
T92072	DRUGINFO	D0T0YA	PMID27387065-Compound-6	Patented
T92072	DRUGINFO	D09GGJ	CVT-124	Discontinued in Phase 3
T92072	DRUGINFO	D07VZV	N-0861	Discontinued in Phase 3
T92072	DRUGINFO	D00YSJ	Tecadenoson	Discontinued in Phase 3
T92072	DRUGINFO	D0K2BQ	BRL-61063	Discontinued in Phase 2
T92072	DRUGINFO	D03JHJ	FK-352	Discontinued in Phase 2
T92072	DRUGINFO	D01VPK	FK-453	Discontinued in Phase 2
T92072	DRUGINFO	D0EK6D	FK-838	Discontinued in Phase 2
T92072	DRUGINFO	D0UH4T	GW-493838	Discontinued in Phase 2
T92072	DRUGINFO	D0V5DX	GR-79236	Discontinued in Phase 1
T92072	DRUGINFO	D08ZBT	SDZ-WAG-994	Discontinued in Phase 1
T92072	DRUGINFO	D0HE1P	BAY 60-6583	Preclinical
T92072	DRUGINFO	D0I7BL	ARISTEROMYCIN	Terminated
T92072	DRUGINFO	D0E4WF	METHYLTHIOADENOSINE	Terminated
T92072	DRUGINFO	D0NQ5I	METRIFUDIL	Terminated
T92072	DRUGINFO	D0Y6GJ	ZM-241385	Terminated
T92072	DRUGINFO	D0VB6X	(1H-Imidazo[4,5-c]quinolin-4-yl)-phenyl-amine HCl	Investigative
T92072	DRUGINFO	D09FUO	(1-Phenyl-propyl)-(9-phenyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D0UM4R	(2-Chloro-9-methyl-9H-purin-6-yl)-phenyl-amine	Investigative
T92072	DRUGINFO	D0D8WN	(9-Methyl-9H-purin-6-yl)-phenyl-amine	Investigative
T92072	DRUGINFO	D0TU7I	(E)-8-(3-chlorostyryl)-caffeine	Investigative
T92072	DRUGINFO	D0V9OO	(R,S)-PHPNECA	Investigative
T92072	DRUGINFO	D0E9QX	(S)-PIA	Investigative
T92072	DRUGINFO	D0R1XY	[3H]CCPA	Investigative
T92072	DRUGINFO	D08RSU	[3H]DPCPX	Investigative
T92072	DRUGINFO	D08EBT	[3H]HEMADO	Investigative
T92072	DRUGINFO	D0K8ZZ	[3H]NECA	Investigative
T92072	DRUGINFO	D0K6ZA	[3H]OSIP339391	Investigative
T92072	DRUGINFO	D07HNM	1,3-Diallyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D02RMR	1,3-Diethyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0T6XM	1,3-Diisobutyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D03KKK	1,3-Dipropyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0U8DW	1-Butyl-8-phenyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D08MRB	1H-Imidazo[4,5-c]quinolin-4-ylamine HCl	Investigative
T92072	DRUGINFO	D0BA7Q	1-Methyl-8-phenyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0F1AS	1-METHYLXANTHINE	Investigative
T92072	DRUGINFO	D0LD0X	1-Propyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0PU6F	2-(1H-benzo[d]imidazol-2-yl)quinoxaline	Investigative
T92072	DRUGINFO	D08CIY	2-(2-furyl)-6-(1H-pyrazol-1-yl)pyrimidin-4-amine	Investigative
T92072	DRUGINFO	D0KJ3H	2-(2''-indolylethyloxy)adenosine	Investigative
T92072	DRUGINFO	D03HBG	2-(3''-(4''-bromo-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0L6YI	2-(3''-(5''-bromo-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0Q1RD	2-(3''(5''-chloro-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0I1IW	2-(3''-(5''-fluoro-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0P0BV	2-(3''-(5''-hydroxyindolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0G6VT	2-(3''-(5''-iodo-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D09VOP	2-(3''-(5''-methoxy-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0G6BI	2-(3''-(6''-bromo-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D02JMR	2-(3''-(6''-chloro-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0QN4U	2-(3''(7''-bromo-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D06RCT	2-(3''-indolylethyloxy)adenosine	Investigative
T92072	DRUGINFO	D00ASZ	2-(3''-pyrrolylethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0N1PT	2-(4-chloro-1H-benzo[d]imidazol-2-yl)quinoxaline	Investigative
T92072	DRUGINFO	D0L2MN	2-(4-chlorophenyl)-6-phenyl-9H-purine	Investigative
T92072	DRUGINFO	D0OX0V	2-(4-ethylthiobenzimidazol-2-yl)quinoxaline	Investigative
T92072	DRUGINFO	D07IPZ	2-(4-hydroxypent-1-yl)-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D0R4LZ	2-(4-methoxyphenyl)-6-phenyl-9H-purine	Investigative
T92072	DRUGINFO	D09VRX	2-(4-methyl-1H-benzo[d]imidazol-2-yl)quinoxaline	Investigative
T92072	DRUGINFO	D0E4LB	2-(5-cyano-1-pent-1-ynyl)-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D0P8MK	2-(6-amino-8-bromo-9H-purin-9-yl)ethanol	Investigative
T92072	DRUGINFO	D0NH5X	2-(6-Cyclopentylamino-purin-9-yl)-ethanol	Investigative
T92072	DRUGINFO	D01PGY	2-(hex-1-ynyl)-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D0T5FY	2,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D0IG5E	2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine	Investigative
T92072	DRUGINFO	D0E7YE	2,6,8-triphenyl-9H-purine	Investigative
T92072	DRUGINFO	D07FGB	2,6-bis(4-tolyl)-9H-purine	Investigative
T92072	DRUGINFO	D03KLO	2,6-dimethyl-8-ethyl-1-deazapurine	Investigative
T92072	DRUGINFO	D0N1QP	2,6-diphenyl-1-deazapurine	Investigative
T92072	DRUGINFO	D00GNW	2,6-diphenyl-8-(1-ethylpropyl)-1-deazapurine	Investigative
T92072	DRUGINFO	D00NFW	2,6-diphenyl-8-ethyl-1-deazapurine	Investigative
T92072	DRUGINFO	D0I2EQ	2,6-diphenyl-8-methyl-1-deazapurine	Investigative
T92072	DRUGINFO	D01NHH	2,6-diphenyl-8-tButyl-1-deazapurine	Investigative
T92072	DRUGINFO	D0RZ2M	2,6-diphenyl-9H-purine	Investigative
T92072	DRUGINFO	D08INY	2,6-Diphenyl-pyrimidin-4-ylamine	Investigative
T92072	DRUGINFO	D02FLH	2,6-dphenyl-8-propyl-1-deazapurine	Investigative
T92072	DRUGINFO	D08JYX	2-[(4-acetylphenyl)ethynyl]-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D0KT3L	2-[(4-fluorophenyl)ethynyl]-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D0F4XB	2-Amino-4,6-di-furan-2-yl-nicotinonitrile	Investigative
T92072	DRUGINFO	D0N2VO	2-Amino-4,6-diphenyl-nicotinonitrile	Investigative
T92072	DRUGINFO	D00HYS	2-Amino-4,6-diphenyl-pyrimidin-5-carbonitrile	Investigative
T92072	DRUGINFO	D0QD3O	2-Amino-4,6-diphenyl-pyrimidine	Investigative
T92072	DRUGINFO	D04ZTH	2-Amino-4,6-di-thiophen-2-yl-nicotinonitrile	Investigative
T92072	DRUGINFO	D0P7FK	2-Amino-4-furan-2-yl-6-phenyl-nicotinonitrile	Investigative
T92072	DRUGINFO	D0KM0Y	2-Amino-4-phenyl-6-thiophen-2-yl-nicotinonitrile	Investigative
T92072	DRUGINFO	D0V9EE	2-Amino-6-furan-2-yl-4-phenyl-nicotinonitrile	Investigative
T92072	DRUGINFO	D06NQD	2-amino-6-phenyl-4-p-tolylnicotinonitrile	Investigative
T92072	DRUGINFO	D0BC7P	2-Amino-6-phenyl-4-thiophen-2-yl-nicotinonitrile	Investigative
T92072	DRUGINFO	D04XLX	2-amino-N-benzyl-6-phenyl-9H-purine-9-carboxamide	Investigative
T92072	DRUGINFO	D0A5KG	2-azido-N6-methyl-9-(beta-D-ribofuranosyl)adenine	Investigative
T92072	DRUGINFO	D0Z1WY	2-chloro-2'-C-methyl-tecadenoson	Investigative
T92072	DRUGINFO	D0UM6O	2-chloro-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D09UDF	2-chloro-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D0C2UJ	2-chloroadenosine	Investigative
T92072	DRUGINFO	D0B1RV	2-Cyclopentyl-1H-imidazo[4,5-c]quinolin-4-ylamine	Investigative
T92072	DRUGINFO	D05TFM	2-ethyl-4-(furan-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D0Y7AV	2-ethyl-4-(furan-3-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D0J6ME	2-ethyl-4-(pyridin-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D0O4KI	2-ethyl-4-(thiazol-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D07YKU	2-ethyl-4-(thiophen-2-yl)thieno[3,2-d]pyrimidine	Investigative
T92072	DRUGINFO	D01VXP	2-ethynyl-N6-methoxyadenosine	Investigative
T92072	DRUGINFO	D07DOE	2'-Me-tecadenoson	Investigative
T92072	DRUGINFO	D0J3TY	2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Investigative
T92072	DRUGINFO	D04PJO	2-m-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Investigative
T92072	DRUGINFO	D0LP5G	2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine	Investigative
T92072	DRUGINFO	D06ZWQ	2-phenyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Investigative
T92072	DRUGINFO	D09HAM	2-phenyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Investigative
T92072	DRUGINFO	D0I7HL	2-phenylpropoxyadenosine	Investigative
T92072	DRUGINFO	D0J4SW	2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4(5H)-one	Investigative
T92072	DRUGINFO	D02TEW	2-p-tolyl-2H-pyrazolo[3,4-c]quinolin-4-amine	Investigative
T92072	DRUGINFO	D08JUQ	2-tolyl-6-phenyl-9H-purine	Investigative
T92072	DRUGINFO	D08AJS	3-(3-chloro-1H-pyrazol-5-yl)quinoxalin-2(1H)-one	Investigative
T92072	DRUGINFO	D0K2QF	3,4-Dichloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D00YOM	3-Benzyl-7-methyl-[1,8]naphthyridin-4-ol	Investigative
T92072	DRUGINFO	D08RGW	3-Benzyl-7-methyl-[1,8]naphthyridine-4-thiol	Investigative
T92072	DRUGINFO	D0YB3X	3-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D02PBY	3-noradamantyl-1,3-dipropylxanthine	Investigative
T92072	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T92072	DRUGINFO	D00OFN	4-(ethylthio)-6-phenyl-1,3,5-triazin-2-amine	Investigative
T92072	DRUGINFO	D0W5CZ	4-(furan-2-yl)-7H-pyrrolo[2,3-d]pyrimidin-2-amine	Investigative
T92072	DRUGINFO	D0QN5I	4-(furan-2-yl)thieno[3,2-d]pyrimidin-2-amine	Investigative
T92072	DRUGINFO	D0CB9B	4-(thiazol-2-yl)thieno[3,2-d]pyrimidin-2-amine	Investigative
T92072	DRUGINFO	D00NYG	4-Amino-2,6-diphenyl-pyrimidine-5-carbonitrile	Investigative
T92072	DRUGINFO	D04LPX	4-Bromo-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D09KUY	4-Chloro-7-methyl-2-phenyl-[1,8]naphthyridine	Investigative
T92072	DRUGINFO	D00UFJ	4-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D07VCN	4-Ethoxy-7-((E)-styryl)-furo[3,2-g]chromen-5-one	Investigative
T92072	DRUGINFO	D0O8QS	4-Methoxy-N-(3-phenyl-isoquinolin-1-yl)-benzamide	Investigative
T92072	DRUGINFO	D0W0QF	4-Methyl-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D0H3QX	4-Nitro-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D04QAD	4-tert-Butyl-N-(4-phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D04TTP	5,7-dibromo-9H-pyrido[3,4-b]indol-6-ol	Investigative
T92072	DRUGINFO	D0ZW9L	5,7-diphenyl-3H-imidazo[4,5-b]pyridin-2-ol	Investigative
T92072	DRUGINFO	D0G8XJ	5-Cl-5-deoxy-(+/-)-ENBA	Investigative
T92072	DRUGINFO	D00MPA	6-(furan-2-yl)-9H-purin-2-amine	Investigative
T92072	DRUGINFO	D0P1JJ	6-ethylamino-2-(3''-indolyl)ethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0Q5CS	6-guanidino-2-(3''-indolylethyloxy)adenosine	Investigative
T92072	DRUGINFO	D0N0OE	7-(3,6,9,12-tetraoxatricos-22-enyl)theophylline	Investigative
T92072	DRUGINFO	D05SYY	7-Bromo-2-phenyl-[1,8]naphthyridin-4-ol	Investigative
T92072	DRUGINFO	D05MCK	7-Chloro-2-phenyl-[1,8]naphthyridin-4-ol	Investigative
T92072	DRUGINFO	D06QRI	7-Dimethylamino-2-phenyl-[1,8]naphthyridin-4-ol	Investigative
T92072	DRUGINFO	D01MOQ	7-Methyl-2-propyl-[1,8]naphthyridin-4-ol	Investigative
T92072	DRUGINFO	D0E8RA	8-Bromo-9-(2,3-dihydroxypropyl)-9H-adenine	Investigative
T92072	DRUGINFO	D0S6QA	8-Bromo-9-(2-butyl)-9H-adenine	Investigative
T92072	DRUGINFO	D0W6FC	8-Bromo-9-(2-hydroxypropyl)-9H-adenine	Investigative
T92072	DRUGINFO	D0CX7N	8-Bromo-9-(3-hydroxypropyl)-9H-adenine	Investigative
T92072	DRUGINFO	D0W8RB	8-Bromo-9-(but-3-enyl)-9H-adenine	Investigative
T92072	DRUGINFO	D0Z8VU	8-Bromo-9-(sec-butyl)-9H-adenine	Investigative
T92072	DRUGINFO	D04LZN	8-Bromo-9-cyclobutyl-9H-adenine	Investigative
T92072	DRUGINFO	D01QBK	8-Bromo-9-cyclohexyl-9H-adenine	Investigative
T92072	DRUGINFO	D0AI8F	8-Bromo-9-cyclopentyl-9H-adenine	Investigative
T92072	DRUGINFO	D01WNA	8-Bromo-9-ethyl-9H-adenine	Investigative
T92072	DRUGINFO	D0B0TX	8-bromo-9-isobutyl-9H-purin-6-amine	Investigative
T92072	DRUGINFO	D06KYP	8-Bromo-9-isopropyl-9H-adenine	Investigative
T92072	DRUGINFO	D0R8OK	8-Bromo-9-methyl-9H-adenine	Investigative
T92072	DRUGINFO	D00CJJ	8-Bromo-9-phenylethyl-9H-adenine	Investigative
T92072	DRUGINFO	D02HOL	8-Bromo-9-propyl-9H-adenine	Investigative
T92072	DRUGINFO	D0L7DL	8-cyclohexyl-6-(4-tolyl)-2-phenyl-9H-purine	Investigative
T92072	DRUGINFO	D0L5JL	8-cyclopentyltheophylline	Investigative
T92072	DRUGINFO	D0V8MD	8-PHENYL THEOPHYLLINE	Investigative
T92072	DRUGINFO	D0B1YW	8-Phenyl-1-propyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0L8DZ	8-Phenyl-3,7-dihydro-purine-2,6-dione	Investigative
T92072	DRUGINFO	D0W3MT	8-propyl-2,6-diphenyl-9H-purine	Investigative
T92072	DRUGINFO	D05ZRR	9-(3-aminobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Investigative
T92072	DRUGINFO	D02NBB	9-(3-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Investigative
T92072	DRUGINFO	D08AXT	9-(4-nitrobenzyl)-6-(furan-2-yl)-9H-purin-2-amine	Investigative
T92072	DRUGINFO	D0S5XP	9-Allyl-8-bromo-9H-adenine	Investigative
T92072	DRUGINFO	D0D3WR	9-benzyl-6-(furan-2-yl)-9H-purin-2-amine	Investigative
T92072	DRUGINFO	D02RBK	9-Benzyl-8-bromo-9H-adenine	Investigative
T92072	DRUGINFO	D0A6JX	9-Cyclobutyl-9H-adenine	Investigative
T92072	DRUGINFO	D0B3UE	9-Cyclopentyl-9H-adenine	Investigative
T92072	DRUGINFO	D01VEU	9-Ethyl-8-phenylethynyl-9H-purin-6-ylamine	Investigative
T92072	DRUGINFO	D03JFX	9-Ethyl-9H-adenine	Investigative
T92072	DRUGINFO	D0DB7A	9-Isopropyl-9H-adenine	Investigative
T92072	DRUGINFO	D02BGA	9-Methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine	Investigative
T92072	DRUGINFO	D04JIR	9-Methyl-9H-adenine	Investigative
T92072	DRUGINFO	D0G8GA	9-Phenyl-9H-purin-6-ylamine	Investigative
T92072	DRUGINFO	D04WHE	9-Propyl-9H-adenine	Investigative
T92072	DRUGINFO	D0F9QT	A-987306	Investigative
T92072	DRUGINFO	D0XE8T	Anthoptilide C	Investigative
T92072	DRUGINFO	D0A4MK	AS100	Investigative
T92072	DRUGINFO	D0Q9GL	AS70	Investigative
T92072	DRUGINFO	D07FZA	AS99	Investigative
T92072	DRUGINFO	D05QNV	ATL802	Investigative
T92072	DRUGINFO	D0ZO1R	Cirsimarin	Investigative
T92072	DRUGINFO	D02HHW	CP608,039	Investigative
T92072	DRUGINFO	D0G2JG	CPFPX	Investigative
T92072	DRUGINFO	D08LZN	Cyclohexyl-(2-phenylsulfanyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D09ETC	Cyclohexyl-(9-ethyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D08VXF	Cyclohexyl-(9-methyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D0N1PS	Cyclopentyl-(9-cyclopentyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D05ZYN	Cyclopentyl-(9-ethyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D01EHP	Cyclopentyl-(9-methyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D01GUK	Cyclopentyl-(9-phenyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D07HKU	DEPX	Investigative
T92072	DRUGINFO	D0NO5E	Ethyl 5-benzoyl-4-phenylthiazol-2-ylcarbamate	Investigative
T92072	DRUGINFO	D0S0RK	flavone	Investigative
T92072	DRUGINFO	D0F9JF	FR-166124	Investigative
T92072	DRUGINFO	D0S2MO	FR194921	Investigative
T92072	DRUGINFO	D0K0OT	GNF-PF-2224	Investigative
T92072	DRUGINFO	D0O1CW	GNF-PF-2700	Investigative
T92072	DRUGINFO	D02WTN	Hexanoic Acid (2,6-diphenylpyrimidin-4-yl)amide	Investigative
T92072	DRUGINFO	D0R6MT	isobutylmethylxanthine	Investigative
T92072	DRUGINFO	D0Y2RM	Isoguanosine	Investigative
T92072	DRUGINFO	D0I3HE	KF26777	Investigative
T92072	DRUGINFO	D0M8NW	Kuanoniamine D	Investigative
T92072	DRUGINFO	D0Y8SB	L-249313	Investigative
T92072	DRUGINFO	D07DTC	L-97-1 intravenous	Investigative
T92072	DRUGINFO	D0P7CS	LUF-5417	Investigative
T92072	DRUGINFO	D02VQK	LUF-5433	Investigative
T92072	DRUGINFO	D0Z3YY	LUF-5735	Investigative
T92072	DRUGINFO	D00WFU	LUF-5737	Investigative
T92072	DRUGINFO	D0Z3BT	LUF-5764	Investigative
T92072	DRUGINFO	D0B8RQ	LUF-5767	Investigative
T92072	DRUGINFO	D0T7GG	LUF-5816	Investigative
T92072	DRUGINFO	D06TSQ	LUF5831	Investigative
T92072	DRUGINFO	D0H2VA	LUF-5853	Investigative
T92072	DRUGINFO	D0LP5V	LUF-5956	Investigative
T92072	DRUGINFO	D09IRV	LUF-5957	Investigative
T92072	DRUGINFO	D0WI4D	LUF-5962	Investigative
T92072	DRUGINFO	D05KEF	LUF-5978	Investigative
T92072	DRUGINFO	D0W1PF	LUF-5980	Investigative
T92072	DRUGINFO	D0Z8NC	LUF-5981	Investigative
T92072	DRUGINFO	D0U8KW	LUF-6258	Investigative
T92072	DRUGINFO	D0L0VU	MRE 2029F20	Investigative
T92072	DRUGINFO	D0A6IO	MRE 3008F20	Investigative
T92072	DRUGINFO	D02SKN	MRS1041	Investigative
T92072	DRUGINFO	D0XC9U	MRS1042	Investigative
T92072	DRUGINFO	D0G6SL	MRS1062	Investigative
T92072	DRUGINFO	D09TBE	MRS1065	Investigative
T92072	DRUGINFO	D0L3BI	MRS1084	Investigative
T92072	DRUGINFO	D04RHI	MRS1086	Investigative
T92072	DRUGINFO	D0B8DR	MRS1093	Investigative
T92072	DRUGINFO	D04GFX	MRS1132	Investigative
T92072	DRUGINFO	D0J1BA	MRS1191	Investigative
T92072	DRUGINFO	D0ZL2A	MRS1523	Investigative
T92072	DRUGINFO	D06KMJ	MRS5151	Investigative
T92072	DRUGINFO	D07RSH	MRS923	Investigative
T92072	DRUGINFO	D0I1EP	MRS928	Investigative
T92072	DRUGINFO	D00JWA	N-(2-(furan-2-yl)-3,4'-bipyridin-6-yl)acetamide	Investigative
T92072	DRUGINFO	D0ZV1T	N-(2,6-diphenylpyrimidin-4-yl)-2-ethylbutyramide	Investigative
T92072	DRUGINFO	D08EZI	N-(2,6-diphenylpyrimidin-4-yl)-3-methylbutyramide	Investigative
T92072	DRUGINFO	D0Z3XC	N-(2,6-diphenylpyrimidin-4-yl)acetamide	Investigative
T92072	DRUGINFO	D02HZJ	N-(2,6-diphenylpyrimidin-4-yl)benzamide	Investigative
T92072	DRUGINFO	D08HBH	N-(2,6-diphenylpyrimidin-4-yl)butyramide	Investigative
T92072	DRUGINFO	D00GQI	N-(2,6-diphenylpyrimidin-4-yl)isobutyramide	Investigative
T92072	DRUGINFO	D02HYT	N-(2,6-diphenylpyrimidin-4-yl)propionamide	Investigative
T92072	DRUGINFO	D01WXR	N-(4,5-diphenylpyrimidin-2-yl)acetamide	Investigative
T92072	DRUGINFO	D0WN3O	N-(4,6-diphenylpyrimidin-2-yl)-2-ethylbutyramide	Investigative
T92072	DRUGINFO	D0N9WG	N-(4,6-diphenylpyrimidin-2-yl)-3-chlorobenzamide	Investigative
T92072	DRUGINFO	D0L4TY	N-(4,6-diphenylpyrimidin-2-yl)-3-methylbutyramide	Investigative
T92072	DRUGINFO	D0C3ID	N-(4,6-diphenylpyrimidin-2-yl)benzamide	Investigative
T92072	DRUGINFO	D01VXC	N-(4,6-diphenylpyrimidin-2-yl)propionamide	Investigative
T92072	DRUGINFO	D00JXL	N-(4-Phenyl-thiazol-2-yl)-benzamide	Investigative
T92072	DRUGINFO	D0B3NZ	N-(5-Benzoyl-4-phenylthiazol-2-yl)benzamide	Investigative
T92072	DRUGINFO	D02JCM	N(6)-cyclohexyladenosine	Investigative
T92072	DRUGINFO	D0Z3IZ	N*6*-Cyclohexyl-N*2*-ethyl-9H-purine-2,6-diamine	Investigative
T92072	DRUGINFO	D02EAO	N*6*-Cyclohexyl-N*2*-phenyl-9H-purine-2,6-diamine	Investigative
T92072	DRUGINFO	D0N2DP	N*6*-Cyclooctyl-N*2*-phenyl-9H-purine-2,6-diamine	Investigative
T92072	DRUGINFO	D0JJ6T	N6-((+/-)-endo-norborn-2-yl)adenosine	Investigative
T92072	DRUGINFO	D0I6MT	N6-[(4-Amino)-phenyl]-9-benzyl-2-phenyladenine	Investigative
T92072	DRUGINFO	D04MMG	N6-[(4-Nitro)-phenyl]-9-benzyl-2-phenyladenine	Investigative
T92072	DRUGINFO	D03RFA	N6-CYCLOPENTYLADENOSINE	Investigative
T92072	DRUGINFO	D0G5ZF	N6-methoxy-2-[(2-pyridinyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D0Y6HQ	N6-methoxy-2-[(3-pyridinyl)ethynyl]-adenosine	Investigative
T92072	DRUGINFO	D0N1QO	N6-methoxy-2-[(4-methoxyphenyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D0Q5HW	N6-methoxy-2-[(4-methylphenyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D0B0QW	N6-methoxy-2-[(4-pentylphenyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D03FVK	N6-methoxy-2-[(4-pyridinyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D0Q3LM	N6-methoxy-2-[2-(trimethylsilyl)ethynyl]adenosine	Investigative
T92072	DRUGINFO	D03POP	N6-methoxy-2-phenylethynyladenosine	Investigative
T92072	DRUGINFO	D0PD0F	Paeoniflorin	Investigative
T92072	DRUGINFO	D07DNX	PD-115199	Investigative
T92072	DRUGINFO	D07HXL	PD-81723	Investigative
T92072	DRUGINFO	D0TC7N	PENECA	Investigative
T92072	DRUGINFO	D07DGH	Pentanoic acid (4,6-diphenylpyrimidin-2-yl)amide	Investigative
T92072	DRUGINFO	D04AGC	Phenyl(2-(trifluoromethyl)quinolin-4-yl)methanol	Investigative
T92072	DRUGINFO	D0BZ3S	Phenyl-(9-phenyl-9H-purin-6-yl)-amine	Investigative
T92072	DRUGINFO	D0L8SN	P-IODOAMPHETAMINE	Investigative
T92072	DRUGINFO	D05XGF	PSB-0788	Investigative
T92072	DRUGINFO	D07PPM	PSB-10	Investigative
T92072	DRUGINFO	D09RKX	PSB-11	Investigative
T92072	DRUGINFO	D08FOT	PSB-1115	Investigative
T92072	DRUGINFO	D00IOF	PSB36	Investigative
T92072	DRUGINFO	D0A9BZ	PSB-601	Investigative
T92072	DRUGINFO	D0Y5WQ	PSB603	Investigative
T92072	DRUGINFO	D0M3CG	R-N6-(phenylisopropyl)adenosine	Investigative
T92072	DRUGINFO	D0B7OW	sakuranetin	Investigative
T92072	DRUGINFO	D0Y9WZ	SB-298	Investigative
T92072	DRUGINFO	D0HK5B	SCH-63390	Investigative
T92072	DRUGINFO	D0O0FP	ST-1535	Investigative
T92072	DRUGINFO	D08BCH	TCPA	Investigative
T92072	DRUGINFO	D0Z7BC	VCP-28	Investigative
T92072	DRUGINFO	D01AAI	VUF5574	Investigative
T92072	DRUGINFO	D04PLH	VUF-8507	Investigative
T92072	DRUGINFO	D0YV1R	WRC-0571	Investigative
T92072	DRUGINFO	D0H9BP	xanthine amine congener	Investigative
T92072	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T92072	KEGGPATH	hsa04024:cAMP signaling pathway		
T92072	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T92072	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T92072	KEGGPATH	hsa05032:Morphine addiction		
T92072	WIKIPATH	WP1824:GPCR downstream signaling		
T92072	WIKIPATH	WP1825:GPCR ligand binding		
T92072	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T92072	WIKIPATH	WP80:Nucleotide GPCRs		
T92072	REACPATH	R-HSA-417973:Adenosine P1 receptors		
T92072	REACPATH	R-HSA-418594:G alpha (i) signalling events		
T92072	NET_PATH	NetPath_11:TCR Signaling Pathway		
T92072	NET_PATH	NetPath_21:RANKL Signaling Pathway		
T92072	PANTPATH	P00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway		
T92072	PANTPATH	P00027:Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway		
				
T74456	TARGETID	T74456		
T74456	FORMERID	TTDS00267		
T74456	UNIPROID	AGTR1_HUMAN		
T74456	TARGNAME	Angiotensin II receptor type-1 (AGTR1)		
T74456	GENENAME	AGTR1		
T74456	TARGTYPE	Successful target		
T74456	SYNONYMS	Type-1 angiotensin II receptor; Angiotensin II type-1 receptor; Angiotensin II receptor 1; Angiotensin 1 receptor; AT2R1B; AT2R1; AT1BR; AT1AR; AT1; AGTR1B; AGTR1A		
T74456	FUNCTION	Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Receptor for angiotensin II.		
T74456	PDBSTRUC	6DO1; 4ZUD; 4YAY; 1ZV0		
T74456	BIOCLASS	GPCR rhodopsin		
T74456	SEQUENCE	MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE		
T74456	DRUGINFO	D0G6SE	ANGIOTENSIN II	Approved
T74456	DRUGINFO	D05FGG	Azilsartan	Approved
T74456	DRUGINFO	D0D5SQ	Candesartan	Approved
T74456	DRUGINFO	D0T7US	Eprosartan	Approved
T74456	DRUGINFO	D00NVX	Forasartan	Approved
T74456	DRUGINFO	D00JAU	Irbesartan	Approved
T74456	DRUGINFO	D0DD0K	Losartan	Approved
T74456	DRUGINFO	D0I7PO	Micardis telmisartan	Approved
T74456	DRUGINFO	D07UBG	Olmesartan medoxomil	Approved
T74456	DRUGINFO	D0B9AO	Saprisartan	Approved
T74456	DRUGINFO	D0K0AT	SARALASIN	Approved
T74456	DRUGINFO	D00VFE	Saralasin Acetate	Approved
T74456	DRUGINFO	D0M7TO	Tasosartan	Approved
T74456	DRUGINFO	D0N6RF	Telmisartan	Approved
T74456	DRUGINFO	D06UDG	Valsartan	Approved
T74456	DRUGINFO	D05FUU	Pratosartan	Phase 3
T74456	DRUGINFO	D0H9QC	S-474474	Phase 3
T74456	DRUGINFO	D0YS1U	sparsentan	Phase 3
T74456	DRUGINFO	D0A2RA	TAK-491	Phase 3
T74456	DRUGINFO	D02BBC	CL-329167	Phase 2
T74456	DRUGINFO	D06LRG	TRV027	Phase 2
T74456	DRUGINFO	D0C3BA	YM-358	Phase 2
T74456	DRUGINFO	D0J2NB	KRH-594	Discontinued in Phase 2
T74456	DRUGINFO	D0DL2S	MILFASARTAN	Discontinued in Phase 2
T74456	DRUGINFO	D06TZT	RIPISARTAN	Discontinued in Phase 2
T74456	DRUGINFO	D0E3XG	Zolasartan	Discontinued in Phase 2
T74456	DRUGINFO	D0A8EG	TAK-591	Discontinued in Phase 1
T74456	DRUGINFO	D00XZP	UR-7198	Discontinued in Phase 1
T74456	DRUGINFO	D06MUI	A-81988	Terminated
T74456	DRUGINFO	D00XTS	CR-3834	Terminated
T74456	DRUGINFO	D0Q6YP	HELENALIN	Terminated
T74456	DRUGINFO	D0GS7N	L-158809	Terminated
T74456	DRUGINFO	D00UBK	L-159689	Terminated
T74456	DRUGINFO	D0Q7SO	RS-66252	Terminated
T74456	DRUGINFO	D0N0JE	UP-275-22	Terminated
T74456	DRUGINFO	D06EQN	XR-510	Terminated
T74456	DRUGINFO	D0N7HN	(E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n	Investigative
T74456	DRUGINFO	D00TWV	[125I]EXP985	Investigative
T74456	DRUGINFO	D07OOI	[3H]GBR12935	Investigative
T74456	DRUGINFO	D0N2WA	[Bpa1]AngII	Investigative
T74456	DRUGINFO	D06PJZ	[Sar1,Bpa2]AngII	Investigative
T74456	DRUGINFO	D07EWK	[Sar1,Bpa3]AngII	Investigative
T74456	DRUGINFO	D0XO1T	[Sar1,Bpa8]AngII	Investigative
T74456	DRUGINFO	D0O1YO	[Sar1,Tdf2]AngII	Investigative
T74456	DRUGINFO	D06DRC	[Sar1,Tdf3]AngII	Investigative
T74456	DRUGINFO	D00LWG	[Sar1,Tdf8]AngII	Investigative
T74456	DRUGINFO	D0U7QE	[Tdf1]AngII	Investigative
T74456	DRUGINFO	D0T6WV	4-(2-Butyl-benzoimidazol-1-ylmethyl)-phenol	Investigative
T74456	DRUGINFO	D0RE7T	4-[(diphenylmethyl)amino]-2-phenylquinazoline	Investigative
T74456	DRUGINFO	D04FQA	4-hydroxy-1-methyl-4-(4-methylphenyl)-3-piperidyl 4-methylphenyl ketone	Investigative
T74456	DRUGINFO	D0I9IB	5-butyl-methyl immidazole carboxylate 30	Investigative
T74456	DRUGINFO	D0L2HK	5-oxo-1-2-4-oxadiazol biphenyl	Investigative
T74456	DRUGINFO	D0D9AS	angiotensin III	Investigative
T74456	DRUGINFO	D00DIJ	CGP-49870	Investigative
T74456	DRUGINFO	D0OO4P	CV-11194	Investigative
T74456	DRUGINFO	D0D1FT	EXP3174	Investigative
T74456	DRUGINFO	D0T1YO	GNF-PF-2307	Investigative
T74456	DRUGINFO	D0F3VE	GNF-PF-2812	Investigative
T74456	DRUGINFO	D01YPD	GNF-PF-3832	Investigative
T74456	DRUGINFO	D0I6HJ	INC-106	Investigative
T74456	DRUGINFO	D04SVT	L-159093	Investigative
T74456	DRUGINFO	D0A4NO	L-162313	Investigative
T74456	DRUGINFO	D0Z7AF	L-162782	Investigative
T74456	DRUGINFO	D0U3WW	L-163,101	Investigative
T74456	DRUGINFO	D05EQC	LY301875	Investigative
T74456	DRUGINFO	D0AD7P	LY303336	Investigative
T74456	DRUGINFO	D0K0TY	N,N`-bis-alkyl butylimmidazole 12b	Investigative
T74456	KEGGPATH	hsa04020:Calcium signaling pathway		
T74456	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T74456	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T74456	KEGGPATH	hsa04261:Adrenergic signaling in cardiomyocytes		
T74456	KEGGPATH	hsa04270:Vascular smooth muscle contraction		
T74456	KEGGPATH	hsa04614:Renin-angiotensin system		
T74456	KEGGPATH	hsa04924:Renin secretion		
T74456	KEGGPATH	hsa05200:Pathways in cancer		
T74456	WIKIPATH	WP1824:GPCR downstream signaling		
T74456	WIKIPATH	WP1825:GPCR ligand binding		
T74456	WIKIPATH	WP2328:Allograft Rejection		
T74456	WIKIPATH	WP24:Peptide GPCRs		
T74456	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T74456	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T74456	WIKIPATH	WP554:ACE Inhibitor Pathway		
T74456	WHIZPATH	PW000563:Angiotensin Metabolism		
T74456	WHIZPATH	PW000564:Muscle/Heart Contraction		
T74456	REACPATH	R-HSA-375276:Peptide ligand-binding receptors		
T74456	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T74456	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T74456	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T74456	INTEPATH	arf6_pathway:Arf6 signaling events		
T74456	INTEPATH	arf6_traffickingpathway:Arf6 trafficking events		
T74456	PANTPATH	P05911:Angiotensin II-stimulated signaling through G proteins and beta-arrestin		
				
T38301	TARGETID	T38301		
T38301	FORMERID	TTDS00421		
T38301	UNIPROID	RIR2_HUMAN		
T38301	TARGNAME	Ribonucleoside-diphosphate reductase M2 (RRM2)		
T38301	GENENAME	RRM2		
T38301	TARGTYPE	Successful target		
T38301	SYNONYMS	Ribonucleotide reductase small subunit; Ribonucleotide reductase small chain; Ribonucleoside-diphosphate reductase subunit M2; RR2		
T38301	FUNCTION	Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Inhibits Wnt signaling. Provides the precursors necessary for DNA synthesis.		
T38301	PDBSTRUC	3VPO; 3VPN; 3VPM; 3OLJ; 2UW2		
T38301	BIOCLASS	CH/CH(2) oxidoreductase		
T38301	ECNUMBER	EC 1.17.4.1		
T38301	SEQUENCE	MLSLRVPLAPITDPQQLQLSPLKGLSLVDKENTPPALSGTRVLASKTARRIFQEPTEPKTKAAAPGVEDEPLLRENPRRFVIFPIEYHDIWQMYKKAEASFWTAEEVDLSKDIQHWESLKPEERYFISHVLAFFAASDGIVNENLVERFSQEVQITEARCFYGFQIAMENIHSEMYSLLIDTYIKDPKEREFLFNAIETMPCVKKKADWALRWIGDKEATYGERVVAFAAVEGIFFSGSFASIFWLKKRGLMPGLTFSNELISRDEGLHCDFACLMFKHLVHKPSEERVREIIINAVRIEQEFLTEALPVKLIGMNCTLMKQYIEFVADRLMLELGFSKVFRVENPFDFMENISLEGKTNFFEKRVGEYQRMGVMSSPTENSFTLDADF		
T38301	DRUGINFO	D03UVS	Gemcitabine	Approved
T38301	DRUGINFO	D07CWD	Hydroxyurea	Approved
T38301	DRUGINFO	D0V0CJ	CO-101	Phase 2
T38301	DRUGINFO	D0DT1R	Triapine	Phase 2
T38301	DRUGINFO	D0A1GR	CALAA-01	Phase 1
T38301	DRUGINFO	D0F2JY	LY-2334737	Phase 1
T38301	DRUGINFO	D05ACQ	Gallium maltolate	Discontinued in Phase 2
T38301	DRUGINFO	D05HZI	MDL 101,731	Discontinued in Phase 2
T38301	DRUGINFO	D0V2RK	NKP-46	Preclinical
T38301	KEGGPATH	hsa00230:Purine metabolism		
T38301	KEGGPATH	hsa00240:Pyrimidine metabolism		
T38301	KEGGPATH	hsa00480:Glutathione metabolism		
T38301	KEGGPATH	hsa01100:Metabolic pathways		
T38301	KEGGPATH	hsa04115:p53 signaling pathway		
T38301	WIKIPATH	WP1601:Fluoropyrimidine Activity		
T38301	WIKIPATH	WP1851:Metabolism of nucleotides		
T38301	WIKIPATH	WP2446:Retinoblastoma (RB) in Cancer		
T38301	WIKIPATH	WP404:Nucleotide Metabolism		
T38301	WHIZPATH	PW000052:Purine Metabolism		
T38301	WHIZPATH	PW000160:Pyrimidine Metabolism		
T38301	REACPATH	R-HSA-113510:E2F mediated regulation of DNA replication		
T38301	REACPATH	R-HSA-69205:G1/S-Specific Transcription		
T38301	NET_PATH	NetPath_4:EGFR1 Signaling Pathway		
T38301	INTEPATH	e2f_pathway:E2F transcription factor network		
T38301	PANTPATH	P00059:p53 pathway		
T38301	PANTPATH	P02738:De novo purine biosynthesis		
T38301	PANTPATH	P02739:De novo pyrimidine deoxyribonucleotide biosynthesis		
T38301	BIOCPATH	PWY66-409:Superpathway of purine nucleotide salvage		
T38301	BIOCPATH	PWY-7184:Pyrimidine deoxyribonucleotides de novo biosynthesis		
T38301	BIOCPATH	PWY-7210:Pyrimidine deoxyribonucleotides biosynthesis from CTP		
T38301	BIOCPATH	PWY-7211:Superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis		
T38301	BIOCPATH	PWY-7226:Guanosine deoxyribonucleotides de novo biosynthesis		
T38301	BIOCPATH	PWY-7227:Adenosine deoxyribonucleotides de novo biosynthesis		
T38301	BIOCPATH	PWY-7228:Guanosine nucleotides de novo biosynthesis		
T38301	BIOCPATH	PWY-841:Purine nucleotides de novo biosynthesis		
				
T05849	TARGETID	T05849		
T05849	FORMERID	TTDS00043		
T05849	UNIPROID	GASR_HUMAN		
T05849	TARGNAME	Gastrin/cholecystokinin type B receptor (CCKBR)		
T05849	GENENAME	CCKBR		
T05849	TARGTYPE	Successful target		
T05849	SYNONYMS	Cholecystokinin-2 receptor; CCKRB; CCK2-R; CCK-BR; CCK-B receptor		
T05849	FUNCTION	The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Receptor for gastrin and cholecystokinin.		
T05849	PDBSTRUC	1L4T		
T05849	BIOCLASS	GPCR rhodopsin		
T05849	SEQUENCE	MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG		
T05849	DRUGINFO	D0Y9TS	Ceruletide	Approved
T05849	DRUGINFO	D0O5TQ	Pentagastrin	Approved
T05849	DRUGINFO	D09XUH	GASTRAZOLE	Phase 3
T05849	DRUGINFO	D0TL7L	Dexloxiglumide	Phase 2
T05849	DRUGINFO	D0K2RY	Itriglumide	Phase 2
T05849	DRUGINFO	D0H5WM	S-0509	Phase 2
T05849	DRUGINFO	D04KHY	Spiroglumide	Phase 2
T05849	DRUGINFO	D02FYE	TT-223	Phase 2
T05849	DRUGINFO	D0H7FW	YF-476	Phase 2
T05849	DRUGINFO	D02RPK	Z 360	Phase 2
T05849	DRUGINFO	D0QJ6L	Demogastrin	Phase 1
T05849	DRUGINFO	D0X4AV	GV-150013	Discontinued in Phase 2
T05849	DRUGINFO	D0Z1RQ	L-365260	Discontinued in Phase 2
T05849	DRUGINFO	D0XJ0S	PD-134308	Discontinued in Phase 2
T05849	DRUGINFO	D07YHY	CR-2093	Discontinued in Phase 1
T05849	DRUGINFO	D0W4OZ	GG-8573	Preclinical
T05849	DRUGINFO	D0E8QK	JNJ-26070109	Preclinical
T05849	DRUGINFO	D06DPS	PD-170292	Preclinical
T05849	DRUGINFO	D07SXO	AG-041R	Terminated
T05849	DRUGINFO	D01ZDR	FR-208419	Terminated
T05849	DRUGINFO	D0EG1F	GR-199114X	Terminated
T05849	DRUGINFO	D05HGU	IQM-95333	Terminated
T05849	DRUGINFO	D00UEG	LY288513	Terminated
T05849	DRUGINFO	D0I3BT	PD-135666	Terminated
T05849	DRUGINFO	D00COB	PD136450	Terminated
T05849	DRUGINFO	D0W8TS	SNF-9007	Terminated
T05849	DRUGINFO	D05HYL	YM-022	Terminated
T05849	DRUGINFO	D0Z4SS	[125I]-BDZ2	Investigative
T05849	DRUGINFO	D02ZWC	[125I]PD142308	Investigative
T05849	DRUGINFO	D0F5WV	[3H]JB-93182	Investigative
T05849	DRUGINFO	D0J0NS	[3H]PBC-264	Investigative
T05849	DRUGINFO	D0IU6I	[3H]PD140376	Investigative
T05849	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T05849	DRUGINFO	D0CE9U	Asp-Tyr(OSO3H)-Met-Gly-Trp-Met-Asp-Phe	Investigative
T05849	DRUGINFO	D0Z4HK	BC-264	Investigative
T05849	DRUGINFO	D0M6ZF	Boc-Asp-Tyr(So3-)-Nle-Gly-Trp-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D05OUQ	CCK-33	Investigative
T05849	DRUGINFO	D0I8AF	CCK-8	Investigative
T05849	DRUGINFO	D0A7RT	Cholecystokinin-9	Investigative
T05849	DRUGINFO	D0C2KS	CI-1015	Investigative
T05849	DRUGINFO	D02VGS	desulfated cholecystokinin-8	Investigative
T05849	DRUGINFO	D02ZML	GW-5823	Investigative
T05849	DRUGINFO	D0S7SO	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-Bo	Investigative
T05849	DRUGINFO	D0V9DY	H-Tyr-D-Ala-Gly-Phe-NH-NH-D-Trp-Nle-Asp-Phe-H	Investigative
T05849	DRUGINFO	D0J7GJ	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-D-Trp-H	Investigative
T05849	DRUGINFO	D03WGS	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Ac	Investigative
T05849	DRUGINFO	D0N6DN	H-Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-Nle-Trp-Boc	Investigative
T05849	DRUGINFO	D0L9RP	PBC-264	Investigative
T05849	DRUGINFO	D0O0IZ	PD-135118	Investigative
T05849	DRUGINFO	D0D2ZM	PD-135158	Investigative
T05849	DRUGINFO	D04VOM	PD-136621	Investigative
T05849	DRUGINFO	D0E4JX	PD-137337	Investigative
T05849	DRUGINFO	D0G7RE	PD-137342	Investigative
T05849	DRUGINFO	D02MIN	PD-138915	Investigative
T05849	DRUGINFO	D0L9OU	PD-138916	Investigative
T05849	DRUGINFO	D0A9EA	PD-138917	Investigative
T05849	DRUGINFO	D00FLQ	PD-140547	Investigative
T05849	DRUGINFO	D08EYZ	PD-140548	Investigative
T05849	DRUGINFO	D0G1CK	PD-140723	Investigative
T05849	DRUGINFO	D08VRJ	PD-149164	Investigative
T05849	DRUGINFO	D09TNC	RB-400	Investigative
T05849	DRUGINFO	D0U5NA	RP-69758	Investigative
T05849	DRUGINFO	D0O0AR	RP-71483	Investigative
T05849	DRUGINFO	D06WOQ	RP-72540	Investigative
T05849	DRUGINFO	D0Y8KY	RP73870	Investigative
T05849	DRUGINFO	D00UPU	RPR-107836	Investigative
T05849	DRUGINFO	D05XXE	Tetragastrin	Investigative
T05849	DRUGINFO	D0R4TA	tetronothiodin	Investigative
T05849	DRUGINFO	D0ES2U	TP-680	Investigative
T05849	DRUGINFO	D06BRA	Tyr-D-Ala-Gly-D-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D07ICW	Tyr-D-Ala-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0QP2S	Tyr-D-Ala-Gly-Phe-NH-NH-Phe-Asp-NMeNle-D-Trp-Boc	Investigative
T05849	DRUGINFO	D0U6OA	Tyr-D-Ala-Gly-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0R4GI	Tyr-D-Ala-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0V0RB	Tyr-D-Nle-Gly-D-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0E2OG	Tyr-D-Nle-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D07LQQ	Tyr-D-Nle-Gly-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D08QKT	Tyr-D-Nle-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D09EMR	Tyr-D-Phe-Gly-D-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0TR0U	Tyr-D-Phe-Gly-D-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D03EPA	Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D01AQC	Tyr-D-Phe-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D01ADK	Tyr-D-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D0X7LC	Tyr-Gly-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	DRUGINFO	D06NIP	Tyr-Pro-Gly-Trp-NMeNle-Asp-Phe-NH2	Investigative
T05849	KEGGPATH	hsa04020:Calcium signaling pathway		
T05849	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T05849	KEGGPATH	hsa04971:Gastric acid secretion		
T05849	WIKIPATH	WP117:GPCRs, Other		
T05849	WIKIPATH	WP1824:GPCR downstream signaling		
T05849	WIKIPATH	WP1825:GPCR ligand binding		
T05849	WIKIPATH	WP24:Peptide GPCRs		
T05849	WIKIPATH	WP2597:Secretion of Hydrochloric Acid in Parietal Cells		
T05849	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T05849	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T05849	WHIZPATH	PW000565:Gastric Acid Production		
T05849	REACPATH	R-HSA-375276:Peptide ligand-binding receptors		
T05849	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T05849	REACPATH	R-HSA-881907:Gastrin-CREB signalling pathway via PKC and MAPK		
T05849	PANTPATH	P06959:CCKR signaling map ST		
				
T72458	TARGETID	T72458		
T72458	FORMERID	TTDC00072		
T72458	UNIPROID	MC4R_HUMAN		
T72458	TARGNAME	Melanocortin receptor 4 (MC4R)		
T72458	GENENAME	MC4R		
T72458	TARGTYPE	Successful target		
T72458	SYNONYMS	MC4-R		
T72458	FUNCTION	Plays a central role in energy homeostasis and somatic growth. This receptor is mediated by G proteins that stimulate adenylate cyclase (cAMP). Receptor specific to the heptapeptide core common to adrenocorticotropic hormone and alpha-, beta-, and gamma-MSH.		
T72458	PDBSTRUC	2IQW; 2IQV; 2IQU; 2IQS; 2IQR		
T72458	BIOCLASS	GPCR rhodopsin		
T72458	SEQUENCE	MVNSTHRGMHTSLHLWNRSSYRLHSNASESLGKGYSDGGCYEQLFVSPEVFVTLGVISLLENILVIVAIAKNKNLHSPMYFFICSLAVADMLVSVSNGSETIVITLLNSTDTDAQSFTVNIDNVIDSVICSSLLASICSLLSIAVDRYFTIFYALQYHNIMTVKRVGIIISCIWAACTVSGILFIIYSDSSAVIICLITMFFTMLALMASLYVHMFLMARLHIKRIAVLPGTGAIRQGANMKGAITLTILIGVFVVCWAPFFLHLIFYISCPQNPYCVCFMSHFNLYLILIMCNSIIDPLIYALRSQELRKTFKEIICCYPLGGLCDLSSRY		
T72458	DRUGINFO	D0X9PF	Bremelanotide	Approved
T72458	DRUGINFO	D03YVO	Methylnaltrexone bromide	Approved
T72458	DRUGINFO	D0YP7B	Setmelanotide	Approved
T72458	DRUGINFO	D0PI8W	Amylin	Phase 4
T72458	DRUGINFO	D0K8NR	AMG 386	Phase 3
T72458	DRUGINFO	D04QUX	PF-446687	Phase 2
T72458	DRUGINFO	D0G2XE	PMX-53	Phase 2
T72458	DRUGINFO	D0H3HV	AP-1030	Phase 1/2
T72458	DRUGINFO	D09XVQ	PT-14	Discontinued in Phase 2
T72458	DRUGINFO	D0J9CF	IDDBCP-150101	Preclinical
T72458	DRUGINFO	D06SDP	Melanotetan II	Preclinical
T72458	DRUGINFO	D0N0IQ	Ro-27-3225	Preclinical
T72458	DRUGINFO	D0D8YP	1-Benzyl-4-methyl-piperazine	Investigative
T72458	DRUGINFO	D00XMP	1-Methyl-4-(1-phenyl-ethyl)-piperazine	Investigative
T72458	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T72458	DRUGINFO	D0A8ME	Ac-[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D07DWH	Ac-dR[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D0B8GR	Ac-His-D-Phe-Arg-2-Nal-NHCH3	Investigative
T72458	DRUGINFO	D0U5KM	Ac-His-DPhe-Arg-Trp-NH2	Investigative
T72458	DRUGINFO	D0U6XP	Ac-Nle-c[Asp-His-DNaI(2')-Pro-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D0CK0K	Ac-Nle-c[Asp-His-DNal(2')-Pro-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D0N6AS	AC-Nle-c[Asp-His-DPhe-Pro-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D05XRI	Ac-R[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D0F6GX	Ac-Tyr-D-Phe-Arg-2-Nal-NHCH3	Investigative
T72458	DRUGINFO	D0ZD3M	Ac-YCit[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D09OMI	Ac-YK[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D07IBF	Ac-YR[CE(1-Me-H)dFRWC]-NH2	Investigative
T72458	DRUGINFO	D07TBR	Ac-YR[CEH(d-2alpha-Nal)RWC]-NH2	Investigative
T72458	DRUGINFO	D0R0BY	Ac-YR[CEH(pCl-dF)RWC]-NH2	Investigative
T72458	DRUGINFO	D0WG8P	Ac-YR[CEH(pF-dF)RWC]-NH2	Investigative
T72458	DRUGINFO	D00VYC	Ac-YR[CEHdFRWC]-NH2	Investigative
T72458	DRUGINFO	D0C7VI	Ac-YR[CEHdFRWC]SPPKD-NH2	Investigative
T72458	DRUGINFO	D09XCH	Ac-YR[CEHFRWC]-NH2	Investigative
T72458	DRUGINFO	D0X1YL	Ac-YRC(Me)*EHdFRWC(Me)NH2	Investigative
T72458	DRUGINFO	D03AZC	Ac-YRMEHdFRWG-NH2	Investigative
T72458	DRUGINFO	D0B4OL	Ac-YRMEHdFRWGSPPKD-NH2	Investigative
T72458	DRUGINFO	D0AU4C	AEKKDEGPYRMEHFRWGSPPKD	Investigative
T72458	DRUGINFO	D02TOS	AMSH	Investigative
T72458	DRUGINFO	D08QRO	BL-6020	Investigative
T72458	DRUGINFO	D0U1UZ	C(his-D-phe-arg-trp-Abu)	Investigative
T72458	DRUGINFO	D0M2QK	C(his-D-phe-arg-trp-Ahp)	Investigative
T72458	DRUGINFO	D0R5KO	C(his-D-phe-arg-trp-Ahx)	Investigative
T72458	DRUGINFO	D09LHF	C(his-D-phe-arg-trp-Aoc)	Investigative
T72458	DRUGINFO	D0V5YV	C(his-L-phe-arg-trp-Aoc)	Investigative
T72458	DRUGINFO	D0WI8M	C[CO-(CH2)2-CO-Nle-D-Nal(2)-Arg-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D08DND	C[CO-(CH2)2-CO-Nle-D-Phe-Arg-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D04YZZ	C[CO-(CH2)3-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D09PDT	C[CO-o-C6H4-CO-Pro-D-Nal(2)-Arg-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D0QW4A	C[CO-o-C6H4-CO-Pro-D-Phe-Arg-Trp-Lys]-NH2	Investigative
T72458	DRUGINFO	D02JVA	C[Nle-Arg-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D07SFD	C[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D07UXW	C[Nle-Asp-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D04BOG	C[Nle-Asp-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D05LLI	C[Nle-Gln-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D05WNC	C[Nle-Glu-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D00TSX	C[Nle-His-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D02MPZ	C[Nle-His-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D0L1MJ	C[Nle-Nle-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D01HTX	C[Nle-Nle-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D0P4GI	C[Nle-Pro-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D0VD7R	C[Nle-Pro-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D06RTP	C[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D0M4EF	C[Nle-Val-D-Phe-Arg-Trp-Glu]-NH2	Investigative
T72458	DRUGINFO	D08EBV	C[Ser-Tyr-Thr-His-Dphe-Arg-Trp-Thr-Ile-Pro]	Investigative
T72458	DRUGINFO	D07RRN	C[Thr-Tyr-Thr-His-DNaf-Arg-Trp-Thr-Ile-Pro]	Investigative
T72458	DRUGINFO	D0R3GC	D-Phe-Arg-2-Nal-NHCH3	Investigative
T72458	DRUGINFO	D0ID5M	GPYRMEHFRWGSPPKD-NH2	Investigative
T72458	DRUGINFO	D07SRW	His-DPhe-Arg-Trp	Investigative
T72458	DRUGINFO	D00HAJ	Hoo-Phe-Orn-Pro-hle-Pff-Phe-NH2	Investigative
T72458	DRUGINFO	D0J0ZG	HS014	Investigative
T72458	DRUGINFO	D00GCC	MCL0129	Investigative
T72458	DRUGINFO	D0Z1QU	MCL-129	Investigative
T72458	DRUGINFO	D0D1BC	Melanocortin-4 Receptor antagonist	Investigative
T72458	DRUGINFO	D09UUC	MK-10	Investigative
T72458	DRUGINFO	D00NOG	MK-11	Investigative
T72458	DRUGINFO	D09HHW	ML-253764	Investigative
T72458	DRUGINFO	D0YB7F	MT-II	Investigative
T72458	DRUGINFO	D0GH5N	NDP-alpha-MSH	Investigative
T72458	DRUGINFO	D0I8SJ	NDP-SYSMEHFRWGKPVG	Investigative
T72458	DRUGINFO	D0D7ZA	Ser-Tyr-Ser-Nle-Glu-His-Dphe-Arg	Investigative
T72458	DRUGINFO	D0N6KO	THIQ	Investigative
T72458	DRUGINFO	D06PNU	Tic-D-Phe-Arg-2-Nal-NHCH3	Investigative
T72458	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T72458	WIKIPATH	WP1824:GPCR downstream signaling		
T72458	WIKIPATH	WP1825:GPCR ligand binding		
T72458	WIKIPATH	WP24:Peptide GPCRs		
T72458	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T72458	REACPATH	R-HSA-375276:Peptide ligand-binding receptors		
T72458	REACPATH	R-HSA-418555:G alpha (s) signalling events		
T72458	INTEPATH	syndecan_3_pathway:Syndecan-3-mediated signaling events		
				
T11288	TARGETID	T11288		
T11288	FORMERID	TTDS00288		
T11288	UNIPROID	MRP1_HUMAN		
T11288	TARGNAME	Multidrug resistance-associated protein 1 (ABCC1)		
T11288	GENENAME	ABCC1		
T11288	TARGTYPE	Successful target		
T11288	SYNONYMS	MRP1; MRP; Leukotriene C(4) transporter; LTC4 transporter; ATP-binding cassette sub-family C member 1		
T11288	FUNCTION	Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency. Mediates export of organic anions and drugs from the cytoplasm.		
T11288	PDBSTRUC	4C3Z; 2CBZ		
T11288	BIOCLASS	ABC transporter		
T11288	ECNUMBER	EC 7.6.2.2		
T11288	SEQUENCE	MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACFPFYFLYLSRHDRGYIQMTPLNKTKTALGFLLWIVCWADLFYSFWERSRGIFLAPVFLVSPTLLGITMLLATFLIQLERRKGVQSSGIMLTFWLVALVCALAILRSKIMTALKEDAQVDLFRDITFYVYFSLLLIQLVLSCFSDRSPLFSETIHDPNPCPESSASFLSRITFWWITGLIVRGYRQPLEGSDLWSLNKEDTSEQVVPVLVKNWKKECAKTRKQPVKVVYSSKDPAQPKESSKVDANEEVEALIVKSPQKEWNPSLFKVLYKTFGPYFLMSFFFKAIHDLMMFSGPQILKLLIKFVNDTKAPDWQGYFYTVLLFVTACLQTLVLHQYFHICFVSGMRIKTAVIGAVYRKALVITNSARKSSTVGEIVNLMSVDAQRFMDLATYINMIWSAPLQVILALYLLWLNLGPSVLAGVAVMVLMVPVNAVMAMKTKTYQVAHMKSKDNRIKLMNEILNGIKVLKLYAWELAFKDKVLAIRQEELKVLKKSAYLSAVGTFTWVCTPFLVALCTFAVYVTIDENNILDAQTAFVSLALFNILRFPLNILPMVISSIVQASVSLKRLRIFLSHEELEPDSIERRPVKDGGGTNSITVRNATFTWARSDPPTLNGITFSIPEGALVAVVGQVGCGKSSLLSALLAEMDKVEGHVAIKGSVAYVPQQAWIQNDSLRENILFGCQLEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQKQRVSLARAVYSNADIYLFDDPLSAVDAHVGKHIFENVIGPKGMLKNKTRILVTHSMSYLPQVDVIIVMSGGKISEMGSYQELLARDGAFAEFLRTYASTEQEQDAEENGVTGVSGPGKEAKQMENGMLVTDSAGKQLQRQLSSSSSYSGDISRHHNSTAELQKAEAKKEETWKLMEADKAQTGQVKLSVYWDYMKAIGLFISFLSIFLFMCNHVSALASNYWLSLWTDDPIVNGTQEHTKVRLSVYGALGISQGIAVFGYSMAVSIGGILASRCLHVDLLHSILRSPMSFFERTPSGNLVNRFSKELDTVDSMIPEVIKMFMGSLFNVIGACIVILLATPIAAIIIPPLGLIYFFVQRFYVASSRQLKRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYYPSIVANRWLAVRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVAVERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGGEKVGIVGRTGAGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLFSGSLRMNLDPFSQYSDEEVWTSLELAHLKDFVSALPDKLDHECAEGGENLSVGQRQLVCLARALLRKTKILVLDEATAAVDLETDDLIQSTIRTQFEDCTVLTIAHRLNTIMDYTRVIVLDKGEIQEYGAPSDLLQQRGLFYSMAKDAGLV		
T11288	DRUGINFO	D0Z3DY	Benzbromarone	Approved
T11288	DRUGINFO	D03DEI	Sulfinpyrazone	Approved
T11288	DRUGINFO	D0KX3H	Pyrrolopyrimidine	Investigative
T11288	DRUGINFO	D04GYT	XR-9456	Investigative
T11288	DRUGINFO	D09HIM	XR-9504	Investigative
T11288	DRUGINFO	D0A4TF	XR-9544	Investigative
T11288	DRUGINFO	D0S8CE	XR-9577	Investigative
T11288	KEGGPATH	hsa02010:ABC transporters		
T11288	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T11288	KEGGPATH	hsa04977:Vitamin digestion and absorption		
T11288	KEGGPATH	hsa05206:MicroRNAs in cancer		
T11288	WIKIPATH	WP1857:Metabolism of water-soluble vitamins and cofactors		
T11288	WIKIPATH	WP229:Irinotecan Pathway		
T11288	WIKIPATH	WP2650:Arachidonic acid metabolism		
T11288	REACPATH	R-HSA-196741:Cobalamin (Cbl, vitamin B12) transport and metabolism		
T11288	REACPATH	R-HSA-382556:ABC-family proteins mediated transport		
T11288	NET_PATH	NetPath_18:IL6 Signaling Pathway		
T11288	INTEPATH	s1p_meta_pathway:Sphingosine 1-phosphate (S1P) pathway		
T11288	INTEPATH	s1p_s1p1_pathway:S1P1 pathway		
				
T37693	TARGETID	T37693		
T37693	FORMERID	TTDC00314		
T37693	UNIPROID	CNR2_HUMAN		
T37693	TARGNAME	Cannabinoid receptor 2 (CB2)		
T37693	GENENAME	CNR2		
T37693	TARGTYPE	Successful target		
T37693	SYNONYMS	hCB2; Cannabinoid CB2 receptor; CX5; CB2B; CB2A; CB-2		
T37693	FUNCTION	May function in inflammatory response, nociceptive transmission and bone homeostasis. Heterotrimeric G protein-coupled receptor for endocannabinoid 2-arachidonoylglycerol mediating inhibition of adenylate cyclase.		
T37693	PDBSTRUC	5ZTY; 2KI9		
T37693	BIOCLASS	GPCR rhodopsin		
T37693	SEQUENCE	MEECWVTEIANGSKDGLDSNPMKDYMILSGPQKTAVAVLCTLLGLLSALENVAVLYLILSSHQLRRKPSYLFIGSLAGADFLASVVFACSFVNFHVFHGVDSKAVFLLKIGSVTMTFTASVGSLLLTAIDRYLCLRYPPSYKALLTRGRALVTLGIMWVLSALVSYLPLMGWTCCPRPCSELFPLIPNDYLLSWLLFIAFLFSGIIYTYGHVLWKAHQHVASLSGHQDRQVPGMARMRLDVRLAKTLGLVLAVLLICWFPVLALMAHSLATTLSDQVKKAFAFCSMLCLINSMVNPVIYALRSGEIRSSAHHCLAHWKKCVRGLGSEAKEEAPRSSVTETEADGKITPWPDSRDLDLSDC		
T37693	DRUGINFO	D07ILQ	Guanfacine extended release	Approved
T37693	DRUGINFO	D0L7AS	NABILONE	Approved
T37693	DRUGINFO	D0Q7NB	842166X	Phase 2
T37693	DRUGINFO	D0I4PW	APD371	Phase 2
T37693	DRUGINFO	D53QMP	Beta-caryophyllene	Phase 2
T37693	DRUGINFO	D05BMC	GW-42004	Phase 2
T37693	DRUGINFO	D00FBC	KHK-6188	Phase 2
T37693	DRUGINFO	D06UIS	LY-2828360	Phase 2
T37693	DRUGINFO	D0J6KZ	S-777469	Phase 2
T37693	DRUGINFO	D0Q8WG	Tedalinab	Phase 1
T37693	DRUGINFO	D0HG0F	1,3,5-triazine derivative 1	Patented
T37693	DRUGINFO	D05CEL	2-cycloalkyl resorcinol cannabinoid ligand derivative 1	Patented
T37693	DRUGINFO	D0H0XC	2-cycloalkyl resorcinol cannabinoid ligand derivative 2	Patented
T37693	DRUGINFO	D0T9OL	Adamantyl derivative 1	Patented
T37693	DRUGINFO	D0GQ8W	Carbazole-3-carboxamide analog 1	Patented
T37693	DRUGINFO	D0LN9D	Cyano(dimethyl)methyl isoxazoles and [1,3,4]-thiadiazoles derivative 1	Patented
T37693	DRUGINFO	D0X5ZS	Cyano(dimethyl)methyl isoxazoles and [1,3,4]-thiadiazoles derivative 2	Patented
T37693	DRUGINFO	D0TC7X	Isoquinoline derivative 1	Patented
T37693	DRUGINFO	D0D1TS	Isoquinoline derivative 2	Patented
T37693	DRUGINFO	D0ZM1H	Isoquinoline derivative 3	Patented
T37693	DRUGINFO	D0YZ8I	JWH-015	Patented
T37693	DRUGINFO	D07IHT	N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 1	Patented
T37693	DRUGINFO	D0WJ3F	N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 2	Patented
T37693	DRUGINFO	D0FA2L	N,N-methylenebis-2-phenylacetamide and benzenesulfonamide derivative 3	Patented
T37693	DRUGINFO	D0RZ4M	Phytocannabinoid/aminoalkylindole derivative 1	Patented
T37693	DRUGINFO	D09WPA	Phytocannabinoid/aminoalkylindole derivative 2	Patented
T37693	DRUGINFO	D0EX1T	PMID27215781-Compound-11	Patented
T37693	DRUGINFO	D0Q9TO	PMID27215781-Compound-12	Patented
T37693	DRUGINFO	D0O2TY	PMID27215781-Compound-13	Patented
T37693	DRUGINFO	D0SR5L	PMID27215781-Compound-19	Patented
T37693	DRUGINFO	D0W9PY	PMID27215781-Compound-2	Patented
T37693	DRUGINFO	D07ULI	PMID27215781-Compound-25	Patented
T37693	DRUGINFO	D0E6YT	PMID27215781-Compound-27	Patented
T37693	DRUGINFO	D03YAA	PMID27215781-Compound-28	Patented
T37693	DRUGINFO	D0XG7K	PMID27215781-Compound-29	Patented
T37693	DRUGINFO	D03YWY	PMID27215781-Compound-30	Patented
T37693	DRUGINFO	D0CR0Y	PMID27215781-Compound-31	Patented
T37693	DRUGINFO	D01PUS	PMID27215781-Compound-32	Patented
T37693	DRUGINFO	D0OE0D	PMID27215781-Compound-33	Patented
T37693	DRUGINFO	D00TIB	PMID27215781-Compound-34	Patented
T37693	DRUGINFO	D07BFP	PMID27215781-Compound-37	Patented
T37693	DRUGINFO	D08XES	PMID27215781-Compound-4	Patented
T37693	DRUGINFO	D09GJQ	Tricyclic phytocannabinoid derivative 1	Patented
T37693	DRUGINFO	D02TOI	Tricyclic phytocannabinoid derivative 2	Patented
T37693	DRUGINFO	D0LF5B	KN-38-7271	Discontinued in Phase 2
T37693	DRUGINFO	D03ACT	PRS-211375 iv	Discontinued in Phase 2
T37693	DRUGINFO	D03KTK	TAK-937	Discontinued in Phase 1
T37693	DRUGINFO	D07XGT	AM-577	Terminated
T37693	DRUGINFO	D0A4XN	PRS-639058	Terminated
T37693	DRUGINFO	D01DTQ	PXS-2076	Terminated
T37693	DRUGINFO	D0J7RW	WIN-55212-2	Terminated
T37693	DRUGINFO	D03HFM	(1R,2R)-N-Arachidonoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D0R7QF	(1R,2S)-N-Arachidonoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D0Q0XV	(1R,2S)-N-Oleoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D0G2EQ	(1S,2S)-N-Arachidonoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D0K7QP	(1S,2S)-N-Oleoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D01MCD	(2R)-N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D01PEC	(2R)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D06DTC	(2S)-N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D01VIA	(4-benzhydrylpiperazin-1-yl)(cyclohexyl)methanone	Investigative
T37693	DRUGINFO	D0Z7OB	(E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide	Investigative
T37693	DRUGINFO	D0T4SE	(E)-N-(4-methoxyphenethyl)undec-2-enamide	Investigative
T37693	DRUGINFO	D08BNY	(E)-N-(4-methoxyphenyl)undec-2-enamide	Investigative
T37693	DRUGINFO	D0D6OH	[3H]CP55940	Investigative
T37693	DRUGINFO	D0K8VR	[3H]HU-243	Investigative
T37693	DRUGINFO	D06BXT	[3H]WIN55212-2	Investigative
T37693	DRUGINFO	D0V7QA	1,4-dihydroindeno[1,2-c]-pyrazole	Investigative
T37693	DRUGINFO	D04XGX	2-(2-Methoxybenzyl)-3H-benzo[f]chromen-3-one	Investigative
T37693	DRUGINFO	D01JHA	2'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Investigative
T37693	DRUGINFO	D0V3YB	3,4-diarylpyrazoline derivative	Investigative
T37693	DRUGINFO	D0G7GF	3'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Investigative
T37693	DRUGINFO	D08JFL	3-benzoyl-1-pentyl-1,4-dihydroquinolin-4-one	Investigative
T37693	DRUGINFO	D01RWS	3-Benzyl-5-isopropyl-8-methylchromen-2-one	Investigative
T37693	DRUGINFO	D08VLG	4-(1,1-dimethyl-heptyl)-2'-methoxy-biphenyl-2-ol	Investigative
T37693	DRUGINFO	D0U3ME	4'-(1,1-dimethyl-heptyl)-3,5-dimethyl-biphenyl	Investigative
T37693	DRUGINFO	D08OAQ	4-(1,1-dimethyl-heptyl)-3'-methoxy-biphenyl-2-ol	Investigative
T37693	DRUGINFO	D08GLU	4'-amino-4-(1,1-dimethyl-heptyl)-biphenyl-2-ol	Investigative
T37693	DRUGINFO	D0N0ME	4-benzhydryl-N-butylpiperazine-1-carboxamide	Investigative
T37693	DRUGINFO	D04ICJ	4-benzhydryl-N-cyclohexylpiperazine-1-carboxamide	Investigative
T37693	DRUGINFO	D02POA	5-(1,1-dimethyl-heptyl)-2-pyridin-3-yl-phenol	Investigative
T37693	DRUGINFO	D03SCD	5-Biphenyl-4-ylmethyl-1-isobutyl-1H-tetrazole	Investigative
T37693	DRUGINFO	D0K8MN	5-Biphenyl-4-ylmethyl-2-isobutyl-2H-tetrazole	Investigative
T37693	DRUGINFO	D03REA	5-Methoxy-3-(2-methoxybenzyl)-2H-chromen-2-one	Investigative
T37693	DRUGINFO	D0R6MB	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0K4PV	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-((R)-1-HYDROXYETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0R9VY	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(1-HYDROXY-2-METHYLPROPAN-2-YL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0OQ5H	6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-N-(HYDROXYMETHYL)-1,2,2-TRIMETHYL-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE-4-CARBOXAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D08TXL	A-796260	Investigative
T37693	DRUGINFO	D0O3NY	AM-1241	Investigative
T37693	DRUGINFO	D04AUM	AM-1710	Investigative
T37693	DRUGINFO	D0E3ET	AM-1714	Investigative
T37693	DRUGINFO	D03GDP	AM-1715	Investigative
T37693	DRUGINFO	D0UD9H	AM-281	Investigative
T37693	DRUGINFO	D02GOH	AM-404	Investigative
T37693	DRUGINFO	D09CKZ	AM-411	Investigative
T37693	DRUGINFO	D03AWH	AM-4768	Investigative
T37693	DRUGINFO	D09FMK	AM-630	Investigative
T37693	DRUGINFO	D02GTT	AR-XYZ	Investigative
T37693	DRUGINFO	D0Z1NH	Cis-N-oleoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D04GDY	DELTA 8-TETRAHYDROCANNOBINOL	Investigative
T37693	DRUGINFO	D0EC6B	Dodeca-2E,4E-dienoic acid isobutylamide	Investigative
T37693	DRUGINFO	D0R1UA	GNF-PF-5188	Investigative
T37693	DRUGINFO	D0UX4A	HU-433	Investigative
T37693	DRUGINFO	D09DSK	JWH-051	Investigative
T37693	DRUGINFO	D0O7ZJ	JWH-120	Investigative
T37693	DRUGINFO	D02VSL	JWH-133	Investigative
T37693	DRUGINFO	D0S3UA	JWH-145	Investigative
T37693	DRUGINFO	D0TN1L	JWH-146	Investigative
T37693	DRUGINFO	D0S2ZR	JWH-147	Investigative
T37693	DRUGINFO	D0GG4T	JWH-150	Investigative
T37693	DRUGINFO	D0F3CH	JWH-151	Investigative
T37693	DRUGINFO	D03RGV	JWH-156	Investigative
T37693	DRUGINFO	D05EWD	JWH-167	Investigative
T37693	DRUGINFO	D00TPO	JWH-201	Investigative
T37693	DRUGINFO	D0P6NA	JWH-202	Investigative
T37693	DRUGINFO	D0M1MQ	JWH-203	Investigative
T37693	DRUGINFO	D08JCV	JWH-204	Investigative
T37693	DRUGINFO	D0WD1F	JWH-205	Investigative
T37693	DRUGINFO	D0X0FB	JWH-206	Investigative
T37693	DRUGINFO	D0GD9G	JWH-207	Investigative
T37693	DRUGINFO	D0Q8SO	JWH-208	Investigative
T37693	DRUGINFO	D0YM8O	JWH-209	Investigative
T37693	DRUGINFO	D09KFJ	JWH-229	Investigative
T37693	DRUGINFO	D0Q4IM	JWH-237	Investigative
T37693	DRUGINFO	D0Z6BY	JWH-243	Investigative
T37693	DRUGINFO	D0I7MW	JWH-244	Investigative
T37693	DRUGINFO	D0TS5I	JWH-245	Investigative
T37693	DRUGINFO	D0Z7FF	JWH-246	Investigative
T37693	DRUGINFO	D0X1EC	JWH-248	Investigative
T37693	DRUGINFO	D0Q6FF	JWH-249	Investigative
T37693	DRUGINFO	D0D4HH	JWH-250	Investigative
T37693	DRUGINFO	D05DXW	JWH-251	Investigative
T37693	DRUGINFO	D0P9KU	JWH-252	Investigative
T37693	DRUGINFO	D01IUI	JWH-253	Investigative
T37693	DRUGINFO	D06EHU	JWH-268	Investigative
T37693	DRUGINFO	D03SRV	JWH-292	Investigative
T37693	DRUGINFO	D0T5WY	JWH-293	Investigative
T37693	DRUGINFO	D04EOZ	JWH-294	Investigative
T37693	DRUGINFO	D0G9EU	JWH-295	Investigative
T37693	DRUGINFO	D0Q4YR	JWH-296	Investigative
T37693	DRUGINFO	D0Y6MS	JWH-297	Investigative
T37693	DRUGINFO	D0I9XR	JWH-302	Investigative
T37693	DRUGINFO	D03DDL	JWH-303	Investigative
T37693	DRUGINFO	D0IW4Q	JWH-305	Investigative
T37693	DRUGINFO	D0L5IM	JWH-306	Investigative
T37693	DRUGINFO	D02QTB	JWH-307	Investigative
T37693	DRUGINFO	D0Q9FB	JWH-308	Investigative
T37693	DRUGINFO	D0O8IC	JWH-309	Investigative
T37693	DRUGINFO	D02UEJ	JWH-311	Investigative
T37693	DRUGINFO	D0RI8G	JWH-312	Investigative
T37693	DRUGINFO	D01JTY	JWH-313	Investigative
T37693	DRUGINFO	D0W9BD	JWH-314	Investigative
T37693	DRUGINFO	D08BGZ	JWH-315	Investigative
T37693	DRUGINFO	D0PC1Z	JWH-323	Investigative
T37693	DRUGINFO	D0Z1XE	JWH-324	Investigative
T37693	DRUGINFO	D0E4OT	JWH-325	Investigative
T37693	DRUGINFO	D0U4JI	JWH-337	Investigative
T37693	DRUGINFO	D01JQX	JWH-342	Investigative
T37693	DRUGINFO	D0M1ZC	JWH-343	Investigative
T37693	DRUGINFO	D09JER	JWH-344	Investigative
T37693	DRUGINFO	D07QUV	JWH-345	Investigative
T37693	DRUGINFO	D0F3XG	JWH-346	Investigative
T37693	DRUGINFO	D0B8AN	JWH-347	Investigative
T37693	DRUGINFO	D0V3TO	JWH-348	Investigative
T37693	DRUGINFO	D0Y9HT	JWH-363	Investigative
T37693	DRUGINFO	D07KZW	JWH-364	Investigative
T37693	DRUGINFO	D0DQ3F	JWH-365	Investigative
T37693	DRUGINFO	D0EE0Q	JWH-366	Investigative
T37693	DRUGINFO	D09PIQ	JWH-367	Investigative
T37693	DRUGINFO	D0DE9L	JWH-368	Investigative
T37693	DRUGINFO	D0ZL2P	JWH-369	Investigative
T37693	DRUGINFO	D04LZA	JWH-370	Investigative
T37693	DRUGINFO	D0R1NR	JWH-371	Investigative
T37693	DRUGINFO	D0E3OY	JWH-372	Investigative
T37693	DRUGINFO	D0R3GN	JWH-373	Investigative
T37693	DRUGINFO	D0A2BC	JWH-385	Investigative
T37693	DRUGINFO	D04TSL	JWH-392	Investigative
T37693	DRUGINFO	D0E0JU	JWH-401	Investigative
T37693	DRUGINFO	D0Y0MY	JWH-402	Investigative
T37693	DRUGINFO	D0N5VO	JWH-403	Investigative
T37693	DRUGINFO	D01MJF	JWH-404	Investigative
T37693	DRUGINFO	D00LZJ	JWH-405	Investigative
T37693	DRUGINFO	D00DNT	JWH-406	Investigative
T37693	DRUGINFO	D00TRZ	JWH-407	Investigative
T37693	DRUGINFO	D06SKK	JWH-440	Investigative
T37693	DRUGINFO	D0X1FX	JWH-441	Investigative
T37693	DRUGINFO	D0EX7J	JWH-442	Investigative
T37693	DRUGINFO	D0P5VJ	KM-233	Investigative
T37693	DRUGINFO	D0D7OR	KM-233-M	Investigative
T37693	DRUGINFO	D0BS7G	L-759,633	Investigative
T37693	DRUGINFO	D02INF	L-759,656	Investigative
T37693	DRUGINFO	D06SRX	MDA-19	Investigative
T37693	DRUGINFO	D0PE8U	N-(1H-indazol-5-yl)icosa-5,8,11,14-tetraenamide	Investigative
T37693	DRUGINFO	D0C4CG	N-(2-chloroethyl)icosa-5,8,11,14-tetraenamide	Investigative
T37693	DRUGINFO	D0Z5CX	N-(3,3-Diphenyl)propyl-2,2-diphenylacetamide	Investigative
T37693	DRUGINFO	D0J3XJ	N-(3-Phenyl)propyl-2-(4-bromophenylacetamide)	Investigative
T37693	DRUGINFO	D0L1UA	N-(4-hydroxybenzyl)icosa-5,8,11,14-tetraenamide	Investigative
T37693	DRUGINFO	D09BYO	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0I4AF	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXY-2,2-DIMETHYLPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0FJ1I	N-(6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-3-HYDROXYPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D0E0AA	N-(7-(2-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDIN-4-YL)-2-HYDROXYACETAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D02NAW	N-(7'-(2-CHLOROPHENYL)-6'-(4-CHLOROPHENYL)-3',4'-DIHYDROSPIRO[CYCLOHEXANE-1,2'-PYRANO[2,3-B]PYRIDINE]-4'-YL)-2-HYDROXY-2-METHYLPROPANAMIDE (ENANTIOMERIC MIX)	Investigative
T37693	DRUGINFO	D06NXC	N-[6-(4-CHLOROPHENYL)-7-(2,4-DICHLOROPHENYL)-2,2-DIMETHYL-3,4-DIHYDRO-2H-PYRANO[2,3-B]PYRIDINE-4-YL]-4,4,4-TRIFLUORO-3-HYDROXYBUTANAMIDE (DIASTEREOMERIC MIX)	Investigative
T37693	DRUGINFO	D06GAF	N1-(4-bromophenyl)-N2,N2-dipentylphthalamide	Investigative
T37693	DRUGINFO	D0CO6T	NAPHTHYRIDINONE	Investigative
T37693	DRUGINFO	D04AMC	N-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D0Y1MM	N-arachidonoyl-O-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D06JFN	N-benzyl-4-bromo-3-(morpholinosulfonyl)benzamide	Investigative
T37693	DRUGINFO	D0Q8QH	N-oleoyl-N-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D0T3CP	N-oleoyl-O-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D0F4BE	O-arachidonoyl-N-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D05TQX	O-oleoyl-N-(2-hydroxyethyl)hydroxylamine	Investigative
T37693	DRUGINFO	D0L6RT	PRAVADOLINE	Investigative
T37693	DRUGINFO	D0J7CR	Rac-cis-N-arachidonoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D04ECZ	Rac-trans-N-oleoylcyclopropanolamide	Investigative
T37693	DRUGINFO	D08RYN	RQ-00202730	Investigative
T37693	DRUGINFO	D05RKV	Sch-036	Investigative
T37693	DRUGINFO	D00ECV	SCH-225336	Investigative
T37693	DRUGINFO	D0G4VV	SCH-356036	Investigative
T37693	DRUGINFO	D0J8KW	SR144528	Investigative
T37693	DRUGINFO	D0PC5A	VER-156084	Investigative
T37693	DRUGINFO	D0ZM1T	VER-156085	Investigative
T37693	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T37693	WIKIPATH	WP1824:GPCR downstream signaling		
T37693	WIKIPATH	WP1825:GPCR ligand binding		
T37693	WIKIPATH	WP247:Small Ligand GPCRs		
T37693	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T37693	REACPATH	R-HSA-373076:Class A/1 (Rhodopsin-like receptors)		
T37693	REACPATH	R-HSA-418594:G alpha (i) signalling events		
				
T77913	TARGETID	T77913		
T77913	FORMERID	TTDS00086		
T77913	UNIPROID	HRH1_HUMAN		
T77913	TARGNAME	Histamine H1 receptor (H1R)		
T77913	GENENAME	HRH1		
T77913	TARGTYPE	Successful target		
T77913	SYNONYMS	HH1R; H1R		
T77913	FUNCTION	In peripheral tissues, the H1 subclass of histamine receptors mediates the contraction of smooth muscles, increase in capillary permeability due to contraction of terminal venules, and catecholamine release from adrenal medulla, as well as mediating neurotransmission in the central nervous system.		
T77913	PDBSTRUC	3RZE		
T77913	BIOCLASS	GPCR rhodopsin		
T77913	SEQUENCE	MSLPNSSCLLEDKMCEGNKTTMASPQLMPLVVVLSTICLVTVGLNLLVLYAVRSERKLHTVGNLYIVSLSVADLIVGAVVMPMNILYLLMSKWSLGRPLCLFWLSMDYVASTASIFSVFILCIDRYRSVQQPLRYLKYRTKTRASATILGAWFLSFLWVIPILGWNHFMQQTSVRREDKCETDFYDVTWFKVMTAIINFYLPTLLMLWFYAKIYKAVRQHCQHRELINRSLPSFSEIKLRPENPKGDAKKPGKESPWEVLKRKPKDAGGGSVLKSPSQTPKEMKSPVVFSQEDDREVDKLYCFPLDIVHMQAAAEGSSRDYVAVNRSHGQLKTDEQGLNTHGASEISEDQMLGDSQSFSRTDSDTTTETAPGKGKLRSGSNTGLDYIKFTWKRLRSHSRQYVSGLHMNRERKAAKQLGFIMAAFILCWIPYFIFFMVIAFCKNCCNEHLHMFTIWLGYINSTLNPLIYPLCNENFKKTFKRILHIRS		
T77913	DRUGINFO	D0ZJ1C	(S)-(+)-Dimethindene maleate	Approved
T77913	DRUGINFO	D06EQP	Aceprometazine	Approved
T77913	DRUGINFO	D0O4EU	Acrivastine	Approved
T77913	DRUGINFO	D0O7JW	Alcaftadine	Approved
T77913	DRUGINFO	D06FZX	Antazoline	Approved
T77913	DRUGINFO	D0N7AD	Azatadine	Approved
T77913	DRUGINFO	D00JVR	Azelastine	Approved
T77913	DRUGINFO	D0U5VZ	Bepotastine	Approved
T77913	DRUGINFO	D0Y5GK	Bromodiphenhydramine	Approved
T77913	DRUGINFO	D08VXO	Brompheniramine	Approved
T77913	DRUGINFO	D03XSJ	Buclizine	Approved
T77913	DRUGINFO	D00FGV	Carbinoxamine	Approved
T77913	DRUGINFO	D0DK8V	Cetirizine	Approved
T77913	DRUGINFO	D0EC6Q	Chlophedianol	Approved
T77913	DRUGINFO	D0B7NG	Chlorpheniramine	Approved
T77913	DRUGINFO	D0Q3YO	Cinnarizine	Approved
T77913	DRUGINFO	D0C5XC	Clemastine	Approved
T77913	DRUGINFO	D08HRJ	Cyclizine	Approved
T77913	DRUGINFO	D00TLN	Cyproheptadine	Approved
T77913	DRUGINFO	D01GBY	Desloratadine	Approved
T77913	DRUGINFO	D02WIW	Dexbrompheniramine	Approved
T77913	DRUGINFO	D05ZGQ	Dexchlorpheniramine Maleate	Approved
T77913	DRUGINFO	D0U8UV	Dimenhydrinate	Approved
T77913	DRUGINFO	D08CTT	Dimethindene	Approved
T77913	DRUGINFO	D01FGR	Diphenhydramine	Approved
T77913	DRUGINFO	D0W6DY	Diphenylpyraline	Approved
T77913	DRUGINFO	D06FES	Doxepin	Approved
T77913	DRUGINFO	D0Y2LR	Doxylamine	Approved
T77913	DRUGINFO	D02XJI	Emedastine	Approved
T77913	DRUGINFO	D0DV3O	Epinastine	Approved
T77913	DRUGINFO	D04USC	Ergotidine	Approved
T77913	DRUGINFO	D0Q0RC	Ethopropazine	Approved
T77913	DRUGINFO	D01KPV	Fexofenadine	Approved
T77913	DRUGINFO	D0O6SX	Hydroxyzine	Approved
T77913	DRUGINFO	D0YG7M	Ketotifen	Approved
T77913	DRUGINFO	D08SEI	Levocabastine	Approved
T77913	DRUGINFO	D0M8PW	Levocetirizine dihydrochloride	Approved
T77913	DRUGINFO	D06ABF	Loratadine	Approved
T77913	DRUGINFO	D08JZS	Mepyramine	Approved
T77913	DRUGINFO	D01NJI	Mepyramine maleate	Approved
T77913	DRUGINFO	D09IMS	Mequitazine	Approved
T77913	DRUGINFO	D0LR0R	Methdilazine	Approved
T77913	DRUGINFO	D06MAJ	Mizolastine	Approved
T77913	DRUGINFO	D05GPO	Olopatadine	Approved
T77913	DRUGINFO	D0AJ5L	Oxatomide	Approved
T77913	DRUGINFO	D0K5LQ	Pemirolast	Approved
T77913	DRUGINFO	D06UDO	Phenindamine	Approved
T77913	DRUGINFO	D04OBB	Pheniramine	Approved
T77913	DRUGINFO	D0T2XU	Promethazine	Approved
T77913	DRUGINFO	D0R9ZB	Propiomazine	Approved
T77913	DRUGINFO	D0E6OC	Tranilast	Approved
T77913	DRUGINFO	D08HZL	Trimeprazine	Approved
T77913	DRUGINFO	D0B4JQ	Tripelennamine	Approved
T77913	DRUGINFO	D0E8CI	Triprolidine	Approved
T77913	DRUGINFO	D0S1CQ	RUPATADINE	Phase 4
T77913	DRUGINFO	D01JFM	AC-170	Phase 3
T77913	DRUGINFO	D0LK4X	Carebastine	Phase 3
T77913	DRUGINFO	D08TLI	E-4716	Phase 2
T77913	DRUGINFO	D04HAF	LY-2624803	Phase 2
T77913	DRUGINFO	D03DRR	Noberastine	Phase 2
T77913	DRUGINFO	D08WOJ	OBE-101	Phase 2
T77913	DRUGINFO	D05XEA	RP5063	Phase 2
T77913	DRUGINFO	D04JIM	UCB-35440	Phase 2
T77913	DRUGINFO	D0E8ZY	Vapitadine	Phase 2
T77913	DRUGINFO	D0R6LF	Citalopram derivative 1	Patented
T77913	DRUGINFO	D0VX6P	Piperidine derivative 1	Patented
T77913	DRUGINFO	D0FA3G	PMID29334795-Compound-61	Patented
T77913	DRUGINFO	D0Y2HR	Astemizole	Withdrawn from market
T77913	DRUGINFO	D08SOF	Terfenadine	Withdrawn from market
T77913	DRUGINFO	D0I5UU	Norastemizole	Discontinued in Preregistration
T77913	DRUGINFO	D04IFU	GSK835726	Discontinued in Phase 2
T77913	DRUGINFO	D08RZV	HSR-609	Discontinued in Phase 2
T77913	DRUGINFO	D02YBP	Mequitamium iodide	Discontinued in Phase 2
T77913	DRUGINFO	D09TEI	ReN-1869	Discontinued in Phase 2
T77913	DRUGINFO	D00WJE	SUN-1334H	Discontinued in Phase 2
T77913	DRUGINFO	D09UXP	AZD-1744	Discontinued in Phase 1
T77913	DRUGINFO	D0B4TT	GSK1004723	Discontinued in Phase 1
T77913	DRUGINFO	D0VZ8S	KA-398	Terminated
T77913	DRUGINFO	D0FQ4M	Selenotifen	Terminated
T77913	DRUGINFO	D01XZI	(-)-trans-H2-PAT	Investigative
T77913	DRUGINFO	D0QW5N	(+)-cis-H2-PAT	Investigative
T77913	DRUGINFO	D0PC7A	(+)-trans-H2-PAT	Investigative
T77913	DRUGINFO	D0B9TV	(+/-)-cis-H2-PAT	Investigative
T77913	DRUGINFO	D0Z1WW	(S)-cetirizine	Investigative
T77913	DRUGINFO	D0I0UW	1-(4-p-Tolyl-butyl)-piperidine	Investigative
T77913	DRUGINFO	D08NXC	1-[(Furan-2(5H)-one)-4-methyl]-desloratadine	Investigative
T77913	DRUGINFO	D0XY3G	2-(2-thiazolyl)ethanamine	Investigative
T77913	DRUGINFO	D0G6AQ	2-(3-bromophenyl)histamine	Investigative
T77913	DRUGINFO	D0T7AR	2-(3-chlorophenyl)histamine	Investigative
T77913	DRUGINFO	D0A6IQ	2-(3-iodophenyl)histamine	Investigative
T77913	DRUGINFO	D03VUU	2-(9,10-dihydroanthracen-9-yl)-N-methylethanamine	Investigative
T77913	DRUGINFO	D0BT1A	2-pyridylethylamine	Investigative
T77913	DRUGINFO	D0B0PP	3,3-diphenylpropan-1-amine	Investigative
T77913	DRUGINFO	D0T2RY	4-(4-butylpiperidin-1-yl)-1-o-tolylbutan-1-one	Investigative
T77913	DRUGINFO	D04SCQ	4,4-Diphenylbutan-1-amine	Investigative
T77913	DRUGINFO	D0Y5QR	8R-Lisuride	Investigative
T77913	DRUGINFO	D05YFZ	9-(2-aminoethyl)-9,10-dihydroanthracene	Investigative
T77913	DRUGINFO	D0S0WX	9-(2-aminopropyl)-9,10-dihydroanthracene	Investigative
T77913	DRUGINFO	D01CXD	9-(Aminomethyl)-9,10-dihydroanthracene	Investigative
T77913	DRUGINFO	D0Y4MC	9-OH-risperidone	Investigative
T77913	DRUGINFO	D05IHR	9-Phenyl-2,3-dihydro-1H-indeno[2,1-c]pyridine	Investigative
T77913	DRUGINFO	D08SLS	arpromidine	Investigative
T77913	DRUGINFO	D0K9KJ	BU-E 47	Investigative
T77913	DRUGINFO	D02YSX	DIMEBOLIN	Investigative
T77913	DRUGINFO	D0PB6B	dimethylhistaprodifen	Investigative
T77913	DRUGINFO	D08TBU	Diphenyl(piperidin-4-yl)methanol	Investigative
T77913	DRUGINFO	D0RG8O	histaprodifen	Investigative
T77913	DRUGINFO	D06QQS	Hydroxyclemastine	Investigative
T77913	DRUGINFO	D0B4SF	impromidine	Investigative
T77913	DRUGINFO	D08RCH	KF-A6	Investigative
T77913	DRUGINFO	D0A1DE	MDL-28163	Investigative
T77913	DRUGINFO	D0G3OY	methylhistaprodifen	Investigative
T77913	DRUGINFO	D01HJZ	N,N-dimethyl-2,2-diphenylethanamine	Investigative
T77913	DRUGINFO	D02SDX	N,N-Dimethyl-3,3-diphenylpropan-1-amine	Investigative
T77913	DRUGINFO	D0S3WR	N,N-dimethyl-4,4-diphenylbutan-1-amine	Investigative
T77913	DRUGINFO	D02GNN	N-methyl-3,3-diphenylpropan-1-amine	Investigative
T77913	DRUGINFO	D05RKS	N-methyl-4,4-diphenylbutan-1-amine	Investigative
T77913	DRUGINFO	D0D3YN	OCTOCLOTHEPIN	Investigative
T77913	DRUGINFO	D04WXI	oxo-arpromidine	Investigative
T77913	DRUGINFO	D0PN9R	R-226161	Investigative
T77913	DRUGINFO	D0H8XV	R-dimethindene	Investigative
T77913	DRUGINFO	D01HUN	UR-PG131A	Investigative
T77913	DRUGINFO	D0AU0F	UR-PG146	Investigative
T77913	DRUGINFO	D0Y9IB	UR-PG153	Investigative
T77913	DRUGINFO	D0UG1U	UR-PG55B	Investigative
T77913	DRUGINFO	D03SNI	VUF-10148	Investigative
T77913	KEGGPATH	hsa04020:Calcium signaling pathway		
T77913	KEGGPATH	hsa04080:Neuroactive ligand-receptor interaction		
T77913	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T77913	WIKIPATH	WP1824:GPCR downstream signaling		
T77913	WIKIPATH	WP1825:GPCR ligand binding		
T77913	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T77913	WIKIPATH	WP395:IL-4 Signaling Pathway		
T77913	WIKIPATH	WP455:GPCRs, Class A Rhodopsin-like		
T77913	WIKIPATH	WP58:Monoamine GPCRs		
T77913	REACPATH	R-HSA-390650:Histamine receptors		
T77913	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T77913	PANTPATH	P04385:Histamine H1 receptor mediated signaling pathway		
				
T58921	TARGETID	T58921		
T58921	FORMERID	TTDS00338		
T58921	UNIPROID	PPARG_HUMAN		
T58921	TARGNAME	Peroxisome proliferator-activated receptor gamma (PPAR-gamma)		
T58921	GENENAME	PPARG		
T58921	TARGTYPE	Successful target		
T58921	SYNONYMS	PPAR-gamma; Nuclear receptor subfamily 1 group C member 3; NR1C3		
T58921	FUNCTION	Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity).		
T58921	PDBSTRUC	6MD4; 6MD2; 6MD1; 6MD0; 6MCZ		
T58921	BIOCLASS	Nuclear hormone receptor		
T58921	SEQUENCE	MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY		
T58921	DRUGINFO	D04BCB	Lobeglitazone	Approved
T58921	DRUGINFO	D03OFF	Pioglitazone	Approved
T58921	DRUGINFO	D0K5ER	Rosiglitazone XR	Approved
T58921	DRUGINFO	D0K8IX	Thiazolidinedione	Approved
T58921	DRUGINFO	D06XZW	Troglitazone	Approved
T58921	DRUGINFO	D0S2BV	Glitazone	Phase 4
T58921	DRUGINFO	D0F3NH	Balaglitazone	Phase 3
T58921	DRUGINFO	D0F5JH	CS-038	Phase 3
T58921	DRUGINFO	D0M0SS	FARGLITAZAR	Phase 3
T58921	DRUGINFO	D0VU5M	Imiglitazar	Phase 3
T58921	DRUGINFO	D0M3UT	MURAGLITAZAR	Phase 3
T58921	DRUGINFO	D02NHD	Ragaglitazar	Phase 3
T58921	DRUGINFO	D08PFA	Rivoglitazone	Phase 3
T58921	DRUGINFO	D0A1AQ	Rosiglitazone + metformin	Phase 3
T58921	DRUGINFO	D0Q6IW	Rosiglitazone + simvastatin	Phase 3
T58921	DRUGINFO	D0H1NL	TESAGLITAZAR	Phase 3
T58921	DRUGINFO	D0T7MN	ZYH-1	Phase 3
T58921	DRUGINFO	D0X7VB	MBX-102	Phase 2/3
T58921	DRUGINFO	D0P5SU	CHS-131	Phase 2
T58921	DRUGINFO	D00PJJ	FK-614	Phase 2
T58921	DRUGINFO	D0E6ME	GED-0507-34-Levo	Phase 2
T58921	DRUGINFO	D08NPG	MBX-2044	Phase 2
T58921	DRUGINFO	D04BPS	Naveglitazar	Phase 2
T58921	DRUGINFO	D02TGD	Netoglitazone	Phase 2
T58921	DRUGINFO	D0W0JP	OMS405	Phase 2
T58921	DRUGINFO	D0PP8G	ONO-5129	Phase 2
T58921	DRUGINFO	D0ZT8A	T3D-959	Phase 1/2
T58921	DRUGINFO	D06TWE	CLX-0921	Phase 1
T58921	DRUGINFO	D07IGC	DSP-8658	Phase 1
T58921	DRUGINFO	D08EEU	Englitazone sodium	Phase 1
T58921	DRUGINFO	D0AX9S	GW-409544	Phase 1
T58921	DRUGINFO	D03RJZ	Oxeglitazar	Phase 1
T58921	DRUGINFO	D0U6AW	1-(biphenyl-4-yl-methyl)-1H-imidazole derivative 1	Patented
T58921	DRUGINFO	D0SV6U	3-phenyl acrylic acid derivative 1	Patented
T58921	DRUGINFO	D0E9GF	A-substituted phenylpropionic acid derivative 1	Patented
T58921	DRUGINFO	D0M5YQ	A-substituted phenylpropionic acid derivative 2	Patented
T58921	DRUGINFO	D0O8PR	Biaromatic compound 1	Patented
T58921	DRUGINFO	D0ZO0D	Cannabinoid quinone derivative 1	Patented
T58921	DRUGINFO	D0M4RD	Crystalline anhydrous toluene derivative 1	Patented
T58921	DRUGINFO	D0HW6Y	Flavonoid derivative 8	Patented
T58921	DRUGINFO	D0UG1W	Fused aromatic compound 1	Patented
T58921	DRUGINFO	D0SL0K	Fused ring compound 1	Patented
T58921	DRUGINFO	D0PO7F	MRL20	Patented
T58921	DRUGINFO	D0H5FI	MRL24	Patented
T58921	DRUGINFO	D09OXG	Phenylpropionic acid derivative 1	Patented
T58921	DRUGINFO	D0NF8V	Phenylpyridine derivative 3	Patented
T58921	DRUGINFO	D0UH5B	PMID25416646-Compound-Figure2-J	Patented
T58921	DRUGINFO	D0G3KY	PMID25416646-Compound-Figure2-K	Patented
T58921	DRUGINFO	D0GG5K	PMID25416646-Compound-Figure2-N	Patented
T58921	DRUGINFO	D0O5IN	PMID25416646-Compound-Figure5-A	Patented
T58921	DRUGINFO	D0V0JN	PMID25416646-Compound-Figure5-C	Patented
T58921	DRUGINFO	D0LA6O	PMID25416646-Compound-Figure5-E	Patented
T58921	DRUGINFO	D05AUY	PMID25416646-Compound-Figure5-H	Patented
T58921	DRUGINFO	D03GFB	Spirolaxine derivative 1	Patented
T58921	DRUGINFO	D0HT9C	Sulfonamide derivative 18	Patented
T58921	DRUGINFO	D0TF0T	Thiazolidine dione crystalline derivative 1	Patented
T58921	DRUGINFO	D0W2IU	AVE-0847	Discontinued in Phase 2
T58921	DRUGINFO	D0S6KX	GSK-677954	Discontinued in Phase 2
T58921	DRUGINFO	D09OHP	Indeglitazar	Discontinued in Phase 2
T58921	DRUGINFO	D02RAU	KRP-297	Discontinued in Phase 2
T58921	DRUGINFO	D02ZKL	Reglixane	Discontinued in Phase 2
T58921	DRUGINFO	D01JGG	Sodelglitazar	Discontinued in Phase 2
T58921	DRUGINFO	D0KL3K	YM-440	Discontinued in Phase 2
T58921	DRUGINFO	D0Z6OI	DS-6930	Discontinued in Phase 1
T58921	DRUGINFO	D06PHO	E-3030	Discontinued in Phase 1
T58921	DRUGINFO	D0B0EB	LY-929	Discontinued in Phase 1
T58921	DRUGINFO	D03GWY	Ciglitazone	Preclinical
T58921	DRUGINFO	D08WOE	MC-3002	Preclinical
T58921	DRUGINFO	D0LB4T	AD-5075	Terminated
T58921	DRUGINFO	D04JVX	AKP-320	Terminated
T58921	DRUGINFO	D0I0RF	BVT-142	Terminated
T58921	DRUGINFO	D0V0TT	CS-204	Terminated
T58921	DRUGINFO	D0N1EF	DARGLITAZONE	Terminated
T58921	DRUGINFO	D08VKZ	Edaglitazone	Terminated
T58921	DRUGINFO	D00YGA	SB-219994	Terminated
T58921	DRUGINFO	D0OW6Z	Sipoglitazar	Terminated
T58921	DRUGINFO	D0J3UU	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	Investigative
T58921	DRUGINFO	D0H4US	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	Investigative
T58921	DRUGINFO	D06MDX	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	Investigative
T58921	DRUGINFO	D0Z5TV	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	Investigative
T58921	DRUGINFO	D01PGU	15-deoxy-Delta(12, 14)-prostaglandin J(2)	Investigative
T58921	DRUGINFO	D00ACX	2-chloro-5-nitro-N-phenylbenzamide	Investigative
T58921	DRUGINFO	D0E5HC	3-(5-methoxy-1H-indol-3-yl)propanoic acid	Investigative
T58921	DRUGINFO	D0SZ4T	9-hydroxyoctadecadienoic acid	Investigative
T58921	DRUGINFO	D01ARG	DB-900	Investigative
T58921	DRUGINFO	D01POG	GW-2331	Investigative
T58921	DRUGINFO	D0O2US	GW7845	Investigative
T58921	DRUGINFO	D0Z4MH	ZY H2	Investigative
T58921	KEGGPATH	hsa03320:PPAR signaling pathway		
T58921	KEGGPATH	hsa04152:AMPK signaling pathway		
T58921	KEGGPATH	hsa04380:Osteoclast differentiation		
T58921	KEGGPATH	hsa05016:Huntington's disease		
T58921	KEGGPATH	hsa05200:Pathways in cancer		
T58921	KEGGPATH	hsa05202:Transcriptional misregulation in cancer		
T58921	KEGGPATH	hsa05216:Thyroid cancer		
T58921	WIKIPATH	WP170:Nuclear Receptors		
T58921	WIKIPATH	WP1982:SREBP signalling		
T58921	WIKIPATH	WP236:Adipogenesis		
T58921	WIKIPATH	WP2751:Transcriptional Regulation of White Adipocyte Differentiation		
T58921	WIKIPATH	WP2797:Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)		
T58921	WIKIPATH	WP2895:Differentiation of white and brown adipocyte   		
T58921	WIKIPATH	WP299:Nuclear Receptors in Lipid Metabolism and Toxicity		
T58921	WIKIPATH	WP363:Wnt Signaling Pathway Netpath		
T58921	REACPATH	R-HSA-1989781:PPARA activates gene expression		
T58921	REACPATH	R-HSA-381340:Transcriptional regulation of white adipocyte differentiation		
T58921	REACPATH	R-HSA-383280:Nuclear Receptor transcription pathway		
T58921	NET_PATH	NetPath_13:IL1 Signaling Pathway		
T58921	NET_PATH	NetPath_22:Leptin Signaling Pathway		
T58921	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T58921	INTEPATH	hdac_classi_pathway:Signaling events mediated by HDAC Class I		
T58921	INTEPATH	nfat_tfpathway:Calcineurin-regulated NFAT-dependent transcription in lymphocytes		
T58921	INTEPATH	rb_1pathway:Regulation of retinoblastoma protein		
T58921	INTEPATH	rxr_vdr_pathway:RXR and RAR heterodimerization with other nuclear receptor		
T58921	INTEPATH	wnt_noncanonical_pathway:Noncanonical Wnt signaling pathway		
T58921	PANTPATH	P06959:CCKR signaling map ST		
				
T60857	TARGETID	T60857		
T60857	FORMERID	TTDR00033		
T60857	UNIPROID	AK1C3_HUMAN		
T60857	TARGNAME	Dihydrodiol dehydrogenase type I (AKR1C3)		
T60857	GENENAME	AKR1C3		
T60857	TARGTYPE	Successful target		
T60857	SYNONYMS	Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase; Testosterone 17-beta-dehydrogenase 5; Prostaglandin F synthase; PGFS; KIAA0119; Indanol dehydrogenase; HSD17B5; HA1753; Dihydrodiol dehydrogenase 3; DDH1; DD3; DD-3; Chlordecone reductase homolog HAKRb; Aldo-keto reductase family 1 member C3; 3-alpha-hydroxysteroid dehydrogenase type 2; 3-alpha-HSD type II, brain; 3-alpha-HSD type 2; 17-beta-hydroxysteroid dehydrogenase type 5; 17-beta-HSD 5		
T60857	FUNCTION	Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone.		
T60857	PDBSTRUC	6GXK; 6F78; 6F2U; 5JM5; 5HNU		
T60857	BIOCLASS	Short-chain dehydrogenases reductase		
T60857	ECNUMBER	EC 1.-.-.-		
T60857	SEQUENCE	MDSKHQCVKLNDGHFMPVLGFGTYAPPEVPRSKALEVTKLAIEAGFRHIDSAHLYNNEEQVGLAIRSKIADGSVKREDIFYTSKLWSTFHRPELVRPALENSLKKAQLDYVDLYLIHSPMSLKPGEELSPTDENGKVIFDIVDLCTTWEAMEKCKDAGLAKSIGVSNFNRRQLEMILNKPGLKYKPVCNQVECHPYFNRSKLLDFCKSKDIVLVAYSALGSQRDKRWVDPNSPVLLEDPVLCALAKKHKRTPALIALRYQLQRGVVVLAKSYNEQRIRQNVQVFEFQLTAEDMKAIDGLDRNLHYFNSDSFASHPNYPYSDEY		
T60857	DRUGINFO	D0B2WJ	Flufenamic Acid	Approved
T60857	DRUGINFO	D0H7XJ	ASP-9521	Phase 1/2
T60857	DRUGINFO	D0G8VB	Beta-naphthylacetic acids derivative 1	Patented
T60857	DRUGINFO	D0GY2Z	Indomethacin analog 1	Patented
T60857	DRUGINFO	D0F0PK	Indomethacin analog 2	Patented
T60857	DRUGINFO	D0E2TY	Indomethacin analog 3	Patented
T60857	DRUGINFO	D0Y7XJ	Isoquinolone derivative 1	Patented
T60857	DRUGINFO	D0S6TL	N-(benzimidazole/indole) benzoic acid derivative 1	Patented
T60857	DRUGINFO	D02JPV	N-(benzimidazole/indole) benzoic acid derivative 2	Patented
T60857	DRUGINFO	D0N3XY	N-(benzimidazolylcarbonyl)-piperidine derivative 1	Patented
T60857	DRUGINFO	D0Q8RC	N-(indolylcarbonyl)-piperidine derivative 1	Patented
T60857	DRUGINFO	D0M6LX	N-(naphthylamino)-benzoate derivative 1	Patented
T60857	DRUGINFO	D05GKS	N-(phenylamino)-benzoate derivative 1	Patented
T60857	DRUGINFO	D0SM2O	N-(pyridinepyrroylylcarbonyl)-piperidine derivative 1	Patented
T60857	DRUGINFO	D0PI1W	Nitrogen/sulfur-substituted estrene derivative 1	Patented
T60857	DRUGINFO	D0MC5H	2-(4-Chlorobenzylidene)cyclopentanone	Investigative
T60857	DRUGINFO	D00XMO	2-(4-chlorobenzylidene)cyclopentyl ethyl ether	Investigative
T60857	DRUGINFO	D0Q9RA	2-(4-chlorobenzylidene)cyclopentylmethyl ether	Investigative
T60857	DRUGINFO	D0V5AQ	2,2-Dibenzylcyclopentanol	Investigative
T60857	DRUGINFO	D03POE	2-[(2,2-diphenylacetyl)amino]benzoic acid	Investigative
T60857	DRUGINFO	D06GOK	2-Methyl-2,4-Pentanediol	Investigative
T60857	DRUGINFO	D0J2FY	2'-Monophosphoadenosine 5'-Diphosphoribose	Investigative
T60857	DRUGINFO	D00DDO	3-Bromo-5-phenylsalicylc acid	Investigative
T60857	DRUGINFO	D0Z0IR	3-Phenylcyclopentanecarboxylic acid	Investigative
T60857	DRUGINFO	D0M8RO	4-ANDROSTENE-3-17-DIONE	Investigative
T60857	DRUGINFO	D0F2ME	Acetate Ion	Investigative
T60857	DRUGINFO	D0K9YS	EM1396	Investigative
T60857	DRUGINFO	D0ZR1V	EM-1424	Investigative
T60857	DRUGINFO	D0DF1Z	M-Phenoxybenzoic Acid For Cis-Isomer	Investigative
T60857	DRUGINFO	D09ALJ	Rutin	Investigative
T60857	KEGGPATH	hsa00140:Steroid hormone biosynthesis		
T60857	KEGGPATH	hsa00590:Arachidonic acid metabolism		
T60857	KEGGPATH	hsa01100:Metabolic pathways		
T60857	KEGGPATH	hsa04913:Ovarian steroidogenesis		
T60857	WIKIPATH	WP2650:Arachidonic acid metabolism		
T60857	WIKIPATH	WP696:Benzo(a)pyrene metabolism		
T60857	WIKIPATH	WP702:Metapathway biotransformation		
T60857	WHIZPATH	PW000044:Arachidonic Acid Metabolism		
T60857	REACPATH	R-HSA-975634:Retinoid metabolism and transport		
T60857	NET_PATH	NetPath_7:TGF_beta_Receptor Signaling Pathway		
T60857	BIOCPATH	PWY66-378:Androgen biosynthesis		
T60857	BIOCPATH	PWY-7305:Superpathway of steroid hormone biosynthesis		
T60857	BIOCPATH	PWY-7455:Allopregnanolone biosynthesis		
				
T80276	TARGETID	T80276		
T80276	FORMERID	TTDNC00388		
T80276	UNIPROID	PK3CA_HUMAN		
T80276	TARGNAME	PI3-kinase alpha (PIK3CA)		
T80276	GENENAME	PIK3CA		
T80276	TARGTYPE	Successful target		
T80276	SYNONYMS	p110alpha; Serine/threonine protein kinase PIK3CA; PtdIns3kinase subunit p110alpha; PtdIns3kinase subunit alpha; PtdIns-3-kinase subunit p110-alpha; PtdIns-3-kinase subunit alpha; Phosphoinositide3kinase catalytic alpha polypeptide; Phosphoinositide-3-kinase catalytic alpha polypeptide; Phosphatidylinositol 4,5bisphosphate 3kinase catalytic subunit alpha isoform; Phosphatidylinositol 4,5bisphosphate 3kinase 110 kDa catalytic subunit alpha; Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform; Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha; PI3kinase subunit alpha; PI3Kalpha; PI3K-alpha; PI3-kinase subunit alpha		
T80276	FUNCTION	Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4-phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. Also has serine-protein kinase activity: phosphorylates PIK3R1 (p85alpha regulatory subunit), EIF4EBP1 and HRAS. Plays a role in the positive regulation of phagocytosis and pinocytosis.		
T80276	PDBSTRUC	6NCT; 5XGJ; 5XGI; 5XGH; 5UL1		
T80276	BIOCLASS	Kinase		
T80276	ECNUMBER	EC 2.7.1.153		
T80276	SEQUENCE	MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN		
T80276	DRUGINFO	D0W7HE	Alpelisib	Approved
T80276	DRUGINFO	D0S5LD	BAY 80-6946	Approved
T80276	DRUGINFO	D01QSO	Buparlisib	Phase 3
T80276	DRUGINFO	D0UP1Z	GDC-0032	Phase 3
T80276	DRUGINFO	D0H1WC	LY3023414	Phase 2
T80276	DRUGINFO	D0Y2NS	MLN1117	Phase 1/2
T80276	DRUGINFO	D05CBJ	PA-799	Phase 1/2
T80276	DRUGINFO	D01LMM	BLY719	Phase 1
T80276	DRUGINFO	DYF2N4	HHCYH33	Phase 1
T80276	DRUGINFO	D0Y0FE	PWT-33597	Phase 1
T80276	DRUGINFO	DOR1I0	ETP-46321	Investigative
T80276	KEGGPATH	hsa00562:Inositol phosphate metabolism		
T80276	KEGGPATH	hsa04012:ErbB signaling pathway		
T80276	KEGGPATH	hsa04014:Ras signaling pathway		
T80276	KEGGPATH	hsa04015:Rap1 signaling pathway		
T80276	KEGGPATH	hsa04022:cGMP-PKG signaling pathway		
T80276	KEGGPATH	hsa04024:cAMP signaling pathway		
T80276	KEGGPATH	hsa04062:Chemokine signaling pathway		
T80276	KEGGPATH	hsa04066:HIF-1 signaling pathway		
T80276	KEGGPATH	hsa04068:FoxO signaling pathway		
T80276	KEGGPATH	hsa04070:Phosphatidylinositol signaling system		
T80276	KEGGPATH	hsa04071:Sphingolipid signaling pathway		
T80276	KEGGPATH	hsa04150:mTOR signaling pathway		
T80276	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T80276	KEGGPATH	hsa04152:AMPK signaling pathway		
T80276	KEGGPATH	hsa04210:Apoptosis		
T80276	KEGGPATH	hsa04261:Adrenergic signaling in cardiomyocytes		
T80276	KEGGPATH	hsa04370:VEGF signaling pathway		
T80276	KEGGPATH	hsa04380:Osteoclast differentiation		
T80276	KEGGPATH	hsa04510:Focal adhesion		
T80276	KEGGPATH	hsa04550:Signaling pathways regulating pluripotency of stem cells		
T80276	KEGGPATH	hsa04611:Platelet activation		
T80276	KEGGPATH	hsa04620:Toll-like receptor signaling pathway		
T80276	KEGGPATH	hsa04630:Jak-STAT signaling pathway		
T80276	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T80276	KEGGPATH	hsa04660:T cell receptor signaling pathway		
T80276	KEGGPATH	hsa04662:B cell receptor signaling pathway		
T80276	KEGGPATH	hsa04664:Fc epsilon RI signaling pathway		
T80276	KEGGPATH	hsa04666:Fc gamma R-mediated phagocytosis		
T80276	KEGGPATH	hsa04668:TNF signaling pathway		
T80276	KEGGPATH	hsa04670:Leukocyte transendothelial migration		
T80276	KEGGPATH	hsa04722:Neurotrophin signaling pathway		
T80276	KEGGPATH	hsa04725:Cholinergic synapse		
T80276	KEGGPATH	hsa04750:Inflammatory mediator regulation of TRP channels		
T80276	KEGGPATH	hsa04810:Regulation of actin cytoskeleton		
T80276	KEGGPATH	hsa04910:Insulin signaling pathway		
T80276	KEGGPATH	hsa04914:Progesterone-mediated oocyte maturation		
T80276	KEGGPATH	hsa04915:Estrogen signaling pathway		
T80276	KEGGPATH	hsa04917:Prolactin signaling pathway		
T80276	KEGGPATH	hsa04919:Thyroid hormone signaling pathway		
T80276	KEGGPATH	hsa04921:Oxytocin signaling pathway		
T80276	KEGGPATH	hsa04923:Regulation of lipolysis in adipocytes		
T80276	KEGGPATH	hsa04930:Type II diabetes mellitus		
T80276	KEGGPATH	hsa04932:Non-alcoholic fatty liver disease (NAFLD)		
T80276	KEGGPATH	hsa04960:Aldosterone-regulated sodium reabsorption		
T80276	KEGGPATH	hsa04973:Carbohydrate digestion and absorption		
T80276	KEGGPATH	hsa05100:Bacterial invasion of epithelial cells		
T80276	KEGGPATH	hsa05142:Chagas disease (American trypanosomiasis)		
T80276	KEGGPATH	hsa05145:Toxoplasmosis		
T80276	KEGGPATH	hsa05146:Amoebiasis		
T80276	KEGGPATH	hsa05160:Hepatitis C		
T80276	KEGGPATH	hsa05161:Hepatitis B		
T80276	KEGGPATH	hsa05162:Measles		
T80276	KEGGPATH	hsa05164:Influenza A		
T80276	KEGGPATH	hsa05166:HTLV-I infection		
T80276	KEGGPATH	hsa05169:Epstein-Barr virus infection		
T80276	KEGGPATH	hsa05200:Pathways in cancer		
T80276	KEGGPATH	hsa05203:Viral carcinogenesis		
T80276	KEGGPATH	hsa05205:Proteoglycans in cancer		
T80276	KEGGPATH	hsa05206:MicroRNAs in cancer		
T80276	KEGGPATH	hsa05210:Colorectal cancer		
T80276	KEGGPATH	hsa05211:Renal cell carcinoma		
T80276	KEGGPATH	hsa05212:Pancreatic cancer		
T80276	KEGGPATH	hsa05213:Endometrial cancer		
T80276	KEGGPATH	hsa05214:Glioma		
T80276	KEGGPATH	hsa05215:Prostate cancer		
T80276	KEGGPATH	hsa05218:Melanoma		
T80276	KEGGPATH	hsa05220:Chronic myeloid leukemia		
T80276	KEGGPATH	hsa05221:Acute myeloid leukemia		
T80276	KEGGPATH	hsa05222:Small cell lung cancer		
T80276	KEGGPATH	hsa05223:Non-small cell lung cancer		
T80276	KEGGPATH	hsa05230:Central carbon metabolism in cancer		
T80276	KEGGPATH	hsa05231:Choline metabolism in cancer		
T80276	WIKIPATH	WP1403:AMPK Signaling		
T80276	WIKIPATH	WP1449:Regulation of toll-like receptor signaling pathway		
T80276	WIKIPATH	WP1539:Angiogenesis		
T80276	WIKIPATH	WP1544:MicroRNAs in cardiomyocyte hypertrophy		
T80276	WIKIPATH	WP1794:Cell surface interactions at the vascular wall		
T80276	WIKIPATH	WP1799:Costimulation by the CD28 family		
T80276	WIKIPATH	WP1824:GPCR downstream signaling		
T80276	WIKIPATH	WP1826:GPVI-mediated activation cascade		
T80276	WIKIPATH	WP1840:Interleukin-3, 5 and GM-CSF signaling		
T80276	WIKIPATH	WP1867:Nephrin interactions		
T80276	WIKIPATH	WP1873:NGF signalling via TRKA from the plasma membrane		
T80276	WIKIPATH	WP1910:Signaling by EGFR		
T80276	WIKIPATH	WP1911:Signaling by FGFR		
T80276	WIKIPATH	WP1913:Signaling by Insulin receptor		
T80276	WIKIPATH	WP1916:Signaling by PDGF		
T80276	WIKIPATH	WP1927:TCR signaling		
T80276	WIKIPATH	WP1982:SREBP signalling		
T80276	WIKIPATH	WP2032:TSH signaling pathway		
T80276	WIKIPATH	WP2038:Regulation of Microtubule Cytoskeleton		
T80276	WIKIPATH	WP2203:TSLP Signaling Pathway		
T80276	WIKIPATH	WP2261:Signaling Pathways in Glioblastoma		
T80276	WIKIPATH	WP2263:Prostate Cancer		
T80276	WIKIPATH	WP2377:Integrated Pancreatic Cancer Pathway		
T80276	WIKIPATH	WP2653:PIP3 activates AKT signaling		
T80276	WIKIPATH	WP2664:Gastrin-CREB signalling pathway via PKC and MAPK		
T80276	WIKIPATH	WP2677:Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)		
T80276	WIKIPATH	WP2694:DAP12 interactions		
T80276	WIKIPATH	WP2713:Signaling by SCF-KIT		
T80276	WIKIPATH	WP2719:Fcgamma receptor (FCGR) dependent phagocytosis		
T80276	WIKIPATH	WP2732:Interleukin-2 signaling		
T80276	WIKIPATH	WP2747:PI Metabolism		
T80276	WIKIPATH	WP2759:Fc epsilon receptor (FCERI) signaling		
T80276	WIKIPATH	WP2780:Signaling by ERBB2		
T80276	WIKIPATH	WP2781:Signaling by ERBB4		
T80276	WIKIPATH	WP2865:IL1 and megakaryotyces in obesity		
T80276	WIKIPATH	WP3:Transcriptional activation by NRF2		
T80276	WIKIPATH	WP313:Signaling of Hepatocyte Growth Factor Receptor		
T80276	WIKIPATH	WP395:IL-4 Signaling Pathway		
T80276	WIKIPATH	WP481:Insulin Signaling		
T80276	WIKIPATH	WP51:Regulation of Actin Cytoskeleton		
T80276	WIKIPATH	WP524:G13 Signaling Pathway		
T80276	WIKIPATH	WP710:DNA Damage Response (only ATM dependent)		
T80276	WIKIPATH	WP722:Serotonin HTR1 Group and FOS Pathway		
T80276	WIKIPATH	WP75:Toll-like receptor signaling pathway		
T80276	WHIZPATH	PW000143:Inositol Metabolism		
T80276	WHIZPATH	PW000168:Phosphatidylinositol Phosphate Metabolism		
T80276	WHIZPATH	PW000445:Intracellular Signalling Through Adenosine Receptor A2a and Adenosine		
T80276	WHIZPATH	PW000446:Intracellular Signalling Through Adenosine Receptor A2b and Adenosine		
T80276	WHIZPATH	PW000453:Fc Epsilon Receptor I Signaling in Mast Cells		
T80276	REACPATH	R-HSA-109704:PI3K Cascade		
T80276	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T80276	REACPATH	R-HSA-1236382:Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants		
T80276	REACPATH	R-HSA-1250342:PI3K events in ERBB4 signaling		
T80276	REACPATH	R-HSA-1257604:PIP3 activates AKT signaling		
T80276	REACPATH	R-HSA-180292:GAB1 signalosome		
T80276	REACPATH	R-HSA-1963642:PI3K events in ERBB2 signaling		
T80276	REACPATH	R-HSA-198203:PI3K/AKT activation		
T80276	REACPATH	R-HSA-2029485:Role of phospholipids in phagocytosis		
T80276	REACPATH	R-HSA-210993:Tie2 Signaling		
T80276	REACPATH	R-HSA-2219530:Constitutive Signaling by Aberrant PI3K in Cancer		
T80276	REACPATH	R-HSA-2424491:DAP12 signaling		
T80276	REACPATH	R-HSA-2730905:Role of LAT2/NTAL/LAB on calcium mobilization		
T80276	REACPATH	R-HSA-373753:Nephrin interactions		
T80276	REACPATH	R-HSA-388841:Costimulation by the CD28 family		
T80276	REACPATH	R-HSA-389357:CD28 dependent PI3K/Akt signaling		
T80276	REACPATH	R-HSA-392451:G beta:gamma signalling through PI3Kgamma		
T80276	REACPATH	R-HSA-416476:G alpha (q) signalling events		
T80276	REACPATH	R-HSA-416482:G alpha (12/13) signalling events		
T80276	REACPATH	R-HSA-4420097:VEGFA-VEGFR2 Pathway		
T80276	REACPATH	R-HSA-512988:Interleukin-3, 5 and GM-CSF signaling		
T80276	REACPATH	R-HSA-5637810:Constitutive Signaling by EGFRvIII		
T80276	REACPATH	R-HSA-5654689:PI-3K cascade:FGFR1		
T80276	REACPATH	R-HSA-5654695:PI-3K cascade:FGFR2		
T80276	REACPATH	R-HSA-5654710:PI-3K cascade:FGFR3		
T80276	REACPATH	R-HSA-5654720:PI-3K cascade:FGFR4		
T80276	REACPATH	R-HSA-912526:Interleukin receptor SHC signaling		
T80276	REACPATH	R-HSA-912631:Regulation of signaling by CBL		
T80276	INTEPATH	a6b1_a6b4_integrin_pathway:a6b1 and a6b4 Integrin signaling		
T80276	INTEPATH	angiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling		
T80276	INTEPATH	ar_nongenomic_pathway:Nongenotropic Androgen signaling		
T80276	INTEPATH	avb3_integrin_pathway:Integrins in angiogenesis		
T80276	INTEPATH	avb3_opn_pathway:Osteopontin-mediated events		
T80276	INTEPATH	bcr_5pathway:BCR signaling pathway		
T80276	INTEPATH	cdc42_pathway:CDC42 signaling events		
T80276	INTEPATH	cxcr3pathway:CXCR3-mediated signaling events		
T80276	INTEPATH	cxcr4_pathway:CXCR4-mediated signaling events		
T80276	INTEPATH	ecadherin_keratinocyte_pathway:E-cadherin signaling in keratinocytes		
T80276	INTEPATH	ecadherin_nascentaj_pathway:E-cadherin signaling in the nascent adherens junction		
T80276	INTEPATH	epha2_fwdpathway:EPHA2 forward signaling		
T80276	INTEPATH	ephbfwdpathway:EPHB forward signaling		
T80276	INTEPATH	ephrinbrevpathway:Ephrin B reverse signaling		
T80276	INTEPATH	er_nongenomic_pathway:Plasma membrane estrogen receptor signaling		
T80276	INTEPATH	erbb1_downstream_pathway:ErbB1 downstream signaling		
T80276	INTEPATH	erbb1_internalization_pathway:Internalization of ErbB1		
T80276	INTEPATH	erbb1_receptor_proximal_pathway:EGF receptor (ErbB1) signaling pathway		
T80276	INTEPATH	erbb2erbb3pathway:ErbB2/ErbB3 signaling events		
T80276	INTEPATH	erbb4_pathway:ErbB4 signaling events		
T80276	INTEPATH	fak_pathway:Signaling events mediated by focal adhesion kinase		
T80276	INTEPATH	faspathway:FAS (CD95) signaling pathway		
T80276	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T80276	INTEPATH	fgf_pathway:FGF signaling pathway		
T80276	INTEPATH	gmcsf_pathway:GMCSF-mediated signaling events		
T80276	INTEPATH	hedgehog_2pathway:Signaling events mediated by the Hedgehog family		
T80276	INTEPATH	ifngpathway:IFN-gamma pathway		
T80276	INTEPATH	igf1_pathway:IGF1 pathway		
T80276	INTEPATH	il1pathway:IL1-mediated signaling events		
T80276	INTEPATH	il2_1pathway:IL2-mediated signaling events		
T80276	INTEPATH	il2_pi3kpathway:IL2 signaling events mediated by PI3K		
T80276	INTEPATH	il2_stat5pathway:IL2 signaling events mediated by STAT5		
T80276	INTEPATH	il23pathway:IL23-mediated signaling events		
T80276	INTEPATH	il3_pathway:IL3-mediated signaling events		
T80276	INTEPATH	il4_2pathway:IL4-mediated signaling events		
T80276	INTEPATH	il5_pathway:IL5-mediated signaling events		
T80276	INTEPATH	il6_7pathway:IL6-mediated signaling events		
T80276	INTEPATH	insulin_pathway:Insulin Pathway		
T80276	INTEPATH	kitpathway:Signaling events mediated by Stem cell factor receptor (c-Kit)		
T80276	INTEPATH	lymphangiogenesis_pathway:VEGFR3 signaling in lymphatic endothelium		
T80276	INTEPATH	met_pathway:Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)		
T80276	INTEPATH	ncadherinpathway:N-cadherin signaling events		
T80276	INTEPATH	nectin_pathway:Nectin adhesion pathway		
T80276	INTEPATH	nephrin_neph1_pathway:Nephrin/Neph1 signaling in the kidney podocyte		
T80276	INTEPATH	netrin_pathway:Netrin-mediated signaling events		
T80276	INTEPATH	nfkappabatypicalpathway:Atypical NF-kappaB pathway		
T80276	INTEPATH	p75ntrpathway:p75(NTR)-mediated signaling		
T80276	INTEPATH	pdgfrapathway:PDGFR-alpha signaling pathway		
T80276	INTEPATH	pdgfrbpathway:PDGFR-beta signaling pathway		
T80276	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T80276	INTEPATH	pi3kplctrkpathway:Trk receptor signaling mediated by PI3K and PLC-gamma		
T80276	INTEPATH	ptp1bpathway:Signaling events mediated by PTP1B		
T80276	INTEPATH	reelinpathway:Reelin signaling pathway		
T80276	INTEPATH	ret_pathway:Signaling events regulated by Ret tyrosine kinase		
T80276	INTEPATH	shp2_pathway:SHP2 signaling		
T80276	INTEPATH	tcptp_pathway:Signaling events mediated by TCPTP		
T80276	INTEPATH	thrombin_par1_pathway:PAR1-mediated thrombin signaling events		
T80276	INTEPATH	trail_pathway:TRAIL signaling pathway		
T80276	INTEPATH	trkrpathway:Neurotrophic factor-mediated Trk receptor signaling		
T80276	INTEPATH	vegfr1_2_pathway:Signaling events mediated by VEGFR1 and VEGFR2		
T80276	INTEPATH	vegfr1_pathway:VEGFR1 specific signals		
T80276	PANTPATH	P00005:Angiogenesis		
T80276	PANTPATH	P00006:Apoptosis signaling pathway		
T80276	PANTPATH	P00009:Axon guidance mediated by netrin		
T80276	PANTPATH	P00010:B cell activation		
T80276	PANTPATH	P00018:EGF receptor signaling pathway		
T80276	PANTPATH	P00019:Endothelin signaling pathway		
T80276	PANTPATH	P00021:FGF signaling pathway		
T80276	PANTPATH	P00030:Hypoxia response via HIF activation		
T80276	PANTPATH	P00031:Inflammation mediated by chemokine and cytokine signaling pathway		
T80276	PANTPATH	P00033:Insulin/IGF pathway-protein kinase B signaling cascade		
T80276	PANTPATH	P00034:Integrin signalling pathway		
T80276	PANTPATH	P00036:Interleukin signaling pathway		
T80276	PANTPATH	P00047:PDGF signaling pathway		
T80276	PANTPATH	P00048:PI3 kinase pathway		
T80276	PANTPATH	P00053:T cell activation		
T80276	PANTPATH	P00056:VEGF signaling pathway		
T80276	PANTPATH	P00059:p53 pathway		
T80276	PANTPATH	P04393:Ras Pathway		
T80276	PANTPATH	P04398:p53 pathway feedback loops 2		
T80276	BIOCPATH	PWY-6352:3-phosphoinositide biosynthesis		
T80276	BIOCPATH	PWY-6371:Superpathway of inositol phosphate compounds		
				
T62431	TARGETID	T62431		
T62431	FORMERID	TTDC00156		
T62431	UNIPROID	KSYK_HUMAN		
T62431	TARGNAME	Tyrosine-protein kinase SYK (SYK)		
T62431	GENENAME	SYK		
T62431	TARGTYPE	Successful target		
T62431	SYNONYMS	p72-Syk; Spleen tyrosine kinase		
T62431	FUNCTION	Regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation and vascular development. Assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and the receptor tyrosine-phosphorylated ITAM domains. The association with the receptor can also be indirect and mediated by adapter proteins containing ITAM or partial hemITAM domains. The phosphorylation of the ITAM domains is generally mediated by SRC subfamily kinases upon engagement of the receptor. More rarely signal transduction via SYK could be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2 and BLNK. Initially identified as essential in B-cell receptor (BCR) signaling, it is necessary for the maturation of B-cells most probably at the pro-B to pre-B transition. Activated upon BCR engagement, it phosphorylates and activates BLNK an adapter linking the activated BCR to downstream signaling adapters and effectors. It also phosphorylates and activates PLCG1 and the PKC signaling pathway. It also phosphorylates BTK and regulates its activity in B-cell antigen receptor (BCR)-coupled signaling. In addition to its function downstream of BCR plays also a role in T-cell receptor signaling. Plays also a crucial role in the innate immune response to fungal, bacterial and viral pathogens. It is for instance activated by the membrane lectin CLEC7A. Upon stimulation by fungal proteins, CLEC7A together with SYK activates immune cells inducing the production of ROS. Also activates the inflammasome and NF-kappa-B-mediated transcription of chemokines and cytokines in presence of pathogens. Regulates neutrophil degranulation and phagocytosis through activation of the MAPK signaling cascade. Required for the stimulation of neutrophil phagocytosis by IL15. Also mediates the activation of dendritic cells by cell necrosis stimuli. Also involved in mast cells activation. Involved in interleukin-3/IL3-mediated signaling pathway in basophils. Also functions downstream of receptors mediating cell adhesion. Relays for instance, integrin-mediated neutrophils and macrophages activation and P-selectin receptor/SELPG-mediated recruitment of leukocytes to inflammatory loci. Plays also a role in non-immune processes. It is for instance involved in vascular development where it may regulate blood and lymphatic vascular separation. It is also required for osteoclast development and function. Functions in the activation of platelets by collagen, mediating PLCG2 phosphorylation and activation. May be coupled to the collagen receptor by the ITAM domain-containing FCER1G. Also activated by the membrane lectin CLEC1B that is required for activation of platelets by PDPN/podoplanin. Involved in platelet adhesion being activated by ITGB3 engaged by fibrinogen. Together with CEACAM20, enhances production of the cytokine CXCL8/IL-8 via the NFKB pathway and may thus have a role in the intestinal immune response. Non-receptor tyrosine kinase which mediates signal transduction downstream of a variety of transmembrane receptors including classical immunoreceptors like the B-cell receptor (BCR).		
T62431	PDBSTRUC	6HM7; 6HM6; 5Y5U; 5Y5T; 5TT7		
T62431	BIOCLASS	Kinase		
T62431	ECNUMBER	EC 2.7.10.2		
T62431	SEQUENCE	MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN		
T62431	DRUGINFO	D0V8HJ	Fostamatinib	Approved
T62431	DRUGINFO	D00OPX	Fostamatinib disodium	Phase 3
T62431	DRUGINFO	D0BI3N	Cerdulatinib	Phase 2
T62431	DRUGINFO	D0BW6F	GS-9876	Phase 2
T62431	DRUGINFO	D0G9AW	GS-9973	Phase 2
T62431	DRUGINFO	D06KTJ	TAK-659	Phase 2
T62431	DRUGINFO	DI1VM3	HM43239	Phase 1/2
T62431	DRUGINFO	D0H2HZ	GSK2646264	Phase 1
T62431	DRUGINFO	DODG42	HMPL-523	Phase 1
T62431	DRUGINFO	D0R9IU	PRT-062607	Phase 1
T62431	DRUGINFO	D0C0SZ	PRT6207	Phase 1
T62431	DRUGINFO	D01IDW	SKI-O-703	Phase 1
T62431	DRUGINFO	D0S6TK	tamatinib	Clinical trial
T62431	DRUGINFO	D0CD6Y	Pyrimidopyridazinone derivative 1	Patented
T62431	DRUGINFO	D0WA1V	Pyrimidopyridazinone derivative 2	Patented
T62431	DRUGINFO	D0JU1R	Pyrrolo-pyrazine derivative 3	Patented
T62431	DRUGINFO	D0Y6ON	Pyrrolo-pyrazine derivative 4	Patented
T62431	DRUGINFO	D08DBE	R-343	Discontinued in Phase 2
T62431	DRUGINFO	D0Y2XQ	PF-3526299	Discontinued in Phase 1
T62431	DRUGINFO	D00EIL	CG-103065	Investigative
T62431	DRUGINFO	D0J3FK	DNX-2000	Investigative
T62431	DRUGINFO	D0A1CM	ELLAGIC ACID	Investigative
T62431	DRUGINFO	D0T4MJ	K00592a	Investigative
T62431	DRUGINFO	D0C7AS	N-Benzyl-4-(2,5-dihydroxy-benzylamino)-benzamide	Investigative
T62431	DRUGINFO	D04TLI	PMID17600705C23	Investigative
T62431	DRUGINFO	D0O6OH	PMID23312943C21	Investigative
T62431	DRUGINFO	D09KEB	PRT-060318	Investigative
T62431	DRUGINFO	D03YUW	SBB007833	Investigative
T62431	DRUGINFO	D04LGK	VRT-750018	Investigative
T62431	KEGGPATH	hsa04064:NF-kappa B signaling pathway		
T62431	KEGGPATH	hsa04151:PI3K-Akt signaling pathway		
T62431	KEGGPATH	hsa04380:Osteoclast differentiation		
T62431	KEGGPATH	hsa04611:Platelet activation		
T62431	KEGGPATH	hsa04650:Natural killer cell mediated cytotoxicity		
T62431	KEGGPATH	hsa04662:B cell receptor signaling pathway		
T62431	KEGGPATH	hsa04664:Fc epsilon RI signaling pathway		
T62431	KEGGPATH	hsa04666:Fc gamma R-mediated phagocytosis		
T62431	KEGGPATH	hsa05152:Tuberculosis		
T62431	KEGGPATH	hsa05169:Epstein-Barr virus infection		
T62431	KEGGPATH	hsa05203:Viral carcinogenesis		
T62431	WIKIPATH	WP127:IL-5 Signaling Pathway		
T62431	WIKIPATH	WP1449:Regulation of toll-like receptor signaling pathway		
T62431	WIKIPATH	WP1826:GPVI-mediated activation cascade		
T62431	WIKIPATH	WP1832:Integrin alphaIIb beta3 signaling		
T62431	WIKIPATH	WP2018:RANKL/RANK Signaling Pathway		
T62431	WIKIPATH	WP23:B Cell Receptor Signaling Pathway		
T62431	WIKIPATH	WP2694:DAP12 interactions		
T62431	WIKIPATH	WP2719:Fcgamma receptor (FCGR) dependent phagocytosis		
T62431	WIKIPATH	WP2732:Interleukin-2 signaling		
T62431	WIKIPATH	WP2746:Signaling by the B Cell Receptor (BCR)		
T62431	WIKIPATH	WP2759:Fc epsilon receptor (FCERI) signaling		
T62431	WIKIPATH	WP286:IL-3 Signaling Pathway		
T62431	WIKIPATH	WP49:IL-2 Signaling Pathway		
T62431	WHIZPATH	PW000453:Fc Epsilon Receptor I Signaling in Mast Cells		
T62431	REACPATH	R-HSA-114604:GPVI-mediated activation cascade		
T62431	REACPATH	R-HSA-2029481:FCGR activation		
T62431	REACPATH	R-HSA-2029482:Regulation of actin dynamics for phagocytic cup formation		
T62431	REACPATH	R-HSA-2029485:Role of phospholipids in phagocytosis		
T62431	REACPATH	R-HSA-2424491:DAP12 signaling		
T62431	REACPATH	R-HSA-2454202:Fc epsilon receptor (FCERI) signaling		
T62431	REACPATH	R-HSA-2730905:Role of LAT2/NTAL/LAB on calcium mobilization		
T62431	REACPATH	R-HSA-2871796:FCERI mediated MAPK activation		
T62431	REACPATH	R-HSA-2871809:FCERI mediated Ca+2 mobilization		
T62431	REACPATH	R-HSA-354192:Integrin alphaIIb beta3 signaling		
T62431	REACPATH	R-HSA-451927:Interleukin-2 signaling		
T62431	REACPATH	R-HSA-5607764:CLEC7A (Dectin-1) signaling		
T62431	REACPATH	R-HSA-5621480:Dectin-2 family		
T62431	REACPATH	R-HSA-912631:Regulation of signaling by CBL		
T62431	REACPATH	R-HSA-983695:Antigen activates B Cell Receptor (BCR) leading to generation of second messengers		
T62431	INTEPATH	alphasynuclein_pathway:Alpha-synuclein signaling		
T62431	INTEPATH	avb3_opn_pathway:Osteopontin-mediated events		
T62431	INTEPATH	bcr_5pathway:BCR signaling pathway		
T62431	INTEPATH	faspathway:FAS (CD95) signaling pathway		
T62431	INTEPATH	fcer1pathway:Fc-epsilon receptor I signaling in mast cells		
T62431	INTEPATH	gmcsf_pathway:GMCSF-mediated signaling events		
T62431	INTEPATH	il2_1pathway:IL2-mediated signaling events		
T62431	INTEPATH	nfkappabatypicalpathway:Atypical NF-kappaB pathway		
T62431	INTEPATH	pi3kcipathway:Class I PI3K signaling events		
T62431	INTEPATH	txa2pathway:Thromboxane A2 receptor signaling		
T62431	PANTPATH	P00010:B cell activation		
				
T97613	TARGETID	T97613		
T97613	FORMERID	TTDI01766		
T97613	UNIPROID	MTR1A_HUMAN		
T97613	TARGNAME	Melatonin receptor type 1A (MTNR1A)		
T97613	GENENAME	MTNR1A		
T97613	TARGTYPE	Successful target		
T97613	SYNONYMS	Mel1a receptor; Mel1AR; Mel-1A-R		
T97613	FUNCTION	Likely to mediate the reproductive and circadian actions of melatonin. The activity of this receptor is mediated by pertussis toxin sensitive G proteins that inhibit adenylate cyclase activity. High affinity receptor for melatonin.		
T97613	PDBSTRUC	6ME5; 6ME4; 6ME3; 6ME2		
T97613	BIOCLASS	GPCR rhodopsin		
T97613	SEQUENCE	MQGNGSALPNASQPVLRGDGARPSWLASALACVLIFTIVVDILGNLLVILSVYRNKKLRNAGNIFVVSLAVADLVVAIYPYPLVLMSIFNNGWNLGYLHCQVSGFLMGLSVIGSIFNITGIAINRYCYICHSLKYDKLYSSKNSLCYVLLIWLLTLAAVLPNLRAGTLQYDPRIYSCTFAQSVSSAYTIAVVVFHFLVPMIIVIFCYLRIWILVLQVRQRVKPDRKPKLKPQDFRNFVTMFVVFVLFAICWAPLNFIGLAVASDPASMVPRIPEWLFVASYYMAYFNSCLNAIIYGLLNQNFRKEYRRIIVSLCTARVFFVDSSNDVADRVKWKPSPLMTNNNVVKVDSV		
T97613	DRUGINFO	D0AN7B	Melatonin	Approved
T97613	DRUGINFO	D0U0KW	Ramelteon	Approved
T97613	DRUGINFO	D0Q5MQ	Tasimelteon	Approved
T97613	DRUGINFO	D0D8FN	LY-156735	Phase 2
T97613	DRUGINFO	D00CVJ	Neu-P11	Phase 2
T97613	DRUGINFO	D0Y8UB	Agomelatine	Withdrawn from market
T97613	DRUGINFO	D0B2CQ	GR-131663	Terminated
T97613	DRUGINFO	D0B1VQ	GR-133347	Terminated
T97613	DRUGINFO	D01ESJ	Luzindole	Terminated
T97613	DRUGINFO	D05GOM	S-20928	Terminated
T97613	DRUGINFO	D0T4